data_2kku_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kku _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 5' ' ' VAL . 24.1 mm 62.12 -168.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -173.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.3 m -145.88 -42.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 154.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.09 -161.24 20.23 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.31 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.77 156.15 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.825 0.85 . . . . 0.0 108.711 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -125.48 135.85 52.75 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.484 0.713 . . . . 0.0 109.657 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -132.4 139.29 34.35 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 123.787 0.835 . . . . 0.0 110.305 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.498 ' HD3' HG11 ' A' ' 130' ' ' VAL . 69.2 Cg_endo -71.75 -26.74 18.94 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.192 2.594 . . . . 0.0 111.901 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt 66.94 117.26 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 125.321 1.449 . . . . 0.0 109.802 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -62.11 -16.65 51.74 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.267 2.645 . . . . 0.0 114.213 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -130.69 -176.38 3.96 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.733 0.813 . . . . 0.0 110.77 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -74.92 6.76 3.73 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.817 0.847 . . . . 0.0 112.87 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -77.97 14.97 0.97 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -62.22 -33.08 73.88 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.863 0.363 . . . . 0.0 110.293 165.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -68.73 -25.8 64.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.505 1.122 . . . . 0.0 111.762 -173.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 6.1 mmp_? -53.49 -49.32 67.76 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.331 1.019 . . . . 0.0 111.574 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 58.9 m-85 -64.54 -31.17 72.26 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.741 -176.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -85.75 -26.61 25.74 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.385 0.674 . . . . 0.0 110.593 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -68.38 -52.63 30.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.607 1.163 . . . . 0.0 109.953 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.5 ptpt -99.79 -16.88 17.93 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.348 -172.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.95 -8.55 50.21 Favored Glycine 0 N--CA 1.475 1.284 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -158.57 107.17 1.94 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.882 0.873 . . . . 0.0 109.546 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.509 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 17.1 t70 -126.2 -179.58 4.79 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.333 1.053 . . . . 0.0 109.259 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.5 t -130.67 113.93 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.244 1.018 . . . . 0.0 109.271 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -94.04 115.03 27.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.159 0.584 . . . . 0.0 109.662 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.36 147.14 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.343 0.592 . . . . 0.0 111.452 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 5.0 mmpt? -134.76 128.83 19.05 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.369 1.468 . . . . 0.0 110.113 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 97.9 Cg_endo -78.44 54.15 4.87 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.827 2.351 . . . . 0.0 112.345 170.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 57.38 97.9 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.558 1.143 . . . . 0.0 111.525 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.479 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 44.8 m -136.8 -54.2 0.72 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.426 0.69 . . . . 0.0 109.817 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 m -79.27 148.59 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.881 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -93.31 -162.28 0.92 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.536 1.134 . . . . 0.0 110.651 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -73.43 3.38 6.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -67.45 -31.41 71.57 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.445 ' HA ' ' HE2' ' A' ' 41' ' ' MET . 0.2 OUTLIER -68.59 90.99 0.41 Allowed 'General case' 0 C--N 1.352 0.714 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.103 178.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.43 153.81 47.64 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.264 0.625 . . . . 0.0 109.459 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.25 102.79 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.228 1.952 . . . . 0.0 111.11 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.13 29.79 0.38 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.66 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.445 ' HE2' ' HA ' ' A' ' 37' ' ' LEU . 26.2 mtm -111.39 -166.53 1.08 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.643 0.777 . . . . 0.0 110.453 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.9 ptpt -117.14 161.09 20.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.893 0.877 . . . . 0.0 110.539 169.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.544 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 t80 -135.73 101.07 4.65 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 45.1 t -84.29 120.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.294 0.569 . . . . 0.0 109.875 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -84.54 108.69 17.44 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 68.0 t80 . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.257 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.454 ' HE2' ' HA ' ' A' ' 126' ' ' PRO . 61.9 m-85 . . . . . 0 CA--C 1.554 1.126 0 CA-C-O 121.132 0.491 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -77.98 -25.6 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 123.509 0.724 . . . . 0.0 111.268 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.28 -165.93 33.31 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 120.173 -0.237 . . . . 0.0 112.758 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 7.3 pt-20 -145.42 178.03 8.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.631 0.772 . . . . 0.0 109.491 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.5 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -157.46 -171.1 3.45 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.497 1.119 . . . . 0.0 108.81 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 24.2 mmt85 -125.79 117.84 24.25 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.438 0.695 . . . . 0.0 110.168 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.544 HG13 ' HB2' ' A' ' 43' ' ' PHE . 49.1 mt -69.27 131.45 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.316 1.046 . . . . 0.0 110.472 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -141.5 -166.61 2.23 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 125.513 1.525 . . . . 0.0 108.967 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -42.68 114.53 0.6 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.744 1.217 . . . . 0.0 113.352 -162.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.5 m -89.3 123.68 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.286 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 90.4 t -90.17 108.2 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HB3' HD12 ' A' ' 108' ' ' LEU . 77.8 mt -95.58 113.87 25.57 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.1 t -153.46 144.18 22.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.576 0.75 . . . . 0.0 109.716 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -74.26 -27.75 60.9 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.54 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 42.7 m-20 -94.88 123.56 57.25 Favored Pre-proline 0 N--CA 1.476 0.859 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.529 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 28.6 Cg_endo -63.84 -25.01 67.87 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.18 1.92 . . . . 0.0 112.447 173.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.529 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 3.5 mpp? -74.53 -18.15 60.64 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.799 0.44 . . . . 0.0 110.887 -174.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 25.9 mm-40 -58.2 -40.76 82.4 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.656 0.782 . . . . 0.0 110.21 170.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -73.7 -29.15 62.11 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.677 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CE2' HD23 ' A' ' 87' ' ' LEU . 66.0 m-85 -86.94 -15.63 38.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.17 -31.87 14.61 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 117.941 0.337 . . . . 0.0 110.174 173.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -76.62 -58.08 3.49 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.096 0.558 . . . . 0.0 109.758 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.739 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 63.3 m-85 -98.42 -67.32 0.85 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.732 0.813 . . . . 0.0 110.091 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.98 -81.38 0.09 OUTLIER Glycine 0 C--N 1.358 1.792 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.482 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.09 -36.9 78.44 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.661 1.184 . . . . 0.0 111.921 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.739 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 26.2 mmt180 -76.19 -20.09 57.82 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.979 0.512 . . . . 0.0 111.322 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 76' ' ' PHE . 30.8 t -79.18 142.4 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -57.12 -41.34 78.82 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -106.43 163.18 13.06 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.489 HG21 ' HG2' ' A' ' 86' ' ' GLU . 9.0 t -98.76 175.71 5.87 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 173.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.31 -28.31 69.22 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.213 0.605 . . . . 0.0 110.89 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.75 -43.48 98.68 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.969 0.908 . . . . 0.0 110.243 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.489 ' HG2' HG21 ' A' ' 83' ' ' THR . 69.7 mm-40 -66.95 -33.9 76.58 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.957 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.438 HD23 ' CE2' ' A' ' 73' ' ' PHE . 32.6 tp -64.53 -52.56 57.13 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.382 0.673 . . . . 0.0 111.029 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -38.3 89.22 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.506 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.05 -33.42 70.25 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.012 0.195 . . . . 0.0 110.671 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -66.81 -48.05 70.14 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.136 0.975 . . . . 0.0 110.918 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.5 mtm -66.44 -41.0 89.78 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.684 0.615 . . . . 0.0 110.172 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -62.2 -40.76 97.17 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.545 0.528 . . . . 0.0 110.705 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.473 0.692 0 C-N-CA 123.205 0.602 . . . . 0.0 111.09 -177.726 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.466 ' H ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -109.9 168.53 9.35 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.181 0.592 . . . . 0.0 109.641 -175.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' ' 65' ' ' LEU . 1.3 tm? -78.2 107.27 10.66 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -89.33 158.4 17.82 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.7 0.8 . . . . 0.0 109.282 172.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.483 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 15.4 ptm -136.27 131.59 34.64 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.051 0.54 . . . . 0.0 110.754 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.504 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . . . -113.0 102.91 10.86 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.763 0.825 . . . . 0.0 109.767 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.1 mt -83.11 128.13 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.448 0.699 . . . . 0.0 109.414 -175.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.91 111.86 18.5 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 58' ' ' ALA . 3.9 mm? -99.17 112.52 24.65 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.47 0.708 . . . . 0.0 110.395 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -120.72 167.15 12.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.446 0.698 . . . . 0.0 109.65 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.5 t70 53.86 54.88 9.15 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.294 1.038 . . . . 0.0 110.35 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.11 107.62 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.415 -175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -83.35 163.91 20.33 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.242 1.017 . . . . 0.0 109.815 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -126.48 132.51 51.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.666 0.786 . . . . 0.0 109.965 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -94.4 97.16 9.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -77.3 -18.26 57.65 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.829 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -83.67 139.19 40.73 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.872 0.869 . . . . 0.0 109.378 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.41 100.02 1.33 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.714 2.276 . . . . 0.0 111.115 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.2 mt -81.19 125.75 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -78.78 116.46 59.91 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.454 ' HA ' ' HE2' ' A' ' 54' ' ' PHE . 9.8 Cg_endo -55.42 129.06 33.13 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.747 2.298 . . . . 0.0 113.182 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -70.3 -20.51 63.02 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.183 0.993 . . . . 0.0 110.416 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -159.27 165.72 32.86 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.92 1.288 . . . . 0.0 108.813 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -71.06 136.19 48.15 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.661 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.498 HG11 ' HD3' ' A' ' 10' ' ' PRO . 41.1 t -111.25 97.72 36.6 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.24 -177.99 2.66 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.546 2.831 . . . . 0.0 112.207 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.67 -33.47 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.521 0.728 . . . . 0.0 110.701 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.34 -25.31 72.45 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.946 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.54 163.16 30.79 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.009 0.338 . . . . 0.0 113.229 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -119.67 146.29 45.71 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.055 0.942 . . . . 0.0 110.66 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -84.16 110.25 18.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.305 0.642 . . . . 0.0 110.236 173.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 119.14 20.63 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 172.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.66 137.9 50.9 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.134 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.676 ' HZ1' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.7 mm 65.78 -176.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 C-N-CA 124.469 1.107 . . . . 0.0 109.283 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -145.92 -42.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.582 1.153 . . . . 0.0 108.045 158.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.551 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.23 -161.49 20.85 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.88 0.738 . . . . 0.0 113.595 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.422 HG13 HD12 ' A' ' 60' ' ' ILE . 9.7 p -121.38 162.0 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -137.42 138.77 40.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.116 0.567 . . . . 0.0 110.129 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -135.46 150.08 71.3 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.936 0.894 . . . . 0.0 110.446 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD3' HG12 ' A' ' 130' ' ' VAL . 91.2 Cg_endo -80.57 -10.83 13.12 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.787 2.325 . . . . 0.0 112.359 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.3 mm 59.79 97.96 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 125.675 1.59 . . . . 0.0 110.879 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -82.63 33.33 0.53 Allowed 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.232 2.621 . . . . 0.0 113.137 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -137.44 162.07 34.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.278 1.031 . . . . 0.0 110.507 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.458 ' H ' ' HD2' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -78.2 -15.72 58.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.76 0.824 . . . . 0.0 110.428 -174.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 82' ' ' LEU . 41.7 m-85 -90.51 31.74 1.01 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.22 1.008 . . . . 0.0 112.354 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -58.74 -22.98 59.06 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.853 0.861 . . . . 0.0 112.017 166.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.421 ' N ' ' SD ' ' A' ' 16' ' ' MET . 26.1 t70 -77.52 -27.45 51.71 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.409 1.084 . . . . 0.0 112.514 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -50.2 -48.69 54.17 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.471 1.108 . . . . 0.0 113.702 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -63.82 -29.41 70.61 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.765 0.666 . . . . 0.0 110.605 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -96.82 -12.58 23.41 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.623 0.769 . . . . 0.0 111.621 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -76.05 -50.17 15.5 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.834 0.853 . . . . 0.0 109.007 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -109.2 -16.13 14.14 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.502 -172.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.82 9.04 74.48 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 114.216 0.446 . . . . 0.0 114.216 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -163.25 92.36 0.74 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.33 1.052 . . . . 0.0 109.811 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -133.35 -176.87 4.29 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -136.43 121.19 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 120.188 1.358 . . . . 0.0 109.813 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -94.61 116.52 28.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.709 0.804 . . . . 0.0 109.922 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 m -98.2 143.29 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.346 0.593 . . . . 0.0 111.374 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.766 ' HG2' HG21 ' A' ' 33' ' ' VAL . 16.5 tppt? -136.64 140.52 32.39 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.5 1.12 . . . . 0.0 109.88 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.631 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 59.0 Cg_endo -72.7 59.52 3.41 Favored 'Trans proline' 0 CA--C 1.56 1.817 0 C-N-CA 122.996 2.464 . . . . 0.0 113.748 166.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.41 33.95 6.08 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.256 1.423 . . . . 0.0 113.856 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 3.3 m -87.48 -17.64 31.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.408 0.683 . . . . 0.0 111.05 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.766 HG21 ' HG2' ' A' ' 29' ' ' LYS . 3.3 t -87.71 150.3 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.252 0.621 . . . . 0.0 109.493 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -70.02 174.96 4.8 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.53 0.681 . . . . 0.0 112.257 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -76.96 -1.36 28.25 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.636 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.67 -23.55 66.81 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.65 0.78 . . . . 0.0 111.034 173.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.512 HD22 HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -65.52 103.32 0.82 Allowed 'General case' 0 C--N 1.353 0.743 0 C-N-CA 123.0 0.52 . . . . 0.0 110.084 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -129.95 150.82 77.0 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.198 0.599 . . . . 0.0 109.65 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.81 107.84 1.96 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.836 2.358 . . . . 0.0 111.042 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.82 -14.57 1.76 Allowed Glycine 0 N--CA 1.467 0.749 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.92 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.551 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 27.9 mtm -78.65 -173.21 3.31 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.367 0.603 . . . . 0.0 111.881 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -112.21 162.74 15.15 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.976 0.91 . . . . 0.0 110.32 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.435 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -135.57 102.71 5.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.162 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.99 126.28 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.352 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -97.69 111.69 23.88 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.7 t80 . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 124.359 1.064 . . . . 0.0 108.934 175.829 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.902 0.382 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.45 -38.54 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 168.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.75 -157.16 28.03 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.526 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.22 179.26 9.13 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.081 0.952 . . . . 0.0 110.031 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' A' ' 114' ' ' LEU . . . -155.17 -172.24 4.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.652 0.781 . . . . 0.0 110.844 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -122.78 119.82 31.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.864 0.866 . . . . 0.0 110.043 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 43' ' ' PHE . 45.9 mt -68.61 135.79 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.664 1.186 . . . . 0.0 111.3 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.7 mmmt -134.51 -178.36 5.02 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 126.344 1.858 . . . . 0.0 108.588 -174.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -40.77 116.45 0.71 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.2 1.4 . . . . 0.0 114.046 -165.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.487 HG13 ' HA ' ' A' ' 112' ' ' ILE . 34.3 m -89.11 116.99 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.857 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.98 115.68 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.736 0.814 . . . . 0.0 109.554 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.9 mt -88.79 119.49 29.33 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.959 0.504 . . . . 0.0 109.688 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -148.28 131.3 16.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.034 0.933 . . . . 0.0 108.796 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -63.0 -31.24 72.33 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.967 0.907 . . . . 0.0 111.576 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.58 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 25.8 m-80 -91.35 119.11 68.76 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.75 -12.94 35.9 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.595 2.197 . . . . 0.0 112.238 172.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.6 mtm -81.5 -24.27 36.8 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.284 1.033 . . . . 0.0 110.704 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.58 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 79.0 mt-30 -70.32 -25.39 63.28 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -69.2 -28.34 66.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.421 0.288 . . . . 0.0 110.747 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -81.65 -20.41 39.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.883 0.473 . . . . 0.0 112.256 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.6 pt-20 -90.84 -25.54 19.83 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 117.979 0.354 . . . . 0.0 111.194 172.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.6 m -85.91 -50.8 6.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.443 0.697 . . . . 0.0 110.957 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.764 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 82.1 m-85 -107.17 -57.68 2.04 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.993 0.917 . . . . 0.0 109.927 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.44 -90.63 0.24 Allowed Glycine 0 C--N 1.355 1.626 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.827 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.37 -35.21 76.84 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.846 0.858 . . . . 0.0 110.621 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.764 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 44.7 mmt-85 -71.37 -28.2 63.88 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-O 119.162 -0.447 . . . . 0.0 110.914 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.529 HG21 ' HB2' ' A' ' 76' ' ' PHE . 57.2 t -71.04 132.3 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -56.78 -50.69 71.54 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.113 0.883 . . . . 0.0 112.213 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 1.8 pt? -94.6 157.47 15.96 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.436 HG23 ' HG2' ' A' ' 86' ' ' GLU . 14.4 t -88.53 168.31 12.69 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.87 -29.07 70.29 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.197 0.199 . . . . 0.0 110.72 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -61.03 -43.07 99.44 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.535 0.734 . . . . 0.0 111.314 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.436 ' HG2' HG23 ' A' ' 83' ' ' THR . 51.0 mm-40 -64.39 -40.09 95.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.284 0.634 . . . . 0.0 111.345 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.447 ' HG ' ' HE2' ' A' ' 91' ' ' MET . 24.4 tp -62.98 -52.27 63.66 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.92 0.763 . . . . 0.0 110.841 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -68.05 -43.23 79.13 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.536 -173.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.23 -33.3 74.33 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.095 0.407 . . . . 0.0 110.106 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -65.26 -45.96 82.42 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.87 0.868 . . . . 0.0 110.638 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.447 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 68.9 mtm -74.16 -27.92 61.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.376 0.671 . . . . 0.0 111.296 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.8 mmmt -75.88 -37.37 58.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.126 177.441 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 121.307 0.575 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -76.52 150.48 36.59 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.445 174.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.96 131.65 41.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -114.99 159.6 20.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.594 0.758 . . . . 0.0 109.681 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.8 ptm -138.01 130.65 29.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.173 0.989 . . . . 0.0 109.203 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.13 101.65 10.86 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.487 ' HA ' HG13 ' A' ' 63' ' ' VAL . 36.8 mt -82.04 118.36 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 44.4 tt0 -81.46 139.89 34.94 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.488 HD13 ' HB1' ' A' ' 58' ' ' ALA . 3.8 mm? -123.57 132.31 53.85 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.967 1.307 . . . . 0.0 109.126 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -140.24 165.5 27.22 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.642 0.777 . . . . 0.0 109.388 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.8 t70 59.0 39.59 23.33 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.275 1.03 . . . . 0.0 110.331 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.8 t -68.26 101.18 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.125 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -74.16 131.51 41.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.604 1.161 . . . . 0.0 109.862 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -92.56 125.97 37.43 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.239 0.543 . . . . 0.0 109.555 172.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.1 98.69 11.92 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.926 0.89 . . . . 0.0 109.338 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.85 -30.75 68.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.652 172.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -84.92 132.8 44.79 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.378 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.58 102.11 1.52 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.118 2.546 . . . . 0.0 111.606 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.8 mt -111.04 129.37 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.284 0.564 . . . . 0.0 110.463 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.79 141.52 64.25 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.938 0.895 . . . . 0.0 109.59 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.92 157.15 58.9 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.186 1.924 . . . . 0.0 112.13 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -63.21 -27.81 69.62 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.881 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -154.35 163.86 39.5 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.984 1.314 . . . . 0.0 107.755 166.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -61.21 136.03 57.93 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.482 HG12 ' HD3' ' A' ' 10' ' ' PRO . 28.7 t -106.01 103.62 45.53 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 -178.37 2.56 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.151 2.568 . . . . 0.0 112.278 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.97 -36.05 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.908 0.883 . . . . 0.0 111.622 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.62 -16.43 77.74 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-N 116.117 -0.492 . . . . 0.0 113.166 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.5 162.97 25.51 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 123.052 0.358 . . . . 0.0 112.962 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -114.79 152.51 31.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.547 0.739 . . . . 0.0 110.188 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.72 117.21 29.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 170.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.1 114.38 21.72 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.31 141.73 51.23 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HB2' HG11 ' A' ' 5' ' ' VAL . 10.0 tp10 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.3 mm 66.05 -174.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.684 0 C-N-CA 124.163 0.985 . . . . 0.0 108.791 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.64 -42.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.858 1.263 . . . . 0.0 107.776 160.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -167.44 -162.54 19.46 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.355 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.406 HG13 HD13 ' A' ' 60' ' ' ILE . 8.6 p -119.44 151.1 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 172.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -122.87 132.35 54.15 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.731 0.813 . . . . 0.0 108.845 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -131.42 144.14 52.16 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.066 0.946 . . . . 0.0 109.673 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.517 ' HD3' HG13 ' A' ' 130' ' ' VAL . 97.3 Cg_endo -74.48 -17.01 21.31 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.576 2.184 . . . . 0.0 112.028 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.493 HG21 ' HA ' ' A' ' 16' ' ' MET . 14.2 mm 49.15 80.88 0.28 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.154 1.382 . . . . 0.0 109.678 -167.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HG3' HG21 ' A' ' 132' ' ' VAL . 96.5 Cg_endo -78.57 15.47 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.001 2.467 . . . . 0.0 112.94 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -104.8 152.74 22.21 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.46 1.104 . . . . 0.0 109.823 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -66.08 -8.38 23.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.652 1.181 . . . . 0.0 112.797 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -97.0 28.05 3.73 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.657 1.183 . . . . 0.0 112.323 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.493 ' HA ' HG21 ' A' ' 11' ' ' ILE . 27.0 ptt? -63.94 -30.16 71.26 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.287 0.565 . . . . 0.0 110.712 174.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -72.05 -21.85 61.47 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.523 1.129 . . . . 0.0 112.595 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 84.4 mmt-85 -58.36 -38.25 76.86 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.959 0.903 . . . . 0.0 112.615 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.402 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 64.5 m-85 -67.18 -30.35 70.28 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 121.087 0.47 . . . . 0.0 110.473 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -96.77 -8.58 30.86 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.158 0.983 . . . . 0.0 110.78 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -84.88 -54.64 4.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.813 1.245 . . . . 0.0 110.03 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.9 ptpt -98.3 -13.8 20.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.814 -171.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.46 -23.81 9.43 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 113.857 0.303 . . . . 0.0 113.857 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -148.72 116.86 6.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.026 0.93 . . . . 0.0 109.487 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.402 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 14.4 t70 -123.44 175.43 6.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.275 0.63 . . . . 0.0 110.001 -170.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.88 109.53 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.42 ' HD2' HD13 ' A' ' 112' ' ' ILE . 85.7 t80 -87.82 108.82 19.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.45 0.7 . . . . 0.0 109.561 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 m -92.59 138.44 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.181 0.515 . . . . 0.0 110.977 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -129.45 147.31 64.63 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.674 1.19 . . . . 0.0 110.068 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -77.15 53.17 4.12 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.985 2.457 . . . . 0.0 111.754 165.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.495 ' HB1' ' HE2' ' A' ' 107' ' ' LYS . . . 38.23 64.93 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.564 1.546 . . . . 0.0 112.928 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -94.02 -27.13 16.48 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.198 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.56 152.76 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.319 1.048 . . . . 0.0 111.141 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -65.87 169.38 6.68 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.505 0.722 . . . . 0.0 109.878 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -68.83 -2.16 8.89 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.66 -30.68 65.62 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.684 0.794 . . . . 0.0 111.502 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.401 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -62.24 116.3 4.89 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.557 0.743 . . . . 0.0 110.588 -179.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.83 152.99 53.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.968 0.907 . . . . 0.0 109.697 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.95 105.99 1.25 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.886 2.391 . . . . 0.0 111.305 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.92 -8.62 1.75 Allowed Glycine 0 N--CA 1.471 0.995 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.237 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.545 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 83.2 mtp -84.51 179.46 7.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.29 1.036 . . . . 0.0 111.305 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -110.23 164.47 12.62 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.91 0.884 . . . . 0.0 110.162 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.443 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 t80 -135.44 94.87 3.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -83.09 120.48 34.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.226 0.536 . . . . 0.0 110.143 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -83.72 97.64 9.23 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.57 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.6 t80 . . . . . 0 CA--C 1.55 0.951 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 163.384 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.61 -28.93 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 122.995 0.518 . . . . 0.0 110.408 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.61 -164.05 34.12 Favored Glycine 0 C--N 1.344 1.019 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.838 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -151.14 178.9 8.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.812 0.845 . . . . 0.0 109.21 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.402 ' HB1' HD13 ' A' ' 114' ' ' LEU . . . -161.5 -172.27 3.29 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.18 0.992 . . . . 0.0 109.685 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -128.7 120.87 27.3 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.807 0.843 . . . . 0.0 110.087 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.443 HG13 ' HB2' ' A' ' 43' ' ' PHE . 54.1 mt -70.66 134.32 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.483 1.113 . . . . 0.0 111.273 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.2 mmmt -131.76 178.42 6.77 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 126.091 1.756 . . . . 0.0 109.82 -175.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -29.13 110.45 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.774 2.03 . . . . 0.0 114.507 -175.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 112' ' ' ILE . 33.4 m -93.11 118.38 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.801 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.0 119.26 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.733 0.813 . . . . 0.0 109.077 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.504 ' HB3' HD13 ' A' ' 108' ' ' LEU . 70.9 mt -101.99 120.77 40.95 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.78 0.832 . . . . 0.0 109.47 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.6 t -152.67 135.12 15.16 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.057 0.943 . . . . 0.0 110.113 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 14.8 mt-10 -63.84 -23.56 67.4 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.149 0.98 . . . . 0.0 112.19 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -102.84 120.16 53.41 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HB3' ' CE3' ' A' ' 109' ' ' TRP . 36.7 Cg_endo -64.74 -19.75 64.66 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.689 2.259 . . . . 0.0 112.189 174.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 44.2 mtm -73.27 -23.86 60.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.847 0.859 . . . . 0.0 110.477 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 23.7 mt-30 -71.05 -23.52 62.16 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.529 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.31 -24.04 54.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.736 0.414 . . . . 0.0 111.017 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.446 ' HE2' HD23 ' A' ' 87' ' ' LEU . 55.4 m-85 -88.35 -27.5 21.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.088 0.555 . . . . 0.0 111.623 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.9 pt-20 -82.46 -27.46 31.85 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 120.388 0.137 . . . . 0.0 110.656 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.5 m -84.89 -50.65 7.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.686 0.394 . . . . 0.0 110.61 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.74 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 89.2 m-85 -107.41 -69.37 0.85 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.153 0.581 . . . . 0.0 110.628 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.2 -80.99 0.07 OUTLIER Glycine 0 C--N 1.358 1.75 0 O-C-N 123.546 0.528 . . . . 0.0 113.515 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.14 -31.86 67.61 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.811 1.244 . . . . 0.0 111.778 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.74 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 30.3 mmt180 -74.02 -36.12 64.41 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.35 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.32 148.84 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.973 0.509 . . . . 0.0 110.677 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.471 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 45.7 p90 -62.56 -34.14 76.36 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -117.16 170.63 8.52 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 86' ' ' GLU . 9.4 t -106.21 175.81 5.37 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -60.93 -31.78 71.3 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.134 0.974 . . . . 0.0 111.577 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.77 -43.01 90.13 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.292 0.637 . . . . 0.0 110.73 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.494 ' HG2' HG23 ' A' ' 83' ' ' THR . 60.1 mm-40 -65.99 -33.86 76.79 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.143 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' HE2' ' A' ' 73' ' ' PHE . 26.7 tp -63.87 -54.54 33.23 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.415 0.686 . . . . 0.0 111.002 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -67.11 -36.88 82.88 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.751 -171.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 90' ' ' TYR . 6.7 pt-20 -66.25 -40.21 90.03 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 173.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.412 ' N ' ' HG3' ' A' ' 89' ' ' GLU . 79.7 t80 -61.87 -40.21 94.61 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.223 1.009 . . . . 0.0 111.055 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.438 ' HE3' ' HG ' ' A' ' 87' ' ' LEU . 71.6 mtm -73.15 -35.07 66.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.068 0.547 . . . . 0.0 110.965 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.0 mmmt -69.85 -25.89 63.95 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.6 0.36 . . . . 0.0 110.608 173.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 123.224 0.609 . . . . 0.0 111.463 177.294 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HD2' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.495 ' HE2' ' HB1' ' A' ' 31' ' ' ALA . 3.9 tmtp? -102.73 138.8 39.15 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' A' ' 65' ' ' LEU . 3.0 tm? -77.2 104.65 7.83 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.412 ' CE3' ' HB3' ' A' ' 69' ' ' PRO . 24.8 m95 -82.93 161.08 21.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.205 0.602 . . . . 0.0 109.524 174.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.6 ptm -136.72 141.96 43.07 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.129 0.971 . . . . 0.0 109.754 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.17 103.97 9.7 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.125 0.97 . . . . 0.0 109.006 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.484 ' HA ' HG11 ' A' ' 63' ' ' VAL . 30.9 mt -81.45 122.45 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -82.96 136.65 34.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.402 HD13 ' HB1' ' A' ' 58' ' ' ALA . 3.9 mm? -123.3 132.73 54.11 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.223 0.609 . . . . 0.0 110.356 -175.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -131.87 172.57 12.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.888 0.875 . . . . 0.0 110.294 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.1 t70 49.05 50.01 18.59 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.809 1.243 . . . . 0.0 111.874 170.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.34 101.61 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.153 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -77.87 148.41 34.65 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.512 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -111.28 111.86 23.21 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.164 0.585 . . . . 0.0 110.32 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -83.9 87.06 7.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.961 0.904 . . . . 0.0 109.244 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.45 -15.08 56.16 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.701 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -80.47 137.61 51.78 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.296 1.039 . . . . 0.0 110.294 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.21 79.6 3.33 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 123.079 2.519 . . . . 0.0 113.178 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.8 mt -98.49 137.4 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.153 0.581 . . . . 0.0 110.598 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -71.22 151.32 94.52 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.258 1.023 . . . . 0.0 111.032 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.42 153.84 65.6 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.195 1.93 . . . . 0.0 111.384 167.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -36.55 74.95 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -152.19 169.51 22.28 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.202 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.98 132.48 48.0 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.32 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.517 HG13 ' HD3' ' A' ' 10' ' ' PRO . 17.6 t -118.89 99.6 51.07 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.093 0.557 . . . . 0.0 109.704 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.19 -174.87 2.12 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.478 2.785 . . . . 0.0 112.591 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.573 HG21 ' HG3' ' A' ' 12' ' ' PRO . 5.5 p -54.91 -40.3 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.661 1.184 . . . . 0.0 112.62 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.63 -12.91 82.41 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 113.581 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.95 159.49 15.09 Favored Glycine 0 C--N 1.348 1.208 0 C-N-CA 122.9 0.286 . . . . 0.0 112.838 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -113.58 150.02 33.65 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.534 0.734 . . . . 0.0 109.082 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -84.05 115.55 22.42 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.42 125.76 29.65 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.99 122.27 22.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 C--O 1.243 0.763 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.05 -172.6 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 5' ' ' VAL . 16.9 mm 64.45 -171.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.879 0 C-N-CA 124.005 0.922 . . . . 0.0 108.912 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.3 m -156.22 -32.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 125.497 1.519 . . . . 0.0 109.131 156.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -166.97 -164.05 21.91 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.324 0.39 . . . . 0.0 112.839 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.431 HG12 HD11 ' A' ' 60' ' ' ILE . 10.4 p -139.0 144.81 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.508 0.723 . . . . 0.0 109.158 173.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 t -116.97 132.59 56.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.946 0.898 . . . . 0.0 110.0 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -133.18 140.64 37.99 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.561 1.144 . . . . 0.0 108.8 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.8 -41.32 24.58 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.085 2.524 . . . . 0.0 111.828 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.4 mt 54.11 77.38 0.44 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 124.67 1.188 . . . . 0.0 110.001 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.63 0.24 6.6 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.103 2.535 . . . . 0.0 113.501 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -69.21 144.86 53.61 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 121.501 0.667 . . . . 0.0 110.499 172.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -59.22 -10.77 3.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.18 1.392 . . . . 0.0 112.852 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -99.43 22.1 11.18 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.445 1.098 . . . . 0.0 112.491 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.9 -29.27 70.2 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.937 0.495 . . . . 0.0 109.877 168.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -67.81 -27.25 66.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.825 1.25 . . . . 0.0 111.898 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 24.3 mmt180 -55.69 -37.03 67.81 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.935 0.894 . . . . 0.0 113.134 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 62.2 m-85 -66.19 -29.67 69.98 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.107 0.479 . . . . 0.0 110.865 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.13 -23.24 18.67 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.585 1.154 . . . . 0.0 110.282 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -74.01 -55.51 6.05 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.815 1.246 . . . . 0.0 110.673 -174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.2 ptpt -93.99 -12.61 28.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.444 0.698 . . . . 0.0 111.24 -175.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.49 -30.63 5.92 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 122.924 0.297 . . . . 0.0 113.192 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.82 118.39 7.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.873 0.869 . . . . 0.0 108.857 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.409 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 16.5 t70 -123.25 -179.43 4.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.765 0.826 . . . . 0.0 109.918 -168.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -134.34 110.55 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.324 1.05 . . . . 0.0 108.847 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -92.94 120.96 33.8 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.86 137.78 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.458 0.646 . . . . 0.0 111.113 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.59 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.6 mmpt? -127.58 133.63 25.3 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.476 1.51 . . . . 0.0 109.947 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.5 55.95 4.92 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.803 2.335 . . . . 0.0 111.113 166.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.2 36.11 4.25 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.201 1.4 . . . . 0.0 113.215 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 9.1 m -64.12 -28.26 69.65 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.667 0.746 . . . . 0.0 110.266 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.494 ' HB ' ' HH ' ' A' ' 136' ' ' TYR . 23.1 m -90.48 150.45 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.756 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -79.88 178.0 8.52 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.91 0.884 . . . . 0.0 109.788 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -69.91 4.24 2.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.217 1.007 . . . . 0.0 113.697 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.7 -26.23 68.56 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.245 0.618 . . . . 0.0 110.198 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.48 110.77 2.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.796 0.838 . . . . 0.0 110.718 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -134.31 152.07 77.46 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.23 102.6 0.96 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.38 2.053 . . . . 0.0 110.845 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.75 35.95 0.21 Allowed Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.365 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.491 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 24.5 mtm -119.0 -168.02 1.49 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.448 0.699 . . . . 0.0 110.726 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -110.1 157.06 19.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.19 0.996 . . . . 0.0 108.864 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.56 ' HB2' HG13 ' A' ' 60' ' ' ILE . 2.7 t80 -134.64 104.43 6.05 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 40.5 t -94.6 121.5 45.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.485 0.66 . . . . 0.0 109.823 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -86.21 103.51 14.9 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.249 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.2 t80 . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 170.611 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 120.416 0.15 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.26 -23.32 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.041 0.536 . . . . 0.0 109.714 169.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.07 -165.1 35.46 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.017 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 11.1 pt-20 -153.65 178.1 10.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.073 0.949 . . . . 0.0 109.581 172.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' A' ' 114' ' ' LEU . . . -162.31 -172.42 3.18 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.013 0.925 . . . . 0.0 110.181 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -124.2 122.74 38.6 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.786 0.834 . . . . 0.0 109.773 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.56 HG13 ' HB2' ' A' ' 43' ' ' PHE . 41.4 mt -72.16 133.52 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.067 0.947 . . . . 0.0 110.6 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -140.16 -166.18 2.05 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.166 1.787 . . . . 0.0 108.065 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -37.71 118.81 0.69 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.273 1.429 . . . . 0.0 114.565 -165.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -98.27 116.21 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 123.087 0.555 . . . . 0.0 109.8 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -91.12 113.05 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.367 0.667 . . . . 0.0 109.36 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.473 ' HB3' HD13 ' A' ' 108' ' ' LEU . 57.5 mt -90.24 124.68 35.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.512 0.725 . . . . 0.0 109.743 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -152.55 138.23 17.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.004 0.921 . . . . 0.0 110.222 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -75.33 -12.05 60.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.582 0.753 . . . . 0.0 111.556 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.544 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 74.7 m-20 -112.01 119.88 43.22 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.329 0.652 . . . . 0.0 109.274 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.94 -12.83 36.56 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.8 2.333 . . . . 0.0 113.33 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.3 mtm -81.99 -22.61 36.47 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.485 0.714 . . . . 0.0 110.945 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.544 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 62.3 mt-30 -70.73 -20.27 62.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.984 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -74.59 -25.53 59.32 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.052 0.541 . . . . 0.0 110.927 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.445 ' HE2' HD23 ' A' ' 87' ' ' LEU . 37.0 m-85 -85.19 -27.72 25.93 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.969 0.508 . . . . 0.0 111.728 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.36 -33.7 48.84 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 120.508 0.194 . . . . 0.0 110.675 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -79.77 -56.42 4.29 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.974 0.51 . . . . 0.0 111.132 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.69 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 37.3 m-85 -103.28 -68.0 0.86 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.249 0.619 . . . . 0.0 109.702 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.76 -81.51 0.12 Allowed Glycine 0 C--N 1.355 1.614 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.118 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.84 -36.18 69.7 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.592 1.157 . . . . 0.0 111.327 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.69 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 26.5 mmt180 -78.54 -30.27 46.85 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.801 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 76' ' ' PHE . 42.7 t -65.12 140.62 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -57.5 -45.99 84.28 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 122.606 0.362 . . . . 0.0 111.697 -174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -105.46 164.04 12.18 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 86' ' ' GLU . 13.0 t -99.24 -179.69 4.32 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -68.76 -29.85 68.33 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.908 0.483 . . . . 0.0 111.338 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.4 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 2.9 m-20 -68.96 -30.23 68.62 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.324 0.583 . . . . 0.0 111.269 174.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.472 ' HG2' HG22 ' A' ' 83' ' ' THR . 58.8 mm-40 -75.32 -28.52 59.69 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.827 174.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.5 ' HG ' ' HE1' ' A' ' 91' ' ' MET . 56.5 tp -69.23 -47.15 65.55 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.712 0.405 . . . . 0.0 110.582 174.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.4 ' HG3' ' HA ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -65.13 -40.16 94.06 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.854 -175.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.32 -33.95 73.93 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.707 0.23 . . . . 0.0 110.664 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.99 -44.52 95.79 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.708 0.803 . . . . 0.0 111.221 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.5 ' HE1' ' HG ' ' A' ' 87' ' ' LEU . 68.8 mtm -77.05 -35.6 56.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.295 0.638 . . . . 0.0 111.186 -176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -70.05 -23.69 63.14 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.423 0.289 . . . . 0.0 110.41 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 CA--C 1.539 0.541 0 C-N-CA 122.818 0.447 . . . . 0.0 111.008 173.579 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.44 ' HD3' ' H ' ' A' ' 108' ' ' LEU . 4.8 tmtp? -135.37 144.42 46.61 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 65' ' ' LEU . 1.5 tm? -77.77 100.25 6.2 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -82.92 159.69 22.25 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.367 0.667 . . . . 0.0 109.381 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.0 ptm -143.37 131.06 21.32 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.611 0.764 . . . . 0.0 110.279 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.17 102.59 11.99 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.813 0.845 . . . . 0.0 109.487 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.432 HG23 HG12 ' A' ' 60' ' ' ILE . 36.0 mt -81.26 127.89 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.748 0.819 . . . . 0.0 109.394 -177.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -81.61 123.47 28.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.429 HD13 ' HB1' ' A' ' 58' ' ' ALA . 4.3 mm? -105.27 129.1 53.71 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.159 0.983 . . . . 0.0 109.528 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.64 175.25 9.72 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.208 1.003 . . . . 0.0 108.492 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 t70 57.63 36.41 26.69 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.876 0.845 . . . . 0.0 110.737 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.16 105.17 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.742 -171.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.65 160.21 21.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.184 0.993 . . . . 0.0 110.472 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -117.5 123.19 45.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.178 0.991 . . . . 0.0 110.54 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -97.12 82.33 3.17 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.49 -24.77 65.62 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.513 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HG3' HG13 ' A' ' 124' ' ' ILE . 16.1 ptpt -81.87 139.42 46.58 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.796 172.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -83.29 65.9 7.7 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 123.235 2.624 . . . . 0.0 112.924 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.403 HG13 ' HG3' ' A' ' 122' ' ' LYS . 39.3 mt -77.02 114.34 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -71.35 145.38 90.55 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.198 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.99 155.19 70.61 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.612 2.208 . . . . 0.0 111.86 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -68.22 -31.07 70.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.617 0.767 . . . . 0.0 109.479 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -128.88 162.21 28.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.144 0.978 . . . . 0.0 109.824 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -77.3 121.88 24.33 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.46 ' HA ' ' HG2' ' A' ' 135' ' ' GLN . 17.8 t -107.69 100.07 32.88 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 122.829 0.451 . . . . 0.0 110.195 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.82 -176.94 3.41 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.01 2.473 . . . . 0.0 111.699 172.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -57.77 -31.22 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.322 1.049 . . . . 0.0 112.756 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.25 -19.27 72.13 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.708 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.76 142.21 3.12 Favored Glycine 0 C--N 1.351 1.361 0 C-N-CA 122.984 0.326 . . . . 0.0 113.031 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.46 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -109.73 157.67 18.89 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.437 0.695 . . . . 0.0 109.836 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.494 ' HH ' ' HB ' ' A' ' 33' ' ' VAL . 33.3 m-85 -87.35 129.1 35.15 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 170.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.1 tt -90.58 125.13 35.53 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.26 144.29 48.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt . . . . . 0 CA--C 1.551 0.989 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.414 HG21 ' N ' ' A' ' 5' ' ' VAL . 26.3 mm 64.85 -177.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 C-N-CA 124.402 1.081 . . . . 0.0 109.577 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 139' ' ' GLU . 1.3 m -150.24 -39.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.807 1.243 . . . . 0.0 108.712 158.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.39 -163.38 22.27 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.178 -176.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.423 HG11 HD22 ' A' ' 37' ' ' LEU . 9.0 p -137.1 141.39 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.663 0.785 . . . . 0.0 109.068 175.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 t -113.93 139.26 49.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.445 0.698 . . . . 0.0 110.163 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -131.55 143.74 50.46 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 123.695 0.798 . . . . 0.0 109.805 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HD3' HG11 ' A' ' 130' ' ' VAL . 85.8 Cg_endo -73.98 -14.59 23.74 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.994 2.463 . . . . 0.0 112.354 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.1 mm 53.6 89.77 0.1 OUTLIER Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.922 1.289 . . . . 0.0 109.86 -174.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.03 24.35 0.54 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.905 2.403 . . . . 0.0 112.702 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 159.52 39.23 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.532 1.533 . . . . 0.0 108.499 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -74.93 -13.07 60.49 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.446 0.698 . . . . 0.0 111.239 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -72.52 6.85 2.13 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.234 1.013 . . . . 0.0 113.597 -172.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -56.76 -34.21 67.36 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.002 0.43 . . . . 0.0 110.058 164.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.47 ' N ' ' SD ' ' A' ' 16' ' ' MET . 19.6 t70 -49.42 -41.49 39.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.647 1.579 . . . . 0.0 112.428 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -54.56 -48.2 72.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.262 1.025 . . . . 0.0 112.465 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.463 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 64.5 m-85 -66.75 -28.9 68.78 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.988 0.805 . . . . 0.0 110.406 -177.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -91.1 -19.32 23.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.01 0.524 . . . . 0.0 111.376 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -76.74 -59.67 2.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.321 0.648 . . . . 0.0 109.497 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -92.73 -10.23 37.83 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.222 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.3 3.02 69.08 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.416 0.447 . . . . 0.0 114.006 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -168.16 100.43 0.44 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.009 0.924 . . . . 0.0 109.736 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.463 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 20.1 t70 -129.05 -170.74 2.33 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.0 t -133.18 117.51 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.94 1.245 . . . . 0.0 109.248 -174.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -90.49 107.33 19.09 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.278 0.631 . . . . 0.0 109.517 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.3 m -87.67 142.85 12.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.423 0.63 . . . . 0.0 109.903 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.529 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 2.1 tpmt? -135.05 128.07 18.43 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.383 1.073 . . . . 0.0 108.53 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.509 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 79.7 Cg_endo -76.26 59.29 5.97 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.716 2.277 . . . . 0.0 111.736 171.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 39.49 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.882 1.673 . . . . 0.0 113.487 -174.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.529 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 27.9 m -127.91 -31.48 2.4 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.384 0.674 . . . . 0.0 109.754 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.79 148.47 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.41 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -87.98 -164.14 1.06 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.129 0.972 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -70.13 -2.21 12.34 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -63.38 -31.32 72.44 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.234 0.47 . . . . 0.0 110.765 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.469 ' HA ' ' HE1' ' A' ' 41' ' ' MET . 1.1 mm? -64.93 117.44 7.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.132 0.573 . . . . 0.0 111.614 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.07 149.81 46.85 Favored Pre-proline 0 C--O 1.244 0.787 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.791 173.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.31 101.88 0.65 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.541 2.16 . . . . 0.0 111.047 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.83 0.62 0.78 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.483 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.469 ' HE1' ' HA ' ' A' ' 37' ' ' LEU . 26.2 mtm -89.7 -169.75 2.57 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 117.319 0.56 . . . . 0.0 110.984 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -107.86 160.06 16.04 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.507 0.723 . . . . 0.0 109.474 173.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.446 ' HB2' HG13 ' A' ' 60' ' ' ILE . 12.3 t80 -134.98 105.25 6.29 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.8 t -90.76 121.13 40.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.175 0.512 . . . . 0.0 109.868 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -82.95 105.16 13.72 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.437 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 56.8 t80 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 66.7 m-85 . . . . . 0 CA--C 1.545 0.768 0 CA-C-O 120.525 0.202 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.53 -33.75 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.932 0.893 . . . . 0.0 110.88 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.6 -168.58 30.88 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.474 -0.33 . . . . 0.0 112.76 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 6.5 pt-20 -147.83 179.46 7.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.396 1.078 . . . . 0.0 108.918 174.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 114' ' ' LEU . . . -164.19 -172.24 2.69 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.679 0.791 . . . . 0.0 110.659 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -123.94 119.03 28.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.507 1.123 . . . . 0.0 109.576 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 43' ' ' PHE . 53.7 mt -71.81 131.78 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.217 1.007 . . . . 0.0 110.733 177.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -138.13 -162.4 1.3 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.212 1.805 . . . . 0.0 107.773 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -38.96 116.0 0.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.821 1.249 . . . . 0.0 113.466 -160.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 35.9 m -96.18 106.36 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 121.735 0.778 . . . . 0.0 109.113 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 86.2 t -89.96 108.02 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.8 mt -89.37 120.32 30.6 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.504 0.722 . . . . 0.0 109.398 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.7 t -151.58 135.73 16.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.557 0.743 . . . . 0.0 110.091 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -70.97 -10.22 59.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.922 0.889 . . . . 0.0 111.837 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -110.12 122.56 38.46 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.58 -22.35 58.41 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.218 1.945 . . . . 0.0 112.282 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 47.5 mtm -70.33 -25.63 63.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.484 0.713 . . . . 0.0 111.415 -169.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -53.56 -35.57 60.93 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.215 1.006 . . . . 0.0 112.03 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.408 ' HE2' ' HB3' ' A' ' 109' ' ' TRP . 5.7 m-85 -77.39 -33.82 55.04 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.525 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.492 ' CE2' HD21 ' A' ' 87' ' ' LEU . 88.1 m-85 -81.5 -16.64 51.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.517 0.727 . . . . 0.0 111.65 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -94.14 -33.57 13.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.462 0.305 . . . . 0.0 111.208 172.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.2 m -78.08 -52.07 9.31 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.989 0.423 . . . . 0.0 110.737 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.789 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 66.9 m-85 -100.16 -53.96 3.0 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.538 0.735 . . . . 0.0 109.951 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.71 -86.44 0.12 Allowed Glycine 0 C--N 1.357 1.731 0 O-C-N 123.938 0.774 . . . . 0.0 113.129 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.92 -43.49 91.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.41 0.684 . . . . 0.0 110.692 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.789 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 25.0 mmt180 -68.74 -18.6 64.25 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-O 118.328 -0.844 . . . . 0.0 112.292 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 76' ' ' PHE . 47.9 t -80.25 131.9 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.628 1.104 . . . . 0.0 108.592 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -51.9 -37.58 52.98 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 124.092 0.87 . . . . 0.0 113.336 -170.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.0 pt? -111.75 160.0 17.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.498 HG23 ' HG2' ' A' ' 86' ' ' GLU . 8.9 t -97.24 173.69 7.09 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -61.26 -27.29 68.35 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.462 0.705 . . . . 0.0 111.438 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.95 -53.14 51.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.569 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 9.2 mm-40 -61.64 -29.74 70.26 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.566 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.492 HD21 ' CE2' ' A' ' 73' ' ' PHE . 25.2 tp -63.5 -58.56 6.63 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.121 0.968 . . . . 0.0 111.096 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -59.92 -41.19 91.18 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.571 0.544 . . . . 0.0 111.607 -172.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.94 -23.74 44.41 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.028 0.531 . . . . 0.0 111.477 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.79 -45.99 73.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.21 0.604 . . . . 0.0 109.788 171.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.3 mtm -67.27 -39.78 86.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.138 0.575 . . . . 0.0 110.381 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.2 mmpt? -64.0 -38.4 90.95 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.606 0.566 . . . . 0.0 110.293 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.3 t . . . . . 0 N--CA 1.474 0.767 0 C-N-CA 123.432 0.693 . . . . 0.0 110.749 177.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.239 0.543 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -134.97 145.27 47.97 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.306 1.042 . . . . 0.0 108.73 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -80.15 121.62 25.8 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.408 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 41.6 m95 -107.77 158.55 17.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.055 0.942 . . . . 0.0 109.347 174.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.2 ptm -144.47 130.92 19.84 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.283 0.633 . . . . 0.0 110.271 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.443 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -103.78 102.38 12.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.637 0.775 . . . . 0.0 109.49 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.81 117.54 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.96 113.0 19.57 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.47 HD12 ' HB1' ' A' ' 58' ' ' ALA . 4.3 mm? -92.53 135.36 34.13 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.063 0.545 . . . . 0.0 110.726 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.81 167.95 20.88 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.645 0.778 . . . . 0.0 109.365 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.2 t70 53.6 47.45 23.86 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.312 1.053 . . . . 0.0 110.586 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 50.5 t -69.84 107.56 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.531 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -93.62 107.12 19.03 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.942 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -68.42 123.36 20.58 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -71.98 96.88 1.77 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 170.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -63.84 -33.37 75.53 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.465 0.706 . . . . 0.0 109.954 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.9 137.85 33.24 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.312 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.16 105.53 1.98 Allowed 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.161 1.907 . . . . 0.0 110.844 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 21.1 mt -91.03 108.14 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.525 0.678 . . . . 0.0 110.566 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -74.64 139.88 74.6 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.968 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -86.7 170.31 7.62 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 122.728 2.285 . . . . 0.0 112.367 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -87.68 -28.14 22.0 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.711 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -144.31 165.91 26.56 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.483 0.713 . . . . 0.0 110.479 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.0 134.2 44.57 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.508 HG11 ' HD3' ' A' ' 10' ' ' PRO . 62.2 t -101.6 100.0 13.04 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.37 176.5 5.58 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.225 2.616 . . . . 0.0 112.308 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.37 -30.81 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.622 0.769 . . . . 0.0 113.063 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.29 -21.23 75.75 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.537 0.523 . . . . 0.0 113.393 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.88 159.06 31.67 Favored Glycine 0 C--N 1.345 1.042 0 C-N-CA 123.453 0.549 . . . . 0.0 112.506 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -115.07 154.49 28.78 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.971 0.908 . . . . 0.0 109.759 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -88.49 124.15 33.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.97 116.11 27.78 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 172.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.66 139.46 52.7 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.521 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 tm-20 . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 5' ' ' VAL . 30.5 mm 67.38 -176.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 C-N-CA 124.168 0.987 . . . . 0.0 109.254 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.429 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.4 m -157.93 -41.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 125.498 1.519 . . . . 0.0 108.041 158.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.94 -161.32 18.97 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.178 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.52 155.9 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.879 0.872 . . . . 0.0 109.267 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -126.56 140.19 52.63 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.723 0.809 . . . . 0.0 109.706 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -141.94 142.84 26.21 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.65 0.78 . . . . 0.0 111.116 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.439 ' HD3' HG12 ' A' ' 130' ' ' VAL . 74.9 Cg_endo -74.99 -12.81 21.54 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.943 2.429 . . . . 0.0 112.565 167.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.1 mm 69.2 123.46 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.815 1.646 . . . . 0.0 109.837 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.43 -7.07 18.05 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 122.894 2.396 . . . . 0.0 113.944 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.513 ' HE3' ' HB3' ' A' ' 86' ' ' GLU . 67.9 mttm -134.62 170.88 15.13 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.448 1.099 . . . . 0.0 109.941 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 14' ' ' ARG . 3.8 tmm_? -75.29 -5.05 42.65 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.597 0.759 . . . . 0.0 110.312 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -76.19 26.81 0.12 Allowed 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.007 0.923 . . . . 0.0 113.319 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -60.26 -32.96 71.65 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.827 0.851 . . . . 0.0 110.057 163.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.18 -21.32 66.75 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.837 0.855 . . . . 0.0 112.913 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 81' ' ' PHE . 37.4 mmt180 -57.43 -45.75 84.3 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.496 0.718 . . . . 0.0 110.796 176.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.463 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 65.8 m-85 -63.04 -31.11 72.18 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.664 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -91.48 -18.52 24.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.981 0.913 . . . . 0.0 111.111 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -72.96 -46.96 49.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.671 1.188 . . . . 0.0 109.84 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.8 ptpt -106.85 -15.87 14.61 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.226 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.76 -5.67 56.84 Favored Glycine 0 N--CA 1.48 1.588 0 N-CA-C 114.27 0.468 . . . . 0.0 114.27 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -161.68 107.83 1.34 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.31 1.044 . . . . 0.0 108.961 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.7 t70 -124.4 179.66 4.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.468 1.107 . . . . 0.0 109.675 -169.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -128.87 109.67 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.44 0.696 . . . . 0.0 109.494 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.459 ' HD2' HD12 ' A' ' 112' ' ' ILE . 88.9 t80 -84.32 111.84 19.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m -89.93 139.45 17.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-O 121.526 0.679 . . . . 0.0 110.208 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.636 ' HG2' HG23 ' A' ' 33' ' ' VAL . 1.5 tpmt? -135.37 127.71 17.94 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.813 1.245 . . . . 0.0 108.507 -174.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.14 60.37 3.86 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.643 2.229 . . . . 0.0 112.725 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.93 21.83 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.215 1.406 . . . . 0.0 114.509 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -64.69 -43.03 94.82 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.641 0.776 . . . . 0.0 111.045 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.636 HG23 ' HG2' ' A' ' 29' ' ' LYS . 20.1 m -72.84 150.33 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.752 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -82.56 -174.17 5.04 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.593 0.757 . . . . 0.0 111.839 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -66.98 -9.27 36.95 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.905 1.282 . . . . 0.0 111.387 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -60.63 -24.82 65.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.883 0.873 . . . . 0.0 110.848 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.479 ' HA ' ' HE1' ' A' ' 41' ' ' MET . 0.1 OUTLIER -73.88 91.83 2.02 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.519 0.728 . . . . 0.0 110.344 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 154.42 47.9 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 123.099 0.559 . . . . 0.0 109.951 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.67 99.25 0.93 Allowed 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.822 2.348 . . . . 0.0 111.476 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.18 -15.77 0.67 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.518 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.479 ' HE1' ' HA ' ' A' ' 37' ' ' LEU . 25.0 mtm -76.65 -178.98 5.03 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 121.554 0.692 . . . . 0.0 112.223 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -106.3 160.08 15.63 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.091 0.956 . . . . 0.0 110.352 171.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -135.49 97.04 3.58 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.4 t -86.82 120.92 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.254 0.549 . . . . 0.0 110.003 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -82.44 102.6 11.41 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.49 0.716 . . . . 0.0 110.115 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.8 t80 . . . . . 0 CA--C 1.546 0.803 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.528 170.4 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.01 -33.34 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.395 0.678 . . . . 0.0 111.272 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.6 -160.48 23.84 Favored Glycine 0 C--N 1.345 1.078 0 C-N-CA 121.546 -0.359 . . . . 0.0 113.131 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.28 177.78 9.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.231 1.012 . . . . 0.0 109.263 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.502 ' HB2' HD11 ' A' ' 114' ' ' LEU . . . -162.49 -173.32 3.51 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.139 0.976 . . . . 0.0 109.573 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -128.01 125.99 40.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.373 0.669 . . . . 0.0 110.228 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.1 mt -74.16 130.31 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.926 1.29 . . . . 0.0 111.288 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.442 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 30.7 mmmt -129.8 -164.39 1.4 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.616 1.567 . . . . 0.0 108.017 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -40.95 114.03 0.44 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.818 1.247 . . . . 0.0 113.743 -163.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -85.42 107.75 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.541 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 53.3 t -88.96 109.33 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.0 mt -87.37 117.82 26.39 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.474 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.3 t -151.18 130.33 12.69 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.155 0.982 . . . . 0.0 108.671 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.81 -6.67 33.86 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -105.51 122.19 43.58 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 170.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HG2' HD22 ' A' ' 87' ' ' LEU . 57.7 Cg_endo -70.85 -15.98 32.99 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.743 2.295 . . . . 0.0 112.647 172.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 36.1 mtm -79.31 -25.03 42.44 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.672 0.789 . . . . 0.0 110.167 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -57.63 -32.43 67.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.403 1.081 . . . . 0.0 110.752 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.69 -19.91 58.77 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.028 0.531 . . . . 0.0 111.722 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -86.64 -34.2 19.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.837 0.455 . . . . 0.0 110.685 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.46 -28.34 56.5 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 120.39 0.138 . . . . 0.0 110.723 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.5 m -83.6 -43.55 15.53 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.223 0.609 . . . . 0.0 111.505 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.777 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 64.0 m-85 -115.19 -67.5 0.99 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.786 0.435 . . . . 0.0 110.123 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.25 -83.92 0.62 Allowed Glycine 0 C--N 1.353 1.521 0 O-C-N 123.601 0.563 . . . . 0.0 113.044 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.73 -22.57 64.32 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.685 0.794 . . . . 0.0 111.831 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.777 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 31.6 mmt180 -72.33 -40.55 67.36 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.845 0.458 . . . . 0.0 111.385 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.5 t -69.52 147.31 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.006 0.522 . . . . 0.0 110.856 -170.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.438 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 28.9 p90 -69.86 -17.85 63.4 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 1.8 pt? -137.09 167.61 21.21 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.9 t -110.04 -179.53 3.82 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.15 -27.92 69.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.25 0.62 . . . . 0.0 111.35 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -62.5 -47.09 85.49 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.573 0.749 . . . . 0.0 111.25 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.513 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 1.8 mp0 -68.48 -29.52 68.15 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.461 HD22 ' HG2' ' A' ' 69' ' ' PRO . 46.8 tp -68.91 -48.9 62.19 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.837 0.455 . . . . 0.0 110.837 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -68.63 -36.68 78.94 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.008 -172.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 8.7 pt-20 -66.6 -36.28 82.24 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.12 -47.33 74.51 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.869 0.868 . . . . 0.0 110.754 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.443 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 67.2 mtm -70.02 -36.9 75.42 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.158 0.583 . . . . 0.0 110.63 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -62.34 -43.0 99.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.04 0.536 . . . . 0.0 110.279 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.48 1.062 0 C-N-CA 123.913 0.885 . . . . 0.0 111.355 -177.267 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.4 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.595 ' HZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -131.7 152.2 51.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.086 0.555 . . . . 0.0 109.738 -177.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -71.64 127.23 31.88 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -116.68 159.12 22.7 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.401 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 14.7 ptm -142.47 130.58 22.0 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.282 0.633 . . . . 0.0 109.873 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.541 ' HB1' ' HB ' ' A' ' 64' ' ' VAL . . . -104.24 101.61 11.33 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.737 0.815 . . . . 0.0 109.198 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.459 HD12 ' HD2' ' A' ' 27' ' ' PHE . 27.9 mt -82.2 120.07 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -81.87 98.37 8.48 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 58' ' ' ALA . 4.4 mm? -81.56 131.41 35.27 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 122.005 -0.434 . . . . 0.0 109.938 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.442 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 1.0 OUTLIER -138.47 159.79 41.2 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.183 0.593 . . . . 0.0 109.415 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.8 t70 53.58 48.33 21.91 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.364 1.065 . . . . 0.0 110.757 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.458 HG11 ' HB3' ' A' ' 19' ' ' PHE . 27.2 t -71.62 101.89 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.206 -174.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.24 154.02 21.03 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.441 -174.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -107.08 138.55 43.04 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.531 0.732 . . . . 0.0 110.01 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -86.34 85.83 7.33 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 169.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.44 -39.23 82.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.072 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -81.66 148.48 61.91 Favored Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.275 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.77 114.94 4.06 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.679 2.253 . . . . 0.0 112.114 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.5 mt -114.5 131.49 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 145.91 30.4 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.24 1.016 . . . . 0.0 109.114 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -80.4 132.89 9.33 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.574 2.183 . . . . 0.0 111.659 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -66.58 -25.35 66.59 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.565 0.746 . . . . 0.0 110.662 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -146.25 166.87 24.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.144 0.978 . . . . 0.0 110.436 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -79.31 135.53 36.76 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.439 HG12 ' HD3' ' A' ' 10' ' ' PRO . 39.1 t -114.09 105.0 54.7 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.86 -174.31 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.168 2.578 . . . . 0.0 112.668 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.4 -34.84 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.889 0.875 . . . . 0.0 110.617 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.54 -24.2 75.23 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.24 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.76 167.42 42.0 Favored Glycine 0 C--N 1.346 1.1 0 C-N-CA 123.201 0.429 . . . . 0.0 112.94 175.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.402 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -118.44 151.84 37.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.082 0.953 . . . . 0.0 109.377 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.449 ' HH ' ' HB ' ' A' ' 33' ' ' VAL . 12.8 m-85 -89.56 128.1 35.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 168.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tt -89.09 118.47 28.83 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.79 115.18 18.25 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.25 1.109 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -170.442 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.446 HG21 ' H ' ' A' ' 5' ' ' VAL . 23.1 mm 62.14 -164.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -172.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.446 ' H ' HG21 ' A' ' 4' ' ' ILE . 2.3 m -148.64 -40.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 154.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.89 -161.68 20.79 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.342 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.59 149.27 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 6.2 t -121.86 134.47 54.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.524 0.73 . . . . 0.0 109.043 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -128.32 144.73 52.98 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.929 0.892 . . . . 0.0 109.217 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 42.1 Cg_exo -56.94 -31.13 88.63 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.132 2.555 . . . . 0.0 111.928 170.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.9 mm 68.45 131.79 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 125.675 1.59 . . . . 0.0 111.033 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.79 135.89 50.31 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.914 2.409 . . . . 0.0 112.078 172.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -66.16 -25.51 66.99 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.781 0.832 . . . . 0.0 112.737 -169.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -66.01 -37.31 85.57 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.302 0.641 . . . . 0.0 110.442 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 25.2 m-85 -114.88 13.33 17.1 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.542 -162.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.7 ttp -60.77 -41.51 95.65 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.022 0.529 . . . . 0.0 110.733 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.47 -18.81 51.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.903 0.881 . . . . 0.0 112.738 -173.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 15' ' ' PHE . 1.3 mmp_? -52.48 -48.48 65.88 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.354 0.662 . . . . 0.0 112.142 -173.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -66.22 -30.09 70.48 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.54 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -94.23 -12.11 28.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.872 0.869 . . . . 0.0 111.379 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -78.66 -52.16 8.82 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.745 0.818 . . . . 0.0 108.858 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -101.72 -16.83 16.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.282 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.67 10.31 63.71 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 114.11 0.404 . . . . 0.0 114.11 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -163.27 92.91 0.76 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.159 0.984 . . . . 0.0 109.049 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -127.3 -177.72 4.17 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.43 -168.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -141.7 117.97 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.062 0.945 . . . . 0.0 109.068 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -100.39 114.16 27.47 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.325 0.65 . . . . 0.0 109.446 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -92.99 141.11 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.264 0.554 . . . . 0.0 111.175 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.88 125.33 20.21 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 125.25 1.42 . . . . 0.0 110.466 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.53 71.26 6.02 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.934 2.423 . . . . 0.0 112.411 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 54.34 23.93 4.74 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.064 1.346 . . . . 0.0 113.35 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -73.2 -49.12 29.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.376 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 m -74.14 149.21 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.592 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -73.39 179.25 4.08 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.367 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.11 -7.77 25.72 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.325 1.05 . . . . 0.0 112.85 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.76 -25.44 66.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.461 0.704 . . . . 0.0 111.007 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.461 ' HA ' ' HE2' ' A' ' 41' ' ' MET . 0.9 OUTLIER -65.22 93.17 0.13 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.644 0.777 . . . . 0.0 111.03 175.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -113.24 149.24 41.14 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.596 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.24 99.56 1.03 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.535 2.156 . . . . 0.0 111.184 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.9 -2.17 0.73 Allowed Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.955 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.461 ' HE2' ' HA ' ' A' ' 37' ' ' LEU . 29.5 mtm -83.2 -170.49 3.07 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.501 0.667 . . . . 0.0 111.607 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.3 ptpt -115.55 162.49 17.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.527 1.131 . . . . 0.0 110.338 171.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.529 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.14 101.05 4.73 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 58.9 t -83.83 119.5 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.532 0.682 . . . . 0.0 109.371 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -85.89 113.46 22.04 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 88.4 t80 . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 171.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 27.5 m-85 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.433 HG22 ' HZ3' ' A' ' 119' ' ' LYS . 3.2 p -125.71 -31.66 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.026 0.93 . . . . 0.0 110.209 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.93 -167.51 35.53 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.154 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 13.6 pt-20 -146.62 177.64 8.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.875 0.87 . . . . 0.0 109.308 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.437 ' HB2' HD11 ' A' ' 114' ' ' LEU . . . -160.45 -172.4 3.54 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.362 1.065 . . . . 0.0 109.348 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 86.0 mmt-85 -123.58 118.81 28.17 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.679 0.792 . . . . 0.0 109.775 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.529 HG13 ' HB2' ' A' ' 43' ' ' PHE . 51.0 mt -69.99 129.27 34.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 O-C-N 124.449 1.093 . . . . 0.0 109.595 174.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 14.7 mmmm -134.41 -172.54 3.04 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 125.553 1.541 . . . . 0.0 108.671 -175.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -32.29 110.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.884 1.674 . . . . 0.0 114.371 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.437 HG13 ' HA ' ' A' ' 112' ' ' ILE . 34.7 m -90.27 117.61 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 68.5 t -90.39 108.8 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.9 mt -86.44 118.97 26.21 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.0 t -152.65 134.27 14.57 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.865 0.866 . . . . 0.0 109.817 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.515 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 58.0 mt-10 -68.98 -11.86 61.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 122.868 0.467 . . . . 0.0 111.495 174.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.575 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 10.1 m-80 -103.23 117.33 60.53 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.401 ' HG2' HD22 ' A' ' 87' ' ' LEU . 59.3 Cg_endo -73.96 -10.24 22.83 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.262 1.975 . . . . 0.0 112.817 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -78.78 -25.12 44.35 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.328 0.651 . . . . 0.0 111.027 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.575 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 75.5 mt-30 -68.68 -21.9 64.4 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.678 176.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -75.44 -23.63 56.94 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.877 0.471 . . . . 0.0 110.801 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -85.25 -32.4 22.6 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.489 0.316 . . . . 0.0 111.707 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.7 pt-20 -75.15 -30.85 60.88 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 120.523 0.202 . . . . 0.0 110.726 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -79.17 -58.36 3.26 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.212 0.605 . . . . 0.0 110.655 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.782 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 61.8 m-85 -101.61 -67.63 0.86 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.579 0.752 . . . . 0.0 110.156 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.7 -84.66 0.77 Allowed Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.83 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.64 -46.55 86.89 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.422 0.689 . . . . 0.0 110.38 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.782 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 29.8 mmt180 -62.43 -30.22 71.07 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 124.066 0.854 . . . . 0.0 111.76 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.461 HG12 HD22 ' A' ' 82' ' ' LEU . 30.8 t -68.15 136.0 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -56.98 -28.51 62.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.583 0.753 . . . . 0.0 112.748 -171.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.461 HD22 HG12 ' A' ' 80' ' ' VAL . 1.8 pt? -123.53 155.28 37.86 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.621 0.768 . . . . 0.0 109.197 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.525 HG23 ' HG2' ' A' ' 86' ' ' GLU . 15.1 t -91.49 176.92 6.38 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.4 -34.41 77.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.673 0.389 . . . . 0.0 111.514 -177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -61.44 -44.72 96.62 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.405 0.682 . . . . 0.0 110.767 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.525 ' HG2' HG23 ' A' ' 83' ' ' THR . 63.8 mm-40 -66.1 -35.44 80.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.357 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.401 HD22 ' HG2' ' A' ' 69' ' ' PRO . 29.1 tp -68.2 -47.95 66.51 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -35.45 78.73 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.21 -31.74 67.97 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 123.162 0.289 . . . . 0.0 110.917 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -66.36 -44.85 82.07 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.77 0.828 . . . . 0.0 110.934 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.3 mtm -76.82 -34.34 57.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.116 0.567 . . . . 0.0 110.454 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -64.38 -35.34 80.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.18 0.592 . . . . 0.0 110.42 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.475 0.783 0 O-C-N 123.688 0.618 . . . . 0.0 110.549 176.746 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.509 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.2 tpmt? -134.77 144.71 47.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.7 0.4 . . . . 0.0 109.966 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.66 113.26 15.33 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -96.9 153.55 17.83 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.5 ptm -132.61 130.05 39.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.277 0.631 . . . . 0.0 109.62 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -98.13 102.45 14.2 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.631 0.772 . . . . 0.0 109.123 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.437 ' HA ' HG13 ' A' ' 63' ' ' VAL . 51.4 mt -78.95 121.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.624 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -78.9 133.15 36.96 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.216 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 58' ' ' ALA . 3.5 mm? -122.01 119.23 30.84 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.351 0.66 . . . . 0.0 109.757 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -125.29 175.89 7.14 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.571 0.748 . . . . 0.0 109.427 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 t70 54.52 36.0 24.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.002 0.921 . . . . 0.0 111.03 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.3 t -65.54 111.07 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.523 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.86 112.92 24.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.111 0.965 . . . . 0.0 110.988 -172.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.433 ' HZ3' HG22 ' A' ' 55' ' ' VAL . 14.5 mmmt -67.18 139.34 57.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.813 0.845 . . . . 0.0 111.498 176.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -82.68 113.72 20.55 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.686 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.9 -28.85 61.75 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.433 0.693 . . . . 0.0 110.018 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -105.69 146.37 32.7 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.522 1.129 . . . . 0.0 110.156 -175.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.42 99.56 1.31 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.727 2.285 . . . . 0.0 111.428 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.4 mt -85.09 123.71 39.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.512 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -75.73 126.85 86.72 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.958 0.903 . . . . 0.0 109.973 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.79 130.13 22.55 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.097 1.865 . . . . 0.0 111.454 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -75.44 -23.5 56.93 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.593 0.757 . . . . 0.0 110.429 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.412 ' NH2' ' HB3' ' A' ' 135' ' ' GLN . 20.3 ptt-85 -149.9 158.73 44.45 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.859 0.864 . . . . 0.0 108.812 171.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.77 142.23 58.26 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.534 0.733 . . . . 0.0 110.935 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.7 96.82 45.29 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 123.268 0.627 . . . . 0.0 109.728 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.49 173.18 9.2 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.049 2.5 . . . . 0.0 112.523 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.37 -19.99 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.634 0.773 . . . . 0.0 112.705 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.46 -18.84 79.53 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.447 0.467 . . . . 0.0 113.328 173.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.06 150.47 9.47 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.48 0.562 . . . . 0.0 112.696 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.412 ' HB3' ' NH2' ' A' ' 128' ' ' ARG . 31.2 mm-40 -109.39 132.65 53.93 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.723 0.809 . . . . 0.0 110.753 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -74.55 101.89 4.34 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.704 0.402 . . . . 0.0 110.326 172.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.76 118.25 13.31 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.6 127.33 49.27 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.563 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.1 mm 63.04 -172.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 C-N-CA 124.296 1.039 . . . . 0.0 109.226 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.54 -45.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 156.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.14 -161.49 18.06 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.938 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 p -122.93 144.99 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -117.72 132.13 56.51 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.17 0.588 . . . . 0.0 109.681 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.438 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . 13.0 m-85 -131.92 142.24 44.45 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 124.09 0.956 . . . . 0.0 109.462 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.522 ' HD3' HG12 ' A' ' 130' ' ' VAL . 61.2 Cg_endo -70.52 -18.86 33.14 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.662 2.241 . . . . 0.0 112.621 175.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 mm 47.82 69.86 2.44 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.605 1.162 . . . . 0.0 109.231 -168.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.425 ' HD3' ' HG2' ' A' ' 10' ' ' PRO . 47.3 Cg_endo -83.54 52.97 4.01 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.334 2.689 . . . . 0.0 110.833 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -148.19 166.45 27.88 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.853 -171.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -59.45 -26.11 64.94 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.238 1.015 . . . . 0.0 111.792 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -84.53 14.62 4.38 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.458 1.103 . . . . 0.0 113.041 -168.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -57.79 -35.37 70.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.321 1.049 . . . . 0.0 111.664 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.97 -23.93 61.51 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -53.78 -51.7 62.59 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.026 0.93 . . . . 0.0 113.18 -172.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -61.58 -30.04 70.42 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.866 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -96.96 -14.17 21.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.035 0.934 . . . . 0.0 110.936 -175.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -78.41 -58.78 3.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.252 1.021 . . . . 0.0 109.453 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -93.49 -18.0 22.79 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.496 -171.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.04 -12.77 16.75 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 114.103 0.401 . . . . 0.0 114.103 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.6 90.95 1.9 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.826 0.85 . . . . 0.0 110.413 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.56 176.41 5.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.639 -174.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.9 t -132.65 110.02 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.954 0.902 . . . . 0.0 108.578 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.86 111.47 22.51 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.711 0.804 . . . . 0.0 110.066 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.7 m -96.05 141.78 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.216 0.606 . . . . 0.0 111.579 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -134.69 144.73 51.96 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.698 1.199 . . . . 0.0 110.533 171.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.75 51.51 3.62 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 123.441 2.761 . . . . 0.0 111.833 169.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 54.26 78.22 0.17 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.74 1.216 . . . . 0.0 111.681 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.2 m -101.77 -47.92 4.46 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.375 0.67 . . . . 0.0 109.869 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 m -81.42 150.17 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.409 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 76.8 m95 -79.7 -163.16 0.49 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.294 1.038 . . . . 0.0 112.385 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -69.6 -14.79 63.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.342 1.057 . . . . 0.0 112.738 -171.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.46 -24.67 67.23 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.414 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -66.01 111.54 3.4 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.09 152.7 70.47 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.743 0.817 . . . . 0.0 109.573 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.2 99.25 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.789 2.326 . . . . 0.0 111.424 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.3 -15.76 0.58 Allowed Glycine 0 N--CA 1.467 0.747 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.577 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.541 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 73.5 mtp -74.62 176.86 6.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.004 0.922 . . . . 0.0 111.804 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -102.67 164.34 11.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.549 0.74 . . . . 0.0 110.285 169.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.439 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -136.7 100.16 4.25 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 175.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.3 t -88.79 120.97 38.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -89.59 107.62 19.19 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.918 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.8 t80 . . . . . 0 CA--C 1.554 1.125 0 C-N-CA 124.398 1.079 . . . . 0.0 109.831 173.043 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.09 -35.41 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.104 0.561 . . . . 0.0 109.972 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.97 -161.71 25.65 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.875 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -153.56 177.96 10.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.772 0.829 . . . . 0.0 109.08 170.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 114' ' ' LEU . . . -158.81 -173.48 4.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.651 0.78 . . . . 0.0 109.727 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -125.14 120.81 32.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.421 0.688 . . . . 0.0 110.37 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.439 HG13 ' HB2' ' A' ' 43' ' ' PHE . 56.5 mt -69.07 135.65 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.843 1.257 . . . . 0.0 111.587 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -135.31 -176.47 4.28 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 126.293 1.837 . . . . 0.0 108.527 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -44.9 123.15 3.62 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.803 1.241 . . . . 0.0 113.74 -164.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 112' ' ' ILE . 33.9 m -92.67 118.64 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.244 -176.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 73.1 t -89.28 109.56 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.97 117.66 30.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.394 0.678 . . . . 0.0 109.343 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -152.11 134.74 15.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.784 0.834 . . . . 0.0 109.597 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.442 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 66.9 mt-10 -69.57 -16.29 63.38 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.312 0.645 . . . . 0.0 111.626 176.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -95.34 119.27 65.74 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.481 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 36.5 Cg_endo -66.94 -20.99 50.66 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.145 1.897 . . . . 0.0 112.483 173.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.481 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.2 mpp? -73.83 -22.61 59.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.824 0.45 . . . . 0.0 110.875 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -57.16 -33.84 67.83 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.953 0.783 . . . . 0.0 111.62 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -78.26 -27.54 47.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 122.857 0.463 . . . . 0.0 111.164 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.436 ' HE2' HD22 ' A' ' 87' ' ' LEU . 71.4 m-85 -86.24 -23.14 26.52 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.987 0.515 . . . . 0.0 111.33 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.16 -27.27 19.7 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.438 0.295 . . . . 0.0 110.935 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.7 m -82.55 -58.03 3.09 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.212 0.53 . . . . 0.0 110.055 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.77 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 69.3 m-85 -96.49 -68.96 0.77 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.521 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.28 -80.72 0.73 Allowed Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.631 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.11 -23.5 64.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.096 0.958 . . . . 0.0 111.351 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 21.2 mmt85 -81.51 -32.46 32.37 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 122.958 0.503 . . . . 0.0 111.217 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.419 HG12 HD21 ' A' ' 82' ' ' LEU . 20.4 t -68.56 146.33 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -63.64 -27.22 69.08 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.419 HD21 HG12 ' A' ' 80' ' ' VAL . 2.5 pt? -122.79 176.58 5.89 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.658 0.383 . . . . 0.0 110.267 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.526 HG21 ' HG2' ' A' ' 86' ' ' GLU . 12.6 t -108.33 172.48 6.82 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -68.13 -25.94 65.54 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.02 0.528 . . . . 0.0 111.222 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -68.77 -41.25 79.06 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.335 0.654 . . . . 0.0 109.893 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' HG2' HG21 ' A' ' 83' ' ' THR . 22.6 mm-40 -66.78 -35.22 79.58 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.162 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.436 HD22 ' HE2' ' A' ' 73' ' ' PHE . 32.1 tp -60.79 -54.26 47.33 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.882 0.873 . . . . 0.0 111.527 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -60.61 -43.36 97.54 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 123.494 0.496 . . . . 0.0 111.193 -172.067 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.37 -29.51 53.35 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.214 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -62.19 -43.78 98.06 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.453 0.701 . . . . 0.0 110.806 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.3 mtm -68.15 -36.93 80.44 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.356 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.7 mmpt? -69.08 -28.54 66.6 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.119 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 123.305 0.642 . . . . 0.0 110.589 176.869 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.442 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 121.348 0.594 . . . . 0.0 111.762 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -138.3 147.95 44.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.074 172.001 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.43 104.9 4.58 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -85.05 156.07 21.25 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.8 ptm -140.94 131.44 25.35 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.534 0.733 . . . . 0.0 109.494 -174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.467 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . . . -111.25 102.32 10.74 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.447 0.699 . . . . 0.0 109.919 -176.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.446 ' HA ' HG12 ' A' ' 63' ' ' VAL . 27.8 mt -82.07 122.82 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.18 131.1 35.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 58' ' ' ALA . 3.9 mm? -118.11 113.54 21.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.103 0.961 . . . . 0.0 109.446 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -114.83 176.09 5.21 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.2 t70 53.95 46.39 25.71 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.135 0.897 . . . . 0.0 111.016 170.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.7 t -74.38 106.59 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.959 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.447 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 1.7 tpmt? -83.66 155.52 23.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.671 1.188 . . . . 0.0 110.735 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -116.68 123.65 47.77 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.904 0.881 . . . . 0.0 109.103 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -74.11 98.42 3.12 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.54 -35.04 78.18 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.916 0.886 . . . . 0.0 109.812 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.411 ' HG3' HG13 ' A' ' 124' ' ' ILE . 15.9 ptpt -91.03 138.07 26.2 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.289 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -83.63 77.0 3.55 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.271 2.648 . . . . 0.0 112.466 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.411 HG13 ' HG3' ' A' ' 122' ' ' LYS . 72.6 mt -84.7 131.65 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -100.28 157.58 33.56 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.02 177.41 7.8 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.209 1.939 . . . . 0.0 111.761 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -94.98 2.6 55.38 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.457 0.703 . . . . 0.0 110.278 178.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -163.43 179.95 6.95 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.941 1.296 . . . . 0.0 109.274 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.79 130.39 35.04 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.522 HG12 ' HD3' ' A' ' 10' ' ' PRO . 39.8 t -104.79 96.39 10.53 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.5 -176.67 2.35 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.02 2.48 . . . . 0.0 112.887 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.46 -35.08 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.25 1.02 . . . . 0.0 111.292 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.77 -24.24 72.71 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.59 -0.732 . . . . 0.0 113.097 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.61 165.07 37.72 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 123.344 0.497 . . . . 0.0 113.002 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -118.37 143.75 46.41 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.694 0.797 . . . . 0.0 109.613 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.409 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 0.7 OUTLIER -79.67 112.89 17.38 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 167.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.7 121.43 26.38 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 145.09 51.88 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.998 0.519 . . . . 0.0 109.988 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.244 0.807 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.512 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HD3' ' HB3' ' A' ' 139' ' ' GLU . 22.2 ptmt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 113.331 0.864 . . . . 0.0 113.331 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.7 mm 67.85 -179.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 C-N-CA 124.157 0.983 . . . . 0.0 109.61 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 139' ' ' GLU . 1.2 m -149.18 -34.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.758 1.223 . . . . 0.0 109.186 161.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.35 -164.0 26.29 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-O 121.433 0.463 . . . . 0.0 112.787 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.91 161.17 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 t -134.5 133.2 40.09 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 122.979 0.512 . . . . 0.0 109.704 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.418 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . 7.2 m-85 -134.76 140.52 35.55 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.06 0.944 . . . . 0.0 110.132 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.544 ' HD3' HG11 ' A' ' 130' ' ' VAL . 93.7 Cg_endo -76.5 -14.9 17.82 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.911 2.408 . . . . 0.0 112.431 172.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 mm 64.59 115.3 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 125.609 1.564 . . . . 0.0 109.559 -172.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -66.77 -14.9 45.63 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.095 2.53 . . . . 0.0 114.085 -168.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -132.61 -175.24 3.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.812 0.845 . . . . 0.0 110.267 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -69.33 2.99 2.5 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 124.184 0.993 . . . . 0.0 112.541 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.51 7.39 2.39 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -66.94 -34.04 76.9 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 119.024 0.829 . . . . 0.0 109.383 170.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.53 -30.04 70.38 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.595 1.158 . . . . 0.0 111.811 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -51.71 -47.35 64.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.423 1.089 . . . . 0.0 111.682 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 65.0 m-85 -66.43 -30.62 71.02 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.692 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.68 -20.17 25.22 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.573 0.749 . . . . 0.0 110.63 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -76.02 -56.92 4.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.392 1.077 . . . . 0.0 110.201 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -96.06 -18.19 20.37 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.741 -171.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.79 -28.64 2.13 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -125.11 96.02 4.7 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 124.436 1.094 . . . . 0.0 108.259 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 13.9 t70 -110.36 176.31 5.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.195 0.598 . . . . 0.0 110.076 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.5 t -136.24 111.71 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.998 0.919 . . . . 0.0 109.114 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.475 ' HD2' HD12 ' A' ' 112' ' ' ILE . 88.3 t80 -84.7 109.07 17.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.479 0.711 . . . . 0.0 110.311 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.88 138.08 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.607 0.718 . . . . 0.0 110.531 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 1.6 tpmt? -136.38 134.64 20.0 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.798 1.239 . . . . 0.0 108.461 -176.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 56.9 Cg_endo -72.86 57.0 3.07 Favored 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 122.745 2.297 . . . . 0.0 113.127 170.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.58 28.44 3.45 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 125.491 1.516 . . . . 0.0 114.005 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.478 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 5.3 m -69.66 -30.26 67.9 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.37 0.668 . . . . 0.0 110.518 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.581 HG12 HD23 ' A' ' 37' ' ' LEU . 21.9 t -85.82 149.02 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -78.14 -173.53 3.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.13 0.972 . . . . 0.0 111.811 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 7.6 tmtt? -71.59 -14.53 62.1 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 123.861 0.865 . . . . 0.0 110.188 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -51.43 -32.32 26.23 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.609 0.764 . . . . 0.0 111.245 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.581 HD23 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -69.48 102.26 1.76 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 123.568 0.747 . . . . 0.0 110.547 178.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.488 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -125.47 151.93 70.88 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.244 0.618 . . . . 0.0 109.987 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.5 99.21 0.7 Allowed 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.857 2.371 . . . . 0.0 111.611 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.77 2.69 0.88 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.497 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.493 ' HE3' ' HA ' ' A' ' 37' ' ' LEU . 29.1 mtm -92.77 -172.72 3.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.06 0.544 . . . . 0.0 111.157 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -109.99 160.01 16.79 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.906 0.882 . . . . 0.0 110.531 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.466 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.04 99.83 4.39 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.7 125.36 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.398 0.618 . . . . 0.0 109.931 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -91.01 114.24 26.72 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.753 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 37.6 t80 . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 171.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 110.848 -0.056 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.14 -32.26 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 168.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.86 -167.22 32.5 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.143 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -158.47 178.28 10.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.612 0.765 . . . . 0.0 109.246 172.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB3' HD11 ' A' ' 114' ' ' LEU . . . -161.19 -173.8 4.03 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.069 0.548 . . . . 0.0 110.646 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -120.85 120.03 34.36 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.305 1.042 . . . . 0.0 109.996 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.466 HG13 ' HB2' ' A' ' 43' ' ' PHE . 53.8 mt -70.62 138.43 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.569 1.148 . . . . 0.0 111.271 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -140.79 -166.73 2.21 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.907 2.083 . . . . 0.0 107.797 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -35.07 122.11 0.56 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.174 1.39 . . . . 0.0 114.524 -164.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.9 m -105.05 105.78 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 121.854 0.835 . . . . 0.0 109.52 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -91.75 114.56 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.593 0.757 . . . . 0.0 110.056 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.527 ' HB3' HD11 ' A' ' 108' ' ' LEU . 36.9 mt -96.41 117.95 31.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.651 0.78 . . . . 0.0 109.544 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.1 t -151.07 139.56 20.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.495 0.718 . . . . 0.0 110.354 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 24.1 mt-10 -66.76 -24.06 66.16 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.388 1.075 . . . . 0.0 111.803 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.527 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 81.5 m-20 -97.59 120.62 60.22 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.454 ' HG2' HD23 ' A' ' 87' ' ' LEU . 38.3 Cg_endo -66.03 -19.2 57.72 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.361 2.041 . . . . 0.0 112.055 171.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 56.9 mtm -71.81 -24.59 61.75 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.08 0.952 . . . . 0.0 111.012 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 16.3 mm100 -60.96 -26.33 67.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.596 0.758 . . . . 0.0 111.507 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -81.82 -25.29 35.3 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.117 0.567 . . . . 0.0 110.844 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' HD22 ' A' ' 87' ' ' LEU . 97.2 m-85 -89.66 -14.49 34.74 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.39 0.676 . . . . 0.0 111.641 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.47 -30.4 17.34 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.294 0.238 . . . . 0.0 110.619 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.8 m -78.07 -59.84 2.62 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.89 0.376 . . . . 0.0 110.771 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.764 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 58.8 m-85 -99.65 -59.1 1.78 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.529 0.732 . . . . 0.0 110.021 -173.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.98 -88.17 0.14 Allowed Glycine 0 C--N 1.356 1.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.494 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -69.49 -21.04 63.72 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.617 0.767 . . . . 0.0 111.699 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.764 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 37.4 mmt180 -72.87 -36.79 67.45 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.349 0.405 . . . . 0.0 110.433 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.433 HG13 HD21 ' A' ' 82' ' ' LEU . 21.4 t -64.07 151.4 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 122.593 0.357 . . . . 0.0 110.345 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.464 ' HD2' ' HA ' ' A' ' 27' ' ' PHE . 41.3 p90 -66.36 -7.88 21.88 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.433 HD21 HG13 ' A' ' 80' ' ' VAL . 1.9 pt? -147.69 172.04 14.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.343 0.657 . . . . 0.0 109.632 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 t -96.38 170.66 9.08 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -66.43 -26.63 67.31 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.36 0.264 . . . . 0.0 110.671 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 4.0 m-20 -60.24 -53.86 52.63 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -58.81 -33.0 69.86 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.561 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.454 HD23 ' HG2' ' A' ' 69' ' ' PRO . 28.5 tp -62.92 -58.22 8.1 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.726 0.641 . . . . 0.0 111.037 174.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -62.64 -38.77 91.55 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.593 0.558 . . . . 0.0 111.917 -171.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 12.1 pt-20 -82.96 -21.92 33.9 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.301 0.64 . . . . 0.0 111.459 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -66.54 -47.05 74.08 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.42 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 69.1 mtm -67.69 -31.53 71.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.427 0.691 . . . . 0.0 110.595 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.4 mmpt? -60.71 -52.23 66.02 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 CA--C 1.551 1.019 0 C-N-CA 123.618 0.767 . . . . 0.0 111.638 -178.5 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 121.013 0.435 . . . . 0.0 109.996 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -134.13 152.65 51.93 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 169.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.7 tm? -76.19 121.35 22.76 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -106.81 159.72 16.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.232 1.013 . . . . 0.0 109.805 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.434 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 15.8 ptm -136.56 130.72 32.81 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.045 0.938 . . . . 0.0 110.045 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.07 102.06 11.07 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.685 0.794 . . . . 0.0 109.434 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.475 HD12 ' HD2' ' A' ' 27' ' ' PHE . 42.2 mt -85.0 121.08 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.75 133.38 35.34 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -117.76 133.3 56.08 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.207 1.003 . . . . 0.0 109.502 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.78 165.36 25.79 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.66 0.784 . . . . 0.0 110.062 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.2 t70 57.23 36.83 27.88 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.365 1.041 . . . . 0.0 110.846 168.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.2 t -63.24 109.56 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.718 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 165.31 23.42 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.031 1.333 . . . . 0.0 110.663 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -130.61 124.9 32.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.552 0.741 . . . . 0.0 110.238 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -88.29 82.48 7.05 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 168.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.56 -32.36 73.08 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.514 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -80.36 148.62 67.15 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.232 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.13 103.64 1.78 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.84 2.36 . . . . 0.0 112.672 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.7 mt -125.01 130.98 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.431 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -97.9 144.26 27.7 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.904 0.882 . . . . 0.0 108.912 178.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.79 176.75 8.71 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.815 2.344 . . . . 0.0 112.932 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -64.15 -32.22 73.71 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.817 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -157.5 163.51 38.36 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 123.62 0.768 . . . . 0.0 109.88 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.27 135.11 54.98 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.997 0.919 . . . . 0.0 108.976 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.544 HG11 ' HD3' ' A' ' 10' ' ' PRO . 47.9 t -108.17 94.6 13.43 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 123.464 0.705 . . . . 0.0 109.616 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.97 -175.35 1.65 Allowed 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.069 2.513 . . . . 0.0 112.868 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.3 m -56.85 -31.19 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.46 1.104 . . . . 0.0 113.711 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.17 -14.86 81.8 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.386 0.429 . . . . 0.0 113.496 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.45 150.83 6.94 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 123.193 0.425 . . . . 0.0 112.923 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -108.81 165.36 11.62 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.575 0.75 . . . . 0.0 110.178 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.0 130.04 46.12 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.99 0.516 . . . . 0.0 109.691 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.75 124.09 38.59 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.57 148.14 46.63 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.487 ' HB2' HG12 ' A' ' 5' ' ' VAL . 3.4 tm-20 . . . . . 0 C--O 1.252 1.207 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 173.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.554 ' HZ3' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.1 mm 63.39 -172.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.09 -45.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 156.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.39 -160.87 18.61 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.168 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.98 139.79 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -107.82 132.31 53.55 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.518 0.727 . . . . 0.0 109.481 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -127.64 141.99 42.74 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.602 0.761 . . . . 0.0 110.485 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD3' HG13 ' A' ' 130' ' ' VAL . 95.9 Cg_endo -73.33 -19.81 21.83 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.167 2.578 . . . . 0.0 113.129 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mm 53.77 92.76 0.06 OUTLIER Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 125.258 1.423 . . . . 0.0 110.413 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.99 17.01 0.75 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.857 2.371 . . . . 0.0 113.291 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -124.72 153.33 42.53 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 110.24 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -11.84 61.15 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.596 1.158 . . . . 0.0 111.395 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -81.32 22.31 0.69 Allowed 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.486 1.114 . . . . 0.0 112.482 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.449 ' HG2' ' HE2' ' A' ' 20' ' ' PHE . 46.2 ttm -64.77 -41.14 96.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.971 0.908 . . . . 0.0 110.003 168.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.7 -19.23 65.64 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.979 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' NH2' ' HZ2' ' A' ' 22' ' ' LYS . 8.1 mmm180 -47.64 -51.66 20.73 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.801 1.24 . . . . 0.0 112.682 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.442 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 49.7 m-85 -69.4 -30.76 68.8 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.451 -174.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.449 ' HE2' ' HG2' ' A' ' 16' ' ' MET . 54.7 m-85 -84.48 -24.68 29.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.714 0.806 . . . . 0.0 110.314 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -68.28 -49.09 62.9 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.92 1.288 . . . . 0.0 109.903 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HZ2' ' NH2' ' A' ' 18' ' ' ARG . 14.0 ptpt -107.33 -16.55 14.36 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.545 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.46 -6.15 70.13 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 114.253 0.461 . . . . 0.0 114.253 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -157.81 111.69 2.55 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.881 0.873 . . . . 0.0 109.643 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.442 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.3 t70 -136.64 -171.54 2.94 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.42 124.73 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.261 1.391 . . . . 0.0 109.644 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -96.62 116.58 29.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.646 0.778 . . . . 0.0 109.322 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 m -89.35 146.86 5.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.494 0.664 . . . . 0.0 110.222 171.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.631 ' HG2' HG22 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -134.62 114.26 12.15 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.7 1.2 . . . . 0.0 109.047 -172.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.53 66.6 2.93 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.438 2.759 . . . . 0.0 113.478 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 108' ' ' LEU . . . 47.35 78.42 0.07 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.006 1.322 . . . . 0.0 113.454 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.458 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 37.8 m -125.49 -58.04 1.44 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.631 HG22 ' HG2' ' A' ' 29' ' ' LYS . 15.4 m -66.96 133.87 30.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.898 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -88.4 -157.58 0.43 Allowed 'General case' 0 CA--C 1.564 1.506 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.905 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -70.83 -1.77 12.73 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -166.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -67.48 -28.9 68.25 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.701 0.8 . . . . 0.0 110.419 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.577 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 1.1 mm? -66.55 119.59 11.96 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.538 0.735 . . . . 0.0 110.645 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 157.48 56.35 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.415 1.086 . . . . 0.0 109.255 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.92 88.84 0.9 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.381 2.054 . . . . 0.0 111.597 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.08 41.72 0.04 OUTLIER Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.042 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.577 ' SD ' ' HA ' ' A' ' 37' ' ' LEU . 87.1 mtp -118.94 -168.8 1.62 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.068 0.947 . . . . 0.0 109.391 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 15.2 ptpt -121.13 162.23 20.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.68 0.792 . . . . 0.0 110.276 168.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.46 ' HB2' HG13 ' A' ' 60' ' ' ILE . 17.5 t80 -134.77 97.1 3.68 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 94.1 t -83.12 119.65 32.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.39 0.614 . . . . 0.0 110.046 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -80.33 99.67 8.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.599 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.536 ' HA ' ' H ' ' A' ' 54' ' ' PHE . 67.0 t80 . . . . . 0 CA--C 1.541 0.605 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.697 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.536 ' H ' ' HA ' ' A' ' 46' ' ' TYR . 3.2 m-30 . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 121.628 0.727 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.664 HG23 ' HZ1' ' A' ' 119' ' ' LYS . 10.0 p -87.62 -15.53 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.297 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.85 -171.15 41.76 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.297 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 7.9 pt-20 -147.56 178.86 8.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.833 0.853 . . . . 0.0 110.156 174.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.41 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -158.4 -171.11 3.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.718 1.207 . . . . 0.0 109.204 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 12.7 mmt85 -129.58 118.92 22.77 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.545 0.738 . . . . 0.0 110.709 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 41' ' ' MET . 54.4 mt -72.13 133.15 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.568 1.147 . . . . 0.0 111.421 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.0 mmmt -133.18 -177.11 4.37 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 126.166 1.786 . . . . 0.0 108.533 -176.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -28.42 113.87 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 126.275 1.83 . . . . 0.0 114.904 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 112' ' ' ILE . 35.2 m -95.44 117.45 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.659 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.6 t -90.18 108.65 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.53 ' HB3' HD12 ' A' ' 108' ' ' LEU . 69.3 mt -87.14 116.7 25.39 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.407 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 46.3 m -148.71 137.05 21.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.616 0.766 . . . . 0.0 109.986 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.408 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 18.8 mt-10 -66.5 -34.82 78.79 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.11 0.964 . . . . 0.0 112.068 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.612 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 73.9 m-20 -89.1 123.8 66.44 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.89 -21.23 64.39 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 122.354 2.036 . . . . 0.0 111.732 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 37.7 mtm -74.35 -19.02 60.6 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.09 0.956 . . . . 0.0 110.91 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.612 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 17.0 mm100 -60.42 -32.41 71.33 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.278 0.631 . . . . 0.0 110.695 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 66' ' ' SER . 5.4 m-85 -77.38 -27.29 52.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.681 -177.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CE2' HD23 ' A' ' 87' ' ' LEU . 73.6 m-85 -91.11 -20.52 21.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.075 0.55 . . . . 0.0 111.94 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.17 -34.27 22.12 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.8 m -81.25 -59.68 2.55 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.999 0.52 . . . . 0.0 110.925 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.789 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 98.1 m-85 -93.19 -64.31 1.11 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.648 0.779 . . . . 0.0 110.207 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.25 -90.66 0.28 Allowed Glycine 0 C--N 1.352 1.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.375 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.29 -9.58 58.85 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.949 0.9 . . . . 0.0 111.808 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.789 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 28.0 mmt85 -78.21 -36.5 47.15 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.87 0.468 . . . . 0.0 110.262 170.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.441 HG13 HD22 ' A' ' 82' ' ' LEU . 35.1 t -75.49 140.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.287 0.635 . . . . 0.0 110.741 -176.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -57.1 -20.63 26.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 1.8 pt? -134.0 170.15 16.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 85' ' ' ASP . 6.9 t -108.11 -176.7 3.13 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 122.051 -0.405 . . . . 0.0 109.981 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.73 -25.37 67.27 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.244 0.618 . . . . 0.0 111.915 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.433 ' H ' HG22 ' A' ' 83' ' ' THR . 23.9 t70 -73.6 -36.42 65.52 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.32 0.648 . . . . 0.0 111.278 174.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.487 ' HA ' ' HG2' ' A' ' 89' ' ' GLU . 1.5 mp0 -74.51 -24.7 59.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.794 -0.566 . . . . 0.0 110.746 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.453 HD23 ' CE2' ' A' ' 73' ' ' PHE . 28.2 tp -67.57 -50.15 59.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.037 0.535 . . . . 0.0 109.691 175.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -40.45 96.11 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.465 0.478 . . . . 0.0 110.979 -175.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 8.6 pt-20 -64.86 -39.76 94.06 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -64.2 -49.46 71.91 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.987 0.915 . . . . 0.0 111.567 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 56.3 mtm -67.98 -44.89 75.61 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.402 0.681 . . . . 0.0 110.233 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -71.92 -26.25 62.22 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.883 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.488 1.467 0 CA-C-N 118.182 0.446 . . . . 0.0 110.802 174.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.26 147.21 49.73 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -176.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.53 HD12 ' HB3' ' A' ' 65' ' ' LEU . 0.4 OUTLIER -82.92 100.44 10.39 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -87.49 159.92 18.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.918 0.887 . . . . 0.0 109.646 171.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.573 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 20.8 ptm -140.18 137.51 34.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.741 0.416 . . . . 0.0 111.436 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.46 102.7 11.29 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.852 0.861 . . . . 0.0 109.949 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.451 ' HA ' HG11 ' A' ' 63' ' ' VAL . 42.6 mt -83.29 121.1 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.753 0.821 . . . . 0.0 109.021 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 39.8 tt0 -80.16 138.04 36.82 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.41 HD13 ' CB ' ' A' ' 58' ' ' ALA . 4.0 mm? -119.13 129.71 55.17 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.88 0.872 . . . . 0.0 109.837 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -128.99 173.14 10.69 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 51.43 54.58 10.83 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.1 0.952 . . . . 0.0 111.762 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.96 115.98 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.692 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER -102.27 152.58 20.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.202 1.001 . . . . 0.0 110.627 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.664 ' HZ1' HG23 ' A' ' 55' ' ' VAL . 26.0 mmmt -104.58 139.73 39.03 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.414 1.086 . . . . 0.0 109.309 170.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -91.1 72.41 6.33 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.46 -24.93 62.96 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.07 173.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.49 ' HZ1' ' HB3' ' A' ' 122' ' ' LYS . 0.2 OUTLIER -79.78 146.05 63.61 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.744 170.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.59 90.25 0.5 Allowed 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.395 2.063 . . . . 0.0 112.811 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 122' ' ' LYS . 24.7 mt -107.7 119.75 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.35 142.53 24.69 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.549 0.74 . . . . 0.0 109.556 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.74 133.98 41.74 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.33 2.02 . . . . 0.0 111.4 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -71.87 -24.6 61.71 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.829 0.851 . . . . 0.0 110.466 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.413 HH21 ' HB3' ' A' ' 135' ' ' GLN . 13.0 ptt180 -156.02 174.73 14.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.477 1.111 . . . . 0.0 109.459 174.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.87 143.49 55.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.225 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.482 HG13 ' HD3' ' A' ' 10' ' ' PRO . 60.3 t -122.83 102.14 38.57 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.89 -175.94 2.59 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.944 2.429 . . . . 0.0 111.854 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.6 p -57.68 -30.75 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 124.293 1.037 . . . . 0.0 112.751 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.34 -15.55 81.12 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.831 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.79 159.85 19.03 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.137 0.398 . . . . 0.0 113.02 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.413 ' HB3' HH21 ' A' ' 128' ' ' ARG . 31.6 mm-40 -116.98 146.92 42.71 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.783 0.833 . . . . 0.0 109.716 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -80.69 118.19 22.03 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.34 122.36 30.2 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.84 133.41 39.73 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.244 0.779 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.378 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.459 HG21 ' H ' ' A' ' 5' ' ' VAL . 21.4 mm 61.62 -163.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -171.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.459 ' H ' HG21 ' A' ' 4' ' ' ILE . 1.8 m -149.47 -42.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 155.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.15 -162.12 21.88 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.101 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.56 149.44 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -117.21 132.52 56.62 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.354 0.662 . . . . 0.0 109.716 176.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -131.83 142.21 44.39 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.142 0.977 . . . . 0.0 109.598 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HD3' HG12 ' A' ' 130' ' ' VAL . 40.6 Cg_endo -66.7 -46.82 3.24 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.402 2.068 . . . . 0.0 111.73 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.3 mt 50.83 71.91 1.4 Allowed Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.218 1.007 . . . . 0.0 108.909 -167.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.29 39.32 0.83 Allowed 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.086 2.524 . . . . 0.0 112.415 -173.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -127.66 162.7 25.92 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.242 1.417 . . . . 0.0 109.116 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -67.62 -16.16 64.02 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.712 0.805 . . . . 0.0 112.392 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -73.76 0.02 14.3 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.107 0.963 . . . . 0.0 112.913 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -67.14 -18.87 65.48 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 117.908 0.322 . . . . 0.0 111.727 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.71 -31.12 72.2 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.243 1.017 . . . . 0.0 111.841 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 12.9 mmt85 -58.15 -38.55 76.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.567 1.147 . . . . 0.0 112.942 -167.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -70.98 -31.17 67.64 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.01 0.524 . . . . 0.0 110.195 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -93.24 -8.64 41.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.902 0.881 . . . . 0.0 110.237 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -85.6 -59.36 2.34 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 124.388 1.075 . . . . 0.0 110.032 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.4 ptpt -99.47 -15.52 18.67 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.196 -170.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.23 -39.54 2.78 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 113.579 0.192 . . . . 0.0 113.579 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.425 ' HZ3' ' HB3' ' A' ' 115' ' ' GLU . 23.7 ttmm -119.54 91.34 3.53 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.911 0.885 . . . . 0.0 109.291 173.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -99.43 175.05 5.99 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.943 0.897 . . . . 0.0 110.059 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.18 110.02 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.104 0.962 . . . . 0.0 108.981 175.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -88.77 118.23 28.31 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.444 0.698 . . . . 0.0 109.684 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.94 132.96 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 121.587 0.708 . . . . 0.0 111.117 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 5.1 mmpt? -120.0 138.7 27.27 Favored Pre-proline 0 C--O 1.215 -0.759 0 C-N-CA 125.376 1.471 . . . . 0.0 109.227 176.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.422 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 73.7 Cg_endo -77.24 46.78 2.06 Favored 'Trans proline' 0 CA--C 1.56 1.803 0 C-N-CA 122.481 2.121 . . . . 0.0 111.708 162.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.43 38.1 17.3 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.319 1.448 . . . . 0.0 112.61 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.413 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 15.0 m -64.28 -38.02 89.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.564 0.746 . . . . 0.0 110.225 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.8 149.88 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.908 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.515 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 90.6 m95 -72.2 -178.55 2.5 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.771 0.828 . . . . 0.0 111.667 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -79.2 10.71 3.35 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.34 0.656 . . . . 0.0 112.27 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -75.12 -20.88 59.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.892 0.877 . . . . 0.0 110.625 174.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.482 ' HA ' ' HE1' ' A' ' 41' ' ' MET . 0.1 OUTLIER -67.27 100.79 0.84 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.642 0.777 . . . . 0.0 110.32 -176.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -119.18 152.45 52.25 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.198 0.599 . . . . 0.0 109.755 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.57 97.69 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.65 2.233 . . . . 0.0 110.936 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.6 -4.73 0.33 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.203 -174.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.482 ' HE1' ' HA ' ' A' ' 37' ' ' LEU . 31.5 mtm -89.88 -171.27 3.1 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.436 0.694 . . . . 0.0 111.689 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -112.6 162.15 16.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.227 1.011 . . . . 0.0 110.573 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 60' ' ' ILE . 3.2 t80 -136.22 102.53 5.02 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 42.1 t -88.86 121.46 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.169 0.509 . . . . 0.0 110.287 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -86.11 126.51 34.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.258 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 52.5 t80 . . . . . 0 CA--C 1.539 0.524 0 C-N-CA 124.411 1.084 . . . . 0.0 109.452 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 25.7 m-85 . . . . . 0 CA--C 1.547 0.843 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.485 HG22 ' HZ1' ' A' ' 119' ' ' LYS . 2.2 p -72.45 -36.11 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 122.829 0.452 . . . . 0.0 111.055 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.45 -160.52 21.18 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.575 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 14.9 pt-20 -154.88 177.16 11.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.606 1.162 . . . . 0.0 108.409 176.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.519 ' HB1' HD11 ' A' ' 114' ' ' LEU . . . -161.49 -173.54 3.83 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.698 0.799 . . . . 0.0 109.531 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -122.31 118.98 29.79 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.777 0.831 . . . . 0.0 109.927 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 43' ' ' PHE . 51.7 mt -68.99 127.96 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.99 174.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -138.2 -164.59 1.65 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.461 1.504 . . . . 0.0 108.311 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -34.5 114.15 0.2 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 125.123 1.369 . . . . 0.0 113.956 -162.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.5 110.89 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-O 121.38 0.61 . . . . 0.0 109.799 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 97.4 t -91.02 108.43 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.8 mt -85.96 115.68 23.72 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 53.5 m -151.94 127.37 9.99 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 40.4 mt-10 -60.99 -47.6 85.72 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.551 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 43.3 m-20 -71.69 119.48 74.39 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.65 -21.39 70.11 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.486 2.124 . . . . 0.0 111.746 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 44.6 mtm -72.4 -20.17 61.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.002 0.921 . . . . 0.0 111.071 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.551 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 17.9 mm100 -60.97 -29.02 69.42 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.244 0.618 . . . . 0.0 111.005 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' A' ' 109' ' ' TRP . 6.3 m-85 -81.93 -27.99 33.04 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.634 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CE2' HD21 ' A' ' 87' ' ' LEU . 87.0 m-85 -87.91 -18.19 29.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.163 0.585 . . . . 0.0 111.832 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.31 -33.32 20.65 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.5 m -82.4 -60.39 2.22 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.078 0.551 . . . . 0.0 111.491 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.735 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 59.5 m-85 -93.81 -55.26 3.31 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.178 0.591 . . . . 0.0 110.136 -177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.83 -89.37 0.12 Allowed Glycine 0 C--N 1.355 1.628 0 O-C-N 124.135 0.897 . . . . 0.0 113.55 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.2 -28.51 68.15 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.079 0.952 . . . . 0.0 110.829 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.735 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 16.0 mmt85 -72.2 -27.88 62.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.034 0.534 . . . . 0.0 111.892 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.4 HG11 HD21 ' A' ' 82' ' ' LEU . 25.2 t -68.72 151.76 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.4 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 41.0 p90 -63.24 -11.08 18.67 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.4 HD21 HG11 ' A' ' 80' ' ' VAL . 1.9 pt? -145.1 173.17 12.14 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.279 1.032 . . . . 0.0 109.138 174.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.538 HG22 ' HG2' ' A' ' 86' ' ' GLU . 15.1 t -104.26 173.85 6.13 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -63.6 -30.35 71.47 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.897 0.479 . . . . 0.0 111.548 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.83 -32.52 67.64 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.538 ' HG2' HG22 ' A' ' 83' ' ' THR . 26.3 mm-40 -70.01 -35.53 74.42 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 172.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.536 ' HG ' ' HE2' ' A' ' 91' ' ' MET . 18.3 tp -62.66 -52.28 63.96 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.073 0.949 . . . . 0.0 111.544 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -42.17 98.41 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.928 -173.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.26 -29.77 65.48 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 122.959 0.162 . . . . 0.0 110.785 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -66.19 -46.86 75.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.557 0.743 . . . . 0.0 110.922 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.536 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 71.7 mtm -69.08 -33.8 74.13 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.969 0.507 . . . . 0.0 110.809 -177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -76.49 -27.5 56.09 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.948 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 121.235 0.541 . . . . 0.0 109.915 176.32 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.085 0.469 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -110.5 154.29 23.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.082 0.953 . . . . 0.0 109.268 -175.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.6 tm? -73.98 116.97 15.22 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.475 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 24.0 m95 -107.85 161.77 14.61 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.867 0.867 . . . . 0.0 108.96 172.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.402 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 12.5 ptm -145.89 130.83 18.2 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.48 0.712 . . . . 0.0 110.399 -176.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -101.93 103.66 14.33 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.206 1.002 . . . . 0.0 109.694 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.4 mt -90.3 120.8 39.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -78.11 109.81 12.52 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.56 0.618 . . . . 0.0 109.459 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.519 HD11 ' HB1' ' A' ' 58' ' ' ALA . 3.9 mm? -95.45 108.69 20.92 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 123.411 0.684 . . . . 0.0 110.536 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.425 ' HB3' ' HZ3' ' A' ' 24' ' ' LYS . 10.7 pt-20 -123.31 172.64 8.49 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.5 t70 58.95 40.73 22.14 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.298 1.039 . . . . 0.0 110.63 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.9 t -70.48 107.93 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.204 -172.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -93.37 114.42 26.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.23 1.012 . . . . 0.0 111.126 -176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.485 ' HZ1' HG22 ' A' ' 55' ' ' VAL . 18.1 mmmt -74.33 136.7 42.55 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 170.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -80.5 110.68 16.19 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.88 -23.18 66.14 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.76 1.224 . . . . 0.0 111.3 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -125.25 149.21 63.31 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.568 1.147 . . . . 0.0 110.315 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.49 96.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 123.522 2.815 . . . . 0.0 113.654 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 17.3 mt -100.03 107.16 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.019 0.528 . . . . 0.0 109.67 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.52 150.25 89.01 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.872 -176.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.433 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 98.0 Cg_endo -72.94 164.88 34.33 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.079 1.852 . . . . 0.0 112.141 174.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -70.2 -41.06 74.17 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 173.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -153.46 177.01 11.38 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.522 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.69 132.93 53.42 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.136 0.974 . . . . 0.0 111.402 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.547 HG12 ' HD3' ' A' ' 10' ' ' PRO . 38.2 t -119.37 97.88 50.3 Favored Pre-proline 0 CA--C 1.553 1.079 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.65 -176.76 3.15 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.053 2.502 . . . . 0.0 112.579 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.18 -26.81 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.354 1.061 . . . . 0.0 112.079 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.04 -20.4 79.96 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.837 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.3 148.85 3.95 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.321 0.486 . . . . 0.0 113.103 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -106.96 151.45 25.27 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.355 0.662 . . . . 0.0 109.363 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.515 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 1.3 m-85 -89.82 122.9 33.32 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 174.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.03 116.84 27.61 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.89 127.32 39.93 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -171.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.585 HG13 ' HB3' ' A' ' 36' ' ' GLU . 25.3 mm 63.8 -169.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 C-N-CA 124.094 0.957 . . . . 0.0 108.764 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' H ' HG21 ' A' ' 4' ' ' ILE . 2.5 m -149.48 -41.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.988 1.315 . . . . 0.0 107.524 156.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.06 -162.57 22.59 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.81 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 p -124.18 156.46 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.425 0.69 . . . . 0.0 109.275 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -126.41 133.03 51.38 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.329 0.652 . . . . 0.0 109.285 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.24 135.85 28.09 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 123.283 0.633 . . . . 0.0 110.745 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HB3' ' HD2' ' A' ' 46' ' ' TYR . 43.1 Cg_endo -93.83 78.07 0.23 Allowed 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 124.078 3.186 . . . . 0.0 110.214 168.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.78 109.3 1.76 Allowed Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.822 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -83.93 30.86 0.52 Allowed 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.213 2.609 . . . . 0.0 112.428 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 15' ' ' PHE . 38.6 mmtm -133.41 148.68 51.81 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.428 1.491 . . . . 0.0 108.674 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -63.06 -15.96 58.3 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.011 0.924 . . . . 0.0 111.693 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.4 ' HD2' ' HB3' ' A' ' 13' ' ' LYS . 59.1 m-85 -72.89 7.05 2.2 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.375 1.07 . . . . 0.0 112.824 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.3 ttp -68.76 -24.18 64.41 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.14 0.576 . . . . 0.0 109.981 165.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.35 -29.02 70.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.998 0.919 . . . . 0.0 110.98 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 27.2 mmt180 -57.63 -41.0 80.49 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 124.382 1.051 . . . . 0.0 111.771 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 58.0 m-85 -65.1 -32.35 74.0 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 123.902 0.751 . . . . 0.0 110.042 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -89.47 -13.59 37.2 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.697 0.799 . . . . 0.0 111.125 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -82.83 -54.45 5.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.954 0.901 . . . . 0.0 110.393 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.2 ptpt -100.8 -8.89 22.22 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.712 -165.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.47 -42.17 3.13 Favored Glycine 0 N--CA 1.475 1.245 0 O-C-N 123.067 0.229 . . . . 0.0 113.109 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -129.64 106.1 8.5 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.395 0.678 . . . . 0.0 109.981 172.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.423 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.2 t70 -107.53 -177.37 3.33 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.494 1.117 . . . . 0.0 109.174 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.2 t -136.81 114.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.36 1.064 . . . . 0.0 109.229 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -85.09 111.65 19.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.599 0.759 . . . . 0.0 110.266 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.57 132.1 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-O 121.2 0.524 . . . . 0.0 110.461 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HD2' ' HD2' ' A' ' 30' ' ' PRO . 58.5 tptt -134.71 130.57 19.8 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.504 1.122 . . . . 0.0 108.335 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HD2' ' HD2' ' A' ' 29' ' ' LYS . 24.9 Cg_endo -61.68 94.95 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 121.872 1.715 . . . . 0.0 109.58 166.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -30.08 79.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.807 2.043 . . . . 0.0 115.674 -163.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 50.7 m -96.11 -30.51 13.49 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.068 172.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.82 142.7 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.315 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -67.41 168.76 10.15 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.263 0.625 . . . . 0.0 112.368 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -58.94 -11.52 3.46 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.21 1.404 . . . . 0.0 113.562 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.585 ' HB3' HG13 ' A' ' 4' ' ' ILE . 7.7 mm-40 -64.64 -17.3 63.91 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.968 0.907 . . . . 0.0 111.939 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.16 100.48 3.08 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.365 0.666 . . . . 0.0 110.04 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.3 152.33 42.57 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.77 82.93 2.03 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.66 2.24 . . . . 0.0 111.918 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.63 43.0 0.02 OUTLIER Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.122 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 34.0 mtm -122.39 -158.83 0.8 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.867 0.867 . . . . 0.0 110.026 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -121.05 158.88 26.85 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.09 0.956 . . . . 0.0 110.309 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -136.41 99.68 4.16 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 41.3 t -83.7 124.59 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.089 0.471 . . . . 0.0 110.068 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -89.51 115.32 26.84 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.498 0.719 . . . . 0.0 109.508 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 10' ' ' PRO . 85.0 t80 . . . . . 0 CA--C 1.54 0.572 0 C-N-CA 124.459 1.103 . . . . 0.0 109.481 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.484 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 17.6 m-30 . . . . . 0 CA--C 1.552 1.026 0 CA-C-O 121.216 0.532 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -77.2 -33.42 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.004 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.53 -166.4 31.77 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.843 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 2.2 pt-20 -149.61 179.36 8.05 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.576 1.15 . . . . 0.0 108.627 176.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 114' ' ' LEU . . . -158.56 -173.65 4.39 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.819 0.848 . . . . 0.0 109.509 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -127.29 116.53 20.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.411 0.684 . . . . 0.0 109.64 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -66.63 137.69 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.915 1.286 . . . . 0.0 111.425 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -141.0 -170.6 3.08 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.351 1.86 . . . . 0.0 108.564 -175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -30.62 113.98 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.586 1.554 . . . . 0.0 114.798 -168.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -97.52 108.88 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-O 121.799 0.809 . . . . 0.0 109.694 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 95.7 t -92.65 109.26 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.93 0.892 . . . . 0.0 109.795 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.56 117.66 27.67 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.4 t -152.99 135.72 15.31 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.768 0.827 . . . . 0.0 109.814 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.462 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 38.1 mt-10 -63.72 -22.16 66.77 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.062 0.545 . . . . 0.0 111.53 172.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -87.76 119.88 70.73 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.188 0.595 . . . . 0.0 109.723 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.31 -8.39 22.62 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 122.418 2.078 . . . . 0.0 112.064 167.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.403 ' HG2' ' HE2' ' A' ' 84' ' ' LYS . 51.7 mtm -89.58 -26.0 21.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.407 1.083 . . . . 0.0 111.21 -174.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.519 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 71.4 mt-30 -68.17 -20.91 64.91 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -74.52 -21.99 59.27 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.508 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.487 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 22.6 m-85 -89.99 -27.81 19.53 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.177 0.591 . . . . 0.0 111.482 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 13.0 pt-20 -76.33 -28.43 56.89 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.3 m -85.98 -60.75 1.92 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.897 0.479 . . . . 0.0 110.788 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.778 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 67.0 m-85 -101.32 -61.84 1.32 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.389 0.675 . . . . 0.0 110.205 -173.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 77.33 -87.54 1.01 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.703 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.33 -12.94 44.96 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.778 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 6.4 mmp_? -69.33 -34.05 74.05 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.291 169.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.414 HG11 HD22 ' A' ' 82' ' ' LEU . 34.7 t -67.62 147.16 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.8 0.44 . . . . 0.0 110.453 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -63.56 -22.27 66.8 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.414 HD22 HG11 ' A' ' 80' ' ' VAL . 2.1 pt? -131.38 162.06 30.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.177 0.591 . . . . 0.0 109.608 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.6 t -106.05 -176.93 3.22 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.403 ' HE2' ' HG2' ' A' ' 70' ' ' MET . 5.3 tppp? -56.39 -43.15 78.99 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.37 0.668 . . . . 0.0 111.142 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.38 -45.8 92.27 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.041 0.936 . . . . 0.0 111.772 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.52 -46.72 88.76 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 123.224 0.327 . . . . 0.0 110.45 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.449 ' HG ' ' HE3' ' A' ' 91' ' ' MET . 43.8 tp -57.27 -50.04 74.16 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.115 0.884 . . . . 0.0 111.46 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -64.28 -45.85 86.22 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.477 0.486 . . . . 0.0 110.775 -175.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.496 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 13.0 pt-20 -74.04 -24.79 59.58 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.451 0.3 . . . . 0.0 110.984 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -71.82 -49.37 39.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.718 0.807 . . . . 0.0 109.997 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.449 ' HE3' ' HG ' ' A' ' 87' ' ' LEU . 64.3 mtm -66.73 -40.76 88.51 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.89 0.744 . . . . 0.0 110.105 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -63.99 -35.59 81.2 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.714 0.634 . . . . 0.0 111.077 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 CA--C 1.55 0.956 0 C-N-CA 122.861 0.464 . . . . 0.0 110.949 176.842 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.462 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.554 1.123 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -132.65 165.05 25.35 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.445 0.698 . . . . 0.0 109.583 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.61 114.32 10.61 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.649 0.779 . . . . 0.0 109.496 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 19.5 m95 -100.35 161.99 13.24 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.319 1.048 . . . . 0.0 109.398 172.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.436 ' HE1' HD13 ' A' ' 112' ' ' ILE . 9.0 ptt? -143.25 138.93 29.96 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.933 0.397 . . . . 0.0 110.766 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.447 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . . . -109.51 103.33 12.2 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.089 0.956 . . . . 0.0 109.74 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.436 HD13 ' HE1' ' A' ' 110' ' ' MET . 22.8 mt -87.03 122.06 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.36 129.77 34.76 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 58' ' ' ALA . 3.6 mm? -117.18 107.58 14.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.795 0.838 . . . . 0.0 110.865 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -106.4 170.83 7.69 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.157 0.583 . . . . 0.0 110.327 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.6 t70 55.21 38.54 30.57 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 124.449 1.093 . . . . 0.0 111.09 168.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.3 t -66.92 101.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.523 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.32 110.66 23.17 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.921 -167.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -65.08 122.27 16.66 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.886 0.875 . . . . 0.0 110.947 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.484 ' HD2' ' HB3' ' A' ' 54' ' ' PHE . 12.8 m-30 -75.9 87.35 2.87 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.36 -30.56 70.97 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.278 172.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -81.91 131.94 55.61 Favored Pre-proline 0 CA--C 1.553 1.089 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.384 168.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.66 84.15 2.03 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.761 2.307 . . . . 0.0 111.557 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.4 mt -73.21 127.04 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.008 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -74.53 130.6 81.54 Favored Pre-proline 0 CA--C 1.553 1.066 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.865 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.45 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 65.7 Cg_endo -71.51 145.13 46.7 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.63 2.22 . . . . 0.0 110.707 169.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.55 -6.22 59.39 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.588 0.755 . . . . 0.0 111.228 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -167.83 177.98 5.46 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.621 1.168 . . . . 0.0 109.402 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.87 138.04 46.03 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 166.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.438 HG13 ' HD3' ' A' ' 10' ' ' PRO . 43.7 t -107.0 100.33 31.47 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 170.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.23 169.25 17.2 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.873 2.382 . . . . 0.0 112.138 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.419 ' HA ' ' HG2' ' A' ' 10' ' ' PRO . 18.7 m -59.25 -20.49 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -173.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.5 -21.93 76.33 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.144 0.277 . . . . 0.0 113.079 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.79 147.47 14.89 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.621 0.629 . . . . 0.0 112.096 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -108.88 148.59 30.39 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.509 0.724 . . . . 0.0 109.33 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -92.27 120.37 32.76 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.459 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.24 122.93 30.13 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 130.04 34.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.322 0.649 . . . . 0.0 109.254 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.588 -171.794 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mm 67.4 -178.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.933 1.293 . . . . 0.0 109.04 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 m -150.15 -47.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 156.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.05 -161.34 19.17 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.516 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 HD11 ' A' ' 60' ' ' ILE . 9.7 p -117.5 161.76 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -133.5 135.96 44.78 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.63 0.772 . . . . 0.0 109.25 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -136.03 146.03 54.92 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.924 0.89 . . . . 0.0 110.371 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.479 ' HD3' HG13 ' A' ' 130' ' ' VAL . 69.3 Cg_endo -70.7 -32.89 13.9 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.872 2.381 . . . . 0.0 112.624 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 mm 53.24 77.9 0.42 Allowed Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 124.105 0.962 . . . . 0.0 108.756 -168.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.17 41.65 1.14 Allowed 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.403 2.736 . . . . 0.0 112.868 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -138.49 158.95 43.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.353 1.461 . . . . 0.0 109.176 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -72.16 -10.95 60.47 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.128 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -79.51 11.61 2.96 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.43 1.092 . . . . 0.0 111.823 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 58.2 ttp -63.01 -35.37 80.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.715 0.806 . . . . 0.0 109.699 166.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.78 -26.17 68.58 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.893 0.877 . . . . 0.0 112.449 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -50.66 -48.02 58.5 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.844 0.858 . . . . 0.0 111.44 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.422 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 75.0 m-85 -67.53 -27.55 67.06 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.807 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -102.12 6.63 40.97 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.342 0.657 . . . . 0.0 110.922 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -93.52 -57.06 2.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.168 0.987 . . . . 0.0 109.41 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -110.98 -19.72 12.68 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.06 32.5 75.98 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 114.917 0.727 . . . . 0.0 114.917 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -161.86 41.77 0.14 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.278 1.031 . . . . 0.0 109.459 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' OD1' ' HA ' ' A' ' 19' ' ' PHE . 3.0 m-20 -81.93 -172.01 3.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.333 -172.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -142.36 110.69 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -86.94 111.76 21.13 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 m -83.99 140.23 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.73 0.776 . . . . 0.0 110.561 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.518 ' HD2' ' HB ' ' A' ' 32' ' ' THR . 15.2 tppt? -134.58 120.98 14.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.966 1.306 . . . . 0.0 109.699 -171.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 95.6 Cg_endo -77.54 53.86 4.5 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.13 2.554 . . . . 0.0 112.829 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 58.12 21.33 7.84 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.518 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 4.5 m -63.63 -36.42 83.77 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.349 0.522 . . . . 0.0 110.294 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -119.93 149.68 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.165 0.986 . . . . 0.0 109.092 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -167.57 -48.96 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.574 0.749 . . . . 0.0 110.348 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -41.59 -51.98 3.86 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.847 1.659 . . . . 0.0 113.641 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 22.8 mt-10 -109.68 -12.51 14.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.595 0.758 . . . . 0.0 110.306 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.436 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -69.23 115.44 8.52 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 123.294 0.637 . . . . 0.0 110.221 -177.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.85 152.15 54.8 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.992 0.917 . . . . 0.0 108.951 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.83 103.16 1.3 Allowed 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.597 2.198 . . . . 0.0 111.616 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.74 -7.07 0.91 Allowed Glycine 0 N--CA 1.476 1.348 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.789 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.519 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 79.0 mtp -83.01 -169.39 2.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.432 1.093 . . . . 0.0 111.068 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 12.3 ptpt -116.0 165.52 13.03 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.713 0.805 . . . . 0.0 110.608 168.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.534 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.1 t80 -135.37 99.06 4.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 87.3 t -84.96 120.07 34.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.23 0.538 . . . . 0.0 109.804 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -84.07 100.16 10.92 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.1 t80 . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 165.656 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.627 ' HB2' ' HB ' ' A' ' 124' ' ' ILE . 1.6 m-85 . . . . . 0 CA--C 1.544 0.734 0 CA-C-O 120.939 0.4 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.17 -38.87 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.93 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.13 -166.66 25.53 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.234 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -145.89 178.68 8.0 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.906 0.882 . . . . 0.0 108.755 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -164.16 -171.71 2.51 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.693 0.797 . . . . 0.0 110.016 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.555 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 11.3 mmt180 -128.73 122.32 30.41 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.249 1.019 . . . . 0.0 109.401 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.534 HG13 ' HB2' ' A' ' 43' ' ' PHE . 57.8 mt -74.34 131.37 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.201 1.0 . . . . 0.0 110.322 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -139.31 -164.71 1.72 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.925 1.69 . . . . 0.0 108.357 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -24.78 109.93 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 126.378 1.871 . . . . 0.0 114.769 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 112' ' ' ILE . 35.0 m -98.76 109.04 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -89.62 110.23 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -87.96 118.26 27.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.516 0.727 . . . . 0.0 109.669 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.3 t -153.62 134.86 14.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.781 0.832 . . . . 0.0 109.581 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 49.3 mt-10 -70.03 -17.53 63.26 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.102 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 36.5 m-80 -91.66 118.76 68.51 Favored Pre-proline 0 C--N 1.357 0.892 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.21 -10.83 30.05 Favored 'Trans proline' 0 CA--C 1.556 1.615 0 C-N-CA 122.473 2.115 . . . . 0.0 112.259 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 46.4 mtm -81.25 -27.56 35.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.168 0.987 . . . . 0.0 111.499 -176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.481 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 47.5 mt-30 -66.21 -24.01 66.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.387 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -74.08 -25.2 59.69 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.872 0.469 . . . . 0.0 110.866 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -80.87 -37.34 30.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.0 0.52 . . . . 0.0 110.892 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.55 -29.03 61.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 121.294 -0.162 . . . . 0.0 111.35 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.4 m -80.74 -47.22 14.26 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.981 0.512 . . . . 0.0 110.682 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.496 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 62.7 m-85 -116.33 -67.23 1.01 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.265 0.626 . . . . 0.0 109.935 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.76 -81.13 1.15 Allowed Glycine 0 C--N 1.35 1.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.835 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.5 -43.97 93.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.902 0.881 . . . . 0.0 110.83 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 25.8 mmt180 -66.44 -30.68 71.09 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.553 -176.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.413 HG13 HD23 ' A' ' 82' ' ' LEU . 40.3 t -66.03 131.21 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -62.51 -22.16 66.07 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -168.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.413 HD23 HG13 ' A' ' 80' ' ' VAL . 2.3 pt? -128.07 160.89 30.58 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 t -97.01 179.33 4.97 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.913 0.324 . . . . 0.0 110.383 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -62.95 -32.59 73.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.104 0.562 . . . . 0.0 111.452 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.5 -45.8 78.38 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.33 0.652 . . . . 0.0 110.627 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.93 -35.46 76.77 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.44 173.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 tp -64.14 -52.73 57.7 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.546 0.529 . . . . 0.0 110.874 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -67.14 -40.44 86.74 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.256 0.348 . . . . 0.0 111.365 -173.114 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.71 -33.32 73.74 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -63.64 -48.26 77.97 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.973 0.909 . . . . 0.0 110.292 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.5 mtm -65.58 -33.0 74.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.052 0.541 . . . . 0.0 110.388 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.2 mmpt? -71.4 -34.89 70.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.621 0.368 . . . . 0.0 110.957 175.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 122.932 0.493 . . . . 0.0 110.543 179.072 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.479 ' H ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 121.132 0.491 . . . . 0.0 112.096 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.4 tpmt? -101.46 151.53 21.83 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.435 -174.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.515 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 2.9 tm? -73.45 110.31 7.65 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 173.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -89.8 158.47 17.48 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.44 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 12.3 ptm -139.51 129.05 24.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.16 0.584 . . . . 0.0 109.796 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.87 100.95 11.67 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 63' ' ' VAL . 23.3 mt -80.95 117.98 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -80.66 110.08 15.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.52 0.676 . . . . 0.0 109.67 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.67 131.62 34.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.405 1.082 . . . . 0.0 109.824 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -139.07 173.29 11.71 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.18 0.592 . . . . 0.0 109.463 171.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.9 t70 56.17 34.56 24.13 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.856 0.862 . . . . 0.0 110.946 170.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.9 t -65.89 106.82 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.698 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.265 -175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.95 162.84 19.26 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.6 1.16 . . . . 0.0 109.969 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.87 124.12 42.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.697 0.799 . . . . 0.0 109.336 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -79.68 103.4 9.56 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.266 0.555 . . . . 0.0 109.674 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.83 -28.23 68.83 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.671 1.188 . . . . 0.0 110.589 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -88.34 139.85 30.24 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.973 0.909 . . . . 0.0 109.831 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.4 92.22 0.94 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.709 2.273 . . . . 0.0 111.86 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 41.5 mt -80.34 138.38 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.88 140.24 23.5 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.67 123.39 12.91 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.53 2.153 . . . . 0.0 112.095 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -57.73 -34.05 69.1 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.553 0.741 . . . . 0.0 109.432 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -150.61 164.69 35.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.388 1.075 . . . . 0.0 109.056 172.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.55 126.52 29.91 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.36 0.664 . . . . 0.0 109.522 -175.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.479 HG13 ' HD3' ' A' ' 10' ' ' PRO . 19.1 t -109.51 99.73 38.62 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.65 -172.85 1.52 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.91 2.407 . . . . 0.0 112.137 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.23 -34.81 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.965 0.906 . . . . 0.0 110.966 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.77 -21.1 77.92 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.203 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.74 163.26 26.71 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 122.92 0.295 . . . . 0.0 113.12 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -115.54 149.89 37.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.999 0.919 . . . . 0.0 109.961 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 9.2 m-85 -85.24 120.1 26.35 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 169.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.7 125.54 33.95 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 128.86 42.28 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 C--O 1.247 0.965 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -171.75 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.485 HG13 ' HB3' ' A' ' 36' ' ' GLU . 27.1 mm 64.35 -168.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.665 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -170.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.3 m -147.31 -39.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.024 0.929 . . . . 0.0 108.729 158.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.02 -161.83 21.21 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.284 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 13.4 p -127.88 155.12 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 t -126.94 136.63 52.54 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -137.15 139.95 29.74 Favored Pre-proline 0 N--CA 1.469 0.522 0 C-N-CA 124.419 1.088 . . . . 0.0 109.369 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 15.4 Cg_exo -65.76 -47.0 4.27 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 123.079 2.519 . . . . 0.0 110.825 169.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.6 mt 67.95 136.12 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 125.366 1.466 . . . . 0.0 110.2 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HB2' ' HD2' ' A' ' 15' ' ' PHE . 81.6 Cg_exo -48.06 124.98 10.98 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.236 1.957 . . . . 0.0 111.356 171.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -59.31 -16.8 24.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.518 1.127 . . . . 0.0 113.052 -174.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -66.98 -45.64 77.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.571 0.748 . . . . 0.0 110.797 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.466 ' HD2' ' HB2' ' A' ' 12' ' ' PRO . 76.3 m-85 -101.2 1.56 39.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.414 1.086 . . . . 0.0 112.071 -174.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -73.15 -40.8 64.56 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.211 0.604 . . . . 0.0 110.354 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -63.86 -25.34 68.12 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.504 0.721 . . . . 0.0 112.132 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -50.67 -44.25 57.64 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 124.96 1.304 . . . . 0.0 112.581 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.539 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 47.9 m-85 -70.37 -27.13 64.08 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.494 0.718 . . . . 0.0 111.526 -174.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -95.97 -17.78 20.75 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.186 0.994 . . . . 0.0 110.15 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -74.6 -58.73 3.1 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.637 1.175 . . . . 0.0 110.506 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -92.57 -14.0 28.89 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.924 -172.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.13 -58.89 4.22 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.813 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -109.88 104.72 13.69 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.317 0.558 . . . . 0.0 110.186 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 11.4 t70 -101.63 179.23 4.41 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.176 0.99 . . . . 0.0 109.757 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.0 t -138.06 110.84 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.393 1.077 . . . . 0.0 109.023 171.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -88.48 111.45 21.83 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.707 0.803 . . . . 0.0 109.937 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.8 m -90.44 126.88 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.619 0.723 . . . . 0.0 111.149 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.542 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 7.4 mmpt? -110.18 134.97 20.6 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.124 1.369 . . . . 0.0 109.726 173.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.77 56.6 6.02 Favored 'Trans proline' 0 CA--C 1.557 1.668 0 C-N-CA 122.501 2.134 . . . . 0.0 110.909 166.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' HB2' ' HE2' ' A' ' 107' ' ' LYS . . . 50.79 37.51 17.16 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.035 1.334 . . . . 0.0 112.919 -176.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.542 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 10.7 m -64.65 -43.39 93.79 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.954 0.902 . . . . 0.0 110.246 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.41 151.32 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.081 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -73.5 -177.38 2.63 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.392 1.077 . . . . 0.0 112.016 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -68.2 -3.72 11.58 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.036 0.934 . . . . 0.0 113.018 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' HB3' HG13 ' A' ' 4' ' ' ILE . 9.5 mm-40 -66.57 -24.81 66.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.214 0.606 . . . . 0.0 110.773 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.515 ' HA ' ' HE3' ' A' ' 41' ' ' MET . 0.1 OUTLIER -68.86 94.65 0.63 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.935 0.494 . . . . 0.0 109.891 178.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.471 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -115.12 149.99 43.54 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.207 0.603 . . . . 0.0 109.438 177.293 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.481 ' HA ' HG23 ' A' ' 60' ' ' ILE . 59.9 Cg_endo -70.95 103.17 1.32 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.948 2.432 . . . . 0.0 110.699 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.64 -16.05 1.09 Allowed Glycine 0 C--O 1.241 0.54 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.512 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.515 ' HE3' ' HA ' ' A' ' 37' ' ' LEU . 25.8 mtm -73.48 -174.49 1.69 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.362 0.665 . . . . 0.0 112.185 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -109.45 159.44 17.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.845 0.858 . . . . 0.0 110.456 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.9 t80 -137.0 98.14 3.68 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 46.7 t -84.55 129.4 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 109.955 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -93.0 119.28 32.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.564 0.746 . . . . 0.0 110.042 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 52.1 t80 . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 124.875 1.27 . . . . 0.0 109.111 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.48 HG21 ' HZ1' ' A' ' 119' ' ' LYS . 3.2 p -85.3 -31.32 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.997 0.919 . . . . 0.0 110.782 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.33 -162.9 26.09 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.869 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 15.2 pt-20 -153.72 178.0 10.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.804 1.242 . . . . 0.0 108.215 175.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HB3' HD11 ' A' ' 114' ' ' LEU . . . -164.24 -176.17 4.31 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.592 0.757 . . . . 0.0 110.091 177.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -122.92 130.6 53.03 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.641 0.776 . . . . 0.0 109.889 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.481 HG23 ' HA ' ' A' ' 39' ' ' PRO . 45.4 mt -74.39 138.1 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.039 1.336 . . . . 0.0 110.751 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -133.4 -168.62 2.13 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.722 2.009 . . . . 0.0 108.438 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -31.28 113.03 0.1 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 126.113 1.765 . . . . 0.0 113.967 -166.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.3 m -92.79 103.23 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.492 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 86.7 t -90.71 109.0 20.35 Favored 'Isoleucine or valine' 0 C--N 1.348 0.512 0 C-N-CA 123.682 0.793 . . . . 0.0 109.067 -172.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.5 mt -84.85 118.54 24.55 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.5 t -149.31 130.35 14.41 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.785 0.834 . . . . 0.0 109.202 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.438 ' HG3' HD21 ' A' ' 108' ' ' LEU . 25.9 mt-10 -67.33 -15.9 63.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.745 0.818 . . . . 0.0 111.513 173.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -103.49 119.32 55.26 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 123.534 0.734 . . . . 0.0 109.099 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.42 -13.37 39.01 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.368 2.046 . . . . 0.0 112.663 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.0 mtm -82.6 -27.94 31.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.643 0.777 . . . . 0.0 111.479 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.51 -22.4 66.72 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.771 0.319 . . . . 0.0 111.545 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -71.99 -25.63 61.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.039 0.535 . . . . 0.0 110.833 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.461 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 21.2 m-85 -87.72 -27.41 22.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.822 0.449 . . . . 0.0 111.572 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.94 -29.04 55.45 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.591 0.234 . . . . 0.0 110.717 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.6 m -86.32 -46.91 9.86 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.136 0.575 . . . . 0.0 111.443 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.75 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 69.3 m-85 -116.01 -62.89 1.53 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.469 0.708 . . . . 0.0 110.082 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 72.35 -92.06 0.57 Allowed Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.019 -0.537 . . . . 0.0 113.382 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.32 -19.2 61.7 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.647 0.779 . . . . 0.0 111.064 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.75 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 23.0 mmt180 -70.67 -37.84 73.72 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.573 173.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.9 t -63.65 149.62 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.711 0.405 . . . . 0.0 110.199 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -64.03 -16.04 60.79 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.0 pt? -142.12 158.59 43.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.476 1.111 . . . . 0.0 108.686 174.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.482 HG23 ' HG3' ' A' ' 86' ' ' GLU . 13.8 t -100.44 -177.53 3.53 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.68 -35.85 79.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.535 0.734 . . . . 0.0 111.751 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.68 -44.99 94.84 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.577 0.751 . . . . 0.0 110.813 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 30.0 mt-10 -72.13 -26.38 62.09 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.68 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.537 ' HG ' ' HE3' ' A' ' 91' ' ' MET . 24.9 tp -71.36 -50.96 26.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.418 0.687 . . . . 0.0 110.785 176.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -36.66 83.13 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.542 0.337 . . . . 0.0 111.205 -173.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.67 -32.88 68.34 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 175.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -65.0 -46.46 81.3 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.716 0.807 . . . . 0.0 110.986 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.537 ' HE3' ' HG ' ' A' ' 87' ' ' LEU . 72.3 mtm -70.43 -39.0 74.66 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.962 0.505 . . . . 0.0 110.696 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -67.16 -32.34 73.37 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.35 0.26 . . . . 0.0 110.675 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 123.149 0.58 . . . . 0.0 110.66 174.942 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.702 0.287 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.523 ' HE2' ' HB2' ' A' ' 31' ' ' ALA . 4.3 tmtp? -85.31 145.9 27.29 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.983 0.913 . . . . 0.0 109.292 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.47 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 3.1 tm? -76.33 107.62 8.71 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 170.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -91.75 162.31 14.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.825 0.85 . . . . 0.0 109.333 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.6 ptm -141.49 131.26 24.25 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.955 0.902 . . . . 0.0 109.321 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.492 ' HB1' ' HB ' ' A' ' 64' ' ' VAL . . . -102.45 101.56 11.78 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.3 mt -80.26 115.09 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -77.96 139.83 39.2 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.407 HD11 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -119.68 131.35 55.4 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.904 0.882 . . . . 0.0 109.292 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -136.39 168.85 18.67 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.744 1.218 . . . . 0.0 109.459 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.6 t70 53.42 36.7 23.74 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.412 1.085 . . . . 0.0 111.21 168.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.69 103.71 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.739 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -90.19 108.51 19.79 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.386 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.48 ' HZ1' HG21 ' A' ' 55' ' ' VAL . 6.6 mmmt -73.5 130.46 40.15 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -78.99 120.25 23.31 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -60.91 -35.3 76.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.022 0.929 . . . . 0.0 110.349 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -116.39 147.62 39.97 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.776 1.231 . . . . 0.0 109.798 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -64.8 97.13 0.27 Allowed 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 123.308 2.672 . . . . 0.0 111.591 172.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.5 mt -83.25 115.53 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.9 147.64 91.55 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.72 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.16 154.81 8.24 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.473 2.115 . . . . 0.0 112.179 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -74.01 -23.11 59.38 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.44 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -150.35 160.35 43.79 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.989 0.915 . . . . 0.0 109.342 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.8 120.62 21.42 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.7 t -94.49 109.49 43.41 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.54 179.77 6.2 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.95 2.433 . . . . 0.0 111.838 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.4 t -59.15 -32.83 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 124.2 1.0 . . . . 0.0 111.794 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.64 -16.62 72.14 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.558 -0.747 . . . . 0.0 113.641 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.04 160.62 15.17 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.119 0.39 . . . . 0.0 113.149 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -118.1 139.07 51.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.599 0.759 . . . . 0.0 109.458 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 106.91 11.79 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.49 114.12 18.17 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.07 148.96 30.72 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.253 1.239 0 CA-C-N 118.217 0.462 . . . . 0.0 110.127 172.189 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.1 mm 68.78 178.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 C-N-CA 124.612 1.165 . . . . 0.0 109.759 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -145.41 -43.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.619 1.168 . . . . 0.0 108.181 160.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.97 -159.17 15.16 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.724 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 60' ' ' ILE . 10.0 p -122.9 151.33 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -123.29 135.56 54.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.843 0.857 . . . . 0.0 109.528 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -137.47 138.88 25.81 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.556 0.742 . . . . 0.0 111.064 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HD3' HG11 ' A' ' 130' ' ' VAL . 91.0 Cg_endo -74.35 -9.57 21.77 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.76 2.307 . . . . 0.0 111.86 169.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 mm 64.83 116.64 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.638 1.575 . . . . 0.0 109.284 -175.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.56 -11.49 20.36 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.815 2.343 . . . . 0.0 113.841 -172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HE2' ' HD1' ' A' ' 90' ' ' TYR . 63.8 mttm -133.66 176.91 8.12 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.543 1.137 . . . . 0.0 110.693 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -71.99 -5.91 38.3 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.021 0.929 . . . . 0.0 112.002 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -73.43 15.13 0.27 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.2 ptp -56.7 -32.29 65.32 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 157.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.28 -45.87 35.21 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.549 1.54 . . . . 0.0 111.79 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 84.2 mmt-85 -58.08 -36.58 73.03 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.134 0.896 . . . . 0.0 112.501 -173.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' HB3' HG13 ' A' ' 117' ' ' VAL . 74.5 m-85 -66.35 -29.35 69.52 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.419 0.45 . . . . 0.0 110.565 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -98.23 -15.31 19.9 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.768 0.827 . . . . 0.0 110.928 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HB3' ' HA ' ' A' ' 18' ' ' ARG . 5.8 tmtm? -78.31 -48.06 16.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.78 1.232 . . . . 0.0 110.275 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.7 ptpt -102.55 -12.36 17.83 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.568 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.94 -14.03 59.74 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.988 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -164.0 114.72 1.3 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.834 0.854 . . . . 0.0 109.4 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 18.9 t70 -133.83 -175.37 3.81 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.1 0.96 . . . . 0.0 110.296 -162.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 113' ' ' GLU . 76.9 t -135.87 119.28 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 121.278 -0.889 . . . . 0.0 109.417 176.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -93.69 115.77 28.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.323 0.649 . . . . 0.0 109.929 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.8 m -93.68 143.56 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.838 0.827 . . . . 0.0 111.163 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.592 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.6 mmpt? -130.15 136.18 28.62 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 126.225 1.81 . . . . 0.0 108.951 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.72 55.21 5.12 Favored 'Trans proline' 0 CA--C 1.552 1.388 0 C-N-CA 122.421 2.081 . . . . 0.0 111.149 166.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.56 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.063 1.345 . . . . 0.0 112.394 -170.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.592 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 24.8 m -126.45 -50.84 1.51 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.35 107.52 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.858 0.863 . . . . 0.0 109.253 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -146.06 1.18 0.86 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.228 0.611 . . . . 0.0 111.533 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 7.6 mtpm? -64.47 -53.62 45.43 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.453 0.644 . . . . 0.0 110.275 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -109.4 -7.98 15.12 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.424 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.459 ' HA ' ' HE3' ' A' ' 41' ' ' MET . 0.1 OUTLIER -65.33 107.11 1.53 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.571 0.748 . . . . 0.0 110.872 -172.407 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.464 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -135.9 152.26 75.44 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.279 0.632 . . . . 0.0 109.909 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.06 102.5 1.08 Allowed 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.971 2.447 . . . . 0.0 111.32 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.25 -19.83 1.2 Allowed Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.666 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.464 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 30.1 mtm -74.64 -177.88 3.38 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.078 0.466 . . . . 0.0 111.234 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -104.04 163.07 12.63 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.341 0.656 . . . . 0.0 110.869 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.464 ' CB ' HD11 ' A' ' 114' ' ' LEU . 2.5 t80 -134.55 102.03 5.16 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 48.7 t -90.17 123.87 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.339 0.59 . . . . 0.0 110.137 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.36 111.43 19.42 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.743 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 76.5 t80 . . . . . 0 CA--C 1.544 0.713 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.399 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.699 HG23 ' HZ1' ' A' ' 119' ' ' LYS . 13.8 p -79.55 -19.69 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.709 0.804 . . . . 0.0 111.279 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.42 -171.45 40.94 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.093 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 21.2 pt-20 -153.82 178.95 9.33 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.788 0.835 . . . . 0.0 109.861 171.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -165.26 -171.33 2.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.705 0.802 . . . . 0.0 110.354 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -123.03 122.44 38.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.65 0.78 . . . . 0.0 111.362 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.436 HD11 HG11 ' A' ' 7' ' ' VAL . 74.6 mt -69.02 136.99 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.445 1.098 . . . . 0.0 111.224 175.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 30.9 mmmt -136.58 -167.73 2.12 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 126.877 2.071 . . . . 0.0 107.697 -177.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -39.88 112.89 0.3 Allowed 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 125.187 1.395 . . . . 0.0 113.706 -166.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.02 106.93 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 95.6 t -90.11 109.53 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.395 0.678 . . . . 0.0 109.26 -174.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.472 ' HB3' HD13 ' A' ' 108' ' ' LEU . 39.1 mt -91.26 115.98 28.46 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 t -151.66 129.66 11.79 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.781 0.832 . . . . 0.0 109.137 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.482 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 45.0 mt-10 -61.75 -21.26 64.38 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.374 0.67 . . . . 0.0 112.248 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -100.58 118.97 59.9 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HG2' HD23 ' A' ' 87' ' ' LEU . 56.3 Cg_endo -69.16 -8.69 24.29 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.956 2.437 . . . . 0.0 113.085 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 50.6 mtm -79.9 -24.72 40.94 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.383 0.673 . . . . 0.0 111.205 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.461 HE21 ' N ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -60.33 -26.49 66.61 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.607 0.763 . . . . 0.0 111.527 175.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -76.71 -20.49 56.51 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.06 0.544 . . . . 0.0 111.116 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -85.81 -38.36 18.25 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.822 0.449 . . . . 0.0 110.537 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -72.42 -23.48 61.09 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 120.34 0.114 . . . . 0.0 111.0 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.3 m -88.5 -44.33 10.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.236 0.614 . . . . 0.0 111.063 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.75 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 64.7 m-85 -118.11 -66.96 1.03 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.071 0.548 . . . . 0.0 110.332 -176.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.09 -81.21 0.68 Allowed Glycine 0 C--N 1.355 1.62 0 O-C-N 123.472 0.483 . . . . 0.0 113.304 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.89 -27.66 69.51 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.363 1.065 . . . . 0.0 111.499 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.75 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 38.6 mmt180 -81.38 -33.12 32.54 Favored 'General case' 0 C--O 1.209 -1.072 0 O-C-N 123.992 0.807 . . . . 0.0 111.975 -176.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 HD22 ' A' ' 82' ' ' LEU . 21.7 t -66.57 145.47 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 118.451 0.569 . . . . 0.0 110.459 -174.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.438 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 34.7 p90 -64.05 -17.25 63.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.446 HD22 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -140.31 158.18 44.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.3 t -95.27 179.56 5.14 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -65.51 -27.13 68.25 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.518 0.727 . . . . 0.0 111.518 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.91 -49.64 67.31 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.905 0.882 . . . . 0.0 110.506 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -62.65 -31.45 72.32 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.186 176.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.523 ' HG ' ' HE2' ' A' ' 91' ' ' MET . 46.1 tp -67.78 -52.15 40.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.433 0.693 . . . . 0.0 111.093 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -63.18 -38.58 91.73 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.234 0.334 . . . . 0.0 111.366 -174.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 13.0 pt-20 -78.88 -23.68 44.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.728 0.411 . . . . 0.0 111.343 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.403 ' HD1' ' HE2' ' A' ' 13' ' ' LYS . 56.9 t80 -66.08 -38.96 89.6 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.378 0.671 . . . . 0.0 109.97 170.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.523 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 71.6 mtm -77.57 -30.82 52.77 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.454 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.8 mmpt? -71.14 -28.83 64.56 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.397 0.279 . . . . 0.0 110.516 171.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.478 0.937 0 C-N-CA 123.388 0.675 . . . . 0.0 110.83 179.083 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 4.2 tmtp? -86.24 140.11 30.43 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' A' ' 65' ' ' LEU . 2.8 tm? -74.28 107.83 6.69 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -89.04 161.85 16.33 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.552 0.741 . . . . 0.0 109.533 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.465 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 15.1 ptm -145.56 131.04 18.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.822 0.849 . . . . 0.0 109.781 -175.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . . . -106.58 101.97 11.38 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.222 0.609 . . . . 0.0 109.56 -178.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.2 mt -78.4 115.46 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -80.95 133.75 35.58 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -177.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 58' ' ' ALA . 3.3 mm? -122.92 122.3 38.25 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.455 0.702 . . . . 0.0 111.279 -174.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -124.41 165.23 18.1 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.572 0.749 . . . . 0.0 110.313 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.0 t70 50.23 53.25 13.2 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.124 1.37 . . . . 0.0 111.29 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 19' ' ' PHE . 41.9 t -74.7 101.45 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.671 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -81.74 146.27 30.06 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.526 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.699 ' HZ1' HG23 ' A' ' 55' ' ' VAL . 19.6 mmmt -101.3 134.86 43.72 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.626 0.771 . . . . 0.0 109.337 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -86.43 88.14 7.57 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 170.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.24 -26.04 63.66 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.649 0.738 . . . . 0.0 109.066 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -81.24 135.98 50.19 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.645 173.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.06 91.94 1.15 Allowed 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.793 2.329 . . . . 0.0 112.573 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.5 mt -105.36 125.11 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.443 0.639 . . . . 0.0 110.651 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.63 148.35 34.46 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.703 1.201 . . . . 0.0 109.338 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.423 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 64.2 Cg_endo -77.9 178.43 7.61 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.194 2.596 . . . . 0.0 113.562 -170.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -84.74 -38.65 19.42 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.131 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -142.22 166.24 25.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.067 0.547 . . . . 0.0 110.832 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.79 134.93 53.14 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 124.236 0.96 . . . . 0.0 109.779 174.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.45 HG11 ' HD3' ' A' ' 10' ' ' PRO . 41.0 t -118.29 102.23 50.62 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.93 178.9 2.55 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.326 2.684 . . . . 0.0 112.249 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.4 t -60.19 -31.74 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.77 0.828 . . . . 0.0 111.07 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.49 -12.53 77.28 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 115.572 -0.74 . . . . 0.0 114.287 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.65 157.83 16.96 Favored Glycine 0 C--N 1.35 1.357 0 C-N-CA 123.035 0.35 . . . . 0.0 113.662 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -117.83 147.23 43.25 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.709 0.803 . . . . 0.0 110.394 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -77.85 112.63 14.92 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 167.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.66 128.94 34.01 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.05 134.98 35.42 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.77 0.428 . . . . 0.0 110.521 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 . . . . . 0 C--O 1.25 1.089 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.779 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.9 mm 64.5 -173.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.599 0 C-N-CA 124.045 0.938 . . . . 0.0 108.55 -174.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.1 m -152.43 -42.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 158.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.63 -159.69 16.03 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.611 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 11.6 p -126.63 152.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 171.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 t -123.72 134.57 53.67 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -127.37 151.08 74.25 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.519 0.728 . . . . 0.0 110.01 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.558 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 56.8 Cg_endo -65.87 -34.46 39.31 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.854 2.369 . . . . 0.0 111.868 175.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.4 mm 67.62 132.98 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.935 1.294 . . . . 0.0 111.198 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.23 110.66 0.68 Allowed 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 121.832 1.688 . . . . 0.0 109.74 165.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 16' ' ' MET . 19.3 pttp -68.77 -3.89 13.98 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -174.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -66.83 -40.52 88.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.602 1.161 . . . . 0.0 109.063 170.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -116.54 16.52 15.54 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.316 1.046 . . . . 0.0 112.0 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.758 ' HB2' ' HA ' ' A' ' 13' ' ' LYS . 56.6 ttp -62.27 -47.04 86.12 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.087 0.555 . . . . 0.0 110.426 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.66 -2.48 20.27 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.906 -175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 1.9 mmm180 -63.19 -49.77 72.94 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.052 0.541 . . . . 0.0 110.3 173.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 51.1 m-85 -61.93 -29.08 69.99 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 124.007 0.817 . . . . 0.0 110.395 -178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -96.97 -12.86 22.82 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.205 1.002 . . . . 0.0 111.527 -174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.69 -50.18 14.3 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.842 0.857 . . . . 0.0 109.479 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.4 ptpt -101.07 -16.64 17.02 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.06 -169.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.87 -11.32 48.16 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-O 119.839 -0.423 . . . . 0.0 114.118 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -159.73 117.54 2.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.028 0.931 . . . . 0.0 109.428 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.46 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 17.9 t70 -124.88 -176.21 3.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.248 1.019 . . . . 0.0 109.307 -172.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -132.27 110.33 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.148 0.979 . . . . 0.0 108.791 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -90.54 109.25 20.4 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 110.0 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.4 m -85.8 129.03 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.545 0.688 . . . . 0.0 111.121 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -112.65 142.42 27.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.896 1.278 . . . . 0.0 109.518 170.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.41 46.23 2.07 Favored 'Trans proline' 0 C--N 1.367 1.5 0 C-N-CA 122.692 2.262 . . . . 0.0 112.16 168.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.21 86.42 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.201 1.401 . . . . 0.0 112.495 -172.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -122.31 7.43 9.63 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.595 0.758 . . . . 0.0 109.842 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.42 ' HB ' ' OH ' ' A' ' 136' ' ' TYR . 14.1 m -127.92 150.16 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.385 1.074 . . . . 0.0 109.776 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -80.9 -172.81 3.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.307 0.643 . . . . 0.0 110.99 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -73.1 9.53 1.19 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -71.61 -29.43 64.67 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.875 0.47 . . . . 0.0 109.845 172.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.42 ' HA ' ' HE3' ' A' ' 41' ' ' MET . 0.3 OUTLIER -65.89 104.85 1.17 Allowed 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.055 0.542 . . . . 0.0 110.053 179.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.5 153.65 77.86 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 123.279 0.632 . . . . 0.0 109.784 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.81 97.12 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.761 2.307 . . . . 0.0 111.094 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.45 43.48 0.1 OUTLIER Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.495 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.42 ' HE3' ' HA ' ' A' ' 37' ' ' LEU . 32.5 mtm -126.94 -171.59 2.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.79 0.836 . . . . 0.0 109.525 174.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.6 ptpt -112.7 158.54 19.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.276 0.63 . . . . 0.0 110.251 169.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.55 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.2 t80 -135.67 101.25 4.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 40.7 t -86.18 130.18 36.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -95.56 112.69 24.36 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.258 0.623 . . . . 0.0 109.455 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 90.1 t80 . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.451 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 62.9 m-85 . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG11 ' SD ' ' A' ' 16' ' ' MET . 3.3 p -87.31 -30.12 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.661 0.784 . . . . 0.0 110.471 174.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.4 -157.76 20.37 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 120.062 -0.299 . . . . 0.0 112.768 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 16.2 pt-20 -154.17 178.61 9.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.179 0.992 . . . . 0.0 109.293 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 114' ' ' LEU . . . -166.76 -172.66 2.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.01 0.924 . . . . 0.0 110.177 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 61.4 mmt-85 -128.22 125.5 39.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.858 0.863 . . . . 0.0 109.69 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.55 HG13 ' HB2' ' A' ' 43' ' ' PHE . 41.3 mt -73.63 137.08 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.199 1.0 . . . . 0.0 111.767 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -134.94 -176.88 4.39 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 126.879 2.072 . . . . 0.0 108.081 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -30.96 112.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.932 1.693 . . . . 0.0 114.328 -170.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -91.61 106.26 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -88.22 110.78 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.4 mt -92.59 119.86 32.46 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.366 0.666 . . . . 0.0 109.436 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.2 t -151.51 134.24 15.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 44.4 mt-10 -74.67 -0.98 19.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.797 0.839 . . . . 0.0 112.299 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.64 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 12.9 m-80 -112.66 120.16 41.62 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.2 -20.84 55.89 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.342 2.028 . . . . 0.0 112.345 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 65.4 mtm -71.79 -24.63 61.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.184 0.994 . . . . 0.0 111.091 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.64 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 36.4 mm-40 -62.58 -28.89 70.19 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.875 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -76.31 -20.06 57.65 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.728 0.411 . . . . 0.0 111.185 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.402 ' HE2' HD22 ' A' ' 87' ' ' LEU . 87.7 m-85 -93.45 -19.56 21.14 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.9 0.48 . . . . 0.0 111.09 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 9.1 pt-20 -84.8 -30.4 24.62 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.808 0.276 . . . . 0.0 110.573 168.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.3 m -80.39 -58.9 2.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.953 0.501 . . . . 0.0 110.644 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.649 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 85.8 m-85 -100.85 -69.68 0.77 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.73 -78.03 0.5 Allowed Glycine 0 C--N 1.353 1.516 0 O-C-N 123.5 0.5 . . . . 0.0 112.622 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.85 -44.68 91.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.756 1.222 . . . . 0.0 111.463 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.649 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 61.1 mmt-85 -64.97 -30.17 71.14 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.677 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.73 149.79 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.563 0.745 . . . . 0.0 111.142 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -65.5 -41.4 93.23 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.088 0.555 . . . . 0.0 112.355 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -109.55 169.03 8.97 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.46 HG21 ' HG2' ' A' ' 86' ' ' GLU . 8.8 t -98.26 168.36 10.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 172.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -68.17 -25.69 65.38 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.201 0.524 . . . . 0.0 111.375 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.7 -52.57 65.11 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.519 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HG2' HG21 ' A' ' 83' ' ' THR . 48.6 mm-40 -57.78 -35.11 70.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.736 0.414 . . . . 0.0 110.78 176.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.409 ' HG ' ' HE1' ' A' ' 91' ' ' MET . 26.5 tp -62.12 -57.27 12.19 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.945 0.898 . . . . 0.0 111.56 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -38.72 85.53 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -172.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -79.16 -27.48 42.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.688 0.395 . . . . 0.0 111.512 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -65.92 -41.67 91.08 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.269 0.628 . . . . 0.0 110.267 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.409 ' HE1' ' HG ' ' A' ' 87' ' ' LEU . 62.5 mtm -72.1 -30.03 64.68 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.763 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -73.86 -33.94 64.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.97 0.508 . . . . 0.0 110.678 171.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 123.359 0.663 . . . . 0.0 111.441 177.748 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.55 0.951 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.595 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -124.28 144.4 50.0 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.047 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.595 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 2.9 tm? -68.41 108.31 3.21 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -97.1 161.14 13.96 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.0 ptm -143.94 131.22 20.81 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.668 0.787 . . . . 0.0 109.568 -174.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.34 101.97 11.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.566 0.746 . . . . 0.0 109.107 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.9 mt -80.2 120.36 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -83.93 139.24 32.71 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 58' ' ' ALA . 3.8 mm? -120.69 121.28 37.93 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.616 1.167 . . . . 0.0 109.026 -177.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -113.94 171.34 7.65 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.011 0.924 . . . . 0.0 108.894 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.4 t70 52.07 46.79 26.01 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.365 1.066 . . . . 0.0 112.167 166.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.9 t -74.88 108.25 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.534 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.76 153.68 20.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.004 0.922 . . . . 0.0 110.302 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -108.26 136.69 47.49 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.739 0.816 . . . . 0.0 110.379 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.451 ' HD2' ' HB2' ' A' ' 54' ' ' PHE . 10.1 m-30 -95.93 78.8 3.23 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.613 0.765 . . . . 0.0 109.128 172.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.95 -24.96 63.43 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.903 169.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.54 ' HG3' HG13 ' A' ' 124' ' ' ILE . 18.5 ptpt -81.7 145.57 54.61 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.385 1.074 . . . . 0.0 109.344 171.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.81 77.26 3.97 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.936 2.424 . . . . 0.0 113.076 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.54 HG13 ' HG3' ' A' ' 122' ' ' LYS . 54.2 mt -86.37 128.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.419 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -109.3 146.48 34.02 Favored Pre-proline 0 C--O 1.242 0.668 0 C-N-CA 123.943 0.897 . . . . 0.0 109.351 -177.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.26 147.04 41.45 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 122.879 2.386 . . . . 0.0 112.397 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -70.12 -26.49 63.98 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.647 0.779 . . . . 0.0 109.273 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -144.62 159.23 43.16 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.202 1.001 . . . . 0.0 109.439 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.5 133.21 38.62 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.0 t -105.85 95.31 10.42 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.45 -175.48 2.7 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.056 2.504 . . . . 0.0 111.957 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.538 ' HA ' ' HG3' ' A' ' 10' ' ' PRO . 27.1 m -57.74 -26.63 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.331 1.052 . . . . 0.0 113.816 -174.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.14 -22.22 74.24 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.259 0.349 . . . . 0.0 113.607 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.08 149.0 8.19 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 112.362 -0.295 . . . . 0.0 112.362 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -108.8 135.94 49.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.508 0.723 . . . . 0.0 109.829 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.42 ' OH ' ' HB ' ' A' ' 33' ' ' VAL . 1.6 m-85 -76.26 109.74 10.2 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.72 114.14 18.41 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 138.82 53.77 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.475 178.655 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.1 mm 65.73 -171.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.49 -39.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 157.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.472 ' HA2' ' HE2' ' A' ' 41' ' ' MET . . . -167.52 -164.35 23.04 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.438 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.458 HG12 HD13 ' A' ' 60' ' ' ILE . 10.9 p -132.08 144.43 37.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 t -113.87 137.64 51.39 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -132.66 145.12 55.8 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.884 0.874 . . . . 0.0 109.21 178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HD3' HG11 ' A' ' 130' ' ' VAL . 30.2 Cg_endo -61.96 -25.04 77.54 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.962 2.442 . . . . 0.0 112.016 173.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.9 mm 68.75 134.03 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.057 1.343 . . . . 0.0 111.913 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -54.62 114.43 1.84 Allowed 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.546 2.164 . . . . 0.0 110.25 169.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -63.47 -28.03 69.68 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.287 1.035 . . . . 0.0 113.436 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -61.43 -36.24 79.8 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.146 0.498 . . . . 0.0 110.46 172.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -107.91 19.15 20.42 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.143 -172.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -66.94 -32.78 74.26 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.626 0.77 . . . . 0.0 110.153 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.32 -33.87 77.0 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.238 1.015 . . . . 0.0 112.195 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 81' ' ' PHE . 11.0 mmt180 -54.09 -52.92 59.47 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.655 1.182 . . . . 0.0 113.277 -164.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.507 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 47.9 m-85 -60.24 -29.36 68.71 Favored 'General case' 0 CA--C 1.554 1.104 0 O-C-N 124.121 0.888 . . . . 0.0 110.743 -174.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -94.7 -24.76 17.0 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.415 1.086 . . . . 0.0 110.674 -176.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.22 -42.73 79.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.92 1.288 . . . . 0.0 111.028 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.7 ptpt -109.33 -16.43 14.04 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.238 -171.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.93 -14.85 9.35 Favored Glycine 0 N--CA 1.479 1.503 0 N-CA-C 114.191 0.436 . . . . 0.0 114.191 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -150.06 105.64 3.4 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.668 1.187 . . . . 0.0 108.94 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.5 t70 -107.32 174.73 5.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 110.585 -175.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -133.88 109.07 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.435 ' HA ' ' HD1' ' A' ' 81' ' ' PHE . 76.9 t80 -91.12 108.92 20.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.337 0.655 . . . . 0.0 109.577 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 m -94.45 132.93 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.516 0.674 . . . . 0.0 110.673 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.631 ' HD3' ' HD2' ' A' ' 30' ' ' PRO . 14.9 tppt? -134.84 133.24 20.94 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.349 1.06 . . . . 0.0 108.793 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.631 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 59.5 Cg_endo -71.73 66.97 3.07 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.669 2.246 . . . . 0.0 113.2 172.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 55.07 17.02 1.74 Allowed 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.158 1.383 . . . . 0.0 114.672 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 m -70.32 -28.37 65.11 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.225 0.61 . . . . 0.0 110.875 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.447 HG21 ' HG2' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -87.6 148.62 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.344 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.475 ' HB2' ' HH ' ' A' ' 136' ' ' TYR . 63.0 m95 -87.72 -168.11 2.11 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.173 0.589 . . . . 0.0 110.917 -175.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -74.58 -1.25 20.68 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -170.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.11 -30.59 70.45 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.967 0.507 . . . . 0.0 110.815 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.84 98.38 0.73 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.29 1.036 . . . . 0.0 111.55 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.433 ' HG3' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -122.28 156.27 60.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.835 1.254 . . . . 0.0 108.883 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.82 107.0 2.11 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.256 1.971 . . . . 0.0 111.472 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.45 31.65 0.46 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.225 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.613 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 88.8 mtp -112.55 -173.99 2.36 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.911 0.884 . . . . 0.0 110.669 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.453 ' HG3' ' HA3' ' A' ' 6' ' ' GLY . 15.2 ptpt -116.85 156.44 27.3 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.387 1.075 . . . . 0.0 109.599 172.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.512 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -136.05 100.15 4.34 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 177.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.1 t -86.3 124.42 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.245 0.545 . . . . 0.0 110.131 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.403 ' HE2' HG13 ' A' ' 117' ' ' VAL . 25.7 m-85 -89.4 106.7 18.62 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.633 0.773 . . . . 0.0 109.876 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.43 ' HA ' ' CD1' ' A' ' 54' ' ' PHE . 78.3 t80 . . . . . 0 N--CA 1.472 0.654 0 O-C-N 124.94 1.4 . . . . 0.0 111.401 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 46' ' ' TYR . 98.4 m-85 . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.31 -34.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.784 0.834 . . . . 0.0 110.449 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.13 -160.04 23.37 Favored Glycine 0 C--N 1.35 1.355 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.972 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 118' ' ' LYS . 7.3 pt-20 -152.19 177.55 10.41 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.69 1.196 . . . . 0.0 109.526 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.477 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.59 -172.3 3.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.938 0.895 . . . . 0.0 110.035 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.8 mmt-85 -123.91 122.3 37.61 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.802 0.841 . . . . 0.0 109.952 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 41' ' ' MET . 36.3 mt -74.56 128.49 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.856 0.862 . . . . 0.0 109.86 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.547 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 31.6 mmmt -132.49 -167.96 1.98 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 125.433 1.493 . . . . 0.0 107.609 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -41.7 113.22 0.4 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.702 1.201 . . . . 0.0 113.69 -163.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.18 111.91 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.738 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.7 109.68 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.19 117.84 26.2 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -148.62 127.39 12.56 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.316 1.047 . . . . 0.0 109.052 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 34.7 mt-10 -65.68 -20.94 66.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.607 0.763 . . . . 0.0 111.921 176.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -99.81 118.0 62.57 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.447 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 40.6 Cg_endo -67.47 -18.6 49.3 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.196 1.931 . . . . 0.0 112.855 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.447 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.2 mpp? -73.63 -25.63 60.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.754 0.421 . . . . 0.0 111.008 -173.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -64.4 -22.78 67.07 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.691 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -78.3 -30.83 48.55 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.022 0.529 . . . . 0.0 110.93 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.474 ' CE2' HD22 ' A' ' 87' ' ' LEU . 92.7 m-85 -82.74 -16.11 49.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.664 0.386 . . . . 0.0 111.915 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.83 -32.03 16.23 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.668 0.213 . . . . 0.0 110.794 171.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 92.8 m -76.75 -41.42 44.93 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 120.848 0.356 . . . . 0.0 111.109 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.692 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 44.0 m-85 -117.83 -67.29 1.0 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.426 0.69 . . . . 0.0 109.219 -175.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.06 -97.84 2.1 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.105 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.71 -22.15 61.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.8 0.44 . . . . 0.0 110.855 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.692 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 31.8 mmt180 -59.91 -37.78 80.42 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.007 0.523 . . . . 0.0 111.294 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.455 HG13 HD22 ' A' ' 82' ' ' LEU . 39.0 t -62.74 145.08 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 O-C-N 123.729 0.643 . . . . 0.0 109.767 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.467 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 41.2 p90 -60.06 -20.1 56.32 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.455 HD22 HG13 ' A' ' 80' ' ' VAL . 1.9 pt? -133.56 164.87 26.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.6 t -98.36 176.33 5.74 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.645 0.657 . . . . 0.0 109.435 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -61.63 -29.44 70.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.195 0.598 . . . . 0.0 111.196 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.96 -45.83 80.34 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.954 0.902 . . . . 0.0 111.409 174.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.4 -36.34 83.4 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.183 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.474 HD22 ' CE2' ' A' ' 73' ' ' PHE . 27.1 tp -60.56 -54.81 40.93 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.469 0.708 . . . . 0.0 110.985 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -64.03 -42.51 97.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.158 -172.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -70.28 -31.11 68.33 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.35 0.26 . . . . 0.0 110.729 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -65.09 -43.62 91.52 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.652 0.781 . . . . 0.0 110.482 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.46 ' HE3' ' HG ' ' A' ' 87' ' ' LEU . 61.4 mtm -74.82 -31.65 61.74 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.365 0.666 . . . . 0.0 110.824 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 31.9 mmmt -69.76 -28.09 65.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.126 0.571 . . . . 0.0 110.691 172.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 CA--C 1.543 0.675 0 C-N-CA 122.965 0.506 . . . . 0.0 110.045 173.13 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.423 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -93.38 150.28 20.58 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.0 0.52 . . . . 0.0 109.728 178.083 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 3.1 tm? -69.29 122.95 19.91 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -106.04 156.25 18.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.489 0.715 . . . . 0.0 109.348 171.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.7 ptm -131.57 129.17 40.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.093 0.957 . . . . 0.0 108.828 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.69 102.24 11.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.443 HG23 HG22 ' A' ' 60' ' ' ILE . 33.8 mt -82.61 121.31 35.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.14 101.43 8.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.1 mm? -87.11 120.56 28.51 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 122.902 0.481 . . . . 0.0 109.779 175.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.547 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 2.1 pp20? -138.34 168.8 18.98 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.1 t70 60.76 30.05 19.42 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.781 0.833 . . . . 0.0 110.654 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.403 HG13 ' HE2' ' A' ' 45' ' ' PHE . 61.0 t -61.19 118.11 3.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.219 -171.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.501 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . 1.6 tpmt? -102.01 152.39 21.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.069 0.947 . . . . 0.0 110.654 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -106.07 138.54 42.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.985 0.914 . . . . 0.0 109.396 174.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -87.18 90.68 8.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.05 -34.63 77.98 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.695 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -85.76 139.37 35.28 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.196 172.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.35 89.15 1.37 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.794 2.329 . . . . 0.0 111.742 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 21.2 mt -72.42 130.24 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.096 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 142.92 57.64 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.014 0.526 . . . . 0.0 109.623 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.02 155.74 19.93 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.404 2.069 . . . . 0.0 113.307 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -74.21 -25.83 59.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.825 173.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -170.49 173.6 5.49 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.194 0.998 . . . . 0.0 109.697 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -67.14 128.18 35.4 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 166.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.447 HG11 ' HD3' ' A' ' 10' ' ' PRO . 78.9 t -101.03 103.63 26.71 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.87 -177.81 1.74 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.229 2.619 . . . . 0.0 113.33 -174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.0 m -61.46 -27.19 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.981 0.913 . . . . 0.0 112.639 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.7 -15.32 75.94 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.183 0.302 . . . . 0.0 113.12 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.28 169.21 39.47 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.351 0.501 . . . . 0.0 112.928 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -120.65 146.51 46.33 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.008 0.923 . . . . 0.0 109.783 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.475 ' HH ' ' HB2' ' A' ' 34' ' ' TRP . 48.0 m-85 -87.51 118.18 26.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.015 0.526 . . . . 0.0 110.141 173.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tt -84.7 128.0 34.38 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 172.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.1 136.96 46.15 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.794 0.438 . . . . 0.0 110.516 -175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 CA--C 1.554 1.133 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.414 177.92 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.41 HG23 ' N ' ' A' ' 5' ' ' VAL . 26.2 mm 66.25 -174.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 124.408 1.083 . . . . 0.0 109.596 -175.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' N ' HG23 ' A' ' 4' ' ' ILE . 2.7 m -154.73 -40.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 125.269 1.427 . . . . 0.0 108.511 158.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.15 -159.15 14.15 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.204 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 12.6 p -126.68 160.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 t -135.41 139.59 44.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.276 0.63 . . . . 0.0 109.864 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -136.65 142.2 38.19 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.011 0.924 . . . . 0.0 109.789 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HB3' ' HD2' ' A' ' 46' ' ' TYR . 47.9 Cg_endo -69.03 -35.56 14.53 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.694 2.263 . . . . 0.0 111.226 168.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.7 mt 61.23 100.95 0.04 OUTLIER Pre-proline 0 C--N 1.361 1.098 0 C-N-CA 125.523 1.529 . . . . 0.0 110.928 -175.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.73 -179.4 2.87 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.456 2.104 . . . . 0.0 111.451 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HG3' ' H ' ' A' ' 14' ' ' ARG . 31.8 tptt 67.86 -176.38 0.2 Allowed 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.744 0.818 . . . . 0.0 109.703 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.535 ' H ' ' HG3' ' A' ' 13' ' ' LYS . 79.8 mtp180 -76.79 -15.09 59.84 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.316 0.646 . . . . 0.0 112.245 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.512 ' CZ ' ' HG2' ' A' ' 86' ' ' GLU . 11.5 m-30 -74.28 7.52 2.76 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -165.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.606 ' SD ' HG11 ' A' ' 55' ' ' VAL . 18.2 tmm? -67.7 -44.54 77.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.217 0.607 . . . . 0.0 109.584 168.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.07 -15.71 63.51 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.859 0.864 . . . . 0.0 113.088 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 20.4 mmt180 -51.82 -50.9 59.92 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.138 0.975 . . . . 0.0 111.685 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.6 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 22.5 m-85 -62.33 -29.03 70.16 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.294 -170.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -93.06 -29.09 15.98 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.322 1.049 . . . . 0.0 110.411 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -63.06 -46.39 87.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.019 0.928 . . . . 0.0 110.638 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.6 ptpt -101.88 -15.35 16.9 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.356 -172.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.11 -7.71 27.99 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -159.31 107.14 1.78 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.6 1.16 . . . . 0.0 108.279 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.6 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.4 t70 -115.68 177.61 4.61 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.984 0.913 . . . . 0.0 109.773 -176.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -132.65 108.98 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -87.93 107.38 18.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 0.0 109.917 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 m -90.07 125.76 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 121.566 0.698 . . . . 0.0 110.906 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.587 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 7.4 mmpt? -108.96 131.58 21.71 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.924 1.29 . . . . 0.0 109.606 174.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.13 54.55 4.97 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.066 2.511 . . . . 0.0 112.267 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 57.6 87.17 0.07 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.609 1.164 . . . . 0.0 111.001 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.587 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 29.1 m -130.65 -68.72 0.68 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.49 0.716 . . . . 0.0 109.344 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -109.0 106.74 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -137.2 -10.67 1.7 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.234 1.014 . . . . 0.0 110.391 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -64.78 -55.7 18.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.211 1.004 . . . . 0.0 110.651 -170.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -102.41 -9.01 20.65 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.085 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.45 ' HA ' ' HE2' ' A' ' 41' ' ' MET . 0.1 OUTLIER -66.95 110.7 3.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.137 0.575 . . . . 0.0 110.979 -173.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.483 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -139.12 150.81 66.12 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.125 0.57 . . . . 0.0 109.476 177.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 105.85 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.838 2.359 . . . . 0.0 111.329 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.1 -17.93 1.74 Allowed Glycine 0 N--CA 1.467 0.716 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.417 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.483 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 29.2 mtm -75.28 -179.82 4.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.547 0.689 . . . . 0.0 111.418 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -106.63 161.69 14.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.931 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -137.24 104.73 5.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.97 134.77 27.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -97.67 102.49 14.26 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.462 ' HD2' ' HB3' ' A' ' 10' ' ' PRO . 88.1 t80 . . . . . 0 C--O 1.24 0.599 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.083 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HE2' ' HA ' ' A' ' 126' ' ' PRO . 90.7 m-85 . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.606 HG11 ' SD ' ' A' ' 16' ' ' MET . 7.3 p -90.11 -34.19 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.697 0.399 . . . . 0.0 111.289 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.06 -160.22 26.36 Favored Glycine 0 C--N 1.345 1.055 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.425 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -149.93 176.95 10.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.288 1.035 . . . . 0.0 109.215 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 114' ' ' LEU . . . -167.01 -179.02 4.44 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.977 0.911 . . . . 0.0 110.44 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -120.34 125.33 47.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.621 0.768 . . . . 0.0 110.49 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.17 130.72 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.54 1.136 . . . . 0.0 110.822 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -126.74 -178.86 4.54 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 125.381 1.472 . . . . 0.0 108.94 176.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -29.76 113.62 0.09 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.358 1.863 . . . . 0.0 114.562 -172.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.76 109.09 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.643 0.735 . . . . 0.0 109.06 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 96.6 t -87.86 109.41 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.2 mt -89.48 121.65 31.91 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.536 0.734 . . . . 0.0 109.399 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 t -149.79 140.31 22.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.502 0.721 . . . . 0.0 110.07 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 25.6 mt-10 -80.15 -9.4 59.71 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.519 177.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.519 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 73.7 m-20 -112.12 119.76 43.32 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 169.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 38.3 Cg_endo -67.38 -15.22 45.06 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.903 2.402 . . . . 0.0 113.056 174.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.434 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.5 mpp? -74.41 -22.87 58.95 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.22 0.608 . . . . 0.0 111.013 -176.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.519 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 56.8 mt-30 -69.28 -26.51 64.79 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.628 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -71.58 -20.46 62.0 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.77 0.428 . . . . 0.0 111.312 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.425 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 24.9 m-85 -88.01 -39.99 14.23 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.828 0.451 . . . . 0.0 110.766 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 13.1 pt-20 -69.28 -27.59 65.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 120.542 0.21 . . . . 0.0 110.575 174.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.0 m -82.89 -61.29 1.91 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 123.042 0.537 . . . . 0.0 110.612 177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.701 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 56.0 m-85 -102.62 -67.78 0.86 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.215 0.606 . . . . 0.0 109.715 -177.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 75.3 -87.33 0.8 Allowed Glycine 0 C--N 1.352 1.436 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.656 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -56.25 -36.52 68.62 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.019 1.327 . . . . 0.0 111.732 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.701 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 34.4 mmt180 -69.35 -36.95 77.38 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.062 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.469 HG12 HD22 ' A' ' 82' ' ' LEU . 21.2 t -64.6 148.97 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -65.35 -8.64 19.34 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.2 pt? -149.79 168.71 22.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.936 0.895 . . . . 0.0 109.11 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 t -112.36 -176.5 2.93 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 172.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -59.69 -33.66 71.88 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.67 0.788 . . . . 0.0 111.922 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -62.69 -43.33 99.08 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.052 0.541 . . . . 0.0 111.222 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 1.6 mp0 -73.0 -25.16 60.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.505 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.533 ' HG ' ' HE2' ' A' ' 91' ' ' MET . 53.6 tp -70.69 -48.89 52.37 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.835 0.454 . . . . 0.0 110.491 176.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -65.76 -39.2 90.8 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.31 0.381 . . . . 0.0 110.964 -176.176 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 6.2 pt-20 -69.79 -33.29 72.17 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.025 0.203 . . . . 0.0 110.828 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -67.16 -43.8 81.37 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.197 0.599 . . . . 0.0 110.522 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.533 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 73.7 mtm -71.06 -40.15 71.82 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.421 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.0 mmpt? -67.26 -30.74 70.71 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 119.803 -0.142 . . . . 0.0 110.64 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.48 1.05 0 C-N-CA 123.753 0.821 . . . . 0.0 110.815 177.3 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.536 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.549 0.938 0 CA-C-O 121.169 0.509 . . . . 0.0 110.365 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 140.66 40.73 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.21 95.3 4.27 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -84.23 155.78 22.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 171.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.456 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 12.3 ptm -136.61 129.55 30.96 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . . . -104.74 100.78 10.42 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -176.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.6 mt -82.18 114.31 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -80.63 102.31 9.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 58' ' ' ALA . 4.2 mm? -86.4 109.27 18.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.19 0.596 . . . . 0.0 110.694 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -106.97 174.51 5.86 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.4 t70 60.2 35.28 21.01 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.03 0.932 . . . . 0.0 111.348 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.38 102.95 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.347 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.91 154.76 23.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.509 1.124 . . . . 0.0 110.362 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -110.6 136.17 50.11 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.031 0.933 . . . . 0.0 110.067 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -91.05 86.92 6.38 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.06 -27.72 64.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.509 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.604 ' HB3' ' HZ2' ' A' ' 122' ' ' LYS . 0.3 OUTLIER -81.04 137.68 49.64 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.358 1.063 . . . . 0.0 109.537 171.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -76.43 95.63 1.05 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.751 2.301 . . . . 0.0 111.84 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.4 mt -87.97 128.24 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.857 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -86.26 129.28 54.18 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.011 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.428 ' HA ' ' HE2' ' A' ' 54' ' ' PHE . 35.1 Cg_endo -68.06 150.0 77.24 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.511 2.14 . . . . 0.0 113.961 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -67.85 -38.58 83.31 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.042 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.5 ptm85 -154.02 176.07 12.65 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.05 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.66 118.5 19.36 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.72 172.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.44 HG13 ' HD3' ' A' ' 10' ' ' PRO . 80.7 t -98.97 100.97 10.92 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.48 177.85 2.47 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.363 2.709 . . . . 0.0 112.528 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.58 -34.37 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 123.952 0.901 . . . . 0.0 111.849 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 -13.62 71.67 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.68 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.19 176.2 51.36 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 123.543 0.592 . . . . 0.0 112.939 175.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -126.27 137.28 53.5 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.54 106.82 4.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 166.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.09 124.71 27.49 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.5 119.98 19.15 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.443 HG21 ' H ' ' A' ' 5' ' ' VAL . 22.7 mm 63.46 -166.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 124.621 1.168 . . . . 0.0 108.526 -175.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.443 ' H ' HG21 ' A' ' 4' ' ' ILE . 1.7 m -151.99 -42.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 156.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.22 -161.13 20.2 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.397 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.41 136.65 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.575 0.75 . . . . 0.0 109.504 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 t -103.16 134.13 47.1 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.515 0.726 . . . . 0.0 109.584 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.65 123.15 11.65 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 123.514 0.726 . . . . 0.0 110.205 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.54 ' HD3' HG12 ' A' ' 130' ' ' VAL . 74.0 Cg_endo -80.26 94.55 1.01 Allowed 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.419 2.079 . . . . 0.0 109.54 165.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.42 110.64 2.89 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.191 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -85.06 33.66 0.49 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.436 2.757 . . . . 0.0 111.683 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HG3' ' HD2' ' A' ' 15' ' ' PHE . 49.9 tptt -141.09 144.5 34.94 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -170.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -74.23 10.08 1.4 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.574 0.75 . . . . 0.0 112.611 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.416 ' HD2' ' HG3' ' A' ' 13' ' ' LYS . 97.6 m-85 -111.79 25.02 12.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.232 1.013 . . . . 0.0 111.758 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.557 ' SD ' HG13 ' A' ' 55' ' ' VAL . 45.2 ttm -62.08 -36.73 82.55 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.667 0.746 . . . . 0.0 109.549 166.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.32 -23.19 67.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.029 1.331 . . . . 0.0 112.417 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -59.58 -42.48 92.59 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.507 0.723 . . . . 0.0 112.09 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -65.28 -30.97 71.88 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.758 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -92.03 -16.07 26.97 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.723 0.809 . . . . 0.0 110.792 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -73.98 -49.94 22.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.389 1.076 . . . . 0.0 109.797 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -110.86 -15.61 13.75 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -172.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.92 8.3 63.92 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 113.992 0.357 . . . . 0.0 113.992 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -159.69 86.85 0.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.966 1.306 . . . . 0.0 107.744 -173.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -134.93 -178.03 4.9 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.795 0.838 . . . . 0.0 108.976 -171.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -139.7 121.51 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.265 0.939 . . . . 0.0 109.764 -171.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -98.0 114.47 26.61 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.646 0.778 . . . . 0.0 109.167 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.0 m -92.18 133.48 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.24 0.543 . . . . 0.0 111.091 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.489 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.0 mmpt? -119.56 130.51 24.8 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.352 1.461 . . . . 0.0 110.113 178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.25 55.52 5.1 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.07 2.513 . . . . 0.0 111.484 169.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 56.47 27.66 12.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.571 1.148 . . . . 0.0 112.923 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.489 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 4.5 m -64.33 -39.31 93.64 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.698 0.799 . . . . 0.0 110.389 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.5 m -82.71 151.14 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.285 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -80.47 -173.95 4.36 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.502 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -65.05 -18.11 65.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.498 1.119 . . . . 0.0 112.902 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -59.12 -22.56 61.05 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.37 0.668 . . . . 0.0 111.515 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 94.39 0.32 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.046 0.538 . . . . 0.0 110.328 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.508 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 3.7 ptpp? -109.66 157.78 36.57 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.55 55.46 5.32 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.212 2.608 . . . . 0.0 112.175 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.94 43.76 0.2 Allowed Glycine 0 C--O 1.239 0.467 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.786 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.508 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 30.9 mtm -130.11 -173.01 2.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.623 1.169 . . . . 0.0 111.074 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.75 165.23 12.76 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.55 1.14 . . . . 0.0 110.518 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -136.2 101.95 4.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 34.2 t -90.54 108.15 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.214 0.53 . . . . 0.0 110.193 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -75.61 120.36 20.91 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.754 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 33.1 t80 . . . . . 0 CA--C 1.551 0.994 0 C-N-CA 124.595 1.158 . . . . 0.0 110.134 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 19.7 m-85 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.557 HG13 ' SD ' ' A' ' 16' ' ' MET . 2.7 p -67.59 -34.74 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 122.996 0.518 . . . . 0.0 110.771 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.93 -165.71 33.76 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.58 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 17.2 pt-20 -141.17 176.75 8.58 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.05 0.94 . . . . 0.0 108.952 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.69 -173.84 4.15 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.077 0.951 . . . . 0.0 109.304 176.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -125.94 119.49 27.89 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.726 0.81 . . . . 0.0 109.494 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.8 mt -71.54 129.78 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 124.397 1.061 . . . . 0.0 110.669 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -132.29 177.26 7.72 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 126.187 1.795 . . . . 0.0 109.006 -174.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -30.35 111.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 125.463 1.727 . . . . 0.0 114.113 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.0 m -87.97 123.93 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.288 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 99.0 t -90.02 107.18 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 108' ' ' LEU . 77.1 mt -88.43 116.76 26.88 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.6 t -153.07 135.76 15.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.644 0.778 . . . . 0.0 110.323 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.12 -34.62 78.47 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.84 0.856 . . . . 0.0 111.669 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 79.1 m-20 -94.41 120.17 65.51 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.004 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.517 ' HG2' HD22 ' A' ' 87' ' ' LEU . 61.1 Cg_endo -72.5 -7.11 20.31 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.082 2.521 . . . . 0.0 113.387 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 45.9 mtm -86.02 -21.93 27.53 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.013 0.525 . . . . 0.0 110.75 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.424 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 30.4 mt-30 -66.44 -22.24 66.21 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.247 174.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -71.59 -26.21 62.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.691 0.396 . . . . 0.0 110.659 175.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -82.8 -31.26 28.27 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.797 0.439 . . . . 0.0 111.179 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.9 -28.86 60.8 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.932 0.333 . . . . 0.0 110.681 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.8 m -81.83 -58.95 2.76 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.132 0.573 . . . . 0.0 110.386 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.803 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 71.9 m-85 -100.86 -62.83 1.19 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.847 0.859 . . . . 0.0 110.329 -174.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.49 -83.23 0.56 Allowed Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.643 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -59.65 -44.09 93.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.622 0.769 . . . . 0.0 110.663 175.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.803 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 29.2 mmt180 -70.32 -19.48 63.07 Favored 'General case' 0 C--O 1.205 -1.278 0 O-C-N 124.013 0.821 . . . . 0.0 111.938 -173.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 76' ' ' PHE . 40.8 t -76.52 131.07 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -54.51 -45.73 73.35 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.903 0.752 . . . . 0.0 112.554 -171.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -100.95 156.93 17.11 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.549 HG23 ' HG2' ' A' ' 86' ' ' GLU . 11.3 t -92.85 173.45 7.75 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -50.78 -41.35 56.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.422 1.089 . . . . 0.0 110.962 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.06 -46.78 87.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.23 1.012 . . . . 0.0 111.353 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.549 ' HG2' HG23 ' A' ' 83' ' ' THR . 42.3 mm-40 -62.96 -37.36 86.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.205 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.517 HD22 ' HG2' ' A' ' 69' ' ' PRO . 45.2 tp -63.99 -54.11 39.57 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.882 0.739 . . . . 0.0 111.091 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -63.27 -43.59 97.51 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.27 0.356 . . . . 0.0 111.036 -173.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 12.9 pt-20 -73.89 -23.69 59.61 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.426 0.291 . . . . 0.0 111.181 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.17 -44.89 87.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.527 0.731 . . . . 0.0 110.122 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.498 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 72.8 mtm -76.53 -30.5 57.16 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.069 0.548 . . . . 0.0 110.908 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.1 mmmt -74.03 -20.11 60.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.201 0.601 . . . . 0.0 110.61 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.543 0.676 0 C-N-CA 122.944 0.498 . . . . 0.0 109.98 174.528 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 121.45 0.643 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.84 149.88 52.32 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 174.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 65' ' ' LEU . 1.3 tm? -76.75 92.39 3.57 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 171.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -75.48 159.25 31.53 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.381 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.7 ptm -140.0 129.68 24.44 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.308 0.643 . . . . 0.0 109.702 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.541 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . . . -97.12 101.36 12.91 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.525 ' HA ' HG12 ' A' ' 63' ' ' VAL . 35.5 mt -80.46 113.85 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.6 110.63 17.14 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -94.33 132.42 38.95 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.409 0.623 . . . . 0.0 110.701 177.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -138.37 170.73 15.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.283 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 t70 59.8 35.84 22.06 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.859 0.838 . . . . 0.0 110.117 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.47 102.59 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.181 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.3 145.6 28.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.624 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -101.32 122.44 43.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -80.58 84.6 6.13 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 165.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.32 -33.5 72.49 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.568 170.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -79.99 137.25 53.64 Favored Pre-proline 0 CA--C 1.553 1.095 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.44 173.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.08 95.7 1.04 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.782 2.322 . . . . 0.0 111.538 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.5 mt -94.63 123.76 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.14 143.57 26.36 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.476 0.71 . . . . 0.0 109.764 -175.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.27 158.69 41.0 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.862 2.375 . . . . 0.0 112.054 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -81.34 -10.44 59.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.463 0.705 . . . . 0.0 110.993 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.5 ptm85 -153.48 172.96 16.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.991 0.916 . . . . 0.0 110.246 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.13 119.31 18.16 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.54 HG12 ' HD3' ' A' ' 10' ' ' PRO . 23.1 t -102.9 99.42 13.76 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.26 -176.28 3.19 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.882 2.388 . . . . 0.0 112.61 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.0 -27.06 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.453 1.101 . . . . 0.0 112.164 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.05 -25.95 75.04 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.205 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.39 148.15 6.98 Favored Glycine 0 C--N 1.348 1.237 0 C-N-CA 123.003 0.335 . . . . 0.0 112.448 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -108.86 142.29 39.67 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.426 0.691 . . . . 0.0 109.581 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -78.62 107.49 11.33 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.79 116.8 14.82 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.09 134.07 52.63 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.867 -1.063 . . . . 0.0 108.365 -177.44 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 5' ' ' VAL . 35.6 mm 67.19 -175.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.456 0 C-N-CA 124.129 0.972 . . . . 0.0 108.71 -174.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.404 ' N ' HG22 ' A' ' 4' ' ' ILE . 2.0 m -148.35 -38.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.228 1.011 . . . . 0.0 108.683 158.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.77 -161.22 19.81 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.482 0.489 . . . . 0.0 113.689 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.427 HG12 HD13 ' A' ' 60' ' ' ILE . 13.5 p -132.02 147.89 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.866 0.866 . . . . 0.0 108.686 175.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -122.76 140.93 52.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.553 0.741 . . . . 0.0 109.958 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -137.63 141.36 33.01 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.13 0.972 . . . . 0.0 110.12 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 20.7 Cg_exo -63.21 -46.73 9.39 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.347 2.698 . . . . 0.0 111.909 175.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.3 mt 51.57 72.13 1.3 Allowed Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.263 1.025 . . . . 0.0 109.603 -171.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.74 38.59 0.75 Allowed 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.261 2.64 . . . . 0.0 112.617 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -124.8 172.7 9.12 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.657 1.183 . . . . 0.0 109.908 -174.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -65.35 -15.23 62.34 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.086 0.954 . . . . 0.0 112.001 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -82.26 0.92 39.16 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.863 0.865 . . . . 0.0 112.778 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -57.43 -36.76 71.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.182 0.993 . . . . 0.0 111.696 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.07 -14.06 58.17 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -53.47 -46.99 70.17 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.411 1.085 . . . . 0.0 112.571 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.438 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 57.7 m-85 -68.54 -28.96 67.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.684 -174.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -93.85 -15.83 24.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.777 0.831 . . . . 0.0 110.452 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -70.69 -49.06 51.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.38 1.072 . . . . 0.0 109.748 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -109.63 -15.14 14.23 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.35 7.07 77.44 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.834 0.293 . . . . 0.0 113.834 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -168.6 90.4 0.26 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.457 1.103 . . . . 0.0 109.944 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.438 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.2 t70 -119.34 -178.04 3.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.267 1.027 . . . . 0.0 108.905 -174.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 113' ' ' GLU . 40.0 t -132.52 119.41 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.053 -1.029 . . . . 0.0 109.396 -177.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 81' ' ' PHE . 56.8 t80 -95.43 110.9 22.88 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.3 m -87.27 139.42 17.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-O 121.377 0.608 . . . . 0.0 110.507 177.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 5.9 mmpt? -125.46 132.43 24.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.198 1.399 . . . . 0.0 109.71 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.39 49.16 3.08 Favored 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 123.124 2.549 . . . . 0.0 111.952 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' LEU . . . 58.27 81.34 0.16 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.171 1.388 . . . . 0.0 111.861 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.56 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 23.5 m -116.43 -72.99 0.66 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -97.76 126.9 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.511 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 50.2 t90 -160.25 -35.93 0.05 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.435 0.294 . . . . 0.0 111.246 -175.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -56.34 -45.96 80.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.539 0.736 . . . . 0.0 112.574 -174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -93.1 -17.53 23.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.467 0.307 . . . . 0.0 110.528 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.516 ' HA ' ' HE2' ' A' ' 41' ' ' MET . 3.0 mm? -61.86 108.2 0.98 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.731 0.812 . . . . 0.0 111.19 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -131.53 150.58 76.75 Favored Pre-proline 0 C--O 1.244 0.765 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.964 172.086 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.25 103.98 1.48 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.432 2.088 . . . . 0.0 110.486 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.75 -8.89 1.35 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.366 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.516 ' HE2' ' HA ' ' A' ' 37' ' ' LEU . 24.1 mtm -80.08 -177.9 6.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.228 0.611 . . . . 0.0 111.649 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -107.22 161.66 14.58 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.835 0.854 . . . . 0.0 110.765 171.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -136.17 101.92 4.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 174.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.5 t -87.6 122.74 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 109.824 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -92.4 120.85 33.31 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.523 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 85.2 t80 . . . . . 0 CA--C 1.557 1.224 0 C-N-CA 124.758 1.223 . . . . 0.0 109.141 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 44.0 m-85 . . . . . 0 CA--C 1.544 0.742 0 CA-C-O 120.687 0.28 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 p -73.9 -37.05 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.886 0.874 . . . . 0.0 110.939 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.66 -163.23 29.11 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.539 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 6.5 pt-20 -143.3 178.88 7.43 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.882 0.873 . . . . 0.0 109.129 173.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -156.88 -172.38 4.02 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.276 1.03 . . . . 0.0 108.879 175.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -125.78 118.09 24.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.965 0.506 . . . . 0.0 110.092 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.486 HG13 ' HB2' ' A' ' 43' ' ' PHE . 43.2 mt -63.93 125.34 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.925 175.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 30.7 mmmt -133.9 -168.28 2.09 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 125.374 1.47 . . . . 0.0 107.721 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -19.65 110.16 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 126.092 1.757 . . . . 0.0 115.058 -171.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 112' ' ' ILE . 29.2 m -103.74 109.97 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.7 t -91.93 118.14 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.404 0.682 . . . . 0.0 109.745 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 108' ' ' LEU . 61.7 mt -94.71 123.26 38.05 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.664 0.786 . . . . 0.0 109.494 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 71' ' ' GLN . 33.4 t -153.16 136.97 16.14 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.503 0.721 . . . . 0.0 110.126 172.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.652 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 45.6 mt-10 -66.32 -17.81 64.98 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 176.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.448 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 14.1 m-20 -97.85 120.73 59.6 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.0 -26.11 58.7 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.436 2.091 . . . . 0.0 112.071 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.411 ' HA ' ' HD2' ' A' ' 73' ' ' PHE . 37.3 mtm -73.19 -22.21 60.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.597 0.759 . . . . 0.0 110.918 -171.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.448 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 21.4 mm-40 -57.3 -33.39 67.63 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.155 0.982 . . . . 0.0 111.587 175.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.52 -31.46 37.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.745 0.418 . . . . 0.0 110.819 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CE2' HD23 ' A' ' 87' ' ' LEU . 85.1 m-85 -79.06 -17.75 54.67 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.125 0.57 . . . . 0.0 111.572 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -94.61 -36.85 11.61 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.436 0.294 . . . . 0.0 111.208 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.6 m -74.8 -57.0 4.19 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.947 0.499 . . . . 0.0 110.809 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.827 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 92.2 m-85 -92.49 -61.73 1.54 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.339 0.656 . . . . 0.0 109.494 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.68 -85.26 0.45 Allowed Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.866 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.04 -37.2 84.04 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.913 0.885 . . . . 0.0 110.639 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.827 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 14.4 mmt85 -65.52 -35.02 79.63 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.223 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.48 HG12 HD22 ' A' ' 82' ' ' LEU . 21.9 t -67.76 143.95 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 118.211 0.46 . . . . 0.0 110.375 -176.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.428 ' HD2' ' HA ' ' A' ' 27' ' ' PHE . 45.2 p90 -62.9 -14.51 47.45 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -173.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.48 HD22 HG12 ' A' ' 80' ' ' VAL . 2.3 pt? -139.68 170.29 16.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.782 0.833 . . . . 0.0 109.272 176.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.467 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.9 t -100.09 170.58 8.38 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 172.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -62.48 -27.74 69.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.24 0.616 . . . . 0.0 111.196 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.54 -49.41 71.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.405 0.682 . . . . 0.0 109.956 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.467 ' HG2' HG22 ' A' ' 83' ' ' THR . 17.3 mm-40 -56.75 -40.77 76.38 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.306 176.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.43 HD23 ' CE2' ' A' ' 73' ' ' PHE . 31.0 tp -58.4 -56.19 25.33 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.911 0.884 . . . . 0.0 112.031 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -61.72 -39.97 93.41 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -171.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.64 -18.88 36.62 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.126 0.571 . . . . 0.0 111.747 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -69.77 -39.74 76.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.37 0.668 . . . . 0.0 109.655 170.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.0 mtm -73.49 -30.8 63.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.302 0.641 . . . . 0.0 110.418 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.5 mmpt? -67.11 -38.07 84.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.626 0.371 . . . . 0.0 110.006 170.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.473 0.708 0 O-C-N 123.831 0.707 . . . . 0.0 110.539 177.895 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.652 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.144 0.497 . . . . 0.0 110.657 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 107' ' ' LYS . 18.2 tptm -101.56 156.67 17.34 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -174.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 65' ' ' LEU . 2.6 tm? -72.44 104.97 3.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -85.96 161.62 18.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.334 0.654 . . . . 0.0 109.251 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.517 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 14.9 ptm -141.67 154.36 45.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.865 0.866 . . . . 0.0 109.868 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.72 104.44 7.18 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.716 0.806 . . . . 0.0 109.825 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.513 ' HA ' HG11 ' A' ' 63' ' ' VAL . 43.0 mt -84.3 119.12 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 123.402 0.681 . . . . 0.0 109.454 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.52 ' HA ' HG22 ' A' ' 26' ' ' VAL . 37.6 tt0 -81.93 98.86 8.76 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 58' ' ' ALA . 3.9 mm? -80.98 131.89 35.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.948 0.499 . . . . 0.0 110.25 174.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 1.3 pp20? -139.72 166.29 25.0 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.687 0.795 . . . . 0.0 109.128 175.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.3 t70 56.84 41.7 27.61 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.833 0.853 . . . . 0.0 111.178 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.32 108.92 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 121.351 0.596 . . . . 0.0 111.134 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.66 157.34 21.16 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.521 1.128 . . . . 0.0 110.216 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -122.91 117.73 26.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.896 0.878 . . . . 0.0 110.072 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -78.18 98.25 5.78 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -65.04 -31.44 72.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.838 0.855 . . . . 0.0 110.578 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -87.36 138.35 32.18 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.248 0.619 . . . . 0.0 110.157 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.33 89.14 1.21 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.658 2.239 . . . . 0.0 111.68 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.1 mt -78.73 131.26 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.398 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.69 144.17 27.98 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 122.986 0.514 . . . . 0.0 109.701 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.34 161.09 28.95 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.315 2.01 . . . . 0.0 112.658 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 127' ' ' LYS . 11.1 mmpt? -68.91 -51.58 38.5 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.366 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -119.02 178.06 4.63 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.613 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.59 140.49 51.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.688 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.94 102.19 30.02 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.04 176.39 7.05 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.604 2.203 . . . . 0.0 112.212 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.2 t -58.89 -32.94 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.276 1.03 . . . . 0.0 111.132 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.68 -15.0 73.1 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.846 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.37 159.54 16.71 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.339 0.495 . . . . 0.0 113.237 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -113.54 145.77 40.7 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.585 0.754 . . . . 0.0 110.46 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -81.63 113.7 19.82 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.4 121.79 26.68 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 140.92 49.04 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 117.81 -1.09 . . . . 0.0 110.007 177.996 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.628 ' HB3' ' HG2' ' A' ' 3' ' ' LYS . 34.6 ttm . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t -64.93 -14.33 59.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.222 1.009 . . . . 0.0 112.575 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.628 ' HG2' ' HB3' ' A' ' 1' ' ' MET . 21.2 ptmt -62.24 -25.93 68.09 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.942 0.497 . . . . 0.0 111.723 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 5' ' ' VAL . 24.1 mm 62.12 -168.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -173.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.3 m -145.88 -42.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 154.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.09 -161.24 20.23 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.31 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.77 156.15 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.825 0.85 . . . . 0.0 108.711 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -125.48 135.85 52.75 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.484 0.713 . . . . 0.0 109.657 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -132.4 139.29 34.35 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 123.787 0.835 . . . . 0.0 110.305 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.498 ' HD3' HG11 ' A' ' 130' ' ' VAL . 69.2 Cg_endo -71.75 -26.74 18.94 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.192 2.594 . . . . 0.0 111.901 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt 66.94 117.26 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 125.321 1.449 . . . . 0.0 109.802 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -62.11 -16.65 51.74 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.267 2.645 . . . . 0.0 114.213 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -130.69 -176.38 3.96 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.733 0.813 . . . . 0.0 110.77 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -74.92 6.76 3.73 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.817 0.847 . . . . 0.0 112.87 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -77.97 14.97 0.97 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -62.22 -33.08 73.88 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.863 0.363 . . . . 0.0 110.293 165.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -68.73 -25.8 64.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.505 1.122 . . . . 0.0 111.762 -173.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 6.1 mmp_? -53.49 -49.32 67.76 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.331 1.019 . . . . 0.0 111.574 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 58.9 m-85 -64.54 -31.17 72.26 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.741 -176.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -85.75 -26.61 25.74 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.385 0.674 . . . . 0.0 110.593 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -68.38 -52.63 30.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.607 1.163 . . . . 0.0 109.953 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.5 ptpt -99.79 -16.88 17.93 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.348 -172.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.95 -8.55 50.21 Favored Glycine 0 N--CA 1.475 1.284 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -158.57 107.17 1.94 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.882 0.873 . . . . 0.0 109.546 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.509 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 17.1 t70 -126.2 -179.58 4.79 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.333 1.053 . . . . 0.0 109.259 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.5 t -130.67 113.93 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.244 1.018 . . . . 0.0 109.271 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -94.04 115.03 27.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.159 0.584 . . . . 0.0 109.662 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.36 147.14 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.343 0.592 . . . . 0.0 111.452 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 5.0 mmpt? -134.76 128.83 19.05 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.369 1.468 . . . . 0.0 110.113 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 97.9 Cg_endo -78.44 54.15 4.87 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.827 2.351 . . . . 0.0 112.345 170.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 57.38 97.9 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.558 1.143 . . . . 0.0 111.525 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.479 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 44.8 m -136.8 -54.2 0.72 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.426 0.69 . . . . 0.0 109.817 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 m -79.27 148.59 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.881 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -93.31 -162.28 0.92 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.536 1.134 . . . . 0.0 110.651 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -73.43 3.38 6.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -67.45 -31.41 71.57 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.445 ' HA ' ' HE2' ' A' ' 41' ' ' MET . 0.2 OUTLIER -68.59 90.99 0.41 Allowed 'General case' 0 C--N 1.352 0.714 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.103 178.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.43 153.81 47.64 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.264 0.625 . . . . 0.0 109.459 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.25 102.79 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.228 1.952 . . . . 0.0 111.11 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.13 29.79 0.38 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.66 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.445 ' HE2' ' HA ' ' A' ' 37' ' ' LEU . 26.2 mtm -111.39 -166.53 1.08 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.643 0.777 . . . . 0.0 110.453 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.9 ptpt -117.14 161.09 20.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.893 0.877 . . . . 0.0 110.539 169.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.544 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 t80 -135.73 101.07 4.65 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 45.1 t -84.29 120.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.294 0.569 . . . . 0.0 109.875 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -84.54 108.69 17.44 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 68.0 t80 -76.76 145.66 38.43 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.257 175.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -104.95 -68.16 0.87 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.254 0.549 . . . . 0.0 110.331 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.1 t -158.75 177.15 11.49 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.303 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -82.01 -162.86 0.59 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.253 0.621 . . . . 0.0 110.584 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 66.78 -150.87 0.2 Allowed 'General case' 0 C--N 1.362 1.131 0 C-N-CA 123.85 0.86 . . . . 0.0 109.836 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.442 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 8.8 m-20 -77.25 -16.37 59.04 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.007 0.523 . . . . 0.0 112.174 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.4 p -102.76 81.12 1.97 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.668 0.746 . . . . 0.0 111.026 -173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.3 170.6 17.22 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.279 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.454 ' HE2' ' HA ' ' A' ' 126' ' ' PRO . 61.9 m-85 56.42 91.58 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.144 0.978 . . . . 0.0 112.217 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -77.98 -25.6 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 123.509 0.724 . . . . 0.0 111.268 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.28 -165.93 33.31 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 120.173 -0.237 . . . . 0.0 112.758 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 7.3 pt-20 -145.42 178.03 8.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.631 0.772 . . . . 0.0 109.491 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.5 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -157.46 -171.1 3.45 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.497 1.119 . . . . 0.0 108.81 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 24.2 mmt85 -125.79 117.84 24.25 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.438 0.695 . . . . 0.0 110.168 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.544 HG13 ' HB2' ' A' ' 43' ' ' PHE . 49.1 mt -69.27 131.45 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.316 1.046 . . . . 0.0 110.472 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -141.5 -166.61 2.23 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 125.513 1.525 . . . . 0.0 108.967 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -42.68 114.53 0.6 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.744 1.217 . . . . 0.0 113.352 -162.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.5 m -89.3 123.68 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.286 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 90.4 t -90.17 108.2 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HB3' HD12 ' A' ' 108' ' ' LEU . 77.8 mt -95.58 113.87 25.57 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.1 t -153.46 144.18 22.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.576 0.75 . . . . 0.0 109.716 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -74.26 -27.75 60.9 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.54 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 42.7 m-20 -94.88 123.56 57.25 Favored Pre-proline 0 N--CA 1.476 0.859 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.529 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 28.6 Cg_endo -63.84 -25.01 67.87 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.18 1.92 . . . . 0.0 112.447 173.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.529 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 3.5 mpp? -74.53 -18.15 60.64 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.799 0.44 . . . . 0.0 110.887 -174.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 25.9 mm-40 -58.2 -40.76 82.4 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.656 0.782 . . . . 0.0 110.21 170.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -73.7 -29.15 62.11 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.677 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CE2' HD23 ' A' ' 87' ' ' LEU . 66.0 m-85 -86.94 -15.63 38.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.17 -31.87 14.61 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 117.941 0.337 . . . . 0.0 110.174 173.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -76.62 -58.08 3.49 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.096 0.558 . . . . 0.0 109.758 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.739 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 63.3 m-85 -98.42 -67.32 0.85 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.732 0.813 . . . . 0.0 110.091 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.98 -81.38 0.09 OUTLIER Glycine 0 C--N 1.358 1.792 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.482 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.09 -36.9 78.44 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.661 1.184 . . . . 0.0 111.921 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.739 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 26.2 mmt180 -76.19 -20.09 57.82 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.979 0.512 . . . . 0.0 111.322 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 76' ' ' PHE . 30.8 t -79.18 142.4 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -57.12 -41.34 78.82 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -106.43 163.18 13.06 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.489 HG21 ' HG2' ' A' ' 86' ' ' GLU . 9.0 t -98.76 175.71 5.87 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 173.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.31 -28.31 69.22 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.213 0.605 . . . . 0.0 110.89 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.75 -43.48 98.68 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.969 0.908 . . . . 0.0 110.243 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.489 ' HG2' HG21 ' A' ' 83' ' ' THR . 69.7 mm-40 -66.95 -33.9 76.58 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.957 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.438 HD23 ' CE2' ' A' ' 73' ' ' PHE . 32.6 tp -64.53 -52.56 57.13 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.382 0.673 . . . . 0.0 111.029 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -38.3 89.22 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.506 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.05 -33.42 70.25 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.012 0.195 . . . . 0.0 110.671 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 76.3 t80 -66.81 -48.05 70.14 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.136 0.975 . . . . 0.0 110.918 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.5 mtm -66.44 -41.0 89.78 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.684 0.615 . . . . 0.0 110.172 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -62.2 -40.76 97.17 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.545 0.528 . . . . 0.0 110.705 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.0 t -62.64 -37.75 87.54 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.205 0.602 . . . . 0.0 111.09 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 81.9 mm-40 -71.3 -34.94 71.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -89.56 -22.13 22.53 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -101.23 -29.49 12.06 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.552 0.614 . . . . 0.0 111.762 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -104.62 -32.29 8.99 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.404 0.282 . . . . 0.0 111.038 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -86.72 56.21 4.67 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.901 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 62.44 -83.42 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.156 1.382 . . . . 0.0 110.138 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 33.6 ttm180 -166.13 73.5 0.17 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 174.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.434 ' H ' ' HA ' ' A' ' 95' ' ' GLU . 2.3 tmt_? -74.38 82.96 1.92 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -109.13 179.67 4.1 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.469 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.6 t -167.54 144.65 4.41 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -72.39 -25.84 61.65 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 124.096 0.872 . . . . 0.0 110.784 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -129.08 166.53 19.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.138 0.975 . . . . 0.0 109.453 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.466 ' H ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -94.58 160.11 14.78 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -109.9 168.53 9.35 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.181 0.592 . . . . 0.0 109.641 -175.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' ' 65' ' ' LEU . 1.3 tm? -78.2 107.27 10.66 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -89.33 158.4 17.82 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.7 0.8 . . . . 0.0 109.282 172.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.483 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 15.4 ptm -136.27 131.59 34.64 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.051 0.54 . . . . 0.0 110.754 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.504 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . . . -113.0 102.91 10.86 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.763 0.825 . . . . 0.0 109.767 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.1 mt -83.11 128.13 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.448 0.699 . . . . 0.0 109.414 -175.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.91 111.86 18.5 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 58' ' ' ALA . 3.9 mm? -99.17 112.52 24.65 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.47 0.708 . . . . 0.0 110.395 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -120.72 167.15 12.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.446 0.698 . . . . 0.0 109.65 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.5 t70 53.86 54.88 9.15 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.294 1.038 . . . . 0.0 110.35 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.11 107.62 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.415 -175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -83.35 163.91 20.33 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.242 1.017 . . . . 0.0 109.815 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -126.48 132.51 51.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.666 0.786 . . . . 0.0 109.965 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -94.4 97.16 9.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -77.3 -18.26 57.65 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.829 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -83.67 139.19 40.73 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.872 0.869 . . . . 0.0 109.378 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.41 100.02 1.33 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.714 2.276 . . . . 0.0 111.115 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.2 mt -81.19 125.75 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.442 ' HG3' ' HA ' ' A' ' 51' ' ' ASP . 0.1 OUTLIER -78.78 116.46 59.91 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.454 ' HA ' ' HE2' ' A' ' 54' ' ' PHE . 9.8 Cg_endo -55.42 129.06 33.13 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.747 2.298 . . . . 0.0 113.182 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -70.3 -20.51 63.02 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.183 0.993 . . . . 0.0 110.416 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -159.27 165.72 32.86 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.92 1.288 . . . . 0.0 108.813 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -71.06 136.19 48.15 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.661 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.498 HG11 ' HD3' ' A' ' 10' ' ' PRO . 41.1 t -111.25 97.72 36.6 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.24 -177.99 2.66 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.546 2.831 . . . . 0.0 112.207 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.67 -33.47 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.521 0.728 . . . . 0.0 110.701 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.34 -25.31 72.45 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.946 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.54 163.16 30.79 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.009 0.338 . . . . 0.0 113.229 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -119.67 146.29 45.71 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.055 0.942 . . . . 0.0 110.66 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -84.16 110.25 18.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.305 0.642 . . . . 0.0 110.236 173.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 119.14 20.63 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 172.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.66 137.9 50.9 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.134 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.925 0.393 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m -67.25 -8.34 31.09 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.26 1.024 . . . . 0.0 113.318 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.676 ' HZ1' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -62.95 -25.26 68.27 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.386 0.674 . . . . 0.0 111.909 174.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.7 mm 65.78 -176.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 C-N-CA 124.469 1.107 . . . . 0.0 109.283 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -145.92 -42.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.582 1.153 . . . . 0.0 108.045 158.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.551 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.23 -161.49 20.85 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.88 0.738 . . . . 0.0 113.595 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.422 HG13 HD12 ' A' ' 60' ' ' ILE . 9.7 p -121.38 162.0 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -137.42 138.77 40.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.116 0.567 . . . . 0.0 110.129 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -135.46 150.08 71.3 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.936 0.894 . . . . 0.0 110.446 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD3' HG12 ' A' ' 130' ' ' VAL . 91.2 Cg_endo -80.57 -10.83 13.12 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.787 2.325 . . . . 0.0 112.359 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.3 mm 59.79 97.96 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 125.675 1.59 . . . . 0.0 110.879 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -82.63 33.33 0.53 Allowed 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.232 2.621 . . . . 0.0 113.137 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -137.44 162.07 34.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.278 1.031 . . . . 0.0 110.507 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.458 ' H ' ' HD2' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -78.2 -15.72 58.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.76 0.824 . . . . 0.0 110.428 -174.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 82' ' ' LEU . 41.7 m-85 -90.51 31.74 1.01 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.22 1.008 . . . . 0.0 112.354 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -58.74 -22.98 59.06 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.853 0.861 . . . . 0.0 112.017 166.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.474 ' HA ' ' CD2' ' A' ' 49' ' ' HIS . 26.1 t70 -77.52 -27.45 51.71 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.409 1.084 . . . . 0.0 112.514 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -50.2 -48.69 54.17 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.471 1.108 . . . . 0.0 113.702 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -63.82 -29.41 70.61 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.765 0.666 . . . . 0.0 110.605 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -96.82 -12.58 23.41 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.623 0.769 . . . . 0.0 111.621 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -76.05 -50.17 15.5 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.834 0.853 . . . . 0.0 109.007 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -109.2 -16.13 14.14 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.502 -172.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.82 9.04 74.48 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 114.216 0.446 . . . . 0.0 114.216 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -163.25 92.36 0.74 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.33 1.052 . . . . 0.0 109.811 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -133.35 -176.87 4.29 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -136.43 121.19 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 120.188 1.358 . . . . 0.0 109.813 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -94.61 116.52 28.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.709 0.804 . . . . 0.0 109.922 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 m -98.2 143.29 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.346 0.593 . . . . 0.0 111.374 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.766 ' HG2' HG21 ' A' ' 33' ' ' VAL . 16.5 tppt? -136.64 140.52 32.39 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.5 1.12 . . . . 0.0 109.88 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.631 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 59.0 Cg_endo -72.7 59.52 3.41 Favored 'Trans proline' 0 CA--C 1.56 1.817 0 C-N-CA 122.996 2.464 . . . . 0.0 113.748 166.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.41 33.95 6.08 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.256 1.423 . . . . 0.0 113.856 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 3.3 m -87.48 -17.64 31.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.408 0.683 . . . . 0.0 111.05 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.766 HG21 ' HG2' ' A' ' 29' ' ' LYS . 3.3 t -87.71 150.3 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.252 0.621 . . . . 0.0 109.493 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -70.02 174.96 4.8 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.53 0.681 . . . . 0.0 112.257 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -76.96 -1.36 28.25 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.636 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.67 -23.55 66.81 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.65 0.78 . . . . 0.0 111.034 173.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.512 HD22 HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -65.52 103.32 0.82 Allowed 'General case' 0 C--N 1.353 0.743 0 C-N-CA 123.0 0.52 . . . . 0.0 110.084 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -129.95 150.82 77.0 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.198 0.599 . . . . 0.0 109.65 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.81 107.84 1.96 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.836 2.358 . . . . 0.0 111.042 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.82 -14.57 1.76 Allowed Glycine 0 N--CA 1.467 0.749 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.92 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.551 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 27.9 mtm -78.65 -173.21 3.31 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.367 0.603 . . . . 0.0 111.881 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -112.21 162.74 15.15 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.976 0.91 . . . . 0.0 110.32 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.435 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -135.57 102.71 5.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.162 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.99 126.28 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.352 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -97.69 111.69 23.88 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -100.86 157.4 16.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.359 1.064 . . . . 0.0 108.934 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 72.48 165.38 0.29 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.648 1.179 . . . . 0.0 111.819 170.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.7 p 60.4 -167.01 0.19 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.505 1.522 . . . . 0.0 112.473 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.474 ' CD2' ' HA ' ' A' ' 17' ' ' ASP . 55.4 t-80 66.99 16.25 10.32 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.303 1.041 . . . . 0.0 112.06 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 65.15 25.07 12.42 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.265 1.026 . . . . 0.0 110.675 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -119.96 -48.78 2.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.779 0.832 . . . . 0.0 110.771 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.7 m 69.29 -75.1 0.07 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.497 1.119 . . . . 0.0 111.924 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.67 83.9 0.89 Allowed Glycine 0 C--N 1.351 1.371 0 N-CA-C 112.157 -0.377 . . . . 0.0 112.157 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 58.61 95.95 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.619 1.167 . . . . 0.0 111.903 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.45 -38.54 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 168.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.75 -157.16 28.03 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.526 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.22 179.26 9.13 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.081 0.952 . . . . 0.0 110.031 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' A' ' 114' ' ' LEU . . . -155.17 -172.24 4.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.652 0.781 . . . . 0.0 110.844 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -122.78 119.82 31.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.864 0.866 . . . . 0.0 110.043 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 43' ' ' PHE . 45.9 mt -68.61 135.79 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.664 1.186 . . . . 0.0 111.3 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.7 mmmt -134.51 -178.36 5.02 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 126.344 1.858 . . . . 0.0 108.588 -174.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -40.77 116.45 0.71 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.2 1.4 . . . . 0.0 114.046 -165.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.487 HG13 ' HA ' ' A' ' 112' ' ' ILE . 34.3 m -89.11 116.99 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.857 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.98 115.68 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.736 0.814 . . . . 0.0 109.554 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.9 mt -88.79 119.49 29.33 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.959 0.504 . . . . 0.0 109.688 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -148.28 131.3 16.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.034 0.933 . . . . 0.0 108.796 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -63.0 -31.24 72.33 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.967 0.907 . . . . 0.0 111.576 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.58 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 25.8 m-80 -91.35 119.11 68.76 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.75 -12.94 35.9 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.595 2.197 . . . . 0.0 112.238 172.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.6 mtm -81.5 -24.27 36.8 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.284 1.033 . . . . 0.0 110.704 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.58 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 79.0 mt-30 -70.32 -25.39 63.28 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -69.2 -28.34 66.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.421 0.288 . . . . 0.0 110.747 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -81.65 -20.41 39.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.883 0.473 . . . . 0.0 112.256 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.6 pt-20 -90.84 -25.54 19.83 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 117.979 0.354 . . . . 0.0 111.194 172.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.6 m -85.91 -50.8 6.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.443 0.697 . . . . 0.0 110.957 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.764 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 82.1 m-85 -107.17 -57.68 2.04 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.993 0.917 . . . . 0.0 109.927 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.44 -90.63 0.24 Allowed Glycine 0 C--N 1.355 1.626 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.827 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.37 -35.21 76.84 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.846 0.858 . . . . 0.0 110.621 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.764 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 44.7 mmt-85 -71.37 -28.2 63.88 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-O 119.162 -0.447 . . . . 0.0 110.914 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.529 HG21 ' HB2' ' A' ' 76' ' ' PHE . 57.2 t -71.04 132.3 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -56.78 -50.69 71.54 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.113 0.883 . . . . 0.0 112.213 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 1.8 pt? -94.6 157.47 15.96 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.436 HG23 ' HG2' ' A' ' 86' ' ' GLU . 14.4 t -88.53 168.31 12.69 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.87 -29.07 70.29 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.197 0.199 . . . . 0.0 110.72 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -61.03 -43.07 99.44 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.535 0.734 . . . . 0.0 111.314 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.436 ' HG2' HG23 ' A' ' 83' ' ' THR . 51.0 mm-40 -64.39 -40.09 95.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.284 0.634 . . . . 0.0 111.345 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.447 ' HG ' ' HE2' ' A' ' 91' ' ' MET . 24.4 tp -62.98 -52.27 63.66 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.92 0.763 . . . . 0.0 110.841 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -68.05 -43.23 79.13 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.536 -173.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.23 -33.3 74.33 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.095 0.407 . . . . 0.0 110.106 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.438 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 49.5 t80 -65.26 -45.96 82.42 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.87 0.868 . . . . 0.0 110.638 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.447 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 68.9 mtm -74.16 -27.92 61.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.376 0.671 . . . . 0.0 111.296 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.8 mmmt -75.88 -37.37 58.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.5 m -60.48 -27.71 67.77 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.126 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 78.6 mm-40 -68.47 -54.08 19.26 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.041 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 100' ' ' ARG . 10.9 pt-20 -72.34 -25.44 61.54 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 6.8 ptm180 -97.79 -20.61 17.43 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -120.75 -64.84 1.2 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 118.172 0.442 . . . . 0.0 110.797 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.44 -94.52 0.33 Allowed Glycine 0 C--N 1.347 1.174 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.304 -172.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -161.33 137.31 8.06 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.103 0.961 . . . . 0.0 109.479 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.44 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 17.5 tpt180 -154.21 75.65 1.01 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.277 0.561 . . . . 0.0 109.834 169.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -78.53 -51.78 9.46 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 65.37 130.54 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 O-C-N 124.954 1.408 . . . . 0.0 113.422 165.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.8 p -69.14 163.63 24.41 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.159 0.584 . . . . 0.0 110.761 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -56.77 -29.12 62.32 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.881 0.872 . . . . 0.0 112.319 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -100.39 141.59 33.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.201 0.6 . . . . 0.0 109.692 172.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 169.04 5.55 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.536 0.734 . . . . 0.0 110.956 176.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -76.52 150.48 36.59 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.445 174.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.96 131.65 41.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -114.99 159.6 20.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.594 0.758 . . . . 0.0 109.681 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.8 ptm -138.01 130.65 29.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.173 0.989 . . . . 0.0 109.203 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.13 101.65 10.86 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.487 ' HA ' HG13 ' A' ' 63' ' ' VAL . 36.8 mt -82.04 118.36 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 44.4 tt0 -81.46 139.89 34.94 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.488 HD13 ' HB1' ' A' ' 58' ' ' ALA . 3.8 mm? -123.57 132.31 53.85 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.967 1.307 . . . . 0.0 109.126 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -140.24 165.5 27.22 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.642 0.777 . . . . 0.0 109.388 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.8 t70 59.0 39.59 23.33 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.275 1.03 . . . . 0.0 110.331 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.8 t -68.26 101.18 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.125 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -74.16 131.51 41.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.604 1.161 . . . . 0.0 109.862 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -92.56 125.97 37.43 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.239 0.543 . . . . 0.0 109.555 172.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.1 98.69 11.92 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.926 0.89 . . . . 0.0 109.338 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.85 -30.75 68.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.652 172.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -84.92 132.8 44.79 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.378 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.58 102.11 1.52 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.118 2.546 . . . . 0.0 111.606 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.8 mt -111.04 129.37 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.284 0.564 . . . . 0.0 110.463 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.79 141.52 64.25 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.938 0.895 . . . . 0.0 109.59 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.92 157.15 58.9 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.186 1.924 . . . . 0.0 112.13 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -63.21 -27.81 69.62 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.881 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -154.35 163.86 39.5 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.984 1.314 . . . . 0.0 107.755 166.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -61.21 136.03 57.93 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.482 HG12 ' HD3' ' A' ' 10' ' ' PRO . 28.7 t -106.01 103.62 45.53 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 -178.37 2.56 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.151 2.568 . . . . 0.0 112.278 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.97 -36.05 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.908 0.883 . . . . 0.0 111.622 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.62 -16.43 77.74 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-N 116.117 -0.492 . . . . 0.0 113.166 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.5 162.97 25.51 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 123.052 0.358 . . . . 0.0 112.962 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -114.79 152.51 31.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.547 0.739 . . . . 0.0 110.188 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.72 117.21 29.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 170.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.1 114.38 21.72 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.31 141.73 51.23 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HB2' HG11 ' A' ' 5' ' ' VAL . 10.0 tp10 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 11.4 tpt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.753 -0.092 . . . . 0.0 110.753 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -59.91 -14.24 14.68 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.651 1.18 . . . . 0.0 114.041 -172.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -64.32 -20.21 65.94 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.3 mm 66.05 -174.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.684 0 C-N-CA 124.163 0.985 . . . . 0.0 108.791 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.64 -42.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.858 1.263 . . . . 0.0 107.776 160.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -167.44 -162.54 19.46 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.355 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.406 HG13 HD13 ' A' ' 60' ' ' ILE . 8.6 p -119.44 151.1 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 172.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -122.87 132.35 54.15 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.731 0.813 . . . . 0.0 108.845 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -131.42 144.14 52.16 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.066 0.946 . . . . 0.0 109.673 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.517 ' HD3' HG13 ' A' ' 130' ' ' VAL . 97.3 Cg_endo -74.48 -17.01 21.31 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.576 2.184 . . . . 0.0 112.028 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.493 HG21 ' HA ' ' A' ' 16' ' ' MET . 14.2 mm 49.15 80.88 0.28 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.154 1.382 . . . . 0.0 109.678 -167.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HG3' HG21 ' A' ' 132' ' ' VAL . 96.5 Cg_endo -78.57 15.47 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.001 2.467 . . . . 0.0 112.94 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -104.8 152.74 22.21 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.46 1.104 . . . . 0.0 109.823 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -66.08 -8.38 23.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.652 1.181 . . . . 0.0 112.797 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -97.0 28.05 3.73 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.657 1.183 . . . . 0.0 112.323 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.493 ' HA ' HG21 ' A' ' 11' ' ' ILE . 27.0 ptt? -63.94 -30.16 71.26 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.287 0.565 . . . . 0.0 110.712 174.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -72.05 -21.85 61.47 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.523 1.129 . . . . 0.0 112.595 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 84.4 mmt-85 -58.36 -38.25 76.86 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.959 0.903 . . . . 0.0 112.615 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.402 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 64.5 m-85 -67.18 -30.35 70.28 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 121.087 0.47 . . . . 0.0 110.473 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -96.77 -8.58 30.86 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.158 0.983 . . . . 0.0 110.78 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -84.88 -54.64 4.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.813 1.245 . . . . 0.0 110.03 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.9 ptpt -98.3 -13.8 20.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.814 -171.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.46 -23.81 9.43 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 113.857 0.303 . . . . 0.0 113.857 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -148.72 116.86 6.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.026 0.93 . . . . 0.0 109.487 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.402 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 14.4 t70 -123.44 175.43 6.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.275 0.63 . . . . 0.0 110.001 -170.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.88 109.53 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.42 ' HD2' HD13 ' A' ' 112' ' ' ILE . 85.7 t80 -87.82 108.82 19.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.45 0.7 . . . . 0.0 109.561 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 m -92.59 138.44 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.181 0.515 . . . . 0.0 110.977 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -129.45 147.31 64.63 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.674 1.19 . . . . 0.0 110.068 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -77.15 53.17 4.12 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.985 2.457 . . . . 0.0 111.754 165.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.495 ' HB1' ' HE2' ' A' ' 107' ' ' LYS . . . 38.23 64.93 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.564 1.546 . . . . 0.0 112.928 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -94.02 -27.13 16.48 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.198 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.56 152.76 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.319 1.048 . . . . 0.0 111.141 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -65.87 169.38 6.68 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.505 0.722 . . . . 0.0 109.878 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -68.83 -2.16 8.89 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.66 -30.68 65.62 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.684 0.794 . . . . 0.0 111.502 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.401 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -62.24 116.3 4.89 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.557 0.743 . . . . 0.0 110.588 -179.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.83 152.99 53.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.968 0.907 . . . . 0.0 109.697 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.95 105.99 1.25 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.886 2.391 . . . . 0.0 111.305 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.92 -8.62 1.75 Allowed Glycine 0 N--CA 1.471 0.995 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.237 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.545 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 83.2 mtp -84.51 179.46 7.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.29 1.036 . . . . 0.0 111.305 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -110.23 164.47 12.62 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.91 0.884 . . . . 0.0 110.162 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.443 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 t80 -135.44 94.87 3.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -83.09 120.48 34.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.226 0.536 . . . . 0.0 110.143 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -83.72 97.64 9.23 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.57 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -71.37 168.75 16.75 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 163.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -161.1 155.3 22.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 m 66.96 -175.64 0.19 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.971 0.909 . . . . 0.0 111.924 172.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -122.9 15.6 10.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.889 0.876 . . . . 0.0 109.072 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -86.75 166.27 15.4 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.268 1.027 . . . . 0.0 111.293 -172.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -37.6 -51.97 1.2 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.257 1.823 . . . . 0.0 113.406 173.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -111.34 145.02 39.6 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.54 45.78 0.26 Allowed Glycine 0 C--N 1.347 1.155 0 C-N-CA 121.406 -0.426 . . . . 0.0 113.706 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -105.81 104.01 13.63 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.61 -28.93 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 122.995 0.518 . . . . 0.0 110.408 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.61 -164.05 34.12 Favored Glycine 0 C--N 1.344 1.019 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.838 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -151.14 178.9 8.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.812 0.845 . . . . 0.0 109.21 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.402 ' HB1' HD13 ' A' ' 114' ' ' LEU . . . -161.5 -172.27 3.29 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.18 0.992 . . . . 0.0 109.685 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -128.7 120.87 27.3 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.807 0.843 . . . . 0.0 110.087 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.443 HG13 ' HB2' ' A' ' 43' ' ' PHE . 54.1 mt -70.66 134.32 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.483 1.113 . . . . 0.0 111.273 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.2 mmmt -131.76 178.42 6.77 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 126.091 1.756 . . . . 0.0 109.82 -175.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -29.13 110.45 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.774 2.03 . . . . 0.0 114.507 -175.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 112' ' ' ILE . 33.4 m -93.11 118.38 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.801 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.0 119.26 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.733 0.813 . . . . 0.0 109.077 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.504 ' HB3' HD13 ' A' ' 108' ' ' LEU . 70.9 mt -101.99 120.77 40.95 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.78 0.832 . . . . 0.0 109.47 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.6 t -152.67 135.12 15.16 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.057 0.943 . . . . 0.0 110.113 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 14.8 mt-10 -63.84 -23.56 67.4 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.149 0.98 . . . . 0.0 112.19 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -102.84 120.16 53.41 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HB3' ' CE3' ' A' ' 109' ' ' TRP . 36.7 Cg_endo -64.74 -19.75 64.66 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.689 2.259 . . . . 0.0 112.189 174.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 44.2 mtm -73.27 -23.86 60.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.847 0.859 . . . . 0.0 110.477 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 23.7 mt-30 -71.05 -23.52 62.16 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.529 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.31 -24.04 54.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.736 0.414 . . . . 0.0 111.017 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.446 ' HE2' HD23 ' A' ' 87' ' ' LEU . 55.4 m-85 -88.35 -27.5 21.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.088 0.555 . . . . 0.0 111.623 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.9 pt-20 -82.46 -27.46 31.85 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 120.388 0.137 . . . . 0.0 110.656 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.5 m -84.89 -50.65 7.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.686 0.394 . . . . 0.0 110.61 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.74 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 89.2 m-85 -107.41 -69.37 0.85 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.153 0.581 . . . . 0.0 110.628 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.2 -80.99 0.07 OUTLIER Glycine 0 C--N 1.358 1.75 0 O-C-N 123.546 0.528 . . . . 0.0 113.515 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.14 -31.86 67.61 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.811 1.244 . . . . 0.0 111.778 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.74 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 30.3 mmt180 -74.02 -36.12 64.41 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.35 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.32 148.84 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.973 0.509 . . . . 0.0 110.677 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.471 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 45.7 p90 -62.56 -34.14 76.36 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -117.16 170.63 8.52 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 86' ' ' GLU . 9.4 t -106.21 175.81 5.37 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -60.93 -31.78 71.3 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.134 0.974 . . . . 0.0 111.577 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.77 -43.01 90.13 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.292 0.637 . . . . 0.0 110.73 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.494 ' HG2' HG23 ' A' ' 83' ' ' THR . 60.1 mm-40 -65.99 -33.86 76.79 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.143 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' HE2' ' A' ' 73' ' ' PHE . 26.7 tp -63.87 -54.54 33.23 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.415 0.686 . . . . 0.0 111.002 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -67.11 -36.88 82.88 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.751 -171.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 90' ' ' TYR . 6.7 pt-20 -66.25 -40.21 90.03 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 173.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.424 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 79.7 t80 -61.87 -40.21 94.61 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.223 1.009 . . . . 0.0 111.055 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.438 ' HE3' ' HG ' ' A' ' 87' ' ' LEU . 71.6 mtm -73.15 -35.07 66.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.068 0.547 . . . . 0.0 110.965 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.0 mmmt -69.85 -25.89 63.95 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.6 0.36 . . . . 0.0 110.608 173.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.442 ' HA ' ' HG2' ' A' ' 96' ' ' ARG . 68.0 m -72.05 -25.03 61.63 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.224 0.609 . . . . 0.0 111.463 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 75.9 mm-40 -78.28 -28.9 47.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.746 0.419 . . . . 0.0 111.75 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.45 -31.63 21.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.844 0.458 . . . . 0.0 111.114 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 93' ' ' SER . 11.9 ptm85 -85.54 -20.65 29.3 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -124.22 28.89 6.56 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.224 0.535 . . . . 0.0 111.326 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -167.41 -172.72 34.87 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.005 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.78 25.5 3.57 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.441 1.097 . . . . 0.0 111.109 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 71.11 -15.13 0.42 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 126.048 1.739 . . . . 0.0 113.211 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 67.98 -55.94 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 125.738 1.615 . . . . 0.0 111.636 -165.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 63.24 78.94 0.27 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.745 1.218 . . . . 0.0 110.742 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -87.48 115.72 25.1 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -64.58 -35.77 82.08 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.13 0.572 . . . . 0.0 111.327 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.421 ' HG3' ' HD2' ' A' ' 106' ' ' LYS . 1.6 tpmt? -104.8 160.38 15.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HD2' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -68.44 158.72 33.11 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.495 ' HE2' ' HB1' ' A' ' 31' ' ' ALA . 3.9 tmtp? -102.73 138.8 39.15 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' A' ' 65' ' ' LEU . 3.0 tm? -77.2 104.65 7.83 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.412 ' CE3' ' HB3' ' A' ' 69' ' ' PRO . 24.8 m95 -82.93 161.08 21.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.205 0.602 . . . . 0.0 109.524 174.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.6 ptm -136.72 141.96 43.07 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.129 0.971 . . . . 0.0 109.754 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.17 103.97 9.7 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.125 0.97 . . . . 0.0 109.006 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.484 ' HA ' HG11 ' A' ' 63' ' ' VAL . 30.9 mt -81.45 122.45 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -82.96 136.65 34.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.402 HD13 ' HB1' ' A' ' 58' ' ' ALA . 3.9 mm? -123.3 132.73 54.11 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.223 0.609 . . . . 0.0 110.356 -175.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -131.87 172.57 12.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.888 0.875 . . . . 0.0 110.294 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.1 t70 49.05 50.01 18.59 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.809 1.243 . . . . 0.0 111.874 170.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.34 101.61 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.153 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -77.87 148.41 34.65 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.512 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -111.28 111.86 23.21 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.164 0.585 . . . . 0.0 110.32 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -83.9 87.06 7.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.961 0.904 . . . . 0.0 109.244 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.45 -15.08 56.16 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.701 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -80.47 137.61 51.78 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.296 1.039 . . . . 0.0 110.294 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.21 79.6 3.33 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 123.079 2.519 . . . . 0.0 113.178 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.8 mt -98.49 137.4 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.153 0.581 . . . . 0.0 110.598 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -71.22 151.32 94.52 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.258 1.023 . . . . 0.0 111.032 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.42 153.84 65.6 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.195 1.93 . . . . 0.0 111.384 167.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -36.55 74.95 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -152.19 169.51 22.28 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.202 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.98 132.48 48.0 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.32 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.517 HG13 ' HD3' ' A' ' 10' ' ' PRO . 17.6 t -118.89 99.6 51.07 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.093 0.557 . . . . 0.0 109.704 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.19 -174.87 2.12 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.478 2.785 . . . . 0.0 112.591 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.573 HG21 ' HG3' ' A' ' 12' ' ' PRO . 5.5 p -54.91 -40.3 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.661 1.184 . . . . 0.0 112.62 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.63 -12.91 82.41 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 113.581 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.95 159.49 15.09 Favored Glycine 0 C--N 1.348 1.208 0 C-N-CA 122.9 0.286 . . . . 0.0 112.838 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -113.58 150.02 33.65 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.534 0.734 . . . . 0.0 109.082 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -84.05 115.55 22.42 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.42 125.76 29.65 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -133.99 122.27 22.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 C--O 1.243 0.763 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.05 -172.6 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.486 ' HB3' ' HG3' ' A' ' 138' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.565 0.221 . . . . 0.0 111.251 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -69.2 -11.09 60.5 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.36 0.664 . . . . 0.0 112.705 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -76.96 -17.29 58.99 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.721 0.808 . . . . 0.0 112.381 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 5' ' ' VAL . 16.9 mm 64.45 -171.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.879 0 C-N-CA 124.005 0.922 . . . . 0.0 108.912 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.3 m -156.22 -32.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 125.497 1.519 . . . . 0.0 109.131 156.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -166.97 -164.05 21.91 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.324 0.39 . . . . 0.0 112.839 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.431 HG12 HD11 ' A' ' 60' ' ' ILE . 10.4 p -139.0 144.81 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.508 0.723 . . . . 0.0 109.158 173.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 t -116.97 132.59 56.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.946 0.898 . . . . 0.0 110.0 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -133.18 140.64 37.99 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.561 1.144 . . . . 0.0 108.8 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.8 -41.32 24.58 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.085 2.524 . . . . 0.0 111.828 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.4 mt 54.11 77.38 0.44 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 124.67 1.188 . . . . 0.0 110.001 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.63 0.24 6.6 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.103 2.535 . . . . 0.0 113.501 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -69.21 144.86 53.61 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 121.501 0.667 . . . . 0.0 110.499 172.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -59.22 -10.77 3.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.18 1.392 . . . . 0.0 112.852 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -99.43 22.1 11.18 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.445 1.098 . . . . 0.0 112.491 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.9 -29.27 70.2 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.937 0.495 . . . . 0.0 109.877 168.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -67.81 -27.25 66.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.825 1.25 . . . . 0.0 111.898 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 24.3 mmt180 -55.69 -37.03 67.81 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.935 0.894 . . . . 0.0 113.134 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 62.2 m-85 -66.19 -29.67 69.98 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.107 0.479 . . . . 0.0 110.865 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.13 -23.24 18.67 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.585 1.154 . . . . 0.0 110.282 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -74.01 -55.51 6.05 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.815 1.246 . . . . 0.0 110.673 -174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.2 ptpt -93.99 -12.61 28.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.444 0.698 . . . . 0.0 111.24 -175.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.49 -30.63 5.92 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 122.924 0.297 . . . . 0.0 113.192 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.82 118.39 7.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.873 0.869 . . . . 0.0 108.857 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.409 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 16.5 t70 -123.25 -179.43 4.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.765 0.826 . . . . 0.0 109.918 -168.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -134.34 110.55 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.324 1.05 . . . . 0.0 108.847 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -92.94 120.96 33.8 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.86 137.78 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.458 0.646 . . . . 0.0 111.113 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.59 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.6 mmpt? -127.58 133.63 25.3 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.476 1.51 . . . . 0.0 109.947 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.5 55.95 4.92 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.803 2.335 . . . . 0.0 111.113 166.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.2 36.11 4.25 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.201 1.4 . . . . 0.0 113.215 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 9.1 m -64.12 -28.26 69.65 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.667 0.746 . . . . 0.0 110.266 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.494 ' HB ' ' HH ' ' A' ' 136' ' ' TYR . 23.1 m -90.48 150.45 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.756 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -79.88 178.0 8.52 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.91 0.884 . . . . 0.0 109.788 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -69.91 4.24 2.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.217 1.007 . . . . 0.0 113.697 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.7 -26.23 68.56 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.245 0.618 . . . . 0.0 110.198 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.48 110.77 2.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.796 0.838 . . . . 0.0 110.718 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -134.31 152.07 77.46 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.23 102.6 0.96 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.38 2.053 . . . . 0.0 110.845 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.75 35.95 0.21 Allowed Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.365 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.491 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 24.5 mtm -119.0 -168.02 1.49 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.448 0.699 . . . . 0.0 110.726 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -110.1 157.06 19.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.19 0.996 . . . . 0.0 108.864 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.56 ' HB2' HG13 ' A' ' 60' ' ' ILE . 2.7 t80 -134.64 104.43 6.05 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 40.5 t -94.6 121.5 45.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.485 0.66 . . . . 0.0 109.823 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -86.21 103.51 14.9 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.249 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -72.99 133.59 44.35 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -69.86 -54.34 13.96 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.143 0.429 . . . . 0.0 111.528 -170.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.5 p -164.63 156.46 15.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.603 0.761 . . . . 0.0 109.155 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -92.34 33.26 1.11 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.377 0.608 . . . . 0.0 111.025 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.77 36.85 1.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.53 1.132 . . . . 0.0 109.157 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 56.16 74.96 0.36 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.749 1.22 . . . . 0.0 109.429 -169.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 m -133.38 175.07 9.73 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.857 -169.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 125' ' ' LYS . . . -101.64 -160.84 26.89 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 170.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -83.83 146.07 28.31 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.332 0.653 . . . . 0.0 110.669 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.26 -23.32 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.041 0.536 . . . . 0.0 109.714 169.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.07 -165.1 35.46 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.017 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 11.1 pt-20 -153.65 178.1 10.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.073 0.949 . . . . 0.0 109.581 172.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' A' ' 114' ' ' LEU . . . -162.31 -172.42 3.18 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.013 0.925 . . . . 0.0 110.181 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -124.2 122.74 38.6 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.786 0.834 . . . . 0.0 109.773 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.56 HG13 ' HB2' ' A' ' 43' ' ' PHE . 41.4 mt -72.16 133.52 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.067 0.947 . . . . 0.0 110.6 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -140.16 -166.18 2.05 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.166 1.787 . . . . 0.0 108.065 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -37.71 118.81 0.69 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.273 1.429 . . . . 0.0 114.565 -165.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -98.27 116.21 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 123.087 0.555 . . . . 0.0 109.8 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -91.12 113.05 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.367 0.667 . . . . 0.0 109.36 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.473 ' HB3' HD13 ' A' ' 108' ' ' LEU . 57.5 mt -90.24 124.68 35.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.512 0.725 . . . . 0.0 109.743 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -152.55 138.23 17.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.004 0.921 . . . . 0.0 110.222 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -75.33 -12.05 60.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.582 0.753 . . . . 0.0 111.556 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.544 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 74.7 m-20 -112.01 119.88 43.22 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.329 0.652 . . . . 0.0 109.274 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.94 -12.83 36.56 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.8 2.333 . . . . 0.0 113.33 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.3 mtm -81.99 -22.61 36.47 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.485 0.714 . . . . 0.0 110.945 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.544 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 62.3 mt-30 -70.73 -20.27 62.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.984 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -74.59 -25.53 59.32 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.052 0.541 . . . . 0.0 110.927 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.445 ' HE2' HD23 ' A' ' 87' ' ' LEU . 37.0 m-85 -85.19 -27.72 25.93 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.969 0.508 . . . . 0.0 111.728 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.36 -33.7 48.84 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 120.508 0.194 . . . . 0.0 110.675 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -79.77 -56.42 4.29 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.974 0.51 . . . . 0.0 111.132 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.69 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 37.3 m-85 -103.28 -68.0 0.86 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.249 0.619 . . . . 0.0 109.702 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.76 -81.51 0.12 Allowed Glycine 0 C--N 1.355 1.614 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.118 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.84 -36.18 69.7 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.592 1.157 . . . . 0.0 111.327 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.69 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 26.5 mmt180 -78.54 -30.27 46.85 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.801 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 76' ' ' PHE . 42.7 t -65.12 140.62 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -57.5 -45.99 84.28 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 122.606 0.362 . . . . 0.0 111.697 -174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -105.46 164.04 12.18 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 86' ' ' GLU . 13.0 t -99.24 -179.69 4.32 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -68.76 -29.85 68.33 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.908 0.483 . . . . 0.0 111.338 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.4 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 2.9 m-20 -68.96 -30.23 68.62 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.324 0.583 . . . . 0.0 111.269 174.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.472 ' HG2' HG22 ' A' ' 83' ' ' THR . 58.8 mm-40 -75.32 -28.52 59.69 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.827 174.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.5 ' HG ' ' HE1' ' A' ' 91' ' ' MET . 56.5 tp -69.23 -47.15 65.55 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.712 0.405 . . . . 0.0 110.582 174.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.4 ' HG3' ' HA ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -65.13 -40.16 94.06 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.854 -175.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.32 -33.95 73.93 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.707 0.23 . . . . 0.0 110.664 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 68.4 t80 -62.99 -44.52 95.79 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.708 0.803 . . . . 0.0 111.221 176.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.5 ' HE1' ' HG ' ' A' ' 87' ' ' LEU . 68.8 mtm -77.05 -35.6 56.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.295 0.638 . . . . 0.0 111.186 -176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -70.05 -23.69 63.14 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.423 0.289 . . . . 0.0 110.41 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.8 t -69.62 -31.37 69.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.818 0.447 . . . . 0.0 111.008 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 26.2 mm-40 -77.74 -13.61 59.85 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -174.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -102.48 -29.71 11.43 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -105.68 -19.92 13.62 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -118.08 -30.14 5.41 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.176 0.59 . . . . 0.0 110.16 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.29 28.63 9.42 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.472 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 73.4 149.44 0.1 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.67 1.588 . . . . 0.0 112.771 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -76.67 -176.39 3.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.35 1.06 . . . . 0.0 111.755 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 71.71 93.15 0.08 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.45 1.5 . . . . 0.0 109.517 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -175.76 5.92 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.094 0.958 . . . . 0.0 109.578 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.7 p -142.9 150.16 39.43 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.585 0.754 . . . . 0.0 110.809 -173.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -70.24 -22.07 62.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.893 0.877 . . . . 0.0 111.112 173.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -67.74 153.49 43.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.481 0.712 . . . . 0.0 110.531 -178.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.25 -171.41 1.87 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.451 0.7 . . . . 0.0 109.161 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.44 ' HD3' ' H ' ' A' ' 108' ' ' LEU . 4.8 tmtp? -135.37 144.42 46.61 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 65' ' ' LEU . 1.5 tm? -77.77 100.25 6.2 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -82.92 159.69 22.25 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.367 0.667 . . . . 0.0 109.381 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.0 ptm -143.37 131.06 21.32 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.611 0.764 . . . . 0.0 110.279 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.17 102.59 11.99 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.813 0.845 . . . . 0.0 109.487 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.432 HG23 HG12 ' A' ' 60' ' ' ILE . 36.0 mt -81.26 127.89 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.748 0.819 . . . . 0.0 109.394 -177.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -81.61 123.47 28.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.429 HD13 ' HB1' ' A' ' 58' ' ' ALA . 4.3 mm? -105.27 129.1 53.71 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.159 0.983 . . . . 0.0 109.528 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.64 175.25 9.72 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.208 1.003 . . . . 0.0 108.492 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 t70 57.63 36.41 26.69 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.876 0.845 . . . . 0.0 110.737 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.16 105.17 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.742 -171.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.65 160.21 21.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.184 0.993 . . . . 0.0 110.472 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -117.5 123.19 45.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.178 0.991 . . . . 0.0 110.54 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -97.12 82.33 3.17 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.49 -24.77 65.62 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.513 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HG3' HG13 ' A' ' 124' ' ' ILE . 16.1 ptpt -81.87 139.42 46.58 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.796 172.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -83.29 65.9 7.7 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 123.235 2.624 . . . . 0.0 112.924 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.403 HG13 ' HG3' ' A' ' 122' ' ' LYS . 39.3 mt -77.02 114.34 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.414 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 12.9 mptt -71.35 145.38 90.55 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.198 -178.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.99 155.19 70.61 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.612 2.208 . . . . 0.0 111.86 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -68.22 -31.07 70.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.617 0.767 . . . . 0.0 109.479 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -128.88 162.21 28.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.144 0.978 . . . . 0.0 109.824 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -77.3 121.88 24.33 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.46 ' HA ' ' HG2' ' A' ' 135' ' ' GLN . 17.8 t -107.69 100.07 32.88 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 122.829 0.451 . . . . 0.0 110.195 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.82 -176.94 3.41 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.01 2.473 . . . . 0.0 111.699 172.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -57.77 -31.22 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.322 1.049 . . . . 0.0 112.756 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.25 -19.27 72.13 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.708 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.76 142.21 3.12 Favored Glycine 0 C--N 1.351 1.361 0 C-N-CA 122.984 0.326 . . . . 0.0 113.031 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.46 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -109.73 157.67 18.89 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.437 0.695 . . . . 0.0 109.836 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.494 ' HH ' ' HB ' ' A' ' 33' ' ' VAL . 33.3 m-85 -87.35 129.1 35.15 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 170.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.1 tt -90.58 125.13 35.53 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.486 ' HG3' ' HB3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -134.26 144.29 48.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttm . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m -63.05 -7.03 4.63 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.347 1.059 . . . . 0.0 113.689 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -59.96 -27.43 66.81 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.243 0.617 . . . . 0.0 112.031 171.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.414 HG21 ' N ' ' A' ' 5' ' ' VAL . 26.3 mm 64.85 -177.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 C-N-CA 124.402 1.081 . . . . 0.0 109.577 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 139' ' ' GLU . 1.3 m -150.24 -39.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.807 1.243 . . . . 0.0 108.712 158.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.39 -163.38 22.27 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.178 -176.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.423 HG11 HD22 ' A' ' 37' ' ' LEU . 9.0 p -137.1 141.39 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.663 0.785 . . . . 0.0 109.068 175.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 t -113.93 139.26 49.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.445 0.698 . . . . 0.0 110.163 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -131.55 143.74 50.46 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 123.695 0.798 . . . . 0.0 109.805 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HD3' HG11 ' A' ' 130' ' ' VAL . 85.8 Cg_endo -73.98 -14.59 23.74 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.994 2.463 . . . . 0.0 112.354 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.1 mm 53.6 89.77 0.1 OUTLIER Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.922 1.289 . . . . 0.0 109.86 -174.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.03 24.35 0.54 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.905 2.403 . . . . 0.0 112.702 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 159.52 39.23 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.532 1.533 . . . . 0.0 108.499 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -74.93 -13.07 60.49 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.446 0.698 . . . . 0.0 111.239 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -72.52 6.85 2.13 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.234 1.013 . . . . 0.0 113.597 -172.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -56.76 -34.21 67.36 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.002 0.43 . . . . 0.0 110.058 164.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.47 ' N ' ' SD ' ' A' ' 16' ' ' MET . 19.6 t70 -49.42 -41.49 39.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.647 1.579 . . . . 0.0 112.428 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -54.56 -48.2 72.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.262 1.025 . . . . 0.0 112.465 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.463 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 64.5 m-85 -66.75 -28.9 68.78 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.988 0.805 . . . . 0.0 110.406 -177.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -91.1 -19.32 23.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.01 0.524 . . . . 0.0 111.376 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -76.74 -59.67 2.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.321 0.648 . . . . 0.0 109.497 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -92.73 -10.23 37.83 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.222 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.3 3.02 69.08 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.416 0.447 . . . . 0.0 114.006 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -168.16 100.43 0.44 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.009 0.924 . . . . 0.0 109.736 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.463 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 20.1 t70 -129.05 -170.74 2.33 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.0 t -133.18 117.51 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.94 1.245 . . . . 0.0 109.248 -174.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -90.49 107.33 19.09 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.278 0.631 . . . . 0.0 109.517 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.3 m -87.67 142.85 12.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.423 0.63 . . . . 0.0 109.903 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.529 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 2.1 tpmt? -135.05 128.07 18.43 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.383 1.073 . . . . 0.0 108.53 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.509 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 79.7 Cg_endo -76.26 59.29 5.97 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.716 2.277 . . . . 0.0 111.736 171.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 39.49 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.882 1.673 . . . . 0.0 113.487 -174.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.529 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 27.9 m -127.91 -31.48 2.4 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.384 0.674 . . . . 0.0 109.754 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.79 148.47 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.41 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -87.98 -164.14 1.06 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.129 0.972 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -70.13 -2.21 12.34 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -63.38 -31.32 72.44 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.234 0.47 . . . . 0.0 110.765 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.469 ' HA ' ' HE1' ' A' ' 41' ' ' MET . 1.1 mm? -64.93 117.44 7.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.132 0.573 . . . . 0.0 111.614 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.07 149.81 46.85 Favored Pre-proline 0 C--O 1.244 0.787 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.791 173.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.31 101.88 0.65 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.541 2.16 . . . . 0.0 111.047 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.83 0.62 0.78 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.483 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.469 ' HE1' ' HA ' ' A' ' 37' ' ' LEU . 26.2 mtm -89.7 -169.75 2.57 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 117.319 0.56 . . . . 0.0 110.984 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -107.86 160.06 16.04 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.507 0.723 . . . . 0.0 109.474 173.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.446 ' HB2' HG13 ' A' ' 60' ' ' ILE . 12.3 t80 -134.98 105.25 6.29 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.8 t -90.76 121.13 40.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.175 0.512 . . . . 0.0 109.868 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -82.95 105.16 13.72 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.437 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 56.8 t80 -79.73 126.28 30.75 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.492 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 24.4 tp60 -76.34 115.8 16.43 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -56.01 83.37 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.809 1.244 . . . . 0.0 113.8 -173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.8 p80 174.19 173.43 0.18 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.01 1.724 . . . . 0.0 109.271 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.31 -178.78 4.13 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.907 0.883 . . . . 0.0 111.718 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.49 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 32.7 t70 61.37 -86.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.174 1.39 . . . . 0.0 112.363 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.469 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 27.2 m -54.07 -35.23 61.82 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.174 0.99 . . . . 0.0 111.977 -172.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.552 ' HA3' ' HD3' ' A' ' 126' ' ' PRO . . . 68.89 -90.87 0.26 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-N 114.799 -1.091 . . . . 0.0 113.517 170.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 66.7 m-85 -102.14 124.34 47.56 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.617 0.767 . . . . 0.0 111.195 -172.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 47' ' ' GLN . 2.6 p -84.53 -33.75 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.932 0.893 . . . . 0.0 110.88 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.6 -168.58 30.88 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.474 -0.33 . . . . 0.0 112.76 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 6.5 pt-20 -147.83 179.46 7.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.396 1.078 . . . . 0.0 108.918 174.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 114' ' ' LEU . . . -164.19 -172.24 2.69 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.679 0.791 . . . . 0.0 110.659 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -123.94 119.03 28.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.507 1.123 . . . . 0.0 109.576 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 43' ' ' PHE . 53.7 mt -71.81 131.78 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.217 1.007 . . . . 0.0 110.733 177.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -138.13 -162.4 1.3 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.212 1.805 . . . . 0.0 107.773 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -38.96 116.0 0.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.821 1.249 . . . . 0.0 113.466 -160.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 35.9 m -96.18 106.36 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 121.735 0.778 . . . . 0.0 109.113 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 86.2 t -89.96 108.02 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.8 mt -89.37 120.32 30.6 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.504 0.722 . . . . 0.0 109.398 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.7 t -151.58 135.73 16.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.557 0.743 . . . . 0.0 110.091 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -70.97 -10.22 59.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.922 0.889 . . . . 0.0 111.837 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -110.12 122.56 38.46 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.58 -22.35 58.41 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.218 1.945 . . . . 0.0 112.282 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 47.5 mtm -70.33 -25.63 63.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.484 0.713 . . . . 0.0 111.415 -169.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -53.56 -35.57 60.93 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.215 1.006 . . . . 0.0 112.03 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.408 ' HE2' ' HB3' ' A' ' 109' ' ' TRP . 5.7 m-85 -77.39 -33.82 55.04 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.525 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.492 ' CE2' HD21 ' A' ' 87' ' ' LEU . 88.1 m-85 -81.5 -16.64 51.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.517 0.727 . . . . 0.0 111.65 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -94.14 -33.57 13.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.462 0.305 . . . . 0.0 111.208 172.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.2 m -78.08 -52.07 9.31 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.989 0.423 . . . . 0.0 110.737 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.789 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 66.9 m-85 -100.16 -53.96 3.0 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.538 0.735 . . . . 0.0 109.951 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.71 -86.44 0.12 Allowed Glycine 0 C--N 1.357 1.731 0 O-C-N 123.938 0.774 . . . . 0.0 113.129 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.92 -43.49 91.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.41 0.684 . . . . 0.0 110.692 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.789 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 25.0 mmt180 -68.74 -18.6 64.25 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-O 118.328 -0.844 . . . . 0.0 112.292 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 76' ' ' PHE . 47.9 t -80.25 131.9 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.628 1.104 . . . . 0.0 108.592 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -51.9 -37.58 52.98 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 124.092 0.87 . . . . 0.0 113.336 -170.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.0 pt? -111.75 160.0 17.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.498 HG23 ' HG2' ' A' ' 86' ' ' GLU . 8.9 t -97.24 173.69 7.09 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -61.26 -27.29 68.35 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.462 0.705 . . . . 0.0 111.438 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.95 -53.14 51.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.569 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 9.2 mm-40 -61.64 -29.74 70.26 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.566 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.492 HD21 ' CE2' ' A' ' 73' ' ' PHE . 25.2 tp -63.5 -58.56 6.63 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.121 0.968 . . . . 0.0 111.096 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -59.92 -41.19 91.18 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.571 0.544 . . . . 0.0 111.607 -172.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.94 -23.74 44.41 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.028 0.531 . . . . 0.0 111.477 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.443 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 62.4 t80 -67.79 -45.99 73.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.21 0.604 . . . . 0.0 109.788 171.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.3 mtm -67.27 -39.78 86.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.138 0.575 . . . . 0.0 110.381 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.2 mmpt? -64.0 -38.4 90.95 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.606 0.566 . . . . 0.0 110.293 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.3 t -62.03 -43.79 98.09 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.432 0.693 . . . . 0.0 110.749 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 28.5 mm-40 -64.25 -43.05 96.08 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.917 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.621 ' HB3' HH11 ' A' ' 99' ' ' ARG . 12.7 pt-20 -88.02 -2.81 58.83 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -99.16 -33.66 10.68 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.796 0.725 . . . . 0.0 110.344 173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -91.36 -20.41 21.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.702 0.401 . . . . 0.0 111.624 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.35 97.36 0.19 Allowed Glycine 0 C--N 1.349 1.252 0 N-CA-C 112.246 -0.341 . . . . 0.0 112.246 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.621 HH11 ' HB3' ' A' ' 95' ' ' GLU . 10.0 tpt180 -72.9 -38.0 67.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.35 0.66 . . . . 0.0 110.695 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 66.49 -80.97 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.369 1.468 . . . . 0.0 111.919 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -84.93 105.62 15.83 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -71.9 90.04 1.11 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.638 0.775 . . . . 0.0 110.045 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.4 m -74.16 84.93 1.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -68.95 156.32 38.77 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.443 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 66.34 -89.38 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.789 1.236 . . . . 0.0 111.135 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.48 -171.54 3.16 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.239 0.543 . . . . 0.0 111.191 172.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -134.97 145.27 47.97 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.306 1.042 . . . . 0.0 108.73 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -80.15 121.62 25.8 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.408 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 41.6 m95 -107.77 158.55 17.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.055 0.942 . . . . 0.0 109.347 174.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.2 ptm -144.47 130.92 19.84 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.283 0.633 . . . . 0.0 110.271 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.443 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -103.78 102.38 12.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.637 0.775 . . . . 0.0 109.49 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.81 117.54 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.96 113.0 19.57 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.47 HD12 ' HB1' ' A' ' 58' ' ' ALA . 4.3 mm? -92.53 135.36 34.13 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.063 0.545 . . . . 0.0 110.726 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.81 167.95 20.88 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.645 0.778 . . . . 0.0 109.365 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.2 t70 53.6 47.45 23.86 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.312 1.053 . . . . 0.0 110.586 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 50.5 t -69.84 107.56 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.531 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -93.62 107.12 19.03 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.942 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -68.42 123.36 20.58 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -71.98 96.88 1.77 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 170.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -63.84 -33.37 75.53 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.465 0.706 . . . . 0.0 109.954 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.9 137.85 33.24 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.312 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.16 105.53 1.98 Allowed 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.161 1.907 . . . . 0.0 110.844 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 21.1 mt -91.03 108.14 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.525 0.678 . . . . 0.0 110.566 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -74.64 139.88 74.6 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.968 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.552 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 63.6 Cg_endo -86.7 170.31 7.62 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 122.728 2.285 . . . . 0.0 112.367 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -87.68 -28.14 22.0 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.711 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -144.31 165.91 26.56 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.483 0.713 . . . . 0.0 110.479 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.0 134.2 44.57 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.508 HG11 ' HD3' ' A' ' 10' ' ' PRO . 62.2 t -101.6 100.0 13.04 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.37 176.5 5.58 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.225 2.616 . . . . 0.0 112.308 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.37 -30.81 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.622 0.769 . . . . 0.0 113.063 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.29 -21.23 75.75 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.537 0.523 . . . . 0.0 113.393 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.88 159.06 31.67 Favored Glycine 0 C--N 1.345 1.042 0 C-N-CA 123.453 0.549 . . . . 0.0 112.506 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -115.07 154.49 28.78 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.971 0.908 . . . . 0.0 109.759 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -88.49 124.15 33.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.97 116.11 27.78 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 172.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.66 139.46 52.7 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.521 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 tm-20 . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 12.0 tpt . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 119.475 -0.298 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.4 m -40.42 -29.83 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 126.656 1.982 . . . . 0.0 115.861 -171.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -62.79 -13.06 28.73 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 5' ' ' VAL . 30.5 mm 67.38 -176.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 C-N-CA 124.168 0.987 . . . . 0.0 109.254 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.429 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.4 m -157.93 -41.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 125.498 1.519 . . . . 0.0 108.041 158.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.94 -161.32 18.97 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.178 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.52 155.9 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.879 0.872 . . . . 0.0 109.267 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -126.56 140.19 52.63 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.723 0.809 . . . . 0.0 109.706 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -141.94 142.84 26.21 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.65 0.78 . . . . 0.0 111.116 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.439 ' HD3' HG12 ' A' ' 130' ' ' VAL . 74.9 Cg_endo -74.99 -12.81 21.54 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.943 2.429 . . . . 0.0 112.565 167.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.1 mm 69.2 123.46 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.815 1.646 . . . . 0.0 109.837 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.43 -7.07 18.05 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 122.894 2.396 . . . . 0.0 113.944 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.513 ' HE3' ' HB3' ' A' ' 86' ' ' GLU . 67.9 mttm -134.62 170.88 15.13 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.448 1.099 . . . . 0.0 109.941 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 14' ' ' ARG . 3.8 tmm_? -75.29 -5.05 42.65 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.597 0.759 . . . . 0.0 110.312 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -76.19 26.81 0.12 Allowed 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.007 0.923 . . . . 0.0 113.319 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -60.26 -32.96 71.65 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.827 0.851 . . . . 0.0 110.057 163.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.18 -21.32 66.75 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.837 0.855 . . . . 0.0 112.913 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 81' ' ' PHE . 37.4 mmt180 -57.43 -45.75 84.3 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.496 0.718 . . . . 0.0 110.796 176.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.463 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 65.8 m-85 -63.04 -31.11 72.18 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.664 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -91.48 -18.52 24.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.981 0.913 . . . . 0.0 111.111 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -72.96 -46.96 49.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.671 1.188 . . . . 0.0 109.84 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.8 ptpt -106.85 -15.87 14.61 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.226 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.76 -5.67 56.84 Favored Glycine 0 N--CA 1.48 1.588 0 N-CA-C 114.27 0.468 . . . . 0.0 114.27 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -161.68 107.83 1.34 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.31 1.044 . . . . 0.0 108.961 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.7 t70 -124.4 179.66 4.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.468 1.107 . . . . 0.0 109.675 -169.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -128.87 109.67 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.44 0.696 . . . . 0.0 109.494 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.459 ' HD2' HD12 ' A' ' 112' ' ' ILE . 88.9 t80 -84.32 111.84 19.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m -89.93 139.45 17.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-O 121.526 0.679 . . . . 0.0 110.208 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.636 ' HG2' HG23 ' A' ' 33' ' ' VAL . 1.5 tpmt? -135.37 127.71 17.94 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.813 1.245 . . . . 0.0 108.507 -174.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.14 60.37 3.86 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.643 2.229 . . . . 0.0 112.725 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.93 21.83 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.215 1.406 . . . . 0.0 114.509 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -64.69 -43.03 94.82 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.641 0.776 . . . . 0.0 111.045 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.636 HG23 ' HG2' ' A' ' 29' ' ' LYS . 20.1 m -72.84 150.33 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.752 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -82.56 -174.17 5.04 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.593 0.757 . . . . 0.0 111.839 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -66.98 -9.27 36.95 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.905 1.282 . . . . 0.0 111.387 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -60.63 -24.82 65.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.883 0.873 . . . . 0.0 110.848 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.479 ' HA ' ' HE1' ' A' ' 41' ' ' MET . 0.1 OUTLIER -73.88 91.83 2.02 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.519 0.728 . . . . 0.0 110.344 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 154.42 47.9 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 123.099 0.559 . . . . 0.0 109.951 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.67 99.25 0.93 Allowed 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.822 2.348 . . . . 0.0 111.476 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.18 -15.77 0.67 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.518 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.479 ' HE1' ' HA ' ' A' ' 37' ' ' LEU . 25.0 mtm -76.65 -178.98 5.03 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 121.554 0.692 . . . . 0.0 112.223 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -106.3 160.08 15.63 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.091 0.956 . . . . 0.0 110.352 171.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -135.49 97.04 3.58 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.4 t -86.82 120.92 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.254 0.549 . . . . 0.0 110.003 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -82.44 102.6 11.41 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.49 0.716 . . . . 0.0 110.115 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -74.95 160.98 29.91 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.528 170.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 70.79 97.07 0.07 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.129 1.372 . . . . 0.0 111.185 174.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 52' ' ' THR . 22.7 t -93.68 36.07 1.11 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.488 0.715 . . . . 0.0 109.59 172.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 57.46 -83.86 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.908 1.283 . . . . 0.0 110.412 -170.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -143.39 77.21 1.55 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.986 0.914 . . . . 0.0 109.157 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -150.99 -66.88 0.19 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.798 0.839 . . . . 0.0 108.906 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.407 ' H ' ' HB3' ' A' ' 48' ' ' SER . 8.9 t -142.84 173.15 11.8 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.074 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.12 -37.57 87.27 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.623 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -127.89 124.72 38.12 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.39 0.676 . . . . 0.0 110.122 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.01 -33.34 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.395 0.678 . . . . 0.0 111.272 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.6 -160.48 23.84 Favored Glycine 0 C--N 1.345 1.078 0 C-N-CA 121.546 -0.359 . . . . 0.0 113.131 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.28 177.78 9.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.231 1.012 . . . . 0.0 109.263 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.502 ' HB2' HD11 ' A' ' 114' ' ' LEU . . . -162.49 -173.32 3.51 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.139 0.976 . . . . 0.0 109.573 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -128.01 125.99 40.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.373 0.669 . . . . 0.0 110.228 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.1 mt -74.16 130.31 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.926 1.29 . . . . 0.0 111.288 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.442 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 30.7 mmmt -129.8 -164.39 1.4 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.616 1.567 . . . . 0.0 108.017 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -40.95 114.03 0.44 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.818 1.247 . . . . 0.0 113.743 -163.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -85.42 107.75 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.541 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 53.3 t -88.96 109.33 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.0 mt -87.37 117.82 26.39 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.474 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.3 t -151.18 130.33 12.69 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.155 0.982 . . . . 0.0 108.671 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.81 -6.67 33.86 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -105.51 122.19 43.58 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 170.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HG2' HD22 ' A' ' 87' ' ' LEU . 57.7 Cg_endo -70.85 -15.98 32.99 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.743 2.295 . . . . 0.0 112.647 172.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 36.1 mtm -79.31 -25.03 42.44 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.672 0.789 . . . . 0.0 110.167 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -57.63 -32.43 67.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.403 1.081 . . . . 0.0 110.752 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.69 -19.91 58.77 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.028 0.531 . . . . 0.0 111.722 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -86.64 -34.2 19.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.837 0.455 . . . . 0.0 110.685 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.46 -28.34 56.5 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 120.39 0.138 . . . . 0.0 110.723 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.5 m -83.6 -43.55 15.53 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.223 0.609 . . . . 0.0 111.505 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.777 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 64.0 m-85 -115.19 -67.5 0.99 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.786 0.435 . . . . 0.0 110.123 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.25 -83.92 0.62 Allowed Glycine 0 C--N 1.353 1.521 0 O-C-N 123.601 0.563 . . . . 0.0 113.044 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.73 -22.57 64.32 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.685 0.794 . . . . 0.0 111.831 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.777 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 31.6 mmt180 -72.33 -40.55 67.36 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.845 0.458 . . . . 0.0 111.385 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.5 t -69.52 147.31 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.006 0.522 . . . . 0.0 110.856 -170.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.438 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 28.9 p90 -69.86 -17.85 63.4 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 1.8 pt? -137.09 167.61 21.21 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.9 t -110.04 -179.53 3.82 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.15 -27.92 69.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.25 0.62 . . . . 0.0 111.35 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -62.5 -47.09 85.49 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.573 0.749 . . . . 0.0 111.25 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.513 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 1.8 mp0 -68.48 -29.52 68.15 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.461 HD22 ' HG2' ' A' ' 69' ' ' PRO . 46.8 tp -68.91 -48.9 62.19 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.837 0.455 . . . . 0.0 110.837 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -68.63 -36.68 78.94 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.008 -172.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 8.7 pt-20 -66.6 -36.28 82.24 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.12 -47.33 74.51 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.869 0.868 . . . . 0.0 110.754 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.443 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 67.2 mtm -70.02 -36.9 75.42 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.158 0.583 . . . . 0.0 110.63 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -62.34 -43.0 99.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.04 0.536 . . . . 0.0 110.279 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 t -58.65 -29.75 66.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.913 0.885 . . . . 0.0 111.355 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -73.09 -54.17 9.19 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -80.94 -5.97 58.12 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -169.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -106.09 -26.74 11.49 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.294 0.497 . . . . 0.0 111.539 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -101.32 -80.65 0.49 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.424 0.29 . . . . 0.0 110.814 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -101.56 -77.32 1.25 Allowed Glycine 0 C--N 1.348 1.194 0 N-CA-C 113.773 0.269 . . . . 0.0 113.773 -169.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -81.68 80.59 7.98 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 122.108 0.956 . . . . 0.0 110.654 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.631 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 41.7 mtm180 -92.91 165.26 12.98 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.919 -175.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 68.51 91.65 0.09 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.856 1.262 . . . . 0.0 111.813 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -168.23 106.36 0.49 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.4 m -148.81 -32.98 0.22 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -172.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -66.25 -55.98 13.49 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.427 0.691 . . . . 0.0 110.055 -175.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -102.74 157.25 17.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.934 -176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.4 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -111.44 -178.8 3.54 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.186 0.594 . . . . 0.0 110.233 -178.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.595 ' HZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -131.7 152.2 51.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.086 0.555 . . . . 0.0 109.738 -177.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -71.64 127.23 31.88 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -116.68 159.12 22.7 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.401 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 14.7 ptm -142.47 130.58 22.0 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.282 0.633 . . . . 0.0 109.873 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.541 ' HB1' ' HB ' ' A' ' 64' ' ' VAL . . . -104.24 101.61 11.33 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.737 0.815 . . . . 0.0 109.198 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.459 HD12 ' HD2' ' A' ' 27' ' ' PHE . 27.9 mt -82.2 120.07 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -81.87 98.37 8.48 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 58' ' ' ALA . 4.4 mm? -81.56 131.41 35.27 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 122.005 -0.434 . . . . 0.0 109.938 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.442 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 1.0 OUTLIER -138.47 159.79 41.2 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.183 0.593 . . . . 0.0 109.415 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.8 t70 53.58 48.33 21.91 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.364 1.065 . . . . 0.0 110.757 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.458 HG11 ' HB3' ' A' ' 19' ' ' PHE . 27.2 t -71.62 101.89 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.206 -174.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.24 154.02 21.03 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.441 -174.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -107.08 138.55 43.04 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.531 0.732 . . . . 0.0 110.01 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -86.34 85.83 7.33 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 169.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.44 -39.23 82.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.072 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -81.66 148.48 61.91 Favored Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.275 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.77 114.94 4.06 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.679 2.253 . . . . 0.0 112.114 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.5 mt -114.5 131.49 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 145.91 30.4 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.24 1.016 . . . . 0.0 109.114 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -80.4 132.89 9.33 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.574 2.183 . . . . 0.0 111.659 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -66.58 -25.35 66.59 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.565 0.746 . . . . 0.0 110.662 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -146.25 166.87 24.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.144 0.978 . . . . 0.0 110.436 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -79.31 135.53 36.76 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.439 HG12 ' HD3' ' A' ' 10' ' ' PRO . 39.1 t -114.09 105.0 54.7 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.86 -174.31 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.168 2.578 . . . . 0.0 112.668 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.4 -34.84 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.889 0.875 . . . . 0.0 110.617 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.54 -24.2 75.23 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.24 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.76 167.42 42.0 Favored Glycine 0 C--N 1.346 1.1 0 C-N-CA 123.201 0.429 . . . . 0.0 112.94 175.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.402 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -118.44 151.84 37.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.082 0.953 . . . . 0.0 109.377 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.449 ' HH ' ' HB ' ' A' ' 33' ' ' VAL . 12.8 m-85 -89.56 128.1 35.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 168.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tt -89.09 118.47 28.83 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -127.79 115.18 18.25 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.25 1.109 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -170.442 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.867 0.365 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -77.6 -12.88 60.01 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.047 0.939 . . . . 0.0 110.998 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -62.23 -24.12 67.06 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.668 0.787 . . . . 0.0 112.416 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.446 HG21 ' H ' ' A' ' 5' ' ' VAL . 23.1 mm 62.14 -164.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -172.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.446 ' H ' HG21 ' A' ' 4' ' ' ILE . 2.3 m -148.64 -40.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 154.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.89 -161.68 20.79 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.342 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.59 149.27 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 6.2 t -121.86 134.47 54.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.524 0.73 . . . . 0.0 109.043 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -128.32 144.73 52.98 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.929 0.892 . . . . 0.0 109.217 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 42.1 Cg_exo -56.94 -31.13 88.63 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.132 2.555 . . . . 0.0 111.928 170.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.9 mm 68.45 131.79 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 125.675 1.59 . . . . 0.0 111.033 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.79 135.89 50.31 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.914 2.409 . . . . 0.0 112.078 172.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -66.16 -25.51 66.99 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.781 0.832 . . . . 0.0 112.737 -169.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -66.01 -37.31 85.57 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.302 0.641 . . . . 0.0 110.442 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 25.2 m-85 -114.88 13.33 17.1 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.542 -162.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.7 ttp -60.77 -41.51 95.65 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.022 0.529 . . . . 0.0 110.733 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.47 -18.81 51.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.903 0.881 . . . . 0.0 112.738 -173.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 15' ' ' PHE . 1.3 mmp_? -52.48 -48.48 65.88 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.354 0.662 . . . . 0.0 112.142 -173.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -66.22 -30.09 70.48 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.54 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -94.23 -12.11 28.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.872 0.869 . . . . 0.0 111.379 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -78.66 -52.16 8.82 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.745 0.818 . . . . 0.0 108.858 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -101.72 -16.83 16.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.282 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.67 10.31 63.71 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 114.11 0.404 . . . . 0.0 114.11 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -163.27 92.91 0.76 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.159 0.984 . . . . 0.0 109.049 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -127.3 -177.72 4.17 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.43 -168.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -141.7 117.97 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.062 0.945 . . . . 0.0 109.068 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -100.39 114.16 27.47 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.325 0.65 . . . . 0.0 109.446 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -92.99 141.11 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.264 0.554 . . . . 0.0 111.175 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.88 125.33 20.21 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 125.25 1.42 . . . . 0.0 110.466 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.53 71.26 6.02 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.934 2.423 . . . . 0.0 112.411 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 54.34 23.93 4.74 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.064 1.346 . . . . 0.0 113.35 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -73.2 -49.12 29.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.376 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 m -74.14 149.21 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.592 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -73.39 179.25 4.08 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.367 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.11 -7.77 25.72 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.325 1.05 . . . . 0.0 112.85 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.76 -25.44 66.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.461 0.704 . . . . 0.0 111.007 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.461 ' HA ' ' HE2' ' A' ' 41' ' ' MET . 0.9 OUTLIER -65.22 93.17 0.13 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.644 0.777 . . . . 0.0 111.03 175.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -113.24 149.24 41.14 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.596 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.24 99.56 1.03 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.535 2.156 . . . . 0.0 111.184 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.9 -2.17 0.73 Allowed Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.955 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.461 ' HE2' ' HA ' ' A' ' 37' ' ' LEU . 29.5 mtm -83.2 -170.49 3.07 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.501 0.667 . . . . 0.0 111.607 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.3 ptpt -115.55 162.49 17.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.527 1.131 . . . . 0.0 110.338 171.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.529 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.14 101.05 4.73 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 58.9 t -83.83 119.5 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.532 0.682 . . . . 0.0 109.371 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -85.89 113.46 22.04 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 88.4 t80 -72.16 145.99 47.7 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 171.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.408 ' HG2' ' HB2' ' A' ' 49' ' ' HIS . 59.8 tt0 -66.51 107.2 1.99 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.517 0.727 . . . . 0.0 110.317 -175.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.9 t -74.16 75.16 1.78 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.85 0.833 . . . . 0.0 109.778 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.408 ' HB2' ' HG2' ' A' ' 47' ' ' GLN . 9.1 m80 -175.04 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.687 1.995 . . . . 0.0 108.066 -170.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 61.07 29.57 19.01 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 124.256 1.022 . . . . 0.0 110.99 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -69.79 -51.6 32.42 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.231 1.012 . . . . 0.0 110.118 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.4 t -139.95 -37.77 0.47 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.561 0.744 . . . . 0.0 110.786 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.91 134.12 4.23 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-O 119.699 -0.5 . . . . 0.0 112.077 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 27.5 m-85 64.53 139.35 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.567 1.547 . . . . 0.0 113.556 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.433 HG22 ' HZ3' ' A' ' 119' ' ' LYS . 3.2 p -125.71 -31.66 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.026 0.93 . . . . 0.0 110.209 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.93 -167.51 35.53 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.154 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 13.6 pt-20 -146.62 177.64 8.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.875 0.87 . . . . 0.0 109.308 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.437 ' HB2' HD11 ' A' ' 114' ' ' LEU . . . -160.45 -172.4 3.54 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.362 1.065 . . . . 0.0 109.348 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 86.0 mmt-85 -123.58 118.81 28.17 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.679 0.792 . . . . 0.0 109.775 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.529 HG13 ' HB2' ' A' ' 43' ' ' PHE . 51.0 mt -69.99 129.27 34.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 O-C-N 124.449 1.093 . . . . 0.0 109.595 174.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 14.7 mmmm -134.41 -172.54 3.04 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 125.553 1.541 . . . . 0.0 108.671 -175.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -32.29 110.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.884 1.674 . . . . 0.0 114.371 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.437 HG13 ' HA ' ' A' ' 112' ' ' ILE . 34.7 m -90.27 117.61 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 68.5 t -90.39 108.8 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.9 mt -86.44 118.97 26.21 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.0 t -152.65 134.27 14.57 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.865 0.866 . . . . 0.0 109.817 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.515 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 58.0 mt-10 -68.98 -11.86 61.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 122.868 0.467 . . . . 0.0 111.495 174.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.575 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 10.1 m-80 -103.23 117.33 60.53 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.401 ' HG2' HD22 ' A' ' 87' ' ' LEU . 59.3 Cg_endo -73.96 -10.24 22.83 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.262 1.975 . . . . 0.0 112.817 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -78.78 -25.12 44.35 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.328 0.651 . . . . 0.0 111.027 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.575 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 75.5 mt-30 -68.68 -21.9 64.4 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.678 176.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -75.44 -23.63 56.94 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.877 0.471 . . . . 0.0 110.801 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -85.25 -32.4 22.6 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.489 0.316 . . . . 0.0 111.707 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.7 pt-20 -75.15 -30.85 60.88 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 120.523 0.202 . . . . 0.0 110.726 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -79.17 -58.36 3.26 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.212 0.605 . . . . 0.0 110.655 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.782 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 61.8 m-85 -101.61 -67.63 0.86 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.579 0.752 . . . . 0.0 110.156 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.7 -84.66 0.77 Allowed Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.83 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.64 -46.55 86.89 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.422 0.689 . . . . 0.0 110.38 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.782 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 29.8 mmt180 -62.43 -30.22 71.07 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 124.066 0.854 . . . . 0.0 111.76 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.461 HG12 HD22 ' A' ' 82' ' ' LEU . 30.8 t -68.15 136.0 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -56.98 -28.51 62.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.583 0.753 . . . . 0.0 112.748 -171.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.461 HD22 HG12 ' A' ' 80' ' ' VAL . 1.8 pt? -123.53 155.28 37.86 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.621 0.768 . . . . 0.0 109.197 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.525 HG23 ' HG2' ' A' ' 86' ' ' GLU . 15.1 t -91.49 176.92 6.38 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.4 -34.41 77.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.673 0.389 . . . . 0.0 111.514 -177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -61.44 -44.72 96.62 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.405 0.682 . . . . 0.0 110.767 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.525 ' HG2' HG23 ' A' ' 83' ' ' THR . 63.8 mm-40 -66.1 -35.44 80.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.357 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.401 HD22 ' HG2' ' A' ' 69' ' ' PRO . 29.1 tp -68.2 -47.95 66.51 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -35.45 78.73 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.21 -31.74 67.97 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 123.162 0.289 . . . . 0.0 110.917 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -66.36 -44.85 82.07 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.77 0.828 . . . . 0.0 110.934 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.3 mtm -76.82 -34.34 57.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.116 0.567 . . . . 0.0 110.454 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -64.38 -35.34 80.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.18 0.592 . . . . 0.0 110.42 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.0 t -56.65 -44.87 81.73 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.688 0.618 . . . . 0.0 110.549 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -66.17 -27.98 68.43 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.779 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.5 -22.32 14.55 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -84.56 -32.72 23.67 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 120.698 0.285 . . . . 0.0 110.587 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.82 -7.1 59.33 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.63 0.372 . . . . 0.0 111.393 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.2 -95.23 0.12 Allowed Glycine 0 C--N 1.345 1.041 0 O-C-N 123.138 0.274 . . . . 0.0 112.58 168.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 56.78 79.81 0.17 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.084 1.354 . . . . 0.0 111.685 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -73.03 -28.72 62.51 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.312 0.645 . . . . 0.0 111.499 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -78.31 132.44 37.45 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -65.38 -29.05 69.73 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.605 0.762 . . . . 0.0 111.797 -168.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m 61.65 49.8 4.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.562 1.145 . . . . 0.0 110.536 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -63.21 -33.37 75.34 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.529 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -96.06 157.72 15.77 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -87.81 -165.69 1.38 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.226 1.01 . . . . 0.0 109.834 -177.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.509 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.2 tpmt? -134.77 144.71 47.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.7 0.4 . . . . 0.0 109.966 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.66 113.26 15.33 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -96.9 153.55 17.83 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.5 ptm -132.61 130.05 39.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.277 0.631 . . . . 0.0 109.62 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -98.13 102.45 14.2 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.631 0.772 . . . . 0.0 109.123 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.437 ' HA ' HG13 ' A' ' 63' ' ' VAL . 51.4 mt -78.95 121.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.624 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -78.9 133.15 36.96 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.216 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 58' ' ' ALA . 3.5 mm? -122.01 119.23 30.84 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.351 0.66 . . . . 0.0 109.757 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -125.29 175.89 7.14 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.571 0.748 . . . . 0.0 109.427 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 t70 54.52 36.0 24.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.002 0.921 . . . . 0.0 111.03 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.3 t -65.54 111.07 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.523 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.86 112.92 24.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.111 0.965 . . . . 0.0 110.988 -172.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.433 ' HZ3' HG22 ' A' ' 55' ' ' VAL . 14.5 mmmt -67.18 139.34 57.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.813 0.845 . . . . 0.0 111.498 176.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -82.68 113.72 20.55 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.686 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.9 -28.85 61.75 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.433 0.693 . . . . 0.0 110.018 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -105.69 146.37 32.7 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.522 1.129 . . . . 0.0 110.156 -175.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.42 99.56 1.31 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.727 2.285 . . . . 0.0 111.428 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.4 mt -85.09 123.71 39.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.512 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -75.73 126.85 86.72 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.958 0.903 . . . . 0.0 109.973 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.79 130.13 22.55 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.097 1.865 . . . . 0.0 111.454 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -75.44 -23.5 56.93 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.593 0.757 . . . . 0.0 110.429 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.412 ' NH2' ' HB3' ' A' ' 135' ' ' GLN . 20.3 ptt-85 -149.9 158.73 44.45 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.859 0.864 . . . . 0.0 108.812 171.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.77 142.23 58.26 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.534 0.733 . . . . 0.0 110.935 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.7 96.82 45.29 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 123.268 0.627 . . . . 0.0 109.728 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.49 173.18 9.2 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.049 2.5 . . . . 0.0 112.523 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.37 -19.99 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.634 0.773 . . . . 0.0 112.705 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.46 -18.84 79.53 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.447 0.467 . . . . 0.0 113.328 173.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.06 150.47 9.47 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.48 0.562 . . . . 0.0 112.696 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.412 ' HB3' ' NH2' ' A' ' 128' ' ' ARG . 31.2 mm-40 -109.39 132.65 53.93 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.723 0.809 . . . . 0.0 110.753 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -74.55 101.89 4.34 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.704 0.402 . . . . 0.0 110.326 172.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.76 118.25 13.31 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.6 127.33 49.27 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.563 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m -71.68 -8.53 54.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.738 0.815 . . . . 0.0 112.897 -174.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -64.21 -26.09 68.36 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.515 0.326 . . . . 0.0 111.638 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.1 mm 63.04 -172.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 C-N-CA 124.296 1.039 . . . . 0.0 109.226 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.54 -45.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 156.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.14 -161.49 18.06 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.938 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 p -122.93 144.99 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -117.72 132.13 56.51 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.17 0.588 . . . . 0.0 109.681 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.438 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . 13.0 m-85 -131.92 142.24 44.45 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 124.09 0.956 . . . . 0.0 109.462 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.522 ' HD3' HG12 ' A' ' 130' ' ' VAL . 61.2 Cg_endo -70.52 -18.86 33.14 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.662 2.241 . . . . 0.0 112.621 175.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 mm 47.82 69.86 2.44 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.605 1.162 . . . . 0.0 109.231 -168.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.425 ' HD3' ' HG2' ' A' ' 10' ' ' PRO . 47.3 Cg_endo -83.54 52.97 4.01 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.334 2.689 . . . . 0.0 110.833 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -148.19 166.45 27.88 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.853 -171.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -59.45 -26.11 64.94 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.238 1.015 . . . . 0.0 111.792 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -84.53 14.62 4.38 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.458 1.103 . . . . 0.0 113.041 -168.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -57.79 -35.37 70.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.321 1.049 . . . . 0.0 111.664 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.97 -23.93 61.51 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -53.78 -51.7 62.59 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.026 0.93 . . . . 0.0 113.18 -172.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -61.58 -30.04 70.42 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.866 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -96.96 -14.17 21.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.035 0.934 . . . . 0.0 110.936 -175.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -78.41 -58.78 3.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.252 1.021 . . . . 0.0 109.453 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -93.49 -18.0 22.79 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.496 -171.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.04 -12.77 16.75 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 114.103 0.401 . . . . 0.0 114.103 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.6 90.95 1.9 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.826 0.85 . . . . 0.0 110.413 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.56 176.41 5.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.639 -174.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.9 t -132.65 110.02 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.954 0.902 . . . . 0.0 108.578 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.86 111.47 22.51 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.711 0.804 . . . . 0.0 110.066 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.7 m -96.05 141.78 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.216 0.606 . . . . 0.0 111.579 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -134.69 144.73 51.96 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.698 1.199 . . . . 0.0 110.533 171.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.75 51.51 3.62 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 123.441 2.761 . . . . 0.0 111.833 169.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 54.26 78.22 0.17 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.74 1.216 . . . . 0.0 111.681 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.2 m -101.77 -47.92 4.46 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.375 0.67 . . . . 0.0 109.869 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 m -81.42 150.17 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.409 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 76.8 m95 -79.7 -163.16 0.49 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.294 1.038 . . . . 0.0 112.385 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -69.6 -14.79 63.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.342 1.057 . . . . 0.0 112.738 -171.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.46 -24.67 67.23 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.414 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -66.01 111.54 3.4 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.09 152.7 70.47 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.743 0.817 . . . . 0.0 109.573 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.2 99.25 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.789 2.326 . . . . 0.0 111.424 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.3 -15.76 0.58 Allowed Glycine 0 N--CA 1.467 0.747 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.577 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.541 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 73.5 mtp -74.62 176.86 6.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.004 0.922 . . . . 0.0 111.804 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -102.67 164.34 11.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.549 0.74 . . . . 0.0 110.285 169.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.439 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -136.7 100.16 4.25 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 175.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.3 t -88.79 120.97 38.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -89.59 107.62 19.19 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.918 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -78.28 169.79 17.69 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.398 1.079 . . . . 0.0 109.831 173.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 70.98 95.53 0.07 Allowed 'General case' 0 C--N 1.356 0.863 0 C-N-CA 125.443 1.497 . . . . 0.0 108.881 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.0 p -52.51 -34.44 49.66 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.823 1.249 . . . . 0.0 111.867 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 169.94 -37.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.904 2.082 . . . . 0.0 107.15 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -136.14 -53.12 0.74 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.011 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -94.14 165.65 12.51 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.161 0.584 . . . . 0.0 111.63 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -64.25 118.99 9.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.721 1.208 . . . . 0.0 111.312 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.95 161.31 10.69 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -83.1 129.64 35.04 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.226 1.013 . . . . 0.0 109.782 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.09 -35.41 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.104 0.561 . . . . 0.0 109.972 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.97 -161.71 25.65 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.875 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -153.56 177.96 10.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.772 0.829 . . . . 0.0 109.08 170.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 114' ' ' LEU . . . -158.81 -173.48 4.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.651 0.78 . . . . 0.0 109.727 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -125.14 120.81 32.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.421 0.688 . . . . 0.0 110.37 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.439 HG13 ' HB2' ' A' ' 43' ' ' PHE . 56.5 mt -69.07 135.65 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.843 1.257 . . . . 0.0 111.587 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -135.31 -176.47 4.28 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 126.293 1.837 . . . . 0.0 108.527 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -44.9 123.15 3.62 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.803 1.241 . . . . 0.0 113.74 -164.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 112' ' ' ILE . 33.9 m -92.67 118.64 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.244 -176.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 73.1 t -89.28 109.56 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.97 117.66 30.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.394 0.678 . . . . 0.0 109.343 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -152.11 134.74 15.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.784 0.834 . . . . 0.0 109.597 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 66.9 mt-10 -69.57 -16.29 63.38 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.312 0.645 . . . . 0.0 111.626 176.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -95.34 119.27 65.74 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.481 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 36.5 Cg_endo -66.94 -20.99 50.66 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.145 1.897 . . . . 0.0 112.483 173.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.481 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.2 mpp? -73.83 -22.61 59.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.824 0.45 . . . . 0.0 110.875 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -57.16 -33.84 67.83 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.953 0.783 . . . . 0.0 111.62 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -78.26 -27.54 47.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 122.857 0.463 . . . . 0.0 111.164 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.436 ' HE2' HD22 ' A' ' 87' ' ' LEU . 71.4 m-85 -86.24 -23.14 26.52 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.987 0.515 . . . . 0.0 111.33 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.16 -27.27 19.7 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.438 0.295 . . . . 0.0 110.935 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.7 m -82.55 -58.03 3.09 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.212 0.53 . . . . 0.0 110.055 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.77 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 69.3 m-85 -96.49 -68.96 0.77 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.521 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.28 -80.72 0.73 Allowed Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.631 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.11 -23.5 64.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.096 0.958 . . . . 0.0 111.351 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 21.2 mmt85 -81.51 -32.46 32.37 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 122.958 0.503 . . . . 0.0 111.217 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.419 HG12 HD21 ' A' ' 82' ' ' LEU . 20.4 t -68.56 146.33 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -63.64 -27.22 69.08 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.419 HD21 HG12 ' A' ' 80' ' ' VAL . 2.5 pt? -122.79 176.58 5.89 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.658 0.383 . . . . 0.0 110.267 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.526 HG21 ' HG2' ' A' ' 86' ' ' GLU . 12.6 t -108.33 172.48 6.82 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -68.13 -25.94 65.54 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.02 0.528 . . . . 0.0 111.222 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -68.77 -41.25 79.06 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.335 0.654 . . . . 0.0 109.893 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' HG2' HG21 ' A' ' 83' ' ' THR . 22.6 mm-40 -66.78 -35.22 79.58 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.162 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.436 HD22 ' HE2' ' A' ' 73' ' ' PHE . 32.1 tp -60.79 -54.26 47.33 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.882 0.873 . . . . 0.0 111.527 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -60.61 -43.36 97.54 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 123.494 0.496 . . . . 0.0 111.193 -172.067 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.37 -29.51 53.35 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.214 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -62.19 -43.78 98.06 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.453 0.701 . . . . 0.0 110.806 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.3 mtm -68.15 -36.93 80.44 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.356 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.7 mmpt? -69.08 -28.54 66.6 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.119 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.478 ' HA ' ' HG2' ' A' ' 96' ' ' ARG . 73.7 m -72.13 -36.86 69.51 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.305 0.642 . . . . 0.0 110.589 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -64.88 -38.45 91.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.923 0.489 . . . . 0.0 111.614 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -86.16 -17.19 35.59 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 93' ' ' SER . 5.3 ptp180 -96.03 -22.74 17.18 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.395 0.543 . . . . 0.0 111.741 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -110.85 -33.96 6.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.608 0.363 . . . . 0.0 111.963 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -124.9 -97.98 1.18 Allowed Glycine 0 N--CA 1.471 1.0 0 C-N-CA 121.763 -0.256 . . . . 0.0 113.349 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -78.44 76.84 4.94 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.555 1.142 . . . . 0.0 111.404 -170.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -72.56 134.98 45.48 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.429 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.46 ' HG2' ' H ' ' A' ' 102' ' ' GLU . 53.1 ttt180 68.37 -179.65 0.23 Allowed 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 124.202 1.001 . . . . 0.0 111.106 169.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.46 ' H ' ' HG2' ' A' ' 101' ' ' ARG . 3.7 mp0 57.63 29.73 17.71 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.371 1.069 . . . . 0.0 111.722 -174.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.9 m -106.63 77.65 1.21 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.807 0.843 . . . . 0.0 109.567 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -122.22 -65.36 1.12 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.058 0.543 . . . . 0.0 110.031 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -73.24 147.4 44.66 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.065 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.442 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -69.7 179.0 2.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.462 0.705 . . . . 0.0 111.762 -176.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -138.3 147.95 44.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.074 172.001 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.43 104.9 4.58 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -85.05 156.07 21.25 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.8 ptm -140.94 131.44 25.35 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.534 0.733 . . . . 0.0 109.494 -174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.467 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . . . -111.25 102.32 10.74 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.447 0.699 . . . . 0.0 109.919 -176.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.446 ' HA ' HG12 ' A' ' 63' ' ' VAL . 27.8 mt -82.07 122.82 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.18 131.1 35.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 58' ' ' ALA . 3.9 mm? -118.11 113.54 21.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.103 0.961 . . . . 0.0 109.446 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -114.83 176.09 5.21 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.2 t70 53.95 46.39 25.71 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.135 0.897 . . . . 0.0 111.016 170.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.7 t -74.38 106.59 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.959 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.447 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 1.7 tpmt? -83.66 155.52 23.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.671 1.188 . . . . 0.0 110.735 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -116.68 123.65 47.77 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.904 0.881 . . . . 0.0 109.103 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -74.11 98.42 3.12 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.54 -35.04 78.18 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.916 0.886 . . . . 0.0 109.812 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.411 ' HG3' HG13 ' A' ' 124' ' ' ILE . 15.9 ptpt -91.03 138.07 26.2 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.289 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -83.63 77.0 3.55 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.271 2.648 . . . . 0.0 112.466 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.411 HG13 ' HG3' ' A' ' 122' ' ' LYS . 72.6 mt -84.7 131.65 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -100.28 157.58 33.56 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.02 177.41 7.8 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.209 1.939 . . . . 0.0 111.761 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -94.98 2.6 55.38 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.457 0.703 . . . . 0.0 110.278 178.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -163.43 179.95 6.95 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.941 1.296 . . . . 0.0 109.274 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.79 130.39 35.04 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.522 HG12 ' HD3' ' A' ' 10' ' ' PRO . 39.8 t -104.79 96.39 10.53 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.5 -176.67 2.35 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.02 2.48 . . . . 0.0 112.887 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.46 -35.08 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.25 1.02 . . . . 0.0 111.292 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.77 -24.24 72.71 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.59 -0.732 . . . . 0.0 113.097 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.61 165.07 37.72 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 123.344 0.497 . . . . 0.0 113.002 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -118.37 143.75 46.41 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.694 0.797 . . . . 0.0 109.613 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.409 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 0.7 OUTLIER -79.67 112.89 17.38 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 167.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.7 121.43 26.38 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 145.09 51.88 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.998 0.519 . . . . 0.0 109.988 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.244 0.807 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.512 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -64.74 -7.43 10.89 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.375 1.07 . . . . 0.0 113.272 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HD3' ' HB3' ' A' ' 139' ' ' GLU . 22.2 ptmt -58.89 -23.03 60.59 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.03 0.932 . . . . 0.0 113.331 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.7 mm 67.85 -179.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 C-N-CA 124.157 0.983 . . . . 0.0 109.61 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 139' ' ' GLU . 1.2 m -149.18 -34.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.758 1.223 . . . . 0.0 109.186 161.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.35 -164.0 26.29 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-O 121.433 0.463 . . . . 0.0 112.787 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.91 161.17 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 t -134.5 133.2 40.09 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 122.979 0.512 . . . . 0.0 109.704 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.418 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . 7.2 m-85 -134.76 140.52 35.55 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.06 0.944 . . . . 0.0 110.132 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.544 ' HD3' HG11 ' A' ' 130' ' ' VAL . 93.7 Cg_endo -76.5 -14.9 17.82 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.911 2.408 . . . . 0.0 112.431 172.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 mm 64.59 115.3 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 125.609 1.564 . . . . 0.0 109.559 -172.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -66.77 -14.9 45.63 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.095 2.53 . . . . 0.0 114.085 -168.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -132.61 -175.24 3.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.812 0.845 . . . . 0.0 110.267 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -69.33 2.99 2.5 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 124.184 0.993 . . . . 0.0 112.541 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.51 7.39 2.39 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -66.94 -34.04 76.9 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 119.024 0.829 . . . . 0.0 109.383 170.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.53 -30.04 70.38 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.595 1.158 . . . . 0.0 111.811 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -51.71 -47.35 64.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.423 1.089 . . . . 0.0 111.682 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 65.0 m-85 -66.43 -30.62 71.02 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.692 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.68 -20.17 25.22 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.573 0.749 . . . . 0.0 110.63 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -76.02 -56.92 4.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.392 1.077 . . . . 0.0 110.201 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -96.06 -18.19 20.37 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.741 -171.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.79 -28.64 2.13 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -125.11 96.02 4.7 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 124.436 1.094 . . . . 0.0 108.259 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 13.9 t70 -110.36 176.31 5.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.195 0.598 . . . . 0.0 110.076 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.5 t -136.24 111.71 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.998 0.919 . . . . 0.0 109.114 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.475 ' HD2' HD12 ' A' ' 112' ' ' ILE . 88.3 t80 -84.7 109.07 17.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.479 0.711 . . . . 0.0 110.311 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.88 138.08 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.607 0.718 . . . . 0.0 110.531 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 1.6 tpmt? -136.38 134.64 20.0 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.798 1.239 . . . . 0.0 108.461 -176.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 56.9 Cg_endo -72.86 57.0 3.07 Favored 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 122.745 2.297 . . . . 0.0 113.127 170.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.58 28.44 3.45 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 125.491 1.516 . . . . 0.0 114.005 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.478 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 5.3 m -69.66 -30.26 67.9 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.37 0.668 . . . . 0.0 110.518 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.581 HG12 HD23 ' A' ' 37' ' ' LEU . 21.9 t -85.82 149.02 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -78.14 -173.53 3.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.13 0.972 . . . . 0.0 111.811 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 7.6 tmtt? -71.59 -14.53 62.1 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 123.861 0.865 . . . . 0.0 110.188 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -51.43 -32.32 26.23 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.609 0.764 . . . . 0.0 111.245 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.581 HD23 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -69.48 102.26 1.76 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 123.568 0.747 . . . . 0.0 110.547 178.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.488 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -125.47 151.93 70.88 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.244 0.618 . . . . 0.0 109.987 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.5 99.21 0.7 Allowed 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.857 2.371 . . . . 0.0 111.611 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.77 2.69 0.88 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.497 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.493 ' HE3' ' HA ' ' A' ' 37' ' ' LEU . 29.1 mtm -92.77 -172.72 3.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.06 0.544 . . . . 0.0 111.157 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -109.99 160.01 16.79 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.906 0.882 . . . . 0.0 110.531 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.466 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.04 99.83 4.39 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.7 125.36 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.398 0.618 . . . . 0.0 109.931 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -91.01 114.24 26.72 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.753 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 37.6 t80 -74.24 145.74 43.83 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 171.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -84.89 70.4 10.87 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.867 0.467 . . . . 0.0 110.363 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 81.0 p 42.09 -81.7 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.361 1.864 . . . . 0.0 113.959 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -154.17 88.73 1.25 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.519 1.128 . . . . 0.0 109.819 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -164.02 170.85 16.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.224 0.61 . . . . 0.0 110.421 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.92 -48.26 82.63 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.413 1.085 . . . . 0.0 111.687 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 p -70.02 102.32 2.0 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.054 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.745 ' HA3' ' HD3' ' A' ' 126' ' ' PRO . . . -62.35 -47.96 85.78 Favored Glycine 0 C--O 1.216 -1.022 0 CA-C-N 114.764 -1.107 . . . . 0.0 114.024 -170.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -97.89 129.47 44.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 117.171 0.486 . . . . 0.0 110.848 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.14 -32.26 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 168.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.86 -167.22 32.5 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.143 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -158.47 178.28 10.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.612 0.765 . . . . 0.0 109.246 172.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB3' HD11 ' A' ' 114' ' ' LEU . . . -161.19 -173.8 4.03 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.069 0.548 . . . . 0.0 110.646 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -120.85 120.03 34.36 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.305 1.042 . . . . 0.0 109.996 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.466 HG13 ' HB2' ' A' ' 43' ' ' PHE . 53.8 mt -70.62 138.43 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.569 1.148 . . . . 0.0 111.271 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -140.79 -166.73 2.21 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.907 2.083 . . . . 0.0 107.797 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -35.07 122.11 0.56 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.174 1.39 . . . . 0.0 114.524 -164.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.9 m -105.05 105.78 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 121.854 0.835 . . . . 0.0 109.52 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -91.75 114.56 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.593 0.757 . . . . 0.0 110.056 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.527 ' HB3' HD11 ' A' ' 108' ' ' LEU . 36.9 mt -96.41 117.95 31.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.651 0.78 . . . . 0.0 109.544 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.1 t -151.07 139.56 20.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.495 0.718 . . . . 0.0 110.354 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 24.1 mt-10 -66.76 -24.06 66.16 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.388 1.075 . . . . 0.0 111.803 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.527 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 81.5 m-20 -97.59 120.62 60.22 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.454 ' HG2' HD23 ' A' ' 87' ' ' LEU . 38.3 Cg_endo -66.03 -19.2 57.72 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.361 2.041 . . . . 0.0 112.055 171.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 56.9 mtm -71.81 -24.59 61.75 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.08 0.952 . . . . 0.0 111.012 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 16.3 mm100 -60.96 -26.33 67.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.596 0.758 . . . . 0.0 111.507 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -81.82 -25.29 35.3 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.117 0.567 . . . . 0.0 110.844 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' HD22 ' A' ' 87' ' ' LEU . 97.2 m-85 -89.66 -14.49 34.74 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.39 0.676 . . . . 0.0 111.641 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.47 -30.4 17.34 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.294 0.238 . . . . 0.0 110.619 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.8 m -78.07 -59.84 2.62 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.89 0.376 . . . . 0.0 110.771 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.764 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 58.8 m-85 -99.65 -59.1 1.78 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.529 0.732 . . . . 0.0 110.021 -173.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.98 -88.17 0.14 Allowed Glycine 0 C--N 1.356 1.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.494 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -69.49 -21.04 63.72 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.617 0.767 . . . . 0.0 111.699 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.764 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 37.4 mmt180 -72.87 -36.79 67.45 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.349 0.405 . . . . 0.0 110.433 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.433 HG13 HD21 ' A' ' 82' ' ' LEU . 21.4 t -64.07 151.4 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 122.593 0.357 . . . . 0.0 110.345 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.464 ' HD2' ' HA ' ' A' ' 27' ' ' PHE . 41.3 p90 -66.36 -7.88 21.88 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.433 HD21 HG13 ' A' ' 80' ' ' VAL . 1.9 pt? -147.69 172.04 14.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.343 0.657 . . . . 0.0 109.632 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 t -96.38 170.66 9.08 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -66.43 -26.63 67.31 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.36 0.264 . . . . 0.0 110.671 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 4.0 m-20 -60.24 -53.86 52.63 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -58.81 -33.0 69.86 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.561 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.454 HD23 ' HG2' ' A' ' 69' ' ' PRO . 28.5 tp -62.92 -58.22 8.1 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.726 0.641 . . . . 0.0 111.037 174.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -62.64 -38.77 91.55 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.593 0.558 . . . . 0.0 111.917 -171.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 12.1 pt-20 -82.96 -21.92 33.9 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.301 0.64 . . . . 0.0 111.459 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.486 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 56.5 t80 -66.54 -47.05 74.08 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 168.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.42 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 69.1 mtm -67.69 -31.53 71.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.427 0.691 . . . . 0.0 110.595 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.4 mmpt? -60.71 -52.23 66.02 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.9 t -58.35 -33.01 69.09 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.618 0.767 . . . . 0.0 111.638 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 29.6 mm-40 -71.38 -44.53 64.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.042 0.537 . . . . 0.0 111.145 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.73 -23.68 31.51 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -96.51 -41.32 8.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.216 0.207 . . . . 0.0 111.008 -172.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -91.08 -48.74 6.79 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.66 0.384 . . . . 0.0 110.045 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -73.94 -78.95 0.55 Allowed Glycine 0 C--N 1.345 1.079 0 O-C-N 123.96 0.787 . . . . 0.0 111.762 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 55.91 89.63 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.011 1.324 . . . . 0.0 110.498 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -71.92 -28.9 63.78 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.278 0.631 . . . . 0.0 110.837 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.489 ' HG3' ' H ' ' A' ' 102' ' ' GLU . 14.3 ptt180 -165.99 -65.01 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.204 1.002 . . . . 0.0 110.033 172.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.489 ' H ' ' HG3' ' A' ' 101' ' ' ARG . 1.2 tm-20 179.0 147.86 0.2 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.9 p -144.38 98.77 3.26 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.866 0.467 . . . . 0.0 111.679 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -103.49 -42.43 5.69 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.441 0.696 . . . . 0.0 109.481 165.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -70.65 155.75 40.35 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.617 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -80.45 179.99 7.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.446 0.698 . . . . 0.0 109.996 175.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -134.13 152.65 51.93 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 169.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.7 tm? -76.19 121.35 22.76 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -106.81 159.72 16.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.232 1.013 . . . . 0.0 109.805 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.434 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 15.8 ptm -136.56 130.72 32.81 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.045 0.938 . . . . 0.0 110.045 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.07 102.06 11.07 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.685 0.794 . . . . 0.0 109.434 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.475 HD12 ' HD2' ' A' ' 27' ' ' PHE . 42.2 mt -85.0 121.08 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.75 133.38 35.34 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -117.76 133.3 56.08 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.207 1.003 . . . . 0.0 109.502 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.78 165.36 25.79 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.66 0.784 . . . . 0.0 110.062 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.2 t70 57.23 36.83 27.88 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.365 1.041 . . . . 0.0 110.846 168.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.2 t -63.24 109.56 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.718 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 165.31 23.42 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.031 1.333 . . . . 0.0 110.663 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -130.61 124.9 32.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.552 0.741 . . . . 0.0 110.238 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -88.29 82.48 7.05 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 168.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.56 -32.36 73.08 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.514 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -80.36 148.62 67.15 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.232 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.13 103.64 1.78 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.84 2.36 . . . . 0.0 112.672 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.7 mt -125.01 130.98 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.431 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -97.9 144.26 27.7 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.904 0.882 . . . . 0.0 108.912 178.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.745 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 86.8 Cg_endo -80.79 176.75 8.71 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.815 2.344 . . . . 0.0 112.932 -177.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -64.15 -32.22 73.71 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.817 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -157.5 163.51 38.36 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 123.62 0.768 . . . . 0.0 109.88 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.27 135.11 54.98 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.997 0.919 . . . . 0.0 108.976 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.544 HG11 ' HD3' ' A' ' 10' ' ' PRO . 47.9 t -108.17 94.6 13.43 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 123.464 0.705 . . . . 0.0 109.616 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.97 -175.35 1.65 Allowed 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.069 2.513 . . . . 0.0 112.868 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.3 m -56.85 -31.19 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.46 1.104 . . . . 0.0 113.711 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.17 -14.86 81.8 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.386 0.429 . . . . 0.0 113.496 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.45 150.83 6.94 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 123.193 0.425 . . . . 0.0 112.923 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -108.81 165.36 11.62 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.575 0.75 . . . . 0.0 110.178 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.0 130.04 46.12 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.99 0.516 . . . . 0.0 109.691 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.75 124.09 38.59 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.57 148.14 46.63 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.487 ' HB2' HG12 ' A' ' 5' ' ' VAL . 3.4 tm-20 . . . . . 0 C--O 1.252 1.207 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 173.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.503 ' HE1' ' HG2' ' A' ' 3' ' ' LYS . 8.2 tmm? . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.488 ' N ' ' SD ' ' A' ' 1' ' ' MET . 18.4 m -53.09 -22.17 5.75 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.917 1.687 . . . . 0.0 114.832 -171.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.554 ' HZ3' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -62.48 -18.89 62.87 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.1 mm 63.39 -172.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.09 -45.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 156.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.39 -160.87 18.61 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.168 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.98 139.79 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -107.82 132.31 53.55 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.518 0.727 . . . . 0.0 109.481 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -127.64 141.99 42.74 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.602 0.761 . . . . 0.0 110.485 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD3' HG13 ' A' ' 130' ' ' VAL . 95.9 Cg_endo -73.33 -19.81 21.83 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.167 2.578 . . . . 0.0 113.129 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mm 53.77 92.76 0.06 OUTLIER Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 125.258 1.423 . . . . 0.0 110.413 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.99 17.01 0.75 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.857 2.371 . . . . 0.0 113.291 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -124.72 153.33 42.53 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 110.24 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -11.84 61.15 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.596 1.158 . . . . 0.0 111.395 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -81.32 22.31 0.69 Allowed 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.486 1.114 . . . . 0.0 112.482 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.449 ' HG2' ' HE2' ' A' ' 20' ' ' PHE . 46.2 ttm -64.77 -41.14 96.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.971 0.908 . . . . 0.0 110.003 168.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.7 -19.23 65.64 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.979 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' NH2' ' HZ2' ' A' ' 22' ' ' LYS . 8.1 mmm180 -47.64 -51.66 20.73 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.801 1.24 . . . . 0.0 112.682 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.442 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 49.7 m-85 -69.4 -30.76 68.8 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.451 -174.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.449 ' HE2' ' HG2' ' A' ' 16' ' ' MET . 54.7 m-85 -84.48 -24.68 29.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.714 0.806 . . . . 0.0 110.314 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -68.28 -49.09 62.9 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.92 1.288 . . . . 0.0 109.903 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HZ2' ' NH2' ' A' ' 18' ' ' ARG . 14.0 ptpt -107.33 -16.55 14.36 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.545 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.46 -6.15 70.13 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 114.253 0.461 . . . . 0.0 114.253 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -157.81 111.69 2.55 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.881 0.873 . . . . 0.0 109.643 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.442 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.3 t70 -136.64 -171.54 2.94 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.42 124.73 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.261 1.391 . . . . 0.0 109.644 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -96.62 116.58 29.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.646 0.778 . . . . 0.0 109.322 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 m -89.35 146.86 5.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.494 0.664 . . . . 0.0 110.222 171.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.631 ' HG2' HG22 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -134.62 114.26 12.15 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.7 1.2 . . . . 0.0 109.047 -172.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.53 66.6 2.93 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.438 2.759 . . . . 0.0 113.478 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 108' ' ' LEU . . . 47.35 78.42 0.07 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.006 1.322 . . . . 0.0 113.454 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.458 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 37.8 m -125.49 -58.04 1.44 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.631 HG22 ' HG2' ' A' ' 29' ' ' LYS . 15.4 m -66.96 133.87 30.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.898 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -88.4 -157.58 0.43 Allowed 'General case' 0 CA--C 1.564 1.506 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.905 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -70.83 -1.77 12.73 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -166.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -67.48 -28.9 68.25 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.701 0.8 . . . . 0.0 110.419 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.577 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 1.1 mm? -66.55 119.59 11.96 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.538 0.735 . . . . 0.0 110.645 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 157.48 56.35 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.415 1.086 . . . . 0.0 109.255 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.92 88.84 0.9 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.381 2.054 . . . . 0.0 111.597 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.08 41.72 0.04 OUTLIER Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.042 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.577 ' SD ' ' HA ' ' A' ' 37' ' ' LEU . 87.1 mtp -118.94 -168.8 1.62 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.068 0.947 . . . . 0.0 109.391 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 15.2 ptpt -121.13 162.23 20.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.68 0.792 . . . . 0.0 110.276 168.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.46 ' HB2' HG13 ' A' ' 60' ' ' ILE . 17.5 t80 -134.77 97.1 3.68 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 94.1 t -83.12 119.65 32.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.39 0.614 . . . . 0.0 110.046 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -80.33 99.67 8.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.599 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.536 ' HA ' ' H ' ' A' ' 54' ' ' PHE . 67.0 t80 -75.83 163.15 27.53 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.697 169.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -136.11 102.96 5.17 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.4 p -92.03 54.35 2.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.763 0.825 . . . . 0.0 111.23 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -161.69 107.35 1.31 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 69.79 -68.8 0.18 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.269 1.428 . . . . 0.0 111.985 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.95 144.31 57.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.877 0.871 . . . . 0.0 109.766 172.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 p -56.91 -45.09 82.9 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.346 0.658 . . . . 0.0 111.989 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.46 -173.47 24.4 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.539 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.536 ' H ' ' HA ' ' A' ' 46' ' ' TYR . 3.2 m-30 56.62 66.88 1.08 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.174 0.99 . . . . 0.0 110.828 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.664 HG23 ' HZ1' ' A' ' 119' ' ' LYS . 10.0 p -87.62 -15.53 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.297 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.85 -171.15 41.76 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.297 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 7.9 pt-20 -147.56 178.86 8.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.833 0.853 . . . . 0.0 110.156 174.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -158.4 -171.11 3.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.718 1.207 . . . . 0.0 109.204 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 12.7 mmt85 -129.58 118.92 22.77 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.545 0.738 . . . . 0.0 110.709 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 41' ' ' MET . 54.4 mt -72.13 133.15 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.568 1.147 . . . . 0.0 111.421 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.0 mmmt -133.18 -177.11 4.37 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 126.166 1.786 . . . . 0.0 108.533 -176.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -28.42 113.87 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 126.275 1.83 . . . . 0.0 114.904 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 112' ' ' ILE . 35.2 m -95.44 117.45 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.659 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.6 t -90.18 108.65 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.53 ' HB3' HD12 ' A' ' 108' ' ' LEU . 69.3 mt -87.14 116.7 25.39 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.407 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 46.3 m -148.71 137.05 21.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.616 0.766 . . . . 0.0 109.986 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.408 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 18.8 mt-10 -66.5 -34.82 78.79 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.11 0.964 . . . . 0.0 112.068 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.612 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 73.9 m-20 -89.1 123.8 66.44 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.89 -21.23 64.39 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 122.354 2.036 . . . . 0.0 111.732 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 37.7 mtm -74.35 -19.02 60.6 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.09 0.956 . . . . 0.0 110.91 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.612 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 17.0 mm100 -60.42 -32.41 71.33 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.278 0.631 . . . . 0.0 110.695 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 66' ' ' SER . 5.4 m-85 -77.38 -27.29 52.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.681 -177.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CE2' HD23 ' A' ' 87' ' ' LEU . 73.6 m-85 -91.11 -20.52 21.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.075 0.55 . . . . 0.0 111.94 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.17 -34.27 22.12 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.8 m -81.25 -59.68 2.55 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.999 0.52 . . . . 0.0 110.925 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.789 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 98.1 m-85 -93.19 -64.31 1.11 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.648 0.779 . . . . 0.0 110.207 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.25 -90.66 0.28 Allowed Glycine 0 C--N 1.352 1.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.375 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.29 -9.58 58.85 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.949 0.9 . . . . 0.0 111.808 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.789 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 28.0 mmt85 -78.21 -36.5 47.15 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.87 0.468 . . . . 0.0 110.262 170.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.441 HG13 HD22 ' A' ' 82' ' ' LEU . 35.1 t -75.49 140.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.287 0.635 . . . . 0.0 110.741 -176.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -57.1 -20.63 26.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 1.8 pt? -134.0 170.15 16.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 85' ' ' ASP . 6.9 t -108.11 -176.7 3.13 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 122.051 -0.405 . . . . 0.0 109.981 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.73 -25.37 67.27 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.244 0.618 . . . . 0.0 111.915 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.433 ' H ' HG22 ' A' ' 83' ' ' THR . 23.9 t70 -73.6 -36.42 65.52 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.32 0.648 . . . . 0.0 111.278 174.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.487 ' HA ' ' HG2' ' A' ' 89' ' ' GLU . 1.5 mp0 -74.51 -24.7 59.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.794 -0.566 . . . . 0.0 110.746 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.453 HD23 ' CE2' ' A' ' 73' ' ' PHE . 28.2 tp -67.57 -50.15 59.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.037 0.535 . . . . 0.0 109.691 175.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -40.45 96.11 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.465 0.478 . . . . 0.0 110.979 -175.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 8.6 pt-20 -64.86 -39.76 94.06 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -64.2 -49.46 71.91 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.987 0.915 . . . . 0.0 111.567 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 56.3 mtm -67.98 -44.89 75.61 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.402 0.681 . . . . 0.0 110.233 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -71.92 -26.25 62.22 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.883 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' A' ' 96' ' ' ARG . 43.4 m -62.73 -33.79 75.86 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.182 0.446 . . . . 0.0 110.802 174.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -68.23 -25.18 65.07 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.653 0.596 . . . . 0.0 111.413 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.597 ' HB2' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -113.27 -18.25 12.12 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -173.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 93' ' ' SER . 13.1 ptm180 -91.85 -27.94 17.63 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 118.233 0.47 . . . . 0.0 110.283 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -102.24 2.23 36.84 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.372 0.669 . . . . 0.0 109.385 169.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -133.97 -134.49 3.45 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.58 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.4 mmt85 -107.99 115.85 30.88 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.013 0.525 . . . . 0.0 110.084 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.597 ' HA ' ' HB2' ' A' ' 95' ' ' GLU . 41.4 ttm180 -78.99 72.84 5.53 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.31 0.644 . . . . 0.0 110.608 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -177.53 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.624 1.57 . . . . 0.0 108.795 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -61.7 92.91 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.949 0.9 . . . . 0.0 109.362 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 t 63.58 -173.26 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.204 1.002 . . . . 0.0 110.783 -172.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -130.53 -49.7 1.07 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -78.68 162.82 25.93 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.657 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -58.51 161.82 4.25 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.765 0.826 . . . . 0.0 112.303 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.26 147.21 49.73 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -176.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.53 HD12 ' HB3' ' A' ' 65' ' ' LEU . 0.4 OUTLIER -82.92 100.44 10.39 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -87.49 159.92 18.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.918 0.887 . . . . 0.0 109.646 171.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.573 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 20.8 ptm -140.18 137.51 34.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.741 0.416 . . . . 0.0 111.436 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.46 102.7 11.29 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.852 0.861 . . . . 0.0 109.949 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.451 ' HA ' HG11 ' A' ' 63' ' ' VAL . 42.6 mt -83.29 121.1 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.753 0.821 . . . . 0.0 109.021 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 39.8 tt0 -80.16 138.04 36.82 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.41 HD13 ' CB ' ' A' ' 58' ' ' ALA . 4.0 mm? -119.13 129.71 55.17 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.88 0.872 . . . . 0.0 109.837 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -128.99 173.14 10.69 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 51.43 54.58 10.83 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.1 0.952 . . . . 0.0 111.762 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.96 115.98 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.692 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER -102.27 152.58 20.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.202 1.001 . . . . 0.0 110.627 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.664 ' HZ1' HG23 ' A' ' 55' ' ' VAL . 26.0 mmmt -104.58 139.73 39.03 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.414 1.086 . . . . 0.0 109.309 170.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -91.1 72.41 6.33 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.46 -24.93 62.96 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.07 173.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.49 ' HZ1' ' HB3' ' A' ' 122' ' ' LYS . 0.2 OUTLIER -79.78 146.05 63.61 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.744 170.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.59 90.25 0.5 Allowed 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.395 2.063 . . . . 0.0 112.811 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 122' ' ' LYS . 24.7 mt -107.7 119.75 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.35 142.53 24.69 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.549 0.74 . . . . 0.0 109.556 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.74 133.98 41.74 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.33 2.02 . . . . 0.0 111.4 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -71.87 -24.6 61.71 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.829 0.851 . . . . 0.0 110.466 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.413 HH21 ' HB3' ' A' ' 135' ' ' GLN . 13.0 ptt180 -156.02 174.73 14.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.477 1.111 . . . . 0.0 109.459 174.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.87 143.49 55.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.225 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.482 HG13 ' HD3' ' A' ' 10' ' ' PRO . 60.3 t -122.83 102.14 38.57 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.89 -175.94 2.59 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.944 2.429 . . . . 0.0 111.854 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.6 p -57.68 -30.75 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 124.293 1.037 . . . . 0.0 112.751 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.34 -15.55 81.12 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.831 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.79 159.85 19.03 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.137 0.398 . . . . 0.0 113.02 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.413 ' HB3' HH21 ' A' ' 128' ' ' ARG . 31.6 mm-40 -116.98 146.92 42.71 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.783 0.833 . . . . 0.0 109.716 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -80.69 118.19 22.03 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.34 122.36 30.2 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.84 133.41 39.73 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.244 0.779 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.378 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.4 ttm . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -68.62 -15.32 63.49 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.119 0.968 . . . . 0.0 112.803 -172.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -63.09 -23.33 67.39 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.027 0.531 . . . . 0.0 111.866 173.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.459 HG21 ' H ' ' A' ' 5' ' ' VAL . 21.4 mm 61.62 -163.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -171.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.459 ' H ' HG21 ' A' ' 4' ' ' ILE . 1.8 m -149.47 -42.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 155.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.15 -162.12 21.88 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.101 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.56 149.44 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -117.21 132.52 56.62 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.354 0.662 . . . . 0.0 109.716 176.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -131.83 142.21 44.39 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.142 0.977 . . . . 0.0 109.598 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HD3' HG12 ' A' ' 130' ' ' VAL . 40.6 Cg_endo -66.7 -46.82 3.24 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.402 2.068 . . . . 0.0 111.73 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.3 mt 50.83 71.91 1.4 Allowed Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.218 1.007 . . . . 0.0 108.909 -167.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.29 39.32 0.83 Allowed 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.086 2.524 . . . . 0.0 112.415 -173.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -127.66 162.7 25.92 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.242 1.417 . . . . 0.0 109.116 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -67.62 -16.16 64.02 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.712 0.805 . . . . 0.0 112.392 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -73.76 0.02 14.3 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.107 0.963 . . . . 0.0 112.913 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -67.14 -18.87 65.48 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 117.908 0.322 . . . . 0.0 111.727 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.71 -31.12 72.2 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.243 1.017 . . . . 0.0 111.841 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 12.9 mmt85 -58.15 -38.55 76.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.567 1.147 . . . . 0.0 112.942 -167.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -70.98 -31.17 67.64 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.01 0.524 . . . . 0.0 110.195 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -93.24 -8.64 41.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.902 0.881 . . . . 0.0 110.237 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -85.6 -59.36 2.34 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 124.388 1.075 . . . . 0.0 110.032 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.4 ptpt -99.47 -15.52 18.67 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.196 -170.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.23 -39.54 2.78 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 113.579 0.192 . . . . 0.0 113.579 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.425 ' HZ3' ' HB3' ' A' ' 115' ' ' GLU . 23.7 ttmm -119.54 91.34 3.53 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.911 0.885 . . . . 0.0 109.291 173.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -99.43 175.05 5.99 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.943 0.897 . . . . 0.0 110.059 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.18 110.02 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.104 0.962 . . . . 0.0 108.981 175.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -88.77 118.23 28.31 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.444 0.698 . . . . 0.0 109.684 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.94 132.96 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 121.587 0.708 . . . . 0.0 111.117 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 5.1 mmpt? -120.0 138.7 27.27 Favored Pre-proline 0 C--O 1.215 -0.759 0 C-N-CA 125.376 1.471 . . . . 0.0 109.227 176.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.422 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 73.7 Cg_endo -77.24 46.78 2.06 Favored 'Trans proline' 0 CA--C 1.56 1.803 0 C-N-CA 122.481 2.121 . . . . 0.0 111.708 162.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.43 38.1 17.3 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.319 1.448 . . . . 0.0 112.61 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.413 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 15.0 m -64.28 -38.02 89.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.564 0.746 . . . . 0.0 110.225 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.8 149.88 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.908 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.515 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 90.6 m95 -72.2 -178.55 2.5 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.771 0.828 . . . . 0.0 111.667 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -79.2 10.71 3.35 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.34 0.656 . . . . 0.0 112.27 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -75.12 -20.88 59.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.892 0.877 . . . . 0.0 110.625 174.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.482 ' HA ' ' HE1' ' A' ' 41' ' ' MET . 0.1 OUTLIER -67.27 100.79 0.84 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.642 0.777 . . . . 0.0 110.32 -176.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -119.18 152.45 52.25 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.198 0.599 . . . . 0.0 109.755 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.57 97.69 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.65 2.233 . . . . 0.0 110.936 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.6 -4.73 0.33 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.203 -174.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.482 ' HE1' ' HA ' ' A' ' 37' ' ' LEU . 31.5 mtm -89.88 -171.27 3.1 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.436 0.694 . . . . 0.0 111.689 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -112.6 162.15 16.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.227 1.011 . . . . 0.0 110.573 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 60' ' ' ILE . 3.2 t80 -136.22 102.53 5.02 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 42.1 t -88.86 121.46 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.169 0.509 . . . . 0.0 110.287 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -86.11 126.51 34.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.258 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 52.5 t80 -103.04 122.79 45.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.411 1.084 . . . . 0.0 109.452 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -79.28 -65.47 0.99 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.056 0.455 . . . . 0.0 110.344 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.3 t -169.27 -178.0 3.03 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.454 -170.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -83.12 3.7 29.57 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.07 0.548 . . . . 0.0 111.43 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 32.6 tt0 -147.65 178.12 8.72 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.939 0.896 . . . . 0.0 109.345 -177.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.424 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 21.3 t70 77.95 -78.08 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.806 1.642 . . . . 0.0 110.549 174.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 123' ' ' PRO . 15.2 t -126.05 -5.53 6.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.392 0.277 . . . . 0.0 111.489 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.22 -82.75 0.25 Allowed Glycine 0 C--N 1.353 1.511 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -176.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 25.7 m-85 -93.86 129.93 40.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.275 1.03 . . . . 0.0 108.899 168.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.485 HG22 ' HZ1' ' A' ' 119' ' ' LYS . 2.2 p -72.45 -36.11 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 122.829 0.452 . . . . 0.0 111.055 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.45 -160.52 21.18 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.575 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 14.9 pt-20 -154.88 177.16 11.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.606 1.162 . . . . 0.0 108.409 176.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.519 ' HB1' HD11 ' A' ' 114' ' ' LEU . . . -161.49 -173.54 3.83 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.698 0.799 . . . . 0.0 109.531 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -122.31 118.98 29.79 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.777 0.831 . . . . 0.0 109.927 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 43' ' ' PHE . 51.7 mt -68.99 127.96 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.99 174.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -138.2 -164.59 1.65 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.461 1.504 . . . . 0.0 108.311 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -34.5 114.15 0.2 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 125.123 1.369 . . . . 0.0 113.956 -162.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.5 110.89 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-O 121.38 0.61 . . . . 0.0 109.799 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 97.4 t -91.02 108.43 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.8 mt -85.96 115.68 23.72 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 53.5 m -151.94 127.37 9.99 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 40.4 mt-10 -60.99 -47.6 85.72 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.551 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 43.3 m-20 -71.69 119.48 74.39 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.65 -21.39 70.11 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.486 2.124 . . . . 0.0 111.746 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 44.6 mtm -72.4 -20.17 61.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.002 0.921 . . . . 0.0 111.071 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.551 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 17.9 mm100 -60.97 -29.02 69.42 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.244 0.618 . . . . 0.0 111.005 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' A' ' 109' ' ' TRP . 6.3 m-85 -81.93 -27.99 33.04 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.634 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CE2' HD21 ' A' ' 87' ' ' LEU . 87.0 m-85 -87.91 -18.19 29.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.163 0.585 . . . . 0.0 111.832 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.31 -33.32 20.65 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.5 m -82.4 -60.39 2.22 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.078 0.551 . . . . 0.0 111.491 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.735 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 59.5 m-85 -93.81 -55.26 3.31 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.178 0.591 . . . . 0.0 110.136 -177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.83 -89.37 0.12 Allowed Glycine 0 C--N 1.355 1.628 0 O-C-N 124.135 0.897 . . . . 0.0 113.55 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.2 -28.51 68.15 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.079 0.952 . . . . 0.0 110.829 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.735 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 16.0 mmt85 -72.2 -27.88 62.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.034 0.534 . . . . 0.0 111.892 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.4 HG11 HD21 ' A' ' 82' ' ' LEU . 25.2 t -68.72 151.76 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.4 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 41.0 p90 -63.24 -11.08 18.67 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.4 HD21 HG11 ' A' ' 80' ' ' VAL . 1.9 pt? -145.1 173.17 12.14 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.279 1.032 . . . . 0.0 109.138 174.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.538 HG22 ' HG2' ' A' ' 86' ' ' GLU . 15.1 t -104.26 173.85 6.13 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -63.6 -30.35 71.47 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.897 0.479 . . . . 0.0 111.548 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.83 -32.52 67.64 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.538 ' HG2' HG22 ' A' ' 83' ' ' THR . 26.3 mm-40 -70.01 -35.53 74.42 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 172.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.536 ' HG ' ' HE2' ' A' ' 91' ' ' MET . 18.3 tp -62.66 -52.28 63.96 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.073 0.949 . . . . 0.0 111.544 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -42.17 98.41 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.928 -173.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.26 -29.77 65.48 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 122.959 0.162 . . . . 0.0 110.785 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 63.3 t80 -66.19 -46.86 75.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.557 0.743 . . . . 0.0 110.922 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.536 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 71.7 mtm -69.08 -33.8 74.13 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.969 0.507 . . . . 0.0 110.809 -177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -76.49 -27.5 56.09 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.948 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.425 ' HA ' ' HG2' ' A' ' 96' ' ' ARG . 26.7 t -63.88 -33.29 75.37 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.235 0.541 . . . . 0.0 109.915 176.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 87.5 mm-40 -73.09 -3.46 26.49 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.874 0.87 . . . . 0.0 112.892 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -126.07 -30.53 2.94 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 93' ' ' SER . 15.4 ptm180 -73.16 -27.86 61.89 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.691 0.397 . . . . 0.0 111.82 -175.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -92.55 -21.72 19.94 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.877 0.471 . . . . 0.0 111.039 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.23 171.02 35.27 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.46 -0.634 . . . . 0.0 112.421 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 69.98 123.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.928 1.291 . . . . 0.0 111.557 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -69.74 112.72 6.39 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.515 0.726 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.531 ' H ' ' HD3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -56.29 96.07 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.454 1.101 . . . . 0.0 111.847 177.318 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -131.38 110.31 10.96 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.0 p -138.66 -43.48 0.49 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.456 1.103 . . . . 0.0 108.938 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.9 tptt 71.76 -72.69 0.11 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.401 1.48 . . . . 0.0 110.398 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -95.57 156.02 16.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.288 1.035 . . . . 0.0 109.085 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 158.13 30.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.958 0.503 . . . . 0.0 110.769 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -110.5 154.29 23.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.082 0.953 . . . . 0.0 109.268 -175.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.6 tm? -73.98 116.97 15.22 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.475 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 24.0 m95 -107.85 161.77 14.61 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.867 0.867 . . . . 0.0 108.96 172.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.402 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 12.5 ptm -145.89 130.83 18.2 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.48 0.712 . . . . 0.0 110.399 -176.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -101.93 103.66 14.33 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.206 1.002 . . . . 0.0 109.694 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.4 mt -90.3 120.8 39.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -78.11 109.81 12.52 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.56 0.618 . . . . 0.0 109.459 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.519 HD11 ' HB1' ' A' ' 58' ' ' ALA . 3.9 mm? -95.45 108.69 20.92 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 123.411 0.684 . . . . 0.0 110.536 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.425 ' HB3' ' HZ3' ' A' ' 24' ' ' LYS . 10.7 pt-20 -123.31 172.64 8.49 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.5 t70 58.95 40.73 22.14 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.298 1.039 . . . . 0.0 110.63 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.9 t -70.48 107.93 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.204 -172.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -93.37 114.42 26.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.23 1.012 . . . . 0.0 111.126 -176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.485 ' HZ1' HG22 ' A' ' 55' ' ' VAL . 18.1 mmmt -74.33 136.7 42.55 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 170.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -80.5 110.68 16.19 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.88 -23.18 66.14 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.76 1.224 . . . . 0.0 111.3 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -125.25 149.21 63.31 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.568 1.147 . . . . 0.0 110.315 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 51.6 Cg_exo -57.49 96.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 123.522 2.815 . . . . 0.0 113.654 171.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 17.3 mt -100.03 107.16 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.019 0.528 . . . . 0.0 109.67 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.52 150.25 89.01 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.872 -176.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.433 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 98.0 Cg_endo -72.94 164.88 34.33 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.079 1.852 . . . . 0.0 112.141 174.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -70.2 -41.06 74.17 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 173.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -153.46 177.01 11.38 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.522 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.69 132.93 53.42 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.136 0.974 . . . . 0.0 111.402 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.547 HG12 ' HD3' ' A' ' 10' ' ' PRO . 38.2 t -119.37 97.88 50.3 Favored Pre-proline 0 CA--C 1.553 1.079 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.65 -176.76 3.15 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.053 2.502 . . . . 0.0 112.579 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.18 -26.81 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.354 1.061 . . . . 0.0 112.079 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.04 -20.4 79.96 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.837 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.3 148.85 3.95 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.321 0.486 . . . . 0.0 113.103 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -106.96 151.45 25.27 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.355 0.662 . . . . 0.0 109.363 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.515 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 1.3 m-85 -89.82 122.9 33.32 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 174.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.03 116.84 27.61 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.89 127.32 39.93 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -171.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -66.6 -16.49 64.22 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.912 0.885 . . . . 0.0 111.958 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.45 -27.44 69.12 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.881 0.872 . . . . 0.0 111.806 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.585 HG13 ' HB3' ' A' ' 36' ' ' GLU . 25.3 mm 63.8 -169.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 C-N-CA 124.094 0.957 . . . . 0.0 108.764 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' H ' HG21 ' A' ' 4' ' ' ILE . 2.5 m -149.48 -41.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.988 1.315 . . . . 0.0 107.524 156.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.06 -162.57 22.59 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.81 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 p -124.18 156.46 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.425 0.69 . . . . 0.0 109.275 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -126.41 133.03 51.38 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.329 0.652 . . . . 0.0 109.285 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.24 135.85 28.09 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 123.283 0.633 . . . . 0.0 110.745 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HB3' ' HD2' ' A' ' 46' ' ' TYR . 43.1 Cg_endo -93.83 78.07 0.23 Allowed 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 124.078 3.186 . . . . 0.0 110.214 168.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.78 109.3 1.76 Allowed Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.822 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -83.93 30.86 0.52 Allowed 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.213 2.609 . . . . 0.0 112.428 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 15' ' ' PHE . 38.6 mmtm -133.41 148.68 51.81 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.428 1.491 . . . . 0.0 108.674 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -63.06 -15.96 58.3 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.011 0.924 . . . . 0.0 111.693 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.4 ' HD2' ' HB3' ' A' ' 13' ' ' LYS . 59.1 m-85 -72.89 7.05 2.2 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.375 1.07 . . . . 0.0 112.824 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.3 ttp -68.76 -24.18 64.41 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.14 0.576 . . . . 0.0 109.981 165.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.35 -29.02 70.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.998 0.919 . . . . 0.0 110.98 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 27.2 mmt180 -57.63 -41.0 80.49 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 124.382 1.051 . . . . 0.0 111.771 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 58.0 m-85 -65.1 -32.35 74.0 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 123.902 0.751 . . . . 0.0 110.042 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -89.47 -13.59 37.2 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.697 0.799 . . . . 0.0 111.125 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -82.83 -54.45 5.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.954 0.901 . . . . 0.0 110.393 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.2 ptpt -100.8 -8.89 22.22 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.712 -165.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.47 -42.17 3.13 Favored Glycine 0 N--CA 1.475 1.245 0 O-C-N 123.067 0.229 . . . . 0.0 113.109 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -129.64 106.1 8.5 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.395 0.678 . . . . 0.0 109.981 172.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.423 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.2 t70 -107.53 -177.37 3.33 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.494 1.117 . . . . 0.0 109.174 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.2 t -136.81 114.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.36 1.064 . . . . 0.0 109.229 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -85.09 111.65 19.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.599 0.759 . . . . 0.0 110.266 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.57 132.1 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-O 121.2 0.524 . . . . 0.0 110.461 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HD2' ' HD2' ' A' ' 30' ' ' PRO . 58.5 tptt -134.71 130.57 19.8 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.504 1.122 . . . . 0.0 108.335 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HD2' ' HD2' ' A' ' 29' ' ' LYS . 24.9 Cg_endo -61.68 94.95 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 121.872 1.715 . . . . 0.0 109.58 166.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -30.08 79.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.807 2.043 . . . . 0.0 115.674 -163.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 50.7 m -96.11 -30.51 13.49 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.068 172.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.82 142.7 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.315 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -67.41 168.76 10.15 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.263 0.625 . . . . 0.0 112.368 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -58.94 -11.52 3.46 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.21 1.404 . . . . 0.0 113.562 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.585 ' HB3' HG13 ' A' ' 4' ' ' ILE . 7.7 mm-40 -64.64 -17.3 63.91 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.968 0.907 . . . . 0.0 111.939 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.16 100.48 3.08 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.365 0.666 . . . . 0.0 110.04 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.3 152.33 42.57 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.77 82.93 2.03 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.66 2.24 . . . . 0.0 111.918 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.63 43.0 0.02 OUTLIER Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.122 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 34.0 mtm -122.39 -158.83 0.8 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.867 0.867 . . . . 0.0 110.026 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -121.05 158.88 26.85 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.09 0.956 . . . . 0.0 110.309 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -136.41 99.68 4.16 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 41.3 t -83.7 124.59 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.089 0.471 . . . . 0.0 110.068 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -89.51 115.32 26.84 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.498 0.719 . . . . 0.0 109.508 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 10' ' ' PRO . 85.0 t80 -101.45 92.6 4.99 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.459 1.103 . . . . 0.0 109.481 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -74.9 96.37 3.12 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 t -85.12 52.2 2.38 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.73 0.776 . . . . 0.0 109.281 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -161.53 21.75 0.12 Allowed 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.61 1.164 . . . . 0.0 109.691 -170.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -131.35 -80.86 0.52 Allowed 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.41 -0.806 . . . . 0.0 110.826 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -166.01 -79.74 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -172.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -77.71 -40.86 39.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.884 0.473 . . . . 0.0 110.557 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.72 -70.77 0.5 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.484 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 17.6 m-30 -60.93 96.39 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.436 0.695 . . . . 0.0 111.363 -177.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -77.2 -33.42 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.004 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.53 -166.4 31.77 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.843 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 2.2 pt-20 -149.61 179.36 8.05 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.576 1.15 . . . . 0.0 108.627 176.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 114' ' ' LEU . . . -158.56 -173.65 4.39 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.819 0.848 . . . . 0.0 109.509 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -127.29 116.53 20.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.411 0.684 . . . . 0.0 109.64 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -66.63 137.69 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.915 1.286 . . . . 0.0 111.425 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -141.0 -170.6 3.08 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.351 1.86 . . . . 0.0 108.564 -175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -30.62 113.98 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.586 1.554 . . . . 0.0 114.798 -168.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -97.52 108.88 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-O 121.799 0.809 . . . . 0.0 109.694 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 95.7 t -92.65 109.26 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.93 0.892 . . . . 0.0 109.795 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.56 117.66 27.67 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.4 t -152.99 135.72 15.31 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.768 0.827 . . . . 0.0 109.814 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.462 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 38.1 mt-10 -63.72 -22.16 66.77 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.062 0.545 . . . . 0.0 111.53 172.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -87.76 119.88 70.73 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.188 0.595 . . . . 0.0 109.723 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.31 -8.39 22.62 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 122.418 2.078 . . . . 0.0 112.064 167.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.403 ' HG2' ' HE2' ' A' ' 84' ' ' LYS . 51.7 mtm -89.58 -26.0 21.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.407 1.083 . . . . 0.0 111.21 -174.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.519 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 71.4 mt-30 -68.17 -20.91 64.91 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -74.52 -21.99 59.27 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.508 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.487 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 22.6 m-85 -89.99 -27.81 19.53 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.177 0.591 . . . . 0.0 111.482 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 13.0 pt-20 -76.33 -28.43 56.89 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.3 m -85.98 -60.75 1.92 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.897 0.479 . . . . 0.0 110.788 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.778 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 67.0 m-85 -101.32 -61.84 1.32 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.389 0.675 . . . . 0.0 110.205 -173.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 77.33 -87.54 1.01 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.703 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.33 -12.94 44.96 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.778 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 6.4 mmp_? -69.33 -34.05 74.05 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.291 169.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.414 HG11 HD22 ' A' ' 82' ' ' LEU . 34.7 t -67.62 147.16 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.8 0.44 . . . . 0.0 110.453 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -63.56 -22.27 66.8 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.414 HD22 HG11 ' A' ' 80' ' ' VAL . 2.1 pt? -131.38 162.06 30.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.177 0.591 . . . . 0.0 109.608 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.6 t -106.05 -176.93 3.22 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.403 ' HE2' ' HG2' ' A' ' 70' ' ' MET . 5.3 tppp? -56.39 -43.15 78.99 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.37 0.668 . . . . 0.0 111.142 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.38 -45.8 92.27 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.041 0.936 . . . . 0.0 111.772 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.52 -46.72 88.76 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 123.224 0.327 . . . . 0.0 110.45 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.449 ' HG ' ' HE3' ' A' ' 91' ' ' MET . 43.8 tp -57.27 -50.04 74.16 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.115 0.884 . . . . 0.0 111.46 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -64.28 -45.85 86.22 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.477 0.486 . . . . 0.0 110.775 -175.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.496 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 13.0 pt-20 -74.04 -24.79 59.58 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.451 0.3 . . . . 0.0 110.984 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 69.4 t80 -71.82 -49.37 39.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.718 0.807 . . . . 0.0 109.997 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.449 ' HE3' ' HG ' ' A' ' 87' ' ' LEU . 64.3 mtm -66.73 -40.76 88.51 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.89 0.744 . . . . 0.0 110.105 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -63.99 -35.59 81.2 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.714 0.634 . . . . 0.0 111.077 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.2 t -63.14 -37.42 87.15 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.861 0.464 . . . . 0.0 110.949 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 67.9 mm-40 -71.28 -41.41 70.03 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.871 0.469 . . . . 0.0 111.218 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -3.5 51.7 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -115.18 -40.16 3.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.005 0.522 . . . . 0.0 111.808 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -83.4 -42.93 16.45 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.88 -93.63 0.38 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 169.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -177.12 151.06 0.78 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.541 1.136 . . . . 0.0 108.1 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -82.16 170.39 15.51 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -102.41 22.2 13.84 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.707 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 50.12 -89.13 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.777 1.631 . . . . 0.0 110.932 -171.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.7 t -172.95 132.73 0.53 Allowed 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.024 0.93 . . . . 0.0 108.681 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -149.91 -68.08 0.2 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -157.29 -92.87 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.462 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -176.36 -160.85 0.07 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.468 1.507 . . . . 0.0 108.046 178.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -132.65 165.05 25.35 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.445 0.698 . . . . 0.0 109.583 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.61 114.32 10.61 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.649 0.779 . . . . 0.0 109.496 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 19.5 m95 -100.35 161.99 13.24 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.319 1.048 . . . . 0.0 109.398 172.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.436 ' HE1' HD13 ' A' ' 112' ' ' ILE . 9.0 ptt? -143.25 138.93 29.96 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.933 0.397 . . . . 0.0 110.766 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.447 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . . . -109.51 103.33 12.2 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.089 0.956 . . . . 0.0 109.74 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.436 HD13 ' HE1' ' A' ' 110' ' ' MET . 22.8 mt -87.03 122.06 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.36 129.77 34.76 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 58' ' ' ALA . 3.6 mm? -117.18 107.58 14.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.795 0.838 . . . . 0.0 110.865 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -106.4 170.83 7.69 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.157 0.583 . . . . 0.0 110.327 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.6 t70 55.21 38.54 30.57 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 124.449 1.093 . . . . 0.0 111.09 168.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.3 t -66.92 101.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.523 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.32 110.66 23.17 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.921 -167.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -65.08 122.27 16.66 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.886 0.875 . . . . 0.0 110.947 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.484 ' HD2' ' HB3' ' A' ' 54' ' ' PHE . 12.8 m-30 -75.9 87.35 2.87 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.36 -30.56 70.97 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.278 172.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -81.91 131.94 55.61 Favored Pre-proline 0 CA--C 1.553 1.089 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.384 168.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.66 84.15 2.03 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.761 2.307 . . . . 0.0 111.557 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.4 mt -73.21 127.04 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.008 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -74.53 130.6 81.54 Favored Pre-proline 0 CA--C 1.553 1.066 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.865 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.45 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 65.7 Cg_endo -71.51 145.13 46.7 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.63 2.22 . . . . 0.0 110.707 169.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.55 -6.22 59.39 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.588 0.755 . . . . 0.0 111.228 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -167.83 177.98 5.46 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.621 1.168 . . . . 0.0 109.402 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.87 138.04 46.03 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 166.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.438 HG13 ' HD3' ' A' ' 10' ' ' PRO . 43.7 t -107.0 100.33 31.47 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 170.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.23 169.25 17.2 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.873 2.382 . . . . 0.0 112.138 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.419 ' HA ' ' HG2' ' A' ' 10' ' ' PRO . 18.7 m -59.25 -20.49 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -173.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.5 -21.93 76.33 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.144 0.277 . . . . 0.0 113.079 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.79 147.47 14.89 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.621 0.629 . . . . 0.0 112.096 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -108.88 148.59 30.39 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.509 0.724 . . . . 0.0 109.33 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -92.27 120.37 32.76 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.459 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.24 122.93 30.13 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 130.04 34.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.322 0.649 . . . . 0.0 109.254 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.588 -171.794 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.479 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 92.0 mmm . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 111.326 0.121 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -60.46 -6.63 1.66 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.36 1.464 . . . . 0.0 114.172 -173.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -61.87 -12.51 18.13 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.739 0.816 . . . . 0.0 112.356 167.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mm 67.4 -178.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.933 1.293 . . . . 0.0 109.04 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 m -150.15 -47.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 156.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.05 -161.34 19.17 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.516 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 HD11 ' A' ' 60' ' ' ILE . 9.7 p -117.5 161.76 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -133.5 135.96 44.78 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.63 0.772 . . . . 0.0 109.25 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -136.03 146.03 54.92 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.924 0.89 . . . . 0.0 110.371 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.479 ' HD3' HG13 ' A' ' 130' ' ' VAL . 69.3 Cg_endo -70.7 -32.89 13.9 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.872 2.381 . . . . 0.0 112.624 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 mm 53.24 77.9 0.42 Allowed Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 124.105 0.962 . . . . 0.0 108.756 -168.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.17 41.65 1.14 Allowed 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.403 2.736 . . . . 0.0 112.868 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -138.49 158.95 43.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.353 1.461 . . . . 0.0 109.176 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -72.16 -10.95 60.47 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.128 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -79.51 11.61 2.96 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.43 1.092 . . . . 0.0 111.823 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 58.2 ttp -63.01 -35.37 80.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.715 0.806 . . . . 0.0 109.699 166.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.78 -26.17 68.58 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.893 0.877 . . . . 0.0 112.449 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -50.66 -48.02 58.5 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.844 0.858 . . . . 0.0 111.44 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.422 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 75.0 m-85 -67.53 -27.55 67.06 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.807 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -102.12 6.63 40.97 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.342 0.657 . . . . 0.0 110.922 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -93.52 -57.06 2.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.168 0.987 . . . . 0.0 109.41 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -110.98 -19.72 12.68 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.06 32.5 75.98 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 114.917 0.727 . . . . 0.0 114.917 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -161.86 41.77 0.14 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.278 1.031 . . . . 0.0 109.459 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' OD1' ' HA ' ' A' ' 19' ' ' PHE . 3.0 m-20 -81.93 -172.01 3.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.333 -172.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -142.36 110.69 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -86.94 111.76 21.13 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 m -83.99 140.23 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.73 0.776 . . . . 0.0 110.561 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.518 ' HD2' ' HB ' ' A' ' 32' ' ' THR . 15.2 tppt? -134.58 120.98 14.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.966 1.306 . . . . 0.0 109.699 -171.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 95.6 Cg_endo -77.54 53.86 4.5 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.13 2.554 . . . . 0.0 112.829 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 58.12 21.33 7.84 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.518 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 4.5 m -63.63 -36.42 83.77 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.349 0.522 . . . . 0.0 110.294 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -119.93 149.68 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.165 0.986 . . . . 0.0 109.092 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -167.57 -48.96 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.574 0.749 . . . . 0.0 110.348 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -41.59 -51.98 3.86 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.847 1.659 . . . . 0.0 113.641 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 22.8 mt-10 -109.68 -12.51 14.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.595 0.758 . . . . 0.0 110.306 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.436 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -69.23 115.44 8.52 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 123.294 0.637 . . . . 0.0 110.221 -177.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.85 152.15 54.8 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.992 0.917 . . . . 0.0 108.951 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.83 103.16 1.3 Allowed 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.597 2.198 . . . . 0.0 111.616 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.74 -7.07 0.91 Allowed Glycine 0 N--CA 1.476 1.348 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.789 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.519 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 79.0 mtp -83.01 -169.39 2.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.432 1.093 . . . . 0.0 111.068 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 12.3 ptpt -116.0 165.52 13.03 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.713 0.805 . . . . 0.0 110.608 168.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.534 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.1 t80 -135.37 99.06 4.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 87.3 t -84.96 120.07 34.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.23 0.538 . . . . 0.0 109.804 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -84.07 100.16 10.92 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -64.05 130.22 43.12 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 165.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.455 ' HB3' ' HA2' ' A' ' 53' ' ' GLY . 51.1 tt0 -74.9 108.9 7.93 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.0 t -65.1 87.57 0.07 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -131.62 -90.31 0.43 Allowed 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.237 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -155.57 -79.3 0.09 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.851 0.86 . . . . 0.0 109.162 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.59 -60.01 1.61 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.1 m -66.61 132.8 48.96 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.428 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 47' ' ' GLN . . . -133.85 -162.5 10.04 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.828 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.627 ' HB2' ' HB ' ' A' ' 124' ' ' ILE . 1.6 m-85 50.64 69.14 0.67 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.279 1.032 . . . . 0.0 111.203 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.17 -38.87 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.93 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.13 -166.66 25.53 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.234 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -145.89 178.68 8.0 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.906 0.882 . . . . 0.0 108.755 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -164.16 -171.71 2.51 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.693 0.797 . . . . 0.0 110.016 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.555 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 11.3 mmt180 -128.73 122.32 30.41 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.249 1.019 . . . . 0.0 109.401 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.534 HG13 ' HB2' ' A' ' 43' ' ' PHE . 57.8 mt -74.34 131.37 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.201 1.0 . . . . 0.0 110.322 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -139.31 -164.71 1.72 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.925 1.69 . . . . 0.0 108.357 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -24.78 109.93 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 126.378 1.871 . . . . 0.0 114.769 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 112' ' ' ILE . 35.0 m -98.76 109.04 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -89.62 110.23 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -87.96 118.26 27.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.516 0.727 . . . . 0.0 109.669 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.3 t -153.62 134.86 14.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.781 0.832 . . . . 0.0 109.581 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 49.3 mt-10 -70.03 -17.53 63.26 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.102 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 36.5 m-80 -91.66 118.76 68.51 Favored Pre-proline 0 C--N 1.357 0.892 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.21 -10.83 30.05 Favored 'Trans proline' 0 CA--C 1.556 1.615 0 C-N-CA 122.473 2.115 . . . . 0.0 112.259 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 46.4 mtm -81.25 -27.56 35.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.168 0.987 . . . . 0.0 111.499 -176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.481 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 47.5 mt-30 -66.21 -24.01 66.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.387 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -74.08 -25.2 59.69 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.872 0.469 . . . . 0.0 110.866 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -80.87 -37.34 30.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.0 0.52 . . . . 0.0 110.892 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.55 -29.03 61.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 121.294 -0.162 . . . . 0.0 111.35 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.4 m -80.74 -47.22 14.26 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.981 0.512 . . . . 0.0 110.682 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.496 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 62.7 m-85 -116.33 -67.23 1.01 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.265 0.626 . . . . 0.0 109.935 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.76 -81.13 1.15 Allowed Glycine 0 C--N 1.35 1.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.835 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.5 -43.97 93.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.902 0.881 . . . . 0.0 110.83 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 25.8 mmt180 -66.44 -30.68 71.09 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.553 -176.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.413 HG13 HD23 ' A' ' 82' ' ' LEU . 40.3 t -66.03 131.21 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -62.51 -22.16 66.07 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -168.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.413 HD23 HG13 ' A' ' 80' ' ' VAL . 2.3 pt? -128.07 160.89 30.58 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 t -97.01 179.33 4.97 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.913 0.324 . . . . 0.0 110.383 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -62.95 -32.59 73.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.104 0.562 . . . . 0.0 111.452 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.5 -45.8 78.38 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.33 0.652 . . . . 0.0 110.627 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.93 -35.46 76.77 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.44 173.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 tp -64.14 -52.73 57.7 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.546 0.529 . . . . 0.0 110.874 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -67.14 -40.44 86.74 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.256 0.348 . . . . 0.0 111.365 -173.114 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.71 -33.32 73.74 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -63.64 -48.26 77.97 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.973 0.909 . . . . 0.0 110.292 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.5 mtm -65.58 -33.0 74.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.052 0.541 . . . . 0.0 110.388 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.2 mmpt? -71.4 -34.89 70.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.621 0.368 . . . . 0.0 110.957 175.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.2 m -70.42 -42.06 72.09 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.932 0.493 . . . . 0.0 110.543 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -72.34 -22.48 61.16 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.239 0.616 . . . . 0.0 111.747 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -89.33 -36.89 15.28 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 119.457 -0.306 . . . . 0.0 111.452 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -77.42 -40.98 41.59 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.454 0.57 . . . . 0.0 111.079 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -82.98 -24.23 33.02 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.785 0.434 . . . . 0.0 110.146 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.13 -77.23 0.66 Allowed Glycine 0 C--N 1.351 1.399 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -173.1 -57.58 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.972 1.309 . . . . 0.0 107.878 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -167.98 164.47 13.78 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -69.03 83.74 0.33 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -82.19 95.15 7.44 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.401 -1.272 . . . . 0.0 107.976 -169.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -165.54 -170.18 1.77 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.121 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -158.62 -55.29 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 172.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -93.89 124.55 37.97 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.762 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.479 ' H ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -61.72 157.49 17.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.936 0.894 . . . . 0.0 112.096 -178.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.4 tpmt? -101.46 151.53 21.83 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.435 -174.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.515 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 2.9 tm? -73.45 110.31 7.65 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 173.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -89.8 158.47 17.48 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.44 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 12.3 ptm -139.51 129.05 24.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.16 0.584 . . . . 0.0 109.796 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.87 100.95 11.67 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 63' ' ' VAL . 23.3 mt -80.95 117.98 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -80.66 110.08 15.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.52 0.676 . . . . 0.0 109.67 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.67 131.62 34.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.405 1.082 . . . . 0.0 109.824 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -139.07 173.29 11.71 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.18 0.592 . . . . 0.0 109.463 171.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.9 t70 56.17 34.56 24.13 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.856 0.862 . . . . 0.0 110.946 170.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.9 t -65.89 106.82 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.698 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.265 -175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.95 162.84 19.26 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.6 1.16 . . . . 0.0 109.969 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.87 124.12 42.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.697 0.799 . . . . 0.0 109.336 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -79.68 103.4 9.56 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.266 0.555 . . . . 0.0 109.674 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.83 -28.23 68.83 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.671 1.188 . . . . 0.0 110.589 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -88.34 139.85 30.24 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.973 0.909 . . . . 0.0 109.831 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.4 92.22 0.94 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.709 2.273 . . . . 0.0 111.86 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 41.5 mt -80.34 138.38 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.88 140.24 23.5 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.67 123.39 12.91 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.53 2.153 . . . . 0.0 112.095 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -57.73 -34.05 69.1 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.553 0.741 . . . . 0.0 109.432 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -150.61 164.69 35.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.388 1.075 . . . . 0.0 109.056 172.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.55 126.52 29.91 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.36 0.664 . . . . 0.0 109.522 -175.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.479 HG13 ' HD3' ' A' ' 10' ' ' PRO . 19.1 t -109.51 99.73 38.62 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.65 -172.85 1.52 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.91 2.407 . . . . 0.0 112.137 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.23 -34.81 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.965 0.906 . . . . 0.0 110.966 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.77 -21.1 77.92 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.203 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.74 163.26 26.71 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 122.92 0.295 . . . . 0.0 113.12 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -115.54 149.89 37.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.999 0.919 . . . . 0.0 109.961 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 9.2 m-85 -85.24 120.1 26.35 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 169.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.7 125.54 33.95 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -130.36 128.86 42.28 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.266 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 C--O 1.247 0.965 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -171.75 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 tpp . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 m -62.47 -18.65 62.28 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.543 1.137 . . . . 0.0 113.639 -170.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -60.68 -22.74 64.22 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.838 0.855 . . . . 0.0 112.929 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.485 HG13 ' HB3' ' A' ' 36' ' ' GLU . 27.1 mm 64.35 -168.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.665 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -170.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.3 m -147.31 -39.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.024 0.929 . . . . 0.0 108.729 158.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.02 -161.83 21.21 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.284 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 13.4 p -127.88 155.12 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 t -126.94 136.63 52.54 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -137.15 139.95 29.74 Favored Pre-proline 0 N--CA 1.469 0.522 0 C-N-CA 124.419 1.088 . . . . 0.0 109.369 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 15.4 Cg_exo -65.76 -47.0 4.27 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 123.079 2.519 . . . . 0.0 110.825 169.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.6 mt 67.95 136.12 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 125.366 1.466 . . . . 0.0 110.2 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HB2' ' HD2' ' A' ' 15' ' ' PHE . 81.6 Cg_exo -48.06 124.98 10.98 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.236 1.957 . . . . 0.0 111.356 171.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -59.31 -16.8 24.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.518 1.127 . . . . 0.0 113.052 -174.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -66.98 -45.64 77.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.571 0.748 . . . . 0.0 110.797 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.466 ' HD2' ' HB2' ' A' ' 12' ' ' PRO . 76.3 m-85 -101.2 1.56 39.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.414 1.086 . . . . 0.0 112.071 -174.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -73.15 -40.8 64.56 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.211 0.604 . . . . 0.0 110.354 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -63.86 -25.34 68.12 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.504 0.721 . . . . 0.0 112.132 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -50.67 -44.25 57.64 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 124.96 1.304 . . . . 0.0 112.581 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.539 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 47.9 m-85 -70.37 -27.13 64.08 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.494 0.718 . . . . 0.0 111.526 -174.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -95.97 -17.78 20.75 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.186 0.994 . . . . 0.0 110.15 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -74.6 -58.73 3.1 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.637 1.175 . . . . 0.0 110.506 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -92.57 -14.0 28.89 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.924 -172.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.13 -58.89 4.22 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.813 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -109.88 104.72 13.69 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.317 0.558 . . . . 0.0 110.186 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 11.4 t70 -101.63 179.23 4.41 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.176 0.99 . . . . 0.0 109.757 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.0 t -138.06 110.84 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.393 1.077 . . . . 0.0 109.023 171.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -88.48 111.45 21.83 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.707 0.803 . . . . 0.0 109.937 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.8 m -90.44 126.88 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.619 0.723 . . . . 0.0 111.149 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.542 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 7.4 mmpt? -110.18 134.97 20.6 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.124 1.369 . . . . 0.0 109.726 173.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.77 56.6 6.02 Favored 'Trans proline' 0 CA--C 1.557 1.668 0 C-N-CA 122.501 2.134 . . . . 0.0 110.909 166.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' HB2' ' HE2' ' A' ' 107' ' ' LYS . . . 50.79 37.51 17.16 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.035 1.334 . . . . 0.0 112.919 -176.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.542 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 10.7 m -64.65 -43.39 93.79 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.954 0.902 . . . . 0.0 110.246 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.41 151.32 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.081 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -73.5 -177.38 2.63 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.392 1.077 . . . . 0.0 112.016 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -68.2 -3.72 11.58 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.036 0.934 . . . . 0.0 113.018 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.485 ' HB3' HG13 ' A' ' 4' ' ' ILE . 9.5 mm-40 -66.57 -24.81 66.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.214 0.606 . . . . 0.0 110.773 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.515 ' HA ' ' HE3' ' A' ' 41' ' ' MET . 0.1 OUTLIER -68.86 94.65 0.63 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.935 0.494 . . . . 0.0 109.891 178.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.471 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -115.12 149.99 43.54 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.207 0.603 . . . . 0.0 109.438 177.293 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.481 ' HA ' HG23 ' A' ' 60' ' ' ILE . 59.9 Cg_endo -70.95 103.17 1.32 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.948 2.432 . . . . 0.0 110.699 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.64 -16.05 1.09 Allowed Glycine 0 C--O 1.241 0.54 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.512 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.515 ' HE3' ' HA ' ' A' ' 37' ' ' LEU . 25.8 mtm -73.48 -174.49 1.69 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.362 0.665 . . . . 0.0 112.185 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -109.45 159.44 17.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.845 0.858 . . . . 0.0 110.456 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.9 t80 -137.0 98.14 3.68 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 46.7 t -84.55 129.4 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 109.955 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -93.0 119.28 32.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.564 0.746 . . . . 0.0 110.042 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 52.1 t80 -91.04 144.32 25.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.875 1.27 . . . . 0.0 109.111 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.6 HE21 HG23 ' A' ' 52' ' ' THR . 9.8 tt0 -139.55 125.92 20.24 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.133 0.573 . . . . 0.0 109.74 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 51' ' ' ASP . 25.3 m 65.21 131.32 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.548 1.539 . . . . 0.0 112.725 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -63.12 -43.01 99.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.491 0.717 . . . . 0.0 112.536 -174.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.11 10.59 10.08 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.435 0.694 . . . . 0.0 111.866 -169.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 48' ' ' SER . 33.3 t70 -147.71 154.16 40.21 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.611 0.764 . . . . 0.0 109.193 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.611 ' HA ' ' HB3' ' A' ' 123' ' ' PRO . 55.0 m 64.15 -72.74 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.977 1.311 . . . . 0.0 111.827 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.455 ' HA3' ' HD3' ' A' ' 126' ' ' PRO . . . 104.46 -69.82 0.26 Allowed Glycine 0 C--O 1.22 -0.761 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -178.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -129.45 127.84 41.71 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.312 0.645 . . . . 0.0 110.293 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.48 HG21 ' HZ1' ' A' ' 119' ' ' LYS . 3.2 p -85.3 -31.32 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.997 0.919 . . . . 0.0 110.782 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.33 -162.9 26.09 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.869 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 15.2 pt-20 -153.72 178.0 10.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.804 1.242 . . . . 0.0 108.215 175.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HB3' HD11 ' A' ' 114' ' ' LEU . . . -164.24 -176.17 4.31 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.592 0.757 . . . . 0.0 110.091 177.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -122.92 130.6 53.03 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.641 0.776 . . . . 0.0 109.889 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.481 HG23 ' HA ' ' A' ' 39' ' ' PRO . 45.4 mt -74.39 138.1 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.039 1.336 . . . . 0.0 110.751 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -133.4 -168.62 2.13 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.722 2.009 . . . . 0.0 108.438 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -31.28 113.03 0.1 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 126.113 1.765 . . . . 0.0 113.967 -166.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.3 m -92.79 103.23 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.492 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 86.7 t -90.71 109.0 20.35 Favored 'Isoleucine or valine' 0 C--N 1.348 0.512 0 C-N-CA 123.682 0.793 . . . . 0.0 109.067 -172.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.5 mt -84.85 118.54 24.55 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.5 t -149.31 130.35 14.41 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.785 0.834 . . . . 0.0 109.202 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.438 ' HG3' HD21 ' A' ' 108' ' ' LEU . 25.9 mt-10 -67.33 -15.9 63.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.745 0.818 . . . . 0.0 111.513 173.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -103.49 119.32 55.26 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 123.534 0.734 . . . . 0.0 109.099 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.42 -13.37 39.01 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.368 2.046 . . . . 0.0 112.663 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.0 mtm -82.6 -27.94 31.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.643 0.777 . . . . 0.0 111.479 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.51 -22.4 66.72 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.771 0.319 . . . . 0.0 111.545 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -71.99 -25.63 61.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.039 0.535 . . . . 0.0 110.833 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.461 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 21.2 m-85 -87.72 -27.41 22.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.822 0.449 . . . . 0.0 111.572 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.94 -29.04 55.45 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.591 0.234 . . . . 0.0 110.717 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.6 m -86.32 -46.91 9.86 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.136 0.575 . . . . 0.0 111.443 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.75 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 69.3 m-85 -116.01 -62.89 1.53 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.469 0.708 . . . . 0.0 110.082 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 72.35 -92.06 0.57 Allowed Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.019 -0.537 . . . . 0.0 113.382 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.32 -19.2 61.7 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.647 0.779 . . . . 0.0 111.064 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.75 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 23.0 mmt180 -70.67 -37.84 73.72 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.573 173.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.9 t -63.65 149.62 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.711 0.405 . . . . 0.0 110.199 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -64.03 -16.04 60.79 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.0 pt? -142.12 158.59 43.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.476 1.111 . . . . 0.0 108.686 174.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.482 HG23 ' HG3' ' A' ' 86' ' ' GLU . 13.8 t -100.44 -177.53 3.53 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.68 -35.85 79.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.535 0.734 . . . . 0.0 111.751 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.68 -44.99 94.84 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.577 0.751 . . . . 0.0 110.813 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 30.0 mt-10 -72.13 -26.38 62.09 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.68 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.537 ' HG ' ' HE3' ' A' ' 91' ' ' MET . 24.9 tp -71.36 -50.96 26.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.418 0.687 . . . . 0.0 110.785 176.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -36.66 83.13 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.542 0.337 . . . . 0.0 111.205 -173.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.67 -32.88 68.34 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 175.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.411 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 70.9 t80 -65.0 -46.46 81.3 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.716 0.807 . . . . 0.0 110.986 175.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.537 ' HE3' ' HG ' ' A' ' 87' ' ' LEU . 72.3 mtm -70.43 -39.0 74.66 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.962 0.505 . . . . 0.0 110.696 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -67.16 -32.34 73.37 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.35 0.26 . . . . 0.0 110.675 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t -65.25 -37.36 86.99 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.149 0.58 . . . . 0.0 110.66 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 89.3 mm-40 -75.7 -7.43 54.34 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 100' ' ' ARG . 10.5 pt-20 -112.6 -18.42 12.38 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 118.33 0.514 . . . . 0.0 111.57 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -100.31 -20.87 15.66 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.457 0.303 . . . . 0.0 111.463 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -117.36 -55.07 2.34 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.16 -140.44 2.84 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.304 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -155.77 102.93 2.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.292 0.637 . . . . 0.0 109.648 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.425 ' HD3' ' HB3' ' A' ' 95' ' ' GLU . 80.8 mtp180 -83.14 -72.77 0.44 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? 59.48 88.46 0.07 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.235 1.014 . . . . 0.0 109.832 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -174.79 140.31 0.56 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.053 0.941 . . . . 0.0 109.614 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.6 p -159.92 -4.61 0.06 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.571 0.748 . . . . 0.0 111.007 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -93.6 -57.63 2.52 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.713 0.805 . . . . 0.0 110.928 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -137.27 121.76 18.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.977 0.511 . . . . 0.0 111.118 -172.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.62 157.87 19.63 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.045 0.938 . . . . 0.0 111.46 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.523 ' HE2' ' HB2' ' A' ' 31' ' ' ALA . 4.3 tmtp? -85.31 145.9 27.29 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.983 0.913 . . . . 0.0 109.292 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.47 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 3.1 tm? -76.33 107.62 8.71 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 170.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -91.75 162.31 14.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.825 0.85 . . . . 0.0 109.333 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.6 ptm -141.49 131.26 24.25 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.955 0.902 . . . . 0.0 109.321 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.492 ' HB1' ' HB ' ' A' ' 64' ' ' VAL . . . -102.45 101.56 11.78 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.3 mt -80.26 115.09 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -77.96 139.83 39.2 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.407 HD11 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -119.68 131.35 55.4 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.904 0.882 . . . . 0.0 109.292 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -136.39 168.85 18.67 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.744 1.218 . . . . 0.0 109.459 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.6 t70 53.42 36.7 23.74 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.412 1.085 . . . . 0.0 111.21 168.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.69 103.71 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.739 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -90.19 108.51 19.79 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.386 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.48 ' HZ1' HG21 ' A' ' 55' ' ' VAL . 6.6 mmmt -73.5 130.46 40.15 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -78.99 120.25 23.31 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -60.91 -35.3 76.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.022 0.929 . . . . 0.0 110.349 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -116.39 147.62 39.97 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.776 1.231 . . . . 0.0 109.798 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.611 ' HB3' ' HA ' ' A' ' 52' ' ' THR . 20.3 Cg_exo -64.8 97.13 0.27 Allowed 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 123.308 2.672 . . . . 0.0 111.591 172.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.5 mt -83.25 115.53 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.9 147.64 91.55 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.72 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.455 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 91.6 Cg_endo -87.16 154.81 8.24 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.473 2.115 . . . . 0.0 112.179 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -74.01 -23.11 59.38 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.44 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -150.35 160.35 43.79 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.989 0.915 . . . . 0.0 109.342 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.8 120.62 21.42 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.7 t -94.49 109.49 43.41 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.54 179.77 6.2 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.95 2.433 . . . . 0.0 111.838 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.4 t -59.15 -32.83 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 124.2 1.0 . . . . 0.0 111.794 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.64 -16.62 72.14 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.558 -0.747 . . . . 0.0 113.641 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.04 160.62 15.17 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.119 0.39 . . . . 0.0 113.149 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -118.1 139.07 51.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.599 0.759 . . . . 0.0 109.458 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 106.91 11.79 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.49 114.12 18.17 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.07 148.96 30.72 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.253 1.239 0 CA-C-N 118.217 0.462 . . . . 0.0 110.127 172.189 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 47.0 ttp . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.5 t -56.56 -15.33 4.16 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -165.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -65.24 -20.5 66.46 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.1 mm 68.78 178.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 C-N-CA 124.612 1.165 . . . . 0.0 109.759 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -145.41 -43.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.619 1.168 . . . . 0.0 108.181 160.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.97 -159.17 15.16 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.724 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 60' ' ' ILE . 10.0 p -122.9 151.33 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -123.29 135.56 54.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.843 0.857 . . . . 0.0 109.528 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -137.47 138.88 25.81 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.556 0.742 . . . . 0.0 111.064 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HD3' HG11 ' A' ' 130' ' ' VAL . 91.0 Cg_endo -74.35 -9.57 21.77 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.76 2.307 . . . . 0.0 111.86 169.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 mm 64.83 116.64 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.638 1.575 . . . . 0.0 109.284 -175.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.56 -11.49 20.36 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.815 2.343 . . . . 0.0 113.841 -172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HE2' ' HD1' ' A' ' 90' ' ' TYR . 63.8 mttm -133.66 176.91 8.12 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.543 1.137 . . . . 0.0 110.693 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -71.99 -5.91 38.3 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.021 0.929 . . . . 0.0 112.002 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -73.43 15.13 0.27 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.2 ptp -56.7 -32.29 65.32 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 157.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.28 -45.87 35.21 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.549 1.54 . . . . 0.0 111.79 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 84.2 mmt-85 -58.08 -36.58 73.03 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.134 0.896 . . . . 0.0 112.501 -173.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' HB3' HG13 ' A' ' 117' ' ' VAL . 74.5 m-85 -66.35 -29.35 69.52 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.419 0.45 . . . . 0.0 110.565 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -98.23 -15.31 19.9 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.768 0.827 . . . . 0.0 110.928 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HB3' ' HA ' ' A' ' 18' ' ' ARG . 5.8 tmtm? -78.31 -48.06 16.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.78 1.232 . . . . 0.0 110.275 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.7 ptpt -102.55 -12.36 17.83 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.568 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.94 -14.03 59.74 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.988 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -164.0 114.72 1.3 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.834 0.854 . . . . 0.0 109.4 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 18.9 t70 -133.83 -175.37 3.81 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.1 0.96 . . . . 0.0 110.296 -162.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 113' ' ' GLU . 76.9 t -135.87 119.28 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 121.278 -0.889 . . . . 0.0 109.417 176.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -93.69 115.77 28.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.323 0.649 . . . . 0.0 109.929 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.8 m -93.68 143.56 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.838 0.827 . . . . 0.0 111.163 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.592 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.6 mmpt? -130.15 136.18 28.62 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 126.225 1.81 . . . . 0.0 108.951 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.72 55.21 5.12 Favored 'Trans proline' 0 CA--C 1.552 1.388 0 C-N-CA 122.421 2.081 . . . . 0.0 111.149 166.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.56 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.063 1.345 . . . . 0.0 112.394 -170.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.592 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 24.8 m -126.45 -50.84 1.51 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.35 107.52 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.858 0.863 . . . . 0.0 109.253 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -146.06 1.18 0.86 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.228 0.611 . . . . 0.0 111.533 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 7.6 mtpm? -64.47 -53.62 45.43 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.453 0.644 . . . . 0.0 110.275 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -109.4 -7.98 15.12 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.424 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.459 ' HA ' ' HE3' ' A' ' 41' ' ' MET . 0.1 OUTLIER -65.33 107.11 1.53 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.571 0.748 . . . . 0.0 110.872 -172.407 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.464 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -135.9 152.26 75.44 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.279 0.632 . . . . 0.0 109.909 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.06 102.5 1.08 Allowed 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.971 2.447 . . . . 0.0 111.32 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.25 -19.83 1.2 Allowed Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.666 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.464 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 30.1 mtm -74.64 -177.88 3.38 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.078 0.466 . . . . 0.0 111.234 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -104.04 163.07 12.63 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.341 0.656 . . . . 0.0 110.869 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.464 ' CB ' HD11 ' A' ' 114' ' ' LEU . 2.5 t80 -134.55 102.03 5.16 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 48.7 t -90.17 123.87 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.339 0.59 . . . . 0.0 110.137 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.36 111.43 19.42 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.743 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 76.5 t80 -83.17 136.49 34.42 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.399 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.709 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 48.4 tt0 -95.28 165.67 12.27 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.8 t -60.68 178.02 0.26 Allowed 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.736 0.814 . . . . 0.0 111.523 172.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -69.75 12.95 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.968 1.307 . . . . 0.0 113.834 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -67.01 -65.74 0.64 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.72 1.208 . . . . 0.0 110.82 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -175.02 148.99 1.05 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.311 1.045 . . . . 0.0 109.155 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.3 m 62.04 100.11 0.03 OUTLIER 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.671 1.232 . . . . 0.0 111.095 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.709 ' HA3' ' HD3' ' A' ' 126' ' ' PRO . . . -57.46 -35.81 74.14 Favored Glycine 0 C--O 1.209 -1.447 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.613 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -107.43 102.61 11.87 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.716 0.758 . . . . 0.0 110.453 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 47' ' ' GLN . 13.8 p -79.55 -19.69 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.709 0.804 . . . . 0.0 111.279 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.42 -171.45 40.94 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.093 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 21.2 pt-20 -153.82 178.95 9.33 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.788 0.835 . . . . 0.0 109.861 171.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -165.26 -171.33 2.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.705 0.802 . . . . 0.0 110.354 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -123.03 122.44 38.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.65 0.78 . . . . 0.0 111.362 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.436 HD11 HG11 ' A' ' 7' ' ' VAL . 74.6 mt -69.02 136.99 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.445 1.098 . . . . 0.0 111.224 175.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 30.9 mmmt -136.58 -167.73 2.12 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 126.877 2.071 . . . . 0.0 107.697 -177.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -39.88 112.89 0.3 Allowed 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 125.187 1.395 . . . . 0.0 113.706 -166.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.02 106.93 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 95.6 t -90.11 109.53 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.395 0.678 . . . . 0.0 109.26 -174.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.472 ' HB3' HD13 ' A' ' 108' ' ' LEU . 39.1 mt -91.26 115.98 28.46 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 t -151.66 129.66 11.79 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.781 0.832 . . . . 0.0 109.137 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.482 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 45.0 mt-10 -61.75 -21.26 64.38 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.374 0.67 . . . . 0.0 112.248 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -100.58 118.97 59.9 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HG2' HD23 ' A' ' 87' ' ' LEU . 56.3 Cg_endo -69.16 -8.69 24.29 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.956 2.437 . . . . 0.0 113.085 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 50.6 mtm -79.9 -24.72 40.94 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.383 0.673 . . . . 0.0 111.205 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.461 HE21 ' N ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -60.33 -26.49 66.61 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.607 0.763 . . . . 0.0 111.527 175.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -76.71 -20.49 56.51 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.06 0.544 . . . . 0.0 111.116 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -85.81 -38.36 18.25 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.822 0.449 . . . . 0.0 110.537 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -72.42 -23.48 61.09 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 120.34 0.114 . . . . 0.0 111.0 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.3 m -88.5 -44.33 10.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.236 0.614 . . . . 0.0 111.063 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.75 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 64.7 m-85 -118.11 -66.96 1.03 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.071 0.548 . . . . 0.0 110.332 -176.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.09 -81.21 0.68 Allowed Glycine 0 C--N 1.355 1.62 0 O-C-N 123.472 0.483 . . . . 0.0 113.304 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.89 -27.66 69.51 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.363 1.065 . . . . 0.0 111.499 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.75 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 38.6 mmt180 -81.38 -33.12 32.54 Favored 'General case' 0 C--O 1.209 -1.072 0 O-C-N 123.992 0.807 . . . . 0.0 111.975 -176.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 HD22 ' A' ' 82' ' ' LEU . 21.7 t -66.57 145.47 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 118.451 0.569 . . . . 0.0 110.459 -174.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.438 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 34.7 p90 -64.05 -17.25 63.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.446 HD22 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -140.31 158.18 44.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.3 t -95.27 179.56 5.14 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -65.51 -27.13 68.25 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.518 0.727 . . . . 0.0 111.518 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.91 -49.64 67.31 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.905 0.882 . . . . 0.0 110.506 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -62.65 -31.45 72.32 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.186 176.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.523 ' HG ' ' HE2' ' A' ' 91' ' ' MET . 46.1 tp -67.78 -52.15 40.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.433 0.693 . . . . 0.0 111.093 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -63.18 -38.58 91.73 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.234 0.334 . . . . 0.0 111.366 -174.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 13.0 pt-20 -78.88 -23.68 44.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.728 0.411 . . . . 0.0 111.343 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.403 ' HD1' ' HE2' ' A' ' 13' ' ' LYS . 56.9 t80 -66.08 -38.96 89.6 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.378 0.671 . . . . 0.0 109.97 170.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.523 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 71.6 mtm -77.57 -30.82 52.77 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.454 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.8 mmpt? -71.14 -28.83 64.56 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.397 0.279 . . . . 0.0 110.516 171.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.2 t -62.91 -31.39 72.45 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.388 0.675 . . . . 0.0 110.83 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -73.99 -22.09 59.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.546 0.738 . . . . 0.0 112.22 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -103.12 -36.04 8.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.928 0.491 . . . . 0.0 111.638 -177.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -82.38 -34.71 28.26 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.342 0.257 . . . . 0.0 111.49 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -97.68 -42.03 7.83 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.73 -159.19 26.11 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.704 172.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -156.1 155.38 32.47 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 70.94 118.45 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.933 1.293 . . . . 0.0 111.168 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.465 ' HG2' ' N ' ' A' ' 102' ' ' GLU . 44.6 ttt85 -153.48 173.45 15.67 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.021 0.928 . . . . 0.0 108.754 -176.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.465 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 44.3 mt-10 77.2 108.75 0.08 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 125.286 1.434 . . . . 0.0 110.753 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.7 m -145.51 142.03 28.83 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.467 1.107 . . . . 0.0 108.822 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -64.43 140.52 58.88 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.442 ' HE2' ' HD3' ' A' ' 106' ' ' LYS . 1.8 tpmt? 72.75 148.17 0.09 Allowed 'General case' 0 N--CA 1.482 1.14 0 O-C-N 125.056 1.472 . . . . 0.0 110.301 -166.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -101.6 166.25 10.8 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.087 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 4.2 tmtp? -86.24 140.11 30.43 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' A' ' 65' ' ' LEU . 2.8 tm? -74.28 107.83 6.69 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -89.04 161.85 16.33 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.552 0.741 . . . . 0.0 109.533 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.465 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 15.1 ptm -145.56 131.04 18.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.822 0.849 . . . . 0.0 109.781 -175.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . . . -106.58 101.97 11.38 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.222 0.609 . . . . 0.0 109.56 -178.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.2 mt -78.4 115.46 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -80.95 133.75 35.58 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -177.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 58' ' ' ALA . 3.3 mm? -122.92 122.3 38.25 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.455 0.702 . . . . 0.0 111.279 -174.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -124.41 165.23 18.1 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.572 0.749 . . . . 0.0 110.313 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.0 t70 50.23 53.25 13.2 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.124 1.37 . . . . 0.0 111.29 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 19' ' ' PHE . 41.9 t -74.7 101.45 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.671 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -81.74 146.27 30.06 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.526 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.699 ' HZ1' HG23 ' A' ' 55' ' ' VAL . 19.6 mmmt -101.3 134.86 43.72 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.626 0.771 . . . . 0.0 109.337 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -86.43 88.14 7.57 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 170.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.24 -26.04 63.66 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.649 0.738 . . . . 0.0 109.066 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -81.24 135.98 50.19 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.645 173.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.06 91.94 1.15 Allowed 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.793 2.329 . . . . 0.0 112.573 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.5 mt -105.36 125.11 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.443 0.639 . . . . 0.0 110.651 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.63 148.35 34.46 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.703 1.201 . . . . 0.0 109.338 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.709 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 64.2 Cg_endo -77.9 178.43 7.61 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.194 2.596 . . . . 0.0 113.562 -170.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -84.74 -38.65 19.42 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.131 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -142.22 166.24 25.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.067 0.547 . . . . 0.0 110.832 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.79 134.93 53.14 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 124.236 0.96 . . . . 0.0 109.779 174.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.45 HG11 ' HD3' ' A' ' 10' ' ' PRO . 41.0 t -118.29 102.23 50.62 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.93 178.9 2.55 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.326 2.684 . . . . 0.0 112.249 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.4 t -60.19 -31.74 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.77 0.828 . . . . 0.0 111.07 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.49 -12.53 77.28 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 115.572 -0.74 . . . . 0.0 114.287 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.65 157.83 16.96 Favored Glycine 0 C--N 1.35 1.357 0 C-N-CA 123.035 0.35 . . . . 0.0 113.662 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -117.83 147.23 43.25 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.709 0.803 . . . . 0.0 110.394 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -77.85 112.63 14.92 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 167.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.66 128.94 34.01 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -138.05 134.98 35.42 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.77 0.428 . . . . 0.0 110.521 -176.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 . . . . . 0 C--O 1.25 1.089 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.779 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 t -63.77 -11.09 23.6 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.544 1.137 . . . . 0.0 113.196 -172.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -59.47 -21.54 60.22 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.9 mm 64.5 -173.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.599 0 C-N-CA 124.045 0.938 . . . . 0.0 108.55 -174.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.1 m -152.43 -42.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 158.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.63 -159.69 16.03 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.611 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 11.6 p -126.63 152.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 171.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 t -123.72 134.57 53.67 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -127.37 151.08 74.25 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.519 0.728 . . . . 0.0 110.01 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.558 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 56.8 Cg_endo -65.87 -34.46 39.31 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.854 2.369 . . . . 0.0 111.868 175.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.4 mm 67.62 132.98 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.935 1.294 . . . . 0.0 111.198 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.23 110.66 0.68 Allowed 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 121.832 1.688 . . . . 0.0 109.74 165.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 16' ' ' MET . 19.3 pttp -68.77 -3.89 13.98 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -174.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -66.83 -40.52 88.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.602 1.161 . . . . 0.0 109.063 170.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -116.54 16.52 15.54 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.316 1.046 . . . . 0.0 112.0 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.758 ' HB2' ' HA ' ' A' ' 13' ' ' LYS . 56.6 ttp -62.27 -47.04 86.12 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.087 0.555 . . . . 0.0 110.426 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.66 -2.48 20.27 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.906 -175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 1.9 mmm180 -63.19 -49.77 72.94 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.052 0.541 . . . . 0.0 110.3 173.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 51.1 m-85 -61.93 -29.08 69.99 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 124.007 0.817 . . . . 0.0 110.395 -178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -96.97 -12.86 22.82 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.205 1.002 . . . . 0.0 111.527 -174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.69 -50.18 14.3 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.842 0.857 . . . . 0.0 109.479 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.4 ptpt -101.07 -16.64 17.02 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.06 -169.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.87 -11.32 48.16 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-O 119.839 -0.423 . . . . 0.0 114.118 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -159.73 117.54 2.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.028 0.931 . . . . 0.0 109.428 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.46 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 17.9 t70 -124.88 -176.21 3.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.248 1.019 . . . . 0.0 109.307 -172.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -132.27 110.33 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.148 0.979 . . . . 0.0 108.791 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -90.54 109.25 20.4 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 110.0 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.4 m -85.8 129.03 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.545 0.688 . . . . 0.0 111.121 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -112.65 142.42 27.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.896 1.278 . . . . 0.0 109.518 170.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.41 46.23 2.07 Favored 'Trans proline' 0 C--N 1.367 1.5 0 C-N-CA 122.692 2.262 . . . . 0.0 112.16 168.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.21 86.42 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.201 1.401 . . . . 0.0 112.495 -172.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -122.31 7.43 9.63 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.595 0.758 . . . . 0.0 109.842 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.42 ' HB ' ' OH ' ' A' ' 136' ' ' TYR . 14.1 m -127.92 150.16 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.385 1.074 . . . . 0.0 109.776 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -80.9 -172.81 3.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.307 0.643 . . . . 0.0 110.99 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -73.1 9.53 1.19 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -71.61 -29.43 64.67 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.875 0.47 . . . . 0.0 109.845 172.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.42 ' HA ' ' HE3' ' A' ' 41' ' ' MET . 0.3 OUTLIER -65.89 104.85 1.17 Allowed 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.055 0.542 . . . . 0.0 110.053 179.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.5 153.65 77.86 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 123.279 0.632 . . . . 0.0 109.784 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.81 97.12 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.761 2.307 . . . . 0.0 111.094 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.45 43.48 0.1 OUTLIER Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.495 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.42 ' HE3' ' HA ' ' A' ' 37' ' ' LEU . 32.5 mtm -126.94 -171.59 2.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.79 0.836 . . . . 0.0 109.525 174.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.6 ptpt -112.7 158.54 19.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.276 0.63 . . . . 0.0 110.251 169.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.55 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.2 t80 -135.67 101.25 4.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 40.7 t -86.18 130.18 36.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -95.56 112.69 24.36 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.258 0.623 . . . . 0.0 109.455 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 90.1 t80 -75.11 150.32 38.83 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -82.64 72.28 9.72 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -177.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.629 ' HB3' ' HB3' ' A' ' 13' ' ' LYS . 92.1 p 51.37 -76.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 127.174 2.19 . . . . 0.0 114.627 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -170.82 176.0 4.31 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 124.542 1.137 . . . . 0.0 108.738 -172.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 71.63 -69.89 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.383 1.473 . . . . 0.0 111.038 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -69.37 118.13 11.86 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.476 0.711 . . . . 0.0 109.342 172.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.465 HG21 ' HD2' ' A' ' 126' ' ' PRO . 12.7 m -82.28 78.09 8.99 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.62 0.724 . . . . 0.0 109.414 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.537 ' HA2' ' HD3' ' A' ' 126' ' ' PRO . . . -165.14 162.35 35.63 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.186 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.451 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 62.9 m-85 -95.18 147.35 23.54 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.719 0.408 . . . . 0.0 110.059 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG11 ' SD ' ' A' ' 16' ' ' MET . 3.3 p -87.31 -30.12 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.661 0.784 . . . . 0.0 110.471 174.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.4 -157.76 20.37 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 120.062 -0.299 . . . . 0.0 112.768 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 16.2 pt-20 -154.17 178.61 9.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.179 0.992 . . . . 0.0 109.293 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 114' ' ' LEU . . . -166.76 -172.66 2.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.01 0.924 . . . . 0.0 110.177 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 61.4 mmt-85 -128.22 125.5 39.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.858 0.863 . . . . 0.0 109.69 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.55 HG13 ' HB2' ' A' ' 43' ' ' PHE . 41.3 mt -73.63 137.08 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.199 1.0 . . . . 0.0 111.767 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -134.94 -176.88 4.39 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 126.879 2.072 . . . . 0.0 108.081 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -30.96 112.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.932 1.693 . . . . 0.0 114.328 -170.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -91.61 106.26 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -88.22 110.78 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.4 mt -92.59 119.86 32.46 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.366 0.666 . . . . 0.0 109.436 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.2 t -151.51 134.24 15.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 44.4 mt-10 -74.67 -0.98 19.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.797 0.839 . . . . 0.0 112.299 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.64 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 12.9 m-80 -112.66 120.16 41.62 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.2 -20.84 55.89 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.342 2.028 . . . . 0.0 112.345 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 65.4 mtm -71.79 -24.63 61.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.184 0.994 . . . . 0.0 111.091 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.64 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 36.4 mm-40 -62.58 -28.89 70.19 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.875 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -76.31 -20.06 57.65 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.728 0.411 . . . . 0.0 111.185 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.402 ' HE2' HD22 ' A' ' 87' ' ' LEU . 87.7 m-85 -93.45 -19.56 21.14 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.9 0.48 . . . . 0.0 111.09 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 9.1 pt-20 -84.8 -30.4 24.62 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.808 0.276 . . . . 0.0 110.573 168.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.3 m -80.39 -58.9 2.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.953 0.501 . . . . 0.0 110.644 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.649 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 85.8 m-85 -100.85 -69.68 0.77 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.73 -78.03 0.5 Allowed Glycine 0 C--N 1.353 1.516 0 O-C-N 123.5 0.5 . . . . 0.0 112.622 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.85 -44.68 91.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.756 1.222 . . . . 0.0 111.463 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.649 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 61.1 mmt-85 -64.97 -30.17 71.14 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.677 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.73 149.79 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.563 0.745 . . . . 0.0 111.142 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -65.5 -41.4 93.23 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.088 0.555 . . . . 0.0 112.355 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -109.55 169.03 8.97 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.46 HG21 ' HG2' ' A' ' 86' ' ' GLU . 8.8 t -98.26 168.36 10.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 172.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -68.17 -25.69 65.38 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.201 0.524 . . . . 0.0 111.375 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.7 -52.57 65.11 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.519 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HG2' HG21 ' A' ' 83' ' ' THR . 48.6 mm-40 -57.78 -35.11 70.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.736 0.414 . . . . 0.0 110.78 176.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.409 ' HG ' ' HE1' ' A' ' 91' ' ' MET . 26.5 tp -62.12 -57.27 12.19 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.945 0.898 . . . . 0.0 111.56 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -38.72 85.53 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -172.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -79.16 -27.48 42.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.688 0.395 . . . . 0.0 111.512 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -65.92 -41.67 91.08 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.269 0.628 . . . . 0.0 110.267 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.409 ' HE1' ' HG ' ' A' ' 87' ' ' LEU . 62.5 mtm -72.1 -30.03 64.68 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.763 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -73.86 -33.94 64.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.97 0.508 . . . . 0.0 110.678 171.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 m -65.09 -26.6 68.29 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.359 0.663 . . . . 0.0 111.441 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -64.47 -47.15 80.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.616 0.366 . . . . 0.0 110.454 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.43 -30.33 23.64 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -172.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -82.35 -42.65 18.44 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.461 0.573 . . . . 0.0 111.864 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -84.2 -20.82 31.71 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.504 0.322 . . . . 0.0 110.855 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.9 -97.12 0.26 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -149.79 -64.61 0.22 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.602 1.161 . . . . 0.0 108.46 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -169.23 158.19 8.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.979 1.312 . . . . 0.0 109.308 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -159.79 116.6 2.56 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.76 162.85 22.76 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.412 1.085 . . . . 0.0 110.031 -175.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.4 m -54.25 -57.37 11.47 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.72 0.637 . . . . 0.0 110.323 176.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.454 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 6.8 mmpt? 50.35 -84.18 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.289 1.435 . . . . 0.0 112.778 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.624 ' HG3' ' HD2' ' A' ' 106' ' ' LYS . 1.0 OUTLIER -156.18 159.03 38.61 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.994 0.918 . . . . 0.0 109.33 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.624 ' HD2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -72.52 170.31 14.63 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.787 175.086 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.595 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -124.28 144.4 50.0 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.047 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.595 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 2.9 tm? -68.41 108.31 3.21 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -97.1 161.14 13.96 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.0 ptm -143.94 131.22 20.81 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.668 0.787 . . . . 0.0 109.568 -174.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.34 101.97 11.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.566 0.746 . . . . 0.0 109.107 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.9 mt -80.2 120.36 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -83.93 139.24 32.71 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 58' ' ' ALA . 3.8 mm? -120.69 121.28 37.93 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.616 1.167 . . . . 0.0 109.026 -177.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -113.94 171.34 7.65 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.011 0.924 . . . . 0.0 108.894 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.4 t70 52.07 46.79 26.01 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.365 1.066 . . . . 0.0 112.167 166.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.9 t -74.88 108.25 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.534 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.76 153.68 20.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.004 0.922 . . . . 0.0 110.302 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -108.26 136.69 47.49 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.739 0.816 . . . . 0.0 110.379 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.451 ' HD2' ' HB2' ' A' ' 54' ' ' PHE . 10.1 m-30 -95.93 78.8 3.23 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.613 0.765 . . . . 0.0 109.128 172.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.95 -24.96 63.43 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.903 169.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.54 ' HG3' HG13 ' A' ' 124' ' ' ILE . 18.5 ptpt -81.7 145.57 54.61 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.385 1.074 . . . . 0.0 109.344 171.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.81 77.26 3.97 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.936 2.424 . . . . 0.0 113.076 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.54 HG13 ' HG3' ' A' ' 122' ' ' LYS . 54.2 mt -86.37 128.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.419 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -109.3 146.48 34.02 Favored Pre-proline 0 C--O 1.242 0.668 0 C-N-CA 123.943 0.897 . . . . 0.0 109.351 -177.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.537 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 10.3 Cg_exo -73.26 147.04 41.45 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 122.879 2.386 . . . . 0.0 112.397 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -70.12 -26.49 63.98 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.647 0.779 . . . . 0.0 109.273 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -144.62 159.23 43.16 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.202 1.001 . . . . 0.0 109.439 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.5 133.21 38.62 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.0 t -105.85 95.31 10.42 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.45 -175.48 2.7 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.056 2.504 . . . . 0.0 111.957 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.538 ' HA ' ' HG3' ' A' ' 10' ' ' PRO . 27.1 m -57.74 -26.63 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.331 1.052 . . . . 0.0 113.816 -174.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.14 -22.22 74.24 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.259 0.349 . . . . 0.0 113.607 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.08 149.0 8.19 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 112.362 -0.295 . . . . 0.0 112.362 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -108.8 135.94 49.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.508 0.723 . . . . 0.0 109.829 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.42 ' OH ' ' HB ' ' A' ' 33' ' ' VAL . 1.6 m-85 -76.26 109.74 10.2 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.72 114.14 18.41 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 138.82 53.77 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.475 178.655 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 121.539 0.685 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -73.93 -17.46 61.02 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.915 -166.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -67.23 -16.32 64.22 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.1 mm 65.73 -171.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.49 -39.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 157.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.472 ' HA2' ' HE2' ' A' ' 41' ' ' MET . . . -167.52 -164.35 23.04 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.438 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.458 HG12 HD13 ' A' ' 60' ' ' ILE . 10.9 p -132.08 144.43 37.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 t -113.87 137.64 51.39 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -132.66 145.12 55.8 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.884 0.874 . . . . 0.0 109.21 178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HD3' HG11 ' A' ' 130' ' ' VAL . 30.2 Cg_endo -61.96 -25.04 77.54 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.962 2.442 . . . . 0.0 112.016 173.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.9 mm 68.75 134.03 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.057 1.343 . . . . 0.0 111.913 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -54.62 114.43 1.84 Allowed 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.546 2.164 . . . . 0.0 110.25 169.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -63.47 -28.03 69.68 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.287 1.035 . . . . 0.0 113.436 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -61.43 -36.24 79.8 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.146 0.498 . . . . 0.0 110.46 172.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -107.91 19.15 20.42 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.143 -172.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -66.94 -32.78 74.26 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.626 0.77 . . . . 0.0 110.153 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.32 -33.87 77.0 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.238 1.015 . . . . 0.0 112.195 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 81' ' ' PHE . 11.0 mmt180 -54.09 -52.92 59.47 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.655 1.182 . . . . 0.0 113.277 -164.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.507 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 47.9 m-85 -60.24 -29.36 68.71 Favored 'General case' 0 CA--C 1.554 1.104 0 O-C-N 124.121 0.888 . . . . 0.0 110.743 -174.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -94.7 -24.76 17.0 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.415 1.086 . . . . 0.0 110.674 -176.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.22 -42.73 79.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.92 1.288 . . . . 0.0 111.028 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.7 ptpt -109.33 -16.43 14.04 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.238 -171.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.93 -14.85 9.35 Favored Glycine 0 N--CA 1.479 1.503 0 N-CA-C 114.191 0.436 . . . . 0.0 114.191 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -150.06 105.64 3.4 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.668 1.187 . . . . 0.0 108.94 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.5 t70 -107.32 174.73 5.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 110.585 -175.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -133.88 109.07 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.435 ' HA ' ' HD1' ' A' ' 81' ' ' PHE . 76.9 t80 -91.12 108.92 20.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.337 0.655 . . . . 0.0 109.577 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 m -94.45 132.93 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.516 0.674 . . . . 0.0 110.673 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.631 ' HD3' ' HD2' ' A' ' 30' ' ' PRO . 14.9 tppt? -134.84 133.24 20.94 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.349 1.06 . . . . 0.0 108.793 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.631 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 59.5 Cg_endo -71.73 66.97 3.07 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.669 2.246 . . . . 0.0 113.2 172.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 55.07 17.02 1.74 Allowed 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.158 1.383 . . . . 0.0 114.672 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 m -70.32 -28.37 65.11 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.225 0.61 . . . . 0.0 110.875 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.447 HG21 ' HG2' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -87.6 148.62 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.344 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.475 ' HB2' ' HH ' ' A' ' 136' ' ' TYR . 63.0 m95 -87.72 -168.11 2.11 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.173 0.589 . . . . 0.0 110.917 -175.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -74.58 -1.25 20.68 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -170.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.11 -30.59 70.45 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.967 0.507 . . . . 0.0 110.815 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.84 98.38 0.73 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.29 1.036 . . . . 0.0 111.55 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.433 ' HG3' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -122.28 156.27 60.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.835 1.254 . . . . 0.0 108.883 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.82 107.0 2.11 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.256 1.971 . . . . 0.0 111.472 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.45 31.65 0.46 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.225 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.613 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 88.8 mtp -112.55 -173.99 2.36 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.911 0.884 . . . . 0.0 110.669 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.453 ' HG3' ' HA3' ' A' ' 6' ' ' GLY . 15.2 ptpt -116.85 156.44 27.3 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.387 1.075 . . . . 0.0 109.599 172.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.512 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -136.05 100.15 4.34 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 177.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.1 t -86.3 124.42 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.245 0.545 . . . . 0.0 110.131 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.403 ' HE2' HG13 ' A' ' 117' ' ' VAL . 25.7 m-85 -89.4 106.7 18.62 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.633 0.773 . . . . 0.0 109.876 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.43 ' HA ' ' CD1' ' A' ' 54' ' ' PHE . 78.3 t80 -77.94 155.92 30.55 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.94 1.4 . . . . 0.0 111.401 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 56.04 -172.19 0.07 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.282 1.833 . . . . 0.0 111.588 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.4 t -165.91 -164.06 0.68 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.246 0.618 . . . . 0.0 109.65 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -56.88 -37.97 72.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.668 0.787 . . . . 0.0 110.359 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -127.26 175.58 8.06 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.945 0.898 . . . . 0.0 110.436 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -77.23 82.94 3.71 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.786 0.834 . . . . 0.0 109.553 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.7 p -121.76 7.92 9.97 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.141 0.976 . . . . 0.0 111.505 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.42 -67.59 3.04 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.238 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 46' ' ' TYR . 98.4 m-85 -132.44 174.01 10.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.249 1.019 . . . . 0.0 109.947 175.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.31 -34.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.784 0.834 . . . . 0.0 110.449 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.13 -160.04 23.37 Favored Glycine 0 C--N 1.35 1.355 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.972 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 118' ' ' LYS . 7.3 pt-20 -152.19 177.55 10.41 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.69 1.196 . . . . 0.0 109.526 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.477 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.59 -172.3 3.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.938 0.895 . . . . 0.0 110.035 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.8 mmt-85 -123.91 122.3 37.61 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.802 0.841 . . . . 0.0 109.952 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 41' ' ' MET . 36.3 mt -74.56 128.49 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.856 0.862 . . . . 0.0 109.86 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.547 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 31.6 mmmt -132.49 -167.96 1.98 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 125.433 1.493 . . . . 0.0 107.609 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -41.7 113.22 0.4 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.702 1.201 . . . . 0.0 113.69 -163.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.18 111.91 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.738 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.7 109.68 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.19 117.84 26.2 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -148.62 127.39 12.56 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.316 1.047 . . . . 0.0 109.052 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 34.7 mt-10 -65.68 -20.94 66.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.607 0.763 . . . . 0.0 111.921 176.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -99.81 118.0 62.57 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.447 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 40.6 Cg_endo -67.47 -18.6 49.3 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.196 1.931 . . . . 0.0 112.855 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.447 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.2 mpp? -73.63 -25.63 60.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.754 0.421 . . . . 0.0 111.008 -173.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -64.4 -22.78 67.07 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.691 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -78.3 -30.83 48.55 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.022 0.529 . . . . 0.0 110.93 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.474 ' CE2' HD22 ' A' ' 87' ' ' LEU . 92.7 m-85 -82.74 -16.11 49.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.664 0.386 . . . . 0.0 111.915 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.83 -32.03 16.23 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.668 0.213 . . . . 0.0 110.794 171.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 92.8 m -76.75 -41.42 44.93 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 120.848 0.356 . . . . 0.0 111.109 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.692 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 44.0 m-85 -117.83 -67.29 1.0 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.426 0.69 . . . . 0.0 109.219 -175.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.06 -97.84 2.1 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.105 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.71 -22.15 61.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.8 0.44 . . . . 0.0 110.855 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.692 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 31.8 mmt180 -59.91 -37.78 80.42 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.007 0.523 . . . . 0.0 111.294 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.455 HG13 HD22 ' A' ' 82' ' ' LEU . 39.0 t -62.74 145.08 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 O-C-N 123.729 0.643 . . . . 0.0 109.767 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.467 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 41.2 p90 -60.06 -20.1 56.32 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.455 HD22 HG13 ' A' ' 80' ' ' VAL . 1.9 pt? -133.56 164.87 26.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.6 t -98.36 176.33 5.74 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.645 0.657 . . . . 0.0 109.435 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -61.63 -29.44 70.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.195 0.598 . . . . 0.0 111.196 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.96 -45.83 80.34 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.954 0.902 . . . . 0.0 111.409 174.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.4 -36.34 83.4 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.183 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.474 HD22 ' CE2' ' A' ' 73' ' ' PHE . 27.1 tp -60.56 -54.81 40.93 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.469 0.708 . . . . 0.0 110.985 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -64.03 -42.51 97.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.158 -172.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -70.28 -31.11 68.33 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.35 0.26 . . . . 0.0 110.729 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.426 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 76.0 t80 -65.09 -43.62 91.52 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.652 0.781 . . . . 0.0 110.482 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.46 ' HE3' ' HG ' ' A' ' 87' ' ' LEU . 61.4 mtm -74.82 -31.65 61.74 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.365 0.666 . . . . 0.0 110.824 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 31.9 mmmt -69.76 -28.09 65.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.126 0.571 . . . . 0.0 110.691 172.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.7 m -74.32 -41.33 61.28 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.965 0.506 . . . . 0.0 110.045 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 90.1 mm-40 -60.74 -46.28 91.04 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.658 0.383 . . . . 0.0 111.565 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.82 -24.86 65.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.862 0.465 . . . . 0.0 112.143 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -97.22 -30.71 12.83 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.69 0.396 . . . . 0.0 111.402 -174.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -89.19 -26.05 21.46 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.692 0.397 . . . . 0.0 111.092 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -155.12 -148.45 5.01 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? 66.58 101.25 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.679 1.192 . . . . 0.0 111.653 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -73.95 -68.57 0.5 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.376 0.67 . . . . 0.0 110.465 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -155.22 103.55 2.37 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -79.31 -168.38 1.49 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.585 0.754 . . . . 0.0 112.15 -170.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -61.25 -11.62 10.2 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.477 1.111 . . . . 0.0 113.876 -171.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.9 tptt 62.63 26.85 15.9 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 123.037 1.399 . . . . 0.0 109.316 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.518 ' HG3' ' HD2' ' A' ' 106' ' ' LYS . 1.1 tpmt? -163.61 162.76 24.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.64 -174.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HD2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -71.62 147.21 47.79 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -93.38 150.28 20.58 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.0 0.52 . . . . 0.0 109.728 178.083 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 3.1 tm? -69.29 122.95 19.91 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -106.04 156.25 18.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.489 0.715 . . . . 0.0 109.348 171.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.7 ptm -131.57 129.17 40.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.093 0.957 . . . . 0.0 108.828 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.69 102.24 11.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.443 HG23 HG22 ' A' ' 60' ' ' ILE . 33.8 mt -82.61 121.31 35.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.14 101.43 8.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.1 mm? -87.11 120.56 28.51 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 122.902 0.481 . . . . 0.0 109.779 175.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.547 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 2.1 pp20? -138.34 168.8 18.98 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.1 t70 60.76 30.05 19.42 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.781 0.833 . . . . 0.0 110.654 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.403 HG13 ' HE2' ' A' ' 45' ' ' PHE . 61.0 t -61.19 118.11 3.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.219 -171.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.501 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . 1.6 tpmt? -102.01 152.39 21.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.069 0.947 . . . . 0.0 110.654 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -106.07 138.54 42.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.985 0.914 . . . . 0.0 109.396 174.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -87.18 90.68 8.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.05 -34.63 77.98 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.695 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -85.76 139.37 35.28 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.196 172.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.35 89.15 1.37 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.794 2.329 . . . . 0.0 111.742 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 21.2 mt -72.42 130.24 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.096 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 142.92 57.64 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.014 0.526 . . . . 0.0 109.623 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.02 155.74 19.93 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.404 2.069 . . . . 0.0 113.307 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -74.21 -25.83 59.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.825 173.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -170.49 173.6 5.49 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.194 0.998 . . . . 0.0 109.697 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -67.14 128.18 35.4 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 166.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.447 HG11 ' HD3' ' A' ' 10' ' ' PRO . 78.9 t -101.03 103.63 26.71 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.87 -177.81 1.74 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.229 2.619 . . . . 0.0 113.33 -174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.0 m -61.46 -27.19 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.981 0.913 . . . . 0.0 112.639 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.7 -15.32 75.94 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.183 0.302 . . . . 0.0 113.12 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.28 169.21 39.47 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.351 0.501 . . . . 0.0 112.928 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -120.65 146.51 46.33 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.008 0.923 . . . . 0.0 109.783 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.475 ' HH ' ' HB2' ' A' ' 34' ' ' TRP . 48.0 m-85 -87.51 118.18 26.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.015 0.526 . . . . 0.0 110.141 173.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tt -84.7 128.0 34.38 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 172.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.1 136.96 46.15 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.794 0.438 . . . . 0.0 110.516 -175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 CA--C 1.554 1.133 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.414 177.92 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.48 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 14.7 tpt . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.4 t -54.18 -18.36 3.73 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.721 1.208 . . . . 0.0 114.1 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -61.03 -21.52 63.69 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.439 1.096 . . . . 0.0 113.545 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.41 HG23 ' N ' ' A' ' 5' ' ' VAL . 26.2 mm 66.25 -174.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 124.408 1.083 . . . . 0.0 109.596 -175.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' N ' HG23 ' A' ' 4' ' ' ILE . 2.7 m -154.73 -40.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 125.269 1.427 . . . . 0.0 108.511 158.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.15 -159.15 14.15 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.204 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 12.6 p -126.68 160.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 t -135.41 139.59 44.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.276 0.63 . . . . 0.0 109.864 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -136.65 142.2 38.19 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.011 0.924 . . . . 0.0 109.789 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HB3' ' HD2' ' A' ' 46' ' ' TYR . 47.9 Cg_endo -69.03 -35.56 14.53 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.694 2.263 . . . . 0.0 111.226 168.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.7 mt 61.23 100.95 0.04 OUTLIER Pre-proline 0 C--N 1.361 1.098 0 C-N-CA 125.523 1.529 . . . . 0.0 110.928 -175.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.73 -179.4 2.87 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.456 2.104 . . . . 0.0 111.451 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HG3' ' H ' ' A' ' 14' ' ' ARG . 31.8 tptt 67.86 -176.38 0.2 Allowed 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.744 0.818 . . . . 0.0 109.703 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.535 ' H ' ' HG3' ' A' ' 13' ' ' LYS . 79.8 mtp180 -76.79 -15.09 59.84 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.316 0.646 . . . . 0.0 112.245 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.512 ' CZ ' ' HG2' ' A' ' 86' ' ' GLU . 11.5 m-30 -74.28 7.52 2.76 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -165.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.606 ' SD ' HG11 ' A' ' 55' ' ' VAL . 18.2 tmm? -67.7 -44.54 77.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.217 0.607 . . . . 0.0 109.584 168.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.07 -15.71 63.51 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.859 0.864 . . . . 0.0 113.088 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 20.4 mmt180 -51.82 -50.9 59.92 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.138 0.975 . . . . 0.0 111.685 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.6 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 22.5 m-85 -62.33 -29.03 70.16 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.294 -170.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -93.06 -29.09 15.98 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.322 1.049 . . . . 0.0 110.411 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -63.06 -46.39 87.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.019 0.928 . . . . 0.0 110.638 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.6 ptpt -101.88 -15.35 16.9 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.356 -172.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.11 -7.71 27.99 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -159.31 107.14 1.78 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.6 1.16 . . . . 0.0 108.279 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.6 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.4 t70 -115.68 177.61 4.61 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.984 0.913 . . . . 0.0 109.773 -176.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -132.65 108.98 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -87.93 107.38 18.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 0.0 109.917 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 m -90.07 125.76 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 121.566 0.698 . . . . 0.0 110.906 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.587 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 7.4 mmpt? -108.96 131.58 21.71 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.924 1.29 . . . . 0.0 109.606 174.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.13 54.55 4.97 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.066 2.511 . . . . 0.0 112.267 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 57.6 87.17 0.07 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.609 1.164 . . . . 0.0 111.001 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.587 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 29.1 m -130.65 -68.72 0.68 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.49 0.716 . . . . 0.0 109.344 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -109.0 106.74 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -137.2 -10.67 1.7 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.234 1.014 . . . . 0.0 110.391 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -64.78 -55.7 18.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.211 1.004 . . . . 0.0 110.651 -170.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -102.41 -9.01 20.65 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.085 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.45 ' HA ' ' HE2' ' A' ' 41' ' ' MET . 0.1 OUTLIER -66.95 110.7 3.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.137 0.575 . . . . 0.0 110.979 -173.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.483 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -139.12 150.81 66.12 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.125 0.57 . . . . 0.0 109.476 177.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 105.85 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.838 2.359 . . . . 0.0 111.329 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.1 -17.93 1.74 Allowed Glycine 0 N--CA 1.467 0.716 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.417 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.483 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 29.2 mtm -75.28 -179.82 4.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.547 0.689 . . . . 0.0 111.418 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -106.63 161.69 14.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.931 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -137.24 104.73 5.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.97 134.77 27.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -97.67 102.49 14.26 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.462 ' HD2' ' HB3' ' A' ' 10' ' ' PRO . 88.1 t80 -70.4 153.42 43.0 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.083 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 69.12 143.47 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.523 1.129 . . . . 0.0 111.222 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.63 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 48.1 m -105.03 178.66 4.5 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.064 0.546 . . . . 0.0 110.77 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -64.07 92.44 0.08 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.527 0.731 . . . . 0.0 109.355 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 75.46 -51.26 0.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.271 1.828 . . . . 0.0 111.95 -167.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.04 162.17 14.63 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.13 0.972 . . . . 0.0 112.977 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.3 m -98.23 142.28 30.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.537 1.135 . . . . 0.0 111.02 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.486 ' HA2' ' HD3' ' A' ' 126' ' ' PRO . . . 137.81 -114.02 1.05 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 176.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HE2' ' HA ' ' A' ' 126' ' ' PRO . 90.7 m-85 -144.56 140.63 28.92 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.248 1.019 . . . . 0.0 108.27 174.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.63 ' HB ' ' HA ' ' A' ' 48' ' ' SER . 7.3 p -90.11 -34.19 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.697 0.399 . . . . 0.0 111.289 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.06 -160.22 26.36 Favored Glycine 0 C--N 1.345 1.055 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.425 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -149.93 176.95 10.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.288 1.035 . . . . 0.0 109.215 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 114' ' ' LEU . . . -167.01 -179.02 4.44 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.977 0.911 . . . . 0.0 110.44 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -120.34 125.33 47.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.621 0.768 . . . . 0.0 110.49 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.17 130.72 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.54 1.136 . . . . 0.0 110.822 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -126.74 -178.86 4.54 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 125.381 1.472 . . . . 0.0 108.94 176.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -29.76 113.62 0.09 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.358 1.863 . . . . 0.0 114.562 -172.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.76 109.09 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.643 0.735 . . . . 0.0 109.06 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 96.6 t -87.86 109.41 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.2 mt -89.48 121.65 31.91 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.536 0.734 . . . . 0.0 109.399 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 t -149.79 140.31 22.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.502 0.721 . . . . 0.0 110.07 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 25.6 mt-10 -80.15 -9.4 59.71 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.519 177.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.519 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 73.7 m-20 -112.12 119.76 43.32 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 169.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 38.3 Cg_endo -67.38 -15.22 45.06 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.903 2.402 . . . . 0.0 113.056 174.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.434 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.5 mpp? -74.41 -22.87 58.95 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.22 0.608 . . . . 0.0 111.013 -176.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.519 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 56.8 mt-30 -69.28 -26.51 64.79 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.628 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -71.58 -20.46 62.0 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.77 0.428 . . . . 0.0 111.312 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.425 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 24.9 m-85 -88.01 -39.99 14.23 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.828 0.451 . . . . 0.0 110.766 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 13.1 pt-20 -69.28 -27.59 65.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 120.542 0.21 . . . . 0.0 110.575 174.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.0 m -82.89 -61.29 1.91 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 123.042 0.537 . . . . 0.0 110.612 177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.701 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 56.0 m-85 -102.62 -67.78 0.86 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.215 0.606 . . . . 0.0 109.715 -177.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 75.3 -87.33 0.8 Allowed Glycine 0 C--N 1.352 1.436 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.656 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -56.25 -36.52 68.62 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.019 1.327 . . . . 0.0 111.732 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.701 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 34.4 mmt180 -69.35 -36.95 77.38 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.062 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.469 HG12 HD22 ' A' ' 82' ' ' LEU . 21.2 t -64.6 148.97 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -65.35 -8.64 19.34 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.2 pt? -149.79 168.71 22.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.936 0.895 . . . . 0.0 109.11 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 t -112.36 -176.5 2.93 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 172.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -59.69 -33.66 71.88 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.67 0.788 . . . . 0.0 111.922 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -62.69 -43.33 99.08 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.052 0.541 . . . . 0.0 111.222 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 1.6 mp0 -73.0 -25.16 60.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.505 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.533 ' HG ' ' HE2' ' A' ' 91' ' ' MET . 53.6 tp -70.69 -48.89 52.37 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.835 0.454 . . . . 0.0 110.491 176.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -65.76 -39.2 90.8 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.31 0.381 . . . . 0.0 110.964 -176.176 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 6.2 pt-20 -69.79 -33.29 72.17 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.025 0.203 . . . . 0.0 110.828 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.46 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 55.7 t80 -67.16 -43.8 81.37 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.197 0.599 . . . . 0.0 110.522 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.533 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 73.7 mtm -71.06 -40.15 71.82 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.421 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.0 mmpt? -67.26 -30.74 70.71 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 119.803 -0.142 . . . . 0.0 110.64 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.2 t -60.99 -44.65 97.09 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.753 0.821 . . . . 0.0 110.815 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 82.5 mm-40 -75.11 -1.81 24.74 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.688 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.481 ' HB3' ' HG2' ' A' ' 100' ' ' ARG . 11.7 pt-20 -121.85 -22.37 5.78 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 175.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 15.1 ptp180 -88.25 -49.54 6.92 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 118.44 0.564 . . . . 0.0 109.621 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -81.15 -38.52 27.03 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -90.77 -138.91 7.8 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.255 175.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -165.33 133.86 3.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.055 0.542 . . . . 0.0 110.294 -174.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.481 ' HG2' ' HB3' ' A' ' 95' ' ' GLU . 8.5 ptp85 -166.84 148.83 6.23 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.846 0.858 . . . . 0.0 109.834 171.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 178.05 78.0 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.702 1.201 . . . . 0.0 109.355 172.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -171.59 127.21 0.64 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.381 0.673 . . . . 0.0 110.001 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 t 58.22 96.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.179 1.392 . . . . 0.0 111.744 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.689 ' HA ' ' HZ3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.64 93.65 2.57 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 173.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -134.09 156.44 48.27 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.774 1.229 . . . . 0.0 108.868 -171.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.536 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -74.4 179.81 4.39 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.22 0.608 . . . . 0.0 110.365 173.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 140.66 40.73 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.21 95.3 4.27 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -84.23 155.78 22.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 171.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.456 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 12.3 ptm -136.61 129.55 30.96 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . . . -104.74 100.78 10.42 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -176.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.6 mt -82.18 114.31 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -80.63 102.31 9.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 58' ' ' ALA . 4.2 mm? -86.4 109.27 18.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.19 0.596 . . . . 0.0 110.694 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -106.97 174.51 5.86 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.4 t70 60.2 35.28 21.01 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.03 0.932 . . . . 0.0 111.348 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.38 102.95 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.347 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.91 154.76 23.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.509 1.124 . . . . 0.0 110.362 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -110.6 136.17 50.11 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.031 0.933 . . . . 0.0 110.067 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -91.05 86.92 6.38 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.06 -27.72 64.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.509 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.604 ' HB3' ' HZ2' ' A' ' 122' ' ' LYS . 0.3 OUTLIER -81.04 137.68 49.64 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.358 1.063 . . . . 0.0 109.537 171.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -76.43 95.63 1.05 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.751 2.301 . . . . 0.0 111.84 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.4 mt -87.97 128.24 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.857 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -86.26 129.28 54.18 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.011 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.486 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 35.1 Cg_endo -68.06 150.0 77.24 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.511 2.14 . . . . 0.0 113.961 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -67.85 -38.58 83.31 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.042 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.5 ptm85 -154.02 176.07 12.65 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.05 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.66 118.5 19.36 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.72 172.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.44 HG13 ' HD3' ' A' ' 10' ' ' PRO . 80.7 t -98.97 100.97 10.92 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.48 177.85 2.47 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.363 2.709 . . . . 0.0 112.528 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.58 -34.37 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 123.952 0.901 . . . . 0.0 111.849 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 -13.62 71.67 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.68 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.19 176.2 51.36 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 123.543 0.592 . . . . 0.0 112.939 175.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -126.27 137.28 53.5 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.54 106.82 4.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 166.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.09 124.71 27.49 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -134.5 119.98 19.15 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 m -64.95 -8.47 15.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -173.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -66.69 -21.83 66.08 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.977 0.511 . . . . 0.0 111.616 172.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.443 HG21 ' H ' ' A' ' 5' ' ' VAL . 22.7 mm 63.46 -166.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 124.621 1.168 . . . . 0.0 108.526 -175.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.443 ' H ' HG21 ' A' ' 4' ' ' ILE . 1.7 m -151.99 -42.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 156.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.22 -161.13 20.2 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.397 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.41 136.65 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.575 0.75 . . . . 0.0 109.504 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 t -103.16 134.13 47.1 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.515 0.726 . . . . 0.0 109.584 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.65 123.15 11.65 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 123.514 0.726 . . . . 0.0 110.205 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.54 ' HD3' HG12 ' A' ' 130' ' ' VAL . 74.0 Cg_endo -80.26 94.55 1.01 Allowed 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.419 2.079 . . . . 0.0 109.54 165.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.42 110.64 2.89 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.191 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -85.06 33.66 0.49 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.436 2.757 . . . . 0.0 111.683 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HG3' ' HD2' ' A' ' 15' ' ' PHE . 49.9 tptt -141.09 144.5 34.94 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -170.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -74.23 10.08 1.4 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.574 0.75 . . . . 0.0 112.611 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.416 ' HD2' ' HG3' ' A' ' 13' ' ' LYS . 97.6 m-85 -111.79 25.02 12.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.232 1.013 . . . . 0.0 111.758 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.557 ' SD ' HG13 ' A' ' 55' ' ' VAL . 45.2 ttm -62.08 -36.73 82.55 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.667 0.746 . . . . 0.0 109.549 166.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.32 -23.19 67.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.029 1.331 . . . . 0.0 112.417 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -59.58 -42.48 92.59 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.507 0.723 . . . . 0.0 112.09 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -65.28 -30.97 71.88 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.758 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -92.03 -16.07 26.97 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.723 0.809 . . . . 0.0 110.792 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -73.98 -49.94 22.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.389 1.076 . . . . 0.0 109.797 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -110.86 -15.61 13.75 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -172.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.92 8.3 63.92 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 113.992 0.357 . . . . 0.0 113.992 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -159.69 86.85 0.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.966 1.306 . . . . 0.0 107.744 -173.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -134.93 -178.03 4.9 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.795 0.838 . . . . 0.0 108.976 -171.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -139.7 121.51 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.265 0.939 . . . . 0.0 109.764 -171.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -98.0 114.47 26.61 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.646 0.778 . . . . 0.0 109.167 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.0 m -92.18 133.48 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.24 0.543 . . . . 0.0 111.091 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.489 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.0 mmpt? -119.56 130.51 24.8 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.352 1.461 . . . . 0.0 110.113 178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.25 55.52 5.1 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.07 2.513 . . . . 0.0 111.484 169.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 56.47 27.66 12.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.571 1.148 . . . . 0.0 112.923 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.489 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 4.5 m -64.33 -39.31 93.64 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.698 0.799 . . . . 0.0 110.389 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.5 m -82.71 151.14 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.285 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -80.47 -173.95 4.36 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.502 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -65.05 -18.11 65.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.498 1.119 . . . . 0.0 112.902 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -59.12 -22.56 61.05 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.37 0.668 . . . . 0.0 111.515 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 94.39 0.32 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.046 0.538 . . . . 0.0 110.328 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.508 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 3.7 ptpp? -109.66 157.78 36.57 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.55 55.46 5.32 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.212 2.608 . . . . 0.0 112.175 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.94 43.76 0.2 Allowed Glycine 0 C--O 1.239 0.467 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.786 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.508 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 30.9 mtm -130.11 -173.01 2.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.623 1.169 . . . . 0.0 111.074 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.75 165.23 12.76 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.55 1.14 . . . . 0.0 110.518 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -136.2 101.95 4.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 34.2 t -90.54 108.15 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.214 0.53 . . . . 0.0 110.193 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -75.61 120.36 20.91 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.754 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 33.1 t80 -105.59 161.56 14.26 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.595 1.158 . . . . 0.0 110.134 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.448 ' O ' ' HE3' ' A' ' 16' ' ' MET . 37.1 tt0 66.25 76.57 0.31 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.297 1.439 . . . . 0.0 109.655 175.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.4 t -60.22 153.85 21.26 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.998 -172.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -57.13 -31.8 65.71 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.231 173.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -106.91 -66.01 1.05 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.842 0.857 . . . . 0.0 110.985 -175.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -97.21 -177.2 3.76 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.767 0.827 . . . . 0.0 111.458 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.1 m -111.82 94.3 4.88 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.432 0.693 . . . . 0.0 109.546 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.26 -173.33 44.23 Favored Glycine 0 C--O 1.243 0.675 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 19.7 m-85 -61.42 108.8 1.0 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 172.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.557 HG13 ' SD ' ' A' ' 16' ' ' MET . 2.7 p -67.59 -34.74 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 122.996 0.518 . . . . 0.0 110.771 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.93 -165.71 33.76 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.58 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 17.2 pt-20 -141.17 176.75 8.58 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.05 0.94 . . . . 0.0 108.952 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.69 -173.84 4.15 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.077 0.951 . . . . 0.0 109.304 176.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -125.94 119.49 27.89 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.726 0.81 . . . . 0.0 109.494 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.8 mt -71.54 129.78 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 124.397 1.061 . . . . 0.0 110.669 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -132.29 177.26 7.72 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 126.187 1.795 . . . . 0.0 109.006 -174.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -30.35 111.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 125.463 1.727 . . . . 0.0 114.113 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.0 m -87.97 123.93 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.288 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 99.0 t -90.02 107.18 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 108' ' ' LEU . 77.1 mt -88.43 116.76 26.88 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.6 t -153.07 135.76 15.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.644 0.778 . . . . 0.0 110.323 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.12 -34.62 78.47 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.84 0.856 . . . . 0.0 111.669 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 79.1 m-20 -94.41 120.17 65.51 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.004 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.517 ' HG2' HD22 ' A' ' 87' ' ' LEU . 61.1 Cg_endo -72.5 -7.11 20.31 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.082 2.521 . . . . 0.0 113.387 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 45.9 mtm -86.02 -21.93 27.53 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.013 0.525 . . . . 0.0 110.75 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.424 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 30.4 mt-30 -66.44 -22.24 66.21 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.247 174.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -71.59 -26.21 62.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.691 0.396 . . . . 0.0 110.659 175.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -82.8 -31.26 28.27 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.797 0.439 . . . . 0.0 111.179 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.9 -28.86 60.8 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.932 0.333 . . . . 0.0 110.681 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.8 m -81.83 -58.95 2.76 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.132 0.573 . . . . 0.0 110.386 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.803 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 71.9 m-85 -100.86 -62.83 1.19 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.847 0.859 . . . . 0.0 110.329 -174.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.49 -83.23 0.56 Allowed Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.643 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -59.65 -44.09 93.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.622 0.769 . . . . 0.0 110.663 175.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.803 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 29.2 mmt180 -70.32 -19.48 63.07 Favored 'General case' 0 C--O 1.205 -1.278 0 O-C-N 124.013 0.821 . . . . 0.0 111.938 -173.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 76' ' ' PHE . 40.8 t -76.52 131.07 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -54.51 -45.73 73.35 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.903 0.752 . . . . 0.0 112.554 -171.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -100.95 156.93 17.11 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.549 HG23 ' HG2' ' A' ' 86' ' ' GLU . 11.3 t -92.85 173.45 7.75 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -50.78 -41.35 56.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.422 1.089 . . . . 0.0 110.962 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.06 -46.78 87.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.23 1.012 . . . . 0.0 111.353 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.549 ' HG2' HG23 ' A' ' 83' ' ' THR . 42.3 mm-40 -62.96 -37.36 86.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.205 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.517 HD22 ' HG2' ' A' ' 69' ' ' PRO . 45.2 tp -63.99 -54.11 39.57 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.882 0.739 . . . . 0.0 111.091 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -63.27 -43.59 97.51 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.27 0.356 . . . . 0.0 111.036 -173.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 12.9 pt-20 -73.89 -23.69 59.61 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.426 0.291 . . . . 0.0 111.181 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.438 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 61.6 t80 -65.17 -44.89 87.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.527 0.731 . . . . 0.0 110.122 172.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.498 ' HE2' ' HG ' ' A' ' 87' ' ' LEU . 72.8 mtm -76.53 -30.5 57.16 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.069 0.548 . . . . 0.0 110.908 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.1 mmmt -74.03 -20.11 60.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.201 0.601 . . . . 0.0 110.61 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -75.37 -34.1 61.1 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.944 0.498 . . . . 0.0 109.98 174.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 62.8 mm-40 -72.65 -18.84 61.53 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -93.22 -10.37 35.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.625 0.37 . . . . 0.0 111.908 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -101.59 -25.63 13.82 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.191 0.451 . . . . 0.0 110.72 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -95.25 -22.84 17.54 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.777 0.431 . . . . 0.0 110.64 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.03 -176.22 14.24 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -99.09 108.07 20.61 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.319 0.648 . . . . 0.0 109.513 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -131.3 38.71 3.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.734 0.813 . . . . 0.0 109.313 171.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -93.34 -21.5 19.53 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.857 0.463 . . . . 0.0 110.357 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.36 -54.28 35.37 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.325 1.05 . . . . 0.0 109.737 -173.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.5 t -162.07 175.67 11.52 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.28 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -77.59 -58.24 3.38 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.349 0.66 . . . . 0.0 109.849 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp 48.9 110.37 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.03 1.332 . . . . 0.0 112.352 -168.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 168.21 20.47 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.45 0.643 . . . . 0.0 110.084 -177.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.84 149.88 52.32 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 174.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 65' ' ' LEU . 1.3 tm? -76.75 92.39 3.57 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 171.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -75.48 159.25 31.53 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.381 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.7 ptm -140.0 129.68 24.44 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.308 0.643 . . . . 0.0 109.702 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.541 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . . . -97.12 101.36 12.91 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.525 ' HA ' HG12 ' A' ' 63' ' ' VAL . 35.5 mt -80.46 113.85 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.6 110.63 17.14 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -94.33 132.42 38.95 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.409 0.623 . . . . 0.0 110.701 177.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -138.37 170.73 15.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.283 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 t70 59.8 35.84 22.06 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.859 0.838 . . . . 0.0 110.117 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.47 102.59 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.181 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.3 145.6 28.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.624 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -101.32 122.44 43.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -80.58 84.6 6.13 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 165.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.32 -33.5 72.49 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.568 170.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -79.99 137.25 53.64 Favored Pre-proline 0 CA--C 1.553 1.095 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.44 173.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.08 95.7 1.04 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.782 2.322 . . . . 0.0 111.538 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.5 mt -94.63 123.76 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.14 143.57 26.36 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.476 0.71 . . . . 0.0 109.764 -175.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.27 158.69 41.0 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.862 2.375 . . . . 0.0 112.054 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -81.34 -10.44 59.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.463 0.705 . . . . 0.0 110.993 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.5 ptm85 -153.48 172.96 16.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.991 0.916 . . . . 0.0 110.246 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.13 119.31 18.16 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.54 HG12 ' HD3' ' A' ' 10' ' ' PRO . 23.1 t -102.9 99.42 13.76 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.26 -176.28 3.19 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.882 2.388 . . . . 0.0 112.61 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.0 -27.06 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.453 1.101 . . . . 0.0 112.164 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.05 -25.95 75.04 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.205 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.39 148.15 6.98 Favored Glycine 0 C--N 1.348 1.237 0 C-N-CA 123.003 0.335 . . . . 0.0 112.448 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -108.86 142.29 39.67 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.426 0.691 . . . . 0.0 109.581 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -78.62 107.49 11.33 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.79 116.8 14.82 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.09 134.07 52.63 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.867 -1.063 . . . . 0.0 108.365 -177.44 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 2' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.415 ' N ' ' SD ' ' A' ' 1' ' ' MET . 51.0 m -60.3 -8.64 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.682 1.193 . . . . 0.0 114.181 -174.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HG2' ' HB3' ' A' ' 1' ' ' MET . 17.4 ptmt -61.84 -18.11 58.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.915 0.886 . . . . 0.0 112.421 173.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 5' ' ' VAL . 35.6 mm 67.19 -175.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.456 0 C-N-CA 124.129 0.972 . . . . 0.0 108.71 -174.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' N ' HG22 ' A' ' 4' ' ' ILE . 2.0 m -148.35 -38.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.228 1.011 . . . . 0.0 108.683 158.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.77 -161.22 19.81 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.482 0.489 . . . . 0.0 113.689 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.427 HG12 HD13 ' A' ' 60' ' ' ILE . 13.5 p -132.02 147.89 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.866 0.866 . . . . 0.0 108.686 175.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -122.76 140.93 52.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.553 0.741 . . . . 0.0 109.958 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -137.63 141.36 33.01 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.13 0.972 . . . . 0.0 110.12 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 20.7 Cg_exo -63.21 -46.73 9.39 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.347 2.698 . . . . 0.0 111.909 175.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.3 mt 51.57 72.13 1.3 Allowed Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.263 1.025 . . . . 0.0 109.603 -171.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.74 38.59 0.75 Allowed 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.261 2.64 . . . . 0.0 112.617 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -124.8 172.7 9.12 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.657 1.183 . . . . 0.0 109.908 -174.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -65.35 -15.23 62.34 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.086 0.954 . . . . 0.0 112.001 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -82.26 0.92 39.16 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.863 0.865 . . . . 0.0 112.778 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -57.43 -36.76 71.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.182 0.993 . . . . 0.0 111.696 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.07 -14.06 58.17 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -53.47 -46.99 70.17 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.411 1.085 . . . . 0.0 112.571 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.438 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 57.7 m-85 -68.54 -28.96 67.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.684 -174.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -93.85 -15.83 24.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.777 0.831 . . . . 0.0 110.452 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -70.69 -49.06 51.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.38 1.072 . . . . 0.0 109.748 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -109.63 -15.14 14.23 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.35 7.07 77.44 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.834 0.293 . . . . 0.0 113.834 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -168.6 90.4 0.26 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.457 1.103 . . . . 0.0 109.944 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.438 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.2 t70 -119.34 -178.04 3.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.267 1.027 . . . . 0.0 108.905 -174.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 113' ' ' GLU . 40.0 t -132.52 119.41 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.053 -1.029 . . . . 0.0 109.396 -177.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 81' ' ' PHE . 56.8 t80 -95.43 110.9 22.88 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.3 m -87.27 139.42 17.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-O 121.377 0.608 . . . . 0.0 110.507 177.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 5.9 mmpt? -125.46 132.43 24.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.198 1.399 . . . . 0.0 109.71 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.39 49.16 3.08 Favored 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 123.124 2.549 . . . . 0.0 111.952 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' LEU . . . 58.27 81.34 0.16 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.171 1.388 . . . . 0.0 111.861 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.56 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 23.5 m -116.43 -72.99 0.66 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -97.76 126.9 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.511 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 50.2 t90 -160.25 -35.93 0.05 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.435 0.294 . . . . 0.0 111.246 -175.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -56.34 -45.96 80.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.539 0.736 . . . . 0.0 112.574 -174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -93.1 -17.53 23.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.467 0.307 . . . . 0.0 110.528 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.516 ' HA ' ' HE2' ' A' ' 41' ' ' MET . 3.0 mm? -61.86 108.2 0.98 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.731 0.812 . . . . 0.0 111.19 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -131.53 150.58 76.75 Favored Pre-proline 0 C--O 1.244 0.765 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.964 172.086 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.25 103.98 1.48 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.432 2.088 . . . . 0.0 110.486 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.75 -8.89 1.35 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.366 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.516 ' HE2' ' HA ' ' A' ' 37' ' ' LEU . 24.1 mtm -80.08 -177.9 6.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.228 0.611 . . . . 0.0 111.649 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -107.22 161.66 14.58 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.835 0.854 . . . . 0.0 110.765 171.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -136.17 101.92 4.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 174.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.5 t -87.6 122.74 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 109.824 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -92.4 120.85 33.31 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.523 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 85.2 t80 -87.26 174.05 8.82 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.758 1.223 . . . . 0.0 109.141 174.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 68.09 95.55 0.06 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.651 1.58 . . . . 0.0 109.114 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.792 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 53.9 p -76.35 67.54 2.59 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.141 0.976 . . . . 0.0 111.633 -173.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 82.7 t60 46.9 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.547 1.539 . . . . 0.0 112.017 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 77.62 -47.53 0.48 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 125.355 1.462 . . . . 0.0 111.139 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.4 ' HB2' ' HG ' ' A' ' 48' ' ' SER . 6.5 m-20 -78.22 167.96 20.58 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.449 1.1 . . . . 0.0 110.933 174.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.1 p -96.01 143.51 27.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.287 0.635 . . . . 0.0 110.486 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 132.71 163.53 10.63 Favored Glycine 0 C--O 1.215 -1.07 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 44.0 m-85 -71.47 113.3 8.36 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 118.203 1.001 . . . . 0.0 110.8 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.792 ' HB ' ' HA ' ' A' ' 48' ' ' SER . 2.7 p -73.9 -37.05 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.886 0.874 . . . . 0.0 110.939 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.66 -163.23 29.11 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.539 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 6.5 pt-20 -143.3 178.88 7.43 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.882 0.873 . . . . 0.0 109.129 173.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -156.88 -172.38 4.02 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.276 1.03 . . . . 0.0 108.879 175.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -125.78 118.09 24.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.965 0.506 . . . . 0.0 110.092 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.486 HG13 ' HB2' ' A' ' 43' ' ' PHE . 43.2 mt -63.93 125.34 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.925 175.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 30.7 mmmt -133.9 -168.28 2.09 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 125.374 1.47 . . . . 0.0 107.721 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -19.65 110.16 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 126.092 1.757 . . . . 0.0 115.058 -171.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 112' ' ' ILE . 29.2 m -103.74 109.97 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.7 t -91.93 118.14 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.404 0.682 . . . . 0.0 109.745 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 108' ' ' LEU . 61.7 mt -94.71 123.26 38.05 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.664 0.786 . . . . 0.0 109.494 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 71' ' ' GLN . 33.4 t -153.16 136.97 16.14 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.503 0.721 . . . . 0.0 110.126 172.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.652 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 45.6 mt-10 -66.32 -17.81 64.98 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 176.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.448 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 14.1 m-20 -97.85 120.73 59.6 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.0 -26.11 58.7 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.436 2.091 . . . . 0.0 112.071 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.411 ' HA ' ' HD2' ' A' ' 73' ' ' PHE . 37.3 mtm -73.19 -22.21 60.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.597 0.759 . . . . 0.0 110.918 -171.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.448 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 21.4 mm-40 -57.3 -33.39 67.63 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.155 0.982 . . . . 0.0 111.587 175.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.52 -31.46 37.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.745 0.418 . . . . 0.0 110.819 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CE2' HD23 ' A' ' 87' ' ' LEU . 85.1 m-85 -79.06 -17.75 54.67 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.125 0.57 . . . . 0.0 111.572 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -94.61 -36.85 11.61 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.436 0.294 . . . . 0.0 111.208 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.6 m -74.8 -57.0 4.19 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.947 0.499 . . . . 0.0 110.809 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.827 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 92.2 m-85 -92.49 -61.73 1.54 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.339 0.656 . . . . 0.0 109.494 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.68 -85.26 0.45 Allowed Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.866 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.04 -37.2 84.04 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.913 0.885 . . . . 0.0 110.639 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.827 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 14.4 mmt85 -65.52 -35.02 79.63 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.223 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.48 HG12 HD22 ' A' ' 82' ' ' LEU . 21.9 t -67.76 143.95 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 118.211 0.46 . . . . 0.0 110.375 -176.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.428 ' HD2' ' HA ' ' A' ' 27' ' ' PHE . 45.2 p90 -62.9 -14.51 47.45 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -173.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.48 HD22 HG12 ' A' ' 80' ' ' VAL . 2.3 pt? -139.68 170.29 16.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.782 0.833 . . . . 0.0 109.272 176.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.467 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.9 t -100.09 170.58 8.38 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 172.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -62.48 -27.74 69.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.24 0.616 . . . . 0.0 111.196 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.54 -49.41 71.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.405 0.682 . . . . 0.0 109.956 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.467 ' HG2' HG22 ' A' ' 83' ' ' THR . 17.3 mm-40 -56.75 -40.77 76.38 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.306 176.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.43 HD23 ' CE2' ' A' ' 73' ' ' PHE . 31.0 tp -58.4 -56.19 25.33 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.911 0.884 . . . . 0.0 112.031 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -61.72 -39.97 93.41 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -171.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.64 -18.88 36.62 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.126 0.571 . . . . 0.0 111.747 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.453 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 81.9 t80 -69.77 -39.74 76.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.37 0.668 . . . . 0.0 109.655 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.0 mtm -73.49 -30.8 63.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.302 0.641 . . . . 0.0 110.418 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.5 mmpt? -67.11 -38.07 84.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.626 0.371 . . . . 0.0 110.006 170.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.1 t -65.73 -32.06 73.39 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.831 0.707 . . . . 0.0 110.539 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 87.1 mm-40 -68.11 -56.26 9.47 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.602 ' HB3' ' HD3' ' A' ' 100' ' ' ARG . 10.6 pt-20 -64.5 -26.1 68.28 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -173.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -91.57 -31.03 16.07 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -110.22 -68.71 0.91 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.016 0.371 . . . . 0.0 111.223 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.2 1.27 50.02 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 114.026 0.37 . . . . 0.0 114.026 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 68.19 151.95 0.08 Allowed 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.009 1.723 . . . . 0.0 112.405 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.602 ' HD3' ' HB3' ' A' ' 95' ' ' GLU . 36.9 mtp180 -143.88 126.01 15.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -69.84 -49.64 50.53 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -170.38 172.15 6.26 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.649 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -81.03 -42.67 20.74 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 160.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 tptp 68.15 -71.32 0.11 Allowed 'General case' 0 C--N 1.364 1.219 0 C-N-CA 125.588 1.555 . . . . 0.0 109.481 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -146.01 143.28 29.35 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.15 1.38 . . . . 0.0 107.596 167.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.652 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -57.95 146.63 31.68 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.144 0.497 . . . . 0.0 110.657 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 107' ' ' LYS . 18.2 tptm -101.56 156.67 17.34 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -174.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 65' ' ' LEU . 2.6 tm? -72.44 104.97 3.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -85.96 161.62 18.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.334 0.654 . . . . 0.0 109.251 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.517 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 14.9 ptm -141.67 154.36 45.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.865 0.866 . . . . 0.0 109.868 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.72 104.44 7.18 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.716 0.806 . . . . 0.0 109.825 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.513 ' HA ' HG11 ' A' ' 63' ' ' VAL . 43.0 mt -84.3 119.12 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 123.402 0.681 . . . . 0.0 109.454 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.52 ' HA ' HG22 ' A' ' 26' ' ' VAL . 37.6 tt0 -81.93 98.86 8.76 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 58' ' ' ALA . 3.9 mm? -80.98 131.89 35.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.948 0.499 . . . . 0.0 110.25 174.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 1.3 pp20? -139.72 166.29 25.0 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.687 0.795 . . . . 0.0 109.128 175.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.3 t70 56.84 41.7 27.61 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.833 0.853 . . . . 0.0 111.178 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.32 108.92 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 121.351 0.596 . . . . 0.0 111.134 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.66 157.34 21.16 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.521 1.128 . . . . 0.0 110.216 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -122.91 117.73 26.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.896 0.878 . . . . 0.0 110.072 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -78.18 98.25 5.78 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -65.04 -31.44 72.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.838 0.855 . . . . 0.0 110.578 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -87.36 138.35 32.18 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.248 0.619 . . . . 0.0 110.157 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.33 89.14 1.21 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.658 2.239 . . . . 0.0 111.68 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.1 mt -78.73 131.26 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.398 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.69 144.17 27.98 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 122.986 0.514 . . . . 0.0 109.701 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.34 161.09 28.95 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.315 2.01 . . . . 0.0 112.658 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 127' ' ' LYS . 11.1 mmpt? -68.91 -51.58 38.5 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.366 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -119.02 178.06 4.63 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.613 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.59 140.49 51.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.688 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.94 102.19 30.02 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.04 176.39 7.05 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.604 2.203 . . . . 0.0 112.212 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.2 t -58.89 -32.94 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.276 1.03 . . . . 0.0 111.132 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.68 -15.0 73.1 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.846 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.37 159.54 16.71 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.339 0.495 . . . . 0.0 113.237 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -113.54 145.77 40.7 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.585 0.754 . . . . 0.0 110.46 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -81.63 113.7 19.82 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.4 121.79 26.68 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 140.92 49.04 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 117.81 -1.09 . . . . 0.0 110.007 177.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 5' ' ' VAL . 24.1 mm 62.12 -168.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -173.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.3 m -145.88 -42.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 154.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.09 -161.24 20.23 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.31 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.77 156.15 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.825 0.85 . . . . 0.0 108.711 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 4.9 t -125.48 135.85 52.75 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.484 0.713 . . . . 0.0 109.657 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -132.4 139.29 34.35 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 123.787 0.835 . . . . 0.0 110.305 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HD3' HG12 ' A' ' 130' ' ' VAL . 69.2 Cg_endo -71.75 -26.74 18.94 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.192 2.594 . . . . 0.0 111.901 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt 66.94 117.26 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 125.321 1.449 . . . . 0.0 109.802 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -62.11 -16.65 51.74 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.267 2.645 . . . . 0.0 114.213 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -130.69 -176.38 3.96 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.733 0.813 . . . . 0.0 110.77 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -74.92 6.76 3.73 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.817 0.847 . . . . 0.0 112.87 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -77.97 14.97 0.97 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -62.22 -33.08 73.88 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.863 0.363 . . . . 0.0 110.293 165.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -68.73 -25.8 64.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.505 1.122 . . . . 0.0 111.762 -173.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 6.1 mmp_? -53.49 -49.32 67.76 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.331 1.019 . . . . 0.0 111.574 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 58.9 m-85 -64.54 -31.17 72.26 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.741 -176.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -85.75 -26.61 25.74 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.385 0.674 . . . . 0.0 110.593 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -68.38 -52.63 30.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.607 1.163 . . . . 0.0 109.953 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.5 ptpt -99.79 -16.88 17.93 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.348 -172.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.95 -8.55 50.21 Favored Glycine 0 N--CA 1.475 1.284 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -158.57 107.17 1.94 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.882 0.873 . . . . 0.0 109.546 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.516 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 17.1 t70 -126.2 -179.58 4.79 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.333 1.053 . . . . 0.0 109.259 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.5 t -130.67 113.93 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.244 1.018 . . . . 0.0 109.271 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -94.04 115.03 27.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.159 0.584 . . . . 0.0 109.662 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.36 147.14 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.343 0.592 . . . . 0.0 111.452 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.561 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 5.0 mmpt? -134.76 128.83 19.05 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.369 1.468 . . . . 0.0 110.113 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 97.9 Cg_endo -78.44 54.15 4.87 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.827 2.351 . . . . 0.0 112.345 170.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 57.38 97.9 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.558 1.143 . . . . 0.0 111.525 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.46 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 44.8 m -136.8 -54.2 0.72 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.426 0.69 . . . . 0.0 109.817 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 m -79.27 148.59 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.881 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -93.31 -162.28 0.92 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.536 1.134 . . . . 0.0 110.651 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -73.43 3.38 6.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -67.45 -31.41 71.57 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.59 90.99 0.41 Allowed 'General case' 0 C--N 1.352 0.714 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.103 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.43 153.81 47.64 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.264 0.625 . . . . 0.0 109.459 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.25 102.79 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.228 1.952 . . . . 0.0 111.11 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.13 29.79 0.38 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.66 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.2 mtm -111.39 -166.53 1.08 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.643 0.777 . . . . 0.0 110.453 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.9 ptpt -117.14 161.09 20.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.893 0.877 . . . . 0.0 110.539 169.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.543 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 t80 -135.73 101.07 4.65 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 45.1 t -84.29 120.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.294 0.569 . . . . 0.0 109.875 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -84.54 108.69 17.44 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 68.0 t80 . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.257 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.425 ' HE2' ' HA ' ' A' ' 126' ' ' PRO . 61.9 m-85 . . . . . 0 CA--C 1.554 1.126 0 CA-C-O 121.132 0.491 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -77.98 -25.6 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 123.509 0.724 . . . . 0.0 111.268 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.28 -165.93 33.31 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 120.173 -0.237 . . . . 0.0 112.758 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 7.3 pt-20 -145.42 178.03 8.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.631 0.772 . . . . 0.0 109.491 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.551 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -157.46 -171.1 3.45 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.497 1.119 . . . . 0.0 108.81 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 24.2 mmt85 -125.79 117.84 24.25 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.438 0.695 . . . . 0.0 110.168 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 43' ' ' PHE . 49.1 mt -69.27 131.45 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.316 1.046 . . . . 0.0 110.472 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -141.5 -166.61 2.23 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 125.513 1.525 . . . . 0.0 108.967 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -42.68 114.53 0.6 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.744 1.217 . . . . 0.0 113.352 -162.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.5 m -89.3 123.68 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.286 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 90.4 t -90.17 108.2 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.574 ' HB3' HD11 ' A' ' 108' ' ' LEU . 77.8 mt -95.58 113.87 25.57 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.1 t -153.46 144.18 22.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.576 0.75 . . . . 0.0 109.716 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -74.26 -27.75 60.9 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.566 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 42.7 m-20 -94.88 123.56 57.25 Favored Pre-proline 0 N--CA 1.476 0.859 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 28.6 Cg_endo -63.84 -25.01 67.87 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.18 1.92 . . . . 0.0 112.447 173.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.524 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 3.5 mpp? -74.53 -18.15 60.64 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.799 0.44 . . . . 0.0 110.887 -174.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.566 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 25.9 mm-40 -58.2 -40.76 82.4 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.656 0.782 . . . . 0.0 110.21 170.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -73.7 -29.15 62.11 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.677 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' A' ' 87' ' ' LEU . 66.0 m-85 -86.94 -15.63 38.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.17 -31.87 14.61 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 117.941 0.337 . . . . 0.0 110.174 173.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -76.62 -58.08 3.49 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.096 0.558 . . . . 0.0 109.758 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.742 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 63.3 m-85 -98.42 -67.32 0.85 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.732 0.813 . . . . 0.0 110.091 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.98 -81.38 0.09 OUTLIER Glycine 0 C--N 1.358 1.792 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.482 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.09 -36.9 78.44 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.661 1.184 . . . . 0.0 111.921 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.742 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 26.2 mmt180 -76.19 -20.09 57.82 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.979 0.512 . . . . 0.0 111.322 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 76' ' ' PHE . 30.8 t -79.18 142.4 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -57.12 -41.34 78.82 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.43 HD23 HG12 ' A' ' 80' ' ' VAL . 2.1 pt? -106.43 163.18 13.06 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.0 t -98.76 175.71 5.87 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 173.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.31 -28.31 69.22 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.213 0.605 . . . . 0.0 110.89 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.75 -43.48 98.68 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.969 0.908 . . . . 0.0 110.243 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.497 ' HG2' HG22 ' A' ' 83' ' ' THR . 69.7 mm-40 -66.95 -33.9 76.58 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.957 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' A' ' 73' ' ' PHE . 32.6 tp -64.53 -52.56 57.13 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.382 0.673 . . . . 0.0 111.029 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -38.3 89.22 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.506 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.05 -33.42 70.25 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.012 0.195 . . . . 0.0 110.671 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -66.81 -48.05 70.14 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.136 0.975 . . . . 0.0 110.918 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.5 mtm -66.44 -41.0 89.78 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.684 0.615 . . . . 0.0 110.172 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -62.2 -40.76 97.17 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.545 0.528 . . . . 0.0 110.705 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.473 0.692 0 C-N-CA 123.205 0.602 . . . . 0.0 111.09 -177.726 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -109.9 168.53 9.35 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.181 0.592 . . . . 0.0 109.641 -175.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.3 tm? -78.2 107.27 10.66 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -89.33 158.4 17.82 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.7 0.8 . . . . 0.0 109.282 172.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.5 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 15.4 ptm -136.27 131.59 34.64 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.051 0.54 . . . . 0.0 110.754 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.51 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -113.0 102.91 10.86 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.763 0.825 . . . . 0.0 109.767 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.1 mt -83.11 128.13 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.448 0.699 . . . . 0.0 109.414 -175.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.91 111.86 18.5 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.551 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -99.17 112.52 24.65 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.47 0.708 . . . . 0.0 110.395 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -120.72 167.15 12.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.446 0.698 . . . . 0.0 109.65 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.5 t70 53.86 54.88 9.15 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.294 1.038 . . . . 0.0 110.35 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.11 107.62 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.415 -175.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -83.35 163.91 20.33 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.242 1.017 . . . . 0.0 109.815 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -126.48 132.51 51.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.666 0.786 . . . . 0.0 109.965 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -94.4 97.16 9.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -77.3 -18.26 57.65 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.829 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -83.67 139.19 40.73 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.872 0.869 . . . . 0.0 109.378 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.41 100.02 1.33 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.714 2.276 . . . . 0.0 111.115 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.2 mt -81.19 125.75 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -78.78 116.46 59.91 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.425 ' HA ' ' HE2' ' A' ' 54' ' ' PHE . 9.8 Cg_endo -55.42 129.06 33.13 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.747 2.298 . . . . 0.0 113.182 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -70.3 -20.51 63.02 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.183 0.993 . . . . 0.0 110.416 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -159.27 165.72 32.86 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.92 1.288 . . . . 0.0 108.813 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -71.06 136.19 48.15 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.661 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.516 HG12 ' HD3' ' A' ' 10' ' ' PRO . 41.1 t -111.25 97.72 36.6 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.24 -177.99 2.66 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.546 2.831 . . . . 0.0 112.207 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.67 -33.47 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.521 0.728 . . . . 0.0 110.701 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.34 -25.31 72.45 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.946 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.54 163.16 30.79 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.009 0.338 . . . . 0.0 113.229 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -119.67 146.29 45.71 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.055 0.942 . . . . 0.0 110.66 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -84.16 110.25 18.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.305 0.642 . . . . 0.0 110.236 173.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 119.14 20.63 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 172.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.404 ' HD3' ' H ' ' A' ' 138' ' ' ARG . 0.4 OUTLIER -129.66 137.9 50.9 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.134 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.453 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.45 HG22 ' H ' ' A' ' 5' ' ' VAL . 22.7 mm 65.78 -176.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 C-N-CA 124.469 1.107 . . . . 0.0 109.283 -176.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -145.92 -42.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.582 1.153 . . . . 0.0 108.045 158.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.23 -161.49 20.85 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.88 0.738 . . . . 0.0 113.595 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.436 HG12 HD11 ' A' ' 60' ' ' ILE . 9.7 p -121.38 162.0 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -137.42 138.77 40.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.116 0.567 . . . . 0.0 110.129 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -135.46 150.08 71.3 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.936 0.894 . . . . 0.0 110.446 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' HG12 ' A' ' 130' ' ' VAL . 91.2 Cg_endo -80.57 -10.83 13.12 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.787 2.325 . . . . 0.0 112.359 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.3 mm 59.79 97.96 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 125.675 1.59 . . . . 0.0 110.879 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -82.63 33.33 0.53 Allowed 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.232 2.621 . . . . 0.0 113.137 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -137.44 162.07 34.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.278 1.031 . . . . 0.0 110.507 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.527 ' H ' ' HD2' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -78.2 -15.72 58.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.76 0.824 . . . . 0.0 110.428 -174.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 82' ' ' LEU . 41.7 m-85 -90.51 31.74 1.01 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.22 1.008 . . . . 0.0 112.354 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -58.74 -22.98 59.06 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.853 0.861 . . . . 0.0 112.017 166.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.421 ' N ' ' SD ' ' A' ' 16' ' ' MET . 26.1 t70 -77.52 -27.45 51.71 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.409 1.084 . . . . 0.0 112.514 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -50.2 -48.69 54.17 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.471 1.108 . . . . 0.0 113.702 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -63.82 -29.41 70.61 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.765 0.666 . . . . 0.0 110.605 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -96.82 -12.58 23.41 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.623 0.769 . . . . 0.0 111.621 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -76.05 -50.17 15.5 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.834 0.853 . . . . 0.0 109.007 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HG3' ' H ' ' A' ' 24' ' ' LYS . 14.7 ptpt -109.2 -16.13 14.14 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.502 -172.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.82 9.04 74.48 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 114.216 0.446 . . . . 0.0 114.216 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.452 ' H ' ' HG3' ' A' ' 22' ' ' LYS . 55.3 pttt -163.25 92.36 0.74 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.33 1.052 . . . . 0.0 109.811 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -133.35 -176.87 4.29 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -136.43 121.19 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 120.188 1.358 . . . . 0.0 109.813 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -94.61 116.52 28.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.709 0.804 . . . . 0.0 109.922 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 m -98.2 143.29 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.346 0.593 . . . . 0.0 111.374 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.779 ' HG2' HG23 ' A' ' 33' ' ' VAL . 16.5 tppt? -136.64 140.52 32.39 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.5 1.12 . . . . 0.0 109.88 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.647 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 59.0 Cg_endo -72.7 59.52 3.41 Favored 'Trans proline' 0 CA--C 1.56 1.817 0 C-N-CA 122.996 2.464 . . . . 0.0 113.748 166.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.41 33.95 6.08 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.256 1.423 . . . . 0.0 113.856 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.408 ' H ' ' HG3' ' A' ' 29' ' ' LYS . 3.3 m -87.48 -17.64 31.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.408 0.683 . . . . 0.0 111.05 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.779 HG23 ' HG2' ' A' ' 29' ' ' LYS . 3.3 t -87.71 150.3 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.252 0.621 . . . . 0.0 109.493 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -70.02 174.96 4.8 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.53 0.681 . . . . 0.0 112.257 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -76.96 -1.36 28.25 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.636 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.67 -23.55 66.81 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.65 0.78 . . . . 0.0 111.034 173.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.536 HD23 HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -65.52 103.32 0.82 Allowed 'General case' 0 C--N 1.353 0.743 0 C-N-CA 123.0 0.52 . . . . 0.0 110.084 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.44 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -129.95 150.82 77.0 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.198 0.599 . . . . 0.0 109.65 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.81 107.84 1.96 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.836 2.358 . . . . 0.0 111.042 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.82 -14.57 1.76 Allowed Glycine 0 N--CA 1.467 0.749 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.92 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.567 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 27.9 mtm -78.65 -173.21 3.31 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.367 0.603 . . . . 0.0 111.881 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -112.21 162.74 15.15 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.976 0.91 . . . . 0.0 110.32 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.43 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -135.57 102.71 5.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.162 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.99 126.28 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.352 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -97.69 111.69 23.88 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.7 t80 . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 124.359 1.064 . . . . 0.0 108.934 175.829 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.902 0.382 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.45 -38.54 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 168.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.75 -157.16 28.03 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.526 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.22 179.26 9.13 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.081 0.952 . . . . 0.0 110.031 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.469 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -155.17 -172.24 4.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.652 0.781 . . . . 0.0 110.844 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -122.78 119.82 31.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.864 0.866 . . . . 0.0 110.043 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.436 HD11 HG12 ' A' ' 7' ' ' VAL . 45.9 mt -68.61 135.79 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.664 1.186 . . . . 0.0 111.3 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.7 mmmt -134.51 -178.36 5.02 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 126.344 1.858 . . . . 0.0 108.588 -174.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -40.77 116.45 0.71 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.2 1.4 . . . . 0.0 114.046 -165.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.3 m -89.11 116.99 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.857 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.98 115.68 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.736 0.814 . . . . 0.0 109.554 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.9 mt -88.79 119.49 29.33 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.959 0.504 . . . . 0.0 109.688 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -148.28 131.3 16.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.034 0.933 . . . . 0.0 108.796 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -63.0 -31.24 72.33 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.967 0.907 . . . . 0.0 111.576 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.591 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 25.8 m-80 -91.35 119.11 68.76 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.428 ' HG2' HD21 ' A' ' 87' ' ' LEU . 53.1 Cg_endo -68.75 -12.94 35.9 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.595 2.197 . . . . 0.0 112.238 172.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.6 mtm -81.5 -24.27 36.8 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.284 1.033 . . . . 0.0 110.704 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.591 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 79.0 mt-30 -70.32 -25.39 63.28 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -69.2 -28.34 66.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.421 0.288 . . . . 0.0 110.747 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.493 ' HE2' HD22 ' A' ' 87' ' ' LEU . 27.5 m-85 -81.65 -20.41 39.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.883 0.473 . . . . 0.0 112.256 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.6 pt-20 -90.84 -25.54 19.83 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 117.979 0.354 . . . . 0.0 111.194 172.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.6 m -85.91 -50.8 6.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.443 0.697 . . . . 0.0 110.957 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.765 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 82.1 m-85 -107.17 -57.68 2.04 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.993 0.917 . . . . 0.0 109.927 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.44 -90.63 0.24 Allowed Glycine 0 C--N 1.355 1.626 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.827 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.37 -35.21 76.84 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.846 0.858 . . . . 0.0 110.621 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.765 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 44.7 mmt-85 -71.37 -28.2 63.88 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-O 119.162 -0.447 . . . . 0.0 110.914 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 76' ' ' PHE . 57.2 t -71.04 132.3 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -56.78 -50.69 71.54 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.113 0.883 . . . . 0.0 112.213 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.515 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 1.8 pt? -94.6 157.47 15.96 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.451 HG22 ' HG2' ' A' ' 86' ' ' GLU . 14.4 t -88.53 168.31 12.69 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.87 -29.07 70.29 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.197 0.199 . . . . 0.0 110.72 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -61.03 -43.07 99.44 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.535 0.734 . . . . 0.0 111.314 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.451 ' HG2' HG22 ' A' ' 83' ' ' THR . 51.0 mm-40 -64.39 -40.09 95.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.284 0.634 . . . . 0.0 111.345 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.493 HD22 ' HE2' ' A' ' 73' ' ' PHE . 24.4 tp -62.98 -52.27 63.66 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.92 0.763 . . . . 0.0 110.841 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -68.05 -43.23 79.13 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.536 -173.394 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.23 -33.3 74.33 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.095 0.407 . . . . 0.0 110.106 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -65.26 -45.96 82.42 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.87 0.868 . . . . 0.0 110.638 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.9 mtm -74.16 -27.92 61.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.376 0.671 . . . . 0.0 111.296 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.8 mmmt -75.88 -37.37 58.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.126 177.441 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 121.307 0.575 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -76.52 150.48 36.59 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.445 174.656 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.96 131.65 41.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -114.99 159.6 20.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.594 0.758 . . . . 0.0 109.681 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.8 ptm -138.01 130.65 29.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.173 0.989 . . . . 0.0 109.203 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.13 101.65 10.86 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.501 ' HA ' HG12 ' A' ' 63' ' ' VAL . 36.8 mt -82.04 118.36 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 44.4 tt0 -81.46 139.89 34.94 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -123.57 132.31 53.85 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.967 1.307 . . . . 0.0 109.126 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -140.24 165.5 27.22 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.642 0.777 . . . . 0.0 109.388 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.8 t70 59.0 39.59 23.33 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.275 1.03 . . . . 0.0 110.331 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.8 t -68.26 101.18 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.125 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -74.16 131.51 41.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.604 1.161 . . . . 0.0 109.862 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -92.56 125.97 37.43 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.239 0.543 . . . . 0.0 109.555 172.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.1 98.69 11.92 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.926 0.89 . . . . 0.0 109.338 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.85 -30.75 68.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.652 172.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -84.92 132.8 44.79 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.378 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.58 102.11 1.52 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.118 2.546 . . . . 0.0 111.606 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.8 mt -111.04 129.37 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.284 0.564 . . . . 0.0 110.463 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.79 141.52 64.25 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.938 0.895 . . . . 0.0 109.59 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.92 157.15 58.9 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.186 1.924 . . . . 0.0 112.13 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -63.21 -27.81 69.62 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.881 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -154.35 163.86 39.5 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.984 1.314 . . . . 0.0 107.755 166.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -61.21 136.03 57.93 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.49 HG12 ' HD3' ' A' ' 10' ' ' PRO . 28.7 t -106.01 103.62 45.53 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 -178.37 2.56 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.151 2.568 . . . . 0.0 112.278 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.97 -36.05 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.908 0.883 . . . . 0.0 111.622 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.62 -16.43 77.74 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-N 116.117 -0.492 . . . . 0.0 113.166 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.5 162.97 25.51 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 123.052 0.358 . . . . 0.0 112.962 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -114.79 152.51 31.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.547 0.739 . . . . 0.0 110.188 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.72 117.21 29.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 170.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.1 114.38 21.72 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.31 141.73 51.23 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.494 ' HB2' HG13 ' A' ' 5' ' ' VAL . 10.0 tp10 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 5' ' ' VAL . 30.3 mm 66.05 -174.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.684 0 C-N-CA 124.163 0.985 . . . . 0.0 108.791 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.451 ' H ' HG22 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -150.64 -42.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.858 1.263 . . . . 0.0 107.776 160.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -167.44 -162.54 19.46 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.355 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.429 HG12 HD11 ' A' ' 60' ' ' ILE . 8.6 p -119.44 151.1 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 172.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -122.87 132.35 54.15 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.731 0.813 . . . . 0.0 108.845 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -131.42 144.14 52.16 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.066 0.946 . . . . 0.0 109.673 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.513 ' HD3' HG12 ' A' ' 130' ' ' VAL . 97.3 Cg_endo -74.48 -17.01 21.31 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.576 2.184 . . . . 0.0 112.028 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 16' ' ' MET . 14.2 mm 49.15 80.88 0.28 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.154 1.382 . . . . 0.0 109.678 -167.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HG3' HG23 ' A' ' 132' ' ' VAL . 96.5 Cg_endo -78.57 15.47 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.001 2.467 . . . . 0.0 112.94 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -104.8 152.74 22.21 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.46 1.104 . . . . 0.0 109.823 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -66.08 -8.38 23.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.652 1.181 . . . . 0.0 112.797 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -97.0 28.05 3.73 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.657 1.183 . . . . 0.0 112.323 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.507 ' HA ' HG21 ' A' ' 11' ' ' ILE . 27.0 ptt? -63.94 -30.16 71.26 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.287 0.565 . . . . 0.0 110.712 174.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -72.05 -21.85 61.47 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.523 1.129 . . . . 0.0 112.595 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 84.4 mmt-85 -58.36 -38.25 76.86 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.959 0.903 . . . . 0.0 112.615 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 64.5 m-85 -67.18 -30.35 70.28 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 121.087 0.47 . . . . 0.0 110.473 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -96.77 -8.58 30.86 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.158 0.983 . . . . 0.0 110.78 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -84.88 -54.64 4.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.813 1.245 . . . . 0.0 110.03 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.9 ptpt -98.3 -13.8 20.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.814 -171.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.46 -23.81 9.43 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 113.857 0.303 . . . . 0.0 113.857 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -148.72 116.86 6.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.026 0.93 . . . . 0.0 109.487 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 14.4 t70 -123.44 175.43 6.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.275 0.63 . . . . 0.0 110.001 -170.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.88 109.53 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.431 ' HD2' HD12 ' A' ' 112' ' ' ILE . 85.7 t80 -87.82 108.82 19.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.45 0.7 . . . . 0.0 109.561 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 m -92.59 138.44 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.181 0.515 . . . . 0.0 110.977 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HD2' ' HD2' ' A' ' 30' ' ' PRO . 13.9 mmtp -129.45 147.31 64.63 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.674 1.19 . . . . 0.0 110.068 170.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HD2' ' A' ' 29' ' ' LYS . 82.0 Cg_endo -77.15 53.17 4.12 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.985 2.457 . . . . 0.0 111.754 165.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 38.23 64.93 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.564 1.546 . . . . 0.0 112.928 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -94.02 -27.13 16.48 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.198 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.56 152.76 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.319 1.048 . . . . 0.0 111.141 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -65.87 169.38 6.68 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.505 0.722 . . . . 0.0 109.878 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -68.83 -2.16 8.89 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.66 -30.68 65.62 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.684 0.794 . . . . 0.0 111.502 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.401 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -62.24 116.3 4.89 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.557 0.743 . . . . 0.0 110.588 -179.234 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.83 152.99 53.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.968 0.907 . . . . 0.0 109.697 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.95 105.99 1.25 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.886 2.391 . . . . 0.0 111.305 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.92 -8.62 1.75 Allowed Glycine 0 N--CA 1.471 0.995 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.237 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.549 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 83.2 mtp -84.51 179.46 7.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.29 1.036 . . . . 0.0 111.305 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.408 ' HG3' ' HA3' ' A' ' 6' ' ' GLY . 14.4 ptpt -110.23 164.47 12.62 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.91 0.884 . . . . 0.0 110.162 172.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.44 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 t80 -135.44 94.87 3.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -83.09 120.48 34.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.226 0.536 . . . . 0.0 110.143 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -83.72 97.64 9.23 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.57 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.6 t80 . . . . . 0 CA--C 1.55 0.951 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 163.384 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.61 -28.93 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 122.995 0.518 . . . . 0.0 110.408 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.44 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . 175.61 -164.05 34.12 Favored Glycine 0 C--N 1.344 1.019 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.838 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -151.14 178.9 8.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.812 0.845 . . . . 0.0 109.21 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -161.5 -172.27 3.29 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.18 0.992 . . . . 0.0 109.685 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -128.7 120.87 27.3 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.807 0.843 . . . . 0.0 110.087 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 43' ' ' PHE . 54.1 mt -70.66 134.32 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.483 1.113 . . . . 0.0 111.273 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.2 mmmt -131.76 178.42 6.77 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 126.091 1.756 . . . . 0.0 109.82 -175.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -29.13 110.45 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.774 2.03 . . . . 0.0 114.507 -175.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 112' ' ' ILE . 33.4 m -93.11 118.38 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.801 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.0 119.26 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.733 0.813 . . . . 0.0 109.077 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HB3' HD11 ' A' ' 108' ' ' LEU . 70.9 mt -101.99 120.77 40.95 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.78 0.832 . . . . 0.0 109.47 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.6 t -152.67 135.12 15.16 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.057 0.943 . . . . 0.0 110.113 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 14.8 mt-10 -63.84 -23.56 67.4 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.149 0.98 . . . . 0.0 112.19 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -102.84 120.16 53.41 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.453 ' HG2' HD21 ' A' ' 87' ' ' LEU . 36.7 Cg_endo -64.74 -19.75 64.66 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.689 2.259 . . . . 0.0 112.189 174.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 44.2 mtm -73.27 -23.86 60.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.847 0.859 . . . . 0.0 110.477 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 23.7 mt-30 -71.05 -23.52 62.16 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.529 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.31 -24.04 54.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.736 0.414 . . . . 0.0 111.017 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.504 ' HE2' HD22 ' A' ' 87' ' ' LEU . 55.4 m-85 -88.35 -27.5 21.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.088 0.555 . . . . 0.0 111.623 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.9 pt-20 -82.46 -27.46 31.85 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 120.388 0.137 . . . . 0.0 110.656 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.5 m -84.89 -50.65 7.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.686 0.394 . . . . 0.0 110.61 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.746 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 89.2 m-85 -107.41 -69.37 0.85 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.153 0.581 . . . . 0.0 110.628 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.2 -80.99 0.07 OUTLIER Glycine 0 C--N 1.358 1.75 0 O-C-N 123.546 0.528 . . . . 0.0 113.515 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.14 -31.86 67.61 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.811 1.244 . . . . 0.0 111.778 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.746 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 30.3 mmt180 -74.02 -36.12 64.41 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.35 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.32 148.84 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.973 0.509 . . . . 0.0 110.677 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.48 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 45.7 p90 -62.56 -34.14 76.36 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 82' ' ' LEU . 2.3 pt? -117.16 170.63 8.52 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.529 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.4 t -106.21 175.81 5.37 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -60.93 -31.78 71.3 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.134 0.974 . . . . 0.0 111.577 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.77 -43.01 90.13 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.292 0.637 . . . . 0.0 110.73 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HG2' HG22 ' A' ' 83' ' ' THR . 60.1 mm-40 -65.99 -33.86 76.79 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.143 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.504 HD22 ' HE2' ' A' ' 73' ' ' PHE . 26.7 tp -63.87 -54.54 33.23 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.415 0.686 . . . . 0.0 111.002 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -67.11 -36.88 82.88 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.751 -171.456 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 90' ' ' TYR . 6.7 pt-20 -66.25 -40.21 90.03 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 173.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.412 ' N ' ' HG3' ' A' ' 89' ' ' GLU . 79.7 t80 -61.87 -40.21 94.61 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.223 1.009 . . . . 0.0 111.055 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.6 mtm -73.15 -35.07 66.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.068 0.547 . . . . 0.0 110.965 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.0 mmmt -69.85 -25.89 63.95 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.6 0.36 . . . . 0.0 110.608 173.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 123.224 0.609 . . . . 0.0 111.463 177.294 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 3.9 tmtp? -102.73 138.8 39.15 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 65' ' ' LEU . 3.0 tm? -77.2 104.65 7.83 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.422 ' CE3' ' HB3' ' A' ' 69' ' ' PRO . 24.8 m95 -82.93 161.08 21.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.205 0.602 . . . . 0.0 109.524 174.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.6 ptm -136.72 141.96 43.07 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.129 0.971 . . . . 0.0 109.754 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.17 103.97 9.7 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.125 0.97 . . . . 0.0 109.006 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.501 ' HA ' HG12 ' A' ' 63' ' ' VAL . 30.9 mt -81.45 122.45 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -82.96 136.65 34.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -123.3 132.73 54.11 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.223 0.609 . . . . 0.0 110.356 -175.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -131.87 172.57 12.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.888 0.875 . . . . 0.0 110.294 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.1 t70 49.05 50.01 18.59 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.809 1.243 . . . . 0.0 111.874 170.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.34 101.61 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.153 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -77.87 148.41 34.65 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.512 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -111.28 111.86 23.21 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.164 0.585 . . . . 0.0 110.32 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.44 ' H ' ' HA2' ' A' ' 56' ' ' GLY . 4.8 m-85 -83.9 87.06 7.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.961 0.904 . . . . 0.0 109.244 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.45 -15.08 56.16 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.701 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -80.47 137.61 51.78 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.296 1.039 . . . . 0.0 110.294 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.21 79.6 3.33 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 123.079 2.519 . . . . 0.0 113.178 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.8 mt -98.49 137.4 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.153 0.581 . . . . 0.0 110.598 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -71.22 151.32 94.52 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.258 1.023 . . . . 0.0 111.032 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.42 153.84 65.6 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.195 1.93 . . . . 0.0 111.384 167.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -36.55 74.95 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -152.19 169.51 22.28 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.202 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.98 132.48 48.0 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.32 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.513 HG12 ' HD3' ' A' ' 10' ' ' PRO . 17.6 t -118.89 99.6 51.07 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.093 0.557 . . . . 0.0 109.704 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.19 -174.87 2.12 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.478 2.785 . . . . 0.0 112.591 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.575 HG23 ' HG3' ' A' ' 12' ' ' PRO . 5.5 p -54.91 -40.3 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.661 1.184 . . . . 0.0 112.62 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.63 -12.91 82.41 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 113.581 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.95 159.49 15.09 Favored Glycine 0 C--N 1.348 1.208 0 C-N-CA 122.9 0.286 . . . . 0.0 112.838 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -113.58 150.02 33.65 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.534 0.734 . . . . 0.0 109.082 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -84.05 115.55 22.42 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.42 125.76 29.65 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.99 122.27 22.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.427 ' HB3' HG11 ' A' ' 5' ' ' VAL . 9.9 tp10 . . . . . 0 C--O 1.243 0.763 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.05 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 5' ' ' VAL . 16.9 mm 64.45 -171.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.879 0 C-N-CA 124.005 0.922 . . . . 0.0 108.912 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.523 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.3 m -156.22 -32.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 125.497 1.519 . . . . 0.0 109.131 156.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -166.97 -164.05 21.91 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.324 0.39 . . . . 0.0 112.839 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.466 HG12 HD11 ' A' ' 60' ' ' ILE . 10.4 p -139.0 144.81 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.508 0.723 . . . . 0.0 109.158 173.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 t -116.97 132.59 56.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.946 0.898 . . . . 0.0 110.0 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -133.18 140.64 37.99 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.561 1.144 . . . . 0.0 108.8 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 25.1 Cg_exo -63.8 -41.32 24.58 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.085 2.524 . . . . 0.0 111.828 169.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.4 mt 54.11 77.38 0.44 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 124.67 1.188 . . . . 0.0 110.001 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.63 0.24 6.6 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.103 2.535 . . . . 0.0 113.501 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -69.21 144.86 53.61 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 121.501 0.667 . . . . 0.0 110.499 172.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -59.22 -10.77 3.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.18 1.392 . . . . 0.0 112.852 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -99.43 22.1 11.18 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.445 1.098 . . . . 0.0 112.491 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.9 -29.27 70.2 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.937 0.495 . . . . 0.0 109.877 168.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -67.81 -27.25 66.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.825 1.25 . . . . 0.0 111.898 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 24.3 mmt180 -55.69 -37.03 67.81 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.935 0.894 . . . . 0.0 113.134 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.415 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 62.2 m-85 -66.19 -29.67 69.98 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.107 0.479 . . . . 0.0 110.865 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.13 -23.24 18.67 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.585 1.154 . . . . 0.0 110.282 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -74.01 -55.51 6.05 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.815 1.246 . . . . 0.0 110.673 -174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.2 ptpt -93.99 -12.61 28.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.444 0.698 . . . . 0.0 111.24 -175.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.49 -30.63 5.92 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 122.924 0.297 . . . . 0.0 113.192 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.82 118.39 7.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.873 0.869 . . . . 0.0 108.857 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 16.5 t70 -123.25 -179.43 4.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.765 0.826 . . . . 0.0 109.918 -168.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -134.34 110.55 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.324 1.05 . . . . 0.0 108.847 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -92.94 120.96 33.8 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.86 137.78 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.458 0.646 . . . . 0.0 111.113 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.6 mmpt? -127.58 133.63 25.3 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.476 1.51 . . . . 0.0 109.947 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.5 55.95 4.92 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.803 2.335 . . . . 0.0 111.113 166.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.2 36.11 4.25 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.201 1.4 . . . . 0.0 113.215 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 9.1 m -64.12 -28.26 69.65 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.667 0.746 . . . . 0.0 110.266 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.1 m -90.48 150.45 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.756 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -79.88 178.0 8.52 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.91 0.884 . . . . 0.0 109.788 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -69.91 4.24 2.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.217 1.007 . . . . 0.0 113.697 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.7 -26.23 68.56 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.245 0.618 . . . . 0.0 110.198 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.48 110.77 2.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.796 0.838 . . . . 0.0 110.718 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -134.31 152.07 77.46 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.23 102.6 0.96 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.38 2.053 . . . . 0.0 110.845 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.75 35.95 0.21 Allowed Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.365 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.499 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 24.5 mtm -119.0 -168.02 1.49 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.448 0.699 . . . . 0.0 110.726 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -110.1 157.06 19.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.19 0.996 . . . . 0.0 108.864 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.562 ' HB2' HG13 ' A' ' 60' ' ' ILE . 2.7 t80 -134.64 104.43 6.05 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 40.5 t -94.6 121.5 45.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.485 0.66 . . . . 0.0 109.823 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -86.21 103.51 14.9 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.249 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 16.2 t80 . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 120.416 0.15 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.26 -23.32 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.041 0.536 . . . . 0.0 109.714 169.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.432 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . 176.07 -165.1 35.46 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.017 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 11.1 pt-20 -153.65 178.1 10.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.073 0.949 . . . . 0.0 109.581 172.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -162.31 -172.42 3.18 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.013 0.925 . . . . 0.0 110.181 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -124.2 122.74 38.6 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.786 0.834 . . . . 0.0 109.773 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 43' ' ' PHE . 41.4 mt -72.16 133.52 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.067 0.947 . . . . 0.0 110.6 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -140.16 -166.18 2.05 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.166 1.787 . . . . 0.0 108.065 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -37.71 118.81 0.69 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.273 1.429 . . . . 0.0 114.565 -165.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -98.27 116.21 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 123.087 0.555 . . . . 0.0 109.8 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -91.12 113.05 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.367 0.667 . . . . 0.0 109.36 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.517 ' HB3' HD11 ' A' ' 108' ' ' LEU . 57.5 mt -90.24 124.68 35.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.512 0.725 . . . . 0.0 109.743 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -152.55 138.23 17.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.004 0.921 . . . . 0.0 110.222 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -75.33 -12.05 60.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.582 0.753 . . . . 0.0 111.556 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.554 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 74.7 m-20 -112.01 119.88 43.22 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.329 0.652 . . . . 0.0 109.274 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HG2' HD21 ' A' ' 87' ' ' LEU . 53.6 Cg_endo -67.94 -12.83 36.56 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.8 2.333 . . . . 0.0 113.33 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.3 mtm -81.99 -22.61 36.47 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.485 0.714 . . . . 0.0 110.945 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.554 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 62.3 mt-30 -70.73 -20.27 62.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.984 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -74.59 -25.53 59.32 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.052 0.541 . . . . 0.0 110.927 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.598 ' HE2' HD22 ' A' ' 87' ' ' LEU . 37.0 m-85 -85.19 -27.72 25.93 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.969 0.508 . . . . 0.0 111.728 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.36 -33.7 48.84 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 120.508 0.194 . . . . 0.0 110.675 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -79.77 -56.42 4.29 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.974 0.51 . . . . 0.0 111.132 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.702 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 37.3 m-85 -103.28 -68.0 0.86 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.249 0.619 . . . . 0.0 109.702 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.76 -81.51 0.12 Allowed Glycine 0 C--N 1.355 1.614 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.118 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.84 -36.18 69.7 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.592 1.157 . . . . 0.0 111.327 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.702 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 26.5 mmt180 -78.54 -30.27 46.85 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.801 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 76' ' ' PHE . 42.7 t -65.12 140.62 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -57.5 -45.99 84.28 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 122.606 0.362 . . . . 0.0 111.697 -174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -105.46 164.04 12.18 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.479 HG22 ' HG2' ' A' ' 86' ' ' GLU . 13.0 t -99.24 -179.69 4.32 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -68.76 -29.85 68.33 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.908 0.483 . . . . 0.0 111.338 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 2.9 m-20 -68.96 -30.23 68.62 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.324 0.583 . . . . 0.0 111.269 174.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.479 ' HG2' HG22 ' A' ' 83' ' ' THR . 58.8 mm-40 -75.32 -28.52 59.69 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.827 174.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.598 HD22 ' HE2' ' A' ' 73' ' ' PHE . 56.5 tp -69.23 -47.15 65.55 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.712 0.405 . . . . 0.0 110.582 174.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -65.13 -40.16 94.06 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.854 -175.61 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.32 -33.95 73.93 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.707 0.23 . . . . 0.0 110.664 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.99 -44.52 95.79 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.708 0.803 . . . . 0.0 111.221 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.8 mtm -77.05 -35.6 56.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.295 0.638 . . . . 0.0 111.186 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -70.05 -23.69 63.14 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.423 0.289 . . . . 0.0 110.41 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 CA--C 1.539 0.541 0 C-N-CA 122.818 0.447 . . . . 0.0 111.008 173.579 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HD3' ' H ' ' A' ' 108' ' ' LEU . 4.8 tmtp? -135.37 144.42 46.61 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.5 tm? -77.77 100.25 6.2 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -82.92 159.69 22.25 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.367 0.667 . . . . 0.0 109.381 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.0 ptm -143.37 131.06 21.32 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.611 0.764 . . . . 0.0 110.279 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.17 102.59 11.99 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.813 0.845 . . . . 0.0 109.487 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.424 HG21 HG12 ' A' ' 60' ' ' ILE . 36.0 mt -81.26 127.89 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.748 0.819 . . . . 0.0 109.394 -177.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -81.61 123.47 28.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.3 mm? -105.27 129.1 53.71 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.159 0.983 . . . . 0.0 109.528 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.64 175.25 9.72 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.208 1.003 . . . . 0.0 108.492 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 t70 57.63 36.41 26.69 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.876 0.845 . . . . 0.0 110.737 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.16 105.17 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.742 -171.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.65 160.21 21.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.184 0.993 . . . . 0.0 110.472 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -117.5 123.19 45.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.178 0.991 . . . . 0.0 110.54 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.432 ' H ' ' HA2' ' A' ' 56' ' ' GLY . 10.3 m-85 -97.12 82.33 3.17 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.49 -24.77 65.62 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.513 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -81.87 139.42 46.58 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.796 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -83.29 65.9 7.7 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 123.235 2.624 . . . . 0.0 112.924 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.3 mt -77.02 114.34 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -71.35 145.38 90.55 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.198 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.99 155.19 70.61 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.612 2.208 . . . . 0.0 111.86 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -68.22 -31.07 70.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.617 0.767 . . . . 0.0 109.479 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -128.88 162.21 28.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.144 0.978 . . . . 0.0 109.824 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -77.3 121.88 24.33 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.477 ' HA ' ' HG2' ' A' ' 135' ' ' GLN . 17.8 t -107.69 100.07 32.88 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 122.829 0.451 . . . . 0.0 110.195 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.82 -176.94 3.41 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.01 2.473 . . . . 0.0 111.699 172.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -57.77 -31.22 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.322 1.049 . . . . 0.0 112.756 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.25 -19.27 72.13 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.708 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.76 142.21 3.12 Favored Glycine 0 C--N 1.351 1.361 0 C-N-CA 122.984 0.326 . . . . 0.0 113.031 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.477 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 14.2 mm100 -109.73 157.67 18.89 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.437 0.695 . . . . 0.0 109.836 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -87.35 129.1 35.15 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 170.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.1 tt -90.58 125.13 35.53 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.26 144.29 48.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt . . . . . 0 CA--C 1.551 0.989 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 5' ' ' VAL . 26.3 mm 64.85 -177.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 C-N-CA 124.402 1.081 . . . . 0.0 109.577 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 139' ' ' GLU . 1.3 m -150.24 -39.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.807 1.243 . . . . 0.0 108.712 158.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.39 -163.38 22.27 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.178 -176.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.432 HG11 HD21 ' A' ' 37' ' ' LEU . 9.0 p -137.1 141.39 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.663 0.785 . . . . 0.0 109.068 175.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 t -113.93 139.26 49.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.445 0.698 . . . . 0.0 110.163 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -131.55 143.74 50.46 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 123.695 0.798 . . . . 0.0 109.805 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' HG12 ' A' ' 130' ' ' VAL . 85.8 Cg_endo -73.98 -14.59 23.74 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.994 2.463 . . . . 0.0 112.354 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.1 mm 53.6 89.77 0.1 OUTLIER Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.922 1.289 . . . . 0.0 109.86 -174.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.03 24.35 0.54 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.905 2.403 . . . . 0.0 112.702 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 159.52 39.23 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.532 1.533 . . . . 0.0 108.499 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -74.93 -13.07 60.49 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.446 0.698 . . . . 0.0 111.239 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -72.52 6.85 2.13 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.234 1.013 . . . . 0.0 113.597 -172.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -56.76 -34.21 67.36 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.002 0.43 . . . . 0.0 110.058 164.425 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.47 ' N ' ' SD ' ' A' ' 16' ' ' MET . 19.6 t70 -49.42 -41.49 39.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.647 1.579 . . . . 0.0 112.428 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -54.56 -48.2 72.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.262 1.025 . . . . 0.0 112.465 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 64.5 m-85 -66.75 -28.9 68.78 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.988 0.805 . . . . 0.0 110.406 -177.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -91.1 -19.32 23.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.01 0.524 . . . . 0.0 111.376 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -76.74 -59.67 2.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.321 0.648 . . . . 0.0 109.497 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -92.73 -10.23 37.83 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.222 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.3 3.02 69.08 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.416 0.447 . . . . 0.0 114.006 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -168.16 100.43 0.44 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.009 0.924 . . . . 0.0 109.736 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.469 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 20.1 t70 -129.05 -170.74 2.33 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.0 t -133.18 117.51 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.94 1.245 . . . . 0.0 109.248 -174.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -90.49 107.33 19.09 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.278 0.631 . . . . 0.0 109.517 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.3 m -87.67 142.85 12.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.423 0.63 . . . . 0.0 109.903 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HE2' ' HD2' ' A' ' 30' ' ' PRO . 2.1 tpmt? -135.05 128.07 18.43 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.383 1.073 . . . . 0.0 108.53 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 79.7 Cg_endo -76.26 59.29 5.97 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.716 2.277 . . . . 0.0 111.736 171.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 39.49 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.882 1.673 . . . . 0.0 113.487 -174.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.499 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 27.9 m -127.91 -31.48 2.4 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.384 0.674 . . . . 0.0 109.754 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.79 148.47 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.41 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -87.98 -164.14 1.06 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.129 0.972 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -70.13 -2.21 12.34 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -63.38 -31.32 72.44 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.234 0.47 . . . . 0.0 110.765 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.432 HD21 HG11 ' A' ' 7' ' ' VAL . 1.1 mm? -64.93 117.44 7.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.132 0.573 . . . . 0.0 111.614 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.07 149.81 46.85 Favored Pre-proline 0 C--O 1.244 0.787 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.791 173.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.31 101.88 0.65 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.541 2.16 . . . . 0.0 111.047 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.83 0.62 0.78 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.483 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.427 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 26.2 mtm -89.7 -169.75 2.57 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 117.319 0.56 . . . . 0.0 110.984 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -107.86 160.06 16.04 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.507 0.723 . . . . 0.0 109.474 173.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CB ' HD11 ' A' ' 114' ' ' LEU . 12.3 t80 -134.98 105.25 6.29 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.8 t -90.76 121.13 40.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.175 0.512 . . . . 0.0 109.868 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -82.95 105.16 13.72 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.437 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 56.8 t80 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 66.7 m-85 . . . . . 0 CA--C 1.545 0.768 0 CA-C-O 120.525 0.202 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.53 -33.75 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.932 0.893 . . . . 0.0 110.88 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.6 -168.58 30.88 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.474 -0.33 . . . . 0.0 112.76 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 6.5 pt-20 -147.83 179.46 7.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.396 1.078 . . . . 0.0 108.918 174.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -164.19 -172.24 2.69 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.679 0.791 . . . . 0.0 110.659 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -123.94 119.03 28.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.507 1.123 . . . . 0.0 109.576 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 43' ' ' PHE . 53.7 mt -71.81 131.78 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.217 1.007 . . . . 0.0 110.733 177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -138.13 -162.4 1.3 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.212 1.805 . . . . 0.0 107.773 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -38.96 116.0 0.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.821 1.249 . . . . 0.0 113.466 -160.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.9 m -96.18 106.36 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 121.735 0.778 . . . . 0.0 109.113 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 86.2 t -89.96 108.02 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.8 mt -89.37 120.32 30.6 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.504 0.722 . . . . 0.0 109.398 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.7 t -151.58 135.73 16.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.557 0.743 . . . . 0.0 110.091 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -70.97 -10.22 59.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.922 0.889 . . . . 0.0 111.837 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -110.12 122.56 38.46 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.58 -22.35 58.41 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.218 1.945 . . . . 0.0 112.282 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 47.5 mtm -70.33 -25.63 63.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.484 0.713 . . . . 0.0 111.415 -169.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -53.56 -35.57 60.93 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.215 1.006 . . . . 0.0 112.03 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.418 ' HE2' ' HB3' ' A' ' 109' ' ' TRP . 5.7 m-85 -77.39 -33.82 55.04 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.525 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CE2' HD22 ' A' ' 87' ' ' LEU . 88.1 m-85 -81.5 -16.64 51.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.517 0.727 . . . . 0.0 111.65 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -94.14 -33.57 13.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.462 0.305 . . . . 0.0 111.208 172.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.2 m -78.08 -52.07 9.31 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.989 0.423 . . . . 0.0 110.737 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.797 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 66.9 m-85 -100.16 -53.96 3.0 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.538 0.735 . . . . 0.0 109.951 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.71 -86.44 0.12 Allowed Glycine 0 C--N 1.357 1.731 0 O-C-N 123.938 0.774 . . . . 0.0 113.129 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.92 -43.49 91.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.41 0.684 . . . . 0.0 110.692 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.797 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 25.0 mmt180 -68.74 -18.6 64.25 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-O 118.328 -0.844 . . . . 0.0 112.292 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 76' ' ' PHE . 47.9 t -80.25 131.9 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.628 1.104 . . . . 0.0 108.592 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -51.9 -37.58 52.98 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 124.092 0.87 . . . . 0.0 113.336 -170.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.0 pt? -111.75 160.0 17.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.539 HG22 ' HG2' ' A' ' 86' ' ' GLU . 8.9 t -97.24 173.69 7.09 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -61.26 -27.29 68.35 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.462 0.705 . . . . 0.0 111.438 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.95 -53.14 51.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.569 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 9.2 mm-40 -61.64 -29.74 70.26 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.566 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.514 HD22 ' CE2' ' A' ' 73' ' ' PHE . 25.2 tp -63.5 -58.56 6.63 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.121 0.968 . . . . 0.0 111.096 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -59.92 -41.19 91.18 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.571 0.544 . . . . 0.0 111.607 -172.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.94 -23.74 44.41 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.028 0.531 . . . . 0.0 111.477 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.79 -45.99 73.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.21 0.604 . . . . 0.0 109.788 171.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.3 mtm -67.27 -39.78 86.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.138 0.575 . . . . 0.0 110.381 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.2 mmpt? -64.0 -38.4 90.95 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.606 0.566 . . . . 0.0 110.293 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.3 t . . . . . 0 N--CA 1.474 0.767 0 C-N-CA 123.432 0.693 . . . . 0.0 110.749 177.975 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.239 0.543 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 30' ' ' PRO . 31.6 tptt -134.97 145.27 47.97 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.306 1.042 . . . . 0.0 108.73 173.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -80.15 121.62 25.8 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.418 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 41.6 m95 -107.77 158.55 17.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.055 0.942 . . . . 0.0 109.347 174.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.2 ptm -144.47 130.92 19.84 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.283 0.633 . . . . 0.0 110.271 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -103.78 102.38 12.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.637 0.775 . . . . 0.0 109.49 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.81 117.54 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.96 113.0 19.57 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.484 HD11 ' CB ' ' A' ' 43' ' ' PHE . 4.3 mm? -92.53 135.36 34.13 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.063 0.545 . . . . 0.0 110.726 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.81 167.95 20.88 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.645 0.778 . . . . 0.0 109.365 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.2 t70 53.6 47.45 23.86 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.312 1.053 . . . . 0.0 110.586 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 50.5 t -69.84 107.56 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.531 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -93.62 107.12 19.03 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.942 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -68.42 123.36 20.58 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -71.98 96.88 1.77 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 170.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -63.84 -33.37 75.53 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.465 0.706 . . . . 0.0 109.954 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.9 137.85 33.24 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.312 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.16 105.53 1.98 Allowed 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.161 1.907 . . . . 0.0 110.844 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 21.1 mt -91.03 108.14 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.525 0.678 . . . . 0.0 110.566 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -74.64 139.88 74.6 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.968 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -86.7 170.31 7.62 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 122.728 2.285 . . . . 0.0 112.367 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -87.68 -28.14 22.0 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.711 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -144.31 165.91 26.56 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.483 0.713 . . . . 0.0 110.479 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.0 134.2 44.57 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.509 HG12 ' HD3' ' A' ' 10' ' ' PRO . 62.2 t -101.6 100.0 13.04 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.37 176.5 5.58 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.225 2.616 . . . . 0.0 112.308 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.37 -30.81 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.622 0.769 . . . . 0.0 113.063 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.29 -21.23 75.75 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.537 0.523 . . . . 0.0 113.393 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.88 159.06 31.67 Favored Glycine 0 C--N 1.345 1.042 0 C-N-CA 123.453 0.549 . . . . 0.0 112.506 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -115.07 154.49 28.78 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.971 0.908 . . . . 0.0 109.759 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -88.49 124.15 33.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.97 116.11 27.78 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 172.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.66 139.46 52.7 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.537 ' HB2' HG13 ' A' ' 5' ' ' VAL . 4.4 tm-20 . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 5' ' ' VAL . 30.5 mm 67.38 -176.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 C-N-CA 124.168 0.987 . . . . 0.0 109.254 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.451 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.4 m -157.93 -41.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 125.498 1.519 . . . . 0.0 108.041 158.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.94 -161.32 18.97 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.178 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.52 155.9 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.879 0.872 . . . . 0.0 109.267 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -126.56 140.19 52.63 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.723 0.809 . . . . 0.0 109.706 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -141.94 142.84 26.21 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.65 0.78 . . . . 0.0 111.116 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HD3' HG12 ' A' ' 130' ' ' VAL . 74.9 Cg_endo -74.99 -12.81 21.54 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.943 2.429 . . . . 0.0 112.565 167.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.1 mm 69.2 123.46 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.815 1.646 . . . . 0.0 109.837 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.43 -7.07 18.05 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 122.894 2.396 . . . . 0.0 113.944 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HE3' ' HB3' ' A' ' 86' ' ' GLU . 67.9 mttm -134.62 170.88 15.13 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.448 1.099 . . . . 0.0 109.941 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -75.29 -5.05 42.65 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.597 0.759 . . . . 0.0 110.312 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -76.19 26.81 0.12 Allowed 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.007 0.923 . . . . 0.0 113.319 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -60.26 -32.96 71.65 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.827 0.851 . . . . 0.0 110.057 163.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.18 -21.32 66.75 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.837 0.855 . . . . 0.0 112.913 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 81' ' ' PHE . 37.4 mmt180 -57.43 -45.75 84.3 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.496 0.718 . . . . 0.0 110.796 176.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.526 ' HB3' HG11 ' A' ' 117' ' ' VAL . 65.8 m-85 -63.04 -31.11 72.18 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.664 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -91.48 -18.52 24.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.981 0.913 . . . . 0.0 111.111 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -72.96 -46.96 49.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.671 1.188 . . . . 0.0 109.84 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.8 ptpt -106.85 -15.87 14.61 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.226 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.76 -5.67 56.84 Favored Glycine 0 N--CA 1.48 1.588 0 N-CA-C 114.27 0.468 . . . . 0.0 114.27 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -161.68 107.83 1.34 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.31 1.044 . . . . 0.0 108.961 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.7 t70 -124.4 179.66 4.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.468 1.107 . . . . 0.0 109.675 -169.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 79' ' ' ARG . 55.3 t -128.87 109.67 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.44 0.696 . . . . 0.0 109.494 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.462 ' HD2' HD12 ' A' ' 112' ' ' ILE . 88.9 t80 -84.32 111.84 19.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m -89.93 139.45 17.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-O 121.526 0.679 . . . . 0.0 110.208 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.646 ' HG2' HG22 ' A' ' 33' ' ' VAL . 1.5 tpmt? -135.37 127.71 17.94 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.813 1.245 . . . . 0.0 108.507 -174.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 63.1 Cg_endo -73.14 60.37 3.86 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.643 2.229 . . . . 0.0 112.725 172.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.93 21.83 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.215 1.406 . . . . 0.0 114.509 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -64.69 -43.03 94.82 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.641 0.776 . . . . 0.0 111.045 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.646 HG22 ' HG2' ' A' ' 29' ' ' LYS . 20.1 m -72.84 150.33 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.752 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -82.56 -174.17 5.04 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.593 0.757 . . . . 0.0 111.839 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -66.98 -9.27 36.95 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.905 1.282 . . . . 0.0 111.387 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -60.63 -24.82 65.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.883 0.873 . . . . 0.0 110.848 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.88 91.83 2.02 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.519 0.728 . . . . 0.0 110.344 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 154.42 47.9 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 123.099 0.559 . . . . 0.0 109.951 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.67 99.25 0.93 Allowed 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.822 2.348 . . . . 0.0 111.476 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.18 -15.77 0.67 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.518 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.46 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 25.0 mtm -76.65 -178.98 5.03 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 121.554 0.692 . . . . 0.0 112.223 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -106.3 160.08 15.63 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.091 0.956 . . . . 0.0 110.352 171.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -135.49 97.04 3.58 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 93.4 t -86.82 120.92 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.254 0.549 . . . . 0.0 110.003 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -82.44 102.6 11.41 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.49 0.716 . . . . 0.0 110.115 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.8 t80 . . . . . 0 CA--C 1.546 0.803 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.528 170.4 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.01 -33.34 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.395 0.678 . . . . 0.0 111.272 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.6 -160.48 23.84 Favored Glycine 0 C--N 1.345 1.078 0 C-N-CA 121.546 -0.359 . . . . 0.0 113.131 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 11.6 pt-20 -151.28 177.78 9.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.231 1.012 . . . . 0.0 109.263 175.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -162.49 -173.32 3.51 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.139 0.976 . . . . 0.0 109.573 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -128.01 125.99 40.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.373 0.669 . . . . 0.0 110.228 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.1 mt -74.16 130.31 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.926 1.29 . . . . 0.0 111.288 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 30.7 mmmt -129.8 -164.39 1.4 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.616 1.567 . . . . 0.0 108.017 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -40.95 114.03 0.44 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.818 1.247 . . . . 0.0 113.743 -163.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -85.42 107.75 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 53.3 t -88.96 109.33 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.0 mt -87.37 117.82 26.39 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.474 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.3 t -151.18 130.33 12.69 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.155 0.982 . . . . 0.0 108.671 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.81 -6.67 33.86 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -105.51 122.19 43.58 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 170.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.576 ' HG2' HD21 ' A' ' 87' ' ' LEU . 57.7 Cg_endo -70.85 -15.98 32.99 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.743 2.295 . . . . 0.0 112.647 172.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 36.1 mtm -79.31 -25.03 42.44 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.672 0.789 . . . . 0.0 110.167 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -57.63 -32.43 67.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.403 1.081 . . . . 0.0 110.752 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.69 -19.91 58.77 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.028 0.531 . . . . 0.0 111.722 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.551 ' HE2' HD22 ' A' ' 87' ' ' LEU . 26.1 m-85 -86.64 -34.2 19.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.837 0.455 . . . . 0.0 110.685 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.46 -28.34 56.5 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 120.39 0.138 . . . . 0.0 110.723 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.5 m -83.6 -43.55 15.53 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.223 0.609 . . . . 0.0 111.505 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.787 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 64.0 m-85 -115.19 -67.5 0.99 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.786 0.435 . . . . 0.0 110.123 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.25 -83.92 0.62 Allowed Glycine 0 C--N 1.353 1.521 0 O-C-N 123.601 0.563 . . . . 0.0 113.044 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.73 -22.57 64.32 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.685 0.794 . . . . 0.0 111.831 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.787 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 31.6 mmt180 -72.33 -40.55 67.36 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.845 0.458 . . . . 0.0 111.385 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.415 HG12 HD23 ' A' ' 82' ' ' LEU . 13.5 t -69.52 147.31 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.006 0.522 . . . . 0.0 110.856 -170.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.447 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 28.9 p90 -69.86 -17.85 63.4 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 1.8 pt? -137.09 167.61 21.21 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 85' ' ' ASP . 13.9 t -110.04 -179.53 3.82 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.15 -27.92 69.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.25 0.62 . . . . 0.0 111.35 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 83' ' ' THR . 10.5 m-20 -62.5 -47.09 85.49 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.573 0.749 . . . . 0.0 111.25 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.512 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 1.8 mp0 -68.48 -29.52 68.15 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.576 HD21 ' HG2' ' A' ' 69' ' ' PRO . 46.8 tp -68.91 -48.9 62.19 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.837 0.455 . . . . 0.0 110.837 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -68.63 -36.68 78.94 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.008 -172.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 8.7 pt-20 -66.6 -36.28 82.24 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.12 -47.33 74.51 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.869 0.868 . . . . 0.0 110.754 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 67.2 mtm -70.02 -36.9 75.42 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.158 0.583 . . . . 0.0 110.63 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -62.34 -43.0 99.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.04 0.536 . . . . 0.0 110.279 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.48 1.062 0 C-N-CA 123.913 0.885 . . . . 0.0 111.355 -177.267 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 152.2 51.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.086 0.555 . . . . 0.0 109.738 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -71.64 127.23 31.88 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -116.68 159.12 22.7 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.404 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 14.7 ptm -142.47 130.58 22.0 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.282 0.633 . . . . 0.0 109.873 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -104.24 101.61 11.33 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.737 0.815 . . . . 0.0 109.198 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.462 HD12 ' HD2' ' A' ' 27' ' ' PHE . 27.9 mt -82.2 120.07 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -81.87 98.37 8.48 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.4 mm? -81.56 131.41 35.27 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 122.005 -0.434 . . . . 0.0 109.938 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.477 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 1.0 OUTLIER -138.47 159.79 41.2 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.183 0.593 . . . . 0.0 109.415 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.8 t70 53.58 48.33 21.91 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.364 1.065 . . . . 0.0 110.757 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 19' ' ' PHE . 27.2 t -71.62 101.89 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.206 -174.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.24 154.02 21.03 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.441 -174.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -107.08 138.55 43.04 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.531 0.732 . . . . 0.0 110.01 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -86.34 85.83 7.33 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 169.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.44 -39.23 82.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.072 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -81.66 148.48 61.91 Favored Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.275 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.77 114.94 4.06 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.679 2.253 . . . . 0.0 112.114 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.5 mt -114.5 131.49 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 145.91 30.4 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.24 1.016 . . . . 0.0 109.114 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -80.4 132.89 9.33 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.574 2.183 . . . . 0.0 111.659 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -66.58 -25.35 66.59 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.565 0.746 . . . . 0.0 110.662 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -146.25 166.87 24.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.144 0.978 . . . . 0.0 110.436 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -79.31 135.53 36.76 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.452 HG12 ' HD3' ' A' ' 10' ' ' PRO . 39.1 t -114.09 105.0 54.7 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.86 -174.31 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.168 2.578 . . . . 0.0 112.668 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.4 -34.84 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.889 0.875 . . . . 0.0 110.617 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.54 -24.2 75.23 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.24 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.76 167.42 42.0 Favored Glycine 0 C--N 1.346 1.1 0 C-N-CA 123.201 0.429 . . . . 0.0 112.94 175.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -118.44 151.84 37.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.082 0.953 . . . . 0.0 109.377 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -89.56 128.1 35.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tt -89.09 118.47 28.83 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.79 115.18 18.25 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.25 1.109 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -170.442 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.556 HG22 ' H ' ' A' ' 5' ' ' VAL . 23.1 mm 62.14 -164.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -172.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.556 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.3 m -148.64 -40.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 154.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.89 -161.68 20.79 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.342 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.59 149.27 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 6.2 t -121.86 134.47 54.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.524 0.73 . . . . 0.0 109.043 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -128.32 144.73 52.98 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.929 0.892 . . . . 0.0 109.217 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 42.1 Cg_exo -56.94 -31.13 88.63 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.132 2.555 . . . . 0.0 111.928 170.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.9 mm 68.45 131.79 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 125.675 1.59 . . . . 0.0 111.033 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.79 135.89 50.31 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.914 2.409 . . . . 0.0 112.078 172.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -66.16 -25.51 66.99 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.781 0.832 . . . . 0.0 112.737 -169.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -66.01 -37.31 85.57 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.302 0.641 . . . . 0.0 110.442 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.417 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 25.2 m-85 -114.88 13.33 17.1 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.542 -162.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.7 ttp -60.77 -41.51 95.65 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.022 0.529 . . . . 0.0 110.733 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.47 -18.81 51.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.903 0.881 . . . . 0.0 112.738 -173.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 15' ' ' PHE . 1.3 mmp_? -52.48 -48.48 65.88 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.354 0.662 . . . . 0.0 112.142 -173.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -66.22 -30.09 70.48 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.54 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -94.23 -12.11 28.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.872 0.869 . . . . 0.0 111.379 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -78.66 -52.16 8.82 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.745 0.818 . . . . 0.0 108.858 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -101.72 -16.83 16.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.282 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.67 10.31 63.71 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 114.11 0.404 . . . . 0.0 114.11 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -163.27 92.91 0.76 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.159 0.984 . . . . 0.0 109.049 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -127.3 -177.72 4.17 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.43 -168.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -141.7 117.97 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.062 0.945 . . . . 0.0 109.068 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -100.39 114.16 27.47 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.325 0.65 . . . . 0.0 109.446 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -92.99 141.11 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.264 0.554 . . . . 0.0 111.175 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.88 125.33 20.21 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 125.25 1.42 . . . . 0.0 110.466 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.53 71.26 6.02 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.934 2.423 . . . . 0.0 112.411 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 54.34 23.93 4.74 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.064 1.346 . . . . 0.0 113.35 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -73.2 -49.12 29.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.376 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 m -74.14 149.21 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.592 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -73.39 179.25 4.08 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.367 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.11 -7.77 25.72 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.325 1.05 . . . . 0.0 112.85 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.76 -25.44 66.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.461 0.704 . . . . 0.0 111.007 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.22 93.17 0.13 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.644 0.777 . . . . 0.0 111.03 175.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.46 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -113.24 149.24 41.14 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.596 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.24 99.56 1.03 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.535 2.156 . . . . 0.0 111.184 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.9 -2.17 0.73 Allowed Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.955 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.46 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 29.5 mtm -83.2 -170.49 3.07 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.501 0.667 . . . . 0.0 111.607 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.3 ptpt -115.55 162.49 17.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.527 1.131 . . . . 0.0 110.338 171.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.526 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.14 101.05 4.73 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 58.9 t -83.83 119.5 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.532 0.682 . . . . 0.0 109.371 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -85.89 113.46 22.04 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 88.4 t80 . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 171.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 27.5 m-85 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 p -125.71 -31.66 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.026 0.93 . . . . 0.0 110.209 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.93 -167.51 35.53 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.154 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 13.6 pt-20 -146.62 177.64 8.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.875 0.87 . . . . 0.0 109.308 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.453 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.45 -172.4 3.54 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.362 1.065 . . . . 0.0 109.348 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 86.0 mmt-85 -123.58 118.81 28.17 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.679 0.792 . . . . 0.0 109.775 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' ' 43' ' ' PHE . 51.0 mt -69.99 129.27 34.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 O-C-N 124.449 1.093 . . . . 0.0 109.595 174.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 14.7 mmmm -134.41 -172.54 3.04 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 125.553 1.541 . . . . 0.0 108.671 -175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -32.29 110.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.884 1.674 . . . . 0.0 114.371 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.7 m -90.27 117.61 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 68.5 t -90.39 108.8 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.9 mt -86.44 118.97 26.21 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.0 t -152.65 134.27 14.57 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.865 0.866 . . . . 0.0 109.817 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.518 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 58.0 mt-10 -68.98 -11.86 61.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 122.868 0.467 . . . . 0.0 111.495 174.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.579 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 10.1 m-80 -103.23 117.33 60.53 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.488 ' HG2' HD21 ' A' ' 87' ' ' LEU . 59.3 Cg_endo -73.96 -10.24 22.83 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.262 1.975 . . . . 0.0 112.817 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -78.78 -25.12 44.35 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.328 0.651 . . . . 0.0 111.027 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.579 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 75.5 mt-30 -68.68 -21.9 64.4 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.678 176.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -75.44 -23.63 56.94 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.877 0.471 . . . . 0.0 110.801 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.556 ' HE2' HD22 ' A' ' 87' ' ' LEU . 31.2 m-85 -85.25 -32.4 22.6 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.489 0.316 . . . . 0.0 111.707 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.7 pt-20 -75.15 -30.85 60.88 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 120.523 0.202 . . . . 0.0 110.726 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -79.17 -58.36 3.26 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.212 0.605 . . . . 0.0 110.655 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.785 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 61.8 m-85 -101.61 -67.63 0.86 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.579 0.752 . . . . 0.0 110.156 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.7 -84.66 0.77 Allowed Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.83 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.64 -46.55 86.89 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.422 0.689 . . . . 0.0 110.38 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.785 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 29.8 mmt180 -62.43 -30.22 71.07 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 124.066 0.854 . . . . 0.0 111.76 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.489 HG12 HD23 ' A' ' 82' ' ' LEU . 30.8 t -68.15 136.0 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -56.98 -28.51 62.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.583 0.753 . . . . 0.0 112.748 -171.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.489 HD23 HG12 ' A' ' 80' ' ' VAL . 1.8 pt? -123.53 155.28 37.86 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.621 0.768 . . . . 0.0 109.197 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.557 HG22 ' HG2' ' A' ' 86' ' ' GLU . 15.1 t -91.49 176.92 6.38 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.4 -34.41 77.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.673 0.389 . . . . 0.0 111.514 -177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -61.44 -44.72 96.62 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.405 0.682 . . . . 0.0 110.767 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HG2' HG22 ' A' ' 83' ' ' THR . 63.8 mm-40 -66.1 -35.44 80.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.357 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.556 HD22 ' HE2' ' A' ' 73' ' ' PHE . 29.1 tp -68.2 -47.95 66.51 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -35.45 78.73 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.21 -31.74 67.97 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 123.162 0.289 . . . . 0.0 110.917 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -66.36 -44.85 82.07 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.77 0.828 . . . . 0.0 110.934 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.3 mtm -76.82 -34.34 57.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.116 0.567 . . . . 0.0 110.454 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -64.38 -35.34 80.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.18 0.592 . . . . 0.0 110.42 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.475 0.783 0 O-C-N 123.688 0.618 . . . . 0.0 110.549 176.746 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.2 tpmt? -134.77 144.71 47.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.7 0.4 . . . . 0.0 109.966 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.66 113.26 15.33 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -96.9 153.55 17.83 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.5 ptm -132.61 130.05 39.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.277 0.631 . . . . 0.0 109.62 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -98.13 102.45 14.2 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.631 0.772 . . . . 0.0 109.123 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.444 ' HA ' HG12 ' A' ' 63' ' ' VAL . 51.4 mt -78.95 121.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -78.9 133.15 36.96 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.216 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.5 mm? -122.01 119.23 30.84 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.351 0.66 . . . . 0.0 109.757 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -125.29 175.89 7.14 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.571 0.748 . . . . 0.0 109.427 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 t70 54.52 36.0 24.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.002 0.921 . . . . 0.0 111.03 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.3 t -65.54 111.07 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.523 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.86 112.92 24.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.111 0.965 . . . . 0.0 110.988 -172.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -67.18 139.34 57.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.813 0.845 . . . . 0.0 111.498 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -82.68 113.72 20.55 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.686 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.9 -28.85 61.75 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.433 0.693 . . . . 0.0 110.018 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -105.69 146.37 32.7 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.522 1.129 . . . . 0.0 110.156 -175.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.42 99.56 1.31 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.727 2.285 . . . . 0.0 111.428 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.4 mt -85.09 123.71 39.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.512 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -75.73 126.85 86.72 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.958 0.903 . . . . 0.0 109.973 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.79 130.13 22.55 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.097 1.865 . . . . 0.0 111.454 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 11.7 mptt -75.44 -23.5 56.93 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.593 0.757 . . . . 0.0 110.429 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 135' ' ' GLN . 20.3 ptt-85 -149.9 158.73 44.45 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.859 0.864 . . . . 0.0 108.812 171.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.77 142.23 58.26 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.534 0.733 . . . . 0.0 110.935 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.7 96.82 45.29 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 123.268 0.627 . . . . 0.0 109.728 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.49 173.18 9.2 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.049 2.5 . . . . 0.0 112.523 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.37 -19.99 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.634 0.773 . . . . 0.0 112.705 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.46 -18.84 79.53 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.447 0.467 . . . . 0.0 113.328 173.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.06 150.47 9.47 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.48 0.562 . . . . 0.0 112.696 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.413 ' HB3' ' NH2' ' A' ' 128' ' ' ARG . 31.2 mm-40 -109.39 132.65 53.93 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.723 0.809 . . . . 0.0 110.753 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -74.55 101.89 4.34 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.704 0.402 . . . . 0.0 110.326 172.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.76 118.25 13.31 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.402 ' H ' ' HD2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -122.6 127.33 49.27 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.622 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.563 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 5' ' ' VAL . 25.1 mm 63.04 -172.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 C-N-CA 124.296 1.039 . . . . 0.0 109.226 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.475 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.6 m -148.54 -45.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 156.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.14 -161.49 18.06 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.938 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.421 HG12 HD11 ' A' ' 60' ' ' ILE . 8.7 p -122.93 144.99 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 171.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -117.72 132.13 56.51 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.17 0.588 . . . . 0.0 109.681 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.443 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . 13.0 m-85 -131.92 142.24 44.45 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 124.09 0.956 . . . . 0.0 109.462 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.526 ' HD3' HG12 ' A' ' 130' ' ' VAL . 61.2 Cg_endo -70.52 -18.86 33.14 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.662 2.241 . . . . 0.0 112.621 175.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 mm 47.82 69.86 2.44 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.605 1.162 . . . . 0.0 109.231 -168.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD3' ' HG2' ' A' ' 10' ' ' PRO . 47.3 Cg_endo -83.54 52.97 4.01 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.334 2.689 . . . . 0.0 110.833 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -148.19 166.45 27.88 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.853 -171.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -59.45 -26.11 64.94 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.238 1.015 . . . . 0.0 111.792 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -84.53 14.62 4.38 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.458 1.103 . . . . 0.0 113.041 -168.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -57.79 -35.37 70.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.321 1.049 . . . . 0.0 111.664 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.97 -23.93 61.51 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -53.78 -51.7 62.59 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.026 0.93 . . . . 0.0 113.18 -172.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -61.58 -30.04 70.42 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.866 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -96.96 -14.17 21.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.035 0.934 . . . . 0.0 110.936 -175.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -78.41 -58.78 3.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.252 1.021 . . . . 0.0 109.453 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 24' ' ' LYS . 13.7 ptpt -93.49 -18.0 22.79 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.496 -171.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.04 -12.77 16.75 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 114.103 0.401 . . . . 0.0 114.103 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' H ' ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -147.6 90.95 1.9 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.826 0.85 . . . . 0.0 110.413 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.56 176.41 5.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.639 -174.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.9 t -132.65 110.02 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.954 0.902 . . . . 0.0 108.578 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.86 111.47 22.51 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.711 0.804 . . . . 0.0 110.066 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.7 m -96.05 141.78 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.216 0.606 . . . . 0.0 111.579 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -134.69 144.73 51.96 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.698 1.199 . . . . 0.0 110.533 171.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.75 51.51 3.62 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 123.441 2.761 . . . . 0.0 111.833 169.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 54.26 78.22 0.17 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.74 1.216 . . . . 0.0 111.681 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.2 m -101.77 -47.92 4.46 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.375 0.67 . . . . 0.0 109.869 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 m -81.42 150.17 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.474 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 76.8 m95 -79.7 -163.16 0.49 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.294 1.038 . . . . 0.0 112.385 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -69.6 -14.79 63.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.342 1.057 . . . . 0.0 112.738 -171.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.46 -24.67 67.23 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.403 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -66.01 111.54 3.4 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.09 152.7 70.47 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.743 0.817 . . . . 0.0 109.573 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.2 99.25 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.789 2.326 . . . . 0.0 111.424 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.3 -15.76 0.58 Allowed Glycine 0 N--CA 1.467 0.747 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.577 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.545 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 73.5 mtp -74.62 176.86 6.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.004 0.922 . . . . 0.0 111.804 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -102.67 164.34 11.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.549 0.74 . . . . 0.0 110.285 169.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.443 ' HE1' ' HB2' ' A' ' 9' ' ' TYR . 0.4 OUTLIER -136.7 100.16 4.25 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 175.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.3 t -88.79 120.97 38.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -89.59 107.62 19.19 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.918 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.8 t80 . . . . . 0 CA--C 1.554 1.125 0 C-N-CA 124.398 1.079 . . . . 0.0 109.831 173.043 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.09 -35.41 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.104 0.561 . . . . 0.0 109.972 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.97 -161.71 25.65 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.875 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -153.56 177.96 10.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.772 0.829 . . . . 0.0 109.08 170.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.496 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -158.81 -173.48 4.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.651 0.78 . . . . 0.0 109.727 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -125.14 120.81 32.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.421 0.688 . . . . 0.0 110.37 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.432 HG13 ' HB2' ' A' ' 43' ' ' PHE . 56.5 mt -69.07 135.65 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.843 1.257 . . . . 0.0 111.587 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -135.31 -176.47 4.28 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 126.293 1.837 . . . . 0.0 108.527 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -44.9 123.15 3.62 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.803 1.241 . . . . 0.0 113.74 -164.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 112' ' ' ILE . 33.9 m -92.67 118.64 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.244 -176.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 73.1 t -89.28 109.56 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.97 117.66 30.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.394 0.678 . . . . 0.0 109.343 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -152.11 134.74 15.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.784 0.834 . . . . 0.0 109.597 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 66.9 mt-10 -69.57 -16.29 63.38 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.312 0.645 . . . . 0.0 111.626 176.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 53.9 m-20 -95.34 119.27 65.74 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 36.5 Cg_endo -66.94 -20.99 50.66 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.145 1.897 . . . . 0.0 112.483 173.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.476 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.2 mpp? -73.83 -22.61 59.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.824 0.45 . . . . 0.0 110.875 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.409 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 78.6 mm-40 -57.16 -33.84 67.83 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.953 0.783 . . . . 0.0 111.62 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -78.26 -27.54 47.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 122.857 0.463 . . . . 0.0 111.164 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.443 ' HE2' HD22 ' A' ' 87' ' ' LEU . 71.4 m-85 -86.24 -23.14 26.52 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.987 0.515 . . . . 0.0 111.33 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.16 -27.27 19.7 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.438 0.295 . . . . 0.0 110.935 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.7 m -82.55 -58.03 3.09 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.212 0.53 . . . . 0.0 110.055 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.773 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 69.3 m-85 -96.49 -68.96 0.77 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.521 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.28 -80.72 0.73 Allowed Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.631 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.11 -23.5 64.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.096 0.958 . . . . 0.0 111.351 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.773 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 21.2 mmt85 -81.51 -32.46 32.37 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 122.958 0.503 . . . . 0.0 111.217 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 HD23 ' A' ' 82' ' ' LEU . 20.4 t -68.56 146.33 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -63.64 -27.22 69.08 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.466 ' H ' HD23 ' A' ' 82' ' ' LEU . 2.5 pt? -122.79 176.58 5.89 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.658 0.383 . . . . 0.0 110.267 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.54 HG22 ' HG2' ' A' ' 86' ' ' GLU . 12.6 t -108.33 172.48 6.82 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -68.13 -25.94 65.54 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.02 0.528 . . . . 0.0 111.222 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -68.77 -41.25 79.06 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.335 0.654 . . . . 0.0 109.893 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.54 ' HG2' HG22 ' A' ' 83' ' ' THR . 22.6 mm-40 -66.78 -35.22 79.58 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.162 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.443 HD22 ' HE2' ' A' ' 73' ' ' PHE . 32.1 tp -60.79 -54.26 47.33 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.882 0.873 . . . . 0.0 111.527 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -60.61 -43.36 97.54 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 123.494 0.496 . . . . 0.0 111.193 -172.067 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.37 -29.51 53.35 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.214 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -62.19 -43.78 98.06 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.453 0.701 . . . . 0.0 110.806 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.3 mtm -68.15 -36.93 80.44 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.356 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.7 mmpt? -69.08 -28.54 66.6 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.119 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 123.305 0.642 . . . . 0.0 110.589 176.869 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 121.348 0.594 . . . . 0.0 111.762 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.624 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -138.3 147.95 44.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.074 172.001 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.43 104.9 4.58 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -85.05 156.07 21.25 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.8 ptm -140.94 131.44 25.35 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.534 0.733 . . . . 0.0 109.494 -174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -111.25 102.32 10.74 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.447 0.699 . . . . 0.0 109.919 -176.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.463 ' HA ' HG12 ' A' ' 63' ' ' VAL . 27.8 mt -82.07 122.82 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.18 131.1 35.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -118.11 113.54 21.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.103 0.961 . . . . 0.0 109.446 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -114.83 176.09 5.21 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.2 t70 53.95 46.39 25.71 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.135 0.897 . . . . 0.0 111.016 170.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.7 t -74.38 106.59 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.959 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.457 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 1.7 tpmt? -83.66 155.52 23.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.671 1.188 . . . . 0.0 110.735 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -116.68 123.65 47.77 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.904 0.881 . . . . 0.0 109.103 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -74.11 98.42 3.12 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.54 -35.04 78.18 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.916 0.886 . . . . 0.0 109.812 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.4 ' HG3' HG13 ' A' ' 124' ' ' ILE . 15.9 ptpt -91.03 138.07 26.2 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.289 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -83.63 77.0 3.55 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.271 2.648 . . . . 0.0 112.466 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.4 HG13 ' HG3' ' A' ' 122' ' ' LYS . 72.6 mt -84.7 131.65 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -100.28 157.58 33.56 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.02 177.41 7.8 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.209 1.939 . . . . 0.0 111.761 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -94.98 2.6 55.38 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.457 0.703 . . . . 0.0 110.278 178.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -163.43 179.95 6.95 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.941 1.296 . . . . 0.0 109.274 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.79 130.39 35.04 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.526 HG12 ' HD3' ' A' ' 10' ' ' PRO . 39.8 t -104.79 96.39 10.53 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.5 -176.67 2.35 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.02 2.48 . . . . 0.0 112.887 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.46 -35.08 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.25 1.02 . . . . 0.0 111.292 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.77 -24.24 72.71 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.59 -0.732 . . . . 0.0 113.097 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.61 165.07 37.72 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 123.344 0.497 . . . . 0.0 113.002 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -118.37 143.75 46.41 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.694 0.797 . . . . 0.0 109.613 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.474 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 0.7 OUTLIER -79.67 112.89 17.38 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 167.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.7 121.43 26.38 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 145.09 51.88 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.998 0.519 . . . . 0.0 109.988 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.244 0.807 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.512 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 139' ' ' GLU . 22.2 ptmt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 113.331 0.864 . . . . 0.0 113.331 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 5' ' ' VAL . 30.7 mm 67.85 -179.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 C-N-CA 124.157 0.983 . . . . 0.0 109.61 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 139' ' ' GLU . 1.2 m -149.18 -34.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.758 1.223 . . . . 0.0 109.186 161.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.466 ' HA2' ' HE3' ' A' ' 41' ' ' MET . . . -171.35 -164.0 26.29 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-O 121.433 0.463 . . . . 0.0 112.787 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.91 161.17 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 t -134.5 133.2 40.09 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 122.979 0.512 . . . . 0.0 109.704 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.43 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . 7.2 m-85 -134.76 140.52 35.55 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.06 0.944 . . . . 0.0 110.132 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HD3' HG12 ' A' ' 130' ' ' VAL . 93.7 Cg_endo -76.5 -14.9 17.82 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.911 2.408 . . . . 0.0 112.431 172.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 mm 64.59 115.3 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 125.609 1.564 . . . . 0.0 109.559 -172.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -66.77 -14.9 45.63 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.095 2.53 . . . . 0.0 114.085 -168.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -132.61 -175.24 3.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.812 0.845 . . . . 0.0 110.267 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -69.33 2.99 2.5 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 124.184 0.993 . . . . 0.0 112.541 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.51 7.39 2.39 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -66.94 -34.04 76.9 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 119.024 0.829 . . . . 0.0 109.383 170.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.53 -30.04 70.38 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.595 1.158 . . . . 0.0 111.811 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 37.3 mmt180 -51.71 -47.35 64.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.423 1.089 . . . . 0.0 111.682 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.412 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 65.0 m-85 -66.43 -30.62 71.02 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.692 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.68 -20.17 25.22 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.573 0.749 . . . . 0.0 110.63 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -76.02 -56.92 4.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.392 1.077 . . . . 0.0 110.201 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.9 ptpt -96.06 -18.19 20.37 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.741 -171.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.79 -28.64 2.13 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -125.11 96.02 4.7 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 124.436 1.094 . . . . 0.0 108.259 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.412 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 13.9 t70 -110.36 176.31 5.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.195 0.598 . . . . 0.0 110.076 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.5 t -136.24 111.71 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.998 0.919 . . . . 0.0 109.114 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.483 ' HD2' HD12 ' A' ' 112' ' ' ILE . 88.3 t80 -84.7 109.07 17.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.479 0.711 . . . . 0.0 110.311 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.88 138.08 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.607 0.718 . . . . 0.0 110.531 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HE2' ' HD2' ' A' ' 30' ' ' PRO . 1.6 tpmt? -136.38 134.64 20.0 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.798 1.239 . . . . 0.0 108.461 -176.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 56.9 Cg_endo -72.86 57.0 3.07 Favored 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 122.745 2.297 . . . . 0.0 113.127 170.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.58 28.44 3.45 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 125.491 1.516 . . . . 0.0 114.005 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.45 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 5.3 m -69.66 -30.26 67.9 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.37 0.668 . . . . 0.0 110.518 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.631 HG11 HD23 ' A' ' 37' ' ' LEU . 21.9 t -85.82 149.02 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -78.14 -173.53 3.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.13 0.972 . . . . 0.0 111.811 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.506 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 7.6 tmtt? -71.59 -14.53 62.1 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 123.861 0.865 . . . . 0.0 110.188 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -51.43 -32.32 26.23 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.609 0.764 . . . . 0.0 111.245 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.631 HD23 HG11 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -69.48 102.26 1.76 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 123.568 0.747 . . . . 0.0 110.547 178.001 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -125.47 151.93 70.88 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.244 0.618 . . . . 0.0 109.987 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.5 99.21 0.7 Allowed 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.857 2.371 . . . . 0.0 111.611 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.77 2.69 0.88 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.497 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.489 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 29.1 mtm -92.77 -172.72 3.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.06 0.544 . . . . 0.0 111.157 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -109.99 160.01 16.79 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.906 0.882 . . . . 0.0 110.531 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.465 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.04 99.83 4.39 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.15 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.2 t -87.7 125.36 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.398 0.618 . . . . 0.0 109.931 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -91.01 114.24 26.72 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.753 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.417 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 37.6 t80 . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 171.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 110.848 -0.056 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.14 -32.26 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 168.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . -172.86 -167.22 32.5 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.143 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 16.0 pt-20 -158.47 178.28 10.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.612 0.765 . . . . 0.0 109.246 172.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.483 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -161.19 -173.8 4.03 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.069 0.548 . . . . 0.0 110.646 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -120.85 120.03 34.36 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.305 1.042 . . . . 0.0 109.996 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 43' ' ' PHE . 53.8 mt -70.62 138.43 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.569 1.148 . . . . 0.0 111.271 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -140.79 -166.73 2.21 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.907 2.083 . . . . 0.0 107.797 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -35.07 122.11 0.56 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.174 1.39 . . . . 0.0 114.524 -164.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.9 m -105.05 105.78 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 121.854 0.835 . . . . 0.0 109.52 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -91.75 114.56 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.593 0.757 . . . . 0.0 110.056 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.547 ' HB3' HD11 ' A' ' 108' ' ' LEU . 36.9 mt -96.41 117.95 31.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.651 0.78 . . . . 0.0 109.544 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.1 t -151.07 139.56 20.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.495 0.718 . . . . 0.0 110.354 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 24.1 mt-10 -66.76 -24.06 66.16 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.388 1.075 . . . . 0.0 111.803 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.557 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 81.5 m-20 -97.59 120.62 60.22 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HG2' HD21 ' A' ' 87' ' ' LEU . 38.3 Cg_endo -66.03 -19.2 57.72 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.361 2.041 . . . . 0.0 112.055 171.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 56.9 mtm -71.81 -24.59 61.75 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.08 0.952 . . . . 0.0 111.012 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.557 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 16.3 mm100 -60.96 -26.33 67.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.596 0.758 . . . . 0.0 111.507 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -81.82 -25.29 35.3 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.117 0.567 . . . . 0.0 110.844 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 87' ' ' LEU . 97.2 m-85 -89.66 -14.49 34.74 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.39 0.676 . . . . 0.0 111.641 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.47 -30.4 17.34 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.294 0.238 . . . . 0.0 110.619 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.8 m -78.07 -59.84 2.62 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.89 0.376 . . . . 0.0 110.771 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.784 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 58.8 m-85 -99.65 -59.1 1.78 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.529 0.732 . . . . 0.0 110.021 -173.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.98 -88.17 0.14 Allowed Glycine 0 C--N 1.356 1.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.494 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -69.49 -21.04 63.72 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.617 0.767 . . . . 0.0 111.699 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.784 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 37.4 mmt180 -72.87 -36.79 67.45 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.349 0.405 . . . . 0.0 110.433 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.47 HG12 HD23 ' A' ' 82' ' ' LEU . 21.4 t -64.07 151.4 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 122.593 0.357 . . . . 0.0 110.345 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.465 ' HD2' ' HA ' ' A' ' 27' ' ' PHE . 41.3 p90 -66.36 -7.88 21.88 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -147.69 172.04 14.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.343 0.657 . . . . 0.0 109.632 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 86' ' ' GLU . 7.4 t -96.38 170.66 9.08 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -66.43 -26.63 67.31 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.36 0.264 . . . . 0.0 110.671 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 4.0 m-20 -60.24 -53.86 52.63 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' H ' HG23 ' A' ' 83' ' ' THR . 49.5 mm-40 -58.81 -33.0 69.86 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.561 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.501 HD21 ' HG2' ' A' ' 69' ' ' PRO . 28.5 tp -62.92 -58.22 8.1 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.726 0.641 . . . . 0.0 111.037 174.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -62.64 -38.77 91.55 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.593 0.558 . . . . 0.0 111.917 -171.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 12.1 pt-20 -82.96 -21.92 33.9 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.301 0.64 . . . . 0.0 111.459 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -66.54 -47.05 74.08 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 69.1 mtm -67.69 -31.53 71.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.427 0.691 . . . . 0.0 110.595 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.4 mmpt? -60.71 -52.23 66.02 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 CA--C 1.551 1.019 0 C-N-CA 123.618 0.767 . . . . 0.0 111.638 -178.5 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 121.013 0.435 . . . . 0.0 109.996 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.612 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -134.13 152.65 51.93 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 169.109 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.7 tm? -76.19 121.35 22.76 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -106.81 159.72 16.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.232 1.013 . . . . 0.0 109.805 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.446 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 15.8 ptm -136.56 130.72 32.81 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.045 0.938 . . . . 0.0 110.045 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.07 102.06 11.07 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.685 0.794 . . . . 0.0 109.434 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.483 HD12 ' HD2' ' A' ' 27' ' ' PHE . 42.2 mt -85.0 121.08 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.75 133.38 35.34 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -117.76 133.3 56.08 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.207 1.003 . . . . 0.0 109.502 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.78 165.36 25.79 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.66 0.784 . . . . 0.0 110.062 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.2 t70 57.23 36.83 27.88 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.365 1.041 . . . . 0.0 110.846 168.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.2 t -63.24 109.56 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.718 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 165.31 23.42 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.031 1.333 . . . . 0.0 110.663 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -130.61 124.9 32.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.552 0.741 . . . . 0.0 110.238 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.415 ' H ' ' HA2' ' A' ' 56' ' ' GLY . 35.0 m-85 -88.29 82.48 7.05 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 168.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.56 -32.36 73.08 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.514 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -80.36 148.62 67.15 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.232 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.13 103.64 1.78 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.84 2.36 . . . . 0.0 112.672 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.7 mt -125.01 130.98 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.515 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -97.9 144.26 27.7 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.904 0.882 . . . . 0.0 108.912 178.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.79 176.75 8.71 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.815 2.344 . . . . 0.0 112.932 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -64.15 -32.22 73.71 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.817 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -157.5 163.51 38.36 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 123.62 0.768 . . . . 0.0 109.88 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.27 135.11 54.98 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.997 0.919 . . . . 0.0 108.976 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.557 HG12 ' HD3' ' A' ' 10' ' ' PRO . 47.9 t -108.17 94.6 13.43 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 123.464 0.705 . . . . 0.0 109.616 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.97 -175.35 1.65 Allowed 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.069 2.513 . . . . 0.0 112.868 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.3 m -56.85 -31.19 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.46 1.104 . . . . 0.0 113.711 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.17 -14.86 81.8 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.386 0.429 . . . . 0.0 113.496 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.45 150.83 6.94 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 123.193 0.425 . . . . 0.0 112.923 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.488 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -108.81 165.36 11.62 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.575 0.75 . . . . 0.0 110.178 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.0 130.04 46.12 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.99 0.516 . . . . 0.0 109.691 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.75 124.09 38.59 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.57 148.14 46.63 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 5' ' ' VAL . 3.4 tm-20 . . . . . 0 C--O 1.252 1.207 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 173.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.41 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 5' ' ' VAL . 29.1 mm 63.39 -172.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -174.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.6 m -151.09 -45.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 156.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.39 -160.87 18.61 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.168 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.98 139.79 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -107.82 132.31 53.55 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.518 0.727 . . . . 0.0 109.481 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -127.64 141.99 42.74 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.602 0.761 . . . . 0.0 110.485 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' HG12 ' A' ' 130' ' ' VAL . 95.9 Cg_endo -73.33 -19.81 21.83 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.167 2.578 . . . . 0.0 113.129 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mm 53.77 92.76 0.06 OUTLIER Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 125.258 1.423 . . . . 0.0 110.413 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.99 17.01 0.75 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.857 2.371 . . . . 0.0 113.291 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -124.72 153.33 42.53 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 110.24 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -11.84 61.15 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.596 1.158 . . . . 0.0 111.395 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -81.32 22.31 0.69 Allowed 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.486 1.114 . . . . 0.0 112.482 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.461 ' HG2' ' HE2' ' A' ' 20' ' ' PHE . 46.2 ttm -64.77 -41.14 96.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.971 0.908 . . . . 0.0 110.003 168.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.7 -19.23 65.64 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.979 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -47.64 -51.66 20.73 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.801 1.24 . . . . 0.0 112.682 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 49.7 m-85 -69.4 -30.76 68.8 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.451 -174.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.461 ' HE2' ' HG2' ' A' ' 16' ' ' MET . 54.7 m-85 -84.48 -24.68 29.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.714 0.806 . . . . 0.0 110.314 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -68.28 -49.09 62.9 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.92 1.288 . . . . 0.0 109.903 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -107.33 -16.55 14.36 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.545 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.46 -6.15 70.13 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 114.253 0.461 . . . . 0.0 114.253 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -157.81 111.69 2.55 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.881 0.873 . . . . 0.0 109.643 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.3 t70 -136.64 -171.54 2.94 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.42 124.73 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.261 1.391 . . . . 0.0 109.644 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -96.62 116.58 29.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.646 0.778 . . . . 0.0 109.322 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 m -89.35 146.86 5.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.494 0.664 . . . . 0.0 110.222 171.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.635 ' HG2' HG22 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -134.62 114.26 12.15 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.7 1.2 . . . . 0.0 109.047 -172.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.53 66.6 2.93 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.438 2.759 . . . . 0.0 113.478 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . 47.35 78.42 0.07 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.006 1.322 . . . . 0.0 113.454 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.438 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 37.8 m -125.49 -58.04 1.44 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.635 HG22 ' HG2' ' A' ' 29' ' ' LYS . 15.4 m -66.96 133.87 30.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.898 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -88.4 -157.58 0.43 Allowed 'General case' 0 CA--C 1.564 1.506 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.905 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -70.83 -1.77 12.73 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -166.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -67.48 -28.9 68.25 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.701 0.8 . . . . 0.0 110.419 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.571 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 1.1 mm? -66.55 119.59 11.96 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.538 0.735 . . . . 0.0 110.645 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 157.48 56.35 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.415 1.086 . . . . 0.0 109.255 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.92 88.84 0.9 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.381 2.054 . . . . 0.0 111.597 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.08 41.72 0.04 OUTLIER Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.042 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.571 ' SD ' ' HA ' ' A' ' 37' ' ' LEU . 87.1 mtp -118.94 -168.8 1.62 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.068 0.947 . . . . 0.0 109.391 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 15.2 ptpt -121.13 162.23 20.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.68 0.792 . . . . 0.0 110.276 168.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.456 ' HB2' HG13 ' A' ' 60' ' ' ILE . 17.5 t80 -134.77 97.1 3.68 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 94.1 t -83.12 119.65 32.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.39 0.614 . . . . 0.0 110.046 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -80.33 99.67 8.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.599 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.0 t80 . . . . . 0 CA--C 1.541 0.605 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.697 169.878 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 121.628 0.727 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.451 HG22 ' NZ ' ' A' ' 119' ' ' LYS . 10.0 p -87.62 -15.53 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.297 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.85 -171.15 41.76 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.297 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 7.9 pt-20 -147.56 178.86 8.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.833 0.853 . . . . 0.0 110.156 174.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.409 ' CB ' HD12 ' A' ' 114' ' ' LEU . . . -158.4 -171.11 3.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.718 1.207 . . . . 0.0 109.204 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 12.7 mmt85 -129.58 118.92 22.77 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.545 0.738 . . . . 0.0 110.709 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 41' ' ' MET . 54.4 mt -72.13 133.15 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.568 1.147 . . . . 0.0 111.421 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.0 mmmt -133.18 -177.11 4.37 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 126.166 1.786 . . . . 0.0 108.533 -176.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -28.42 113.87 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 126.275 1.83 . . . . 0.0 114.904 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 112' ' ' ILE . 35.2 m -95.44 117.45 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.659 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.6 t -90.18 108.65 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.534 ' HB3' HD11 ' A' ' 108' ' ' LEU . 69.3 mt -87.14 116.7 25.39 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.4 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 46.3 m -148.71 137.05 21.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.616 0.766 . . . . 0.0 109.986 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 18.8 mt-10 -66.5 -34.82 78.79 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.11 0.964 . . . . 0.0 112.068 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.646 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 73.9 m-20 -89.1 123.8 66.44 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.89 -21.23 64.39 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 122.354 2.036 . . . . 0.0 111.732 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 37.7 mtm -74.35 -19.02 60.6 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.09 0.956 . . . . 0.0 110.91 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.646 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 17.0 mm100 -60.42 -32.41 71.33 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.278 0.631 . . . . 0.0 110.695 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 66' ' ' SER . 5.4 m-85 -77.38 -27.29 52.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.681 -177.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.464 ' CE2' HD22 ' A' ' 87' ' ' LEU . 73.6 m-85 -91.11 -20.52 21.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.075 0.55 . . . . 0.0 111.94 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.17 -34.27 22.12 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.8 m -81.25 -59.68 2.55 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.999 0.52 . . . . 0.0 110.925 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.796 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 98.1 m-85 -93.19 -64.31 1.11 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.648 0.779 . . . . 0.0 110.207 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.25 -90.66 0.28 Allowed Glycine 0 C--N 1.352 1.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.375 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.29 -9.58 58.85 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.949 0.9 . . . . 0.0 111.808 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.796 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 28.0 mmt85 -78.21 -36.5 47.15 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.87 0.468 . . . . 0.0 110.262 170.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 82' ' ' LEU . 35.1 t -75.49 140.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.287 0.635 . . . . 0.0 110.741 -176.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -57.1 -20.63 26.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 1.8 pt? -134.0 170.15 16.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.9 t -108.11 -176.7 3.13 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 122.051 -0.405 . . . . 0.0 109.981 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.73 -25.37 67.27 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.244 0.618 . . . . 0.0 111.915 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.515 ' H ' HG23 ' A' ' 83' ' ' THR . 23.9 t70 -73.6 -36.42 65.52 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.32 0.648 . . . . 0.0 111.278 174.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 1.5 mp0 -74.51 -24.7 59.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.794 -0.566 . . . . 0.0 110.746 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.464 HD22 ' CE2' ' A' ' 73' ' ' PHE . 28.2 tp -67.57 -50.15 59.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.037 0.535 . . . . 0.0 109.691 175.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -40.45 96.11 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.465 0.478 . . . . 0.0 110.979 -175.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.476 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 8.6 pt-20 -64.86 -39.76 94.06 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -64.2 -49.46 71.91 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.987 0.915 . . . . 0.0 111.567 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 56.3 mtm -67.98 -44.89 75.61 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.402 0.681 . . . . 0.0 110.233 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -71.92 -26.25 62.22 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.883 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.488 1.467 0 CA-C-N 118.182 0.446 . . . . 0.0 110.802 174.963 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.26 147.21 49.73 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -176.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 65' ' ' LEU . 0.4 OUTLIER -82.92 100.44 10.39 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.288 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -87.49 159.92 18.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.918 0.887 . . . . 0.0 109.646 171.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.584 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 20.8 ptm -140.18 137.51 34.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.741 0.416 . . . . 0.0 111.436 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.46 102.7 11.29 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.852 0.861 . . . . 0.0 109.949 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.456 ' HA ' HG12 ' A' ' 63' ' ' VAL . 42.6 mt -83.29 121.1 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.753 0.821 . . . . 0.0 109.021 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 39.8 tt0 -80.16 138.04 36.82 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.409 HD12 ' CB ' ' A' ' 58' ' ' ALA . 4.0 mm? -119.13 129.71 55.17 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.88 0.872 . . . . 0.0 109.837 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -128.99 173.14 10.69 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 51.43 54.58 10.83 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.1 0.952 . . . . 0.0 111.762 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.96 115.98 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.692 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER -102.27 152.58 20.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.202 1.001 . . . . 0.0 110.627 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.451 ' NZ ' HG22 ' A' ' 55' ' ' VAL . 26.0 mmmt -104.58 139.73 39.03 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.414 1.086 . . . . 0.0 109.309 170.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -91.1 72.41 6.33 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.46 -24.93 62.96 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.07 173.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.409 ' HG3' HG13 ' A' ' 124' ' ' ILE . 0.2 OUTLIER -79.78 146.05 63.61 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.744 170.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.59 90.25 0.5 Allowed 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.395 2.063 . . . . 0.0 112.811 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 122' ' ' LYS . 24.7 mt -107.7 119.75 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.35 142.53 24.69 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.549 0.74 . . . . 0.0 109.556 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.74 133.98 41.74 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.33 2.02 . . . . 0.0 111.4 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -71.87 -24.6 61.71 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.829 0.851 . . . . 0.0 110.466 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.433 HH21 ' HB3' ' A' ' 135' ' ' GLN . 13.0 ptt180 -156.02 174.73 14.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.477 1.111 . . . . 0.0 109.459 174.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.87 143.49 55.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.225 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.49 HG12 ' HD3' ' A' ' 10' ' ' PRO . 60.3 t -122.83 102.14 38.57 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.89 -175.94 2.59 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.944 2.429 . . . . 0.0 111.854 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.6 p -57.68 -30.75 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 124.293 1.037 . . . . 0.0 112.751 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.34 -15.55 81.12 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.831 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.79 159.85 19.03 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.137 0.398 . . . . 0.0 113.02 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.433 ' HB3' HH21 ' A' ' 128' ' ' ARG . 31.6 mm-40 -116.98 146.92 42.71 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.783 0.833 . . . . 0.0 109.716 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -80.69 118.19 22.03 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.34 122.36 30.2 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.428 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -134.84 133.41 39.73 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.677 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.244 0.779 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.378 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 5' ' ' VAL . 21.4 mm 61.62 -163.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -171.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.582 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.8 m -149.47 -42.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 155.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.15 -162.12 21.88 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.101 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.56 149.44 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -117.21 132.52 56.62 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.354 0.662 . . . . 0.0 109.716 176.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -131.83 142.21 44.39 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.142 0.977 . . . . 0.0 109.598 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HD3' HG12 ' A' ' 130' ' ' VAL . 40.6 Cg_endo -66.7 -46.82 3.24 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.402 2.068 . . . . 0.0 111.73 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.3 mt 50.83 71.91 1.4 Allowed Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.218 1.007 . . . . 0.0 108.909 -167.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.29 39.32 0.83 Allowed 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.086 2.524 . . . . 0.0 112.415 -173.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -127.66 162.7 25.92 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.242 1.417 . . . . 0.0 109.116 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -67.62 -16.16 64.02 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.712 0.805 . . . . 0.0 112.392 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -73.76 0.02 14.3 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.107 0.963 . . . . 0.0 112.913 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -67.14 -18.87 65.48 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 117.908 0.322 . . . . 0.0 111.727 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.71 -31.12 72.2 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.243 1.017 . . . . 0.0 111.841 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 12.9 mmt85 -58.15 -38.55 76.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.567 1.147 . . . . 0.0 112.942 -167.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -70.98 -31.17 67.64 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.01 0.524 . . . . 0.0 110.195 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -93.24 -8.64 41.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.902 0.881 . . . . 0.0 110.237 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -85.6 -59.36 2.34 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 124.388 1.075 . . . . 0.0 110.032 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.4 ptpt -99.47 -15.52 18.67 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.196 -170.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.23 -39.54 2.78 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 113.579 0.192 . . . . 0.0 113.579 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -119.54 91.34 3.53 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.911 0.885 . . . . 0.0 109.291 173.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -99.43 175.05 5.99 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.943 0.897 . . . . 0.0 110.059 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.18 110.02 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.104 0.962 . . . . 0.0 108.981 175.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -88.77 118.23 28.31 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.444 0.698 . . . . 0.0 109.684 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.94 132.96 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 121.587 0.708 . . . . 0.0 111.117 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 5.1 mmpt? -120.0 138.7 27.27 Favored Pre-proline 0 C--O 1.215 -0.759 0 C-N-CA 125.376 1.471 . . . . 0.0 109.227 176.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.427 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 73.7 Cg_endo -77.24 46.78 2.06 Favored 'Trans proline' 0 CA--C 1.56 1.803 0 C-N-CA 122.481 2.121 . . . . 0.0 111.708 162.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.43 38.1 17.3 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.319 1.448 . . . . 0.0 112.61 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 m -64.28 -38.02 89.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.564 0.746 . . . . 0.0 110.225 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.8 149.88 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.908 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.566 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 90.6 m95 -72.2 -178.55 2.5 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.771 0.828 . . . . 0.0 111.667 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -79.2 10.71 3.35 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.34 0.656 . . . . 0.0 112.27 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -75.12 -20.88 59.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.892 0.877 . . . . 0.0 110.625 174.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.27 100.79 0.84 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.642 0.777 . . . . 0.0 110.32 -176.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 3.2 ptpp? -119.18 152.45 52.25 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.198 0.599 . . . . 0.0 109.755 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.57 97.69 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.65 2.233 . . . . 0.0 110.936 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.6 -4.73 0.33 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.203 -174.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.431 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 31.5 mtm -89.88 -171.27 3.1 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.436 0.694 . . . . 0.0 111.689 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 12.9 ptpt -112.6 162.15 16.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.227 1.011 . . . . 0.0 110.573 172.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.499 ' HB2' HG13 ' A' ' 60' ' ' ILE . 3.2 t80 -136.22 102.53 5.02 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 42.1 t -88.86 121.46 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.169 0.509 . . . . 0.0 110.287 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -86.11 126.51 34.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.258 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 52.5 t80 . . . . . 0 CA--C 1.539 0.524 0 C-N-CA 124.411 1.084 . . . . 0.0 109.452 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 25.7 m-85 . . . . . 0 CA--C 1.547 0.843 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.45 -36.11 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 122.829 0.452 . . . . 0.0 111.055 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.45 -160.52 21.18 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.575 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 14.9 pt-20 -154.88 177.16 11.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.606 1.162 . . . . 0.0 108.409 176.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.536 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -161.49 -173.54 3.83 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.698 0.799 . . . . 0.0 109.531 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -122.31 118.98 29.79 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.777 0.831 . . . . 0.0 109.927 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.499 HG13 ' HB2' ' A' ' 43' ' ' PHE . 51.7 mt -68.99 127.96 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.99 174.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -138.2 -164.59 1.65 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.461 1.504 . . . . 0.0 108.311 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -34.5 114.15 0.2 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 125.123 1.369 . . . . 0.0 113.956 -162.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.5 110.89 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-O 121.38 0.61 . . . . 0.0 109.799 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 97.4 t -91.02 108.43 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.8 mt -85.96 115.68 23.72 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 53.5 m -151.94 127.37 9.99 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 40.4 mt-10 -60.99 -47.6 85.72 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.577 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 43.3 m-20 -71.69 119.48 74.39 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.65 -21.39 70.11 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.486 2.124 . . . . 0.0 111.746 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 44.6 mtm -72.4 -20.17 61.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.002 0.921 . . . . 0.0 111.071 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.577 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 17.9 mm100 -60.97 -29.02 69.42 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.244 0.618 . . . . 0.0 111.005 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.488 ' HE2' ' HB3' ' A' ' 109' ' ' TRP . 6.3 m-85 -81.93 -27.99 33.04 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.634 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.498 ' CE2' HD22 ' A' ' 87' ' ' LEU . 87.0 m-85 -87.91 -18.19 29.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.163 0.585 . . . . 0.0 111.832 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.31 -33.32 20.65 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.5 m -82.4 -60.39 2.22 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.078 0.551 . . . . 0.0 111.491 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.755 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 59.5 m-85 -93.81 -55.26 3.31 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.178 0.591 . . . . 0.0 110.136 -177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 65.83 -89.37 0.12 Allowed Glycine 0 C--N 1.355 1.628 0 O-C-N 124.135 0.897 . . . . 0.0 113.55 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.2 -28.51 68.15 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.079 0.952 . . . . 0.0 110.829 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.755 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 16.0 mmt85 -72.2 -27.88 62.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.034 0.534 . . . . 0.0 111.892 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.435 HG12 HD23 ' A' ' 82' ' ' LEU . 25.2 t -68.72 151.76 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.41 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 41.0 p90 -63.24 -11.08 18.67 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -145.1 173.17 12.14 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.279 1.032 . . . . 0.0 109.138 174.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.612 HG22 ' HG2' ' A' ' 86' ' ' GLU . 15.1 t -104.26 173.85 6.13 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -63.6 -30.35 71.47 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.897 0.479 . . . . 0.0 111.548 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.83 -32.52 67.64 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.612 ' HG2' HG22 ' A' ' 83' ' ' THR . 26.3 mm-40 -70.01 -35.53 74.42 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 172.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.498 HD22 ' CE2' ' A' ' 73' ' ' PHE . 18.3 tp -62.66 -52.28 63.96 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.073 0.949 . . . . 0.0 111.544 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -42.17 98.41 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.928 -173.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.26 -29.77 65.48 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 122.959 0.162 . . . . 0.0 110.785 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -66.19 -46.86 75.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.557 0.743 . . . . 0.0 110.922 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.7 mtm -69.08 -33.8 74.13 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.969 0.507 . . . . 0.0 110.809 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -76.49 -27.5 56.09 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.948 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 121.235 0.541 . . . . 0.0 109.915 176.32 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.085 0.469 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -110.5 154.29 23.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.082 0.953 . . . . 0.0 109.268 -175.492 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.6 tm? -73.98 116.97 15.22 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.488 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 24.0 m95 -107.85 161.77 14.61 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.867 0.867 . . . . 0.0 108.96 172.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.419 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 12.5 ptm -145.89 130.83 18.2 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.48 0.712 . . . . 0.0 110.399 -176.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -101.93 103.66 14.33 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.206 1.002 . . . . 0.0 109.694 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.4 mt -90.3 120.8 39.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -78.11 109.81 12.52 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.56 0.618 . . . . 0.0 109.459 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -95.45 108.69 20.92 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 123.411 0.684 . . . . 0.0 110.536 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.31 172.64 8.49 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.5 t70 58.95 40.73 22.14 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.298 1.039 . . . . 0.0 110.63 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.9 t -70.48 107.93 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.204 -172.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -93.37 114.42 26.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.23 1.012 . . . . 0.0 111.126 -176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -74.33 136.7 42.55 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 170.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -80.5 110.68 16.19 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.88 -23.18 66.14 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.76 1.224 . . . . 0.0 111.3 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -125.25 149.21 63.31 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.568 1.147 . . . . 0.0 110.315 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.49 96.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 123.522 2.815 . . . . 0.0 113.654 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 17.3 mt -100.03 107.16 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.019 0.528 . . . . 0.0 109.67 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.52 150.25 89.01 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.872 -176.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.423 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 98.0 Cg_endo -72.94 164.88 34.33 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.079 1.852 . . . . 0.0 112.141 174.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -70.2 -41.06 74.17 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 173.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -153.46 177.01 11.38 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.522 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.69 132.93 53.42 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.136 0.974 . . . . 0.0 111.402 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.585 HG12 ' HD3' ' A' ' 10' ' ' PRO . 38.2 t -119.37 97.88 50.3 Favored Pre-proline 0 CA--C 1.553 1.079 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.65 -176.76 3.15 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.053 2.502 . . . . 0.0 112.579 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.18 -26.81 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.354 1.061 . . . . 0.0 112.079 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.04 -20.4 79.96 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.837 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.3 148.85 3.95 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.321 0.486 . . . . 0.0 113.103 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -106.96 151.45 25.27 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.355 0.662 . . . . 0.0 109.363 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.566 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 1.3 m-85 -89.82 122.9 33.32 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 174.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.03 116.84 27.61 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.89 127.32 39.93 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -171.985 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.587 HG13 ' HB3' ' A' ' 36' ' ' GLU . 25.3 mm 63.8 -169.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 C-N-CA 124.094 0.957 . . . . 0.0 108.764 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.516 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.5 m -149.48 -41.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.988 1.315 . . . . 0.0 107.524 156.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.06 -162.57 22.59 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.81 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 p -124.18 156.46 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.425 0.69 . . . . 0.0 109.275 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -126.41 133.03 51.38 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.329 0.652 . . . . 0.0 109.285 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.24 135.85 28.09 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 123.283 0.633 . . . . 0.0 110.745 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.457 ' HB3' ' HD2' ' A' ' 46' ' ' TYR . 43.1 Cg_endo -93.83 78.07 0.23 Allowed 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 124.078 3.186 . . . . 0.0 110.214 168.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.78 109.3 1.76 Allowed Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.822 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -83.93 30.86 0.52 Allowed 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.213 2.609 . . . . 0.0 112.428 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 15' ' ' PHE . 38.6 mmtm -133.41 148.68 51.81 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.428 1.491 . . . . 0.0 108.674 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -63.06 -15.96 58.3 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.011 0.924 . . . . 0.0 111.693 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.409 ' HD2' ' HB3' ' A' ' 13' ' ' LYS . 59.1 m-85 -72.89 7.05 2.2 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.375 1.07 . . . . 0.0 112.824 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.3 ttp -68.76 -24.18 64.41 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.14 0.576 . . . . 0.0 109.981 165.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.35 -29.02 70.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.998 0.919 . . . . 0.0 110.98 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 27.2 mmt180 -57.63 -41.0 80.49 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 124.382 1.051 . . . . 0.0 111.771 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.43 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 58.0 m-85 -65.1 -32.35 74.0 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 123.902 0.751 . . . . 0.0 110.042 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -89.47 -13.59 37.2 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.697 0.799 . . . . 0.0 111.125 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -82.83 -54.45 5.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.954 0.901 . . . . 0.0 110.393 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.2 ptpt -100.8 -8.89 22.22 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.712 -165.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.47 -42.17 3.13 Favored Glycine 0 N--CA 1.475 1.245 0 O-C-N 123.067 0.229 . . . . 0.0 113.109 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -129.64 106.1 8.5 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.395 0.678 . . . . 0.0 109.981 172.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.43 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.2 t70 -107.53 -177.37 3.33 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.494 1.117 . . . . 0.0 109.174 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.2 t -136.81 114.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.36 1.064 . . . . 0.0 109.229 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -85.09 111.65 19.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.599 0.759 . . . . 0.0 110.266 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.57 132.1 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-O 121.2 0.524 . . . . 0.0 110.461 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HD2' ' HD2' ' A' ' 30' ' ' PRO . 58.5 tptt -134.71 130.57 19.8 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.504 1.122 . . . . 0.0 108.335 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 109' ' ' TRP . 24.9 Cg_endo -61.68 94.95 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 121.872 1.715 . . . . 0.0 109.58 166.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -30.08 79.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.807 2.043 . . . . 0.0 115.674 -163.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 50.7 m -96.11 -30.51 13.49 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.068 172.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.82 142.7 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.315 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -67.41 168.76 10.15 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.263 0.625 . . . . 0.0 112.368 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -58.94 -11.52 3.46 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.21 1.404 . . . . 0.0 113.562 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.587 ' HB3' HG13 ' A' ' 4' ' ' ILE . 7.7 mm-40 -64.64 -17.3 63.91 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.968 0.907 . . . . 0.0 111.939 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.16 100.48 3.08 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.365 0.666 . . . . 0.0 110.04 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.3 152.33 42.57 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.77 82.93 2.03 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.66 2.24 . . . . 0.0 111.918 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.63 43.0 0.02 OUTLIER Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.122 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 34.0 mtm -122.39 -158.83 0.8 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.867 0.867 . . . . 0.0 110.026 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -121.05 158.88 26.85 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.09 0.956 . . . . 0.0 110.309 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.41 ' CB ' HD11 ' A' ' 114' ' ' LEU . 2.5 t80 -136.41 99.68 4.16 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 41.3 t -83.7 124.59 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.089 0.471 . . . . 0.0 110.068 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -89.51 115.32 26.84 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.498 0.719 . . . . 0.0 109.508 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.457 ' HD2' ' HB3' ' A' ' 10' ' ' PRO . 85.0 t80 . . . . . 0 CA--C 1.54 0.572 0 C-N-CA 124.459 1.103 . . . . 0.0 109.481 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.506 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 17.6 m-30 . . . . . 0 CA--C 1.552 1.026 0 CA-C-O 121.216 0.532 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -77.2 -33.42 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.004 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . -173.53 -166.4 31.77 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.843 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 2.2 pt-20 -149.61 179.36 8.05 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.576 1.15 . . . . 0.0 108.627 176.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.546 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -158.56 -173.65 4.39 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.819 0.848 . . . . 0.0 109.509 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -127.29 116.53 20.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.411 0.684 . . . . 0.0 109.64 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -66.63 137.69 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.915 1.286 . . . . 0.0 111.425 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -141.0 -170.6 3.08 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.351 1.86 . . . . 0.0 108.564 -175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -30.62 113.98 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.586 1.554 . . . . 0.0 114.798 -168.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -97.52 108.88 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-O 121.799 0.809 . . . . 0.0 109.694 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 95.7 t -92.65 109.26 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.93 0.892 . . . . 0.0 109.795 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.56 117.66 27.67 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.4 t -152.99 135.72 15.31 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.768 0.827 . . . . 0.0 109.814 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.469 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 38.1 mt-10 -63.72 -22.16 66.77 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.062 0.545 . . . . 0.0 111.53 172.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -87.76 119.88 70.73 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.188 0.595 . . . . 0.0 109.723 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.31 -8.39 22.62 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 122.418 2.078 . . . . 0.0 112.064 167.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 51.7 mtm -89.58 -26.0 21.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.407 1.083 . . . . 0.0 111.21 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.49 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 71.4 mt-30 -68.17 -20.91 64.91 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -74.52 -21.99 59.27 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.508 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.487 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 22.6 m-85 -89.99 -27.81 19.53 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.177 0.591 . . . . 0.0 111.482 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 13.0 pt-20 -76.33 -28.43 56.89 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.3 m -85.98 -60.75 1.92 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.897 0.479 . . . . 0.0 110.788 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.792 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 67.0 m-85 -101.32 -61.84 1.32 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.389 0.675 . . . . 0.0 110.205 -173.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 77.33 -87.54 1.01 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.703 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.33 -12.94 44.96 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.792 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 6.4 mmp_? -69.33 -34.05 74.05 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.291 169.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.433 HG12 HD23 ' A' ' 82' ' ' LEU . 34.7 t -67.62 147.16 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.8 0.44 . . . . 0.0 110.453 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -63.56 -22.27 66.8 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.433 HD23 HG12 ' A' ' 80' ' ' VAL . 2.1 pt? -131.38 162.06 30.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.177 0.591 . . . . 0.0 109.608 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.443 HG23 ' H ' ' A' ' 85' ' ' ASP . 5.6 t -106.05 -176.93 3.22 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -56.39 -43.15 78.99 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.37 0.668 . . . . 0.0 111.142 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.443 ' H ' HG23 ' A' ' 83' ' ' THR . 14.4 m-20 -60.38 -45.8 92.27 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.041 0.936 . . . . 0.0 111.772 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.52 -46.72 88.76 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 123.224 0.327 . . . . 0.0 110.45 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.422 HD22 ' HE2' ' A' ' 73' ' ' PHE . 43.8 tp -57.27 -50.04 74.16 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.115 0.884 . . . . 0.0 111.46 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.494 ' HD3' ' N ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -64.28 -45.85 86.22 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.477 0.486 . . . . 0.0 110.775 -175.29 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.494 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 13.0 pt-20 -74.04 -24.79 59.58 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.451 0.3 . . . . 0.0 110.984 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -71.82 -49.37 39.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.718 0.807 . . . . 0.0 109.997 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.3 mtm -66.73 -40.76 88.51 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.89 0.744 . . . . 0.0 110.105 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 31.2 mmmt -63.99 -35.59 81.2 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.714 0.634 . . . . 0.0 111.077 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 CA--C 1.55 0.956 0 C-N-CA 122.861 0.464 . . . . 0.0 110.949 176.842 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.469 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.554 1.123 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 16.9 tptm -132.65 165.05 25.35 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.445 0.698 . . . . 0.0 109.583 175.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.61 114.32 10.61 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.649 0.779 . . . . 0.0 109.496 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 19.5 m95 -100.35 161.99 13.24 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.319 1.048 . . . . 0.0 109.398 172.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.514 ' HE3' HD11 ' A' ' 112' ' ' ILE . 9.0 ptt? -143.25 138.93 29.96 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.933 0.397 . . . . 0.0 110.766 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -109.51 103.33 12.2 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.089 0.956 . . . . 0.0 109.74 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.514 HD11 ' HE3' ' A' ' 110' ' ' MET . 22.8 mt -87.03 122.06 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.36 129.77 34.76 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.6 mm? -117.18 107.58 14.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.795 0.838 . . . . 0.0 110.865 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -106.4 170.83 7.69 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.157 0.583 . . . . 0.0 110.327 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.6 t70 55.21 38.54 30.57 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 124.449 1.093 . . . . 0.0 111.09 168.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.3 t -66.92 101.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.523 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.32 110.66 23.17 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.921 -167.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -65.08 122.27 16.66 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.886 0.875 . . . . 0.0 110.947 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.506 ' HD2' ' HB3' ' A' ' 54' ' ' PHE . 12.8 m-30 -75.9 87.35 2.87 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.36 -30.56 70.97 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.278 172.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -81.91 131.94 55.61 Favored Pre-proline 0 CA--C 1.553 1.089 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.384 168.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.66 84.15 2.03 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.761 2.307 . . . . 0.0 111.557 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.4 mt -73.21 127.04 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.008 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -74.53 130.6 81.54 Favored Pre-proline 0 CA--C 1.553 1.066 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.865 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.454 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 65.7 Cg_endo -71.51 145.13 46.7 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.63 2.22 . . . . 0.0 110.707 169.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -83.55 -6.22 59.39 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.588 0.755 . . . . 0.0 111.228 -179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -167.83 177.98 5.46 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.621 1.168 . . . . 0.0 109.402 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.87 138.04 46.03 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 166.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.446 HG12 ' HD3' ' A' ' 10' ' ' PRO . 43.7 t -107.0 100.33 31.47 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 170.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.23 169.25 17.2 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.873 2.382 . . . . 0.0 112.138 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.442 ' HA ' ' HG2' ' A' ' 10' ' ' PRO . 18.7 m -59.25 -20.49 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -173.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.5 -21.93 76.33 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.144 0.277 . . . . 0.0 113.079 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.79 147.47 14.89 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.621 0.629 . . . . 0.0 112.096 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -108.88 148.59 30.39 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.509 0.724 . . . . 0.0 109.33 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -92.27 120.37 32.76 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.459 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.24 122.93 30.13 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 130.04 34.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.322 0.649 . . . . 0.0 109.254 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.588 -171.794 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mm 67.4 -178.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.933 1.293 . . . . 0.0 109.04 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 m -150.15 -47.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 156.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.527 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.05 -161.34 19.17 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.516 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.499 HG12 HD11 ' A' ' 60' ' ' ILE . 9.7 p -117.5 161.76 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -133.5 135.96 44.78 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.63 0.772 . . . . 0.0 109.25 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -136.03 146.03 54.92 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.924 0.89 . . . . 0.0 110.371 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD3' HG12 ' A' ' 130' ' ' VAL . 69.3 Cg_endo -70.7 -32.89 13.9 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.872 2.381 . . . . 0.0 112.624 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 mm 53.24 77.9 0.42 Allowed Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 124.105 0.962 . . . . 0.0 108.756 -168.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.17 41.65 1.14 Allowed 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.403 2.736 . . . . 0.0 112.868 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -138.49 158.95 43.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.353 1.461 . . . . 0.0 109.176 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -72.16 -10.95 60.47 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.128 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -79.51 11.61 2.96 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.43 1.092 . . . . 0.0 111.823 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 58.2 ttp -63.01 -35.37 80.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.715 0.806 . . . . 0.0 109.699 166.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.78 -26.17 68.58 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.893 0.877 . . . . 0.0 112.449 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -50.66 -48.02 58.5 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.844 0.858 . . . . 0.0 111.44 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.422 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 75.0 m-85 -67.53 -27.55 67.06 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.807 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -102.12 6.63 40.97 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.342 0.657 . . . . 0.0 110.922 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -93.52 -57.06 2.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.168 0.987 . . . . 0.0 109.41 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -110.98 -19.72 12.68 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.06 32.5 75.98 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 114.917 0.727 . . . . 0.0 114.917 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -161.86 41.77 0.14 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.278 1.031 . . . . 0.0 109.459 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' OD1' ' HA ' ' A' ' 19' ' ' PHE . 3.0 m-20 -81.93 -172.01 3.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.333 -172.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -142.36 110.69 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.412 ' H ' HD23 ' A' ' 114' ' ' LEU . 91.9 t80 -86.94 111.76 21.13 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 m -83.99 140.23 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.73 0.776 . . . . 0.0 110.561 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HD2' ' HB ' ' A' ' 32' ' ' THR . 15.2 tppt? -134.58 120.98 14.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.966 1.306 . . . . 0.0 109.699 -171.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 95.6 Cg_endo -77.54 53.86 4.5 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.13 2.554 . . . . 0.0 112.829 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 58.12 21.33 7.84 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.521 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 4.5 m -63.63 -36.42 83.77 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.349 0.522 . . . . 0.0 110.294 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -119.93 149.68 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.165 0.986 . . . . 0.0 109.092 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -167.57 -48.96 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.574 0.749 . . . . 0.0 110.348 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -41.59 -51.98 3.86 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.847 1.659 . . . . 0.0 113.641 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 22.8 mt-10 -109.68 -12.51 14.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.595 0.758 . . . . 0.0 110.306 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.425 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -69.23 115.44 8.52 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 123.294 0.637 . . . . 0.0 110.221 -177.117 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -143.85 152.15 54.8 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.992 0.917 . . . . 0.0 108.951 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.83 103.16 1.3 Allowed 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.597 2.198 . . . . 0.0 111.616 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.74 -7.07 0.91 Allowed Glycine 0 N--CA 1.476 1.348 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.789 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.527 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 79.0 mtp -83.01 -169.39 2.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.432 1.093 . . . . 0.0 111.068 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 12.3 ptpt -116.0 165.52 13.03 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.713 0.805 . . . . 0.0 110.608 168.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.535 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.1 t80 -135.37 99.06 4.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 87.3 t -84.96 120.07 34.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.23 0.538 . . . . 0.0 109.804 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -84.07 100.16 10.92 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.1 t80 . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 165.656 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.641 ' HB2' ' HB ' ' A' ' 124' ' ' ILE . 1.6 m-85 . . . . . 0 CA--C 1.544 0.734 0 CA-C-O 120.939 0.4 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.17 -38.87 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.93 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.13 -166.66 25.53 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.234 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -145.89 178.68 8.0 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.906 0.882 . . . . 0.0 108.755 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -164.16 -171.71 2.51 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.693 0.797 . . . . 0.0 110.016 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 11.3 mmt180 -128.73 122.32 30.41 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.249 1.019 . . . . 0.0 109.401 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' A' ' 43' ' ' PHE . 57.8 mt -74.34 131.37 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.201 1.0 . . . . 0.0 110.322 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -139.31 -164.71 1.72 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.925 1.69 . . . . 0.0 108.357 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -24.78 109.93 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 126.378 1.871 . . . . 0.0 114.769 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 112' ' ' ILE . 35.0 m -98.76 109.04 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 94.7 t -89.62 110.23 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -87.96 118.26 27.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.516 0.727 . . . . 0.0 109.669 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.3 t -153.62 134.86 14.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.781 0.832 . . . . 0.0 109.581 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 49.3 mt-10 -70.03 -17.53 63.26 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.102 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.494 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 36.5 m-80 -91.66 118.76 68.51 Favored Pre-proline 0 C--N 1.357 0.892 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.456 ' HG2' HD21 ' A' ' 87' ' ' LEU . 50.0 Cg_endo -69.21 -10.83 30.05 Favored 'Trans proline' 0 CA--C 1.556 1.615 0 C-N-CA 122.473 2.115 . . . . 0.0 112.259 171.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 46.4 mtm -81.25 -27.56 35.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.168 0.987 . . . . 0.0 111.499 -176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 47.5 mt-30 -66.21 -24.01 66.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.387 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -74.08 -25.2 59.69 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.872 0.469 . . . . 0.0 110.866 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.543 ' HE2' HD22 ' A' ' 87' ' ' LEU . 33.3 m-85 -80.87 -37.34 30.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.0 0.52 . . . . 0.0 110.892 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.55 -29.03 61.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 121.294 -0.162 . . . . 0.0 111.35 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.4 m -80.74 -47.22 14.26 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.981 0.512 . . . . 0.0 110.682 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 62.7 m-85 -116.33 -67.23 1.01 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.265 0.626 . . . . 0.0 109.935 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.76 -81.13 1.15 Allowed Glycine 0 C--N 1.35 1.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.835 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.5 -43.97 93.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.902 0.881 . . . . 0.0 110.83 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 25.8 mmt180 -66.44 -30.68 71.09 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.553 -176.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.424 HG12 HD23 ' A' ' 82' ' ' LEU . 40.3 t -66.03 131.21 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -62.51 -22.16 66.07 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -168.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.424 HD23 HG12 ' A' ' 80' ' ' VAL . 2.3 pt? -128.07 160.89 30.58 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 85' ' ' ASP . 8.2 t -97.01 179.33 4.97 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.913 0.324 . . . . 0.0 110.383 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -62.95 -32.59 73.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.104 0.562 . . . . 0.0 111.452 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.414 ' H ' HG23 ' A' ' 83' ' ' THR . 5.6 m-20 -66.5 -45.8 78.38 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.33 0.652 . . . . 0.0 110.627 176.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.93 -35.46 76.77 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.44 173.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.543 HD22 ' HE2' ' A' ' 73' ' ' PHE . 40.5 tp -64.14 -52.73 57.7 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.546 0.529 . . . . 0.0 110.874 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -67.14 -40.44 86.74 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.256 0.348 . . . . 0.0 111.365 -173.114 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.71 -33.32 73.74 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -63.64 -48.26 77.97 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.973 0.909 . . . . 0.0 110.292 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.5 mtm -65.58 -33.0 74.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.052 0.541 . . . . 0.0 110.388 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.2 mmpt? -71.4 -34.89 70.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.621 0.368 . . . . 0.0 110.957 175.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 122.932 0.493 . . . . 0.0 110.543 179.072 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 121.132 0.491 . . . . 0.0 112.096 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.4 tpmt? -101.46 151.53 21.83 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.435 -174.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 2.9 tm? -73.45 110.31 7.65 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 173.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -89.8 158.47 17.48 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.449 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 12.3 ptm -139.51 129.05 24.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.16 0.584 . . . . 0.0 109.796 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.402 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -100.87 100.95 11.67 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.454 ' HA ' HG12 ' A' ' 63' ' ' VAL . 23.3 mt -80.95 117.98 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -80.66 110.08 15.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.52 0.676 . . . . 0.0 109.67 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 27' ' ' PHE . 4.0 mm? -88.67 131.62 34.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.405 1.082 . . . . 0.0 109.824 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -139.07 173.29 11.71 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.18 0.592 . . . . 0.0 109.463 171.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.9 t70 56.17 34.56 24.13 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.856 0.862 . . . . 0.0 110.946 170.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.9 t -65.89 106.82 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.698 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.265 -175.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.95 162.84 19.26 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.6 1.16 . . . . 0.0 109.969 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.87 124.12 42.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.697 0.799 . . . . 0.0 109.336 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -79.68 103.4 9.56 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.266 0.555 . . . . 0.0 109.674 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.83 -28.23 68.83 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.671 1.188 . . . . 0.0 110.589 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -88.34 139.85 30.24 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.973 0.909 . . . . 0.0 109.831 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.4 92.22 0.94 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.709 2.273 . . . . 0.0 111.86 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.641 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 41.5 mt -80.34 138.38 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.88 140.24 23.5 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.67 123.39 12.91 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.53 2.153 . . . . 0.0 112.095 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -57.73 -34.05 69.1 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.553 0.741 . . . . 0.0 109.432 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -150.61 164.69 35.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.388 1.075 . . . . 0.0 109.056 172.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.55 126.52 29.91 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.36 0.664 . . . . 0.0 109.522 -175.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.482 HG12 ' HD3' ' A' ' 10' ' ' PRO . 19.1 t -109.51 99.73 38.62 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.65 -172.85 1.52 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.91 2.407 . . . . 0.0 112.137 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.23 -34.81 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.965 0.906 . . . . 0.0 110.966 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.77 -21.1 77.92 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.203 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.74 163.26 26.71 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 122.92 0.295 . . . . 0.0 113.12 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -115.54 149.89 37.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.999 0.919 . . . . 0.0 109.961 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 9.2 m-85 -85.24 120.1 26.35 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 169.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.7 125.54 33.95 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 128.86 42.28 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 C--O 1.247 0.965 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -171.75 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 5' ' ' VAL . 27.1 mm 64.35 -168.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.665 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -170.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.534 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.3 m -147.31 -39.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.024 0.929 . . . . 0.0 108.729 158.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.02 -161.83 21.21 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.284 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 13.4 p -127.88 155.12 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 t -126.94 136.63 52.54 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -137.15 139.95 29.74 Favored Pre-proline 0 N--CA 1.469 0.522 0 C-N-CA 124.419 1.088 . . . . 0.0 109.369 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 15.4 Cg_exo -65.76 -47.0 4.27 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 123.079 2.519 . . . . 0.0 110.825 169.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.6 mt 67.95 136.12 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 125.366 1.466 . . . . 0.0 110.2 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.482 ' HB2' ' HD2' ' A' ' 15' ' ' PHE . 81.6 Cg_exo -48.06 124.98 10.98 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.236 1.957 . . . . 0.0 111.356 171.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -59.31 -16.8 24.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.518 1.127 . . . . 0.0 113.052 -174.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -66.98 -45.64 77.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.571 0.748 . . . . 0.0 110.797 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.482 ' HD2' ' HB2' ' A' ' 12' ' ' PRO . 76.3 m-85 -101.2 1.56 39.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.414 1.086 . . . . 0.0 112.071 -174.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -73.15 -40.8 64.56 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.211 0.604 . . . . 0.0 110.354 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -63.86 -25.34 68.12 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.504 0.721 . . . . 0.0 112.132 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -50.67 -44.25 57.64 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 124.96 1.304 . . . . 0.0 112.581 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.54 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 47.9 m-85 -70.37 -27.13 64.08 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.494 0.718 . . . . 0.0 111.526 -174.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -95.97 -17.78 20.75 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.186 0.994 . . . . 0.0 110.15 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -74.6 -58.73 3.1 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.637 1.175 . . . . 0.0 110.506 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -92.57 -14.0 28.89 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.924 -172.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.13 -58.89 4.22 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.813 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -109.88 104.72 13.69 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.317 0.558 . . . . 0.0 110.186 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 11.4 t70 -101.63 179.23 4.41 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.176 0.99 . . . . 0.0 109.757 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.0 t -138.06 110.84 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.393 1.077 . . . . 0.0 109.023 171.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -88.48 111.45 21.83 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.707 0.803 . . . . 0.0 109.937 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.8 m -90.44 126.88 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.619 0.723 . . . . 0.0 111.149 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 7.4 mmpt? -110.18 134.97 20.6 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.124 1.369 . . . . 0.0 109.726 173.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.77 56.6 6.02 Favored 'Trans proline' 0 CA--C 1.557 1.668 0 C-N-CA 122.501 2.134 . . . . 0.0 110.909 166.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 50.79 37.51 17.16 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.035 1.334 . . . . 0.0 112.919 -176.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 10.7 m -64.65 -43.39 93.79 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.954 0.902 . . . . 0.0 110.246 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.41 151.32 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.081 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.466 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 62.6 m95 -73.5 -177.38 2.63 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.392 1.077 . . . . 0.0 112.016 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -68.2 -3.72 11.58 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.036 0.934 . . . . 0.0 113.018 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HB3' HG13 ' A' ' 4' ' ' ILE . 9.5 mm-40 -66.57 -24.81 66.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.214 0.606 . . . . 0.0 110.773 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 94.65 0.63 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.935 0.494 . . . . 0.0 109.891 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.472 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -115.12 149.99 43.54 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.207 0.603 . . . . 0.0 109.438 177.293 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.473 ' HA ' HG22 ' A' ' 60' ' ' ILE . 59.9 Cg_endo -70.95 103.17 1.32 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.948 2.432 . . . . 0.0 110.699 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.64 -16.05 1.09 Allowed Glycine 0 C--O 1.241 0.54 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.512 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.477 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 25.8 mtm -73.48 -174.49 1.69 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.362 0.665 . . . . 0.0 112.185 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -109.45 159.44 17.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.845 0.858 . . . . 0.0 110.456 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.9 t80 -137.0 98.14 3.68 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 46.7 t -84.55 129.4 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 109.955 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -93.0 119.28 32.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.564 0.746 . . . . 0.0 110.042 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 52.1 t80 . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 124.875 1.27 . . . . 0.0 109.111 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 p -85.3 -31.32 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.997 0.919 . . . . 0.0 110.782 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.33 -162.9 26.09 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.869 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 15.2 pt-20 -153.72 178.0 10.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.804 1.242 . . . . 0.0 108.215 175.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -164.24 -176.17 4.31 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.592 0.757 . . . . 0.0 110.091 177.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -122.92 130.6 53.03 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.641 0.776 . . . . 0.0 109.889 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 39' ' ' PRO . 45.4 mt -74.39 138.1 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.039 1.336 . . . . 0.0 110.751 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -133.4 -168.62 2.13 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.722 2.009 . . . . 0.0 108.438 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -31.28 113.03 0.1 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 126.113 1.765 . . . . 0.0 113.967 -166.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.3 m -92.79 103.23 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 86.7 t -90.71 109.0 20.35 Favored 'Isoleucine or valine' 0 C--N 1.348 0.512 0 C-N-CA 123.682 0.793 . . . . 0.0 109.067 -172.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.5 mt -84.85 118.54 24.55 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.405 ' HB3' ' CE1' ' A' ' 72' ' ' PHE . 47.5 t -149.31 130.35 14.41 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.785 0.834 . . . . 0.0 109.202 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.423 ' HG3' HD23 ' A' ' 108' ' ' LEU . 25.9 mt-10 -67.33 -15.9 63.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.745 0.818 . . . . 0.0 111.513 173.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -103.49 119.32 55.26 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 123.534 0.734 . . . . 0.0 109.099 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.42 -13.37 39.01 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.368 2.046 . . . . 0.0 112.663 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.0 mtm -82.6 -27.94 31.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.643 0.777 . . . . 0.0 111.479 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.51 -22.4 66.72 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.771 0.319 . . . . 0.0 111.545 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 66' ' ' SER . 15.0 m-85 -71.99 -25.63 61.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.039 0.535 . . . . 0.0 110.833 174.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.599 ' HE2' HD22 ' A' ' 87' ' ' LEU . 21.2 m-85 -87.72 -27.41 22.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.822 0.449 . . . . 0.0 111.572 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.94 -29.04 55.45 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.591 0.234 . . . . 0.0 110.717 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.6 m -86.32 -46.91 9.86 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.136 0.575 . . . . 0.0 111.443 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.771 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 69.3 m-85 -116.01 -62.89 1.53 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.469 0.708 . . . . 0.0 110.082 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 72.35 -92.06 0.57 Allowed Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.019 -0.537 . . . . 0.0 113.382 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.32 -19.2 61.7 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.647 0.779 . . . . 0.0 111.064 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.771 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 23.0 mmt180 -70.67 -37.84 73.72 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.573 173.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.9 t -63.65 149.62 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.711 0.405 . . . . 0.0 110.199 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -64.03 -16.04 60.79 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.0 pt? -142.12 158.59 43.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.476 1.111 . . . . 0.0 108.686 174.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.48 HG22 ' HG3' ' A' ' 86' ' ' GLU . 13.8 t -100.44 -177.53 3.53 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.68 -35.85 79.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.535 0.734 . . . . 0.0 111.751 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.68 -44.99 94.84 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.577 0.751 . . . . 0.0 110.813 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 30.0 mt-10 -72.13 -26.38 62.09 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.68 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.599 HD22 ' HE2' ' A' ' 73' ' ' PHE . 24.9 tp -71.36 -50.96 26.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.418 0.687 . . . . 0.0 110.785 176.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -66.61 -36.66 83.13 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.542 0.337 . . . . 0.0 111.205 -173.164 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.67 -32.88 68.34 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 175.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -65.0 -46.46 81.3 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.716 0.807 . . . . 0.0 110.986 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.3 mtm -70.43 -39.0 74.66 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.962 0.505 . . . . 0.0 110.696 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.7 mmmt -67.16 -32.34 73.37 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.35 0.26 . . . . 0.0 110.675 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 123.149 0.58 . . . . 0.0 110.66 174.942 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.702 0.287 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 31' ' ' ALA . 4.3 tmtp? -85.31 145.9 27.29 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.983 0.913 . . . . 0.0 109.292 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.482 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 3.1 tm? -76.33 107.62 8.71 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 170.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -91.75 162.31 14.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.825 0.85 . . . . 0.0 109.333 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.6 ptm -141.49 131.26 24.25 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.955 0.902 . . . . 0.0 109.321 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -102.45 101.56 11.78 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.3 mt -80.26 115.09 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -77.96 139.83 39.2 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -119.68 131.35 55.4 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.904 0.882 . . . . 0.0 109.292 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -136.39 168.85 18.67 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.744 1.218 . . . . 0.0 109.459 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.6 t70 53.42 36.7 23.74 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.412 1.085 . . . . 0.0 111.21 168.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.69 103.71 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.739 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -90.19 108.51 19.79 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.386 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -73.5 130.46 40.15 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -78.99 120.25 23.31 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -60.91 -35.3 76.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.022 0.929 . . . . 0.0 110.349 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -116.39 147.62 39.97 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.776 1.231 . . . . 0.0 109.798 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -64.8 97.13 0.27 Allowed 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 123.308 2.672 . . . . 0.0 111.591 172.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.5 mt -83.25 115.53 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.9 147.64 91.55 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.72 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.403 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 91.6 Cg_endo -87.16 154.81 8.24 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.473 2.115 . . . . 0.0 112.179 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -74.01 -23.11 59.38 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.44 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 126' ' ' PRO . 13.4 ptm180 -150.35 160.35 43.79 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.989 0.915 . . . . 0.0 109.342 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 129' ' ' LEU . 2.6 pt? -75.8 120.62 21.42 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.7 t -94.49 109.49 43.41 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.54 179.77 6.2 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.95 2.433 . . . . 0.0 111.838 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.4 t -59.15 -32.83 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 124.2 1.0 . . . . 0.0 111.794 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.64 -16.62 72.14 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.558 -0.747 . . . . 0.0 113.641 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.04 160.62 15.17 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.119 0.39 . . . . 0.0 113.149 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -118.1 139.07 51.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.599 0.759 . . . . 0.0 109.458 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.466 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 0.2 OUTLIER -79.42 106.91 11.79 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.552 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.49 114.12 18.17 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.4 ' HD3' ' H ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -110.07 148.96 30.72 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.524 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.253 1.239 0 CA-C-N 118.217 0.462 . . . . 0.0 110.127 172.189 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 5' ' ' VAL . 23.1 mm 68.78 178.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 C-N-CA 124.612 1.165 . . . . 0.0 109.759 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.419 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.7 m -145.41 -43.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.619 1.168 . . . . 0.0 108.181 160.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.97 -159.17 15.16 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.724 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 HD11 ' A' ' 60' ' ' ILE . 10.0 p -122.9 151.33 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -123.29 135.56 54.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.843 0.857 . . . . 0.0 109.528 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -137.47 138.88 25.81 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.556 0.742 . . . . 0.0 111.064 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 91.0 Cg_endo -74.35 -9.57 21.77 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.76 2.307 . . . . 0.0 111.86 169.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 mm 64.83 116.64 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.638 1.575 . . . . 0.0 109.284 -175.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.56 -11.49 20.36 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.815 2.343 . . . . 0.0 113.841 -172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HE2' ' HD1' ' A' ' 90' ' ' TYR . 63.8 mttm -133.66 176.91 8.12 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.543 1.137 . . . . 0.0 110.693 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -71.99 -5.91 38.3 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.021 0.929 . . . . 0.0 112.002 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -73.43 15.13 0.27 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.2 ptp -56.7 -32.29 65.32 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 157.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.28 -45.87 35.21 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.549 1.54 . . . . 0.0 111.79 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 84.2 mmt-85 -58.08 -36.58 73.03 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.134 0.896 . . . . 0.0 112.501 -173.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HB3' HG11 ' A' ' 117' ' ' VAL . 74.5 m-85 -66.35 -29.35 69.52 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.419 0.45 . . . . 0.0 110.565 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -98.23 -15.31 19.9 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.768 0.827 . . . . 0.0 110.928 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 18' ' ' ARG . 5.8 tmtm? -78.31 -48.06 16.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.78 1.232 . . . . 0.0 110.275 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.7 ptpt -102.55 -12.36 17.83 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.568 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.94 -14.03 59.74 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.988 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -164.0 114.72 1.3 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.834 0.854 . . . . 0.0 109.4 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 18.9 t70 -133.83 -175.37 3.81 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.1 0.96 . . . . 0.0 110.296 -162.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 113' ' ' GLU . 76.9 t -135.87 119.28 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 121.278 -0.889 . . . . 0.0 109.417 176.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -93.69 115.77 28.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.323 0.649 . . . . 0.0 109.929 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.8 m -93.68 143.56 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.838 0.827 . . . . 0.0 111.163 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.6 mmpt? -130.15 136.18 28.62 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 126.225 1.81 . . . . 0.0 108.951 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.72 55.21 5.12 Favored 'Trans proline' 0 CA--C 1.552 1.388 0 C-N-CA 122.421 2.081 . . . . 0.0 111.149 166.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.56 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.063 1.345 . . . . 0.0 112.394 -170.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.563 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 24.8 m -126.45 -50.84 1.51 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.35 107.52 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.858 0.863 . . . . 0.0 109.253 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -146.06 1.18 0.86 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.228 0.611 . . . . 0.0 111.533 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -64.47 -53.62 45.43 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.453 0.644 . . . . 0.0 110.275 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -109.4 -7.98 15.12 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.424 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.33 107.11 1.53 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.571 0.748 . . . . 0.0 110.872 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.471 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -135.9 152.26 75.44 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.279 0.632 . . . . 0.0 109.909 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.06 102.5 1.08 Allowed 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.971 2.447 . . . . 0.0 111.32 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.25 -19.83 1.2 Allowed Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.666 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.471 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 30.1 mtm -74.64 -177.88 3.38 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.078 0.466 . . . . 0.0 111.234 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -104.04 163.07 12.63 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.341 0.656 . . . . 0.0 110.869 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.489 ' CB ' HD11 ' A' ' 114' ' ' LEU . 2.5 t80 -134.55 102.03 5.16 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 48.7 t -90.17 123.87 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.339 0.59 . . . . 0.0 110.137 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.36 111.43 19.42 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.743 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 76.5 t80 . . . . . 0 CA--C 1.544 0.713 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.399 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.55 -19.69 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.709 0.804 . . . . 0.0 111.279 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.42 -171.45 40.94 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.093 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 21.2 pt-20 -153.82 178.95 9.33 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.788 0.835 . . . . 0.0 109.861 171.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -165.26 -171.33 2.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.705 0.802 . . . . 0.0 110.354 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -123.03 122.44 38.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.65 0.78 . . . . 0.0 111.362 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.457 HD11 HG12 ' A' ' 7' ' ' VAL . 74.6 mt -69.02 136.99 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.445 1.098 . . . . 0.0 111.224 175.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 30.9 mmmt -136.58 -167.73 2.12 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 126.877 2.071 . . . . 0.0 107.697 -177.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -39.88 112.89 0.3 Allowed 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 125.187 1.395 . . . . 0.0 113.706 -166.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.02 106.93 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 95.6 t -90.11 109.53 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.395 0.678 . . . . 0.0 109.26 -174.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 108' ' ' LEU . 39.1 mt -91.26 115.98 28.46 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 t -151.66 129.66 11.79 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.781 0.832 . . . . 0.0 109.137 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.515 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 45.0 mt-10 -61.75 -21.26 64.38 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.374 0.67 . . . . 0.0 112.248 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -100.58 118.97 59.9 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.509 ' HG2' HD21 ' A' ' 87' ' ' LEU . 56.3 Cg_endo -69.16 -8.69 24.29 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.956 2.437 . . . . 0.0 113.085 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 50.6 mtm -79.9 -24.72 40.94 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.383 0.673 . . . . 0.0 111.205 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.405 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -60.33 -26.49 66.61 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.607 0.763 . . . . 0.0 111.527 175.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -76.71 -20.49 56.51 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.06 0.544 . . . . 0.0 111.116 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.478 ' HE2' HD22 ' A' ' 87' ' ' LEU . 30.2 m-85 -85.81 -38.36 18.25 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.822 0.449 . . . . 0.0 110.537 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.0 pt-20 -72.42 -23.48 61.09 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 120.34 0.114 . . . . 0.0 111.0 175.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.3 m -88.5 -44.33 10.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.236 0.614 . . . . 0.0 111.063 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.763 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 64.7 m-85 -118.11 -66.96 1.03 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.071 0.548 . . . . 0.0 110.332 -176.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.09 -81.21 0.68 Allowed Glycine 0 C--N 1.355 1.62 0 O-C-N 123.472 0.483 . . . . 0.0 113.304 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.89 -27.66 69.51 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.363 1.065 . . . . 0.0 111.499 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.763 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 38.6 mmt180 -81.38 -33.12 32.54 Favored 'General case' 0 C--O 1.209 -1.072 0 O-C-N 123.992 0.807 . . . . 0.0 111.975 -176.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.463 HG12 HD23 ' A' ' 82' ' ' LEU . 21.7 t -66.57 145.47 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 118.451 0.569 . . . . 0.0 110.459 -174.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.447 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 34.7 p90 -64.05 -17.25 63.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.463 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -140.31 158.18 44.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.3 t -95.27 179.56 5.14 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -65.51 -27.13 68.25 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.518 0.727 . . . . 0.0 111.518 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.91 -49.64 67.31 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.905 0.882 . . . . 0.0 110.506 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -62.65 -31.45 72.32 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.186 176.273 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.509 HD21 ' HG2' ' A' ' 69' ' ' PRO . 46.1 tp -67.78 -52.15 40.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.433 0.693 . . . . 0.0 111.093 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -63.18 -38.58 91.73 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.234 0.334 . . . . 0.0 111.366 -174.068 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.412 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 13.0 pt-20 -78.88 -23.68 44.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.728 0.411 . . . . 0.0 111.343 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.416 ' HD1' ' HE2' ' A' ' 13' ' ' LYS . 56.9 t80 -66.08 -38.96 89.6 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.378 0.671 . . . . 0.0 109.97 170.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.6 mtm -77.57 -30.82 52.77 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.454 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.8 mmpt? -71.14 -28.83 64.56 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.397 0.279 . . . . 0.0 110.516 171.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.478 0.937 0 C-N-CA 123.388 0.675 . . . . 0.0 110.83 179.083 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 4.2 tmtp? -86.24 140.11 30.43 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 65' ' ' LEU . 2.8 tm? -74.28 107.83 6.69 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -89.04 161.85 16.33 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.552 0.741 . . . . 0.0 109.533 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.485 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 15.1 ptm -145.56 131.04 18.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.822 0.849 . . . . 0.0 109.781 -175.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -106.58 101.97 11.38 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.222 0.609 . . . . 0.0 109.56 -178.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.2 mt -78.4 115.46 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -80.95 133.75 35.58 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -177.024 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' ' 43' ' ' PHE . 3.3 mm? -122.92 122.3 38.25 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.455 0.702 . . . . 0.0 111.279 -174.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -124.41 165.23 18.1 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.572 0.749 . . . . 0.0 110.313 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.0 t70 50.23 53.25 13.2 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.124 1.37 . . . . 0.0 111.29 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.541 HG11 ' HB3' ' A' ' 19' ' ' PHE . 41.9 t -74.7 101.45 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.671 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -81.74 146.27 30.06 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.526 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -101.3 134.86 43.72 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.626 0.771 . . . . 0.0 109.337 171.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -86.43 88.14 7.57 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 170.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.24 -26.04 63.66 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.649 0.738 . . . . 0.0 109.066 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -81.24 135.98 50.19 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.645 173.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.06 91.94 1.15 Allowed 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.793 2.329 . . . . 0.0 112.573 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.5 mt -105.36 125.11 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.443 0.639 . . . . 0.0 110.651 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.63 148.35 34.46 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.703 1.201 . . . . 0.0 109.338 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.421 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 64.2 Cg_endo -77.9 178.43 7.61 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.194 2.596 . . . . 0.0 113.562 -170.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -84.74 -38.65 19.42 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.131 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -142.22 166.24 25.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.067 0.547 . . . . 0.0 110.832 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 129' ' ' LEU . 2.6 pt? -66.79 134.93 53.14 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 124.236 0.96 . . . . 0.0 109.779 174.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.466 HG12 ' HD3' ' A' ' 10' ' ' PRO . 41.0 t -118.29 102.23 50.62 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.93 178.9 2.55 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.326 2.684 . . . . 0.0 112.249 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.4 t -60.19 -31.74 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.77 0.828 . . . . 0.0 111.07 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.49 -12.53 77.28 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 115.572 -0.74 . . . . 0.0 114.287 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.65 157.83 16.96 Favored Glycine 0 C--N 1.35 1.357 0 C-N-CA 123.035 0.35 . . . . 0.0 113.662 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -117.83 147.23 43.25 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.709 0.803 . . . . 0.0 110.394 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -77.85 112.63 14.92 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 167.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.66 128.94 34.01 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.05 134.98 35.42 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.77 0.428 . . . . 0.0 110.521 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 . . . . . 0 C--O 1.25 1.089 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.779 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 5' ' ' VAL . 24.9 mm 64.5 -173.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.599 0 C-N-CA 124.045 0.938 . . . . 0.0 108.55 -174.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.473 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.1 m -152.43 -42.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 158.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.63 -159.69 16.03 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.611 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 11.6 p -126.63 152.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 171.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 t -123.72 134.57 53.67 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -127.37 151.08 74.25 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.519 0.728 . . . . 0.0 110.01 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HG3' ' HA ' ' A' ' 132' ' ' VAL . 56.8 Cg_endo -65.87 -34.46 39.31 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.854 2.369 . . . . 0.0 111.868 175.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.4 mm 67.62 132.98 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.935 1.294 . . . . 0.0 111.198 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.23 110.66 0.68 Allowed 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 121.832 1.688 . . . . 0.0 109.74 165.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.788 ' HA ' ' HB2' ' A' ' 16' ' ' MET . 19.3 pttp -68.77 -3.89 13.98 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -174.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -66.83 -40.52 88.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.602 1.161 . . . . 0.0 109.063 170.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -116.54 16.52 15.54 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.316 1.046 . . . . 0.0 112.0 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.788 ' HB2' ' HA ' ' A' ' 13' ' ' LYS . 56.6 ttp -62.27 -47.04 86.12 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.087 0.555 . . . . 0.0 110.426 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.66 -2.48 20.27 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.906 -175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 1.9 mmm180 -63.19 -49.77 72.94 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.052 0.541 . . . . 0.0 110.3 173.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 51.1 m-85 -61.93 -29.08 69.99 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 124.007 0.817 . . . . 0.0 110.395 -178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -96.97 -12.86 22.82 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.205 1.002 . . . . 0.0 111.527 -174.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.69 -50.18 14.3 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.842 0.857 . . . . 0.0 109.479 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.4 ptpt -101.07 -16.64 17.02 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.06 -169.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.87 -11.32 48.16 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-O 119.839 -0.423 . . . . 0.0 114.118 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -159.73 117.54 2.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.028 0.931 . . . . 0.0 109.428 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.465 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 17.9 t70 -124.88 -176.21 3.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.248 1.019 . . . . 0.0 109.307 -172.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -132.27 110.33 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.148 0.979 . . . . 0.0 108.791 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -90.54 109.25 20.4 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 110.0 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.4 m -85.8 129.03 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.545 0.688 . . . . 0.0 111.121 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -112.65 142.42 27.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.896 1.278 . . . . 0.0 109.518 170.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.41 46.23 2.07 Favored 'Trans proline' 0 C--N 1.367 1.5 0 C-N-CA 122.692 2.262 . . . . 0.0 112.16 168.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.21 86.42 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.201 1.401 . . . . 0.0 112.495 -172.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -122.31 7.43 9.63 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.595 0.758 . . . . 0.0 109.842 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.425 ' HB ' ' OH ' ' A' ' 136' ' ' TYR . 14.1 m -127.92 150.16 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.385 1.074 . . . . 0.0 109.776 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -80.9 -172.81 3.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.307 0.643 . . . . 0.0 110.99 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -73.1 9.53 1.19 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -71.61 -29.43 64.67 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.875 0.47 . . . . 0.0 109.845 172.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.89 104.85 1.17 Allowed 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.055 0.542 . . . . 0.0 110.053 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -135.5 153.65 77.86 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 123.279 0.632 . . . . 0.0 109.784 -177.696 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.81 97.12 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.761 2.307 . . . . 0.0 111.094 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.45 43.48 0.1 OUTLIER Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.495 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.419 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 32.5 mtm -126.94 -171.59 2.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.79 0.836 . . . . 0.0 109.525 174.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.6 ptpt -112.7 158.54 19.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.276 0.63 . . . . 0.0 110.251 169.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.54 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.2 t80 -135.67 101.25 4.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 40.7 t -86.18 130.18 36.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -95.56 112.69 24.36 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.258 0.623 . . . . 0.0 109.455 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.573 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 90.1 t80 . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.46 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 62.9 m-85 . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.457 HG11 ' SD ' ' A' ' 16' ' ' MET . 3.3 p -87.31 -30.12 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.661 0.784 . . . . 0.0 110.471 174.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.4 -157.76 20.37 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 120.062 -0.299 . . . . 0.0 112.768 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 16.2 pt-20 -154.17 178.61 9.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.179 0.992 . . . . 0.0 109.293 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -166.76 -172.66 2.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.01 0.924 . . . . 0.0 110.177 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 61.4 mmt-85 -128.22 125.5 39.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.858 0.863 . . . . 0.0 109.69 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.54 HG13 ' HB2' ' A' ' 43' ' ' PHE . 41.3 mt -73.63 137.08 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.199 1.0 . . . . 0.0 111.767 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -134.94 -176.88 4.39 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 126.879 2.072 . . . . 0.0 108.081 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -30.96 112.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.932 1.693 . . . . 0.0 114.328 -170.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 112' ' ' ILE . 27.5 m -91.61 106.26 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -88.22 110.78 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.4 mt -92.59 119.86 32.46 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.366 0.666 . . . . 0.0 109.436 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.2 t -151.51 134.24 15.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 44.4 mt-10 -74.67 -0.98 19.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.797 0.839 . . . . 0.0 112.299 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.682 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 12.9 m-80 -112.66 120.16 41.62 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.2 -20.84 55.89 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.342 2.028 . . . . 0.0 112.345 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 65.4 mtm -71.79 -24.63 61.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.184 0.994 . . . . 0.0 111.091 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.682 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 36.4 mm-40 -62.58 -28.89 70.19 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.875 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -76.31 -20.06 57.65 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.728 0.411 . . . . 0.0 111.185 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CE2' HD22 ' A' ' 87' ' ' LEU . 87.7 m-85 -93.45 -19.56 21.14 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.9 0.48 . . . . 0.0 111.09 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 9.1 pt-20 -84.8 -30.4 24.62 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.808 0.276 . . . . 0.0 110.573 168.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.3 m -80.39 -58.9 2.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.953 0.501 . . . . 0.0 110.644 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.64 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 85.8 m-85 -100.85 -69.68 0.77 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.73 -78.03 0.5 Allowed Glycine 0 C--N 1.353 1.516 0 O-C-N 123.5 0.5 . . . . 0.0 112.622 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.85 -44.68 91.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.756 1.222 . . . . 0.0 111.463 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.64 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 61.1 mmt-85 -64.97 -30.17 71.14 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.677 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.73 149.79 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.563 0.745 . . . . 0.0 111.142 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -65.5 -41.4 93.23 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.088 0.555 . . . . 0.0 112.355 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -109.55 169.03 8.97 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.466 HG22 ' HG2' ' A' ' 86' ' ' GLU . 8.8 t -98.26 168.36 10.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 172.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -68.17 -25.69 65.38 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.201 0.524 . . . . 0.0 111.375 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.7 -52.57 65.11 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.519 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.466 ' HG2' HG22 ' A' ' 83' ' ' THR . 48.6 mm-40 -57.78 -35.11 70.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.736 0.414 . . . . 0.0 110.78 176.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.419 HD22 ' CE2' ' A' ' 73' ' ' PHE . 26.5 tp -62.12 -57.27 12.19 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.945 0.898 . . . . 0.0 111.56 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -38.72 85.53 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -172.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -79.16 -27.48 42.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.688 0.395 . . . . 0.0 111.512 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -65.92 -41.67 91.08 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.269 0.628 . . . . 0.0 110.267 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 62.5 mtm -72.1 -30.03 64.68 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.763 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -73.86 -33.94 64.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.97 0.508 . . . . 0.0 110.678 171.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 123.359 0.663 . . . . 0.0 111.441 177.748 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.55 0.951 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -124.28 144.4 50.0 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.047 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.604 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 2.9 tm? -68.41 108.31 3.21 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -97.1 161.14 13.96 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.0 ptm -143.94 131.22 20.81 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.668 0.787 . . . . 0.0 109.568 -174.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.34 101.97 11.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.566 0.746 . . . . 0.0 109.107 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.419 ' HA ' HG12 ' A' ' 63' ' ' VAL . 36.9 mt -80.2 120.36 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -83.93 139.24 32.71 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -120.69 121.28 37.93 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.616 1.167 . . . . 0.0 109.026 -177.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -113.94 171.34 7.65 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.011 0.924 . . . . 0.0 108.894 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.4 t70 52.07 46.79 26.01 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.365 1.066 . . . . 0.0 112.167 166.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.9 t -74.88 108.25 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.534 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.76 153.68 20.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.004 0.922 . . . . 0.0 110.302 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -108.26 136.69 47.49 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.739 0.816 . . . . 0.0 110.379 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.46 ' HD2' ' HB2' ' A' ' 54' ' ' PHE . 10.1 m-30 -95.93 78.8 3.23 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.613 0.765 . . . . 0.0 109.128 172.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.95 -24.96 63.43 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.903 169.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.537 ' HG3' HG13 ' A' ' 124' ' ' ILE . 18.5 ptpt -81.7 145.57 54.61 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.385 1.074 . . . . 0.0 109.344 171.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.81 77.26 3.97 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.936 2.424 . . . . 0.0 113.076 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.537 HG13 ' HG3' ' A' ' 122' ' ' LYS . 54.2 mt -86.37 128.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -109.3 146.48 34.02 Favored Pre-proline 0 C--O 1.242 0.668 0 C-N-CA 123.943 0.897 . . . . 0.0 109.351 -177.707 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.26 147.04 41.45 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 122.879 2.386 . . . . 0.0 112.397 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -70.12 -26.49 63.98 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.647 0.779 . . . . 0.0 109.273 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -144.62 159.23 43.16 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.202 1.001 . . . . 0.0 109.439 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.5 133.21 38.62 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.0 t -105.85 95.31 10.42 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.45 -175.48 2.7 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.056 2.504 . . . . 0.0 111.957 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.585 ' HA ' ' HG3' ' A' ' 10' ' ' PRO . 27.1 m -57.74 -26.63 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.331 1.052 . . . . 0.0 113.816 -174.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.14 -22.22 74.24 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.259 0.349 . . . . 0.0 113.607 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.08 149.0 8.19 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 112.362 -0.295 . . . . 0.0 112.362 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -108.8 135.94 49.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.508 0.723 . . . . 0.0 109.829 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.425 ' OH ' ' HB ' ' A' ' 33' ' ' VAL . 1.6 m-85 -76.26 109.74 10.2 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.72 114.14 18.41 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -125.99 138.82 53.77 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.607 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.475 178.655 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 5' ' ' VAL . 27.1 mm 65.73 -171.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -143.49 -39.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 157.464 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.472 ' HA3' ' HG3' ' A' ' 42' ' ' LYS . . . -167.52 -164.35 23.04 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.438 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.448 HG12 HD11 ' A' ' 60' ' ' ILE . 10.9 p -132.08 144.43 37.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 t -113.87 137.64 51.39 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -132.66 145.12 55.8 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.884 0.874 . . . . 0.0 109.21 178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HD3' HG12 ' A' ' 130' ' ' VAL . 30.2 Cg_endo -61.96 -25.04 77.54 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.962 2.442 . . . . 0.0 112.016 173.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.9 mm 68.75 134.03 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.057 1.343 . . . . 0.0 111.913 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -54.62 114.43 1.84 Allowed 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.546 2.164 . . . . 0.0 110.25 169.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -63.47 -28.03 69.68 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.287 1.035 . . . . 0.0 113.436 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -61.43 -36.24 79.8 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.146 0.498 . . . . 0.0 110.46 172.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -107.91 19.15 20.42 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.143 -172.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.401 ' SD ' HG21 ' A' ' 55' ' ' VAL . 16.0 tmm? -66.94 -32.78 74.26 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.626 0.77 . . . . 0.0 110.153 175.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.32 -33.87 77.0 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.238 1.015 . . . . 0.0 112.195 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 81' ' ' PHE . 11.0 mmt180 -54.09 -52.92 59.47 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.655 1.182 . . . . 0.0 113.277 -164.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 47.9 m-85 -60.24 -29.36 68.71 Favored 'General case' 0 CA--C 1.554 1.104 0 O-C-N 124.121 0.888 . . . . 0.0 110.743 -174.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -94.7 -24.76 17.0 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.415 1.086 . . . . 0.0 110.674 -176.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.22 -42.73 79.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.92 1.288 . . . . 0.0 111.028 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.7 ptpt -109.33 -16.43 14.04 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.238 -171.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.93 -14.85 9.35 Favored Glycine 0 N--CA 1.479 1.503 0 N-CA-C 114.191 0.436 . . . . 0.0 114.191 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -150.06 105.64 3.4 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.668 1.187 . . . . 0.0 108.94 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.5 t70 -107.32 174.73 5.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 110.585 -175.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -133.88 109.07 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.435 ' HD2' HD12 ' A' ' 112' ' ' ILE . 76.9 t80 -91.12 108.92 20.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.337 0.655 . . . . 0.0 109.577 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 m -94.45 132.93 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.516 0.674 . . . . 0.0 110.673 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.645 ' HD3' ' HD2' ' A' ' 30' ' ' PRO . 14.9 tppt? -134.84 133.24 20.94 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.349 1.06 . . . . 0.0 108.793 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.645 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 59.5 Cg_endo -71.73 66.97 3.07 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.669 2.246 . . . . 0.0 113.2 172.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 55.07 17.02 1.74 Allowed 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.158 1.383 . . . . 0.0 114.672 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 m -70.32 -28.37 65.11 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.225 0.61 . . . . 0.0 110.875 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.45 HG23 ' HG2' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -87.6 148.62 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.344 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -87.72 -168.11 2.11 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.173 0.589 . . . . 0.0 110.917 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -74.58 -1.25 20.68 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -170.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.11 -30.59 70.45 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.967 0.507 . . . . 0.0 110.815 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.84 98.38 0.73 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.29 1.036 . . . . 0.0 111.55 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HG3' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -122.28 156.27 60.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.835 1.254 . . . . 0.0 108.883 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.82 107.0 2.11 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.256 1.971 . . . . 0.0 111.472 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.45 31.65 0.46 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.225 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.641 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 88.8 mtp -112.55 -173.99 2.36 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.911 0.884 . . . . 0.0 110.669 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.472 ' HG3' ' HA3' ' A' ' 6' ' ' GLY . 15.2 ptpt -116.85 156.44 27.3 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.387 1.075 . . . . 0.0 109.599 172.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.502 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -136.05 100.15 4.34 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 177.676 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.1 t -86.3 124.42 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.245 0.545 . . . . 0.0 110.131 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.422 ' HE2' HG13 ' A' ' 117' ' ' VAL . 25.7 m-85 -89.4 106.7 18.62 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.633 0.773 . . . . 0.0 109.876 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.406 ' HA ' ' CD1' ' A' ' 54' ' ' PHE . 78.3 t80 . . . . . 0 N--CA 1.472 0.654 0 O-C-N 124.94 1.4 . . . . 0.0 111.401 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 46' ' ' TYR . 98.4 m-85 . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.401 HG21 ' SD ' ' A' ' 16' ' ' MET . 7.7 p -118.31 -34.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.784 0.834 . . . . 0.0 110.449 173.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.13 -160.04 23.37 Favored Glycine 0 C--N 1.35 1.355 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.972 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.521 ' HG3' ' HB3' ' A' ' 118' ' ' LYS . 7.3 pt-20 -152.19 177.55 10.41 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.69 1.196 . . . . 0.0 109.526 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.494 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.59 -172.3 3.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.938 0.895 . . . . 0.0 110.035 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.8 mmt-85 -123.91 122.3 37.61 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.802 0.841 . . . . 0.0 109.952 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.641 ' HB ' ' HB2' ' A' ' 41' ' ' MET . 36.3 mt -74.56 128.49 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.856 0.862 . . . . 0.0 109.86 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.589 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 31.6 mmmt -132.49 -167.96 1.98 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 125.433 1.493 . . . . 0.0 107.609 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -41.7 113.22 0.4 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.702 1.201 . . . . 0.0 113.69 -163.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.18 111.91 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.738 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.7 109.68 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.19 117.84 26.2 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -148.62 127.39 12.56 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.316 1.047 . . . . 0.0 109.052 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 34.7 mt-10 -65.68 -20.94 66.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.607 0.763 . . . . 0.0 111.921 176.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -99.81 118.0 62.57 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.44 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 40.6 Cg_endo -67.47 -18.6 49.3 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.196 1.931 . . . . 0.0 112.855 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.44 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.2 mpp? -73.63 -25.63 60.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.754 0.421 . . . . 0.0 111.008 -173.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -64.4 -22.78 67.07 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.691 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -78.3 -30.83 48.55 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.022 0.529 . . . . 0.0 110.93 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.512 ' CE2' HD22 ' A' ' 87' ' ' LEU . 92.7 m-85 -82.74 -16.11 49.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.664 0.386 . . . . 0.0 111.915 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.83 -32.03 16.23 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.668 0.213 . . . . 0.0 110.794 171.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 92.8 m -76.75 -41.42 44.93 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 120.848 0.356 . . . . 0.0 111.109 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.712 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 44.0 m-85 -117.83 -67.29 1.0 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.426 0.69 . . . . 0.0 109.219 -175.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.06 -97.84 2.1 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.105 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.71 -22.15 61.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.8 0.44 . . . . 0.0 110.855 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.712 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 31.8 mmt180 -59.91 -37.78 80.42 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.007 0.523 . . . . 0.0 111.294 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.482 HG12 HD23 ' A' ' 82' ' ' LEU . 39.0 t -62.74 145.08 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 O-C-N 123.729 0.643 . . . . 0.0 109.767 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 41.2 p90 -60.06 -20.1 56.32 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.482 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -133.56 164.87 26.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.6 t -98.36 176.33 5.74 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.645 0.657 . . . . 0.0 109.435 173.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -61.63 -29.44 70.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.195 0.598 . . . . 0.0 111.196 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.46 ' H ' HG23 ' A' ' 83' ' ' THR . 3.2 m-20 -65.96 -45.83 80.34 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.954 0.902 . . . . 0.0 111.409 174.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.4 -36.34 83.4 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.183 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.512 HD22 ' CE2' ' A' ' 73' ' ' PHE . 27.1 tp -60.56 -54.81 40.93 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.469 0.708 . . . . 0.0 110.985 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -64.03 -42.51 97.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.158 -172.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -70.28 -31.11 68.33 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.35 0.26 . . . . 0.0 110.729 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -65.09 -43.62 91.52 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.652 0.781 . . . . 0.0 110.482 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 61.4 mtm -74.82 -31.65 61.74 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.365 0.666 . . . . 0.0 110.824 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 31.9 mmmt -69.76 -28.09 65.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.126 0.571 . . . . 0.0 110.691 172.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 CA--C 1.543 0.675 0 C-N-CA 122.965 0.506 . . . . 0.0 110.045 173.13 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -93.38 150.28 20.58 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.0 0.52 . . . . 0.0 109.728 178.083 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 3.1 tm? -69.29 122.95 19.91 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -106.04 156.25 18.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.489 0.715 . . . . 0.0 109.348 171.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.7 ptm -131.57 129.17 40.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.093 0.957 . . . . 0.0 108.828 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.69 102.24 11.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 60' ' ' ILE . 33.8 mt -82.61 121.31 35.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.14 101.43 8.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.494 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.1 mm? -87.11 120.56 28.51 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 122.902 0.481 . . . . 0.0 109.779 175.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.589 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 2.1 pp20? -138.34 168.8 18.98 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.1 t70 60.76 30.05 19.42 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.781 0.833 . . . . 0.0 110.654 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.422 HG13 ' HE2' ' A' ' 45' ' ' PHE . 61.0 t -61.19 118.11 3.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.219 -171.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . 1.6 tpmt? -102.01 152.39 21.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.069 0.947 . . . . 0.0 110.654 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -106.07 138.54 42.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.985 0.914 . . . . 0.0 109.396 174.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -87.18 90.68 8.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.05 -34.63 77.98 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.695 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -85.76 139.37 35.28 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.196 172.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.35 89.15 1.37 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.794 2.329 . . . . 0.0 111.742 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 21.2 mt -72.42 130.24 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.096 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 142.92 57.64 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.014 0.526 . . . . 0.0 109.623 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.02 155.74 19.93 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.404 2.069 . . . . 0.0 113.307 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -74.21 -25.83 59.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.825 173.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -170.49 173.6 5.49 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.194 0.998 . . . . 0.0 109.697 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -67.14 128.18 35.4 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 166.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.467 HG12 ' HD3' ' A' ' 10' ' ' PRO . 78.9 t -101.03 103.63 26.71 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.87 -177.81 1.74 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.229 2.619 . . . . 0.0 113.33 -174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.0 m -61.46 -27.19 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.981 0.913 . . . . 0.0 112.639 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.7 -15.32 75.94 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.183 0.302 . . . . 0.0 113.12 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.28 169.21 39.47 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.351 0.501 . . . . 0.0 112.928 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -120.65 146.51 46.33 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.008 0.923 . . . . 0.0 109.783 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -87.51 118.18 26.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.015 0.526 . . . . 0.0 110.141 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tt -84.7 128.0 34.38 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 172.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.439 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -133.1 136.96 46.15 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.794 0.438 . . . . 0.0 110.516 -175.009 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 CA--C 1.554 1.133 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.414 177.92 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.446 HG22 ' H ' ' A' ' 5' ' ' VAL . 26.2 mm 66.25 -174.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 124.408 1.083 . . . . 0.0 109.596 -175.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 139' ' ' GLU . 2.7 m -154.73 -40.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 125.269 1.427 . . . . 0.0 108.511 158.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.15 -159.15 14.15 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.204 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 12.6 p -126.68 160.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 t -135.41 139.59 44.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.276 0.63 . . . . 0.0 109.864 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -136.65 142.2 38.19 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.011 0.924 . . . . 0.0 109.789 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HD3' HG12 ' A' ' 130' ' ' VAL . 47.9 Cg_endo -69.03 -35.56 14.53 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.694 2.263 . . . . 0.0 111.226 168.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.7 mt 61.23 100.95 0.04 OUTLIER Pre-proline 0 C--N 1.361 1.098 0 C-N-CA 125.523 1.529 . . . . 0.0 110.928 -175.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.73 -179.4 2.87 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.456 2.104 . . . . 0.0 111.451 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.536 ' HG3' ' H ' ' A' ' 14' ' ' ARG . 31.8 tptt 67.86 -176.38 0.2 Allowed 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.744 0.818 . . . . 0.0 109.703 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.536 ' H ' ' HG3' ' A' ' 13' ' ' LYS . 79.8 mtp180 -76.79 -15.09 59.84 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.316 0.646 . . . . 0.0 112.245 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.527 ' CZ ' ' HG2' ' A' ' 86' ' ' GLU . 11.5 m-30 -74.28 7.52 2.76 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -165.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.623 ' SD ' HG11 ' A' ' 55' ' ' VAL . 18.2 tmm? -67.7 -44.54 77.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.217 0.607 . . . . 0.0 109.584 168.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.07 -15.71 63.51 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.859 0.864 . . . . 0.0 113.088 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG2' ' HA ' ' A' ' 15' ' ' PHE . 20.4 mmt180 -51.82 -50.9 59.92 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.138 0.975 . . . . 0.0 111.685 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.604 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 22.5 m-85 -62.33 -29.03 70.16 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.294 -170.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -93.06 -29.09 15.98 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.322 1.049 . . . . 0.0 110.411 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -63.06 -46.39 87.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.019 0.928 . . . . 0.0 110.638 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.6 ptpt -101.88 -15.35 16.9 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.356 -172.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.11 -7.71 27.99 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -159.31 107.14 1.78 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.6 1.16 . . . . 0.0 108.279 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.604 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.4 t70 -115.68 177.61 4.61 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.984 0.913 . . . . 0.0 109.773 -176.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -132.65 108.98 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -87.93 107.38 18.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 0.0 109.917 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 m -90.07 125.76 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 121.566 0.698 . . . . 0.0 110.906 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 7.4 mmpt? -108.96 131.58 21.71 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.924 1.29 . . . . 0.0 109.606 174.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.13 54.55 4.97 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.066 2.511 . . . . 0.0 112.267 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 57.6 87.17 0.07 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.609 1.164 . . . . 0.0 111.001 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 29.1 m -130.65 -68.72 0.68 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.49 0.716 . . . . 0.0 109.344 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -109.0 106.74 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -137.2 -10.67 1.7 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.234 1.014 . . . . 0.0 110.391 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -64.78 -55.7 18.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.211 1.004 . . . . 0.0 110.651 -170.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -102.41 -9.01 20.65 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.085 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 110.7 3.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.137 0.575 . . . . 0.0 110.979 -173.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -139.12 150.81 66.12 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.125 0.57 . . . . 0.0 109.476 177.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 105.85 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.838 2.359 . . . . 0.0 111.329 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.1 -17.93 1.74 Allowed Glycine 0 N--CA 1.467 0.716 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.417 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.486 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 29.2 mtm -75.28 -179.82 4.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.547 0.689 . . . . 0.0 111.418 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -106.63 161.69 14.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.931 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -137.24 104.73 5.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.97 134.77 27.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -97.67 102.49 14.26 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.459 ' HD2' ' HB3' ' A' ' 10' ' ' PRO . 88.1 t80 . . . . . 0 C--O 1.24 0.599 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.083 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.623 HG11 ' SD ' ' A' ' 16' ' ' MET . 7.3 p -90.11 -34.19 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.697 0.399 . . . . 0.0 111.289 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.06 -160.22 26.36 Favored Glycine 0 C--N 1.345 1.055 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.425 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -149.93 176.95 10.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.288 1.035 . . . . 0.0 109.215 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -167.01 -179.02 4.44 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.977 0.911 . . . . 0.0 110.44 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -120.34 125.33 47.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.621 0.768 . . . . 0.0 110.49 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.17 130.72 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.54 1.136 . . . . 0.0 110.822 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -126.74 -178.86 4.54 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 125.381 1.472 . . . . 0.0 108.94 176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -29.76 113.62 0.09 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.358 1.863 . . . . 0.0 114.562 -172.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.76 109.09 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.643 0.735 . . . . 0.0 109.06 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 96.6 t -87.86 109.41 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.2 mt -89.48 121.65 31.91 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.536 0.734 . . . . 0.0 109.399 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 t -149.79 140.31 22.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.502 0.721 . . . . 0.0 110.07 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.537 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 25.6 mt-10 -80.15 -9.4 59.71 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.519 177.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 73.7 m-20 -112.12 119.76 43.32 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 169.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HG2' HD21 ' A' ' 87' ' ' LEU . 38.3 Cg_endo -67.38 -15.22 45.06 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.903 2.402 . . . . 0.0 113.056 174.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.43 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.5 mpp? -74.41 -22.87 58.95 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.22 0.608 . . . . 0.0 111.013 -176.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.528 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 56.8 mt-30 -69.28 -26.51 64.79 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.628 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -71.58 -20.46 62.0 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.77 0.428 . . . . 0.0 111.312 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.551 ' HE2' HD22 ' A' ' 87' ' ' LEU . 24.9 m-85 -88.01 -39.99 14.23 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.828 0.451 . . . . 0.0 110.766 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 13.1 pt-20 -69.28 -27.59 65.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 120.542 0.21 . . . . 0.0 110.575 174.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.0 m -82.89 -61.29 1.91 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 123.042 0.537 . . . . 0.0 110.612 177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.72 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 56.0 m-85 -102.62 -67.78 0.86 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.215 0.606 . . . . 0.0 109.715 -177.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 75.3 -87.33 0.8 Allowed Glycine 0 C--N 1.352 1.436 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.656 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -56.25 -36.52 68.62 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.019 1.327 . . . . 0.0 111.732 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.72 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 34.4 mmt180 -69.35 -36.95 77.38 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.062 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.5 HG12 HD23 ' A' ' 82' ' ' LEU . 21.2 t -64.6 148.97 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -65.35 -8.64 19.34 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.2 pt? -149.79 168.71 22.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.936 0.895 . . . . 0.0 109.11 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.0 t -112.36 -176.5 2.93 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 172.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -59.69 -33.66 71.88 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.67 0.788 . . . . 0.0 111.922 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.454 ' H ' HG23 ' A' ' 83' ' ' THR . 15.7 m-20 -62.69 -43.33 99.08 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.052 0.541 . . . . 0.0 111.222 175.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 1.6 mp0 -73.0 -25.16 60.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.505 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.551 HD22 ' HE2' ' A' ' 73' ' ' PHE . 53.6 tp -70.69 -48.89 52.37 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.835 0.454 . . . . 0.0 110.491 176.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -65.76 -39.2 90.8 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.31 0.381 . . . . 0.0 110.964 -176.176 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 6.2 pt-20 -69.79 -33.29 72.17 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.025 0.203 . . . . 0.0 110.828 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -67.16 -43.8 81.37 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.197 0.599 . . . . 0.0 110.522 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 73.7 mtm -71.06 -40.15 71.82 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.421 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.0 mmpt? -67.26 -30.74 70.71 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 119.803 -0.142 . . . . 0.0 110.64 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.48 1.05 0 C-N-CA 123.753 0.821 . . . . 0.0 110.815 177.3 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.549 0.938 0 CA-C-O 121.169 0.509 . . . . 0.0 110.365 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 140.66 40.73 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.21 95.3 4.27 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -84.23 155.78 22.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 171.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.464 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 12.3 ptm -136.61 129.55 30.96 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -104.74 100.78 10.42 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -176.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.6 mt -82.18 114.31 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -80.63 102.31 9.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.2 mm? -86.4 109.27 18.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.19 0.596 . . . . 0.0 110.694 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -106.97 174.51 5.86 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.4 t70 60.2 35.28 21.01 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.03 0.932 . . . . 0.0 111.348 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.38 102.95 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.347 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.91 154.76 23.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.509 1.124 . . . . 0.0 110.362 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -110.6 136.17 50.11 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.031 0.933 . . . . 0.0 110.067 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -91.05 86.92 6.38 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.06 -27.72 64.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.509 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.04 137.68 49.64 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.358 1.063 . . . . 0.0 109.537 171.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -76.43 95.63 1.05 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.751 2.301 . . . . 0.0 111.84 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.4 mt -87.97 128.24 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.857 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -86.26 129.28 54.18 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.011 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.06 150.0 77.24 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.511 2.14 . . . . 0.0 113.961 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -67.85 -38.58 83.31 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.042 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.5 ptm85 -154.02 176.07 12.65 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.05 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.66 118.5 19.36 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.72 172.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.46 HG12 ' HD3' ' A' ' 10' ' ' PRO . 80.7 t -98.97 100.97 10.92 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.48 177.85 2.47 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.363 2.709 . . . . 0.0 112.528 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.58 -34.37 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 123.952 0.901 . . . . 0.0 111.849 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 -13.62 71.67 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.68 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.19 176.2 51.36 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 123.543 0.592 . . . . 0.0 112.939 175.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -126.27 137.28 53.5 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.54 106.82 4.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 166.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.09 124.71 27.49 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.5 119.98 19.15 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.457 ' HB3' HG11 ' A' ' 5' ' ' VAL . 12.5 tp10 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 5' ' ' VAL . 22.7 mm 63.46 -166.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 124.621 1.168 . . . . 0.0 108.526 -175.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.549 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.7 m -151.99 -42.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 156.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.22 -161.13 20.2 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.397 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.41 136.65 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.575 0.75 . . . . 0.0 109.504 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 t -103.16 134.13 47.1 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.515 0.726 . . . . 0.0 109.584 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.65 123.15 11.65 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 123.514 0.726 . . . . 0.0 110.205 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.611 ' HD3' HG12 ' A' ' 130' ' ' VAL . 74.0 Cg_endo -80.26 94.55 1.01 Allowed 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.419 2.079 . . . . 0.0 109.54 165.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.42 110.64 2.89 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.191 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -85.06 33.66 0.49 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.436 2.757 . . . . 0.0 111.683 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HG3' ' HD2' ' A' ' 15' ' ' PHE . 49.9 tptt -141.09 144.5 34.94 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -170.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -74.23 10.08 1.4 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.574 0.75 . . . . 0.0 112.611 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.427 ' HD2' ' HG3' ' A' ' 13' ' ' LYS . 97.6 m-85 -111.79 25.02 12.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.232 1.013 . . . . 0.0 111.758 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.553 ' SD ' HG11 ' A' ' 55' ' ' VAL . 45.2 ttm -62.08 -36.73 82.55 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.667 0.746 . . . . 0.0 109.549 166.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.32 -23.19 67.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.029 1.331 . . . . 0.0 112.417 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -59.58 -42.48 92.59 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.507 0.723 . . . . 0.0 112.09 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -65.28 -30.97 71.88 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.758 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -92.03 -16.07 26.97 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.723 0.809 . . . . 0.0 110.792 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -73.98 -49.94 22.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.389 1.076 . . . . 0.0 109.797 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -110.86 -15.61 13.75 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -172.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.92 8.3 63.92 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 113.992 0.357 . . . . 0.0 113.992 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -159.69 86.85 0.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.966 1.306 . . . . 0.0 107.744 -173.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -134.93 -178.03 4.9 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.795 0.838 . . . . 0.0 108.976 -171.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -139.7 121.51 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.265 0.939 . . . . 0.0 109.764 -171.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -98.0 114.47 26.61 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.646 0.778 . . . . 0.0 109.167 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.0 m -92.18 133.48 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.24 0.543 . . . . 0.0 111.091 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 6.0 mmpt? -119.56 130.51 24.8 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.352 1.461 . . . . 0.0 110.113 178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.25 55.52 5.1 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.07 2.513 . . . . 0.0 111.484 169.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 56.47 27.66 12.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.571 1.148 . . . . 0.0 112.923 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.479 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 4.5 m -64.33 -39.31 93.64 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.698 0.799 . . . . 0.0 110.389 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.5 m -82.71 151.14 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.285 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -80.47 -173.95 4.36 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.502 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -65.05 -18.11 65.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.498 1.119 . . . . 0.0 112.902 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -59.12 -22.56 61.05 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.37 0.668 . . . . 0.0 111.515 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 94.39 0.32 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.046 0.538 . . . . 0.0 110.328 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 3.7 ptpp? -109.66 157.78 36.57 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.55 55.46 5.32 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.212 2.608 . . . . 0.0 112.175 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.94 43.76 0.2 Allowed Glycine 0 C--O 1.239 0.467 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.786 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.521 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 30.9 mtm -130.11 -173.01 2.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.623 1.169 . . . . 0.0 111.074 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.75 165.23 12.76 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.55 1.14 . . . . 0.0 110.518 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.408 ' CB ' HD11 ' A' ' 114' ' ' LEU . 4.1 t80 -136.2 101.95 4.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 34.2 t -90.54 108.15 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.214 0.53 . . . . 0.0 110.193 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -75.61 120.36 20.91 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.754 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 33.1 t80 . . . . . 0 CA--C 1.551 0.994 0 C-N-CA 124.595 1.158 . . . . 0.0 110.134 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 19.7 m-85 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.553 HG11 ' SD ' ' A' ' 16' ' ' MET . 2.7 p -67.59 -34.74 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 122.996 0.518 . . . . 0.0 110.771 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.93 -165.71 33.76 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.58 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 17.2 pt-20 -141.17 176.75 8.58 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.05 0.94 . . . . 0.0 108.952 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.471 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.69 -173.84 4.15 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.077 0.951 . . . . 0.0 109.304 176.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -125.94 119.49 27.89 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.726 0.81 . . . . 0.0 109.494 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.8 mt -71.54 129.78 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 124.397 1.061 . . . . 0.0 110.669 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -132.29 177.26 7.72 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 126.187 1.795 . . . . 0.0 109.006 -174.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -30.35 111.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 125.463 1.727 . . . . 0.0 114.113 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.0 m -87.97 123.93 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.288 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 99.0 t -90.02 107.18 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.591 ' HB3' HD11 ' A' ' 108' ' ' LEU . 77.1 mt -88.43 116.76 26.88 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.6 t -153.07 135.76 15.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.644 0.778 . . . . 0.0 110.323 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.12 -34.62 78.47 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.84 0.856 . . . . 0.0 111.669 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.432 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 79.1 m-20 -94.41 120.17 65.51 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.004 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.557 ' HG2' HD21 ' A' ' 87' ' ' LEU . 61.1 Cg_endo -72.5 -7.11 20.31 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.082 2.521 . . . . 0.0 113.387 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 45.9 mtm -86.02 -21.93 27.53 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.013 0.525 . . . . 0.0 110.75 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.432 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 30.4 mt-30 -66.44 -22.24 66.21 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.247 174.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -71.59 -26.21 62.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.691 0.396 . . . . 0.0 110.659 175.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.41 ' HE2' HD22 ' A' ' 87' ' ' LEU . 33.1 m-85 -82.8 -31.26 28.27 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.797 0.439 . . . . 0.0 111.179 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.9 -28.86 60.8 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.932 0.333 . . . . 0.0 110.681 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.8 m -81.83 -58.95 2.76 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.132 0.573 . . . . 0.0 110.386 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.805 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 71.9 m-85 -100.86 -62.83 1.19 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.847 0.859 . . . . 0.0 110.329 -174.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.49 -83.23 0.56 Allowed Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.643 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -59.65 -44.09 93.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.622 0.769 . . . . 0.0 110.663 175.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.805 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 29.2 mmt180 -70.32 -19.48 63.07 Favored 'General case' 0 C--O 1.205 -1.278 0 O-C-N 124.013 0.821 . . . . 0.0 111.938 -173.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 76' ' ' PHE . 40.8 t -76.52 131.07 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -54.51 -45.73 73.35 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.903 0.752 . . . . 0.0 112.554 -171.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.417 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -100.95 156.93 17.11 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.578 HG22 ' HG2' ' A' ' 86' ' ' GLU . 11.3 t -92.85 173.45 7.75 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -50.78 -41.35 56.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.422 1.089 . . . . 0.0 110.962 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.06 -46.78 87.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.23 1.012 . . . . 0.0 111.353 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.578 ' HG2' HG22 ' A' ' 83' ' ' THR . 42.3 mm-40 -62.96 -37.36 86.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.205 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.557 HD21 ' HG2' ' A' ' 69' ' ' PRO . 45.2 tp -63.99 -54.11 39.57 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.882 0.739 . . . . 0.0 111.091 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -63.27 -43.59 97.51 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.27 0.356 . . . . 0.0 111.036 -173.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 12.9 pt-20 -73.89 -23.69 59.61 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.426 0.291 . . . . 0.0 111.181 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.17 -44.89 87.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.527 0.731 . . . . 0.0 110.122 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.8 mtm -76.53 -30.5 57.16 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.069 0.548 . . . . 0.0 110.908 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.1 mmmt -74.03 -20.11 60.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.201 0.601 . . . . 0.0 110.61 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.543 0.676 0 C-N-CA 122.944 0.498 . . . . 0.0 109.98 174.528 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 121.45 0.643 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -131.84 149.88 52.32 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 174.282 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.3 tm? -76.75 92.39 3.57 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 171.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -75.48 159.25 31.53 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.381 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.7 ptm -140.0 129.68 24.44 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.308 0.643 . . . . 0.0 109.702 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -97.12 101.36 12.91 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.54 ' HA ' HG12 ' A' ' 63' ' ' VAL . 35.5 mt -80.46 113.85 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.6 110.63 17.14 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -94.33 132.42 38.95 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.409 0.623 . . . . 0.0 110.701 177.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -138.37 170.73 15.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.283 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 t70 59.8 35.84 22.06 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.859 0.838 . . . . 0.0 110.117 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.47 102.59 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.181 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.3 145.6 28.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.624 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -101.32 122.44 43.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -80.58 84.6 6.13 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 165.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.32 -33.5 72.49 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.568 170.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -79.99 137.25 53.64 Favored Pre-proline 0 CA--C 1.553 1.095 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.44 173.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.08 95.7 1.04 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.782 2.322 . . . . 0.0 111.538 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.5 mt -94.63 123.76 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.14 143.57 26.36 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.476 0.71 . . . . 0.0 109.764 -175.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.27 158.69 41.0 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.862 2.375 . . . . 0.0 112.054 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -81.34 -10.44 59.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.463 0.705 . . . . 0.0 110.993 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.5 ptm85 -153.48 172.96 16.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.991 0.916 . . . . 0.0 110.246 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.13 119.31 18.16 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.611 HG12 ' HD3' ' A' ' 10' ' ' PRO . 23.1 t -102.9 99.42 13.76 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.26 -176.28 3.19 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.882 2.388 . . . . 0.0 112.61 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.0 -27.06 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.453 1.101 . . . . 0.0 112.164 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.05 -25.95 75.04 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.205 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.39 148.15 6.98 Favored Glycine 0 C--N 1.348 1.237 0 C-N-CA 123.003 0.335 . . . . 0.0 112.448 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -108.86 142.29 39.67 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.426 0.691 . . . . 0.0 109.581 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -78.62 107.49 11.33 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.79 116.8 14.82 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.09 134.07 52.63 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.867 -1.063 . . . . 0.0 108.365 -177.44 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 5' ' ' VAL . 35.6 mm 67.19 -175.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.456 0 C-N-CA 124.129 0.972 . . . . 0.0 108.71 -174.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' N ' HG22 ' A' ' 4' ' ' ILE . 2.0 m -148.35 -38.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.228 1.011 . . . . 0.0 108.683 158.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.77 -161.22 19.81 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.482 0.489 . . . . 0.0 113.689 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.425 HG12 HD11 ' A' ' 60' ' ' ILE . 13.5 p -132.02 147.89 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.866 0.866 . . . . 0.0 108.686 175.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -122.76 140.93 52.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.553 0.741 . . . . 0.0 109.958 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -137.63 141.36 33.01 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.13 0.972 . . . . 0.0 110.12 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 20.7 Cg_exo -63.21 -46.73 9.39 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.347 2.698 . . . . 0.0 111.909 175.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.3 mt 51.57 72.13 1.3 Allowed Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.263 1.025 . . . . 0.0 109.603 -171.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.74 38.59 0.75 Allowed 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.261 2.64 . . . . 0.0 112.617 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -124.8 172.7 9.12 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.657 1.183 . . . . 0.0 109.908 -174.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -65.35 -15.23 62.34 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.086 0.954 . . . . 0.0 112.001 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -82.26 0.92 39.16 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.863 0.865 . . . . 0.0 112.778 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -57.43 -36.76 71.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.182 0.993 . . . . 0.0 111.696 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.07 -14.06 58.17 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -53.47 -46.99 70.17 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.411 1.085 . . . . 0.0 112.571 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 57.7 m-85 -68.54 -28.96 67.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.684 -174.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -93.85 -15.83 24.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.777 0.831 . . . . 0.0 110.452 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -70.69 -49.06 51.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.38 1.072 . . . . 0.0 109.748 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -109.63 -15.14 14.23 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.35 7.07 77.44 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.834 0.293 . . . . 0.0 113.834 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -168.6 90.4 0.26 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.457 1.103 . . . . 0.0 109.944 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.446 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.2 t70 -119.34 -178.04 3.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.267 1.027 . . . . 0.0 108.905 -174.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 113' ' ' GLU . 40.0 t -132.52 119.41 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.053 -1.029 . . . . 0.0 109.396 -177.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 81' ' ' PHE . 56.8 t80 -95.43 110.9 22.88 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.3 m -87.27 139.42 17.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-O 121.377 0.608 . . . . 0.0 110.507 177.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.55 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 5.9 mmpt? -125.46 132.43 24.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.198 1.399 . . . . 0.0 109.71 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.39 49.16 3.08 Favored 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 123.124 2.549 . . . . 0.0 111.952 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . 58.27 81.34 0.16 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.171 1.388 . . . . 0.0 111.861 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 23.5 m -116.43 -72.99 0.66 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -97.76 126.9 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 50.2 t90 -160.25 -35.93 0.05 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.435 0.294 . . . . 0.0 111.246 -175.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -56.34 -45.96 80.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.539 0.736 . . . . 0.0 112.574 -174.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -93.1 -17.53 23.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.467 0.307 . . . . 0.0 110.528 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 34' ' ' TRP . 3.0 mm? -61.86 108.2 0.98 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.731 0.812 . . . . 0.0 111.19 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -131.53 150.58 76.75 Favored Pre-proline 0 C--O 1.244 0.765 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.964 172.086 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.25 103.98 1.48 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.432 2.088 . . . . 0.0 110.486 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.75 -8.89 1.35 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.366 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.406 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 24.1 mtm -80.08 -177.9 6.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.228 0.611 . . . . 0.0 111.649 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -107.22 161.66 14.58 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.835 0.854 . . . . 0.0 110.765 171.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.478 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -136.17 101.92 4.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 174.513 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.5 t -87.6 122.74 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 109.824 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -92.4 120.85 33.31 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.523 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 85.2 t80 . . . . . 0 CA--C 1.557 1.224 0 C-N-CA 124.758 1.223 . . . . 0.0 109.141 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 44.0 m-85 . . . . . 0 CA--C 1.544 0.742 0 CA-C-O 120.687 0.28 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 p -73.9 -37.05 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.886 0.874 . . . . 0.0 110.939 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.66 -163.23 29.11 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.539 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 6.5 pt-20 -143.3 178.88 7.43 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.882 0.873 . . . . 0.0 109.129 173.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.511 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -156.88 -172.38 4.02 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.276 1.03 . . . . 0.0 108.879 175.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -125.78 118.09 24.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.965 0.506 . . . . 0.0 110.092 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 43' ' ' PHE . 43.2 mt -63.93 125.34 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.925 175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.448 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 30.7 mmmt -133.9 -168.28 2.09 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 125.374 1.47 . . . . 0.0 107.721 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -19.65 110.16 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 126.092 1.757 . . . . 0.0 115.058 -171.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 112' ' ' ILE . 29.2 m -103.74 109.97 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.7 t -91.93 118.14 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.404 0.682 . . . . 0.0 109.745 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HB3' HD11 ' A' ' 108' ' ' LEU . 61.7 mt -94.71 123.26 38.05 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.664 0.786 . . . . 0.0 109.494 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 71' ' ' GLN . 33.4 t -153.16 136.97 16.14 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.503 0.721 . . . . 0.0 110.126 172.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.686 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 45.6 mt-10 -66.32 -17.81 64.98 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 176.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 14.1 m-20 -97.85 120.73 59.6 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.0 -26.11 58.7 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.436 2.091 . . . . 0.0 112.071 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.417 ' HA ' ' HD2' ' A' ' 73' ' ' PHE . 37.3 mtm -73.19 -22.21 60.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.597 0.759 . . . . 0.0 110.918 -171.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.47 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 21.4 mm-40 -57.3 -33.39 67.63 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.155 0.982 . . . . 0.0 111.587 175.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.52 -31.46 37.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.745 0.418 . . . . 0.0 110.819 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CE2' HD22 ' A' ' 87' ' ' LEU . 85.1 m-85 -79.06 -17.75 54.67 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.125 0.57 . . . . 0.0 111.572 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -94.61 -36.85 11.61 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.436 0.294 . . . . 0.0 111.208 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.6 m -74.8 -57.0 4.19 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.947 0.499 . . . . 0.0 110.809 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.843 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 92.2 m-85 -92.49 -61.73 1.54 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.339 0.656 . . . . 0.0 109.494 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.68 -85.26 0.45 Allowed Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.866 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.04 -37.2 84.04 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.913 0.885 . . . . 0.0 110.639 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.843 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 14.4 mmt85 -65.52 -35.02 79.63 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.223 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.494 HG12 HD23 ' A' ' 82' ' ' LEU . 21.9 t -67.76 143.95 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 118.211 0.46 . . . . 0.0 110.375 -176.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.42 ' HD2' ' HA ' ' A' ' 27' ' ' PHE . 45.2 p90 -62.9 -14.51 47.45 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -173.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.494 HD23 HG12 ' A' ' 80' ' ' VAL . 2.3 pt? -139.68 170.29 16.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.782 0.833 . . . . 0.0 109.272 176.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.9 t -100.09 170.58 8.38 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 172.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -62.48 -27.74 69.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.24 0.616 . . . . 0.0 111.196 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.54 -49.41 71.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.405 0.682 . . . . 0.0 109.956 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.498 ' HG2' HG22 ' A' ' 83' ' ' THR . 17.3 mm-40 -56.75 -40.77 76.38 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.306 176.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.476 HD22 ' CE2' ' A' ' 73' ' ' PHE . 31.0 tp -58.4 -56.19 25.33 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.911 0.884 . . . . 0.0 112.031 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -61.72 -39.97 93.41 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -171.404 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.64 -18.88 36.62 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.126 0.571 . . . . 0.0 111.747 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -69.77 -39.74 76.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.37 0.668 . . . . 0.0 109.655 170.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.0 mtm -73.49 -30.8 63.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.302 0.641 . . . . 0.0 110.418 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.5 mmpt? -67.11 -38.07 84.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.626 0.371 . . . . 0.0 110.006 170.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.473 0.708 0 O-C-N 123.831 0.707 . . . . 0.0 110.539 177.895 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.686 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.144 0.497 . . . . 0.0 110.657 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 18.2 tptm -101.56 156.67 17.34 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -174.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 65' ' ' LEU . 2.6 tm? -72.44 104.97 3.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -85.96 161.62 18.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.334 0.654 . . . . 0.0 109.251 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.537 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 14.9 ptm -141.67 154.36 45.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.865 0.866 . . . . 0.0 109.868 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.72 104.44 7.18 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.716 0.806 . . . . 0.0 109.825 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.506 ' HA ' HG12 ' A' ' 63' ' ' VAL . 43.0 mt -84.3 119.12 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 123.402 0.681 . . . . 0.0 109.454 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.555 ' HA ' HG22 ' A' ' 26' ' ' VAL . 37.6 tt0 -81.93 98.86 8.76 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -80.98 131.89 35.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.948 0.499 . . . . 0.0 110.25 174.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 1.3 pp20? -139.72 166.29 25.0 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.687 0.795 . . . . 0.0 109.128 175.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.3 t70 56.84 41.7 27.61 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.833 0.853 . . . . 0.0 111.178 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.32 108.92 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 121.351 0.596 . . . . 0.0 111.134 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.66 157.34 21.16 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.521 1.128 . . . . 0.0 110.216 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -122.91 117.73 26.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.896 0.878 . . . . 0.0 110.072 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -78.18 98.25 5.78 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -65.04 -31.44 72.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.838 0.855 . . . . 0.0 110.578 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -87.36 138.35 32.18 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.248 0.619 . . . . 0.0 110.157 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.33 89.14 1.21 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.658 2.239 . . . . 0.0 111.68 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.1 mt -78.73 131.26 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.398 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.424 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -100.69 144.17 27.98 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 122.986 0.514 . . . . 0.0 109.701 -178.204 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.34 161.09 28.95 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.315 2.01 . . . . 0.0 112.658 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 127' ' ' LYS . 11.1 mmpt? -68.91 -51.58 38.5 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.366 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -119.02 178.06 4.63 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.613 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.59 140.49 51.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.688 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.94 102.19 30.02 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.04 176.39 7.05 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.604 2.203 . . . . 0.0 112.212 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.2 t -58.89 -32.94 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.276 1.03 . . . . 0.0 111.132 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.68 -15.0 73.1 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.846 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.37 159.54 16.71 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.339 0.495 . . . . 0.0 113.237 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -113.54 145.77 40.7 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.585 0.754 . . . . 0.0 110.46 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -81.63 113.7 19.82 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.4 121.79 26.68 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.432 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -117.99 140.92 49.04 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.382 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 117.81 -1.09 . . . . 0.0 110.007 177.996 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.643 ' HB3' ' HG2' ' A' ' 3' ' ' LYS . 34.6 ttm . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t -64.93 -14.33 59.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.222 1.009 . . . . 0.0 112.575 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.643 ' HG2' ' HB3' ' A' ' 1' ' ' MET . 21.2 ptmt -62.24 -25.93 68.09 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.942 0.497 . . . . 0.0 111.723 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 5' ' ' VAL . 24.1 mm 62.12 -168.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -173.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.3 m -145.88 -42.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 154.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.09 -161.24 20.23 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.31 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.77 156.15 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.825 0.85 . . . . 0.0 108.711 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 4.9 t -125.48 135.85 52.75 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.484 0.713 . . . . 0.0 109.657 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -132.4 139.29 34.35 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 123.787 0.835 . . . . 0.0 110.305 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HD3' HG12 ' A' ' 130' ' ' VAL . 69.2 Cg_endo -71.75 -26.74 18.94 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.192 2.594 . . . . 0.0 111.901 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt 66.94 117.26 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 125.321 1.449 . . . . 0.0 109.802 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -62.11 -16.65 51.74 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.267 2.645 . . . . 0.0 114.213 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -130.69 -176.38 3.96 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.733 0.813 . . . . 0.0 110.77 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -74.92 6.76 3.73 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.817 0.847 . . . . 0.0 112.87 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -77.97 14.97 0.97 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -62.22 -33.08 73.88 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.863 0.363 . . . . 0.0 110.293 165.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -68.73 -25.8 64.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.505 1.122 . . . . 0.0 111.762 -173.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 6.1 mmp_? -53.49 -49.32 67.76 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.331 1.019 . . . . 0.0 111.574 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 58.9 m-85 -64.54 -31.17 72.26 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.741 -176.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -85.75 -26.61 25.74 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.385 0.674 . . . . 0.0 110.593 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -68.38 -52.63 30.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.607 1.163 . . . . 0.0 109.953 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.5 ptpt -99.79 -16.88 17.93 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.348 -172.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.95 -8.55 50.21 Favored Glycine 0 N--CA 1.475 1.284 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -158.57 107.17 1.94 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.882 0.873 . . . . 0.0 109.546 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 17.1 t70 -126.2 -179.58 4.79 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.333 1.053 . . . . 0.0 109.259 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.5 t -130.67 113.93 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.244 1.018 . . . . 0.0 109.271 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -94.04 115.03 27.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.159 0.584 . . . . 0.0 109.662 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.36 147.14 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.343 0.592 . . . . 0.0 111.452 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.561 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 5.0 mmpt? -134.76 128.83 19.05 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.369 1.468 . . . . 0.0 110.113 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 97.9 Cg_endo -78.44 54.15 4.87 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.827 2.351 . . . . 0.0 112.345 170.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 57.38 97.9 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.558 1.143 . . . . 0.0 111.525 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.46 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 44.8 m -136.8 -54.2 0.72 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.426 0.69 . . . . 0.0 109.817 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 m -79.27 148.59 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.881 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -93.31 -162.28 0.92 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.536 1.134 . . . . 0.0 110.651 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -73.43 3.38 6.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -67.45 -31.41 71.57 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.59 90.99 0.41 Allowed 'General case' 0 C--N 1.352 0.714 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.103 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.43 153.81 47.64 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.264 0.625 . . . . 0.0 109.459 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.25 102.79 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.228 1.952 . . . . 0.0 111.11 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.13 29.79 0.38 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.66 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.2 mtm -111.39 -166.53 1.08 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.643 0.777 . . . . 0.0 110.453 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.9 ptpt -117.14 161.09 20.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.893 0.877 . . . . 0.0 110.539 169.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.543 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 t80 -135.73 101.07 4.65 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 45.1 t -84.29 120.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.294 0.569 . . . . 0.0 109.875 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -84.54 108.69 17.44 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 68.0 t80 -76.76 145.66 38.43 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.257 175.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -104.95 -68.16 0.87 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.254 0.549 . . . . 0.0 110.331 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.1 t -158.75 177.15 11.49 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.303 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -82.01 -162.86 0.59 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.253 0.621 . . . . 0.0 110.584 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 66.78 -150.87 0.2 Allowed 'General case' 0 C--N 1.362 1.131 0 C-N-CA 123.85 0.86 . . . . 0.0 109.836 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 8.8 m-20 -77.25 -16.37 59.04 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.007 0.523 . . . . 0.0 112.174 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.4 p -102.76 81.12 1.97 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.668 0.746 . . . . 0.0 111.026 -173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.3 170.6 17.22 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.279 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.425 ' HE2' ' HA ' ' A' ' 126' ' ' PRO . 61.9 m-85 56.42 91.58 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.144 0.978 . . . . 0.0 112.217 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -77.98 -25.6 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 123.509 0.724 . . . . 0.0 111.268 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.28 -165.93 33.31 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 120.173 -0.237 . . . . 0.0 112.758 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 7.3 pt-20 -145.42 178.03 8.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.631 0.772 . . . . 0.0 109.491 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.551 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -157.46 -171.1 3.45 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.497 1.119 . . . . 0.0 108.81 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 24.2 mmt85 -125.79 117.84 24.25 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.438 0.695 . . . . 0.0 110.168 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 43' ' ' PHE . 49.1 mt -69.27 131.45 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.316 1.046 . . . . 0.0 110.472 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -141.5 -166.61 2.23 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 125.513 1.525 . . . . 0.0 108.967 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -42.68 114.53 0.6 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.744 1.217 . . . . 0.0 113.352 -162.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.5 m -89.3 123.68 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.286 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 90.4 t -90.17 108.2 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.574 ' HB3' HD11 ' A' ' 108' ' ' LEU . 77.8 mt -95.58 113.87 25.57 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.1 t -153.46 144.18 22.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.576 0.75 . . . . 0.0 109.716 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -74.26 -27.75 60.9 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.566 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 42.7 m-20 -94.88 123.56 57.25 Favored Pre-proline 0 N--CA 1.476 0.859 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 28.6 Cg_endo -63.84 -25.01 67.87 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.18 1.92 . . . . 0.0 112.447 173.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.524 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 3.5 mpp? -74.53 -18.15 60.64 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.799 0.44 . . . . 0.0 110.887 -174.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.566 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 25.9 mm-40 -58.2 -40.76 82.4 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.656 0.782 . . . . 0.0 110.21 170.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -73.7 -29.15 62.11 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.677 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' A' ' 87' ' ' LEU . 66.0 m-85 -86.94 -15.63 38.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.17 -31.87 14.61 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 117.941 0.337 . . . . 0.0 110.174 173.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -76.62 -58.08 3.49 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.096 0.558 . . . . 0.0 109.758 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.742 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 63.3 m-85 -98.42 -67.32 0.85 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.732 0.813 . . . . 0.0 110.091 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.98 -81.38 0.09 OUTLIER Glycine 0 C--N 1.358 1.792 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.482 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.09 -36.9 78.44 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.661 1.184 . . . . 0.0 111.921 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.742 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 26.2 mmt180 -76.19 -20.09 57.82 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.979 0.512 . . . . 0.0 111.322 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 76' ' ' PHE . 30.8 t -79.18 142.4 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -57.12 -41.34 78.82 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.43 HD23 HG12 ' A' ' 80' ' ' VAL . 2.1 pt? -106.43 163.18 13.06 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.0 t -98.76 175.71 5.87 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 173.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.31 -28.31 69.22 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.213 0.605 . . . . 0.0 110.89 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.75 -43.48 98.68 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.969 0.908 . . . . 0.0 110.243 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.497 ' HG2' HG22 ' A' ' 83' ' ' THR . 69.7 mm-40 -66.95 -33.9 76.58 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.957 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' A' ' 73' ' ' PHE . 32.6 tp -64.53 -52.56 57.13 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.382 0.673 . . . . 0.0 111.029 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -38.3 89.22 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.506 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.05 -33.42 70.25 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.012 0.195 . . . . 0.0 110.671 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.438 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 76.3 t80 -66.81 -48.05 70.14 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.136 0.975 . . . . 0.0 110.918 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.5 mtm -66.44 -41.0 89.78 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.684 0.615 . . . . 0.0 110.172 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -62.2 -40.76 97.17 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.545 0.528 . . . . 0.0 110.705 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.0 t -62.64 -37.75 87.54 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.205 0.602 . . . . 0.0 111.09 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 81.9 mm-40 -71.3 -34.94 71.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HA ' ' H ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -89.56 -22.13 22.53 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -101.23 -29.49 12.06 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.552 0.614 . . . . 0.0 111.762 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -104.62 -32.29 8.99 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.404 0.282 . . . . 0.0 111.038 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -86.72 56.21 4.67 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.901 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 62.44 -83.42 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.156 1.382 . . . . 0.0 110.138 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 33.6 ttm180 -166.13 73.5 0.17 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 174.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.459 ' H ' ' HA ' ' A' ' 95' ' ' GLU . 2.3 tmt_? -74.38 82.96 1.92 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -109.13 179.67 4.1 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.469 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.6 t -167.54 144.65 4.41 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -72.39 -25.84 61.65 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 124.096 0.872 . . . . 0.0 110.784 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -129.08 166.53 19.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.138 0.975 . . . . 0.0 109.453 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.554 ' H ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -94.58 160.11 14.78 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.315 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -109.9 168.53 9.35 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.181 0.592 . . . . 0.0 109.641 -175.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.3 tm? -78.2 107.27 10.66 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -89.33 158.4 17.82 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.7 0.8 . . . . 0.0 109.282 172.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.5 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 15.4 ptm -136.27 131.59 34.64 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.051 0.54 . . . . 0.0 110.754 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.51 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -113.0 102.91 10.86 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.763 0.825 . . . . 0.0 109.767 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.1 mt -83.11 128.13 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.448 0.699 . . . . 0.0 109.414 -175.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.91 111.86 18.5 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.551 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -99.17 112.52 24.65 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.47 0.708 . . . . 0.0 110.395 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -120.72 167.15 12.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.446 0.698 . . . . 0.0 109.65 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.5 t70 53.86 54.88 9.15 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.294 1.038 . . . . 0.0 110.35 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.11 107.62 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.415 -175.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -83.35 163.91 20.33 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.242 1.017 . . . . 0.0 109.815 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -126.48 132.51 51.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.666 0.786 . . . . 0.0 109.965 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -94.4 97.16 9.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -77.3 -18.26 57.65 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.829 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -83.67 139.19 40.73 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.872 0.869 . . . . 0.0 109.378 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.41 100.02 1.33 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.714 2.276 . . . . 0.0 111.115 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.2 mt -81.19 125.75 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.437 ' HG3' ' HA ' ' A' ' 51' ' ' ASP . 0.1 OUTLIER -78.78 116.46 59.91 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.425 ' HA ' ' HE2' ' A' ' 54' ' ' PHE . 9.8 Cg_endo -55.42 129.06 33.13 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.747 2.298 . . . . 0.0 113.182 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -70.3 -20.51 63.02 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.183 0.993 . . . . 0.0 110.416 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -159.27 165.72 32.86 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.92 1.288 . . . . 0.0 108.813 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -71.06 136.19 48.15 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.661 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.516 HG12 ' HD3' ' A' ' 10' ' ' PRO . 41.1 t -111.25 97.72 36.6 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.24 -177.99 2.66 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.546 2.831 . . . . 0.0 112.207 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.67 -33.47 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.521 0.728 . . . . 0.0 110.701 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.34 -25.31 72.45 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.946 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.54 163.16 30.79 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.009 0.338 . . . . 0.0 113.229 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -119.67 146.29 45.71 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.055 0.942 . . . . 0.0 110.66 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -84.16 110.25 18.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.305 0.642 . . . . 0.0 110.236 173.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 119.14 20.63 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 172.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.404 ' HD3' ' H ' ' A' ' 138' ' ' ARG . 0.4 OUTLIER -129.66 137.9 50.9 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.134 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.925 0.393 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m -67.25 -8.34 31.09 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.26 1.024 . . . . 0.0 113.318 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -62.95 -25.26 68.27 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.386 0.674 . . . . 0.0 111.909 174.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.45 HG22 ' H ' ' A' ' 5' ' ' VAL . 22.7 mm 65.78 -176.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 C-N-CA 124.469 1.107 . . . . 0.0 109.283 -176.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -145.92 -42.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.582 1.153 . . . . 0.0 108.045 158.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.23 -161.49 20.85 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.88 0.738 . . . . 0.0 113.595 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.436 HG12 HD11 ' A' ' 60' ' ' ILE . 9.7 p -121.38 162.0 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -137.42 138.77 40.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.116 0.567 . . . . 0.0 110.129 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -135.46 150.08 71.3 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.936 0.894 . . . . 0.0 110.446 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' HG12 ' A' ' 130' ' ' VAL . 91.2 Cg_endo -80.57 -10.83 13.12 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.787 2.325 . . . . 0.0 112.359 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.3 mm 59.79 97.96 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 125.675 1.59 . . . . 0.0 110.879 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -82.63 33.33 0.53 Allowed 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.232 2.621 . . . . 0.0 113.137 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -137.44 162.07 34.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.278 1.031 . . . . 0.0 110.507 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.527 ' H ' ' HD2' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -78.2 -15.72 58.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.76 0.824 . . . . 0.0 110.428 -174.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 82' ' ' LEU . 41.7 m-85 -90.51 31.74 1.01 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.22 1.008 . . . . 0.0 112.354 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -58.74 -22.98 59.06 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.853 0.861 . . . . 0.0 112.017 166.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.463 ' HA ' ' CD2' ' A' ' 49' ' ' HIS . 26.1 t70 -77.52 -27.45 51.71 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.409 1.084 . . . . 0.0 112.514 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -50.2 -48.69 54.17 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.471 1.108 . . . . 0.0 113.702 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -63.82 -29.41 70.61 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.765 0.666 . . . . 0.0 110.605 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -96.82 -12.58 23.41 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.623 0.769 . . . . 0.0 111.621 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -76.05 -50.17 15.5 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.834 0.853 . . . . 0.0 109.007 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HG3' ' H ' ' A' ' 24' ' ' LYS . 14.7 ptpt -109.2 -16.13 14.14 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.502 -172.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.82 9.04 74.48 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 114.216 0.446 . . . . 0.0 114.216 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.452 ' H ' ' HG3' ' A' ' 22' ' ' LYS . 55.3 pttt -163.25 92.36 0.74 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.33 1.052 . . . . 0.0 109.811 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -133.35 -176.87 4.29 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -136.43 121.19 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 120.188 1.358 . . . . 0.0 109.813 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -94.61 116.52 28.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.709 0.804 . . . . 0.0 109.922 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 m -98.2 143.29 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.346 0.593 . . . . 0.0 111.374 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.779 ' HG2' HG23 ' A' ' 33' ' ' VAL . 16.5 tppt? -136.64 140.52 32.39 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.5 1.12 . . . . 0.0 109.88 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.647 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 59.0 Cg_endo -72.7 59.52 3.41 Favored 'Trans proline' 0 CA--C 1.56 1.817 0 C-N-CA 122.996 2.464 . . . . 0.0 113.748 166.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.41 33.95 6.08 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.256 1.423 . . . . 0.0 113.856 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.408 ' H ' ' HG3' ' A' ' 29' ' ' LYS . 3.3 m -87.48 -17.64 31.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.408 0.683 . . . . 0.0 111.05 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.779 HG23 ' HG2' ' A' ' 29' ' ' LYS . 3.3 t -87.71 150.3 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.252 0.621 . . . . 0.0 109.493 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -70.02 174.96 4.8 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.53 0.681 . . . . 0.0 112.257 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -76.96 -1.36 28.25 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.636 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.67 -23.55 66.81 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.65 0.78 . . . . 0.0 111.034 173.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.536 HD23 HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -65.52 103.32 0.82 Allowed 'General case' 0 C--N 1.353 0.743 0 C-N-CA 123.0 0.52 . . . . 0.0 110.084 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.44 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -129.95 150.82 77.0 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.198 0.599 . . . . 0.0 109.65 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.81 107.84 1.96 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.836 2.358 . . . . 0.0 111.042 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.82 -14.57 1.76 Allowed Glycine 0 N--CA 1.467 0.749 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.92 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.567 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 27.9 mtm -78.65 -173.21 3.31 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.367 0.603 . . . . 0.0 111.881 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -112.21 162.74 15.15 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.976 0.91 . . . . 0.0 110.32 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.43 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -135.57 102.71 5.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.162 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.99 126.28 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.352 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -97.69 111.69 23.88 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -100.86 157.4 16.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.359 1.064 . . . . 0.0 108.934 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 72.48 165.38 0.29 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.648 1.179 . . . . 0.0 111.819 170.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.7 p 60.4 -167.01 0.19 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.505 1.522 . . . . 0.0 112.473 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.463 ' CD2' ' HA ' ' A' ' 17' ' ' ASP . 55.4 t-80 66.99 16.25 10.32 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.303 1.041 . . . . 0.0 112.06 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 65.15 25.07 12.42 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.265 1.026 . . . . 0.0 110.675 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -119.96 -48.78 2.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.779 0.832 . . . . 0.0 110.771 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.7 m 69.29 -75.1 0.07 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.497 1.119 . . . . 0.0 111.924 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.67 83.9 0.89 Allowed Glycine 0 C--N 1.351 1.371 0 N-CA-C 112.157 -0.377 . . . . 0.0 112.157 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 58.61 95.95 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.619 1.167 . . . . 0.0 111.903 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.45 -38.54 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 168.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.75 -157.16 28.03 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.526 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.22 179.26 9.13 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.081 0.952 . . . . 0.0 110.031 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.469 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -155.17 -172.24 4.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.652 0.781 . . . . 0.0 110.844 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -122.78 119.82 31.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.864 0.866 . . . . 0.0 110.043 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.436 HD11 HG12 ' A' ' 7' ' ' VAL . 45.9 mt -68.61 135.79 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.664 1.186 . . . . 0.0 111.3 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.7 mmmt -134.51 -178.36 5.02 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 126.344 1.858 . . . . 0.0 108.588 -174.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -40.77 116.45 0.71 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.2 1.4 . . . . 0.0 114.046 -165.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.3 m -89.11 116.99 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.857 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.98 115.68 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.736 0.814 . . . . 0.0 109.554 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.9 mt -88.79 119.49 29.33 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.959 0.504 . . . . 0.0 109.688 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -148.28 131.3 16.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.034 0.933 . . . . 0.0 108.796 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -63.0 -31.24 72.33 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.967 0.907 . . . . 0.0 111.576 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.591 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 25.8 m-80 -91.35 119.11 68.76 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.428 ' HG2' HD21 ' A' ' 87' ' ' LEU . 53.1 Cg_endo -68.75 -12.94 35.9 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.595 2.197 . . . . 0.0 112.238 172.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.6 mtm -81.5 -24.27 36.8 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.284 1.033 . . . . 0.0 110.704 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.591 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 79.0 mt-30 -70.32 -25.39 63.28 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -69.2 -28.34 66.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.421 0.288 . . . . 0.0 110.747 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.493 ' HE2' HD22 ' A' ' 87' ' ' LEU . 27.5 m-85 -81.65 -20.41 39.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.883 0.473 . . . . 0.0 112.256 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.6 pt-20 -90.84 -25.54 19.83 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 117.979 0.354 . . . . 0.0 111.194 172.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.6 m -85.91 -50.8 6.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.443 0.697 . . . . 0.0 110.957 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.765 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 82.1 m-85 -107.17 -57.68 2.04 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.993 0.917 . . . . 0.0 109.927 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.44 -90.63 0.24 Allowed Glycine 0 C--N 1.355 1.626 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.827 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.37 -35.21 76.84 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.846 0.858 . . . . 0.0 110.621 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.765 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 44.7 mmt-85 -71.37 -28.2 63.88 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-O 119.162 -0.447 . . . . 0.0 110.914 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 76' ' ' PHE . 57.2 t -71.04 132.3 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -56.78 -50.69 71.54 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.113 0.883 . . . . 0.0 112.213 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.515 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 1.8 pt? -94.6 157.47 15.96 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.451 HG22 ' HG2' ' A' ' 86' ' ' GLU . 14.4 t -88.53 168.31 12.69 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.87 -29.07 70.29 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.197 0.199 . . . . 0.0 110.72 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -61.03 -43.07 99.44 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.535 0.734 . . . . 0.0 111.314 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.451 ' HG2' HG22 ' A' ' 83' ' ' THR . 51.0 mm-40 -64.39 -40.09 95.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.284 0.634 . . . . 0.0 111.345 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.493 HD22 ' HE2' ' A' ' 73' ' ' PHE . 24.4 tp -62.98 -52.27 63.66 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.92 0.763 . . . . 0.0 110.841 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -68.05 -43.23 79.13 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.536 -173.394 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.23 -33.3 74.33 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.095 0.407 . . . . 0.0 110.106 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 49.5 t80 -65.26 -45.96 82.42 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.87 0.868 . . . . 0.0 110.638 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.9 mtm -74.16 -27.92 61.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.376 0.671 . . . . 0.0 111.296 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.8 mmmt -75.88 -37.37 58.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.5 m -60.48 -27.71 67.77 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.126 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 78.6 mm-40 -68.47 -54.08 19.26 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.041 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 100' ' ' ARG . 10.9 pt-20 -72.34 -25.44 61.54 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 6.8 ptm180 -97.79 -20.61 17.43 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -120.75 -64.84 1.2 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 118.172 0.442 . . . . 0.0 110.797 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.44 -94.52 0.33 Allowed Glycine 0 C--N 1.347 1.174 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.304 -172.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -161.33 137.31 8.06 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.103 0.961 . . . . 0.0 109.479 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.456 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 17.5 tpt180 -154.21 75.65 1.01 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.277 0.561 . . . . 0.0 109.834 169.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -78.53 -51.78 9.46 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 65.37 130.54 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 O-C-N 124.954 1.408 . . . . 0.0 113.422 165.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.8 p -69.14 163.63 24.41 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.159 0.584 . . . . 0.0 110.761 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -56.77 -29.12 62.32 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.881 0.872 . . . . 0.0 112.319 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -100.39 141.59 33.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.201 0.6 . . . . 0.0 109.692 172.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.462 ' HD2' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -64.87 169.04 5.55 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.536 0.734 . . . . 0.0 110.956 176.277 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -76.52 150.48 36.59 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.445 174.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.96 131.65 41.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -114.99 159.6 20.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.594 0.758 . . . . 0.0 109.681 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.8 ptm -138.01 130.65 29.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.173 0.989 . . . . 0.0 109.203 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.13 101.65 10.86 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.501 ' HA ' HG12 ' A' ' 63' ' ' VAL . 36.8 mt -82.04 118.36 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 44.4 tt0 -81.46 139.89 34.94 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -123.57 132.31 53.85 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.967 1.307 . . . . 0.0 109.126 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -140.24 165.5 27.22 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.642 0.777 . . . . 0.0 109.388 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.8 t70 59.0 39.59 23.33 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.275 1.03 . . . . 0.0 110.331 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.8 t -68.26 101.18 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.125 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -74.16 131.51 41.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.604 1.161 . . . . 0.0 109.862 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -92.56 125.97 37.43 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.239 0.543 . . . . 0.0 109.555 172.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.1 98.69 11.92 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.926 0.89 . . . . 0.0 109.338 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.85 -30.75 68.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.652 172.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -84.92 132.8 44.79 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.378 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.58 102.11 1.52 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.118 2.546 . . . . 0.0 111.606 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.8 mt -111.04 129.37 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.284 0.564 . . . . 0.0 110.463 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.79 141.52 64.25 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.938 0.895 . . . . 0.0 109.59 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.92 157.15 58.9 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.186 1.924 . . . . 0.0 112.13 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -63.21 -27.81 69.62 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.881 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -154.35 163.86 39.5 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.984 1.314 . . . . 0.0 107.755 166.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -61.21 136.03 57.93 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.49 HG12 ' HD3' ' A' ' 10' ' ' PRO . 28.7 t -106.01 103.62 45.53 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 -178.37 2.56 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.151 2.568 . . . . 0.0 112.278 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.97 -36.05 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.908 0.883 . . . . 0.0 111.622 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.62 -16.43 77.74 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-N 116.117 -0.492 . . . . 0.0 113.166 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.5 162.97 25.51 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 123.052 0.358 . . . . 0.0 112.962 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -114.79 152.51 31.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.547 0.739 . . . . 0.0 110.188 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.72 117.21 29.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 170.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.1 114.38 21.72 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.31 141.73 51.23 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.494 ' HB2' HG13 ' A' ' 5' ' ' VAL . 10.0 tp10 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 11.4 tpt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.753 -0.092 . . . . 0.0 110.753 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -59.91 -14.24 14.68 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.651 1.18 . . . . 0.0 114.041 -172.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -64.32 -20.21 65.94 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 5' ' ' VAL . 30.3 mm 66.05 -174.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.684 0 C-N-CA 124.163 0.985 . . . . 0.0 108.791 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' H ' HG22 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -150.64 -42.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.858 1.263 . . . . 0.0 107.776 160.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -167.44 -162.54 19.46 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.355 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.429 HG12 HD11 ' A' ' 60' ' ' ILE . 8.6 p -119.44 151.1 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 172.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -122.87 132.35 54.15 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.731 0.813 . . . . 0.0 108.845 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -131.42 144.14 52.16 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.066 0.946 . . . . 0.0 109.673 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.513 ' HD3' HG12 ' A' ' 130' ' ' VAL . 97.3 Cg_endo -74.48 -17.01 21.31 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.576 2.184 . . . . 0.0 112.028 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 16' ' ' MET . 14.2 mm 49.15 80.88 0.28 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.154 1.382 . . . . 0.0 109.678 -167.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HG3' HG23 ' A' ' 132' ' ' VAL . 96.5 Cg_endo -78.57 15.47 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.001 2.467 . . . . 0.0 112.94 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -104.8 152.74 22.21 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.46 1.104 . . . . 0.0 109.823 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -66.08 -8.38 23.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.652 1.181 . . . . 0.0 112.797 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -97.0 28.05 3.73 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.657 1.183 . . . . 0.0 112.323 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.507 ' HA ' HG21 ' A' ' 11' ' ' ILE . 27.0 ptt? -63.94 -30.16 71.26 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.287 0.565 . . . . 0.0 110.712 174.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -72.05 -21.85 61.47 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.523 1.129 . . . . 0.0 112.595 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 84.4 mmt-85 -58.36 -38.25 76.86 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.959 0.903 . . . . 0.0 112.615 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 64.5 m-85 -67.18 -30.35 70.28 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 121.087 0.47 . . . . 0.0 110.473 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -96.77 -8.58 30.86 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.158 0.983 . . . . 0.0 110.78 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -84.88 -54.64 4.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.813 1.245 . . . . 0.0 110.03 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.9 ptpt -98.3 -13.8 20.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.814 -171.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.46 -23.81 9.43 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 113.857 0.303 . . . . 0.0 113.857 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -148.72 116.86 6.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.026 0.93 . . . . 0.0 109.487 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 14.4 t70 -123.44 175.43 6.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.275 0.63 . . . . 0.0 110.001 -170.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.88 109.53 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.431 ' HD2' HD12 ' A' ' 112' ' ' ILE . 85.7 t80 -87.82 108.82 19.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.45 0.7 . . . . 0.0 109.561 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 m -92.59 138.44 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.181 0.515 . . . . 0.0 110.977 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HD2' ' HD2' ' A' ' 30' ' ' PRO . 13.9 mmtp -129.45 147.31 64.63 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.674 1.19 . . . . 0.0 110.068 170.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HD2' ' A' ' 29' ' ' LYS . 82.0 Cg_endo -77.15 53.17 4.12 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.985 2.457 . . . . 0.0 111.754 165.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 38.23 64.93 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.564 1.546 . . . . 0.0 112.928 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -94.02 -27.13 16.48 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.198 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.56 152.76 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.319 1.048 . . . . 0.0 111.141 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -65.87 169.38 6.68 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.505 0.722 . . . . 0.0 109.878 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -68.83 -2.16 8.89 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.66 -30.68 65.62 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.684 0.794 . . . . 0.0 111.502 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.401 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -62.24 116.3 4.89 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.557 0.743 . . . . 0.0 110.588 -179.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.83 152.99 53.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.968 0.907 . . . . 0.0 109.697 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.95 105.99 1.25 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.886 2.391 . . . . 0.0 111.305 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.92 -8.62 1.75 Allowed Glycine 0 N--CA 1.471 0.995 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.237 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.549 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 83.2 mtp -84.51 179.46 7.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.29 1.036 . . . . 0.0 111.305 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.408 ' HG3' ' HA3' ' A' ' 6' ' ' GLY . 14.4 ptpt -110.23 164.47 12.62 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.91 0.884 . . . . 0.0 110.162 172.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.44 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 t80 -135.44 94.87 3.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -83.09 120.48 34.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.226 0.536 . . . . 0.0 110.143 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -83.72 97.64 9.23 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.57 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -71.37 168.75 16.75 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 163.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -161.1 155.3 22.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 m 66.96 -175.64 0.19 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.971 0.909 . . . . 0.0 111.924 172.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -122.9 15.6 10.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.889 0.876 . . . . 0.0 109.072 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -86.75 166.27 15.4 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.268 1.027 . . . . 0.0 111.293 -172.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -37.6 -51.97 1.2 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.257 1.823 . . . . 0.0 113.406 173.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -111.34 145.02 39.6 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.54 45.78 0.26 Allowed Glycine 0 C--N 1.347 1.155 0 C-N-CA 121.406 -0.426 . . . . 0.0 113.706 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -105.81 104.01 13.63 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.61 -28.93 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 122.995 0.518 . . . . 0.0 110.408 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.44 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . 175.61 -164.05 34.12 Favored Glycine 0 C--N 1.344 1.019 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.838 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -151.14 178.9 8.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.812 0.845 . . . . 0.0 109.21 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -161.5 -172.27 3.29 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.18 0.992 . . . . 0.0 109.685 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -128.7 120.87 27.3 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.807 0.843 . . . . 0.0 110.087 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 43' ' ' PHE . 54.1 mt -70.66 134.32 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.483 1.113 . . . . 0.0 111.273 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.2 mmmt -131.76 178.42 6.77 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 126.091 1.756 . . . . 0.0 109.82 -175.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -29.13 110.45 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.774 2.03 . . . . 0.0 114.507 -175.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 112' ' ' ILE . 33.4 m -93.11 118.38 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.801 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.0 119.26 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.733 0.813 . . . . 0.0 109.077 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HB3' HD11 ' A' ' 108' ' ' LEU . 70.9 mt -101.99 120.77 40.95 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.78 0.832 . . . . 0.0 109.47 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.6 t -152.67 135.12 15.16 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.057 0.943 . . . . 0.0 110.113 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 14.8 mt-10 -63.84 -23.56 67.4 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.149 0.98 . . . . 0.0 112.19 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -102.84 120.16 53.41 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.453 ' HG2' HD21 ' A' ' 87' ' ' LEU . 36.7 Cg_endo -64.74 -19.75 64.66 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.689 2.259 . . . . 0.0 112.189 174.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 44.2 mtm -73.27 -23.86 60.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.847 0.859 . . . . 0.0 110.477 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 23.7 mt-30 -71.05 -23.52 62.16 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.529 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.31 -24.04 54.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.736 0.414 . . . . 0.0 111.017 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.504 ' HE2' HD22 ' A' ' 87' ' ' LEU . 55.4 m-85 -88.35 -27.5 21.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.088 0.555 . . . . 0.0 111.623 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.9 pt-20 -82.46 -27.46 31.85 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 120.388 0.137 . . . . 0.0 110.656 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.5 m -84.89 -50.65 7.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.686 0.394 . . . . 0.0 110.61 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.746 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 89.2 m-85 -107.41 -69.37 0.85 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.153 0.581 . . . . 0.0 110.628 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.2 -80.99 0.07 OUTLIER Glycine 0 C--N 1.358 1.75 0 O-C-N 123.546 0.528 . . . . 0.0 113.515 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.14 -31.86 67.61 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.811 1.244 . . . . 0.0 111.778 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.746 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 30.3 mmt180 -74.02 -36.12 64.41 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.35 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.32 148.84 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.973 0.509 . . . . 0.0 110.677 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.48 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 45.7 p90 -62.56 -34.14 76.36 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 82' ' ' LEU . 2.3 pt? -117.16 170.63 8.52 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.529 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.4 t -106.21 175.81 5.37 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -60.93 -31.78 71.3 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.134 0.974 . . . . 0.0 111.577 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.77 -43.01 90.13 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.292 0.637 . . . . 0.0 110.73 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HG2' HG22 ' A' ' 83' ' ' THR . 60.1 mm-40 -65.99 -33.86 76.79 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.143 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.504 HD22 ' HE2' ' A' ' 73' ' ' PHE . 26.7 tp -63.87 -54.54 33.23 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.415 0.686 . . . . 0.0 111.002 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -67.11 -36.88 82.88 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.751 -171.456 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 90' ' ' TYR . 6.7 pt-20 -66.25 -40.21 90.03 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 173.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.429 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 79.7 t80 -61.87 -40.21 94.61 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.223 1.009 . . . . 0.0 111.055 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.6 mtm -73.15 -35.07 66.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.068 0.547 . . . . 0.0 110.965 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.0 mmmt -69.85 -25.89 63.95 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.6 0.36 . . . . 0.0 110.608 173.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.46 ' HA ' ' HG2' ' A' ' 96' ' ' ARG . 68.0 m -72.05 -25.03 61.63 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.224 0.609 . . . . 0.0 111.463 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 75.9 mm-40 -78.28 -28.9 47.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.746 0.419 . . . . 0.0 111.75 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.45 -31.63 21.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.844 0.458 . . . . 0.0 111.114 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 93' ' ' SER . 11.9 ptm85 -85.54 -20.65 29.3 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -124.22 28.89 6.56 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.224 0.535 . . . . 0.0 111.326 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -167.41 -172.72 34.87 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.005 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.78 25.5 3.57 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.441 1.097 . . . . 0.0 111.109 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 71.11 -15.13 0.42 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 126.048 1.739 . . . . 0.0 113.211 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 67.98 -55.94 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 125.738 1.615 . . . . 0.0 111.636 -165.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 63.24 78.94 0.27 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.745 1.218 . . . . 0.0 110.742 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -87.48 115.72 25.1 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -64.58 -35.77 82.08 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.13 0.572 . . . . 0.0 111.327 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HG3' ' HD2' ' A' ' 106' ' ' LYS . 1.6 tpmt? -104.8 160.38 15.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HD2' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -68.44 158.72 33.11 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 3.9 tmtp? -102.73 138.8 39.15 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 65' ' ' LEU . 3.0 tm? -77.2 104.65 7.83 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.422 ' CE3' ' HB3' ' A' ' 69' ' ' PRO . 24.8 m95 -82.93 161.08 21.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.205 0.602 . . . . 0.0 109.524 174.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.6 ptm -136.72 141.96 43.07 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.129 0.971 . . . . 0.0 109.754 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.17 103.97 9.7 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.125 0.97 . . . . 0.0 109.006 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.501 ' HA ' HG12 ' A' ' 63' ' ' VAL . 30.9 mt -81.45 122.45 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -82.96 136.65 34.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -123.3 132.73 54.11 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.223 0.609 . . . . 0.0 110.356 -175.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -131.87 172.57 12.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.888 0.875 . . . . 0.0 110.294 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.1 t70 49.05 50.01 18.59 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.809 1.243 . . . . 0.0 111.874 170.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.34 101.61 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.153 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -77.87 148.41 34.65 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.512 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -111.28 111.86 23.21 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.164 0.585 . . . . 0.0 110.32 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.44 ' H ' ' HA2' ' A' ' 56' ' ' GLY . 4.8 m-85 -83.9 87.06 7.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.961 0.904 . . . . 0.0 109.244 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.45 -15.08 56.16 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.701 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -80.47 137.61 51.78 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.296 1.039 . . . . 0.0 110.294 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.21 79.6 3.33 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 123.079 2.519 . . . . 0.0 113.178 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.8 mt -98.49 137.4 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.153 0.581 . . . . 0.0 110.598 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -71.22 151.32 94.52 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.258 1.023 . . . . 0.0 111.032 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.42 153.84 65.6 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.195 1.93 . . . . 0.0 111.384 167.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -36.55 74.95 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -152.19 169.51 22.28 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.202 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.98 132.48 48.0 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.32 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.513 HG12 ' HD3' ' A' ' 10' ' ' PRO . 17.6 t -118.89 99.6 51.07 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.093 0.557 . . . . 0.0 109.704 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.19 -174.87 2.12 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.478 2.785 . . . . 0.0 112.591 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.575 HG23 ' HG3' ' A' ' 12' ' ' PRO . 5.5 p -54.91 -40.3 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.661 1.184 . . . . 0.0 112.62 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.63 -12.91 82.41 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 113.581 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.95 159.49 15.09 Favored Glycine 0 C--N 1.348 1.208 0 C-N-CA 122.9 0.286 . . . . 0.0 112.838 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -113.58 150.02 33.65 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.534 0.734 . . . . 0.0 109.082 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -84.05 115.55 22.42 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.42 125.76 29.65 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -133.99 122.27 22.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.427 ' HB3' HG11 ' A' ' 5' ' ' VAL . 9.9 tp10 . . . . . 0 C--O 1.243 0.763 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.05 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.503 ' HB3' ' HG3' ' A' ' 138' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.565 0.221 . . . . 0.0 111.251 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -69.2 -11.09 60.5 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.36 0.664 . . . . 0.0 112.705 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -76.96 -17.29 58.99 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.721 0.808 . . . . 0.0 112.381 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 5' ' ' VAL . 16.9 mm 64.45 -171.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.879 0 C-N-CA 124.005 0.922 . . . . 0.0 108.912 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.523 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.3 m -156.22 -32.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 125.497 1.519 . . . . 0.0 109.131 156.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -166.97 -164.05 21.91 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.324 0.39 . . . . 0.0 112.839 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.466 HG12 HD11 ' A' ' 60' ' ' ILE . 10.4 p -139.0 144.81 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.508 0.723 . . . . 0.0 109.158 173.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 t -116.97 132.59 56.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.946 0.898 . . . . 0.0 110.0 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -133.18 140.64 37.99 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.561 1.144 . . . . 0.0 108.8 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 25.1 Cg_exo -63.8 -41.32 24.58 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.085 2.524 . . . . 0.0 111.828 169.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.4 mt 54.11 77.38 0.44 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 124.67 1.188 . . . . 0.0 110.001 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.63 0.24 6.6 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.103 2.535 . . . . 0.0 113.501 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -69.21 144.86 53.61 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 121.501 0.667 . . . . 0.0 110.499 172.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -59.22 -10.77 3.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.18 1.392 . . . . 0.0 112.852 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -99.43 22.1 11.18 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.445 1.098 . . . . 0.0 112.491 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.9 -29.27 70.2 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.937 0.495 . . . . 0.0 109.877 168.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -67.81 -27.25 66.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.825 1.25 . . . . 0.0 111.898 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 24.3 mmt180 -55.69 -37.03 67.81 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.935 0.894 . . . . 0.0 113.134 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.415 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 62.2 m-85 -66.19 -29.67 69.98 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.107 0.479 . . . . 0.0 110.865 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.13 -23.24 18.67 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.585 1.154 . . . . 0.0 110.282 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -74.01 -55.51 6.05 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.815 1.246 . . . . 0.0 110.673 -174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.2 ptpt -93.99 -12.61 28.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.444 0.698 . . . . 0.0 111.24 -175.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.49 -30.63 5.92 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 122.924 0.297 . . . . 0.0 113.192 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.82 118.39 7.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.873 0.869 . . . . 0.0 108.857 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 16.5 t70 -123.25 -179.43 4.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.765 0.826 . . . . 0.0 109.918 -168.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -134.34 110.55 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.324 1.05 . . . . 0.0 108.847 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -92.94 120.96 33.8 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.86 137.78 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.458 0.646 . . . . 0.0 111.113 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.6 mmpt? -127.58 133.63 25.3 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.476 1.51 . . . . 0.0 109.947 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.5 55.95 4.92 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.803 2.335 . . . . 0.0 111.113 166.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.2 36.11 4.25 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.201 1.4 . . . . 0.0 113.215 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 9.1 m -64.12 -28.26 69.65 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.667 0.746 . . . . 0.0 110.266 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.1 m -90.48 150.45 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.756 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -79.88 178.0 8.52 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.91 0.884 . . . . 0.0 109.788 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -69.91 4.24 2.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.217 1.007 . . . . 0.0 113.697 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.7 -26.23 68.56 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.245 0.618 . . . . 0.0 110.198 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.48 110.77 2.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.796 0.838 . . . . 0.0 110.718 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -134.31 152.07 77.46 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.23 102.6 0.96 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.38 2.053 . . . . 0.0 110.845 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.75 35.95 0.21 Allowed Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.365 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.499 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 24.5 mtm -119.0 -168.02 1.49 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.448 0.699 . . . . 0.0 110.726 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -110.1 157.06 19.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.19 0.996 . . . . 0.0 108.864 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.562 ' HB2' HG13 ' A' ' 60' ' ' ILE . 2.7 t80 -134.64 104.43 6.05 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 40.5 t -94.6 121.5 45.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.485 0.66 . . . . 0.0 109.823 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -86.21 103.51 14.9 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.249 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 16.2 t80 -72.99 133.59 44.35 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 170.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -69.86 -54.34 13.96 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.143 0.429 . . . . 0.0 111.528 -170.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.5 p -164.63 156.46 15.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.603 0.761 . . . . 0.0 109.155 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -92.34 33.26 1.11 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.377 0.608 . . . . 0.0 111.025 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.77 36.85 1.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.53 1.132 . . . . 0.0 109.157 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 56.16 74.96 0.36 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.749 1.22 . . . . 0.0 109.429 -169.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 m -133.38 175.07 9.73 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.857 -169.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 125' ' ' LYS . . . -101.64 -160.84 26.89 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 170.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -83.83 146.07 28.31 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.332 0.653 . . . . 0.0 110.669 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.26 -23.32 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.041 0.536 . . . . 0.0 109.714 169.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.432 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . 176.07 -165.1 35.46 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.017 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 11.1 pt-20 -153.65 178.1 10.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.073 0.949 . . . . 0.0 109.581 172.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -162.31 -172.42 3.18 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.013 0.925 . . . . 0.0 110.181 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -124.2 122.74 38.6 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.786 0.834 . . . . 0.0 109.773 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 43' ' ' PHE . 41.4 mt -72.16 133.52 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.067 0.947 . . . . 0.0 110.6 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -140.16 -166.18 2.05 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.166 1.787 . . . . 0.0 108.065 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -37.71 118.81 0.69 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.273 1.429 . . . . 0.0 114.565 -165.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -98.27 116.21 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 123.087 0.555 . . . . 0.0 109.8 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -91.12 113.05 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.367 0.667 . . . . 0.0 109.36 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.517 ' HB3' HD11 ' A' ' 108' ' ' LEU . 57.5 mt -90.24 124.68 35.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.512 0.725 . . . . 0.0 109.743 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -152.55 138.23 17.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.004 0.921 . . . . 0.0 110.222 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -75.33 -12.05 60.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.582 0.753 . . . . 0.0 111.556 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.554 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 74.7 m-20 -112.01 119.88 43.22 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.329 0.652 . . . . 0.0 109.274 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HG2' HD21 ' A' ' 87' ' ' LEU . 53.6 Cg_endo -67.94 -12.83 36.56 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.8 2.333 . . . . 0.0 113.33 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.3 mtm -81.99 -22.61 36.47 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.485 0.714 . . . . 0.0 110.945 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.554 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 62.3 mt-30 -70.73 -20.27 62.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.984 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -74.59 -25.53 59.32 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.052 0.541 . . . . 0.0 110.927 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.598 ' HE2' HD22 ' A' ' 87' ' ' LEU . 37.0 m-85 -85.19 -27.72 25.93 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.969 0.508 . . . . 0.0 111.728 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.36 -33.7 48.84 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 120.508 0.194 . . . . 0.0 110.675 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -79.77 -56.42 4.29 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.974 0.51 . . . . 0.0 111.132 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.702 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 37.3 m-85 -103.28 -68.0 0.86 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.249 0.619 . . . . 0.0 109.702 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.76 -81.51 0.12 Allowed Glycine 0 C--N 1.355 1.614 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.118 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.84 -36.18 69.7 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.592 1.157 . . . . 0.0 111.327 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.702 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 26.5 mmt180 -78.54 -30.27 46.85 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.801 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 76' ' ' PHE . 42.7 t -65.12 140.62 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -57.5 -45.99 84.28 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 122.606 0.362 . . . . 0.0 111.697 -174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -105.46 164.04 12.18 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.479 HG22 ' HG2' ' A' ' 86' ' ' GLU . 13.0 t -99.24 -179.69 4.32 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -68.76 -29.85 68.33 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.908 0.483 . . . . 0.0 111.338 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 2.9 m-20 -68.96 -30.23 68.62 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.324 0.583 . . . . 0.0 111.269 174.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.479 ' HG2' HG22 ' A' ' 83' ' ' THR . 58.8 mm-40 -75.32 -28.52 59.69 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.827 174.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.598 HD22 ' HE2' ' A' ' 73' ' ' PHE . 56.5 tp -69.23 -47.15 65.55 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.712 0.405 . . . . 0.0 110.582 174.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -65.13 -40.16 94.06 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.854 -175.61 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.32 -33.95 73.93 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.707 0.23 . . . . 0.0 110.664 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.433 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 68.4 t80 -62.99 -44.52 95.79 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.708 0.803 . . . . 0.0 111.221 176.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.8 mtm -77.05 -35.6 56.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.295 0.638 . . . . 0.0 111.186 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -70.05 -23.69 63.14 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.423 0.289 . . . . 0.0 110.41 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.8 t -69.62 -31.37 69.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.818 0.447 . . . . 0.0 111.008 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 26.2 mm-40 -77.74 -13.61 59.85 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -174.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -102.48 -29.71 11.43 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -105.68 -19.92 13.62 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -118.08 -30.14 5.41 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.176 0.59 . . . . 0.0 110.16 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.29 28.63 9.42 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.472 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 73.4 149.44 0.1 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.67 1.588 . . . . 0.0 112.771 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -76.67 -176.39 3.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.35 1.06 . . . . 0.0 111.755 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 71.71 93.15 0.08 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.45 1.5 . . . . 0.0 109.517 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -175.76 5.92 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.094 0.958 . . . . 0.0 109.578 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.7 p -142.9 150.16 39.43 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.585 0.754 . . . . 0.0 110.809 -173.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -70.24 -22.07 62.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.893 0.877 . . . . 0.0 111.112 173.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -67.74 153.49 43.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.481 0.712 . . . . 0.0 110.531 -178.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.25 -171.41 1.87 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.451 0.7 . . . . 0.0 109.161 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HD3' ' H ' ' A' ' 108' ' ' LEU . 4.8 tmtp? -135.37 144.42 46.61 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.5 tm? -77.77 100.25 6.2 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -82.92 159.69 22.25 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.367 0.667 . . . . 0.0 109.381 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.0 ptm -143.37 131.06 21.32 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.611 0.764 . . . . 0.0 110.279 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.17 102.59 11.99 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.813 0.845 . . . . 0.0 109.487 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.424 HG21 HG12 ' A' ' 60' ' ' ILE . 36.0 mt -81.26 127.89 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.748 0.819 . . . . 0.0 109.394 -177.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -81.61 123.47 28.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.3 mm? -105.27 129.1 53.71 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.159 0.983 . . . . 0.0 109.528 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.64 175.25 9.72 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.208 1.003 . . . . 0.0 108.492 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 t70 57.63 36.41 26.69 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.876 0.845 . . . . 0.0 110.737 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.16 105.17 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.742 -171.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.65 160.21 21.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.184 0.993 . . . . 0.0 110.472 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -117.5 123.19 45.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.178 0.991 . . . . 0.0 110.54 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.432 ' H ' ' HA2' ' A' ' 56' ' ' GLY . 10.3 m-85 -97.12 82.33 3.17 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.49 -24.77 65.62 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.513 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -81.87 139.42 46.58 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.796 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -83.29 65.9 7.7 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 123.235 2.624 . . . . 0.0 112.924 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.3 mt -77.02 114.34 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 12.9 mptt -71.35 145.38 90.55 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.198 -178.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.99 155.19 70.61 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.612 2.208 . . . . 0.0 111.86 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -68.22 -31.07 70.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.617 0.767 . . . . 0.0 109.479 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -128.88 162.21 28.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.144 0.978 . . . . 0.0 109.824 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -77.3 121.88 24.33 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.477 ' HA ' ' HG2' ' A' ' 135' ' ' GLN . 17.8 t -107.69 100.07 32.88 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 122.829 0.451 . . . . 0.0 110.195 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.82 -176.94 3.41 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.01 2.473 . . . . 0.0 111.699 172.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -57.77 -31.22 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.322 1.049 . . . . 0.0 112.756 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.25 -19.27 72.13 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.708 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.76 142.21 3.12 Favored Glycine 0 C--N 1.351 1.361 0 C-N-CA 122.984 0.326 . . . . 0.0 113.031 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.477 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 14.2 mm100 -109.73 157.67 18.89 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.437 0.695 . . . . 0.0 109.836 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -87.35 129.1 35.15 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 170.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.1 tt -90.58 125.13 35.53 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.503 ' HG3' ' HB3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -134.26 144.29 48.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttm . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m -63.05 -7.03 4.63 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.347 1.059 . . . . 0.0 113.689 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -59.96 -27.43 66.81 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.243 0.617 . . . . 0.0 112.031 171.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 5' ' ' VAL . 26.3 mm 64.85 -177.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 C-N-CA 124.402 1.081 . . . . 0.0 109.577 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 139' ' ' GLU . 1.3 m -150.24 -39.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.807 1.243 . . . . 0.0 108.712 158.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.39 -163.38 22.27 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.178 -176.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.432 HG11 HD21 ' A' ' 37' ' ' LEU . 9.0 p -137.1 141.39 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.663 0.785 . . . . 0.0 109.068 175.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 t -113.93 139.26 49.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.445 0.698 . . . . 0.0 110.163 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -131.55 143.74 50.46 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 123.695 0.798 . . . . 0.0 109.805 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' HG12 ' A' ' 130' ' ' VAL . 85.8 Cg_endo -73.98 -14.59 23.74 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.994 2.463 . . . . 0.0 112.354 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.1 mm 53.6 89.77 0.1 OUTLIER Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.922 1.289 . . . . 0.0 109.86 -174.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.03 24.35 0.54 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.905 2.403 . . . . 0.0 112.702 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 159.52 39.23 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.532 1.533 . . . . 0.0 108.499 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -74.93 -13.07 60.49 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.446 0.698 . . . . 0.0 111.239 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -72.52 6.85 2.13 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.234 1.013 . . . . 0.0 113.597 -172.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -56.76 -34.21 67.36 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.002 0.43 . . . . 0.0 110.058 164.425 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.47 ' N ' ' SD ' ' A' ' 16' ' ' MET . 19.6 t70 -49.42 -41.49 39.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.647 1.579 . . . . 0.0 112.428 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -54.56 -48.2 72.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.262 1.025 . . . . 0.0 112.465 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 64.5 m-85 -66.75 -28.9 68.78 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.988 0.805 . . . . 0.0 110.406 -177.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -91.1 -19.32 23.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.01 0.524 . . . . 0.0 111.376 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -76.74 -59.67 2.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.321 0.648 . . . . 0.0 109.497 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -92.73 -10.23 37.83 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.222 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.3 3.02 69.08 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.416 0.447 . . . . 0.0 114.006 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -168.16 100.43 0.44 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.009 0.924 . . . . 0.0 109.736 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 20.1 t70 -129.05 -170.74 2.33 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.0 t -133.18 117.51 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.94 1.245 . . . . 0.0 109.248 -174.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -90.49 107.33 19.09 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.278 0.631 . . . . 0.0 109.517 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.3 m -87.67 142.85 12.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.423 0.63 . . . . 0.0 109.903 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HE2' ' HD2' ' A' ' 30' ' ' PRO . 2.1 tpmt? -135.05 128.07 18.43 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.383 1.073 . . . . 0.0 108.53 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 79.7 Cg_endo -76.26 59.29 5.97 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.716 2.277 . . . . 0.0 111.736 171.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 39.49 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.882 1.673 . . . . 0.0 113.487 -174.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.499 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 27.9 m -127.91 -31.48 2.4 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.384 0.674 . . . . 0.0 109.754 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.79 148.47 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.41 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -87.98 -164.14 1.06 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.129 0.972 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -70.13 -2.21 12.34 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -63.38 -31.32 72.44 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.234 0.47 . . . . 0.0 110.765 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.432 HD21 HG11 ' A' ' 7' ' ' VAL . 1.1 mm? -64.93 117.44 7.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.132 0.573 . . . . 0.0 111.614 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.07 149.81 46.85 Favored Pre-proline 0 C--O 1.244 0.787 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.791 173.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.31 101.88 0.65 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.541 2.16 . . . . 0.0 111.047 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.83 0.62 0.78 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.483 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.427 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 26.2 mtm -89.7 -169.75 2.57 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 117.319 0.56 . . . . 0.0 110.984 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -107.86 160.06 16.04 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.507 0.723 . . . . 0.0 109.474 173.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CB ' HD11 ' A' ' 114' ' ' LEU . 12.3 t80 -134.98 105.25 6.29 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.8 t -90.76 121.13 40.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.175 0.512 . . . . 0.0 109.868 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -82.95 105.16 13.72 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.437 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 56.8 t80 -79.73 126.28 30.75 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.507 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 24.4 tp60 -76.34 115.8 16.43 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -56.01 83.37 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.809 1.244 . . . . 0.0 113.8 -173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.8 p80 174.19 173.43 0.18 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.01 1.724 . . . . 0.0 109.271 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.31 -178.78 4.13 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.907 0.883 . . . . 0.0 111.718 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.49 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 32.7 t70 61.37 -86.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.174 1.39 . . . . 0.0 112.363 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.49 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 27.2 m -54.07 -35.23 61.82 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.174 0.99 . . . . 0.0 111.977 -172.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.548 ' HA3' ' HD3' ' A' ' 126' ' ' PRO . . . 68.89 -90.87 0.26 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-N 114.799 -1.091 . . . . 0.0 113.517 170.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 66.7 m-85 -102.14 124.34 47.56 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.617 0.767 . . . . 0.0 111.195 -172.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 47' ' ' GLN . 2.6 p -84.53 -33.75 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.932 0.893 . . . . 0.0 110.88 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.6 -168.58 30.88 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.474 -0.33 . . . . 0.0 112.76 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 6.5 pt-20 -147.83 179.46 7.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.396 1.078 . . . . 0.0 108.918 174.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -164.19 -172.24 2.69 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.679 0.791 . . . . 0.0 110.659 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -123.94 119.03 28.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.507 1.123 . . . . 0.0 109.576 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 43' ' ' PHE . 53.7 mt -71.81 131.78 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.217 1.007 . . . . 0.0 110.733 177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -138.13 -162.4 1.3 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.212 1.805 . . . . 0.0 107.773 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -38.96 116.0 0.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.821 1.249 . . . . 0.0 113.466 -160.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.9 m -96.18 106.36 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 121.735 0.778 . . . . 0.0 109.113 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 86.2 t -89.96 108.02 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.8 mt -89.37 120.32 30.6 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.504 0.722 . . . . 0.0 109.398 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.7 t -151.58 135.73 16.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.557 0.743 . . . . 0.0 110.091 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -70.97 -10.22 59.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.922 0.889 . . . . 0.0 111.837 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -110.12 122.56 38.46 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.58 -22.35 58.41 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.218 1.945 . . . . 0.0 112.282 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 47.5 mtm -70.33 -25.63 63.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.484 0.713 . . . . 0.0 111.415 -169.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -53.56 -35.57 60.93 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.215 1.006 . . . . 0.0 112.03 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.418 ' HE2' ' HB3' ' A' ' 109' ' ' TRP . 5.7 m-85 -77.39 -33.82 55.04 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.525 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CE2' HD22 ' A' ' 87' ' ' LEU . 88.1 m-85 -81.5 -16.64 51.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.517 0.727 . . . . 0.0 111.65 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -94.14 -33.57 13.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.462 0.305 . . . . 0.0 111.208 172.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.2 m -78.08 -52.07 9.31 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.989 0.423 . . . . 0.0 110.737 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.797 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 66.9 m-85 -100.16 -53.96 3.0 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.538 0.735 . . . . 0.0 109.951 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.71 -86.44 0.12 Allowed Glycine 0 C--N 1.357 1.731 0 O-C-N 123.938 0.774 . . . . 0.0 113.129 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.92 -43.49 91.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.41 0.684 . . . . 0.0 110.692 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.797 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 25.0 mmt180 -68.74 -18.6 64.25 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-O 118.328 -0.844 . . . . 0.0 112.292 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 76' ' ' PHE . 47.9 t -80.25 131.9 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.628 1.104 . . . . 0.0 108.592 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -51.9 -37.58 52.98 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 124.092 0.87 . . . . 0.0 113.336 -170.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.0 pt? -111.75 160.0 17.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.539 HG22 ' HG2' ' A' ' 86' ' ' GLU . 8.9 t -97.24 173.69 7.09 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -61.26 -27.29 68.35 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.462 0.705 . . . . 0.0 111.438 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.95 -53.14 51.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.569 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 9.2 mm-40 -61.64 -29.74 70.26 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.566 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.514 HD22 ' CE2' ' A' ' 73' ' ' PHE . 25.2 tp -63.5 -58.56 6.63 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.121 0.968 . . . . 0.0 111.096 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -59.92 -41.19 91.18 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.571 0.544 . . . . 0.0 111.607 -172.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.94 -23.74 44.41 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.028 0.531 . . . . 0.0 111.477 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.45 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 62.4 t80 -67.79 -45.99 73.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.21 0.604 . . . . 0.0 109.788 171.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.3 mtm -67.27 -39.78 86.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.138 0.575 . . . . 0.0 110.381 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.2 mmpt? -64.0 -38.4 90.95 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.606 0.566 . . . . 0.0 110.293 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.3 t -62.03 -43.79 98.09 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.432 0.693 . . . . 0.0 110.749 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 28.5 mm-40 -64.25 -43.05 96.08 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.917 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.642 ' HB3' HH11 ' A' ' 99' ' ' ARG . 12.7 pt-20 -88.02 -2.81 58.83 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -99.16 -33.66 10.68 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.796 0.725 . . . . 0.0 110.344 173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -91.36 -20.41 21.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.702 0.401 . . . . 0.0 111.624 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.35 97.36 0.19 Allowed Glycine 0 C--N 1.349 1.252 0 N-CA-C 112.246 -0.341 . . . . 0.0 112.246 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.642 HH11 ' HB3' ' A' ' 95' ' ' GLU . 10.0 tpt180 -72.9 -38.0 67.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.35 0.66 . . . . 0.0 110.695 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 66.49 -80.97 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.369 1.468 . . . . 0.0 111.919 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -84.93 105.62 15.83 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -71.9 90.04 1.11 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.638 0.775 . . . . 0.0 110.045 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.4 m -74.16 84.93 1.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -68.95 156.32 38.77 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.443 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 66.34 -89.38 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.789 1.236 . . . . 0.0 111.135 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.48 -171.54 3.16 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.239 0.543 . . . . 0.0 111.191 172.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 30' ' ' PRO . 31.6 tptt -134.97 145.27 47.97 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.306 1.042 . . . . 0.0 108.73 173.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -80.15 121.62 25.8 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.418 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 41.6 m95 -107.77 158.55 17.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.055 0.942 . . . . 0.0 109.347 174.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.2 ptm -144.47 130.92 19.84 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.283 0.633 . . . . 0.0 110.271 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -103.78 102.38 12.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.637 0.775 . . . . 0.0 109.49 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.81 117.54 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.96 113.0 19.57 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.484 HD11 ' CB ' ' A' ' 43' ' ' PHE . 4.3 mm? -92.53 135.36 34.13 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.063 0.545 . . . . 0.0 110.726 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.81 167.95 20.88 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.645 0.778 . . . . 0.0 109.365 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.2 t70 53.6 47.45 23.86 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.312 1.053 . . . . 0.0 110.586 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 50.5 t -69.84 107.56 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.531 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -93.62 107.12 19.03 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.942 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -68.42 123.36 20.58 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -71.98 96.88 1.77 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 170.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -63.84 -33.37 75.53 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.465 0.706 . . . . 0.0 109.954 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.9 137.85 33.24 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.312 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.16 105.53 1.98 Allowed 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.161 1.907 . . . . 0.0 110.844 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 21.1 mt -91.03 108.14 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.525 0.678 . . . . 0.0 110.566 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -74.64 139.88 74.6 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.968 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.548 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 63.6 Cg_endo -86.7 170.31 7.62 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 122.728 2.285 . . . . 0.0 112.367 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -87.68 -28.14 22.0 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.711 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -144.31 165.91 26.56 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.483 0.713 . . . . 0.0 110.479 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.0 134.2 44.57 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.509 HG12 ' HD3' ' A' ' 10' ' ' PRO . 62.2 t -101.6 100.0 13.04 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.37 176.5 5.58 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.225 2.616 . . . . 0.0 112.308 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.37 -30.81 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.622 0.769 . . . . 0.0 113.063 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.29 -21.23 75.75 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.537 0.523 . . . . 0.0 113.393 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.88 159.06 31.67 Favored Glycine 0 C--N 1.345 1.042 0 C-N-CA 123.453 0.549 . . . . 0.0 112.506 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -115.07 154.49 28.78 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.971 0.908 . . . . 0.0 109.759 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -88.49 124.15 33.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.97 116.11 27.78 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 172.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.66 139.46 52.7 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.537 ' HB2' HG13 ' A' ' 5' ' ' VAL . 4.4 tm-20 . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.456 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 12.0 tpt . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 119.475 -0.298 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.4 m -40.42 -29.83 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 126.656 1.982 . . . . 0.0 115.861 -171.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -62.79 -13.06 28.73 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 5' ' ' VAL . 30.5 mm 67.38 -176.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 C-N-CA 124.168 0.987 . . . . 0.0 109.254 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.4 m -157.93 -41.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 125.498 1.519 . . . . 0.0 108.041 158.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.94 -161.32 18.97 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.178 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.52 155.9 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.879 0.872 . . . . 0.0 109.267 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -126.56 140.19 52.63 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.723 0.809 . . . . 0.0 109.706 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -141.94 142.84 26.21 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.65 0.78 . . . . 0.0 111.116 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HD3' HG12 ' A' ' 130' ' ' VAL . 74.9 Cg_endo -74.99 -12.81 21.54 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.943 2.429 . . . . 0.0 112.565 167.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.1 mm 69.2 123.46 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.815 1.646 . . . . 0.0 109.837 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.43 -7.07 18.05 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 122.894 2.396 . . . . 0.0 113.944 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HE3' ' HB3' ' A' ' 86' ' ' GLU . 67.9 mttm -134.62 170.88 15.13 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.448 1.099 . . . . 0.0 109.941 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -75.29 -5.05 42.65 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.597 0.759 . . . . 0.0 110.312 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -76.19 26.81 0.12 Allowed 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.007 0.923 . . . . 0.0 113.319 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -60.26 -32.96 71.65 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.827 0.851 . . . . 0.0 110.057 163.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.18 -21.32 66.75 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.837 0.855 . . . . 0.0 112.913 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 81' ' ' PHE . 37.4 mmt180 -57.43 -45.75 84.3 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.496 0.718 . . . . 0.0 110.796 176.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.526 ' HB3' HG11 ' A' ' 117' ' ' VAL . 65.8 m-85 -63.04 -31.11 72.18 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.664 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -91.48 -18.52 24.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.981 0.913 . . . . 0.0 111.111 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -72.96 -46.96 49.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.671 1.188 . . . . 0.0 109.84 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.8 ptpt -106.85 -15.87 14.61 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.226 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.76 -5.67 56.84 Favored Glycine 0 N--CA 1.48 1.588 0 N-CA-C 114.27 0.468 . . . . 0.0 114.27 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -161.68 107.83 1.34 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.31 1.044 . . . . 0.0 108.961 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.7 t70 -124.4 179.66 4.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.468 1.107 . . . . 0.0 109.675 -169.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 79' ' ' ARG . 55.3 t -128.87 109.67 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.44 0.696 . . . . 0.0 109.494 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.462 ' HD2' HD12 ' A' ' 112' ' ' ILE . 88.9 t80 -84.32 111.84 19.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m -89.93 139.45 17.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-O 121.526 0.679 . . . . 0.0 110.208 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.646 ' HG2' HG22 ' A' ' 33' ' ' VAL . 1.5 tpmt? -135.37 127.71 17.94 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.813 1.245 . . . . 0.0 108.507 -174.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 63.1 Cg_endo -73.14 60.37 3.86 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.643 2.229 . . . . 0.0 112.725 172.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.93 21.83 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.215 1.406 . . . . 0.0 114.509 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -64.69 -43.03 94.82 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.641 0.776 . . . . 0.0 111.045 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.646 HG22 ' HG2' ' A' ' 29' ' ' LYS . 20.1 m -72.84 150.33 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.752 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -82.56 -174.17 5.04 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.593 0.757 . . . . 0.0 111.839 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -66.98 -9.27 36.95 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.905 1.282 . . . . 0.0 111.387 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -60.63 -24.82 65.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.883 0.873 . . . . 0.0 110.848 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.88 91.83 2.02 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.519 0.728 . . . . 0.0 110.344 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 154.42 47.9 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 123.099 0.559 . . . . 0.0 109.951 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.67 99.25 0.93 Allowed 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.822 2.348 . . . . 0.0 111.476 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.18 -15.77 0.67 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.518 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.46 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 25.0 mtm -76.65 -178.98 5.03 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 121.554 0.692 . . . . 0.0 112.223 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -106.3 160.08 15.63 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.091 0.956 . . . . 0.0 110.352 171.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -135.49 97.04 3.58 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 93.4 t -86.82 120.92 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.254 0.549 . . . . 0.0 110.003 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -82.44 102.6 11.41 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.49 0.716 . . . . 0.0 110.115 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -74.95 160.98 29.91 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.528 170.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 70.79 97.07 0.07 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.129 1.372 . . . . 0.0 111.185 174.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.466 ' HB3' ' H ' ' A' ' 52' ' ' THR . 22.7 t -93.68 36.07 1.11 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.488 0.715 . . . . 0.0 109.59 172.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 57.46 -83.86 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.908 1.283 . . . . 0.0 110.412 -170.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -143.39 77.21 1.55 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.986 0.914 . . . . 0.0 109.157 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -150.99 -66.88 0.19 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.798 0.839 . . . . 0.0 108.906 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.466 ' H ' ' HB3' ' A' ' 48' ' ' SER . 8.9 t -142.84 173.15 11.8 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.074 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.12 -37.57 87.27 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.623 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -127.89 124.72 38.12 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.39 0.676 . . . . 0.0 110.122 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.01 -33.34 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.395 0.678 . . . . 0.0 111.272 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.6 -160.48 23.84 Favored Glycine 0 C--N 1.345 1.078 0 C-N-CA 121.546 -0.359 . . . . 0.0 113.131 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 11.6 pt-20 -151.28 177.78 9.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.231 1.012 . . . . 0.0 109.263 175.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -162.49 -173.32 3.51 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.139 0.976 . . . . 0.0 109.573 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -128.01 125.99 40.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.373 0.669 . . . . 0.0 110.228 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.1 mt -74.16 130.31 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.926 1.29 . . . . 0.0 111.288 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 30.7 mmmt -129.8 -164.39 1.4 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.616 1.567 . . . . 0.0 108.017 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -40.95 114.03 0.44 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.818 1.247 . . . . 0.0 113.743 -163.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -85.42 107.75 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 53.3 t -88.96 109.33 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.0 mt -87.37 117.82 26.39 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.474 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.3 t -151.18 130.33 12.69 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.155 0.982 . . . . 0.0 108.671 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.81 -6.67 33.86 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -105.51 122.19 43.58 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 170.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.576 ' HG2' HD21 ' A' ' 87' ' ' LEU . 57.7 Cg_endo -70.85 -15.98 32.99 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.743 2.295 . . . . 0.0 112.647 172.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 36.1 mtm -79.31 -25.03 42.44 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.672 0.789 . . . . 0.0 110.167 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -57.63 -32.43 67.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.403 1.081 . . . . 0.0 110.752 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.69 -19.91 58.77 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.028 0.531 . . . . 0.0 111.722 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.551 ' HE2' HD22 ' A' ' 87' ' ' LEU . 26.1 m-85 -86.64 -34.2 19.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.837 0.455 . . . . 0.0 110.685 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.46 -28.34 56.5 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 120.39 0.138 . . . . 0.0 110.723 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.5 m -83.6 -43.55 15.53 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.223 0.609 . . . . 0.0 111.505 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.787 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 64.0 m-85 -115.19 -67.5 0.99 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.786 0.435 . . . . 0.0 110.123 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.25 -83.92 0.62 Allowed Glycine 0 C--N 1.353 1.521 0 O-C-N 123.601 0.563 . . . . 0.0 113.044 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.73 -22.57 64.32 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.685 0.794 . . . . 0.0 111.831 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.787 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 31.6 mmt180 -72.33 -40.55 67.36 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.845 0.458 . . . . 0.0 111.385 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.415 HG12 HD23 ' A' ' 82' ' ' LEU . 13.5 t -69.52 147.31 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.006 0.522 . . . . 0.0 110.856 -170.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.447 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 28.9 p90 -69.86 -17.85 63.4 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 1.8 pt? -137.09 167.61 21.21 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 85' ' ' ASP . 13.9 t -110.04 -179.53 3.82 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.15 -27.92 69.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.25 0.62 . . . . 0.0 111.35 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 83' ' ' THR . 10.5 m-20 -62.5 -47.09 85.49 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.573 0.749 . . . . 0.0 111.25 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.512 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 1.8 mp0 -68.48 -29.52 68.15 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.576 HD21 ' HG2' ' A' ' 69' ' ' PRO . 46.8 tp -68.91 -48.9 62.19 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.837 0.455 . . . . 0.0 110.837 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -68.63 -36.68 78.94 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.008 -172.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 8.7 pt-20 -66.6 -36.28 82.24 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.12 -47.33 74.51 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.869 0.868 . . . . 0.0 110.754 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 67.2 mtm -70.02 -36.9 75.42 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.158 0.583 . . . . 0.0 110.63 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -62.34 -43.0 99.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.04 0.536 . . . . 0.0 110.279 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 t -58.65 -29.75 66.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.913 0.885 . . . . 0.0 111.355 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -73.09 -54.17 9.19 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -80.94 -5.97 58.12 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -169.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -106.09 -26.74 11.49 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.294 0.497 . . . . 0.0 111.539 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -101.32 -80.65 0.49 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.424 0.29 . . . . 0.0 110.814 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -101.56 -77.32 1.25 Allowed Glycine 0 C--N 1.348 1.194 0 N-CA-C 113.773 0.269 . . . . 0.0 113.773 -169.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -81.68 80.59 7.98 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 122.108 0.956 . . . . 0.0 110.654 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.631 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 41.7 mtm180 -92.91 165.26 12.98 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.919 -175.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 68.51 91.65 0.09 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.856 1.262 . . . . 0.0 111.813 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -168.23 106.36 0.49 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.4 m -148.81 -32.98 0.22 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -172.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -66.25 -55.98 13.49 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.427 0.691 . . . . 0.0 110.055 -175.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -102.74 157.25 17.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.934 -176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.482 ' HD2' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -111.44 -178.8 3.54 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.186 0.594 . . . . 0.0 110.233 -178.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 152.2 51.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.086 0.555 . . . . 0.0 109.738 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -71.64 127.23 31.88 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -116.68 159.12 22.7 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.404 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 14.7 ptm -142.47 130.58 22.0 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.282 0.633 . . . . 0.0 109.873 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -104.24 101.61 11.33 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.737 0.815 . . . . 0.0 109.198 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.462 HD12 ' HD2' ' A' ' 27' ' ' PHE . 27.9 mt -82.2 120.07 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -81.87 98.37 8.48 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.4 mm? -81.56 131.41 35.27 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 122.005 -0.434 . . . . 0.0 109.938 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.477 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 1.0 OUTLIER -138.47 159.79 41.2 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.183 0.593 . . . . 0.0 109.415 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.8 t70 53.58 48.33 21.91 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.364 1.065 . . . . 0.0 110.757 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 19' ' ' PHE . 27.2 t -71.62 101.89 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.206 -174.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.24 154.02 21.03 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.441 -174.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -107.08 138.55 43.04 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.531 0.732 . . . . 0.0 110.01 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -86.34 85.83 7.33 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 169.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.44 -39.23 82.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.072 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -81.66 148.48 61.91 Favored Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.275 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.77 114.94 4.06 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.679 2.253 . . . . 0.0 112.114 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.5 mt -114.5 131.49 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 145.91 30.4 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.24 1.016 . . . . 0.0 109.114 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -80.4 132.89 9.33 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.574 2.183 . . . . 0.0 111.659 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -66.58 -25.35 66.59 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.565 0.746 . . . . 0.0 110.662 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -146.25 166.87 24.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.144 0.978 . . . . 0.0 110.436 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -79.31 135.53 36.76 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.452 HG12 ' HD3' ' A' ' 10' ' ' PRO . 39.1 t -114.09 105.0 54.7 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.86 -174.31 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.168 2.578 . . . . 0.0 112.668 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.4 -34.84 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.889 0.875 . . . . 0.0 110.617 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.54 -24.2 75.23 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.24 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.76 167.42 42.0 Favored Glycine 0 C--N 1.346 1.1 0 C-N-CA 123.201 0.429 . . . . 0.0 112.94 175.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -118.44 151.84 37.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.082 0.953 . . . . 0.0 109.377 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -89.56 128.1 35.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tt -89.09 118.47 28.83 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -127.79 115.18 18.25 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.25 1.109 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -170.442 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.867 0.365 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -77.6 -12.88 60.01 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.047 0.939 . . . . 0.0 110.998 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -62.23 -24.12 67.06 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.668 0.787 . . . . 0.0 112.416 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.556 HG22 ' H ' ' A' ' 5' ' ' VAL . 23.1 mm 62.14 -164.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -172.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.556 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.3 m -148.64 -40.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 154.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.89 -161.68 20.79 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.342 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.59 149.27 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 6.2 t -121.86 134.47 54.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.524 0.73 . . . . 0.0 109.043 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -128.32 144.73 52.98 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.929 0.892 . . . . 0.0 109.217 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 42.1 Cg_exo -56.94 -31.13 88.63 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.132 2.555 . . . . 0.0 111.928 170.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.9 mm 68.45 131.79 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 125.675 1.59 . . . . 0.0 111.033 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.79 135.89 50.31 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.914 2.409 . . . . 0.0 112.078 172.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -66.16 -25.51 66.99 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.781 0.832 . . . . 0.0 112.737 -169.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -66.01 -37.31 85.57 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.302 0.641 . . . . 0.0 110.442 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.417 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 25.2 m-85 -114.88 13.33 17.1 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.542 -162.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.7 ttp -60.77 -41.51 95.65 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.022 0.529 . . . . 0.0 110.733 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.47 -18.81 51.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.903 0.881 . . . . 0.0 112.738 -173.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 15' ' ' PHE . 1.3 mmp_? -52.48 -48.48 65.88 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.354 0.662 . . . . 0.0 112.142 -173.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -66.22 -30.09 70.48 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.54 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -94.23 -12.11 28.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.872 0.869 . . . . 0.0 111.379 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -78.66 -52.16 8.82 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.745 0.818 . . . . 0.0 108.858 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -101.72 -16.83 16.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.282 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.67 10.31 63.71 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 114.11 0.404 . . . . 0.0 114.11 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -163.27 92.91 0.76 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.159 0.984 . . . . 0.0 109.049 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -127.3 -177.72 4.17 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.43 -168.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -141.7 117.97 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.062 0.945 . . . . 0.0 109.068 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -100.39 114.16 27.47 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.325 0.65 . . . . 0.0 109.446 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -92.99 141.11 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.264 0.554 . . . . 0.0 111.175 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.88 125.33 20.21 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 125.25 1.42 . . . . 0.0 110.466 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.53 71.26 6.02 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.934 2.423 . . . . 0.0 112.411 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 54.34 23.93 4.74 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.064 1.346 . . . . 0.0 113.35 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -73.2 -49.12 29.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.376 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 m -74.14 149.21 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.592 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -73.39 179.25 4.08 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.367 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.11 -7.77 25.72 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.325 1.05 . . . . 0.0 112.85 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.76 -25.44 66.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.461 0.704 . . . . 0.0 111.007 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.22 93.17 0.13 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.644 0.777 . . . . 0.0 111.03 175.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.46 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -113.24 149.24 41.14 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.596 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.24 99.56 1.03 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.535 2.156 . . . . 0.0 111.184 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.9 -2.17 0.73 Allowed Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.955 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.46 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 29.5 mtm -83.2 -170.49 3.07 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.501 0.667 . . . . 0.0 111.607 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.3 ptpt -115.55 162.49 17.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.527 1.131 . . . . 0.0 110.338 171.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.526 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.14 101.05 4.73 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 58.9 t -83.83 119.5 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.532 0.682 . . . . 0.0 109.371 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -85.89 113.46 22.04 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 88.4 t80 -72.16 145.99 47.7 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 171.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' A' ' 49' ' ' HIS . 59.8 tt0 -66.51 107.2 1.99 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.517 0.727 . . . . 0.0 110.317 -175.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.9 t -74.16 75.16 1.78 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.85 0.833 . . . . 0.0 109.778 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.427 ' HB2' ' HG2' ' A' ' 47' ' ' GLN . 9.1 m80 -175.04 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.687 1.995 . . . . 0.0 108.066 -170.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 61.07 29.57 19.01 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 124.256 1.022 . . . . 0.0 110.99 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -69.79 -51.6 32.42 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.231 1.012 . . . . 0.0 110.118 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.4 t -139.95 -37.77 0.47 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.561 0.744 . . . . 0.0 110.786 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.91 134.12 4.23 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-O 119.699 -0.5 . . . . 0.0 112.077 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 27.5 m-85 64.53 139.35 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.567 1.547 . . . . 0.0 113.556 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 p -125.71 -31.66 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.026 0.93 . . . . 0.0 110.209 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.93 -167.51 35.53 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.154 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 13.6 pt-20 -146.62 177.64 8.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.875 0.87 . . . . 0.0 109.308 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.453 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.45 -172.4 3.54 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.362 1.065 . . . . 0.0 109.348 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 86.0 mmt-85 -123.58 118.81 28.17 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.679 0.792 . . . . 0.0 109.775 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' ' 43' ' ' PHE . 51.0 mt -69.99 129.27 34.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 O-C-N 124.449 1.093 . . . . 0.0 109.595 174.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 14.7 mmmm -134.41 -172.54 3.04 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 125.553 1.541 . . . . 0.0 108.671 -175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -32.29 110.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.884 1.674 . . . . 0.0 114.371 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.7 m -90.27 117.61 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 68.5 t -90.39 108.8 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.9 mt -86.44 118.97 26.21 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.0 t -152.65 134.27 14.57 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.865 0.866 . . . . 0.0 109.817 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.518 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 58.0 mt-10 -68.98 -11.86 61.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 122.868 0.467 . . . . 0.0 111.495 174.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.579 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 10.1 m-80 -103.23 117.33 60.53 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.488 ' HG2' HD21 ' A' ' 87' ' ' LEU . 59.3 Cg_endo -73.96 -10.24 22.83 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.262 1.975 . . . . 0.0 112.817 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -78.78 -25.12 44.35 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.328 0.651 . . . . 0.0 111.027 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.579 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 75.5 mt-30 -68.68 -21.9 64.4 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.678 176.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -75.44 -23.63 56.94 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.877 0.471 . . . . 0.0 110.801 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.556 ' HE2' HD22 ' A' ' 87' ' ' LEU . 31.2 m-85 -85.25 -32.4 22.6 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.489 0.316 . . . . 0.0 111.707 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.7 pt-20 -75.15 -30.85 60.88 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 120.523 0.202 . . . . 0.0 110.726 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -79.17 -58.36 3.26 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.212 0.605 . . . . 0.0 110.655 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.785 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 61.8 m-85 -101.61 -67.63 0.86 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.579 0.752 . . . . 0.0 110.156 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.7 -84.66 0.77 Allowed Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.83 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.64 -46.55 86.89 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.422 0.689 . . . . 0.0 110.38 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.785 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 29.8 mmt180 -62.43 -30.22 71.07 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 124.066 0.854 . . . . 0.0 111.76 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.489 HG12 HD23 ' A' ' 82' ' ' LEU . 30.8 t -68.15 136.0 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -56.98 -28.51 62.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.583 0.753 . . . . 0.0 112.748 -171.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.489 HD23 HG12 ' A' ' 80' ' ' VAL . 1.8 pt? -123.53 155.28 37.86 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.621 0.768 . . . . 0.0 109.197 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.557 HG22 ' HG2' ' A' ' 86' ' ' GLU . 15.1 t -91.49 176.92 6.38 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.4 -34.41 77.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.673 0.389 . . . . 0.0 111.514 -177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -61.44 -44.72 96.62 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.405 0.682 . . . . 0.0 110.767 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HG2' HG22 ' A' ' 83' ' ' THR . 63.8 mm-40 -66.1 -35.44 80.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.357 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.556 HD22 ' HE2' ' A' ' 73' ' ' PHE . 29.1 tp -68.2 -47.95 66.51 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -35.45 78.73 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.21 -31.74 67.97 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 123.162 0.289 . . . . 0.0 110.917 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -66.36 -44.85 82.07 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.77 0.828 . . . . 0.0 110.934 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.3 mtm -76.82 -34.34 57.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.116 0.567 . . . . 0.0 110.454 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -64.38 -35.34 80.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.18 0.592 . . . . 0.0 110.42 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.0 t -56.65 -44.87 81.73 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.688 0.618 . . . . 0.0 110.549 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -66.17 -27.98 68.43 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.779 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.5 -22.32 14.55 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -84.56 -32.72 23.67 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 120.698 0.285 . . . . 0.0 110.587 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.82 -7.1 59.33 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.63 0.372 . . . . 0.0 111.393 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.2 -95.23 0.12 Allowed Glycine 0 C--N 1.345 1.041 0 O-C-N 123.138 0.274 . . . . 0.0 112.58 168.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 56.78 79.81 0.17 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.084 1.354 . . . . 0.0 111.685 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -73.03 -28.72 62.51 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.312 0.645 . . . . 0.0 111.499 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -78.31 132.44 37.45 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -65.38 -29.05 69.73 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.605 0.762 . . . . 0.0 111.797 -168.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m 61.65 49.8 4.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.562 1.145 . . . . 0.0 110.536 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -63.21 -33.37 75.34 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.529 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -96.06 157.72 15.77 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -87.81 -165.69 1.38 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.226 1.01 . . . . 0.0 109.834 -177.057 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.2 tpmt? -134.77 144.71 47.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.7 0.4 . . . . 0.0 109.966 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.66 113.26 15.33 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -96.9 153.55 17.83 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.5 ptm -132.61 130.05 39.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.277 0.631 . . . . 0.0 109.62 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -98.13 102.45 14.2 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.631 0.772 . . . . 0.0 109.123 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.444 ' HA ' HG12 ' A' ' 63' ' ' VAL . 51.4 mt -78.95 121.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -78.9 133.15 36.96 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.216 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.5 mm? -122.01 119.23 30.84 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.351 0.66 . . . . 0.0 109.757 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -125.29 175.89 7.14 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.571 0.748 . . . . 0.0 109.427 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 t70 54.52 36.0 24.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.002 0.921 . . . . 0.0 111.03 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.3 t -65.54 111.07 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.523 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.86 112.92 24.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.111 0.965 . . . . 0.0 110.988 -172.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -67.18 139.34 57.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.813 0.845 . . . . 0.0 111.498 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -82.68 113.72 20.55 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.686 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.9 -28.85 61.75 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.433 0.693 . . . . 0.0 110.018 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -105.69 146.37 32.7 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.522 1.129 . . . . 0.0 110.156 -175.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.42 99.56 1.31 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.727 2.285 . . . . 0.0 111.428 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.4 mt -85.09 123.71 39.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.512 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -75.73 126.85 86.72 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.958 0.903 . . . . 0.0 109.973 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.79 130.13 22.55 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.097 1.865 . . . . 0.0 111.454 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 11.7 mptt -75.44 -23.5 56.93 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.593 0.757 . . . . 0.0 110.429 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 135' ' ' GLN . 20.3 ptt-85 -149.9 158.73 44.45 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.859 0.864 . . . . 0.0 108.812 171.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.77 142.23 58.26 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.534 0.733 . . . . 0.0 110.935 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.7 96.82 45.29 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 123.268 0.627 . . . . 0.0 109.728 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.49 173.18 9.2 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.049 2.5 . . . . 0.0 112.523 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.37 -19.99 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.634 0.773 . . . . 0.0 112.705 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.46 -18.84 79.53 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.447 0.467 . . . . 0.0 113.328 173.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.06 150.47 9.47 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.48 0.562 . . . . 0.0 112.696 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.413 ' HB3' ' NH2' ' A' ' 128' ' ' ARG . 31.2 mm-40 -109.39 132.65 53.93 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.723 0.809 . . . . 0.0 110.753 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -74.55 101.89 4.34 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.704 0.402 . . . . 0.0 110.326 172.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.76 118.25 13.31 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.402 ' H ' ' HD2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -122.6 127.33 49.27 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.622 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.563 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m -71.68 -8.53 54.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.738 0.815 . . . . 0.0 112.897 -174.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -64.21 -26.09 68.36 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.515 0.326 . . . . 0.0 111.638 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 5' ' ' VAL . 25.1 mm 63.04 -172.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 C-N-CA 124.296 1.039 . . . . 0.0 109.226 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.475 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.6 m -148.54 -45.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 156.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.14 -161.49 18.06 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.938 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.421 HG12 HD11 ' A' ' 60' ' ' ILE . 8.7 p -122.93 144.99 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 171.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -117.72 132.13 56.51 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.17 0.588 . . . . 0.0 109.681 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.443 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . 13.0 m-85 -131.92 142.24 44.45 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 124.09 0.956 . . . . 0.0 109.462 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.526 ' HD3' HG12 ' A' ' 130' ' ' VAL . 61.2 Cg_endo -70.52 -18.86 33.14 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.662 2.241 . . . . 0.0 112.621 175.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 mm 47.82 69.86 2.44 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.605 1.162 . . . . 0.0 109.231 -168.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD3' ' HG2' ' A' ' 10' ' ' PRO . 47.3 Cg_endo -83.54 52.97 4.01 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.334 2.689 . . . . 0.0 110.833 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -148.19 166.45 27.88 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.853 -171.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -59.45 -26.11 64.94 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.238 1.015 . . . . 0.0 111.792 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -84.53 14.62 4.38 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.458 1.103 . . . . 0.0 113.041 -168.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -57.79 -35.37 70.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.321 1.049 . . . . 0.0 111.664 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.97 -23.93 61.51 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -53.78 -51.7 62.59 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.026 0.93 . . . . 0.0 113.18 -172.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -61.58 -30.04 70.42 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.866 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -96.96 -14.17 21.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.035 0.934 . . . . 0.0 110.936 -175.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -78.41 -58.78 3.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.252 1.021 . . . . 0.0 109.453 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 24' ' ' LYS . 13.7 ptpt -93.49 -18.0 22.79 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.496 -171.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.04 -12.77 16.75 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 114.103 0.401 . . . . 0.0 114.103 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' H ' ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -147.6 90.95 1.9 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.826 0.85 . . . . 0.0 110.413 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.56 176.41 5.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.639 -174.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.9 t -132.65 110.02 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.954 0.902 . . . . 0.0 108.578 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.86 111.47 22.51 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.711 0.804 . . . . 0.0 110.066 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.7 m -96.05 141.78 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.216 0.606 . . . . 0.0 111.579 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -134.69 144.73 51.96 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.698 1.199 . . . . 0.0 110.533 171.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.75 51.51 3.62 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 123.441 2.761 . . . . 0.0 111.833 169.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 54.26 78.22 0.17 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.74 1.216 . . . . 0.0 111.681 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.2 m -101.77 -47.92 4.46 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.375 0.67 . . . . 0.0 109.869 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 m -81.42 150.17 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.474 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 76.8 m95 -79.7 -163.16 0.49 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.294 1.038 . . . . 0.0 112.385 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -69.6 -14.79 63.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.342 1.057 . . . . 0.0 112.738 -171.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.46 -24.67 67.23 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.403 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -66.01 111.54 3.4 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.09 152.7 70.47 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.743 0.817 . . . . 0.0 109.573 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.2 99.25 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.789 2.326 . . . . 0.0 111.424 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.3 -15.76 0.58 Allowed Glycine 0 N--CA 1.467 0.747 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.577 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.545 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 73.5 mtp -74.62 176.86 6.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.004 0.922 . . . . 0.0 111.804 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -102.67 164.34 11.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.549 0.74 . . . . 0.0 110.285 169.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.443 ' HE1' ' HB2' ' A' ' 9' ' ' TYR . 0.4 OUTLIER -136.7 100.16 4.25 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 175.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.3 t -88.79 120.97 38.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -89.59 107.62 19.19 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.918 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -78.28 169.79 17.69 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.398 1.079 . . . . 0.0 109.831 173.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 70.98 95.53 0.07 Allowed 'General case' 0 C--N 1.356 0.863 0 C-N-CA 125.443 1.497 . . . . 0.0 108.881 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.0 p -52.51 -34.44 49.66 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.823 1.249 . . . . 0.0 111.867 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 169.94 -37.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.904 2.082 . . . . 0.0 107.15 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -136.14 -53.12 0.74 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.011 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -94.14 165.65 12.51 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.161 0.584 . . . . 0.0 111.63 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -64.25 118.99 9.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.721 1.208 . . . . 0.0 111.312 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.95 161.31 10.69 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -83.1 129.64 35.04 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.226 1.013 . . . . 0.0 109.782 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.09 -35.41 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.104 0.561 . . . . 0.0 109.972 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.97 -161.71 25.65 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.875 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -153.56 177.96 10.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.772 0.829 . . . . 0.0 109.08 170.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.496 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -158.81 -173.48 4.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.651 0.78 . . . . 0.0 109.727 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -125.14 120.81 32.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.421 0.688 . . . . 0.0 110.37 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.432 HG13 ' HB2' ' A' ' 43' ' ' PHE . 56.5 mt -69.07 135.65 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.843 1.257 . . . . 0.0 111.587 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -135.31 -176.47 4.28 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 126.293 1.837 . . . . 0.0 108.527 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -44.9 123.15 3.62 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.803 1.241 . . . . 0.0 113.74 -164.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 112' ' ' ILE . 33.9 m -92.67 118.64 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.244 -176.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 73.1 t -89.28 109.56 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.97 117.66 30.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.394 0.678 . . . . 0.0 109.343 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -152.11 134.74 15.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.784 0.834 . . . . 0.0 109.597 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 66.9 mt-10 -69.57 -16.29 63.38 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.312 0.645 . . . . 0.0 111.626 176.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 53.9 m-20 -95.34 119.27 65.74 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 36.5 Cg_endo -66.94 -20.99 50.66 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.145 1.897 . . . . 0.0 112.483 173.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.476 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.2 mpp? -73.83 -22.61 59.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.824 0.45 . . . . 0.0 110.875 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.409 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 78.6 mm-40 -57.16 -33.84 67.83 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.953 0.783 . . . . 0.0 111.62 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -78.26 -27.54 47.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 122.857 0.463 . . . . 0.0 111.164 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.443 ' HE2' HD22 ' A' ' 87' ' ' LEU . 71.4 m-85 -86.24 -23.14 26.52 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.987 0.515 . . . . 0.0 111.33 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.16 -27.27 19.7 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.438 0.295 . . . . 0.0 110.935 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.7 m -82.55 -58.03 3.09 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.212 0.53 . . . . 0.0 110.055 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.773 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 69.3 m-85 -96.49 -68.96 0.77 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.521 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.28 -80.72 0.73 Allowed Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.631 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.11 -23.5 64.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.096 0.958 . . . . 0.0 111.351 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.773 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 21.2 mmt85 -81.51 -32.46 32.37 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 122.958 0.503 . . . . 0.0 111.217 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 HD23 ' A' ' 82' ' ' LEU . 20.4 t -68.56 146.33 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -63.64 -27.22 69.08 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.466 ' H ' HD23 ' A' ' 82' ' ' LEU . 2.5 pt? -122.79 176.58 5.89 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.658 0.383 . . . . 0.0 110.267 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.54 HG22 ' HG2' ' A' ' 86' ' ' GLU . 12.6 t -108.33 172.48 6.82 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -68.13 -25.94 65.54 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.02 0.528 . . . . 0.0 111.222 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -68.77 -41.25 79.06 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.335 0.654 . . . . 0.0 109.893 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.54 ' HG2' HG22 ' A' ' 83' ' ' THR . 22.6 mm-40 -66.78 -35.22 79.58 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.162 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.443 HD22 ' HE2' ' A' ' 73' ' ' PHE . 32.1 tp -60.79 -54.26 47.33 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.882 0.873 . . . . 0.0 111.527 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -60.61 -43.36 97.54 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 123.494 0.496 . . . . 0.0 111.193 -172.067 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.37 -29.51 53.35 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.214 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -62.19 -43.78 98.06 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.453 0.701 . . . . 0.0 110.806 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.3 mtm -68.15 -36.93 80.44 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.356 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.7 mmpt? -69.08 -28.54 66.6 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.119 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.482 ' HA ' ' HG2' ' A' ' 96' ' ' ARG . 73.7 m -72.13 -36.86 69.51 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.305 0.642 . . . . 0.0 110.589 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -64.88 -38.45 91.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.923 0.489 . . . . 0.0 111.614 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -86.16 -17.19 35.59 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.482 ' HG2' ' HA ' ' A' ' 93' ' ' SER . 5.3 ptp180 -96.03 -22.74 17.18 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.395 0.543 . . . . 0.0 111.741 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -110.85 -33.96 6.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.608 0.363 . . . . 0.0 111.963 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -124.9 -97.98 1.18 Allowed Glycine 0 N--CA 1.471 1.0 0 C-N-CA 121.763 -0.256 . . . . 0.0 113.349 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -78.44 76.84 4.94 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.555 1.142 . . . . 0.0 111.404 -170.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -72.56 134.98 45.48 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.429 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.475 ' HG2' ' H ' ' A' ' 102' ' ' GLU . 53.1 ttt180 68.37 -179.65 0.23 Allowed 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 124.202 1.001 . . . . 0.0 111.106 169.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.475 ' H ' ' HG2' ' A' ' 101' ' ' ARG . 3.7 mp0 57.63 29.73 17.71 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.371 1.069 . . . . 0.0 111.722 -174.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.9 m -106.63 77.65 1.21 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.807 0.843 . . . . 0.0 109.567 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -122.22 -65.36 1.12 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.058 0.543 . . . . 0.0 110.031 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -73.24 147.4 44.66 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.065 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -69.7 179.0 2.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.462 0.705 . . . . 0.0 111.762 -176.196 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.624 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -138.3 147.95 44.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.074 172.001 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.43 104.9 4.58 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -85.05 156.07 21.25 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.8 ptm -140.94 131.44 25.35 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.534 0.733 . . . . 0.0 109.494 -174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -111.25 102.32 10.74 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.447 0.699 . . . . 0.0 109.919 -176.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.463 ' HA ' HG12 ' A' ' 63' ' ' VAL . 27.8 mt -82.07 122.82 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.18 131.1 35.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -118.11 113.54 21.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.103 0.961 . . . . 0.0 109.446 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -114.83 176.09 5.21 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.2 t70 53.95 46.39 25.71 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.135 0.897 . . . . 0.0 111.016 170.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.7 t -74.38 106.59 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.959 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.457 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 1.7 tpmt? -83.66 155.52 23.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.671 1.188 . . . . 0.0 110.735 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -116.68 123.65 47.77 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.904 0.881 . . . . 0.0 109.103 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -74.11 98.42 3.12 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.54 -35.04 78.18 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.916 0.886 . . . . 0.0 109.812 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.4 ' HG3' HG13 ' A' ' 124' ' ' ILE . 15.9 ptpt -91.03 138.07 26.2 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.289 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -83.63 77.0 3.55 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.271 2.648 . . . . 0.0 112.466 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.4 HG13 ' HG3' ' A' ' 122' ' ' LYS . 72.6 mt -84.7 131.65 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -100.28 157.58 33.56 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.02 177.41 7.8 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.209 1.939 . . . . 0.0 111.761 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -94.98 2.6 55.38 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.457 0.703 . . . . 0.0 110.278 178.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -163.43 179.95 6.95 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.941 1.296 . . . . 0.0 109.274 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.79 130.39 35.04 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.526 HG12 ' HD3' ' A' ' 10' ' ' PRO . 39.8 t -104.79 96.39 10.53 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.5 -176.67 2.35 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.02 2.48 . . . . 0.0 112.887 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.46 -35.08 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.25 1.02 . . . . 0.0 111.292 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.77 -24.24 72.71 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.59 -0.732 . . . . 0.0 113.097 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.61 165.07 37.72 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 123.344 0.497 . . . . 0.0 113.002 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -118.37 143.75 46.41 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.694 0.797 . . . . 0.0 109.613 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.474 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 0.7 OUTLIER -79.67 112.89 17.38 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 167.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.7 121.43 26.38 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 145.09 51.88 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.998 0.519 . . . . 0.0 109.988 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.244 0.807 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.512 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -64.74 -7.43 10.89 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.375 1.07 . . . . 0.0 113.272 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 139' ' ' GLU . 22.2 ptmt -58.89 -23.03 60.59 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.03 0.932 . . . . 0.0 113.331 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 5' ' ' VAL . 30.7 mm 67.85 -179.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 C-N-CA 124.157 0.983 . . . . 0.0 109.61 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 139' ' ' GLU . 1.2 m -149.18 -34.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.758 1.223 . . . . 0.0 109.186 161.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.466 ' HA2' ' HE3' ' A' ' 41' ' ' MET . . . -171.35 -164.0 26.29 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-O 121.433 0.463 . . . . 0.0 112.787 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.91 161.17 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 t -134.5 133.2 40.09 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 122.979 0.512 . . . . 0.0 109.704 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.43 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . 7.2 m-85 -134.76 140.52 35.55 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.06 0.944 . . . . 0.0 110.132 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HD3' HG12 ' A' ' 130' ' ' VAL . 93.7 Cg_endo -76.5 -14.9 17.82 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.911 2.408 . . . . 0.0 112.431 172.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 mm 64.59 115.3 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 125.609 1.564 . . . . 0.0 109.559 -172.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -66.77 -14.9 45.63 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.095 2.53 . . . . 0.0 114.085 -168.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -132.61 -175.24 3.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.812 0.845 . . . . 0.0 110.267 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -69.33 2.99 2.5 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 124.184 0.993 . . . . 0.0 112.541 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.51 7.39 2.39 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -66.94 -34.04 76.9 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 119.024 0.829 . . . . 0.0 109.383 170.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.53 -30.04 70.38 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.595 1.158 . . . . 0.0 111.811 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 37.3 mmt180 -51.71 -47.35 64.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.423 1.089 . . . . 0.0 111.682 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.412 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 65.0 m-85 -66.43 -30.62 71.02 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.692 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.68 -20.17 25.22 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.573 0.749 . . . . 0.0 110.63 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -76.02 -56.92 4.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.392 1.077 . . . . 0.0 110.201 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.9 ptpt -96.06 -18.19 20.37 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.741 -171.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.79 -28.64 2.13 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -125.11 96.02 4.7 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 124.436 1.094 . . . . 0.0 108.259 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 13.9 t70 -110.36 176.31 5.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.195 0.598 . . . . 0.0 110.076 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.5 t -136.24 111.71 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.998 0.919 . . . . 0.0 109.114 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.483 ' HD2' HD12 ' A' ' 112' ' ' ILE . 88.3 t80 -84.7 109.07 17.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.479 0.711 . . . . 0.0 110.311 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.88 138.08 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.607 0.718 . . . . 0.0 110.531 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HE2' ' HD2' ' A' ' 30' ' ' PRO . 1.6 tpmt? -136.38 134.64 20.0 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.798 1.239 . . . . 0.0 108.461 -176.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 56.9 Cg_endo -72.86 57.0 3.07 Favored 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 122.745 2.297 . . . . 0.0 113.127 170.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.58 28.44 3.45 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 125.491 1.516 . . . . 0.0 114.005 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.45 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 5.3 m -69.66 -30.26 67.9 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.37 0.668 . . . . 0.0 110.518 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.631 HG11 HD23 ' A' ' 37' ' ' LEU . 21.9 t -85.82 149.02 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -78.14 -173.53 3.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.13 0.972 . . . . 0.0 111.811 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 7.6 tmtt? -71.59 -14.53 62.1 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 123.861 0.865 . . . . 0.0 110.188 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -51.43 -32.32 26.23 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.609 0.764 . . . . 0.0 111.245 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.631 HD23 HG11 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -69.48 102.26 1.76 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 123.568 0.747 . . . . 0.0 110.547 178.001 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -125.47 151.93 70.88 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.244 0.618 . . . . 0.0 109.987 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.5 99.21 0.7 Allowed 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.857 2.371 . . . . 0.0 111.611 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.77 2.69 0.88 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.497 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.489 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 29.1 mtm -92.77 -172.72 3.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.06 0.544 . . . . 0.0 111.157 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -109.99 160.01 16.79 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.906 0.882 . . . . 0.0 110.531 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.465 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.04 99.83 4.39 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.2 t -87.7 125.36 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.398 0.618 . . . . 0.0 109.931 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -91.01 114.24 26.72 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.753 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.417 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 37.6 t80 -74.24 145.74 43.83 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 171.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -84.89 70.4 10.87 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.867 0.467 . . . . 0.0 110.363 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 81.0 p 42.09 -81.7 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.361 1.864 . . . . 0.0 113.959 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -154.17 88.73 1.25 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.519 1.128 . . . . 0.0 109.819 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -164.02 170.85 16.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.224 0.61 . . . . 0.0 110.421 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.92 -48.26 82.63 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.413 1.085 . . . . 0.0 111.687 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 p -70.02 102.32 2.0 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.054 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.767 ' HA3' ' HD3' ' A' ' 126' ' ' PRO . . . -62.35 -47.96 85.78 Favored Glycine 0 C--O 1.216 -1.022 0 CA-C-N 114.764 -1.107 . . . . 0.0 114.024 -170.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -97.89 129.47 44.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 117.171 0.486 . . . . 0.0 110.848 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.14 -32.26 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 168.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . -172.86 -167.22 32.5 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.143 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 16.0 pt-20 -158.47 178.28 10.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.612 0.765 . . . . 0.0 109.246 172.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.483 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -161.19 -173.8 4.03 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.069 0.548 . . . . 0.0 110.646 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -120.85 120.03 34.36 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.305 1.042 . . . . 0.0 109.996 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 43' ' ' PHE . 53.8 mt -70.62 138.43 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.569 1.148 . . . . 0.0 111.271 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -140.79 -166.73 2.21 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.907 2.083 . . . . 0.0 107.797 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -35.07 122.11 0.56 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.174 1.39 . . . . 0.0 114.524 -164.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.9 m -105.05 105.78 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 121.854 0.835 . . . . 0.0 109.52 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -91.75 114.56 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.593 0.757 . . . . 0.0 110.056 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.547 ' HB3' HD11 ' A' ' 108' ' ' LEU . 36.9 mt -96.41 117.95 31.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.651 0.78 . . . . 0.0 109.544 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.1 t -151.07 139.56 20.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.495 0.718 . . . . 0.0 110.354 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 24.1 mt-10 -66.76 -24.06 66.16 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.388 1.075 . . . . 0.0 111.803 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.557 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 81.5 m-20 -97.59 120.62 60.22 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HG2' HD21 ' A' ' 87' ' ' LEU . 38.3 Cg_endo -66.03 -19.2 57.72 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.361 2.041 . . . . 0.0 112.055 171.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 56.9 mtm -71.81 -24.59 61.75 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.08 0.952 . . . . 0.0 111.012 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.557 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 16.3 mm100 -60.96 -26.33 67.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.596 0.758 . . . . 0.0 111.507 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -81.82 -25.29 35.3 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.117 0.567 . . . . 0.0 110.844 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 87' ' ' LEU . 97.2 m-85 -89.66 -14.49 34.74 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.39 0.676 . . . . 0.0 111.641 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.47 -30.4 17.34 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.294 0.238 . . . . 0.0 110.619 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.8 m -78.07 -59.84 2.62 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.89 0.376 . . . . 0.0 110.771 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.784 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 58.8 m-85 -99.65 -59.1 1.78 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.529 0.732 . . . . 0.0 110.021 -173.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.98 -88.17 0.14 Allowed Glycine 0 C--N 1.356 1.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.494 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -69.49 -21.04 63.72 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.617 0.767 . . . . 0.0 111.699 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.784 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 37.4 mmt180 -72.87 -36.79 67.45 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.349 0.405 . . . . 0.0 110.433 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.47 HG12 HD23 ' A' ' 82' ' ' LEU . 21.4 t -64.07 151.4 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 122.593 0.357 . . . . 0.0 110.345 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.465 ' HD2' ' HA ' ' A' ' 27' ' ' PHE . 41.3 p90 -66.36 -7.88 21.88 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -147.69 172.04 14.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.343 0.657 . . . . 0.0 109.632 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 86' ' ' GLU . 7.4 t -96.38 170.66 9.08 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -66.43 -26.63 67.31 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.36 0.264 . . . . 0.0 110.671 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 4.0 m-20 -60.24 -53.86 52.63 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' H ' HG23 ' A' ' 83' ' ' THR . 49.5 mm-40 -58.81 -33.0 69.86 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.561 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.501 HD21 ' HG2' ' A' ' 69' ' ' PRO . 28.5 tp -62.92 -58.22 8.1 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.726 0.641 . . . . 0.0 111.037 174.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -62.64 -38.77 91.55 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.593 0.558 . . . . 0.0 111.917 -171.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 12.1 pt-20 -82.96 -21.92 33.9 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.301 0.64 . . . . 0.0 111.459 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 56.5 t80 -66.54 -47.05 74.08 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 168.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 69.1 mtm -67.69 -31.53 71.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.427 0.691 . . . . 0.0 110.595 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.4 mmpt? -60.71 -52.23 66.02 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.9 t -58.35 -33.01 69.09 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.618 0.767 . . . . 0.0 111.638 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 29.6 mm-40 -71.38 -44.53 64.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.042 0.537 . . . . 0.0 111.145 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.73 -23.68 31.51 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -96.51 -41.32 8.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.216 0.207 . . . . 0.0 111.008 -172.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -91.08 -48.74 6.79 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.66 0.384 . . . . 0.0 110.045 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -73.94 -78.95 0.55 Allowed Glycine 0 C--N 1.345 1.079 0 O-C-N 123.96 0.787 . . . . 0.0 111.762 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 55.91 89.63 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.011 1.324 . . . . 0.0 110.498 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -71.92 -28.9 63.78 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.278 0.631 . . . . 0.0 110.837 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.515 ' HG3' ' H ' ' A' ' 102' ' ' GLU . 14.3 ptt180 -165.99 -65.01 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.204 1.002 . . . . 0.0 110.033 172.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.515 ' H ' ' HG3' ' A' ' 101' ' ' ARG . 1.2 tm-20 179.0 147.86 0.2 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.9 p -144.38 98.77 3.26 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.866 0.467 . . . . 0.0 111.679 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -103.49 -42.43 5.69 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.441 0.696 . . . . 0.0 109.481 165.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -70.65 155.75 40.35 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.617 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -80.45 179.99 7.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.446 0.698 . . . . 0.0 109.996 175.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.612 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -134.13 152.65 51.93 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 169.109 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.7 tm? -76.19 121.35 22.76 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -106.81 159.72 16.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.232 1.013 . . . . 0.0 109.805 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.446 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 15.8 ptm -136.56 130.72 32.81 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.045 0.938 . . . . 0.0 110.045 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.07 102.06 11.07 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.685 0.794 . . . . 0.0 109.434 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.483 HD12 ' HD2' ' A' ' 27' ' ' PHE . 42.2 mt -85.0 121.08 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.75 133.38 35.34 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -117.76 133.3 56.08 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.207 1.003 . . . . 0.0 109.502 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.78 165.36 25.79 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.66 0.784 . . . . 0.0 110.062 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.2 t70 57.23 36.83 27.88 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.365 1.041 . . . . 0.0 110.846 168.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.2 t -63.24 109.56 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.718 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 165.31 23.42 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.031 1.333 . . . . 0.0 110.663 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -130.61 124.9 32.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.552 0.741 . . . . 0.0 110.238 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.415 ' H ' ' HA2' ' A' ' 56' ' ' GLY . 35.0 m-85 -88.29 82.48 7.05 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 168.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.56 -32.36 73.08 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.514 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -80.36 148.62 67.15 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.232 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.13 103.64 1.78 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.84 2.36 . . . . 0.0 112.672 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.7 mt -125.01 130.98 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.515 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -97.9 144.26 27.7 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.904 0.882 . . . . 0.0 108.912 178.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.767 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 86.8 Cg_endo -80.79 176.75 8.71 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.815 2.344 . . . . 0.0 112.932 -177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -64.15 -32.22 73.71 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.817 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -157.5 163.51 38.36 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 123.62 0.768 . . . . 0.0 109.88 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.27 135.11 54.98 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.997 0.919 . . . . 0.0 108.976 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.557 HG12 ' HD3' ' A' ' 10' ' ' PRO . 47.9 t -108.17 94.6 13.43 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 123.464 0.705 . . . . 0.0 109.616 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.97 -175.35 1.65 Allowed 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.069 2.513 . . . . 0.0 112.868 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.3 m -56.85 -31.19 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.46 1.104 . . . . 0.0 113.711 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.17 -14.86 81.8 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.386 0.429 . . . . 0.0 113.496 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.45 150.83 6.94 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 123.193 0.425 . . . . 0.0 112.923 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.488 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -108.81 165.36 11.62 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.575 0.75 . . . . 0.0 110.178 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.0 130.04 46.12 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.99 0.516 . . . . 0.0 109.691 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.75 124.09 38.59 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.57 148.14 46.63 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 5' ' ' VAL . 3.4 tm-20 . . . . . 0 C--O 1.252 1.207 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 173.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 2' ' ' SER . 8.2 tmm? . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.488 ' N ' ' SD ' ' A' ' 1' ' ' MET . 18.4 m -53.09 -22.17 5.75 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.917 1.687 . . . . 0.0 114.832 -171.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -62.48 -18.89 62.87 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 5' ' ' VAL . 29.1 mm 63.39 -172.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -174.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.6 m -151.09 -45.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 156.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.39 -160.87 18.61 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.168 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.98 139.79 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -107.82 132.31 53.55 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.518 0.727 . . . . 0.0 109.481 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -127.64 141.99 42.74 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.602 0.761 . . . . 0.0 110.485 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' HG12 ' A' ' 130' ' ' VAL . 95.9 Cg_endo -73.33 -19.81 21.83 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.167 2.578 . . . . 0.0 113.129 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mm 53.77 92.76 0.06 OUTLIER Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 125.258 1.423 . . . . 0.0 110.413 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.99 17.01 0.75 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.857 2.371 . . . . 0.0 113.291 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -124.72 153.33 42.53 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 110.24 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -11.84 61.15 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.596 1.158 . . . . 0.0 111.395 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -81.32 22.31 0.69 Allowed 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.486 1.114 . . . . 0.0 112.482 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.461 ' HG2' ' HE2' ' A' ' 20' ' ' PHE . 46.2 ttm -64.77 -41.14 96.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.971 0.908 . . . . 0.0 110.003 168.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.7 -19.23 65.64 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.979 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -47.64 -51.66 20.73 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.801 1.24 . . . . 0.0 112.682 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 49.7 m-85 -69.4 -30.76 68.8 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.451 -174.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.461 ' HE2' ' HG2' ' A' ' 16' ' ' MET . 54.7 m-85 -84.48 -24.68 29.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.714 0.806 . . . . 0.0 110.314 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -68.28 -49.09 62.9 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.92 1.288 . . . . 0.0 109.903 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -107.33 -16.55 14.36 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.545 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.46 -6.15 70.13 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 114.253 0.461 . . . . 0.0 114.253 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -157.81 111.69 2.55 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.881 0.873 . . . . 0.0 109.643 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.3 t70 -136.64 -171.54 2.94 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.42 124.73 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.261 1.391 . . . . 0.0 109.644 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -96.62 116.58 29.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.646 0.778 . . . . 0.0 109.322 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 m -89.35 146.86 5.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.494 0.664 . . . . 0.0 110.222 171.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.635 ' HG2' HG22 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -134.62 114.26 12.15 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.7 1.2 . . . . 0.0 109.047 -172.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.53 66.6 2.93 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.438 2.759 . . . . 0.0 113.478 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . 47.35 78.42 0.07 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.006 1.322 . . . . 0.0 113.454 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.438 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 37.8 m -125.49 -58.04 1.44 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.635 HG22 ' HG2' ' A' ' 29' ' ' LYS . 15.4 m -66.96 133.87 30.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.898 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -88.4 -157.58 0.43 Allowed 'General case' 0 CA--C 1.564 1.506 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.905 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -70.83 -1.77 12.73 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -166.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -67.48 -28.9 68.25 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.701 0.8 . . . . 0.0 110.419 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.571 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 1.1 mm? -66.55 119.59 11.96 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.538 0.735 . . . . 0.0 110.645 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 157.48 56.35 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.415 1.086 . . . . 0.0 109.255 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.92 88.84 0.9 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.381 2.054 . . . . 0.0 111.597 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.08 41.72 0.04 OUTLIER Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.042 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.571 ' SD ' ' HA ' ' A' ' 37' ' ' LEU . 87.1 mtp -118.94 -168.8 1.62 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.068 0.947 . . . . 0.0 109.391 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 15.2 ptpt -121.13 162.23 20.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.68 0.792 . . . . 0.0 110.276 168.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.456 ' HB2' HG13 ' A' ' 60' ' ' ILE . 17.5 t80 -134.77 97.1 3.68 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 94.1 t -83.12 119.65 32.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.39 0.614 . . . . 0.0 110.046 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -80.33 99.67 8.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.599 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.612 ' HA ' ' H ' ' A' ' 54' ' ' PHE . 67.0 t80 -75.83 163.15 27.53 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.697 169.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -136.11 102.96 5.17 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.4 p -92.03 54.35 2.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.763 0.825 . . . . 0.0 111.23 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -161.69 107.35 1.31 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 69.79 -68.8 0.18 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.269 1.428 . . . . 0.0 111.985 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.95 144.31 57.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.877 0.871 . . . . 0.0 109.766 172.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 p -56.91 -45.09 82.9 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.346 0.658 . . . . 0.0 111.989 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.46 -173.47 24.4 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.539 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.612 ' H ' ' HA ' ' A' ' 46' ' ' TYR . 3.2 m-30 56.62 66.88 1.08 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.174 0.99 . . . . 0.0 110.828 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.451 HG22 ' NZ ' ' A' ' 119' ' ' LYS . 10.0 p -87.62 -15.53 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.297 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.85 -171.15 41.76 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.297 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 7.9 pt-20 -147.56 178.86 8.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.833 0.853 . . . . 0.0 110.156 174.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.409 ' CB ' HD12 ' A' ' 114' ' ' LEU . . . -158.4 -171.11 3.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.718 1.207 . . . . 0.0 109.204 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 12.7 mmt85 -129.58 118.92 22.77 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.545 0.738 . . . . 0.0 110.709 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 41' ' ' MET . 54.4 mt -72.13 133.15 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.568 1.147 . . . . 0.0 111.421 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.0 mmmt -133.18 -177.11 4.37 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 126.166 1.786 . . . . 0.0 108.533 -176.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -28.42 113.87 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 126.275 1.83 . . . . 0.0 114.904 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 112' ' ' ILE . 35.2 m -95.44 117.45 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.659 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.6 t -90.18 108.65 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.534 ' HB3' HD11 ' A' ' 108' ' ' LEU . 69.3 mt -87.14 116.7 25.39 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.4 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 46.3 m -148.71 137.05 21.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.616 0.766 . . . . 0.0 109.986 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 18.8 mt-10 -66.5 -34.82 78.79 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.11 0.964 . . . . 0.0 112.068 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.646 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 73.9 m-20 -89.1 123.8 66.44 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.89 -21.23 64.39 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 122.354 2.036 . . . . 0.0 111.732 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 37.7 mtm -74.35 -19.02 60.6 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.09 0.956 . . . . 0.0 110.91 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.646 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 17.0 mm100 -60.42 -32.41 71.33 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.278 0.631 . . . . 0.0 110.695 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 66' ' ' SER . 5.4 m-85 -77.38 -27.29 52.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.681 -177.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.464 ' CE2' HD22 ' A' ' 87' ' ' LEU . 73.6 m-85 -91.11 -20.52 21.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.075 0.55 . . . . 0.0 111.94 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.17 -34.27 22.12 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.8 m -81.25 -59.68 2.55 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.999 0.52 . . . . 0.0 110.925 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.796 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 98.1 m-85 -93.19 -64.31 1.11 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.648 0.779 . . . . 0.0 110.207 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.25 -90.66 0.28 Allowed Glycine 0 C--N 1.352 1.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.375 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.29 -9.58 58.85 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.949 0.9 . . . . 0.0 111.808 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.796 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 28.0 mmt85 -78.21 -36.5 47.15 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.87 0.468 . . . . 0.0 110.262 170.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 82' ' ' LEU . 35.1 t -75.49 140.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.287 0.635 . . . . 0.0 110.741 -176.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -57.1 -20.63 26.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 1.8 pt? -134.0 170.15 16.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.9 t -108.11 -176.7 3.13 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 122.051 -0.405 . . . . 0.0 109.981 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.73 -25.37 67.27 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.244 0.618 . . . . 0.0 111.915 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.515 ' H ' HG23 ' A' ' 83' ' ' THR . 23.9 t70 -73.6 -36.42 65.52 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.32 0.648 . . . . 0.0 111.278 174.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 1.5 mp0 -74.51 -24.7 59.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.794 -0.566 . . . . 0.0 110.746 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD22 ' CE2' ' A' ' 73' ' ' PHE . 28.2 tp -67.57 -50.15 59.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.037 0.535 . . . . 0.0 109.691 175.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -40.45 96.11 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.465 0.478 . . . . 0.0 110.979 -175.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.476 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 8.6 pt-20 -64.86 -39.76 94.06 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -64.2 -49.46 71.91 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.987 0.915 . . . . 0.0 111.567 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 56.3 mtm -67.98 -44.89 75.61 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.402 0.681 . . . . 0.0 110.233 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -71.92 -26.25 62.22 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.883 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.471 ' HA ' ' HG2' ' A' ' 96' ' ' ARG . 43.4 m -62.73 -33.79 75.86 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.182 0.446 . . . . 0.0 110.802 174.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -68.23 -25.18 65.07 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.653 0.596 . . . . 0.0 111.413 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -113.27 -18.25 12.12 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -173.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' A' ' 93' ' ' SER . 13.1 ptm180 -91.85 -27.94 17.63 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 118.233 0.47 . . . . 0.0 110.283 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -102.24 2.23 36.84 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.372 0.669 . . . . 0.0 109.385 169.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -133.97 -134.49 3.45 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.58 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.4 mmt85 -107.99 115.85 30.88 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.013 0.525 . . . . 0.0 110.084 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.584 ' HA ' ' HB2' ' A' ' 95' ' ' GLU . 41.4 ttm180 -78.99 72.84 5.53 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.31 0.644 . . . . 0.0 110.608 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -177.53 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.624 1.57 . . . . 0.0 108.795 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -61.7 92.91 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.949 0.9 . . . . 0.0 109.362 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 t 63.58 -173.26 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.204 1.002 . . . . 0.0 110.783 -172.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -130.53 -49.7 1.07 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -78.68 162.82 25.93 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.657 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -58.51 161.82 4.25 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.765 0.826 . . . . 0.0 112.303 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.26 147.21 49.73 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -176.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 65' ' ' LEU . 0.4 OUTLIER -82.92 100.44 10.39 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.288 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -87.49 159.92 18.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.918 0.887 . . . . 0.0 109.646 171.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.584 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 20.8 ptm -140.18 137.51 34.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.741 0.416 . . . . 0.0 111.436 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.46 102.7 11.29 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.852 0.861 . . . . 0.0 109.949 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.456 ' HA ' HG12 ' A' ' 63' ' ' VAL . 42.6 mt -83.29 121.1 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.753 0.821 . . . . 0.0 109.021 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 39.8 tt0 -80.16 138.04 36.82 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.409 HD12 ' CB ' ' A' ' 58' ' ' ALA . 4.0 mm? -119.13 129.71 55.17 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.88 0.872 . . . . 0.0 109.837 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -128.99 173.14 10.69 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 51.43 54.58 10.83 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.1 0.952 . . . . 0.0 111.762 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.96 115.98 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.692 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER -102.27 152.58 20.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.202 1.001 . . . . 0.0 110.627 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.451 ' NZ ' HG22 ' A' ' 55' ' ' VAL . 26.0 mmmt -104.58 139.73 39.03 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.414 1.086 . . . . 0.0 109.309 170.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -91.1 72.41 6.33 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.46 -24.93 62.96 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.07 173.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.409 ' HG3' HG13 ' A' ' 124' ' ' ILE . 0.2 OUTLIER -79.78 146.05 63.61 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.744 170.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.59 90.25 0.5 Allowed 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.395 2.063 . . . . 0.0 112.811 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 122' ' ' LYS . 24.7 mt -107.7 119.75 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.35 142.53 24.69 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.549 0.74 . . . . 0.0 109.556 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.74 133.98 41.74 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.33 2.02 . . . . 0.0 111.4 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -71.87 -24.6 61.71 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.829 0.851 . . . . 0.0 110.466 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.433 HH21 ' HB3' ' A' ' 135' ' ' GLN . 13.0 ptt180 -156.02 174.73 14.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.477 1.111 . . . . 0.0 109.459 174.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.87 143.49 55.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.225 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.49 HG12 ' HD3' ' A' ' 10' ' ' PRO . 60.3 t -122.83 102.14 38.57 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.89 -175.94 2.59 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.944 2.429 . . . . 0.0 111.854 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.6 p -57.68 -30.75 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 124.293 1.037 . . . . 0.0 112.751 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.34 -15.55 81.12 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.831 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.79 159.85 19.03 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.137 0.398 . . . . 0.0 113.02 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.433 ' HB3' HH21 ' A' ' 128' ' ' ARG . 31.6 mm-40 -116.98 146.92 42.71 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.783 0.833 . . . . 0.0 109.716 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -80.69 118.19 22.03 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.34 122.36 30.2 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.428 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -134.84 133.41 39.73 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.677 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.244 0.779 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.378 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.4 ttm . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -68.62 -15.32 63.49 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.119 0.968 . . . . 0.0 112.803 -172.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -63.09 -23.33 67.39 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.027 0.531 . . . . 0.0 111.866 173.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 5' ' ' VAL . 21.4 mm 61.62 -163.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -171.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.582 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.8 m -149.47 -42.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 155.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.15 -162.12 21.88 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.101 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.56 149.44 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -117.21 132.52 56.62 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.354 0.662 . . . . 0.0 109.716 176.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -131.83 142.21 44.39 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.142 0.977 . . . . 0.0 109.598 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HD3' HG12 ' A' ' 130' ' ' VAL . 40.6 Cg_endo -66.7 -46.82 3.24 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.402 2.068 . . . . 0.0 111.73 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.3 mt 50.83 71.91 1.4 Allowed Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.218 1.007 . . . . 0.0 108.909 -167.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.29 39.32 0.83 Allowed 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.086 2.524 . . . . 0.0 112.415 -173.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -127.66 162.7 25.92 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.242 1.417 . . . . 0.0 109.116 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -67.62 -16.16 64.02 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.712 0.805 . . . . 0.0 112.392 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -73.76 0.02 14.3 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.107 0.963 . . . . 0.0 112.913 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -67.14 -18.87 65.48 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 117.908 0.322 . . . . 0.0 111.727 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.71 -31.12 72.2 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.243 1.017 . . . . 0.0 111.841 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 12.9 mmt85 -58.15 -38.55 76.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.567 1.147 . . . . 0.0 112.942 -167.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -70.98 -31.17 67.64 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.01 0.524 . . . . 0.0 110.195 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -93.24 -8.64 41.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.902 0.881 . . . . 0.0 110.237 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -85.6 -59.36 2.34 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 124.388 1.075 . . . . 0.0 110.032 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.4 ptpt -99.47 -15.52 18.67 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.196 -170.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.23 -39.54 2.78 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 113.579 0.192 . . . . 0.0 113.579 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -119.54 91.34 3.53 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.911 0.885 . . . . 0.0 109.291 173.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -99.43 175.05 5.99 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.943 0.897 . . . . 0.0 110.059 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.18 110.02 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.104 0.962 . . . . 0.0 108.981 175.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -88.77 118.23 28.31 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.444 0.698 . . . . 0.0 109.684 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.94 132.96 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 121.587 0.708 . . . . 0.0 111.117 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 5.1 mmpt? -120.0 138.7 27.27 Favored Pre-proline 0 C--O 1.215 -0.759 0 C-N-CA 125.376 1.471 . . . . 0.0 109.227 176.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.427 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 73.7 Cg_endo -77.24 46.78 2.06 Favored 'Trans proline' 0 CA--C 1.56 1.803 0 C-N-CA 122.481 2.121 . . . . 0.0 111.708 162.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.43 38.1 17.3 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.319 1.448 . . . . 0.0 112.61 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 m -64.28 -38.02 89.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.564 0.746 . . . . 0.0 110.225 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.8 149.88 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.908 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.566 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 90.6 m95 -72.2 -178.55 2.5 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.771 0.828 . . . . 0.0 111.667 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -79.2 10.71 3.35 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.34 0.656 . . . . 0.0 112.27 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -75.12 -20.88 59.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.892 0.877 . . . . 0.0 110.625 174.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.27 100.79 0.84 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.642 0.777 . . . . 0.0 110.32 -176.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 3.2 ptpp? -119.18 152.45 52.25 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.198 0.599 . . . . 0.0 109.755 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.57 97.69 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.65 2.233 . . . . 0.0 110.936 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.6 -4.73 0.33 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.203 -174.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.431 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 31.5 mtm -89.88 -171.27 3.1 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.436 0.694 . . . . 0.0 111.689 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 12.9 ptpt -112.6 162.15 16.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.227 1.011 . . . . 0.0 110.573 172.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.499 ' HB2' HG13 ' A' ' 60' ' ' ILE . 3.2 t80 -136.22 102.53 5.02 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 42.1 t -88.86 121.46 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.169 0.509 . . . . 0.0 110.287 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -86.11 126.51 34.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.258 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 52.5 t80 -103.04 122.79 45.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.411 1.084 . . . . 0.0 109.452 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -79.28 -65.47 0.99 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.056 0.455 . . . . 0.0 110.344 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.3 t -169.27 -178.0 3.03 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.454 -170.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -83.12 3.7 29.57 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.07 0.548 . . . . 0.0 111.43 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 32.6 tt0 -147.65 178.12 8.72 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.939 0.896 . . . . 0.0 109.345 -177.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.469 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 21.3 t70 77.95 -78.08 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.806 1.642 . . . . 0.0 110.549 174.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.2 t -126.05 -5.53 6.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.392 0.277 . . . . 0.0 111.489 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.22 -82.75 0.25 Allowed Glycine 0 C--N 1.353 1.511 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -176.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 25.7 m-85 -93.86 129.93 40.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.275 1.03 . . . . 0.0 108.899 168.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.45 -36.11 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 122.829 0.452 . . . . 0.0 111.055 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.45 -160.52 21.18 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.575 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 14.9 pt-20 -154.88 177.16 11.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.606 1.162 . . . . 0.0 108.409 176.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.536 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -161.49 -173.54 3.83 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.698 0.799 . . . . 0.0 109.531 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -122.31 118.98 29.79 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.777 0.831 . . . . 0.0 109.927 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.499 HG13 ' HB2' ' A' ' 43' ' ' PHE . 51.7 mt -68.99 127.96 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.99 174.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -138.2 -164.59 1.65 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.461 1.504 . . . . 0.0 108.311 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -34.5 114.15 0.2 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 125.123 1.369 . . . . 0.0 113.956 -162.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.5 110.89 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-O 121.38 0.61 . . . . 0.0 109.799 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 97.4 t -91.02 108.43 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.8 mt -85.96 115.68 23.72 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 53.5 m -151.94 127.37 9.99 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 40.4 mt-10 -60.99 -47.6 85.72 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.577 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 43.3 m-20 -71.69 119.48 74.39 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.65 -21.39 70.11 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.486 2.124 . . . . 0.0 111.746 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 44.6 mtm -72.4 -20.17 61.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.002 0.921 . . . . 0.0 111.071 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.577 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 17.9 mm100 -60.97 -29.02 69.42 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.244 0.618 . . . . 0.0 111.005 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.488 ' HE2' ' HB3' ' A' ' 109' ' ' TRP . 6.3 m-85 -81.93 -27.99 33.04 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.634 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.498 ' CE2' HD22 ' A' ' 87' ' ' LEU . 87.0 m-85 -87.91 -18.19 29.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.163 0.585 . . . . 0.0 111.832 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.31 -33.32 20.65 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.5 m -82.4 -60.39 2.22 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.078 0.551 . . . . 0.0 111.491 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.755 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 59.5 m-85 -93.81 -55.26 3.31 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.178 0.591 . . . . 0.0 110.136 -177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 65.83 -89.37 0.12 Allowed Glycine 0 C--N 1.355 1.628 0 O-C-N 124.135 0.897 . . . . 0.0 113.55 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.2 -28.51 68.15 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.079 0.952 . . . . 0.0 110.829 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.755 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 16.0 mmt85 -72.2 -27.88 62.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.034 0.534 . . . . 0.0 111.892 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.435 HG12 HD23 ' A' ' 82' ' ' LEU . 25.2 t -68.72 151.76 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.41 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 41.0 p90 -63.24 -11.08 18.67 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -145.1 173.17 12.14 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.279 1.032 . . . . 0.0 109.138 174.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.612 HG22 ' HG2' ' A' ' 86' ' ' GLU . 15.1 t -104.26 173.85 6.13 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -63.6 -30.35 71.47 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.897 0.479 . . . . 0.0 111.548 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.83 -32.52 67.64 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.612 ' HG2' HG22 ' A' ' 83' ' ' THR . 26.3 mm-40 -70.01 -35.53 74.42 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 172.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.498 HD22 ' CE2' ' A' ' 73' ' ' PHE . 18.3 tp -62.66 -52.28 63.96 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.073 0.949 . . . . 0.0 111.544 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -42.17 98.41 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.928 -173.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.26 -29.77 65.48 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 122.959 0.162 . . . . 0.0 110.785 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.412 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 63.3 t80 -66.19 -46.86 75.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.557 0.743 . . . . 0.0 110.922 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.7 mtm -69.08 -33.8 74.13 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.969 0.507 . . . . 0.0 110.809 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -76.49 -27.5 56.09 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.948 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.424 ' HA ' ' HG2' ' A' ' 96' ' ' ARG . 26.7 t -63.88 -33.29 75.37 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.235 0.541 . . . . 0.0 109.915 176.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 87.5 mm-40 -73.09 -3.46 26.49 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.874 0.87 . . . . 0.0 112.892 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -126.07 -30.53 2.94 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.424 ' HG2' ' HA ' ' A' ' 93' ' ' SER . 15.4 ptm180 -73.16 -27.86 61.89 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.691 0.397 . . . . 0.0 111.82 -175.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -92.55 -21.72 19.94 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.877 0.471 . . . . 0.0 111.039 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.23 171.02 35.27 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.46 -0.634 . . . . 0.0 112.421 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 69.98 123.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.928 1.291 . . . . 0.0 111.557 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -69.74 112.72 6.39 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.515 0.726 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.612 ' H ' ' HD3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -56.29 96.07 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.454 1.101 . . . . 0.0 111.847 177.318 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -131.38 110.31 10.96 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.0 p -138.66 -43.48 0.49 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.456 1.103 . . . . 0.0 108.938 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.9 tptt 71.76 -72.69 0.11 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.401 1.48 . . . . 0.0 110.398 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -95.57 156.02 16.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.288 1.035 . . . . 0.0 109.085 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HD2' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -66.36 158.13 30.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.958 0.503 . . . . 0.0 110.769 178.083 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -110.5 154.29 23.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.082 0.953 . . . . 0.0 109.268 -175.492 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.6 tm? -73.98 116.97 15.22 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.488 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 24.0 m95 -107.85 161.77 14.61 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.867 0.867 . . . . 0.0 108.96 172.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.419 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 12.5 ptm -145.89 130.83 18.2 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.48 0.712 . . . . 0.0 110.399 -176.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -101.93 103.66 14.33 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.206 1.002 . . . . 0.0 109.694 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.4 mt -90.3 120.8 39.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -78.11 109.81 12.52 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.56 0.618 . . . . 0.0 109.459 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -95.45 108.69 20.92 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 123.411 0.684 . . . . 0.0 110.536 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.31 172.64 8.49 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.5 t70 58.95 40.73 22.14 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.298 1.039 . . . . 0.0 110.63 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.9 t -70.48 107.93 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.204 -172.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -93.37 114.42 26.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.23 1.012 . . . . 0.0 111.126 -176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -74.33 136.7 42.55 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 170.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -80.5 110.68 16.19 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.88 -23.18 66.14 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.76 1.224 . . . . 0.0 111.3 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -125.25 149.21 63.31 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.568 1.147 . . . . 0.0 110.315 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.49 96.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 123.522 2.815 . . . . 0.0 113.654 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 17.3 mt -100.03 107.16 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.019 0.528 . . . . 0.0 109.67 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.52 150.25 89.01 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.872 -176.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.423 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 98.0 Cg_endo -72.94 164.88 34.33 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.079 1.852 . . . . 0.0 112.141 174.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -70.2 -41.06 74.17 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 173.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -153.46 177.01 11.38 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.522 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.69 132.93 53.42 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.136 0.974 . . . . 0.0 111.402 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.585 HG12 ' HD3' ' A' ' 10' ' ' PRO . 38.2 t -119.37 97.88 50.3 Favored Pre-proline 0 CA--C 1.553 1.079 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.65 -176.76 3.15 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.053 2.502 . . . . 0.0 112.579 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.18 -26.81 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.354 1.061 . . . . 0.0 112.079 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.04 -20.4 79.96 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.837 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.3 148.85 3.95 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.321 0.486 . . . . 0.0 113.103 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -106.96 151.45 25.27 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.355 0.662 . . . . 0.0 109.363 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.566 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 1.3 m-85 -89.82 122.9 33.32 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 174.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.03 116.84 27.61 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.89 127.32 39.93 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -171.985 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -66.6 -16.49 64.22 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.912 0.885 . . . . 0.0 111.958 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.45 -27.44 69.12 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.881 0.872 . . . . 0.0 111.806 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.587 HG13 ' HB3' ' A' ' 36' ' ' GLU . 25.3 mm 63.8 -169.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 C-N-CA 124.094 0.957 . . . . 0.0 108.764 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.516 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.5 m -149.48 -41.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.988 1.315 . . . . 0.0 107.524 156.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.06 -162.57 22.59 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.81 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 p -124.18 156.46 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.425 0.69 . . . . 0.0 109.275 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -126.41 133.03 51.38 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.329 0.652 . . . . 0.0 109.285 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.24 135.85 28.09 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 123.283 0.633 . . . . 0.0 110.745 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.457 ' HB3' ' HD2' ' A' ' 46' ' ' TYR . 43.1 Cg_endo -93.83 78.07 0.23 Allowed 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 124.078 3.186 . . . . 0.0 110.214 168.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.78 109.3 1.76 Allowed Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.822 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -83.93 30.86 0.52 Allowed 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.213 2.609 . . . . 0.0 112.428 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 15' ' ' PHE . 38.6 mmtm -133.41 148.68 51.81 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.428 1.491 . . . . 0.0 108.674 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -63.06 -15.96 58.3 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.011 0.924 . . . . 0.0 111.693 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.409 ' HD2' ' HB3' ' A' ' 13' ' ' LYS . 59.1 m-85 -72.89 7.05 2.2 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.375 1.07 . . . . 0.0 112.824 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.3 ttp -68.76 -24.18 64.41 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.14 0.576 . . . . 0.0 109.981 165.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.35 -29.02 70.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.998 0.919 . . . . 0.0 110.98 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 27.2 mmt180 -57.63 -41.0 80.49 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 124.382 1.051 . . . . 0.0 111.771 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.43 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 58.0 m-85 -65.1 -32.35 74.0 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 123.902 0.751 . . . . 0.0 110.042 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -89.47 -13.59 37.2 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.697 0.799 . . . . 0.0 111.125 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -82.83 -54.45 5.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.954 0.901 . . . . 0.0 110.393 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.2 ptpt -100.8 -8.89 22.22 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.712 -165.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.47 -42.17 3.13 Favored Glycine 0 N--CA 1.475 1.245 0 O-C-N 123.067 0.229 . . . . 0.0 113.109 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -129.64 106.1 8.5 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.395 0.678 . . . . 0.0 109.981 172.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.43 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.2 t70 -107.53 -177.37 3.33 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.494 1.117 . . . . 0.0 109.174 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.2 t -136.81 114.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.36 1.064 . . . . 0.0 109.229 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -85.09 111.65 19.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.599 0.759 . . . . 0.0 110.266 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.57 132.1 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-O 121.2 0.524 . . . . 0.0 110.461 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HD2' ' HD2' ' A' ' 30' ' ' PRO . 58.5 tptt -134.71 130.57 19.8 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.504 1.122 . . . . 0.0 108.335 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 109' ' ' TRP . 24.9 Cg_endo -61.68 94.95 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 121.872 1.715 . . . . 0.0 109.58 166.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -30.08 79.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.807 2.043 . . . . 0.0 115.674 -163.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 50.7 m -96.11 -30.51 13.49 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.068 172.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.82 142.7 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.315 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -67.41 168.76 10.15 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.263 0.625 . . . . 0.0 112.368 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -58.94 -11.52 3.46 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.21 1.404 . . . . 0.0 113.562 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.587 ' HB3' HG13 ' A' ' 4' ' ' ILE . 7.7 mm-40 -64.64 -17.3 63.91 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.968 0.907 . . . . 0.0 111.939 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.16 100.48 3.08 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.365 0.666 . . . . 0.0 110.04 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.3 152.33 42.57 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.77 82.93 2.03 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.66 2.24 . . . . 0.0 111.918 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.63 43.0 0.02 OUTLIER Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.122 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 34.0 mtm -122.39 -158.83 0.8 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.867 0.867 . . . . 0.0 110.026 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -121.05 158.88 26.85 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.09 0.956 . . . . 0.0 110.309 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.41 ' CB ' HD11 ' A' ' 114' ' ' LEU . 2.5 t80 -136.41 99.68 4.16 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 41.3 t -83.7 124.59 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.089 0.471 . . . . 0.0 110.068 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -89.51 115.32 26.84 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.498 0.719 . . . . 0.0 109.508 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.457 ' HD2' ' HB3' ' A' ' 10' ' ' PRO . 85.0 t80 -101.45 92.6 4.99 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.459 1.103 . . . . 0.0 109.481 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -74.9 96.37 3.12 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 t -85.12 52.2 2.38 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.73 0.776 . . . . 0.0 109.281 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -161.53 21.75 0.12 Allowed 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.61 1.164 . . . . 0.0 109.691 -170.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -131.35 -80.86 0.52 Allowed 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.41 -0.806 . . . . 0.0 110.826 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -166.01 -79.74 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -172.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -77.71 -40.86 39.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.884 0.473 . . . . 0.0 110.557 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.72 -70.77 0.5 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.506 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 17.6 m-30 -60.93 96.39 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.436 0.695 . . . . 0.0 111.363 -177.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -77.2 -33.42 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.004 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . -173.53 -166.4 31.77 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.843 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 2.2 pt-20 -149.61 179.36 8.05 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.576 1.15 . . . . 0.0 108.627 176.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.546 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -158.56 -173.65 4.39 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.819 0.848 . . . . 0.0 109.509 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -127.29 116.53 20.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.411 0.684 . . . . 0.0 109.64 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -66.63 137.69 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.915 1.286 . . . . 0.0 111.425 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -141.0 -170.6 3.08 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.351 1.86 . . . . 0.0 108.564 -175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -30.62 113.98 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.586 1.554 . . . . 0.0 114.798 -168.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -97.52 108.88 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-O 121.799 0.809 . . . . 0.0 109.694 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 95.7 t -92.65 109.26 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.93 0.892 . . . . 0.0 109.795 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.56 117.66 27.67 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.4 t -152.99 135.72 15.31 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.768 0.827 . . . . 0.0 109.814 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.469 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 38.1 mt-10 -63.72 -22.16 66.77 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.062 0.545 . . . . 0.0 111.53 172.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -87.76 119.88 70.73 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.188 0.595 . . . . 0.0 109.723 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.31 -8.39 22.62 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 122.418 2.078 . . . . 0.0 112.064 167.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 51.7 mtm -89.58 -26.0 21.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.407 1.083 . . . . 0.0 111.21 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.49 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 71.4 mt-30 -68.17 -20.91 64.91 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -74.52 -21.99 59.27 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.508 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.487 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 22.6 m-85 -89.99 -27.81 19.53 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.177 0.591 . . . . 0.0 111.482 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 13.0 pt-20 -76.33 -28.43 56.89 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.3 m -85.98 -60.75 1.92 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.897 0.479 . . . . 0.0 110.788 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.792 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 67.0 m-85 -101.32 -61.84 1.32 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.389 0.675 . . . . 0.0 110.205 -173.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 77.33 -87.54 1.01 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.703 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.33 -12.94 44.96 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.792 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 6.4 mmp_? -69.33 -34.05 74.05 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.291 169.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.433 HG12 HD23 ' A' ' 82' ' ' LEU . 34.7 t -67.62 147.16 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.8 0.44 . . . . 0.0 110.453 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -63.56 -22.27 66.8 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.433 HD23 HG12 ' A' ' 80' ' ' VAL . 2.1 pt? -131.38 162.06 30.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.177 0.591 . . . . 0.0 109.608 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.443 HG23 ' H ' ' A' ' 85' ' ' ASP . 5.6 t -106.05 -176.93 3.22 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -56.39 -43.15 78.99 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.37 0.668 . . . . 0.0 111.142 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.443 ' H ' HG23 ' A' ' 83' ' ' THR . 14.4 m-20 -60.38 -45.8 92.27 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.041 0.936 . . . . 0.0 111.772 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.52 -46.72 88.76 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 123.224 0.327 . . . . 0.0 110.45 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.422 HD22 ' HE2' ' A' ' 73' ' ' PHE . 43.8 tp -57.27 -50.04 74.16 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.115 0.884 . . . . 0.0 111.46 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.494 ' HD3' ' N ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -64.28 -45.85 86.22 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.477 0.486 . . . . 0.0 110.775 -175.29 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.494 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 13.0 pt-20 -74.04 -24.79 59.58 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.451 0.3 . . . . 0.0 110.984 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 69.4 t80 -71.82 -49.37 39.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.718 0.807 . . . . 0.0 109.997 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.3 mtm -66.73 -40.76 88.51 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.89 0.744 . . . . 0.0 110.105 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HE3' HH21 ' A' ' 96' ' ' ARG . 31.2 mmmt -63.99 -35.59 81.2 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.714 0.634 . . . . 0.0 111.077 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.2 t -63.14 -37.42 87.15 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.861 0.464 . . . . 0.0 110.949 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 67.9 mm-40 -71.28 -41.41 70.03 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.871 0.469 . . . . 0.0 111.218 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -3.5 51.7 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.426 HH21 ' HE3' ' A' ' 92' ' ' LYS . 15.9 ptp180 -115.18 -40.16 3.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.005 0.522 . . . . 0.0 111.808 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -83.4 -42.93 16.45 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.88 -93.63 0.38 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 169.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -177.12 151.06 0.78 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.541 1.136 . . . . 0.0 108.1 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -82.16 170.39 15.51 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -102.41 22.2 13.84 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.707 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 50.12 -89.13 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.777 1.631 . . . . 0.0 110.932 -171.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.7 t -172.95 132.73 0.53 Allowed 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.024 0.93 . . . . 0.0 108.681 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -149.91 -68.08 0.2 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -157.29 -92.87 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.469 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -176.36 -160.85 0.07 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.468 1.507 . . . . 0.0 108.046 178.46 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 16.9 tptm -132.65 165.05 25.35 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.445 0.698 . . . . 0.0 109.583 175.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.61 114.32 10.61 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.649 0.779 . . . . 0.0 109.496 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 19.5 m95 -100.35 161.99 13.24 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.319 1.048 . . . . 0.0 109.398 172.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.514 ' HE3' HD11 ' A' ' 112' ' ' ILE . 9.0 ptt? -143.25 138.93 29.96 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.933 0.397 . . . . 0.0 110.766 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -109.51 103.33 12.2 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.089 0.956 . . . . 0.0 109.74 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.514 HD11 ' HE3' ' A' ' 110' ' ' MET . 22.8 mt -87.03 122.06 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.36 129.77 34.76 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.6 mm? -117.18 107.58 14.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.795 0.838 . . . . 0.0 110.865 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -106.4 170.83 7.69 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.157 0.583 . . . . 0.0 110.327 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.6 t70 55.21 38.54 30.57 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 124.449 1.093 . . . . 0.0 111.09 168.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.3 t -66.92 101.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.523 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.32 110.66 23.17 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.921 -167.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -65.08 122.27 16.66 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.886 0.875 . . . . 0.0 110.947 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.506 ' HD2' ' HB3' ' A' ' 54' ' ' PHE . 12.8 m-30 -75.9 87.35 2.87 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.36 -30.56 70.97 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.278 172.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -81.91 131.94 55.61 Favored Pre-proline 0 CA--C 1.553 1.089 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.384 168.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.66 84.15 2.03 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.761 2.307 . . . . 0.0 111.557 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.4 mt -73.21 127.04 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.008 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -74.53 130.6 81.54 Favored Pre-proline 0 CA--C 1.553 1.066 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.865 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.454 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 65.7 Cg_endo -71.51 145.13 46.7 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.63 2.22 . . . . 0.0 110.707 169.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -83.55 -6.22 59.39 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.588 0.755 . . . . 0.0 111.228 -179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -167.83 177.98 5.46 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.621 1.168 . . . . 0.0 109.402 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.87 138.04 46.03 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 166.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.446 HG12 ' HD3' ' A' ' 10' ' ' PRO . 43.7 t -107.0 100.33 31.47 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 170.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.23 169.25 17.2 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.873 2.382 . . . . 0.0 112.138 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.442 ' HA ' ' HG2' ' A' ' 10' ' ' PRO . 18.7 m -59.25 -20.49 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -173.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.5 -21.93 76.33 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.144 0.277 . . . . 0.0 113.079 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.79 147.47 14.89 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.621 0.629 . . . . 0.0 112.096 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -108.88 148.59 30.39 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.509 0.724 . . . . 0.0 109.33 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -92.27 120.37 32.76 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.459 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.24 122.93 30.13 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 130.04 34.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.322 0.649 . . . . 0.0 109.254 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.588 -171.794 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 92.0 mmm . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 111.326 0.121 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -60.46 -6.63 1.66 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.36 1.464 . . . . 0.0 114.172 -173.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -61.87 -12.51 18.13 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.739 0.816 . . . . 0.0 112.356 167.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mm 67.4 -178.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.933 1.293 . . . . 0.0 109.04 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 m -150.15 -47.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 156.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.527 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.05 -161.34 19.17 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.516 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.499 HG12 HD11 ' A' ' 60' ' ' ILE . 9.7 p -117.5 161.76 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -133.5 135.96 44.78 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.63 0.772 . . . . 0.0 109.25 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -136.03 146.03 54.92 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.924 0.89 . . . . 0.0 110.371 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD3' HG12 ' A' ' 130' ' ' VAL . 69.3 Cg_endo -70.7 -32.89 13.9 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.872 2.381 . . . . 0.0 112.624 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 mm 53.24 77.9 0.42 Allowed Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 124.105 0.962 . . . . 0.0 108.756 -168.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.17 41.65 1.14 Allowed 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.403 2.736 . . . . 0.0 112.868 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -138.49 158.95 43.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.353 1.461 . . . . 0.0 109.176 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -72.16 -10.95 60.47 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.128 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -79.51 11.61 2.96 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.43 1.092 . . . . 0.0 111.823 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 58.2 ttp -63.01 -35.37 80.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.715 0.806 . . . . 0.0 109.699 166.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.78 -26.17 68.58 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.893 0.877 . . . . 0.0 112.449 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -50.66 -48.02 58.5 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.844 0.858 . . . . 0.0 111.44 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.422 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 75.0 m-85 -67.53 -27.55 67.06 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.807 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -102.12 6.63 40.97 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.342 0.657 . . . . 0.0 110.922 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -93.52 -57.06 2.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.168 0.987 . . . . 0.0 109.41 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -110.98 -19.72 12.68 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.06 32.5 75.98 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 114.917 0.727 . . . . 0.0 114.917 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -161.86 41.77 0.14 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.278 1.031 . . . . 0.0 109.459 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' OD1' ' HA ' ' A' ' 19' ' ' PHE . 3.0 m-20 -81.93 -172.01 3.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.333 -172.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -142.36 110.69 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.412 ' H ' HD23 ' A' ' 114' ' ' LEU . 91.9 t80 -86.94 111.76 21.13 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 m -83.99 140.23 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.73 0.776 . . . . 0.0 110.561 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HD2' ' HB ' ' A' ' 32' ' ' THR . 15.2 tppt? -134.58 120.98 14.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.966 1.306 . . . . 0.0 109.699 -171.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 95.6 Cg_endo -77.54 53.86 4.5 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.13 2.554 . . . . 0.0 112.829 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 58.12 21.33 7.84 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.521 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 4.5 m -63.63 -36.42 83.77 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.349 0.522 . . . . 0.0 110.294 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -119.93 149.68 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.165 0.986 . . . . 0.0 109.092 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -167.57 -48.96 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.574 0.749 . . . . 0.0 110.348 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -41.59 -51.98 3.86 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.847 1.659 . . . . 0.0 113.641 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 22.8 mt-10 -109.68 -12.51 14.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.595 0.758 . . . . 0.0 110.306 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.425 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -69.23 115.44 8.52 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 123.294 0.637 . . . . 0.0 110.221 -177.117 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -143.85 152.15 54.8 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.992 0.917 . . . . 0.0 108.951 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.83 103.16 1.3 Allowed 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.597 2.198 . . . . 0.0 111.616 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.74 -7.07 0.91 Allowed Glycine 0 N--CA 1.476 1.348 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.789 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.527 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 79.0 mtp -83.01 -169.39 2.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.432 1.093 . . . . 0.0 111.068 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 12.3 ptpt -116.0 165.52 13.03 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.713 0.805 . . . . 0.0 110.608 168.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.535 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.1 t80 -135.37 99.06 4.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 87.3 t -84.96 120.07 34.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.23 0.538 . . . . 0.0 109.804 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -84.07 100.16 10.92 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.41 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 61.1 t80 -64.05 130.22 43.12 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 165.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.464 ' HB3' ' HA2' ' A' ' 53' ' ' GLY . 51.1 tt0 -74.9 108.9 7.93 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.0 t -65.1 87.57 0.07 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -131.62 -90.31 0.43 Allowed 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.237 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -155.57 -79.3 0.09 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.851 0.86 . . . . 0.0 109.162 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.59 -60.01 1.61 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.1 m -66.61 132.8 48.96 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.428 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 47' ' ' GLN . . . -133.85 -162.5 10.04 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.828 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.641 ' HB2' ' HB ' ' A' ' 124' ' ' ILE . 1.6 m-85 50.64 69.14 0.67 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.279 1.032 . . . . 0.0 111.203 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.17 -38.87 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.93 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.13 -166.66 25.53 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.234 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -145.89 178.68 8.0 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.906 0.882 . . . . 0.0 108.755 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -164.16 -171.71 2.51 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.693 0.797 . . . . 0.0 110.016 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 11.3 mmt180 -128.73 122.32 30.41 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.249 1.019 . . . . 0.0 109.401 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' A' ' 43' ' ' PHE . 57.8 mt -74.34 131.37 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.201 1.0 . . . . 0.0 110.322 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -139.31 -164.71 1.72 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.925 1.69 . . . . 0.0 108.357 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -24.78 109.93 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 126.378 1.871 . . . . 0.0 114.769 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 112' ' ' ILE . 35.0 m -98.76 109.04 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 94.7 t -89.62 110.23 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -87.96 118.26 27.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.516 0.727 . . . . 0.0 109.669 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.3 t -153.62 134.86 14.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.781 0.832 . . . . 0.0 109.581 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 49.3 mt-10 -70.03 -17.53 63.26 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.102 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.494 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 36.5 m-80 -91.66 118.76 68.51 Favored Pre-proline 0 C--N 1.357 0.892 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.456 ' HG2' HD21 ' A' ' 87' ' ' LEU . 50.0 Cg_endo -69.21 -10.83 30.05 Favored 'Trans proline' 0 CA--C 1.556 1.615 0 C-N-CA 122.473 2.115 . . . . 0.0 112.259 171.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 46.4 mtm -81.25 -27.56 35.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.168 0.987 . . . . 0.0 111.499 -176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 47.5 mt-30 -66.21 -24.01 66.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.387 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -74.08 -25.2 59.69 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.872 0.469 . . . . 0.0 110.866 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.543 ' HE2' HD22 ' A' ' 87' ' ' LEU . 33.3 m-85 -80.87 -37.34 30.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.0 0.52 . . . . 0.0 110.892 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.55 -29.03 61.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 121.294 -0.162 . . . . 0.0 111.35 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.4 m -80.74 -47.22 14.26 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.981 0.512 . . . . 0.0 110.682 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 62.7 m-85 -116.33 -67.23 1.01 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.265 0.626 . . . . 0.0 109.935 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.76 -81.13 1.15 Allowed Glycine 0 C--N 1.35 1.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.835 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.5 -43.97 93.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.902 0.881 . . . . 0.0 110.83 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 25.8 mmt180 -66.44 -30.68 71.09 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.553 -176.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.424 HG12 HD23 ' A' ' 82' ' ' LEU . 40.3 t -66.03 131.21 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -62.51 -22.16 66.07 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -168.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.424 HD23 HG12 ' A' ' 80' ' ' VAL . 2.3 pt? -128.07 160.89 30.58 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 85' ' ' ASP . 8.2 t -97.01 179.33 4.97 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.913 0.324 . . . . 0.0 110.383 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -62.95 -32.59 73.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.104 0.562 . . . . 0.0 111.452 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.414 ' H ' HG23 ' A' ' 83' ' ' THR . 5.6 m-20 -66.5 -45.8 78.38 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.33 0.652 . . . . 0.0 110.627 176.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.93 -35.46 76.77 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.44 173.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.543 HD22 ' HE2' ' A' ' 73' ' ' PHE . 40.5 tp -64.14 -52.73 57.7 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.546 0.529 . . . . 0.0 110.874 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -67.14 -40.44 86.74 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.256 0.348 . . . . 0.0 111.365 -173.114 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.71 -33.32 73.74 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -63.64 -48.26 77.97 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.973 0.909 . . . . 0.0 110.292 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.5 mtm -65.58 -33.0 74.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.052 0.541 . . . . 0.0 110.388 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.2 mmpt? -71.4 -34.89 70.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.621 0.368 . . . . 0.0 110.957 175.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.2 m -70.42 -42.06 72.09 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.932 0.493 . . . . 0.0 110.543 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -72.34 -22.48 61.16 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.239 0.616 . . . . 0.0 111.747 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -89.33 -36.89 15.28 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 119.457 -0.306 . . . . 0.0 111.452 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -77.42 -40.98 41.59 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.454 0.57 . . . . 0.0 111.079 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -82.98 -24.23 33.02 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.785 0.434 . . . . 0.0 110.146 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.13 -77.23 0.66 Allowed Glycine 0 C--N 1.351 1.399 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -173.1 -57.58 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.972 1.309 . . . . 0.0 107.878 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -167.98 164.47 13.78 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -69.03 83.74 0.33 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -82.19 95.15 7.44 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.401 -1.272 . . . . 0.0 107.976 -169.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -165.54 -170.18 1.77 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.121 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -158.62 -55.29 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 172.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -93.89 124.55 37.97 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.762 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.541 ' H ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -61.72 157.49 17.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.936 0.894 . . . . 0.0 112.096 -178.117 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.4 tpmt? -101.46 151.53 21.83 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.435 -174.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 2.9 tm? -73.45 110.31 7.65 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 173.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -89.8 158.47 17.48 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.449 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 12.3 ptm -139.51 129.05 24.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.16 0.584 . . . . 0.0 109.796 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.402 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -100.87 100.95 11.67 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.454 ' HA ' HG12 ' A' ' 63' ' ' VAL . 23.3 mt -80.95 117.98 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -80.66 110.08 15.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.52 0.676 . . . . 0.0 109.67 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 27' ' ' PHE . 4.0 mm? -88.67 131.62 34.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.405 1.082 . . . . 0.0 109.824 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -139.07 173.29 11.71 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.18 0.592 . . . . 0.0 109.463 171.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.9 t70 56.17 34.56 24.13 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.856 0.862 . . . . 0.0 110.946 170.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.9 t -65.89 106.82 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.698 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.265 -175.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.95 162.84 19.26 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.6 1.16 . . . . 0.0 109.969 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.87 124.12 42.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.697 0.799 . . . . 0.0 109.336 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -79.68 103.4 9.56 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.266 0.555 . . . . 0.0 109.674 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.83 -28.23 68.83 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.671 1.188 . . . . 0.0 110.589 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -88.34 139.85 30.24 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.973 0.909 . . . . 0.0 109.831 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.4 92.22 0.94 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.709 2.273 . . . . 0.0 111.86 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.641 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 41.5 mt -80.34 138.38 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.88 140.24 23.5 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.67 123.39 12.91 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.53 2.153 . . . . 0.0 112.095 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -57.73 -34.05 69.1 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.553 0.741 . . . . 0.0 109.432 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -150.61 164.69 35.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.388 1.075 . . . . 0.0 109.056 172.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.55 126.52 29.91 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.36 0.664 . . . . 0.0 109.522 -175.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.482 HG12 ' HD3' ' A' ' 10' ' ' PRO . 19.1 t -109.51 99.73 38.62 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.65 -172.85 1.52 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.91 2.407 . . . . 0.0 112.137 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.23 -34.81 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.965 0.906 . . . . 0.0 110.966 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.77 -21.1 77.92 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.203 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.74 163.26 26.71 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 122.92 0.295 . . . . 0.0 113.12 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -115.54 149.89 37.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.999 0.919 . . . . 0.0 109.961 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 9.2 m-85 -85.24 120.1 26.35 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 169.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.7 125.54 33.95 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -130.36 128.86 42.28 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.266 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 C--O 1.247 0.965 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -171.75 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 tpp . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 m -62.47 -18.65 62.28 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.543 1.137 . . . . 0.0 113.639 -170.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -60.68 -22.74 64.22 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.838 0.855 . . . . 0.0 112.929 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 5' ' ' VAL . 27.1 mm 64.35 -168.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.665 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -170.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.534 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.3 m -147.31 -39.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.024 0.929 . . . . 0.0 108.729 158.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.02 -161.83 21.21 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.284 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 13.4 p -127.88 155.12 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 t -126.94 136.63 52.54 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -137.15 139.95 29.74 Favored Pre-proline 0 N--CA 1.469 0.522 0 C-N-CA 124.419 1.088 . . . . 0.0 109.369 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 15.4 Cg_exo -65.76 -47.0 4.27 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 123.079 2.519 . . . . 0.0 110.825 169.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.6 mt 67.95 136.12 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 125.366 1.466 . . . . 0.0 110.2 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.482 ' HB2' ' HD2' ' A' ' 15' ' ' PHE . 81.6 Cg_exo -48.06 124.98 10.98 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.236 1.957 . . . . 0.0 111.356 171.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -59.31 -16.8 24.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.518 1.127 . . . . 0.0 113.052 -174.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -66.98 -45.64 77.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.571 0.748 . . . . 0.0 110.797 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.482 ' HD2' ' HB2' ' A' ' 12' ' ' PRO . 76.3 m-85 -101.2 1.56 39.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.414 1.086 . . . . 0.0 112.071 -174.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -73.15 -40.8 64.56 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.211 0.604 . . . . 0.0 110.354 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -63.86 -25.34 68.12 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.504 0.721 . . . . 0.0 112.132 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -50.67 -44.25 57.64 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 124.96 1.304 . . . . 0.0 112.581 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.54 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 47.9 m-85 -70.37 -27.13 64.08 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.494 0.718 . . . . 0.0 111.526 -174.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -95.97 -17.78 20.75 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.186 0.994 . . . . 0.0 110.15 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -74.6 -58.73 3.1 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.637 1.175 . . . . 0.0 110.506 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -92.57 -14.0 28.89 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.924 -172.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.13 -58.89 4.22 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.813 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -109.88 104.72 13.69 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.317 0.558 . . . . 0.0 110.186 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 11.4 t70 -101.63 179.23 4.41 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.176 0.99 . . . . 0.0 109.757 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.0 t -138.06 110.84 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.393 1.077 . . . . 0.0 109.023 171.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -88.48 111.45 21.83 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.707 0.803 . . . . 0.0 109.937 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.8 m -90.44 126.88 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.619 0.723 . . . . 0.0 111.149 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 7.4 mmpt? -110.18 134.97 20.6 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.124 1.369 . . . . 0.0 109.726 173.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.77 56.6 6.02 Favored 'Trans proline' 0 CA--C 1.557 1.668 0 C-N-CA 122.501 2.134 . . . . 0.0 110.909 166.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 50.79 37.51 17.16 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.035 1.334 . . . . 0.0 112.919 -176.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 10.7 m -64.65 -43.39 93.79 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.954 0.902 . . . . 0.0 110.246 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.41 151.32 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.081 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.466 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 62.6 m95 -73.5 -177.38 2.63 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.392 1.077 . . . . 0.0 112.016 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -68.2 -3.72 11.58 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.036 0.934 . . . . 0.0 113.018 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HB3' HG13 ' A' ' 4' ' ' ILE . 9.5 mm-40 -66.57 -24.81 66.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.214 0.606 . . . . 0.0 110.773 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 94.65 0.63 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.935 0.494 . . . . 0.0 109.891 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.472 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -115.12 149.99 43.54 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.207 0.603 . . . . 0.0 109.438 177.293 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.473 ' HA ' HG22 ' A' ' 60' ' ' ILE . 59.9 Cg_endo -70.95 103.17 1.32 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.948 2.432 . . . . 0.0 110.699 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.64 -16.05 1.09 Allowed Glycine 0 C--O 1.241 0.54 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.512 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.477 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 25.8 mtm -73.48 -174.49 1.69 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.362 0.665 . . . . 0.0 112.185 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -109.45 159.44 17.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.845 0.858 . . . . 0.0 110.456 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.9 t80 -137.0 98.14 3.68 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 46.7 t -84.55 129.4 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 109.955 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -93.0 119.28 32.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.564 0.746 . . . . 0.0 110.042 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 52.1 t80 -91.04 144.32 25.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.875 1.27 . . . . 0.0 109.111 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 63.1 tt0 -139.55 125.92 20.24 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.133 0.573 . . . . 0.0 109.74 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 51' ' ' ASP . 25.3 m 65.21 131.32 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.548 1.539 . . . . 0.0 112.725 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -63.12 -43.01 99.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.491 0.717 . . . . 0.0 112.536 -174.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.11 10.59 10.08 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.435 0.694 . . . . 0.0 111.866 -169.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 48' ' ' SER . 33.3 t70 -147.71 154.16 40.21 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.611 0.764 . . . . 0.0 109.193 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.627 ' HA ' ' HB3' ' A' ' 123' ' ' PRO . 55.0 m 64.15 -72.74 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.977 1.311 . . . . 0.0 111.827 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 126' ' ' PRO . . . 104.46 -69.82 0.26 Allowed Glycine 0 C--O 1.22 -0.761 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -178.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -129.45 127.84 41.71 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.312 0.645 . . . . 0.0 110.293 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 47' ' ' GLN . 3.2 p -85.3 -31.32 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.997 0.919 . . . . 0.0 110.782 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.33 -162.9 26.09 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.869 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 15.2 pt-20 -153.72 178.0 10.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.804 1.242 . . . . 0.0 108.215 175.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -164.24 -176.17 4.31 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.592 0.757 . . . . 0.0 110.091 177.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -122.92 130.6 53.03 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.641 0.776 . . . . 0.0 109.889 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 39' ' ' PRO . 45.4 mt -74.39 138.1 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.039 1.336 . . . . 0.0 110.751 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -133.4 -168.62 2.13 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.722 2.009 . . . . 0.0 108.438 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -31.28 113.03 0.1 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 126.113 1.765 . . . . 0.0 113.967 -166.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.3 m -92.79 103.23 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 86.7 t -90.71 109.0 20.35 Favored 'Isoleucine or valine' 0 C--N 1.348 0.512 0 C-N-CA 123.682 0.793 . . . . 0.0 109.067 -172.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.5 mt -84.85 118.54 24.55 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.405 ' HB3' ' CE1' ' A' ' 72' ' ' PHE . 47.5 t -149.31 130.35 14.41 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.785 0.834 . . . . 0.0 109.202 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' HG3' HD23 ' A' ' 108' ' ' LEU . 25.9 mt-10 -67.33 -15.9 63.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.745 0.818 . . . . 0.0 111.513 173.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -103.49 119.32 55.26 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 123.534 0.734 . . . . 0.0 109.099 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.42 -13.37 39.01 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.368 2.046 . . . . 0.0 112.663 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.0 mtm -82.6 -27.94 31.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.643 0.777 . . . . 0.0 111.479 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.51 -22.4 66.72 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.771 0.319 . . . . 0.0 111.545 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 66' ' ' SER . 15.0 m-85 -71.99 -25.63 61.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.039 0.535 . . . . 0.0 110.833 174.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.599 ' HE2' HD22 ' A' ' 87' ' ' LEU . 21.2 m-85 -87.72 -27.41 22.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.822 0.449 . . . . 0.0 111.572 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.94 -29.04 55.45 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.591 0.234 . . . . 0.0 110.717 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.6 m -86.32 -46.91 9.86 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.136 0.575 . . . . 0.0 111.443 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.771 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 69.3 m-85 -116.01 -62.89 1.53 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.469 0.708 . . . . 0.0 110.082 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 72.35 -92.06 0.57 Allowed Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.019 -0.537 . . . . 0.0 113.382 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.32 -19.2 61.7 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.647 0.779 . . . . 0.0 111.064 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.771 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 23.0 mmt180 -70.67 -37.84 73.72 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.573 173.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.9 t -63.65 149.62 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.711 0.405 . . . . 0.0 110.199 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -64.03 -16.04 60.79 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.0 pt? -142.12 158.59 43.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.476 1.111 . . . . 0.0 108.686 174.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.48 HG22 ' HG3' ' A' ' 86' ' ' GLU . 13.8 t -100.44 -177.53 3.53 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.68 -35.85 79.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.535 0.734 . . . . 0.0 111.751 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.68 -44.99 94.84 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.577 0.751 . . . . 0.0 110.813 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 30.0 mt-10 -72.13 -26.38 62.09 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.68 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.599 HD22 ' HE2' ' A' ' 73' ' ' PHE . 24.9 tp -71.36 -50.96 26.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.418 0.687 . . . . 0.0 110.785 176.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -66.61 -36.66 83.13 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.542 0.337 . . . . 0.0 111.205 -173.164 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.67 -32.88 68.34 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 175.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.418 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 70.9 t80 -65.0 -46.46 81.3 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.716 0.807 . . . . 0.0 110.986 175.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.3 mtm -70.43 -39.0 74.66 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.962 0.505 . . . . 0.0 110.696 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.7 mmmt -67.16 -32.34 73.37 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.35 0.26 . . . . 0.0 110.675 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t -65.25 -37.36 86.99 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.149 0.58 . . . . 0.0 110.66 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 89.3 mm-40 -75.7 -7.43 54.34 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' HB3' ' HD3' ' A' ' 100' ' ' ARG . 10.5 pt-20 -112.6 -18.42 12.38 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 118.33 0.514 . . . . 0.0 111.57 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -100.31 -20.87 15.66 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.457 0.303 . . . . 0.0 111.463 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -117.36 -55.07 2.34 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.16 -140.44 2.84 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.304 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -155.77 102.93 2.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.292 0.637 . . . . 0.0 109.648 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.436 ' HD3' ' HB3' ' A' ' 95' ' ' GLU . 80.8 mtp180 -83.14 -72.77 0.44 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? 59.48 88.46 0.07 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.235 1.014 . . . . 0.0 109.832 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -174.79 140.31 0.56 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.053 0.941 . . . . 0.0 109.614 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.6 p -159.92 -4.61 0.06 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.571 0.748 . . . . 0.0 111.007 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -93.6 -57.63 2.52 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.713 0.805 . . . . 0.0 110.928 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -137.27 121.76 18.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.977 0.511 . . . . 0.0 111.118 -172.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HD2' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -62.62 157.87 19.63 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.045 0.938 . . . . 0.0 111.46 176.202 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 31' ' ' ALA . 4.3 tmtp? -85.31 145.9 27.29 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.983 0.913 . . . . 0.0 109.292 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.482 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 3.1 tm? -76.33 107.62 8.71 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 170.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -91.75 162.31 14.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.825 0.85 . . . . 0.0 109.333 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.6 ptm -141.49 131.26 24.25 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.955 0.902 . . . . 0.0 109.321 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -102.45 101.56 11.78 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.3 mt -80.26 115.09 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -77.96 139.83 39.2 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -119.68 131.35 55.4 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.904 0.882 . . . . 0.0 109.292 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -136.39 168.85 18.67 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.744 1.218 . . . . 0.0 109.459 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.6 t70 53.42 36.7 23.74 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.412 1.085 . . . . 0.0 111.21 168.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.69 103.71 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.739 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -90.19 108.51 19.79 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.386 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -73.5 130.46 40.15 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -78.99 120.25 23.31 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -60.91 -35.3 76.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.022 0.929 . . . . 0.0 110.349 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -116.39 147.62 39.97 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.776 1.231 . . . . 0.0 109.798 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.627 ' HB3' ' HA ' ' A' ' 52' ' ' THR . 20.3 Cg_exo -64.8 97.13 0.27 Allowed 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 123.308 2.672 . . . . 0.0 111.591 172.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.5 mt -83.25 115.53 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.9 147.64 91.55 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.72 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.454 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 91.6 Cg_endo -87.16 154.81 8.24 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.473 2.115 . . . . 0.0 112.179 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -74.01 -23.11 59.38 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.44 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 126' ' ' PRO . 13.4 ptm180 -150.35 160.35 43.79 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.989 0.915 . . . . 0.0 109.342 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 129' ' ' LEU . 2.6 pt? -75.8 120.62 21.42 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.7 t -94.49 109.49 43.41 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.54 179.77 6.2 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.95 2.433 . . . . 0.0 111.838 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.4 t -59.15 -32.83 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 124.2 1.0 . . . . 0.0 111.794 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.64 -16.62 72.14 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.558 -0.747 . . . . 0.0 113.641 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.04 160.62 15.17 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.119 0.39 . . . . 0.0 113.149 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -118.1 139.07 51.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.599 0.759 . . . . 0.0 109.458 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.466 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 0.2 OUTLIER -79.42 106.91 11.79 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.552 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.49 114.12 18.17 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.4 ' HD3' ' H ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -110.07 148.96 30.72 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.524 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.253 1.239 0 CA-C-N 118.217 0.462 . . . . 0.0 110.127 172.189 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 47.0 ttp . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.5 t -56.56 -15.33 4.16 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -165.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -65.24 -20.5 66.46 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 5' ' ' VAL . 23.1 mm 68.78 178.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 C-N-CA 124.612 1.165 . . . . 0.0 109.759 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.419 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.7 m -145.41 -43.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.619 1.168 . . . . 0.0 108.181 160.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.97 -159.17 15.16 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.724 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 HD11 ' A' ' 60' ' ' ILE . 10.0 p -122.9 151.33 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -123.29 135.56 54.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.843 0.857 . . . . 0.0 109.528 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -137.47 138.88 25.81 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.556 0.742 . . . . 0.0 111.064 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 91.0 Cg_endo -74.35 -9.57 21.77 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.76 2.307 . . . . 0.0 111.86 169.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 mm 64.83 116.64 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.638 1.575 . . . . 0.0 109.284 -175.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.56 -11.49 20.36 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.815 2.343 . . . . 0.0 113.841 -172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HE2' ' HD1' ' A' ' 90' ' ' TYR . 63.8 mttm -133.66 176.91 8.12 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.543 1.137 . . . . 0.0 110.693 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -71.99 -5.91 38.3 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.021 0.929 . . . . 0.0 112.002 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -73.43 15.13 0.27 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.2 ptp -56.7 -32.29 65.32 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 157.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.28 -45.87 35.21 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.549 1.54 . . . . 0.0 111.79 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 84.2 mmt-85 -58.08 -36.58 73.03 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.134 0.896 . . . . 0.0 112.501 -173.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HB3' HG11 ' A' ' 117' ' ' VAL . 74.5 m-85 -66.35 -29.35 69.52 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.419 0.45 . . . . 0.0 110.565 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -98.23 -15.31 19.9 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.768 0.827 . . . . 0.0 110.928 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 18' ' ' ARG . 5.8 tmtm? -78.31 -48.06 16.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.78 1.232 . . . . 0.0 110.275 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.7 ptpt -102.55 -12.36 17.83 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.568 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.94 -14.03 59.74 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.988 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -164.0 114.72 1.3 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.834 0.854 . . . . 0.0 109.4 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 18.9 t70 -133.83 -175.37 3.81 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.1 0.96 . . . . 0.0 110.296 -162.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 113' ' ' GLU . 76.9 t -135.87 119.28 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 121.278 -0.889 . . . . 0.0 109.417 176.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -93.69 115.77 28.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.323 0.649 . . . . 0.0 109.929 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.8 m -93.68 143.56 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.838 0.827 . . . . 0.0 111.163 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.6 mmpt? -130.15 136.18 28.62 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 126.225 1.81 . . . . 0.0 108.951 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.72 55.21 5.12 Favored 'Trans proline' 0 CA--C 1.552 1.388 0 C-N-CA 122.421 2.081 . . . . 0.0 111.149 166.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.56 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.063 1.345 . . . . 0.0 112.394 -170.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.563 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 24.8 m -126.45 -50.84 1.51 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.35 107.52 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.858 0.863 . . . . 0.0 109.253 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -146.06 1.18 0.86 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.228 0.611 . . . . 0.0 111.533 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -64.47 -53.62 45.43 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.453 0.644 . . . . 0.0 110.275 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -109.4 -7.98 15.12 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.424 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.33 107.11 1.53 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.571 0.748 . . . . 0.0 110.872 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.471 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -135.9 152.26 75.44 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.279 0.632 . . . . 0.0 109.909 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.06 102.5 1.08 Allowed 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.971 2.447 . . . . 0.0 111.32 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.25 -19.83 1.2 Allowed Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.666 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.471 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 30.1 mtm -74.64 -177.88 3.38 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.078 0.466 . . . . 0.0 111.234 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -104.04 163.07 12.63 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.341 0.656 . . . . 0.0 110.869 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.489 ' CB ' HD11 ' A' ' 114' ' ' LEU . 2.5 t80 -134.55 102.03 5.16 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 48.7 t -90.17 123.87 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.339 0.59 . . . . 0.0 110.137 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.36 111.43 19.42 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.743 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 76.5 t80 -83.17 136.49 34.42 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.399 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.709 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 48.4 tt0 -95.28 165.67 12.27 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.8 t -60.68 178.02 0.26 Allowed 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.736 0.814 . . . . 0.0 111.523 172.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -69.75 12.95 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.968 1.307 . . . . 0.0 113.834 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -67.01 -65.74 0.64 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.72 1.208 . . . . 0.0 110.82 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -175.02 148.99 1.05 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.311 1.045 . . . . 0.0 109.155 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.3 m 62.04 100.11 0.03 OUTLIER 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.671 1.232 . . . . 0.0 111.095 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.713 ' HA3' ' HD3' ' A' ' 126' ' ' PRO . . . -57.46 -35.81 74.14 Favored Glycine 0 C--O 1.209 -1.447 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.613 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -107.43 102.61 11.87 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.716 0.758 . . . . 0.0 110.453 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 47' ' ' GLN . 13.8 p -79.55 -19.69 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.709 0.804 . . . . 0.0 111.279 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.42 -171.45 40.94 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.093 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 21.2 pt-20 -153.82 178.95 9.33 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.788 0.835 . . . . 0.0 109.861 171.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -165.26 -171.33 2.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.705 0.802 . . . . 0.0 110.354 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -123.03 122.44 38.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.65 0.78 . . . . 0.0 111.362 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.457 HD11 HG12 ' A' ' 7' ' ' VAL . 74.6 mt -69.02 136.99 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.445 1.098 . . . . 0.0 111.224 175.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 30.9 mmmt -136.58 -167.73 2.12 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 126.877 2.071 . . . . 0.0 107.697 -177.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -39.88 112.89 0.3 Allowed 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 125.187 1.395 . . . . 0.0 113.706 -166.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.02 106.93 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 95.6 t -90.11 109.53 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.395 0.678 . . . . 0.0 109.26 -174.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 108' ' ' LEU . 39.1 mt -91.26 115.98 28.46 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 t -151.66 129.66 11.79 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.781 0.832 . . . . 0.0 109.137 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.515 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 45.0 mt-10 -61.75 -21.26 64.38 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.374 0.67 . . . . 0.0 112.248 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -100.58 118.97 59.9 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.509 ' HG2' HD21 ' A' ' 87' ' ' LEU . 56.3 Cg_endo -69.16 -8.69 24.29 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.956 2.437 . . . . 0.0 113.085 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 50.6 mtm -79.9 -24.72 40.94 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.383 0.673 . . . . 0.0 111.205 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.405 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -60.33 -26.49 66.61 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.607 0.763 . . . . 0.0 111.527 175.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -76.71 -20.49 56.51 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.06 0.544 . . . . 0.0 111.116 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.478 ' HE2' HD22 ' A' ' 87' ' ' LEU . 30.2 m-85 -85.81 -38.36 18.25 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.822 0.449 . . . . 0.0 110.537 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.0 pt-20 -72.42 -23.48 61.09 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 120.34 0.114 . . . . 0.0 111.0 175.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.3 m -88.5 -44.33 10.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.236 0.614 . . . . 0.0 111.063 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.763 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 64.7 m-85 -118.11 -66.96 1.03 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.071 0.548 . . . . 0.0 110.332 -176.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.09 -81.21 0.68 Allowed Glycine 0 C--N 1.355 1.62 0 O-C-N 123.472 0.483 . . . . 0.0 113.304 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.89 -27.66 69.51 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.363 1.065 . . . . 0.0 111.499 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.763 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 38.6 mmt180 -81.38 -33.12 32.54 Favored 'General case' 0 C--O 1.209 -1.072 0 O-C-N 123.992 0.807 . . . . 0.0 111.975 -176.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.463 HG12 HD23 ' A' ' 82' ' ' LEU . 21.7 t -66.57 145.47 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 118.451 0.569 . . . . 0.0 110.459 -174.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.447 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 34.7 p90 -64.05 -17.25 63.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.463 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -140.31 158.18 44.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.3 t -95.27 179.56 5.14 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -65.51 -27.13 68.25 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.518 0.727 . . . . 0.0 111.518 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.91 -49.64 67.31 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.905 0.882 . . . . 0.0 110.506 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -62.65 -31.45 72.32 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.186 176.273 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.509 HD21 ' HG2' ' A' ' 69' ' ' PRO . 46.1 tp -67.78 -52.15 40.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.433 0.693 . . . . 0.0 111.093 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -63.18 -38.58 91.73 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.234 0.334 . . . . 0.0 111.366 -174.068 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.412 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 13.0 pt-20 -78.88 -23.68 44.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.728 0.411 . . . . 0.0 111.343 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.416 ' HD1' ' HE2' ' A' ' 13' ' ' LYS . 56.9 t80 -66.08 -38.96 89.6 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.378 0.671 . . . . 0.0 109.97 170.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.6 mtm -77.57 -30.82 52.77 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.454 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.8 mmpt? -71.14 -28.83 64.56 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.397 0.279 . . . . 0.0 110.516 171.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.2 t -62.91 -31.39 72.45 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.388 0.675 . . . . 0.0 110.83 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -73.99 -22.09 59.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.546 0.738 . . . . 0.0 112.22 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -103.12 -36.04 8.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.928 0.491 . . . . 0.0 111.638 -177.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -82.38 -34.71 28.26 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.342 0.257 . . . . 0.0 111.49 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -97.68 -42.03 7.83 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.73 -159.19 26.11 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.704 172.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -156.1 155.38 32.47 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 70.94 118.45 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.933 1.293 . . . . 0.0 111.168 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 102' ' ' GLU . 44.6 ttt85 -153.48 173.45 15.67 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.021 0.928 . . . . 0.0 108.754 -176.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.471 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 44.3 mt-10 77.2 108.75 0.08 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 125.286 1.434 . . . . 0.0 110.753 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.7 m -145.51 142.03 28.83 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.467 1.107 . . . . 0.0 108.822 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -64.43 140.52 58.88 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.465 ' HE2' ' HD3' ' A' ' 106' ' ' LYS . 1.8 tpmt? 72.75 148.17 0.09 Allowed 'General case' 0 N--CA 1.482 1.14 0 O-C-N 125.056 1.472 . . . . 0.0 110.301 -166.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -101.6 166.25 10.8 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.087 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 4.2 tmtp? -86.24 140.11 30.43 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 65' ' ' LEU . 2.8 tm? -74.28 107.83 6.69 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -89.04 161.85 16.33 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.552 0.741 . . . . 0.0 109.533 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.485 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 15.1 ptm -145.56 131.04 18.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.822 0.849 . . . . 0.0 109.781 -175.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -106.58 101.97 11.38 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.222 0.609 . . . . 0.0 109.56 -178.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.2 mt -78.4 115.46 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -80.95 133.75 35.58 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -177.024 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' ' 43' ' ' PHE . 3.3 mm? -122.92 122.3 38.25 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.455 0.702 . . . . 0.0 111.279 -174.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -124.41 165.23 18.1 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.572 0.749 . . . . 0.0 110.313 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.0 t70 50.23 53.25 13.2 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.124 1.37 . . . . 0.0 111.29 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.541 HG11 ' HB3' ' A' ' 19' ' ' PHE . 41.9 t -74.7 101.45 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.671 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -81.74 146.27 30.06 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.526 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -101.3 134.86 43.72 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.626 0.771 . . . . 0.0 109.337 171.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -86.43 88.14 7.57 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 170.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.24 -26.04 63.66 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.649 0.738 . . . . 0.0 109.066 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -81.24 135.98 50.19 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.645 173.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.06 91.94 1.15 Allowed 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.793 2.329 . . . . 0.0 112.573 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.5 mt -105.36 125.11 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.443 0.639 . . . . 0.0 110.651 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.63 148.35 34.46 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.703 1.201 . . . . 0.0 109.338 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.713 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 64.2 Cg_endo -77.9 178.43 7.61 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.194 2.596 . . . . 0.0 113.562 -170.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -84.74 -38.65 19.42 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.131 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -142.22 166.24 25.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.067 0.547 . . . . 0.0 110.832 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 129' ' ' LEU . 2.6 pt? -66.79 134.93 53.14 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 124.236 0.96 . . . . 0.0 109.779 174.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.466 HG12 ' HD3' ' A' ' 10' ' ' PRO . 41.0 t -118.29 102.23 50.62 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.93 178.9 2.55 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.326 2.684 . . . . 0.0 112.249 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.4 t -60.19 -31.74 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.77 0.828 . . . . 0.0 111.07 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.49 -12.53 77.28 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 115.572 -0.74 . . . . 0.0 114.287 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.65 157.83 16.96 Favored Glycine 0 C--N 1.35 1.357 0 C-N-CA 123.035 0.35 . . . . 0.0 113.662 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -117.83 147.23 43.25 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.709 0.803 . . . . 0.0 110.394 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -77.85 112.63 14.92 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 167.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.66 128.94 34.01 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -138.05 134.98 35.42 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.77 0.428 . . . . 0.0 110.521 -176.389 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 . . . . . 0 C--O 1.25 1.089 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.779 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 t -63.77 -11.09 23.6 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.544 1.137 . . . . 0.0 113.196 -172.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -59.47 -21.54 60.22 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 5' ' ' VAL . 24.9 mm 64.5 -173.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.599 0 C-N-CA 124.045 0.938 . . . . 0.0 108.55 -174.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.473 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.1 m -152.43 -42.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 158.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.63 -159.69 16.03 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.611 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 11.6 p -126.63 152.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 171.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 t -123.72 134.57 53.67 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -127.37 151.08 74.25 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.519 0.728 . . . . 0.0 110.01 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HG3' ' HA ' ' A' ' 132' ' ' VAL . 56.8 Cg_endo -65.87 -34.46 39.31 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.854 2.369 . . . . 0.0 111.868 175.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.4 mm 67.62 132.98 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.935 1.294 . . . . 0.0 111.198 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.23 110.66 0.68 Allowed 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 121.832 1.688 . . . . 0.0 109.74 165.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.788 ' HA ' ' HB2' ' A' ' 16' ' ' MET . 19.3 pttp -68.77 -3.89 13.98 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -174.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -66.83 -40.52 88.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.602 1.161 . . . . 0.0 109.063 170.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -116.54 16.52 15.54 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.316 1.046 . . . . 0.0 112.0 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.788 ' HB2' ' HA ' ' A' ' 13' ' ' LYS . 56.6 ttp -62.27 -47.04 86.12 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.087 0.555 . . . . 0.0 110.426 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.66 -2.48 20.27 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.906 -175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 1.9 mmm180 -63.19 -49.77 72.94 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.052 0.541 . . . . 0.0 110.3 173.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 51.1 m-85 -61.93 -29.08 69.99 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 124.007 0.817 . . . . 0.0 110.395 -178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -96.97 -12.86 22.82 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.205 1.002 . . . . 0.0 111.527 -174.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.69 -50.18 14.3 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.842 0.857 . . . . 0.0 109.479 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.4 ptpt -101.07 -16.64 17.02 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.06 -169.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.87 -11.32 48.16 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-O 119.839 -0.423 . . . . 0.0 114.118 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -159.73 117.54 2.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.028 0.931 . . . . 0.0 109.428 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.465 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 17.9 t70 -124.88 -176.21 3.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.248 1.019 . . . . 0.0 109.307 -172.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -132.27 110.33 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.148 0.979 . . . . 0.0 108.791 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -90.54 109.25 20.4 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 110.0 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.4 m -85.8 129.03 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.545 0.688 . . . . 0.0 111.121 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -112.65 142.42 27.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.896 1.278 . . . . 0.0 109.518 170.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.41 46.23 2.07 Favored 'Trans proline' 0 C--N 1.367 1.5 0 C-N-CA 122.692 2.262 . . . . 0.0 112.16 168.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.21 86.42 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.201 1.401 . . . . 0.0 112.495 -172.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -122.31 7.43 9.63 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.595 0.758 . . . . 0.0 109.842 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.425 ' HB ' ' OH ' ' A' ' 136' ' ' TYR . 14.1 m -127.92 150.16 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.385 1.074 . . . . 0.0 109.776 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -80.9 -172.81 3.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.307 0.643 . . . . 0.0 110.99 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -73.1 9.53 1.19 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -71.61 -29.43 64.67 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.875 0.47 . . . . 0.0 109.845 172.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.89 104.85 1.17 Allowed 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.055 0.542 . . . . 0.0 110.053 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -135.5 153.65 77.86 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 123.279 0.632 . . . . 0.0 109.784 -177.696 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.81 97.12 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.761 2.307 . . . . 0.0 111.094 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.45 43.48 0.1 OUTLIER Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.495 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.419 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 32.5 mtm -126.94 -171.59 2.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.79 0.836 . . . . 0.0 109.525 174.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.6 ptpt -112.7 158.54 19.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.276 0.63 . . . . 0.0 110.251 169.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.54 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.2 t80 -135.67 101.25 4.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 40.7 t -86.18 130.18 36.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -95.56 112.69 24.36 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.258 0.623 . . . . 0.0 109.455 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.573 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 90.1 t80 -75.11 150.32 38.83 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -82.64 72.28 9.72 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -177.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.645 ' HB3' ' HB3' ' A' ' 13' ' ' LYS . 92.1 p 51.37 -76.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 127.174 2.19 . . . . 0.0 114.627 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -170.82 176.0 4.31 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 124.542 1.137 . . . . 0.0 108.738 -172.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 71.63 -69.89 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.383 1.473 . . . . 0.0 111.038 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -69.37 118.13 11.86 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.476 0.711 . . . . 0.0 109.342 172.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.488 HG22 ' HD2' ' A' ' 126' ' ' PRO . 12.7 m -82.28 78.09 8.99 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.62 0.724 . . . . 0.0 109.414 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.536 ' HA2' ' HD3' ' A' ' 126' ' ' PRO . . . -165.14 162.35 35.63 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.186 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.46 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 62.9 m-85 -95.18 147.35 23.54 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.719 0.408 . . . . 0.0 110.059 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.457 HG11 ' SD ' ' A' ' 16' ' ' MET . 3.3 p -87.31 -30.12 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.661 0.784 . . . . 0.0 110.471 174.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.4 -157.76 20.37 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 120.062 -0.299 . . . . 0.0 112.768 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 16.2 pt-20 -154.17 178.61 9.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.179 0.992 . . . . 0.0 109.293 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -166.76 -172.66 2.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.01 0.924 . . . . 0.0 110.177 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 61.4 mmt-85 -128.22 125.5 39.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.858 0.863 . . . . 0.0 109.69 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.54 HG13 ' HB2' ' A' ' 43' ' ' PHE . 41.3 mt -73.63 137.08 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.199 1.0 . . . . 0.0 111.767 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -134.94 -176.88 4.39 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 126.879 2.072 . . . . 0.0 108.081 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -30.96 112.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.932 1.693 . . . . 0.0 114.328 -170.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 112' ' ' ILE . 27.5 m -91.61 106.26 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -88.22 110.78 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.4 mt -92.59 119.86 32.46 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.366 0.666 . . . . 0.0 109.436 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.2 t -151.51 134.24 15.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 44.4 mt-10 -74.67 -0.98 19.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.797 0.839 . . . . 0.0 112.299 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.682 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 12.9 m-80 -112.66 120.16 41.62 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.2 -20.84 55.89 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.342 2.028 . . . . 0.0 112.345 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 65.4 mtm -71.79 -24.63 61.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.184 0.994 . . . . 0.0 111.091 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.682 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 36.4 mm-40 -62.58 -28.89 70.19 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.875 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -76.31 -20.06 57.65 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.728 0.411 . . . . 0.0 111.185 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CE2' HD22 ' A' ' 87' ' ' LEU . 87.7 m-85 -93.45 -19.56 21.14 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.9 0.48 . . . . 0.0 111.09 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 9.1 pt-20 -84.8 -30.4 24.62 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.808 0.276 . . . . 0.0 110.573 168.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.3 m -80.39 -58.9 2.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.953 0.501 . . . . 0.0 110.644 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.64 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 85.8 m-85 -100.85 -69.68 0.77 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.73 -78.03 0.5 Allowed Glycine 0 C--N 1.353 1.516 0 O-C-N 123.5 0.5 . . . . 0.0 112.622 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.85 -44.68 91.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.756 1.222 . . . . 0.0 111.463 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.64 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 61.1 mmt-85 -64.97 -30.17 71.14 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.677 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.73 149.79 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.563 0.745 . . . . 0.0 111.142 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -65.5 -41.4 93.23 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.088 0.555 . . . . 0.0 112.355 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -109.55 169.03 8.97 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.466 HG22 ' HG2' ' A' ' 86' ' ' GLU . 8.8 t -98.26 168.36 10.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 172.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -68.17 -25.69 65.38 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.201 0.524 . . . . 0.0 111.375 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.7 -52.57 65.11 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.519 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.466 ' HG2' HG22 ' A' ' 83' ' ' THR . 48.6 mm-40 -57.78 -35.11 70.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.736 0.414 . . . . 0.0 110.78 176.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.419 HD22 ' CE2' ' A' ' 73' ' ' PHE . 26.5 tp -62.12 -57.27 12.19 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.945 0.898 . . . . 0.0 111.56 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -38.72 85.53 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -172.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -79.16 -27.48 42.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.688 0.395 . . . . 0.0 111.512 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -65.92 -41.67 91.08 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.269 0.628 . . . . 0.0 110.267 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 62.5 mtm -72.1 -30.03 64.68 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.763 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -73.86 -33.94 64.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.97 0.508 . . . . 0.0 110.678 171.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 m -65.09 -26.6 68.29 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.359 0.663 . . . . 0.0 111.441 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -64.47 -47.15 80.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.616 0.366 . . . . 0.0 110.454 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.43 -30.33 23.64 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -172.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -82.35 -42.65 18.44 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.461 0.573 . . . . 0.0 111.864 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -84.2 -20.82 31.71 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.504 0.322 . . . . 0.0 110.855 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.9 -97.12 0.26 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -149.79 -64.61 0.22 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.602 1.161 . . . . 0.0 108.46 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -169.23 158.19 8.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.979 1.312 . . . . 0.0 109.308 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -159.79 116.6 2.56 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.76 162.85 22.76 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.412 1.085 . . . . 0.0 110.031 -175.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.4 m -54.25 -57.37 11.47 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.72 0.637 . . . . 0.0 110.323 176.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.493 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 6.8 mmpt? 50.35 -84.18 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.289 1.435 . . . . 0.0 112.778 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.635 ' HG3' ' HD2' ' A' ' 106' ' ' LYS . 1.0 OUTLIER -156.18 159.03 38.61 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.994 0.918 . . . . 0.0 109.33 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.635 ' HD2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -72.52 170.31 14.63 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.787 175.086 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -124.28 144.4 50.0 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.047 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.604 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 2.9 tm? -68.41 108.31 3.21 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -97.1 161.14 13.96 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.0 ptm -143.94 131.22 20.81 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.668 0.787 . . . . 0.0 109.568 -174.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.34 101.97 11.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.566 0.746 . . . . 0.0 109.107 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.419 ' HA ' HG12 ' A' ' 63' ' ' VAL . 36.9 mt -80.2 120.36 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -83.93 139.24 32.71 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -120.69 121.28 37.93 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.616 1.167 . . . . 0.0 109.026 -177.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -113.94 171.34 7.65 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.011 0.924 . . . . 0.0 108.894 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.4 t70 52.07 46.79 26.01 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.365 1.066 . . . . 0.0 112.167 166.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.9 t -74.88 108.25 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.534 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.76 153.68 20.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.004 0.922 . . . . 0.0 110.302 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -108.26 136.69 47.49 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.739 0.816 . . . . 0.0 110.379 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.46 ' HD2' ' HB2' ' A' ' 54' ' ' PHE . 10.1 m-30 -95.93 78.8 3.23 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.613 0.765 . . . . 0.0 109.128 172.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.95 -24.96 63.43 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.903 169.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.537 ' HG3' HG13 ' A' ' 124' ' ' ILE . 18.5 ptpt -81.7 145.57 54.61 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.385 1.074 . . . . 0.0 109.344 171.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.81 77.26 3.97 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.936 2.424 . . . . 0.0 113.076 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.537 HG13 ' HG3' ' A' ' 122' ' ' LYS . 54.2 mt -86.37 128.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -109.3 146.48 34.02 Favored Pre-proline 0 C--O 1.242 0.668 0 C-N-CA 123.943 0.897 . . . . 0.0 109.351 -177.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.536 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 10.3 Cg_exo -73.26 147.04 41.45 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 122.879 2.386 . . . . 0.0 112.397 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -70.12 -26.49 63.98 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.647 0.779 . . . . 0.0 109.273 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -144.62 159.23 43.16 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.202 1.001 . . . . 0.0 109.439 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.5 133.21 38.62 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.0 t -105.85 95.31 10.42 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.45 -175.48 2.7 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.056 2.504 . . . . 0.0 111.957 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.585 ' HA ' ' HG3' ' A' ' 10' ' ' PRO . 27.1 m -57.74 -26.63 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.331 1.052 . . . . 0.0 113.816 -174.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.14 -22.22 74.24 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.259 0.349 . . . . 0.0 113.607 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.08 149.0 8.19 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 112.362 -0.295 . . . . 0.0 112.362 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -108.8 135.94 49.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.508 0.723 . . . . 0.0 109.829 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.425 ' OH ' ' HB ' ' A' ' 33' ' ' VAL . 1.6 m-85 -76.26 109.74 10.2 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.72 114.14 18.41 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -125.99 138.82 53.77 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.607 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.475 178.655 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 121.539 0.685 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -73.93 -17.46 61.02 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.915 -166.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -67.23 -16.32 64.22 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 5' ' ' VAL . 27.1 mm 65.73 -171.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -143.49 -39.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 157.464 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.472 ' HA3' ' HG3' ' A' ' 42' ' ' LYS . . . -167.52 -164.35 23.04 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.438 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.448 HG12 HD11 ' A' ' 60' ' ' ILE . 10.9 p -132.08 144.43 37.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 t -113.87 137.64 51.39 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -132.66 145.12 55.8 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.884 0.874 . . . . 0.0 109.21 178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HD3' HG12 ' A' ' 130' ' ' VAL . 30.2 Cg_endo -61.96 -25.04 77.54 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.962 2.442 . . . . 0.0 112.016 173.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.9 mm 68.75 134.03 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.057 1.343 . . . . 0.0 111.913 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -54.62 114.43 1.84 Allowed 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.546 2.164 . . . . 0.0 110.25 169.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -63.47 -28.03 69.68 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.287 1.035 . . . . 0.0 113.436 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -61.43 -36.24 79.8 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.146 0.498 . . . . 0.0 110.46 172.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -107.91 19.15 20.42 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.143 -172.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.401 ' SD ' HG21 ' A' ' 55' ' ' VAL . 16.0 tmm? -66.94 -32.78 74.26 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.626 0.77 . . . . 0.0 110.153 175.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.32 -33.87 77.0 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.238 1.015 . . . . 0.0 112.195 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 81' ' ' PHE . 11.0 mmt180 -54.09 -52.92 59.47 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.655 1.182 . . . . 0.0 113.277 -164.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 47.9 m-85 -60.24 -29.36 68.71 Favored 'General case' 0 CA--C 1.554 1.104 0 O-C-N 124.121 0.888 . . . . 0.0 110.743 -174.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -94.7 -24.76 17.0 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.415 1.086 . . . . 0.0 110.674 -176.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.22 -42.73 79.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.92 1.288 . . . . 0.0 111.028 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.7 ptpt -109.33 -16.43 14.04 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.238 -171.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.93 -14.85 9.35 Favored Glycine 0 N--CA 1.479 1.503 0 N-CA-C 114.191 0.436 . . . . 0.0 114.191 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -150.06 105.64 3.4 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.668 1.187 . . . . 0.0 108.94 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.5 t70 -107.32 174.73 5.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 110.585 -175.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -133.88 109.07 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.435 ' HD2' HD12 ' A' ' 112' ' ' ILE . 76.9 t80 -91.12 108.92 20.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.337 0.655 . . . . 0.0 109.577 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 m -94.45 132.93 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.516 0.674 . . . . 0.0 110.673 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.645 ' HD3' ' HD2' ' A' ' 30' ' ' PRO . 14.9 tppt? -134.84 133.24 20.94 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.349 1.06 . . . . 0.0 108.793 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.645 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 59.5 Cg_endo -71.73 66.97 3.07 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.669 2.246 . . . . 0.0 113.2 172.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 55.07 17.02 1.74 Allowed 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.158 1.383 . . . . 0.0 114.672 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 m -70.32 -28.37 65.11 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.225 0.61 . . . . 0.0 110.875 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.45 HG23 ' HG2' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -87.6 148.62 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.344 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -87.72 -168.11 2.11 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.173 0.589 . . . . 0.0 110.917 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -74.58 -1.25 20.68 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -170.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.11 -30.59 70.45 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.967 0.507 . . . . 0.0 110.815 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.84 98.38 0.73 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.29 1.036 . . . . 0.0 111.55 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HG3' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -122.28 156.27 60.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.835 1.254 . . . . 0.0 108.883 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.82 107.0 2.11 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.256 1.971 . . . . 0.0 111.472 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.45 31.65 0.46 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.225 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.641 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 88.8 mtp -112.55 -173.99 2.36 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.911 0.884 . . . . 0.0 110.669 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.472 ' HG3' ' HA3' ' A' ' 6' ' ' GLY . 15.2 ptpt -116.85 156.44 27.3 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.387 1.075 . . . . 0.0 109.599 172.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.502 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -136.05 100.15 4.34 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 177.676 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.1 t -86.3 124.42 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.245 0.545 . . . . 0.0 110.131 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.422 ' HE2' HG13 ' A' ' 117' ' ' VAL . 25.7 m-85 -89.4 106.7 18.62 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.633 0.773 . . . . 0.0 109.876 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.406 ' HA ' ' CD1' ' A' ' 54' ' ' PHE . 78.3 t80 -77.94 155.92 30.55 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.94 1.4 . . . . 0.0 111.401 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 56.04 -172.19 0.07 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.282 1.833 . . . . 0.0 111.588 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.4 t -165.91 -164.06 0.68 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.246 0.618 . . . . 0.0 109.65 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -56.88 -37.97 72.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.668 0.787 . . . . 0.0 110.359 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -127.26 175.58 8.06 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.945 0.898 . . . . 0.0 110.436 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -77.23 82.94 3.71 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.786 0.834 . . . . 0.0 109.553 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.7 p -121.76 7.92 9.97 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.141 0.976 . . . . 0.0 111.505 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.42 -67.59 3.04 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.238 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 46' ' ' TYR . 98.4 m-85 -132.44 174.01 10.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.249 1.019 . . . . 0.0 109.947 175.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.401 HG21 ' SD ' ' A' ' 16' ' ' MET . 7.7 p -118.31 -34.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.784 0.834 . . . . 0.0 110.449 173.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.13 -160.04 23.37 Favored Glycine 0 C--N 1.35 1.355 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.972 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.521 ' HG3' ' HB3' ' A' ' 118' ' ' LYS . 7.3 pt-20 -152.19 177.55 10.41 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.69 1.196 . . . . 0.0 109.526 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.494 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.59 -172.3 3.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.938 0.895 . . . . 0.0 110.035 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.8 mmt-85 -123.91 122.3 37.61 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.802 0.841 . . . . 0.0 109.952 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.641 ' HB ' ' HB2' ' A' ' 41' ' ' MET . 36.3 mt -74.56 128.49 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.856 0.862 . . . . 0.0 109.86 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.589 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 31.6 mmmt -132.49 -167.96 1.98 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 125.433 1.493 . . . . 0.0 107.609 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -41.7 113.22 0.4 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.702 1.201 . . . . 0.0 113.69 -163.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.18 111.91 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.738 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.7 109.68 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.19 117.84 26.2 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -148.62 127.39 12.56 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.316 1.047 . . . . 0.0 109.052 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 34.7 mt-10 -65.68 -20.94 66.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.607 0.763 . . . . 0.0 111.921 176.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -99.81 118.0 62.57 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.44 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 40.6 Cg_endo -67.47 -18.6 49.3 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.196 1.931 . . . . 0.0 112.855 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.44 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.2 mpp? -73.63 -25.63 60.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.754 0.421 . . . . 0.0 111.008 -173.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -64.4 -22.78 67.07 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.691 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -78.3 -30.83 48.55 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.022 0.529 . . . . 0.0 110.93 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.512 ' CE2' HD22 ' A' ' 87' ' ' LEU . 92.7 m-85 -82.74 -16.11 49.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.664 0.386 . . . . 0.0 111.915 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.83 -32.03 16.23 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.668 0.213 . . . . 0.0 110.794 171.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 92.8 m -76.75 -41.42 44.93 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 120.848 0.356 . . . . 0.0 111.109 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.712 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 44.0 m-85 -117.83 -67.29 1.0 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.426 0.69 . . . . 0.0 109.219 -175.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.06 -97.84 2.1 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.105 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.71 -22.15 61.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.8 0.44 . . . . 0.0 110.855 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.712 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 31.8 mmt180 -59.91 -37.78 80.42 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.007 0.523 . . . . 0.0 111.294 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.482 HG12 HD23 ' A' ' 82' ' ' LEU . 39.0 t -62.74 145.08 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 O-C-N 123.729 0.643 . . . . 0.0 109.767 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 41.2 p90 -60.06 -20.1 56.32 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.482 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -133.56 164.87 26.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.6 t -98.36 176.33 5.74 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.645 0.657 . . . . 0.0 109.435 173.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -61.63 -29.44 70.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.195 0.598 . . . . 0.0 111.196 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.46 ' H ' HG23 ' A' ' 83' ' ' THR . 3.2 m-20 -65.96 -45.83 80.34 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.954 0.902 . . . . 0.0 111.409 174.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.4 -36.34 83.4 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.183 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.512 HD22 ' CE2' ' A' ' 73' ' ' PHE . 27.1 tp -60.56 -54.81 40.93 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.469 0.708 . . . . 0.0 110.985 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -64.03 -42.51 97.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.158 -172.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -70.28 -31.11 68.33 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.35 0.26 . . . . 0.0 110.729 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 76.0 t80 -65.09 -43.62 91.52 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.652 0.781 . . . . 0.0 110.482 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 61.4 mtm -74.82 -31.65 61.74 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.365 0.666 . . . . 0.0 110.824 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 31.9 mmmt -69.76 -28.09 65.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.126 0.571 . . . . 0.0 110.691 172.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.7 m -74.32 -41.33 61.28 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.965 0.506 . . . . 0.0 110.045 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 90.1 mm-40 -60.74 -46.28 91.04 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.658 0.383 . . . . 0.0 111.565 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.82 -24.86 65.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.862 0.465 . . . . 0.0 112.143 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -97.22 -30.71 12.83 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.69 0.396 . . . . 0.0 111.402 -174.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -89.19 -26.05 21.46 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.692 0.397 . . . . 0.0 111.092 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -155.12 -148.45 5.01 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? 66.58 101.25 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.679 1.192 . . . . 0.0 111.653 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -73.95 -68.57 0.5 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.376 0.67 . . . . 0.0 110.465 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -155.22 103.55 2.37 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -79.31 -168.38 1.49 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.585 0.754 . . . . 0.0 112.15 -170.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -61.25 -11.62 10.2 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.477 1.111 . . . . 0.0 113.876 -171.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.9 tptt 62.63 26.85 15.9 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 123.037 1.399 . . . . 0.0 109.316 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.528 ' HG3' ' HD2' ' A' ' 106' ' ' LYS . 1.1 tpmt? -163.61 162.76 24.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.64 -174.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.528 ' HD2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -71.62 147.21 47.79 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -93.38 150.28 20.58 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.0 0.52 . . . . 0.0 109.728 178.083 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 3.1 tm? -69.29 122.95 19.91 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -106.04 156.25 18.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.489 0.715 . . . . 0.0 109.348 171.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.7 ptm -131.57 129.17 40.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.093 0.957 . . . . 0.0 108.828 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.69 102.24 11.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 60' ' ' ILE . 33.8 mt -82.61 121.31 35.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.14 101.43 8.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.494 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.1 mm? -87.11 120.56 28.51 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 122.902 0.481 . . . . 0.0 109.779 175.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.589 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 2.1 pp20? -138.34 168.8 18.98 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.1 t70 60.76 30.05 19.42 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.781 0.833 . . . . 0.0 110.654 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.422 HG13 ' HE2' ' A' ' 45' ' ' PHE . 61.0 t -61.19 118.11 3.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.219 -171.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . 1.6 tpmt? -102.01 152.39 21.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.069 0.947 . . . . 0.0 110.654 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -106.07 138.54 42.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.985 0.914 . . . . 0.0 109.396 174.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -87.18 90.68 8.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.05 -34.63 77.98 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.695 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -85.76 139.37 35.28 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.196 172.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.35 89.15 1.37 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.794 2.329 . . . . 0.0 111.742 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 21.2 mt -72.42 130.24 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.096 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 142.92 57.64 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.014 0.526 . . . . 0.0 109.623 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.02 155.74 19.93 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.404 2.069 . . . . 0.0 113.307 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -74.21 -25.83 59.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.825 173.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -170.49 173.6 5.49 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.194 0.998 . . . . 0.0 109.697 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -67.14 128.18 35.4 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 166.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.467 HG12 ' HD3' ' A' ' 10' ' ' PRO . 78.9 t -101.03 103.63 26.71 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.87 -177.81 1.74 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.229 2.619 . . . . 0.0 113.33 -174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.0 m -61.46 -27.19 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.981 0.913 . . . . 0.0 112.639 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.7 -15.32 75.94 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.183 0.302 . . . . 0.0 113.12 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.28 169.21 39.47 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.351 0.501 . . . . 0.0 112.928 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -120.65 146.51 46.33 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.008 0.923 . . . . 0.0 109.783 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -87.51 118.18 26.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.015 0.526 . . . . 0.0 110.141 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tt -84.7 128.0 34.38 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 172.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.439 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -133.1 136.96 46.15 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.794 0.438 . . . . 0.0 110.516 -175.009 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 CA--C 1.554 1.133 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.414 177.92 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 14.7 tpt . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.4 t -54.18 -18.36 3.73 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.721 1.208 . . . . 0.0 114.1 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -61.03 -21.52 63.69 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.439 1.096 . . . . 0.0 113.545 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.446 HG22 ' H ' ' A' ' 5' ' ' VAL . 26.2 mm 66.25 -174.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 124.408 1.083 . . . . 0.0 109.596 -175.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 139' ' ' GLU . 2.7 m -154.73 -40.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 125.269 1.427 . . . . 0.0 108.511 158.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.15 -159.15 14.15 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.204 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 12.6 p -126.68 160.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 t -135.41 139.59 44.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.276 0.63 . . . . 0.0 109.864 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -136.65 142.2 38.19 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.011 0.924 . . . . 0.0 109.789 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HD3' HG12 ' A' ' 130' ' ' VAL . 47.9 Cg_endo -69.03 -35.56 14.53 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.694 2.263 . . . . 0.0 111.226 168.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.7 mt 61.23 100.95 0.04 OUTLIER Pre-proline 0 C--N 1.361 1.098 0 C-N-CA 125.523 1.529 . . . . 0.0 110.928 -175.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.73 -179.4 2.87 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.456 2.104 . . . . 0.0 111.451 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.536 ' HG3' ' H ' ' A' ' 14' ' ' ARG . 31.8 tptt 67.86 -176.38 0.2 Allowed 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.744 0.818 . . . . 0.0 109.703 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.536 ' H ' ' HG3' ' A' ' 13' ' ' LYS . 79.8 mtp180 -76.79 -15.09 59.84 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.316 0.646 . . . . 0.0 112.245 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.527 ' CZ ' ' HG2' ' A' ' 86' ' ' GLU . 11.5 m-30 -74.28 7.52 2.76 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -165.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.623 ' SD ' HG11 ' A' ' 55' ' ' VAL . 18.2 tmm? -67.7 -44.54 77.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.217 0.607 . . . . 0.0 109.584 168.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.07 -15.71 63.51 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.859 0.864 . . . . 0.0 113.088 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG2' ' HA ' ' A' ' 15' ' ' PHE . 20.4 mmt180 -51.82 -50.9 59.92 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.138 0.975 . . . . 0.0 111.685 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.604 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 22.5 m-85 -62.33 -29.03 70.16 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.294 -170.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -93.06 -29.09 15.98 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.322 1.049 . . . . 0.0 110.411 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -63.06 -46.39 87.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.019 0.928 . . . . 0.0 110.638 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.6 ptpt -101.88 -15.35 16.9 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.356 -172.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.11 -7.71 27.99 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -159.31 107.14 1.78 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.6 1.16 . . . . 0.0 108.279 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.604 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.4 t70 -115.68 177.61 4.61 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.984 0.913 . . . . 0.0 109.773 -176.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -132.65 108.98 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -87.93 107.38 18.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 0.0 109.917 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 m -90.07 125.76 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 121.566 0.698 . . . . 0.0 110.906 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 7.4 mmpt? -108.96 131.58 21.71 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.924 1.29 . . . . 0.0 109.606 174.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.13 54.55 4.97 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.066 2.511 . . . . 0.0 112.267 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 57.6 87.17 0.07 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.609 1.164 . . . . 0.0 111.001 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 29.1 m -130.65 -68.72 0.68 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.49 0.716 . . . . 0.0 109.344 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -109.0 106.74 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -137.2 -10.67 1.7 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.234 1.014 . . . . 0.0 110.391 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -64.78 -55.7 18.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.211 1.004 . . . . 0.0 110.651 -170.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -102.41 -9.01 20.65 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.085 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 110.7 3.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.137 0.575 . . . . 0.0 110.979 -173.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -139.12 150.81 66.12 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.125 0.57 . . . . 0.0 109.476 177.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 105.85 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.838 2.359 . . . . 0.0 111.329 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.1 -17.93 1.74 Allowed Glycine 0 N--CA 1.467 0.716 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.417 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.486 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 29.2 mtm -75.28 -179.82 4.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.547 0.689 . . . . 0.0 111.418 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -106.63 161.69 14.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.931 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -137.24 104.73 5.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.97 134.77 27.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -97.67 102.49 14.26 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.459 ' HD2' ' HB3' ' A' ' 10' ' ' PRO . 88.1 t80 -70.4 153.42 43.0 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.083 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 69.12 143.47 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.523 1.129 . . . . 0.0 111.222 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.638 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 48.1 m -105.03 178.66 4.5 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.064 0.546 . . . . 0.0 110.77 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -64.07 92.44 0.08 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.527 0.731 . . . . 0.0 109.355 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 75.46 -51.26 0.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.271 1.828 . . . . 0.0 111.95 -167.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.04 162.17 14.63 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.13 0.972 . . . . 0.0 112.977 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.3 m -98.23 142.28 30.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.537 1.135 . . . . 0.0 111.02 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.506 ' HA2' ' HD3' ' A' ' 126' ' ' PRO . . . 137.81 -114.02 1.05 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 176.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -144.56 140.63 28.92 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.248 1.019 . . . . 0.0 108.27 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.638 ' HB ' ' HA ' ' A' ' 48' ' ' SER . 7.3 p -90.11 -34.19 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.697 0.399 . . . . 0.0 111.289 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.06 -160.22 26.36 Favored Glycine 0 C--N 1.345 1.055 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.425 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -149.93 176.95 10.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.288 1.035 . . . . 0.0 109.215 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -167.01 -179.02 4.44 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.977 0.911 . . . . 0.0 110.44 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -120.34 125.33 47.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.621 0.768 . . . . 0.0 110.49 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.17 130.72 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.54 1.136 . . . . 0.0 110.822 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -126.74 -178.86 4.54 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 125.381 1.472 . . . . 0.0 108.94 176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -29.76 113.62 0.09 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.358 1.863 . . . . 0.0 114.562 -172.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.76 109.09 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.643 0.735 . . . . 0.0 109.06 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 96.6 t -87.86 109.41 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.2 mt -89.48 121.65 31.91 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.536 0.734 . . . . 0.0 109.399 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 t -149.79 140.31 22.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.502 0.721 . . . . 0.0 110.07 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.537 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 25.6 mt-10 -80.15 -9.4 59.71 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.519 177.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 73.7 m-20 -112.12 119.76 43.32 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 169.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HG2' HD21 ' A' ' 87' ' ' LEU . 38.3 Cg_endo -67.38 -15.22 45.06 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.903 2.402 . . . . 0.0 113.056 174.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.43 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.5 mpp? -74.41 -22.87 58.95 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.22 0.608 . . . . 0.0 111.013 -176.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.528 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 56.8 mt-30 -69.28 -26.51 64.79 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.628 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -71.58 -20.46 62.0 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.77 0.428 . . . . 0.0 111.312 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.551 ' HE2' HD22 ' A' ' 87' ' ' LEU . 24.9 m-85 -88.01 -39.99 14.23 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.828 0.451 . . . . 0.0 110.766 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 13.1 pt-20 -69.28 -27.59 65.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 120.542 0.21 . . . . 0.0 110.575 174.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.0 m -82.89 -61.29 1.91 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 123.042 0.537 . . . . 0.0 110.612 177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.72 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 56.0 m-85 -102.62 -67.78 0.86 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.215 0.606 . . . . 0.0 109.715 -177.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 75.3 -87.33 0.8 Allowed Glycine 0 C--N 1.352 1.436 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.656 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -56.25 -36.52 68.62 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.019 1.327 . . . . 0.0 111.732 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.72 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 34.4 mmt180 -69.35 -36.95 77.38 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.062 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.5 HG12 HD23 ' A' ' 82' ' ' LEU . 21.2 t -64.6 148.97 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -65.35 -8.64 19.34 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.2 pt? -149.79 168.71 22.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.936 0.895 . . . . 0.0 109.11 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.0 t -112.36 -176.5 2.93 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 172.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -59.69 -33.66 71.88 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.67 0.788 . . . . 0.0 111.922 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.454 ' H ' HG23 ' A' ' 83' ' ' THR . 15.7 m-20 -62.69 -43.33 99.08 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.052 0.541 . . . . 0.0 111.222 175.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 1.6 mp0 -73.0 -25.16 60.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.505 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.551 HD22 ' HE2' ' A' ' 73' ' ' PHE . 53.6 tp -70.69 -48.89 52.37 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.835 0.454 . . . . 0.0 110.491 176.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -65.76 -39.2 90.8 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.31 0.381 . . . . 0.0 110.964 -176.176 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 6.2 pt-20 -69.79 -33.29 72.17 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.025 0.203 . . . . 0.0 110.828 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.472 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 55.7 t80 -67.16 -43.8 81.37 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.197 0.599 . . . . 0.0 110.522 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 73.7 mtm -71.06 -40.15 71.82 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.421 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.0 mmpt? -67.26 -30.74 70.71 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 119.803 -0.142 . . . . 0.0 110.64 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.2 t -60.99 -44.65 97.09 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.753 0.821 . . . . 0.0 110.815 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 82.5 mm-40 -75.11 -1.81 24.74 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.688 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.505 ' HB3' ' HG2' ' A' ' 100' ' ' ARG . 11.7 pt-20 -121.85 -22.37 5.78 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 175.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 15.1 ptp180 -88.25 -49.54 6.92 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 118.44 0.564 . . . . 0.0 109.621 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -81.15 -38.52 27.03 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -90.77 -138.91 7.8 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.255 175.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -165.33 133.86 3.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.055 0.542 . . . . 0.0 110.294 -174.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.505 ' HG2' ' HB3' ' A' ' 95' ' ' GLU . 8.5 ptp85 -166.84 148.83 6.23 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.846 0.858 . . . . 0.0 109.834 171.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 178.05 78.0 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.702 1.201 . . . . 0.0 109.355 172.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -171.59 127.21 0.64 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.381 0.673 . . . . 0.0 110.001 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 t 58.22 96.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.179 1.392 . . . . 0.0 111.744 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.64 93.65 2.57 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 173.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -134.09 156.44 48.27 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.774 1.229 . . . . 0.0 108.868 -171.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -74.4 179.81 4.39 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.22 0.608 . . . . 0.0 110.365 173.53 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 140.66 40.73 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.21 95.3 4.27 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -84.23 155.78 22.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 171.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.464 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 12.3 ptm -136.61 129.55 30.96 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -104.74 100.78 10.42 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -176.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.6 mt -82.18 114.31 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -80.63 102.31 9.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.2 mm? -86.4 109.27 18.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.19 0.596 . . . . 0.0 110.694 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -106.97 174.51 5.86 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.4 t70 60.2 35.28 21.01 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.03 0.932 . . . . 0.0 111.348 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.38 102.95 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.347 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.91 154.76 23.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.509 1.124 . . . . 0.0 110.362 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -110.6 136.17 50.11 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.031 0.933 . . . . 0.0 110.067 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -91.05 86.92 6.38 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.06 -27.72 64.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.509 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.04 137.68 49.64 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.358 1.063 . . . . 0.0 109.537 171.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -76.43 95.63 1.05 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.751 2.301 . . . . 0.0 111.84 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.4 mt -87.97 128.24 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.857 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -86.26 129.28 54.18 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.011 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.506 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 35.1 Cg_endo -68.06 150.0 77.24 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.511 2.14 . . . . 0.0 113.961 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -67.85 -38.58 83.31 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.042 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.5 ptm85 -154.02 176.07 12.65 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.05 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.66 118.5 19.36 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.72 172.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.46 HG12 ' HD3' ' A' ' 10' ' ' PRO . 80.7 t -98.97 100.97 10.92 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.48 177.85 2.47 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.363 2.709 . . . . 0.0 112.528 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.58 -34.37 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 123.952 0.901 . . . . 0.0 111.849 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 -13.62 71.67 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.68 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.19 176.2 51.36 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 123.543 0.592 . . . . 0.0 112.939 175.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -126.27 137.28 53.5 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.54 106.82 4.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 166.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.09 124.71 27.49 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -134.5 119.98 19.15 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.457 ' HB3' HG11 ' A' ' 5' ' ' VAL . 12.5 tp10 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 m -64.95 -8.47 15.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -173.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -66.69 -21.83 66.08 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.977 0.511 . . . . 0.0 111.616 172.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 5' ' ' VAL . 22.7 mm 63.46 -166.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 124.621 1.168 . . . . 0.0 108.526 -175.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.549 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.7 m -151.99 -42.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 156.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.22 -161.13 20.2 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.397 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.41 136.65 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.575 0.75 . . . . 0.0 109.504 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 t -103.16 134.13 47.1 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.515 0.726 . . . . 0.0 109.584 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.65 123.15 11.65 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 123.514 0.726 . . . . 0.0 110.205 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.611 ' HD3' HG12 ' A' ' 130' ' ' VAL . 74.0 Cg_endo -80.26 94.55 1.01 Allowed 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.419 2.079 . . . . 0.0 109.54 165.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.42 110.64 2.89 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.191 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -85.06 33.66 0.49 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.436 2.757 . . . . 0.0 111.683 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HG3' ' HD2' ' A' ' 15' ' ' PHE . 49.9 tptt -141.09 144.5 34.94 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -170.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -74.23 10.08 1.4 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.574 0.75 . . . . 0.0 112.611 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.427 ' HD2' ' HG3' ' A' ' 13' ' ' LYS . 97.6 m-85 -111.79 25.02 12.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.232 1.013 . . . . 0.0 111.758 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.553 ' SD ' HG11 ' A' ' 55' ' ' VAL . 45.2 ttm -62.08 -36.73 82.55 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.667 0.746 . . . . 0.0 109.549 166.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.32 -23.19 67.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.029 1.331 . . . . 0.0 112.417 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -59.58 -42.48 92.59 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.507 0.723 . . . . 0.0 112.09 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -65.28 -30.97 71.88 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.758 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -92.03 -16.07 26.97 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.723 0.809 . . . . 0.0 110.792 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -73.98 -49.94 22.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.389 1.076 . . . . 0.0 109.797 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -110.86 -15.61 13.75 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -172.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.92 8.3 63.92 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 113.992 0.357 . . . . 0.0 113.992 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -159.69 86.85 0.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.966 1.306 . . . . 0.0 107.744 -173.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -134.93 -178.03 4.9 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.795 0.838 . . . . 0.0 108.976 -171.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -139.7 121.51 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.265 0.939 . . . . 0.0 109.764 -171.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -98.0 114.47 26.61 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.646 0.778 . . . . 0.0 109.167 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.0 m -92.18 133.48 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.24 0.543 . . . . 0.0 111.091 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 6.0 mmpt? -119.56 130.51 24.8 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.352 1.461 . . . . 0.0 110.113 178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.25 55.52 5.1 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.07 2.513 . . . . 0.0 111.484 169.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 56.47 27.66 12.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.571 1.148 . . . . 0.0 112.923 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.479 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 4.5 m -64.33 -39.31 93.64 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.698 0.799 . . . . 0.0 110.389 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.5 m -82.71 151.14 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.285 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -80.47 -173.95 4.36 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.502 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -65.05 -18.11 65.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.498 1.119 . . . . 0.0 112.902 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -59.12 -22.56 61.05 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.37 0.668 . . . . 0.0 111.515 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 94.39 0.32 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.046 0.538 . . . . 0.0 110.328 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 3.7 ptpp? -109.66 157.78 36.57 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.55 55.46 5.32 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.212 2.608 . . . . 0.0 112.175 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.94 43.76 0.2 Allowed Glycine 0 C--O 1.239 0.467 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.786 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.521 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 30.9 mtm -130.11 -173.01 2.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.623 1.169 . . . . 0.0 111.074 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.75 165.23 12.76 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.55 1.14 . . . . 0.0 110.518 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.408 ' CB ' HD11 ' A' ' 114' ' ' LEU . 4.1 t80 -136.2 101.95 4.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 34.2 t -90.54 108.15 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.214 0.53 . . . . 0.0 110.193 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -75.61 120.36 20.91 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.754 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 33.1 t80 -105.59 161.56 14.26 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.595 1.158 . . . . 0.0 110.134 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 66.25 76.57 0.31 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.297 1.439 . . . . 0.0 109.655 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.4 t -60.22 153.85 21.26 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.998 -172.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -57.13 -31.8 65.71 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.231 173.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -106.91 -66.01 1.05 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.842 0.857 . . . . 0.0 110.985 -175.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -97.21 -177.2 3.76 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.767 0.827 . . . . 0.0 111.458 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.1 m -111.82 94.3 4.88 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.432 0.693 . . . . 0.0 109.546 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.26 -173.33 44.23 Favored Glycine 0 C--O 1.243 0.675 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 19.7 m-85 -61.42 108.8 1.0 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 172.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG11 ' SD ' ' A' ' 16' ' ' MET . 2.7 p -67.59 -34.74 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 122.996 0.518 . . . . 0.0 110.771 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.93 -165.71 33.76 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.58 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 17.2 pt-20 -141.17 176.75 8.58 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.05 0.94 . . . . 0.0 108.952 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.471 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.69 -173.84 4.15 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.077 0.951 . . . . 0.0 109.304 176.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -125.94 119.49 27.89 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.726 0.81 . . . . 0.0 109.494 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.8 mt -71.54 129.78 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 124.397 1.061 . . . . 0.0 110.669 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -132.29 177.26 7.72 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 126.187 1.795 . . . . 0.0 109.006 -174.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -30.35 111.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 125.463 1.727 . . . . 0.0 114.113 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.0 m -87.97 123.93 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.288 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 99.0 t -90.02 107.18 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.591 ' HB3' HD11 ' A' ' 108' ' ' LEU . 77.1 mt -88.43 116.76 26.88 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.6 t -153.07 135.76 15.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.644 0.778 . . . . 0.0 110.323 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.12 -34.62 78.47 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.84 0.856 . . . . 0.0 111.669 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.432 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 79.1 m-20 -94.41 120.17 65.51 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.004 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.557 ' HG2' HD21 ' A' ' 87' ' ' LEU . 61.1 Cg_endo -72.5 -7.11 20.31 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.082 2.521 . . . . 0.0 113.387 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 45.9 mtm -86.02 -21.93 27.53 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.013 0.525 . . . . 0.0 110.75 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.432 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 30.4 mt-30 -66.44 -22.24 66.21 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.247 174.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -71.59 -26.21 62.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.691 0.396 . . . . 0.0 110.659 175.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.41 ' HE2' HD22 ' A' ' 87' ' ' LEU . 33.1 m-85 -82.8 -31.26 28.27 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.797 0.439 . . . . 0.0 111.179 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.9 -28.86 60.8 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.932 0.333 . . . . 0.0 110.681 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.8 m -81.83 -58.95 2.76 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.132 0.573 . . . . 0.0 110.386 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.805 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 71.9 m-85 -100.86 -62.83 1.19 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.847 0.859 . . . . 0.0 110.329 -174.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.49 -83.23 0.56 Allowed Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.643 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -59.65 -44.09 93.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.622 0.769 . . . . 0.0 110.663 175.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.805 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 29.2 mmt180 -70.32 -19.48 63.07 Favored 'General case' 0 C--O 1.205 -1.278 0 O-C-N 124.013 0.821 . . . . 0.0 111.938 -173.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 76' ' ' PHE . 40.8 t -76.52 131.07 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -54.51 -45.73 73.35 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.903 0.752 . . . . 0.0 112.554 -171.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.417 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -100.95 156.93 17.11 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.578 HG22 ' HG2' ' A' ' 86' ' ' GLU . 11.3 t -92.85 173.45 7.75 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -50.78 -41.35 56.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.422 1.089 . . . . 0.0 110.962 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.06 -46.78 87.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.23 1.012 . . . . 0.0 111.353 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.578 ' HG2' HG22 ' A' ' 83' ' ' THR . 42.3 mm-40 -62.96 -37.36 86.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.205 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.557 HD21 ' HG2' ' A' ' 69' ' ' PRO . 45.2 tp -63.99 -54.11 39.57 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.882 0.739 . . . . 0.0 111.091 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -63.27 -43.59 97.51 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.27 0.356 . . . . 0.0 111.036 -173.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 12.9 pt-20 -73.89 -23.69 59.61 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.426 0.291 . . . . 0.0 111.181 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.445 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 61.6 t80 -65.17 -44.89 87.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.527 0.731 . . . . 0.0 110.122 172.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.8 mtm -76.53 -30.5 57.16 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.069 0.548 . . . . 0.0 110.908 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.1 mmmt -74.03 -20.11 60.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.201 0.601 . . . . 0.0 110.61 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -75.37 -34.1 61.1 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.944 0.498 . . . . 0.0 109.98 174.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 62.8 mm-40 -72.65 -18.84 61.53 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -93.22 -10.37 35.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.625 0.37 . . . . 0.0 111.908 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -101.59 -25.63 13.82 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.191 0.451 . . . . 0.0 110.72 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -95.25 -22.84 17.54 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.777 0.431 . . . . 0.0 110.64 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.03 -176.22 14.24 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -99.09 108.07 20.61 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.319 0.648 . . . . 0.0 109.513 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -131.3 38.71 3.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.734 0.813 . . . . 0.0 109.313 171.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -93.34 -21.5 19.53 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.857 0.463 . . . . 0.0 110.357 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.36 -54.28 35.37 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.325 1.05 . . . . 0.0 109.737 -173.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.5 t -162.07 175.67 11.52 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.28 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -77.59 -58.24 3.38 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.349 0.66 . . . . 0.0 109.849 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp 48.9 110.37 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.03 1.332 . . . . 0.0 112.352 -168.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 168.21 20.47 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.45 0.643 . . . . 0.0 110.084 -177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -131.84 149.88 52.32 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 174.282 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.3 tm? -76.75 92.39 3.57 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 171.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -75.48 159.25 31.53 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.381 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.7 ptm -140.0 129.68 24.44 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.308 0.643 . . . . 0.0 109.702 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -97.12 101.36 12.91 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.54 ' HA ' HG12 ' A' ' 63' ' ' VAL . 35.5 mt -80.46 113.85 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.6 110.63 17.14 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -94.33 132.42 38.95 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.409 0.623 . . . . 0.0 110.701 177.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -138.37 170.73 15.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.283 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 t70 59.8 35.84 22.06 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.859 0.838 . . . . 0.0 110.117 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.47 102.59 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.181 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.3 145.6 28.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.624 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -101.32 122.44 43.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -80.58 84.6 6.13 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 165.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.32 -33.5 72.49 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.568 170.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -79.99 137.25 53.64 Favored Pre-proline 0 CA--C 1.553 1.095 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.44 173.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.08 95.7 1.04 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.782 2.322 . . . . 0.0 111.538 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.5 mt -94.63 123.76 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.14 143.57 26.36 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.476 0.71 . . . . 0.0 109.764 -175.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.27 158.69 41.0 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.862 2.375 . . . . 0.0 112.054 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -81.34 -10.44 59.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.463 0.705 . . . . 0.0 110.993 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.5 ptm85 -153.48 172.96 16.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.991 0.916 . . . . 0.0 110.246 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.13 119.31 18.16 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.611 HG12 ' HD3' ' A' ' 10' ' ' PRO . 23.1 t -102.9 99.42 13.76 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.26 -176.28 3.19 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.882 2.388 . . . . 0.0 112.61 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.0 -27.06 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.453 1.101 . . . . 0.0 112.164 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.05 -25.95 75.04 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.205 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.39 148.15 6.98 Favored Glycine 0 C--N 1.348 1.237 0 C-N-CA 123.003 0.335 . . . . 0.0 112.448 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -108.86 142.29 39.67 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.426 0.691 . . . . 0.0 109.581 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -78.62 107.49 11.33 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.79 116.8 14.82 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.09 134.07 52.63 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.867 -1.063 . . . . 0.0 108.365 -177.44 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 2' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.415 ' N ' ' SD ' ' A' ' 1' ' ' MET . 51.0 m -60.3 -8.64 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.682 1.193 . . . . 0.0 114.181 -174.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 1' ' ' MET . 17.4 ptmt -61.84 -18.11 58.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.915 0.886 . . . . 0.0 112.421 173.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 5' ' ' VAL . 35.6 mm 67.19 -175.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.456 0 C-N-CA 124.129 0.972 . . . . 0.0 108.71 -174.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' N ' HG22 ' A' ' 4' ' ' ILE . 2.0 m -148.35 -38.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.228 1.011 . . . . 0.0 108.683 158.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.77 -161.22 19.81 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.482 0.489 . . . . 0.0 113.689 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.425 HG12 HD11 ' A' ' 60' ' ' ILE . 13.5 p -132.02 147.89 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.866 0.866 . . . . 0.0 108.686 175.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -122.76 140.93 52.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.553 0.741 . . . . 0.0 109.958 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -137.63 141.36 33.01 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.13 0.972 . . . . 0.0 110.12 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 20.7 Cg_exo -63.21 -46.73 9.39 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.347 2.698 . . . . 0.0 111.909 175.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.3 mt 51.57 72.13 1.3 Allowed Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.263 1.025 . . . . 0.0 109.603 -171.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.74 38.59 0.75 Allowed 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.261 2.64 . . . . 0.0 112.617 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -124.8 172.7 9.12 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.657 1.183 . . . . 0.0 109.908 -174.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -65.35 -15.23 62.34 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.086 0.954 . . . . 0.0 112.001 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -82.26 0.92 39.16 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.863 0.865 . . . . 0.0 112.778 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -57.43 -36.76 71.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.182 0.993 . . . . 0.0 111.696 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.07 -14.06 58.17 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -53.47 -46.99 70.17 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.411 1.085 . . . . 0.0 112.571 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 57.7 m-85 -68.54 -28.96 67.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.684 -174.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -93.85 -15.83 24.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.777 0.831 . . . . 0.0 110.452 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -70.69 -49.06 51.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.38 1.072 . . . . 0.0 109.748 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -109.63 -15.14 14.23 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.35 7.07 77.44 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.834 0.293 . . . . 0.0 113.834 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -168.6 90.4 0.26 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.457 1.103 . . . . 0.0 109.944 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.2 t70 -119.34 -178.04 3.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.267 1.027 . . . . 0.0 108.905 -174.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 113' ' ' GLU . 40.0 t -132.52 119.41 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.053 -1.029 . . . . 0.0 109.396 -177.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 81' ' ' PHE . 56.8 t80 -95.43 110.9 22.88 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.3 m -87.27 139.42 17.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-O 121.377 0.608 . . . . 0.0 110.507 177.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.55 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 5.9 mmpt? -125.46 132.43 24.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.198 1.399 . . . . 0.0 109.71 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.39 49.16 3.08 Favored 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 123.124 2.549 . . . . 0.0 111.952 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . 58.27 81.34 0.16 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.171 1.388 . . . . 0.0 111.861 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 23.5 m -116.43 -72.99 0.66 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -97.76 126.9 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 50.2 t90 -160.25 -35.93 0.05 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.435 0.294 . . . . 0.0 111.246 -175.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -56.34 -45.96 80.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.539 0.736 . . . . 0.0 112.574 -174.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -93.1 -17.53 23.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.467 0.307 . . . . 0.0 110.528 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 34' ' ' TRP . 3.0 mm? -61.86 108.2 0.98 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.731 0.812 . . . . 0.0 111.19 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -131.53 150.58 76.75 Favored Pre-proline 0 C--O 1.244 0.765 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.964 172.086 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.25 103.98 1.48 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.432 2.088 . . . . 0.0 110.486 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.75 -8.89 1.35 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.366 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.406 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 24.1 mtm -80.08 -177.9 6.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.228 0.611 . . . . 0.0 111.649 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -107.22 161.66 14.58 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.835 0.854 . . . . 0.0 110.765 171.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.478 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -136.17 101.92 4.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 174.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.5 t -87.6 122.74 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 109.824 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -92.4 120.85 33.31 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.523 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 85.2 t80 -87.26 174.05 8.82 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.758 1.223 . . . . 0.0 109.141 174.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 68.09 95.55 0.06 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.651 1.58 . . . . 0.0 109.114 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.825 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 53.9 p -76.35 67.54 2.59 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.141 0.976 . . . . 0.0 111.633 -173.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 82.7 t60 46.9 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.547 1.539 . . . . 0.0 112.017 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 77.62 -47.53 0.48 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 125.355 1.462 . . . . 0.0 111.139 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.22 167.96 20.58 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.449 1.1 . . . . 0.0 110.933 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.1 p -96.01 143.51 27.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.287 0.635 . . . . 0.0 110.486 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 132.71 163.53 10.63 Favored Glycine 0 C--O 1.215 -1.07 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 44.0 m-85 -71.47 113.3 8.36 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 118.203 1.001 . . . . 0.0 110.8 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.825 ' HB ' ' HA ' ' A' ' 48' ' ' SER . 2.7 p -73.9 -37.05 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.886 0.874 . . . . 0.0 110.939 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.66 -163.23 29.11 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.539 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 6.5 pt-20 -143.3 178.88 7.43 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.882 0.873 . . . . 0.0 109.129 173.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.511 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -156.88 -172.38 4.02 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.276 1.03 . . . . 0.0 108.879 175.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -125.78 118.09 24.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.965 0.506 . . . . 0.0 110.092 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 43' ' ' PHE . 43.2 mt -63.93 125.34 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.925 175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.448 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 30.7 mmmt -133.9 -168.28 2.09 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 125.374 1.47 . . . . 0.0 107.721 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -19.65 110.16 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 126.092 1.757 . . . . 0.0 115.058 -171.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 112' ' ' ILE . 29.2 m -103.74 109.97 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.7 t -91.93 118.14 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.404 0.682 . . . . 0.0 109.745 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HB3' HD11 ' A' ' 108' ' ' LEU . 61.7 mt -94.71 123.26 38.05 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.664 0.786 . . . . 0.0 109.494 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 71' ' ' GLN . 33.4 t -153.16 136.97 16.14 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.503 0.721 . . . . 0.0 110.126 172.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.686 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 45.6 mt-10 -66.32 -17.81 64.98 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 176.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 14.1 m-20 -97.85 120.73 59.6 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.0 -26.11 58.7 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.436 2.091 . . . . 0.0 112.071 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.417 ' HA ' ' HD2' ' A' ' 73' ' ' PHE . 37.3 mtm -73.19 -22.21 60.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.597 0.759 . . . . 0.0 110.918 -171.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 21.4 mm-40 -57.3 -33.39 67.63 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.155 0.982 . . . . 0.0 111.587 175.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.52 -31.46 37.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.745 0.418 . . . . 0.0 110.819 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CE2' HD22 ' A' ' 87' ' ' LEU . 85.1 m-85 -79.06 -17.75 54.67 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.125 0.57 . . . . 0.0 111.572 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -94.61 -36.85 11.61 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.436 0.294 . . . . 0.0 111.208 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.6 m -74.8 -57.0 4.19 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.947 0.499 . . . . 0.0 110.809 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.843 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 92.2 m-85 -92.49 -61.73 1.54 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.339 0.656 . . . . 0.0 109.494 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.68 -85.26 0.45 Allowed Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.866 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.04 -37.2 84.04 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.913 0.885 . . . . 0.0 110.639 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.843 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 14.4 mmt85 -65.52 -35.02 79.63 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.223 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.494 HG12 HD23 ' A' ' 82' ' ' LEU . 21.9 t -67.76 143.95 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 118.211 0.46 . . . . 0.0 110.375 -176.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.42 ' HD2' ' HA ' ' A' ' 27' ' ' PHE . 45.2 p90 -62.9 -14.51 47.45 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -173.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.494 HD23 HG12 ' A' ' 80' ' ' VAL . 2.3 pt? -139.68 170.29 16.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.782 0.833 . . . . 0.0 109.272 176.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.9 t -100.09 170.58 8.38 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 172.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -62.48 -27.74 69.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.24 0.616 . . . . 0.0 111.196 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.54 -49.41 71.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.405 0.682 . . . . 0.0 109.956 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.498 ' HG2' HG22 ' A' ' 83' ' ' THR . 17.3 mm-40 -56.75 -40.77 76.38 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.306 176.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.476 HD22 ' CE2' ' A' ' 73' ' ' PHE . 31.0 tp -58.4 -56.19 25.33 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.911 0.884 . . . . 0.0 112.031 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -61.72 -39.97 93.41 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -171.404 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.64 -18.88 36.62 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.126 0.571 . . . . 0.0 111.747 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.459 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 81.9 t80 -69.77 -39.74 76.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.37 0.668 . . . . 0.0 109.655 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.0 mtm -73.49 -30.8 63.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.302 0.641 . . . . 0.0 110.418 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.5 mmpt? -67.11 -38.07 84.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.626 0.371 . . . . 0.0 110.006 170.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.1 t -65.73 -32.06 73.39 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.831 0.707 . . . . 0.0 110.539 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 87.1 mm-40 -68.11 -56.26 9.47 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.603 ' HB3' ' HD3' ' A' ' 100' ' ' ARG . 10.6 pt-20 -64.5 -26.1 68.28 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -173.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -91.57 -31.03 16.07 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -110.22 -68.71 0.91 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.016 0.371 . . . . 0.0 111.223 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.2 1.27 50.02 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 114.026 0.37 . . . . 0.0 114.026 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 68.19 151.95 0.08 Allowed 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.009 1.723 . . . . 0.0 112.405 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.603 ' HD3' ' HB3' ' A' ' 95' ' ' GLU . 36.9 mtp180 -143.88 126.01 15.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -69.84 -49.64 50.53 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -170.38 172.15 6.26 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.649 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -81.03 -42.67 20.74 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 160.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 tptp 68.15 -71.32 0.11 Allowed 'General case' 0 C--N 1.364 1.219 0 C-N-CA 125.588 1.555 . . . . 0.0 109.481 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -146.01 143.28 29.35 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.15 1.38 . . . . 0.0 107.596 167.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.686 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -57.95 146.63 31.68 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.144 0.497 . . . . 0.0 110.657 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 18.2 tptm -101.56 156.67 17.34 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -174.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 65' ' ' LEU . 2.6 tm? -72.44 104.97 3.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -85.96 161.62 18.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.334 0.654 . . . . 0.0 109.251 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.537 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 14.9 ptm -141.67 154.36 45.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.865 0.866 . . . . 0.0 109.868 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.72 104.44 7.18 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.716 0.806 . . . . 0.0 109.825 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.506 ' HA ' HG12 ' A' ' 63' ' ' VAL . 43.0 mt -84.3 119.12 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 123.402 0.681 . . . . 0.0 109.454 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.555 ' HA ' HG22 ' A' ' 26' ' ' VAL . 37.6 tt0 -81.93 98.86 8.76 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -80.98 131.89 35.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.948 0.499 . . . . 0.0 110.25 174.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 1.3 pp20? -139.72 166.29 25.0 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.687 0.795 . . . . 0.0 109.128 175.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.3 t70 56.84 41.7 27.61 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.833 0.853 . . . . 0.0 111.178 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.32 108.92 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 121.351 0.596 . . . . 0.0 111.134 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.66 157.34 21.16 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.521 1.128 . . . . 0.0 110.216 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -122.91 117.73 26.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.896 0.878 . . . . 0.0 110.072 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -78.18 98.25 5.78 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -65.04 -31.44 72.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.838 0.855 . . . . 0.0 110.578 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -87.36 138.35 32.18 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.248 0.619 . . . . 0.0 110.157 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.33 89.14 1.21 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.658 2.239 . . . . 0.0 111.68 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.1 mt -78.73 131.26 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.398 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.424 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -100.69 144.17 27.98 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 122.986 0.514 . . . . 0.0 109.701 -178.204 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.34 161.09 28.95 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.315 2.01 . . . . 0.0 112.658 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 127' ' ' LYS . 11.1 mmpt? -68.91 -51.58 38.5 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.366 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -119.02 178.06 4.63 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.613 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.59 140.49 51.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.688 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.94 102.19 30.02 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.04 176.39 7.05 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.604 2.203 . . . . 0.0 112.212 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.2 t -58.89 -32.94 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.276 1.03 . . . . 0.0 111.132 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.68 -15.0 73.1 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.846 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.37 159.54 16.71 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.339 0.495 . . . . 0.0 113.237 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -113.54 145.77 40.7 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.585 0.754 . . . . 0.0 110.46 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -81.63 113.7 19.82 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.4 121.79 26.68 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.432 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -117.99 140.92 49.04 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.382 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 117.81 -1.09 . . . . 0.0 110.007 177.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 5' ' ' VAL . 24.1 mm 62.12 -168.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -173.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.3 m -145.88 -42.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 154.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.09 -161.24 20.23 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.31 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.77 156.15 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.825 0.85 . . . . 0.0 108.711 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 4.9 t -125.48 135.85 52.75 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.484 0.713 . . . . 0.0 109.657 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -132.4 139.29 34.35 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 123.787 0.835 . . . . 0.0 110.305 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HD3' HG12 ' A' ' 130' ' ' VAL . 69.2 Cg_endo -71.75 -26.74 18.94 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.192 2.594 . . . . 0.0 111.901 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt 66.94 117.26 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 125.321 1.449 . . . . 0.0 109.802 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -62.11 -16.65 51.74 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.267 2.645 . . . . 0.0 114.213 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -130.69 -176.38 3.96 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.733 0.813 . . . . 0.0 110.77 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -74.92 6.76 3.73 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.817 0.847 . . . . 0.0 112.87 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -77.97 14.97 0.97 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -62.22 -33.08 73.88 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.863 0.363 . . . . 0.0 110.293 165.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -68.73 -25.8 64.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.505 1.122 . . . . 0.0 111.762 -173.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 6.1 mmp_? -53.49 -49.32 67.76 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.331 1.019 . . . . 0.0 111.574 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 58.9 m-85 -64.54 -31.17 72.26 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.741 -176.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -85.75 -26.61 25.74 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.385 0.674 . . . . 0.0 110.593 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -68.38 -52.63 30.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.607 1.163 . . . . 0.0 109.953 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.5 ptpt -99.79 -16.88 17.93 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.348 -172.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.95 -8.55 50.21 Favored Glycine 0 N--CA 1.475 1.284 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -158.57 107.17 1.94 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.882 0.873 . . . . 0.0 109.546 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.516 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 17.1 t70 -126.2 -179.58 4.79 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.333 1.053 . . . . 0.0 109.259 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.5 t -130.67 113.93 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.244 1.018 . . . . 0.0 109.271 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -94.04 115.03 27.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.159 0.584 . . . . 0.0 109.662 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.36 147.14 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.343 0.592 . . . . 0.0 111.452 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.561 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 5.0 mmpt? -134.76 128.83 19.05 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.369 1.468 . . . . 0.0 110.113 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 97.9 Cg_endo -78.44 54.15 4.87 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.827 2.351 . . . . 0.0 112.345 170.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 57.38 97.9 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.558 1.143 . . . . 0.0 111.525 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.46 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 44.8 m -136.8 -54.2 0.72 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.426 0.69 . . . . 0.0 109.817 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 m -79.27 148.59 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.881 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -93.31 -162.28 0.92 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.536 1.134 . . . . 0.0 110.651 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -73.43 3.38 6.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -67.45 -31.41 71.57 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.59 90.99 0.41 Allowed 'General case' 0 C--N 1.352 0.714 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.103 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.43 153.81 47.64 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.264 0.625 . . . . 0.0 109.459 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.25 102.79 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.228 1.952 . . . . 0.0 111.11 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.13 29.79 0.38 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.66 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.2 mtm -111.39 -166.53 1.08 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.643 0.777 . . . . 0.0 110.453 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.9 ptpt -117.14 161.09 20.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.893 0.877 . . . . 0.0 110.539 169.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.543 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 t80 -135.73 101.07 4.65 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 45.1 t -84.29 120.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.294 0.569 . . . . 0.0 109.875 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -84.54 108.69 17.44 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 68.0 t80 . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.257 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.425 ' HE2' ' HA ' ' A' ' 126' ' ' PRO . 61.9 m-85 . . . . . 0 CA--C 1.554 1.126 0 CA-C-O 121.132 0.491 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -77.98 -25.6 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 123.509 0.724 . . . . 0.0 111.268 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.28 -165.93 33.31 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 120.173 -0.237 . . . . 0.0 112.758 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 7.3 pt-20 -145.42 178.03 8.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.631 0.772 . . . . 0.0 109.491 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.551 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -157.46 -171.1 3.45 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.497 1.119 . . . . 0.0 108.81 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 24.2 mmt85 -125.79 117.84 24.25 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.438 0.695 . . . . 0.0 110.168 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 43' ' ' PHE . 49.1 mt -69.27 131.45 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.316 1.046 . . . . 0.0 110.472 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -141.5 -166.61 2.23 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 125.513 1.525 . . . . 0.0 108.967 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -42.68 114.53 0.6 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.744 1.217 . . . . 0.0 113.352 -162.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.5 m -89.3 123.68 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.286 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 90.4 t -90.17 108.2 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.574 ' HB3' HD11 ' A' ' 108' ' ' LEU . 77.8 mt -95.58 113.87 25.57 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.1 t -153.46 144.18 22.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.576 0.75 . . . . 0.0 109.716 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -74.26 -27.75 60.9 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.566 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 42.7 m-20 -94.88 123.56 57.25 Favored Pre-proline 0 N--CA 1.476 0.859 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 28.6 Cg_endo -63.84 -25.01 67.87 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.18 1.92 . . . . 0.0 112.447 173.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.524 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 3.5 mpp? -74.53 -18.15 60.64 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.799 0.44 . . . . 0.0 110.887 -174.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.566 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 25.9 mm-40 -58.2 -40.76 82.4 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.656 0.782 . . . . 0.0 110.21 170.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -73.7 -29.15 62.11 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.677 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' A' ' 87' ' ' LEU . 66.0 m-85 -86.94 -15.63 38.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.17 -31.87 14.61 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 117.941 0.337 . . . . 0.0 110.174 173.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -76.62 -58.08 3.49 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.096 0.558 . . . . 0.0 109.758 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.742 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 63.3 m-85 -98.42 -67.32 0.85 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.732 0.813 . . . . 0.0 110.091 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.98 -81.38 0.09 OUTLIER Glycine 0 C--N 1.358 1.792 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.482 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.09 -36.9 78.44 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.661 1.184 . . . . 0.0 111.921 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.742 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 26.2 mmt180 -76.19 -20.09 57.82 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.979 0.512 . . . . 0.0 111.322 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 76' ' ' PHE . 30.8 t -79.18 142.4 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -57.12 -41.34 78.82 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.43 HD23 HG12 ' A' ' 80' ' ' VAL . 2.1 pt? -106.43 163.18 13.06 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.0 t -98.76 175.71 5.87 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 173.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.31 -28.31 69.22 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.213 0.605 . . . . 0.0 110.89 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.75 -43.48 98.68 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.969 0.908 . . . . 0.0 110.243 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.497 ' HG2' HG22 ' A' ' 83' ' ' THR . 69.7 mm-40 -66.95 -33.9 76.58 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.957 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' A' ' 73' ' ' PHE . 32.6 tp -64.53 -52.56 57.13 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.382 0.673 . . . . 0.0 111.029 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -38.3 89.22 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.506 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.05 -33.42 70.25 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.012 0.195 . . . . 0.0 110.671 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -66.81 -48.05 70.14 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.136 0.975 . . . . 0.0 110.918 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.5 mtm -66.44 -41.0 89.78 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.684 0.615 . . . . 0.0 110.172 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -62.2 -40.76 97.17 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.545 0.528 . . . . 0.0 110.705 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.473 0.692 0 C-N-CA 123.205 0.602 . . . . 0.0 111.09 -177.726 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -109.9 168.53 9.35 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.181 0.592 . . . . 0.0 109.641 -175.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.3 tm? -78.2 107.27 10.66 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -89.33 158.4 17.82 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.7 0.8 . . . . 0.0 109.282 172.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.5 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 15.4 ptm -136.27 131.59 34.64 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.051 0.54 . . . . 0.0 110.754 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.51 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -113.0 102.91 10.86 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.763 0.825 . . . . 0.0 109.767 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.1 mt -83.11 128.13 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.448 0.699 . . . . 0.0 109.414 -175.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.91 111.86 18.5 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.551 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -99.17 112.52 24.65 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.47 0.708 . . . . 0.0 110.395 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -120.72 167.15 12.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.446 0.698 . . . . 0.0 109.65 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.5 t70 53.86 54.88 9.15 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.294 1.038 . . . . 0.0 110.35 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.11 107.62 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.415 -175.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -83.35 163.91 20.33 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.242 1.017 . . . . 0.0 109.815 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -126.48 132.51 51.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.666 0.786 . . . . 0.0 109.965 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -94.4 97.16 9.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -77.3 -18.26 57.65 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.829 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -83.67 139.19 40.73 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.872 0.869 . . . . 0.0 109.378 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.41 100.02 1.33 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.714 2.276 . . . . 0.0 111.115 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.2 mt -81.19 125.75 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -78.78 116.46 59.91 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.425 ' HA ' ' HE2' ' A' ' 54' ' ' PHE . 9.8 Cg_endo -55.42 129.06 33.13 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.747 2.298 . . . . 0.0 113.182 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -70.3 -20.51 63.02 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.183 0.993 . . . . 0.0 110.416 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -159.27 165.72 32.86 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.92 1.288 . . . . 0.0 108.813 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -71.06 136.19 48.15 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.661 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.516 HG12 ' HD3' ' A' ' 10' ' ' PRO . 41.1 t -111.25 97.72 36.6 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.24 -177.99 2.66 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.546 2.831 . . . . 0.0 112.207 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.67 -33.47 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.521 0.728 . . . . 0.0 110.701 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.34 -25.31 72.45 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.946 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.54 163.16 30.79 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.009 0.338 . . . . 0.0 113.229 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -119.67 146.29 45.71 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.055 0.942 . . . . 0.0 110.66 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -84.16 110.25 18.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.305 0.642 . . . . 0.0 110.236 173.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 119.14 20.63 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 172.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.404 ' HD3' ' H ' ' A' ' 138' ' ' ARG . 0.4 OUTLIER -129.66 137.9 50.9 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.134 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.453 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.45 HG22 ' H ' ' A' ' 5' ' ' VAL . 22.7 mm 65.78 -176.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 C-N-CA 124.469 1.107 . . . . 0.0 109.283 -176.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -145.92 -42.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.582 1.153 . . . . 0.0 108.045 158.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.23 -161.49 20.85 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.88 0.738 . . . . 0.0 113.595 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.436 HG12 HD11 ' A' ' 60' ' ' ILE . 9.7 p -121.38 162.0 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -137.42 138.77 40.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.116 0.567 . . . . 0.0 110.129 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -135.46 150.08 71.3 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.936 0.894 . . . . 0.0 110.446 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' HG12 ' A' ' 130' ' ' VAL . 91.2 Cg_endo -80.57 -10.83 13.12 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.787 2.325 . . . . 0.0 112.359 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.3 mm 59.79 97.96 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 125.675 1.59 . . . . 0.0 110.879 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -82.63 33.33 0.53 Allowed 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.232 2.621 . . . . 0.0 113.137 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -137.44 162.07 34.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.278 1.031 . . . . 0.0 110.507 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.527 ' H ' ' HD2' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -78.2 -15.72 58.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.76 0.824 . . . . 0.0 110.428 -174.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 82' ' ' LEU . 41.7 m-85 -90.51 31.74 1.01 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.22 1.008 . . . . 0.0 112.354 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -58.74 -22.98 59.06 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.853 0.861 . . . . 0.0 112.017 166.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.421 ' N ' ' SD ' ' A' ' 16' ' ' MET . 26.1 t70 -77.52 -27.45 51.71 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.409 1.084 . . . . 0.0 112.514 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -50.2 -48.69 54.17 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.471 1.108 . . . . 0.0 113.702 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -63.82 -29.41 70.61 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.765 0.666 . . . . 0.0 110.605 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -96.82 -12.58 23.41 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.623 0.769 . . . . 0.0 111.621 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -76.05 -50.17 15.5 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.834 0.853 . . . . 0.0 109.007 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HG3' ' H ' ' A' ' 24' ' ' LYS . 14.7 ptpt -109.2 -16.13 14.14 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.502 -172.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.82 9.04 74.48 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 114.216 0.446 . . . . 0.0 114.216 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.452 ' H ' ' HG3' ' A' ' 22' ' ' LYS . 55.3 pttt -163.25 92.36 0.74 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.33 1.052 . . . . 0.0 109.811 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -133.35 -176.87 4.29 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -136.43 121.19 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 120.188 1.358 . . . . 0.0 109.813 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -94.61 116.52 28.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.709 0.804 . . . . 0.0 109.922 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 m -98.2 143.29 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.346 0.593 . . . . 0.0 111.374 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.779 ' HG2' HG23 ' A' ' 33' ' ' VAL . 16.5 tppt? -136.64 140.52 32.39 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.5 1.12 . . . . 0.0 109.88 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.647 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 59.0 Cg_endo -72.7 59.52 3.41 Favored 'Trans proline' 0 CA--C 1.56 1.817 0 C-N-CA 122.996 2.464 . . . . 0.0 113.748 166.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.41 33.95 6.08 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.256 1.423 . . . . 0.0 113.856 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.408 ' H ' ' HG3' ' A' ' 29' ' ' LYS . 3.3 m -87.48 -17.64 31.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.408 0.683 . . . . 0.0 111.05 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.779 HG23 ' HG2' ' A' ' 29' ' ' LYS . 3.3 t -87.71 150.3 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.252 0.621 . . . . 0.0 109.493 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -70.02 174.96 4.8 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.53 0.681 . . . . 0.0 112.257 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -76.96 -1.36 28.25 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.636 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.67 -23.55 66.81 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.65 0.78 . . . . 0.0 111.034 173.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.536 HD23 HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -65.52 103.32 0.82 Allowed 'General case' 0 C--N 1.353 0.743 0 C-N-CA 123.0 0.52 . . . . 0.0 110.084 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.44 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -129.95 150.82 77.0 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.198 0.599 . . . . 0.0 109.65 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.81 107.84 1.96 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.836 2.358 . . . . 0.0 111.042 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.82 -14.57 1.76 Allowed Glycine 0 N--CA 1.467 0.749 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.92 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.567 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 27.9 mtm -78.65 -173.21 3.31 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.367 0.603 . . . . 0.0 111.881 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -112.21 162.74 15.15 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.976 0.91 . . . . 0.0 110.32 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.43 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -135.57 102.71 5.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.99 126.28 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.352 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -97.69 111.69 23.88 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.7 t80 . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 124.359 1.064 . . . . 0.0 108.934 175.829 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.902 0.382 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.45 -38.54 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 168.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.75 -157.16 28.03 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.526 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.22 179.26 9.13 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.081 0.952 . . . . 0.0 110.031 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.469 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -155.17 -172.24 4.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.652 0.781 . . . . 0.0 110.844 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -122.78 119.82 31.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.864 0.866 . . . . 0.0 110.043 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.436 HD11 HG12 ' A' ' 7' ' ' VAL . 45.9 mt -68.61 135.79 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.664 1.186 . . . . 0.0 111.3 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.7 mmmt -134.51 -178.36 5.02 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 126.344 1.858 . . . . 0.0 108.588 -174.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -40.77 116.45 0.71 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.2 1.4 . . . . 0.0 114.046 -165.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.3 m -89.11 116.99 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.857 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.98 115.68 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.736 0.814 . . . . 0.0 109.554 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.9 mt -88.79 119.49 29.33 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.959 0.504 . . . . 0.0 109.688 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -148.28 131.3 16.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.034 0.933 . . . . 0.0 108.796 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -63.0 -31.24 72.33 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.967 0.907 . . . . 0.0 111.576 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.591 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 25.8 m-80 -91.35 119.11 68.76 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.428 ' HG2' HD21 ' A' ' 87' ' ' LEU . 53.1 Cg_endo -68.75 -12.94 35.9 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.595 2.197 . . . . 0.0 112.238 172.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.6 mtm -81.5 -24.27 36.8 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.284 1.033 . . . . 0.0 110.704 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.591 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 79.0 mt-30 -70.32 -25.39 63.28 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -69.2 -28.34 66.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.421 0.288 . . . . 0.0 110.747 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.493 ' HE2' HD22 ' A' ' 87' ' ' LEU . 27.5 m-85 -81.65 -20.41 39.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.883 0.473 . . . . 0.0 112.256 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.6 pt-20 -90.84 -25.54 19.83 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 117.979 0.354 . . . . 0.0 111.194 172.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.6 m -85.91 -50.8 6.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.443 0.697 . . . . 0.0 110.957 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.765 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 82.1 m-85 -107.17 -57.68 2.04 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.993 0.917 . . . . 0.0 109.927 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.44 -90.63 0.24 Allowed Glycine 0 C--N 1.355 1.626 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.827 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.37 -35.21 76.84 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.846 0.858 . . . . 0.0 110.621 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.765 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 44.7 mmt-85 -71.37 -28.2 63.88 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-O 119.162 -0.447 . . . . 0.0 110.914 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 76' ' ' PHE . 57.2 t -71.04 132.3 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -56.78 -50.69 71.54 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.113 0.883 . . . . 0.0 112.213 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.515 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 1.8 pt? -94.6 157.47 15.96 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.451 HG22 ' HG2' ' A' ' 86' ' ' GLU . 14.4 t -88.53 168.31 12.69 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.87 -29.07 70.29 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.197 0.199 . . . . 0.0 110.72 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -61.03 -43.07 99.44 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.535 0.734 . . . . 0.0 111.314 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.451 ' HG2' HG22 ' A' ' 83' ' ' THR . 51.0 mm-40 -64.39 -40.09 95.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.284 0.634 . . . . 0.0 111.345 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.493 HD22 ' HE2' ' A' ' 73' ' ' PHE . 24.4 tp -62.98 -52.27 63.66 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.92 0.763 . . . . 0.0 110.841 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -68.05 -43.23 79.13 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.536 -173.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.23 -33.3 74.33 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.095 0.407 . . . . 0.0 110.106 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -65.26 -45.96 82.42 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.87 0.868 . . . . 0.0 110.638 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.9 mtm -74.16 -27.92 61.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.376 0.671 . . . . 0.0 111.296 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.8 mmmt -75.88 -37.37 58.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.126 177.441 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 121.307 0.575 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -76.52 150.48 36.59 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.445 174.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.96 131.65 41.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -114.99 159.6 20.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.594 0.758 . . . . 0.0 109.681 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.8 ptm -138.01 130.65 29.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.173 0.989 . . . . 0.0 109.203 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.13 101.65 10.86 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.501 ' HA ' HG12 ' A' ' 63' ' ' VAL . 36.8 mt -82.04 118.36 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 44.4 tt0 -81.46 139.89 34.94 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -123.57 132.31 53.85 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.967 1.307 . . . . 0.0 109.126 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -140.24 165.5 27.22 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.642 0.777 . . . . 0.0 109.388 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.8 t70 59.0 39.59 23.33 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.275 1.03 . . . . 0.0 110.331 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.8 t -68.26 101.18 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.125 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -74.16 131.51 41.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.604 1.161 . . . . 0.0 109.862 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -92.56 125.97 37.43 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.239 0.543 . . . . 0.0 109.555 172.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.1 98.69 11.92 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.926 0.89 . . . . 0.0 109.338 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.85 -30.75 68.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.652 172.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -84.92 132.8 44.79 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.378 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.58 102.11 1.52 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.118 2.546 . . . . 0.0 111.606 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.8 mt -111.04 129.37 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.284 0.564 . . . . 0.0 110.463 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.79 141.52 64.25 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.938 0.895 . . . . 0.0 109.59 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.92 157.15 58.9 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.186 1.924 . . . . 0.0 112.13 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -63.21 -27.81 69.62 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.881 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -154.35 163.86 39.5 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.984 1.314 . . . . 0.0 107.755 166.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -61.21 136.03 57.93 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.49 HG12 ' HD3' ' A' ' 10' ' ' PRO . 28.7 t -106.01 103.62 45.53 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 -178.37 2.56 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.151 2.568 . . . . 0.0 112.278 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.97 -36.05 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.908 0.883 . . . . 0.0 111.622 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.62 -16.43 77.74 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-N 116.117 -0.492 . . . . 0.0 113.166 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.5 162.97 25.51 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 123.052 0.358 . . . . 0.0 112.962 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -114.79 152.51 31.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.547 0.739 . . . . 0.0 110.188 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.72 117.21 29.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 170.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.1 114.38 21.72 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.31 141.73 51.23 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.494 ' HB2' HG13 ' A' ' 5' ' ' VAL . 10.0 tp10 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 5' ' ' VAL . 30.3 mm 66.05 -174.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.684 0 C-N-CA 124.163 0.985 . . . . 0.0 108.791 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.451 ' H ' HG22 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -150.64 -42.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.858 1.263 . . . . 0.0 107.776 160.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -167.44 -162.54 19.46 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.355 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.429 HG12 HD11 ' A' ' 60' ' ' ILE . 8.6 p -119.44 151.1 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 172.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -122.87 132.35 54.15 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.731 0.813 . . . . 0.0 108.845 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -131.42 144.14 52.16 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.066 0.946 . . . . 0.0 109.673 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.513 ' HD3' HG12 ' A' ' 130' ' ' VAL . 97.3 Cg_endo -74.48 -17.01 21.31 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.576 2.184 . . . . 0.0 112.028 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 16' ' ' MET . 14.2 mm 49.15 80.88 0.28 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.154 1.382 . . . . 0.0 109.678 -167.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HG3' HG23 ' A' ' 132' ' ' VAL . 96.5 Cg_endo -78.57 15.47 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.001 2.467 . . . . 0.0 112.94 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -104.8 152.74 22.21 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.46 1.104 . . . . 0.0 109.823 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -66.08 -8.38 23.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.652 1.181 . . . . 0.0 112.797 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -97.0 28.05 3.73 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.657 1.183 . . . . 0.0 112.323 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.507 ' HA ' HG21 ' A' ' 11' ' ' ILE . 27.0 ptt? -63.94 -30.16 71.26 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.287 0.565 . . . . 0.0 110.712 174.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -72.05 -21.85 61.47 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.523 1.129 . . . . 0.0 112.595 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 84.4 mmt-85 -58.36 -38.25 76.86 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.959 0.903 . . . . 0.0 112.615 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 64.5 m-85 -67.18 -30.35 70.28 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 121.087 0.47 . . . . 0.0 110.473 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -96.77 -8.58 30.86 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.158 0.983 . . . . 0.0 110.78 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -84.88 -54.64 4.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.813 1.245 . . . . 0.0 110.03 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.9 ptpt -98.3 -13.8 20.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.814 -171.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.46 -23.81 9.43 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 113.857 0.303 . . . . 0.0 113.857 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -148.72 116.86 6.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.026 0.93 . . . . 0.0 109.487 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 14.4 t70 -123.44 175.43 6.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.275 0.63 . . . . 0.0 110.001 -170.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.88 109.53 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.431 ' HD2' HD12 ' A' ' 112' ' ' ILE . 85.7 t80 -87.82 108.82 19.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.45 0.7 . . . . 0.0 109.561 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 m -92.59 138.44 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.181 0.515 . . . . 0.0 110.977 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HD2' ' HD2' ' A' ' 30' ' ' PRO . 13.9 mmtp -129.45 147.31 64.63 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.674 1.19 . . . . 0.0 110.068 170.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HD2' ' A' ' 29' ' ' LYS . 82.0 Cg_endo -77.15 53.17 4.12 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.985 2.457 . . . . 0.0 111.754 165.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 38.23 64.93 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.564 1.546 . . . . 0.0 112.928 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -94.02 -27.13 16.48 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.198 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.56 152.76 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.319 1.048 . . . . 0.0 111.141 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -65.87 169.38 6.68 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.505 0.722 . . . . 0.0 109.878 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -68.83 -2.16 8.89 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.66 -30.68 65.62 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.684 0.794 . . . . 0.0 111.502 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.401 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -62.24 116.3 4.89 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.557 0.743 . . . . 0.0 110.588 -179.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.83 152.99 53.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.968 0.907 . . . . 0.0 109.697 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.95 105.99 1.25 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.886 2.391 . . . . 0.0 111.305 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.92 -8.62 1.75 Allowed Glycine 0 N--CA 1.471 0.995 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.237 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.549 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 83.2 mtp -84.51 179.46 7.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.29 1.036 . . . . 0.0 111.305 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.408 ' HG3' ' HA3' ' A' ' 6' ' ' GLY . 14.4 ptpt -110.23 164.47 12.62 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.91 0.884 . . . . 0.0 110.162 172.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.44 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 t80 -135.44 94.87 3.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -83.09 120.48 34.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.226 0.536 . . . . 0.0 110.143 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -83.72 97.64 9.23 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.57 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.6 t80 . . . . . 0 CA--C 1.55 0.951 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 163.384 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.61 -28.93 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 122.995 0.518 . . . . 0.0 110.408 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.44 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . 175.61 -164.05 34.12 Favored Glycine 0 C--N 1.344 1.019 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.838 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -151.14 178.9 8.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.812 0.845 . . . . 0.0 109.21 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -161.5 -172.27 3.29 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.18 0.992 . . . . 0.0 109.685 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -128.7 120.87 27.3 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.807 0.843 . . . . 0.0 110.087 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 43' ' ' PHE . 54.1 mt -70.66 134.32 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.483 1.113 . . . . 0.0 111.273 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.2 mmmt -131.76 178.42 6.77 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 126.091 1.756 . . . . 0.0 109.82 -175.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -29.13 110.45 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.774 2.03 . . . . 0.0 114.507 -175.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 112' ' ' ILE . 33.4 m -93.11 118.38 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.801 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.0 119.26 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.733 0.813 . . . . 0.0 109.077 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HB3' HD11 ' A' ' 108' ' ' LEU . 70.9 mt -101.99 120.77 40.95 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.78 0.832 . . . . 0.0 109.47 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.6 t -152.67 135.12 15.16 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.057 0.943 . . . . 0.0 110.113 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 14.8 mt-10 -63.84 -23.56 67.4 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.149 0.98 . . . . 0.0 112.19 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -102.84 120.16 53.41 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.453 ' HG2' HD21 ' A' ' 87' ' ' LEU . 36.7 Cg_endo -64.74 -19.75 64.66 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.689 2.259 . . . . 0.0 112.189 174.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 44.2 mtm -73.27 -23.86 60.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.847 0.859 . . . . 0.0 110.477 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 23.7 mt-30 -71.05 -23.52 62.16 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.529 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.31 -24.04 54.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.736 0.414 . . . . 0.0 111.017 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.504 ' HE2' HD22 ' A' ' 87' ' ' LEU . 55.4 m-85 -88.35 -27.5 21.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.088 0.555 . . . . 0.0 111.623 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.9 pt-20 -82.46 -27.46 31.85 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 120.388 0.137 . . . . 0.0 110.656 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.5 m -84.89 -50.65 7.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.686 0.394 . . . . 0.0 110.61 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.746 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 89.2 m-85 -107.41 -69.37 0.85 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.153 0.581 . . . . 0.0 110.628 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.2 -80.99 0.07 OUTLIER Glycine 0 C--N 1.358 1.75 0 O-C-N 123.546 0.528 . . . . 0.0 113.515 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.14 -31.86 67.61 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.811 1.244 . . . . 0.0 111.778 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.746 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 30.3 mmt180 -74.02 -36.12 64.41 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.35 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.32 148.84 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.973 0.509 . . . . 0.0 110.677 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.48 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 45.7 p90 -62.56 -34.14 76.36 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 82' ' ' LEU . 2.3 pt? -117.16 170.63 8.52 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.529 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.4 t -106.21 175.81 5.37 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -60.93 -31.78 71.3 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.134 0.974 . . . . 0.0 111.577 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.77 -43.01 90.13 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.292 0.637 . . . . 0.0 110.73 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HG2' HG22 ' A' ' 83' ' ' THR . 60.1 mm-40 -65.99 -33.86 76.79 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.143 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.504 HD22 ' HE2' ' A' ' 73' ' ' PHE . 26.7 tp -63.87 -54.54 33.23 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.415 0.686 . . . . 0.0 111.002 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -67.11 -36.88 82.88 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.751 -171.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 90' ' ' TYR . 6.7 pt-20 -66.25 -40.21 90.03 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 173.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.412 ' N ' ' HG3' ' A' ' 89' ' ' GLU . 79.7 t80 -61.87 -40.21 94.61 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.223 1.009 . . . . 0.0 111.055 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.6 mtm -73.15 -35.07 66.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.068 0.547 . . . . 0.0 110.965 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.0 mmmt -69.85 -25.89 63.95 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.6 0.36 . . . . 0.0 110.608 173.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 123.224 0.609 . . . . 0.0 111.463 177.294 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 3.9 tmtp? -102.73 138.8 39.15 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 65' ' ' LEU . 3.0 tm? -77.2 104.65 7.83 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.422 ' CE3' ' HB3' ' A' ' 69' ' ' PRO . 24.8 m95 -82.93 161.08 21.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.205 0.602 . . . . 0.0 109.524 174.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.6 ptm -136.72 141.96 43.07 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.129 0.971 . . . . 0.0 109.754 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.17 103.97 9.7 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.125 0.97 . . . . 0.0 109.006 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.501 ' HA ' HG12 ' A' ' 63' ' ' VAL . 30.9 mt -81.45 122.45 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -82.96 136.65 34.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -123.3 132.73 54.11 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.223 0.609 . . . . 0.0 110.356 -175.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -131.87 172.57 12.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.888 0.875 . . . . 0.0 110.294 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.1 t70 49.05 50.01 18.59 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.809 1.243 . . . . 0.0 111.874 170.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.34 101.61 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.153 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -77.87 148.41 34.65 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.512 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -111.28 111.86 23.21 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.164 0.585 . . . . 0.0 110.32 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.44 ' H ' ' HA2' ' A' ' 56' ' ' GLY . 4.8 m-85 -83.9 87.06 7.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.961 0.904 . . . . 0.0 109.244 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.45 -15.08 56.16 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.701 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -80.47 137.61 51.78 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.296 1.039 . . . . 0.0 110.294 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.21 79.6 3.33 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 123.079 2.519 . . . . 0.0 113.178 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.8 mt -98.49 137.4 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.153 0.581 . . . . 0.0 110.598 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -71.22 151.32 94.52 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.258 1.023 . . . . 0.0 111.032 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.42 153.84 65.6 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.195 1.93 . . . . 0.0 111.384 167.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -36.55 74.95 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -152.19 169.51 22.28 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.202 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.98 132.48 48.0 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.32 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.513 HG12 ' HD3' ' A' ' 10' ' ' PRO . 17.6 t -118.89 99.6 51.07 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.093 0.557 . . . . 0.0 109.704 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.19 -174.87 2.12 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.478 2.785 . . . . 0.0 112.591 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.575 HG23 ' HG3' ' A' ' 12' ' ' PRO . 5.5 p -54.91 -40.3 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.661 1.184 . . . . 0.0 112.62 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.63 -12.91 82.41 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 113.581 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.95 159.49 15.09 Favored Glycine 0 C--N 1.348 1.208 0 C-N-CA 122.9 0.286 . . . . 0.0 112.838 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -113.58 150.02 33.65 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.534 0.734 . . . . 0.0 109.082 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -84.05 115.55 22.42 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.42 125.76 29.65 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.99 122.27 22.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.427 ' HB3' HG11 ' A' ' 5' ' ' VAL . 9.9 tp10 . . . . . 0 C--O 1.243 0.763 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.05 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 5' ' ' VAL . 16.9 mm 64.45 -171.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.879 0 C-N-CA 124.005 0.922 . . . . 0.0 108.912 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.523 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.3 m -156.22 -32.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 125.497 1.519 . . . . 0.0 109.131 156.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -166.97 -164.05 21.91 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.324 0.39 . . . . 0.0 112.839 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.466 HG12 HD11 ' A' ' 60' ' ' ILE . 10.4 p -139.0 144.81 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.508 0.723 . . . . 0.0 109.158 173.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 t -116.97 132.59 56.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.946 0.898 . . . . 0.0 110.0 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -133.18 140.64 37.99 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.561 1.144 . . . . 0.0 108.8 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 25.1 Cg_exo -63.8 -41.32 24.58 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.085 2.524 . . . . 0.0 111.828 169.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.4 mt 54.11 77.38 0.44 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 124.67 1.188 . . . . 0.0 110.001 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.63 0.24 6.6 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.103 2.535 . . . . 0.0 113.501 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -69.21 144.86 53.61 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 121.501 0.667 . . . . 0.0 110.499 172.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -59.22 -10.77 3.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.18 1.392 . . . . 0.0 112.852 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -99.43 22.1 11.18 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.445 1.098 . . . . 0.0 112.491 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.9 -29.27 70.2 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.937 0.495 . . . . 0.0 109.877 168.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -67.81 -27.25 66.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.825 1.25 . . . . 0.0 111.898 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 24.3 mmt180 -55.69 -37.03 67.81 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.935 0.894 . . . . 0.0 113.134 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.415 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 62.2 m-85 -66.19 -29.67 69.98 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.107 0.479 . . . . 0.0 110.865 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.13 -23.24 18.67 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.585 1.154 . . . . 0.0 110.282 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -74.01 -55.51 6.05 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.815 1.246 . . . . 0.0 110.673 -174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.2 ptpt -93.99 -12.61 28.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.444 0.698 . . . . 0.0 111.24 -175.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.49 -30.63 5.92 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 122.924 0.297 . . . . 0.0 113.192 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.82 118.39 7.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.873 0.869 . . . . 0.0 108.857 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 16.5 t70 -123.25 -179.43 4.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.765 0.826 . . . . 0.0 109.918 -168.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -134.34 110.55 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.324 1.05 . . . . 0.0 108.847 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -92.94 120.96 33.8 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.86 137.78 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.458 0.646 . . . . 0.0 111.113 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.6 mmpt? -127.58 133.63 25.3 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.476 1.51 . . . . 0.0 109.947 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.5 55.95 4.92 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.803 2.335 . . . . 0.0 111.113 166.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.2 36.11 4.25 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.201 1.4 . . . . 0.0 113.215 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 9.1 m -64.12 -28.26 69.65 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.667 0.746 . . . . 0.0 110.266 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.1 m -90.48 150.45 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.756 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -79.88 178.0 8.52 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.91 0.884 . . . . 0.0 109.788 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -69.91 4.24 2.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.217 1.007 . . . . 0.0 113.697 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.7 -26.23 68.56 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.245 0.618 . . . . 0.0 110.198 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.48 110.77 2.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.796 0.838 . . . . 0.0 110.718 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -134.31 152.07 77.46 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.23 102.6 0.96 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.38 2.053 . . . . 0.0 110.845 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.75 35.95 0.21 Allowed Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.365 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.499 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 24.5 mtm -119.0 -168.02 1.49 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.448 0.699 . . . . 0.0 110.726 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -110.1 157.06 19.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.19 0.996 . . . . 0.0 108.864 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.562 ' HB2' HG13 ' A' ' 60' ' ' ILE . 2.7 t80 -134.64 104.43 6.05 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 40.5 t -94.6 121.5 45.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.485 0.66 . . . . 0.0 109.823 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -86.21 103.51 14.9 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.249 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 16.2 t80 . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 120.416 0.15 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.26 -23.32 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.041 0.536 . . . . 0.0 109.714 169.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.432 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . 176.07 -165.1 35.46 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.017 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 11.1 pt-20 -153.65 178.1 10.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.073 0.949 . . . . 0.0 109.581 172.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -162.31 -172.42 3.18 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.013 0.925 . . . . 0.0 110.181 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -124.2 122.74 38.6 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.786 0.834 . . . . 0.0 109.773 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 43' ' ' PHE . 41.4 mt -72.16 133.52 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.067 0.947 . . . . 0.0 110.6 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -140.16 -166.18 2.05 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.166 1.787 . . . . 0.0 108.065 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -37.71 118.81 0.69 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.273 1.429 . . . . 0.0 114.565 -165.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -98.27 116.21 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 123.087 0.555 . . . . 0.0 109.8 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -91.12 113.05 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.367 0.667 . . . . 0.0 109.36 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.517 ' HB3' HD11 ' A' ' 108' ' ' LEU . 57.5 mt -90.24 124.68 35.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.512 0.725 . . . . 0.0 109.743 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -152.55 138.23 17.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.004 0.921 . . . . 0.0 110.222 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -75.33 -12.05 60.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.582 0.753 . . . . 0.0 111.556 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.554 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 74.7 m-20 -112.01 119.88 43.22 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.329 0.652 . . . . 0.0 109.274 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HG2' HD21 ' A' ' 87' ' ' LEU . 53.6 Cg_endo -67.94 -12.83 36.56 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.8 2.333 . . . . 0.0 113.33 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.3 mtm -81.99 -22.61 36.47 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.485 0.714 . . . . 0.0 110.945 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.554 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 62.3 mt-30 -70.73 -20.27 62.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.984 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -74.59 -25.53 59.32 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.052 0.541 . . . . 0.0 110.927 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.598 ' HE2' HD22 ' A' ' 87' ' ' LEU . 37.0 m-85 -85.19 -27.72 25.93 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.969 0.508 . . . . 0.0 111.728 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.36 -33.7 48.84 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 120.508 0.194 . . . . 0.0 110.675 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -79.77 -56.42 4.29 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.974 0.51 . . . . 0.0 111.132 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.702 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 37.3 m-85 -103.28 -68.0 0.86 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.249 0.619 . . . . 0.0 109.702 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.76 -81.51 0.12 Allowed Glycine 0 C--N 1.355 1.614 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.118 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.84 -36.18 69.7 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.592 1.157 . . . . 0.0 111.327 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.702 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 26.5 mmt180 -78.54 -30.27 46.85 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.801 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 76' ' ' PHE . 42.7 t -65.12 140.62 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -57.5 -45.99 84.28 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 122.606 0.362 . . . . 0.0 111.697 -174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -105.46 164.04 12.18 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.479 HG22 ' HG2' ' A' ' 86' ' ' GLU . 13.0 t -99.24 -179.69 4.32 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -68.76 -29.85 68.33 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.908 0.483 . . . . 0.0 111.338 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 2.9 m-20 -68.96 -30.23 68.62 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.324 0.583 . . . . 0.0 111.269 174.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.479 ' HG2' HG22 ' A' ' 83' ' ' THR . 58.8 mm-40 -75.32 -28.52 59.69 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.827 174.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.598 HD22 ' HE2' ' A' ' 73' ' ' PHE . 56.5 tp -69.23 -47.15 65.55 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.712 0.405 . . . . 0.0 110.582 174.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -65.13 -40.16 94.06 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.854 -175.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.32 -33.95 73.93 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.707 0.23 . . . . 0.0 110.664 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.99 -44.52 95.79 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.708 0.803 . . . . 0.0 111.221 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.8 mtm -77.05 -35.6 56.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.295 0.638 . . . . 0.0 111.186 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -70.05 -23.69 63.14 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.423 0.289 . . . . 0.0 110.41 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 CA--C 1.539 0.541 0 C-N-CA 122.818 0.447 . . . . 0.0 111.008 173.579 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HD3' ' H ' ' A' ' 108' ' ' LEU . 4.8 tmtp? -135.37 144.42 46.61 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.5 tm? -77.77 100.25 6.2 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -82.92 159.69 22.25 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.367 0.667 . . . . 0.0 109.381 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.0 ptm -143.37 131.06 21.32 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.611 0.764 . . . . 0.0 110.279 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.17 102.59 11.99 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.813 0.845 . . . . 0.0 109.487 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.424 HG21 HG12 ' A' ' 60' ' ' ILE . 36.0 mt -81.26 127.89 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.748 0.819 . . . . 0.0 109.394 -177.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -81.61 123.47 28.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.3 mm? -105.27 129.1 53.71 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.159 0.983 . . . . 0.0 109.528 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.64 175.25 9.72 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.208 1.003 . . . . 0.0 108.492 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 t70 57.63 36.41 26.69 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.876 0.845 . . . . 0.0 110.737 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.16 105.17 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.742 -171.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.65 160.21 21.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.184 0.993 . . . . 0.0 110.472 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -117.5 123.19 45.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.178 0.991 . . . . 0.0 110.54 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.432 ' H ' ' HA2' ' A' ' 56' ' ' GLY . 10.3 m-85 -97.12 82.33 3.17 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.49 -24.77 65.62 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.513 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -81.87 139.42 46.58 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.796 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -83.29 65.9 7.7 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 123.235 2.624 . . . . 0.0 112.924 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.3 mt -77.02 114.34 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -71.35 145.38 90.55 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.198 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.99 155.19 70.61 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.612 2.208 . . . . 0.0 111.86 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -68.22 -31.07 70.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.617 0.767 . . . . 0.0 109.479 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -128.88 162.21 28.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.144 0.978 . . . . 0.0 109.824 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -77.3 121.88 24.33 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.477 ' HA ' ' HG2' ' A' ' 135' ' ' GLN . 17.8 t -107.69 100.07 32.88 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 122.829 0.451 . . . . 0.0 110.195 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.82 -176.94 3.41 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.01 2.473 . . . . 0.0 111.699 172.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -57.77 -31.22 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.322 1.049 . . . . 0.0 112.756 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.25 -19.27 72.13 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.708 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.76 142.21 3.12 Favored Glycine 0 C--N 1.351 1.361 0 C-N-CA 122.984 0.326 . . . . 0.0 113.031 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.477 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -109.73 157.67 18.89 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.437 0.695 . . . . 0.0 109.836 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -87.35 129.1 35.15 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 170.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.1 tt -90.58 125.13 35.53 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.26 144.29 48.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt . . . . . 0 CA--C 1.551 0.989 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 5' ' ' VAL . 26.3 mm 64.85 -177.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 C-N-CA 124.402 1.081 . . . . 0.0 109.577 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 139' ' ' GLU . 1.3 m -150.24 -39.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.807 1.243 . . . . 0.0 108.712 158.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.39 -163.38 22.27 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.178 -176.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.432 HG11 HD21 ' A' ' 37' ' ' LEU . 9.0 p -137.1 141.39 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.663 0.785 . . . . 0.0 109.068 175.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 t -113.93 139.26 49.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.445 0.698 . . . . 0.0 110.163 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -131.55 143.74 50.46 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 123.695 0.798 . . . . 0.0 109.805 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' HG12 ' A' ' 130' ' ' VAL . 85.8 Cg_endo -73.98 -14.59 23.74 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.994 2.463 . . . . 0.0 112.354 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.1 mm 53.6 89.77 0.1 OUTLIER Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.922 1.289 . . . . 0.0 109.86 -174.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.03 24.35 0.54 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.905 2.403 . . . . 0.0 112.702 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 159.52 39.23 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.532 1.533 . . . . 0.0 108.499 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -74.93 -13.07 60.49 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.446 0.698 . . . . 0.0 111.239 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -72.52 6.85 2.13 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.234 1.013 . . . . 0.0 113.597 -172.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -56.76 -34.21 67.36 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.002 0.43 . . . . 0.0 110.058 164.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.47 ' N ' ' SD ' ' A' ' 16' ' ' MET . 19.6 t70 -49.42 -41.49 39.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.647 1.579 . . . . 0.0 112.428 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -54.56 -48.2 72.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.262 1.025 . . . . 0.0 112.465 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 64.5 m-85 -66.75 -28.9 68.78 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.988 0.805 . . . . 0.0 110.406 -177.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -91.1 -19.32 23.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.01 0.524 . . . . 0.0 111.376 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -76.74 -59.67 2.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.321 0.648 . . . . 0.0 109.497 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -92.73 -10.23 37.83 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.222 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.3 3.02 69.08 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.416 0.447 . . . . 0.0 114.006 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -168.16 100.43 0.44 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.009 0.924 . . . . 0.0 109.736 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.469 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 20.1 t70 -129.05 -170.74 2.33 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.0 t -133.18 117.51 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.94 1.245 . . . . 0.0 109.248 -174.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -90.49 107.33 19.09 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.278 0.631 . . . . 0.0 109.517 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.3 m -87.67 142.85 12.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.423 0.63 . . . . 0.0 109.903 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HE2' ' HD2' ' A' ' 30' ' ' PRO . 2.1 tpmt? -135.05 128.07 18.43 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.383 1.073 . . . . 0.0 108.53 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 79.7 Cg_endo -76.26 59.29 5.97 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.716 2.277 . . . . 0.0 111.736 171.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 39.49 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.882 1.673 . . . . 0.0 113.487 -174.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.499 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 27.9 m -127.91 -31.48 2.4 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.384 0.674 . . . . 0.0 109.754 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.79 148.47 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.41 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -87.98 -164.14 1.06 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.129 0.972 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -70.13 -2.21 12.34 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -63.38 -31.32 72.44 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.234 0.47 . . . . 0.0 110.765 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.432 HD21 HG11 ' A' ' 7' ' ' VAL . 1.1 mm? -64.93 117.44 7.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.132 0.573 . . . . 0.0 111.614 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.07 149.81 46.85 Favored Pre-proline 0 C--O 1.244 0.787 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.791 173.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.31 101.88 0.65 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.541 2.16 . . . . 0.0 111.047 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.83 0.62 0.78 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.483 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.427 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 26.2 mtm -89.7 -169.75 2.57 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 117.319 0.56 . . . . 0.0 110.984 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -107.86 160.06 16.04 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.507 0.723 . . . . 0.0 109.474 173.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CB ' HD11 ' A' ' 114' ' ' LEU . 12.3 t80 -134.98 105.25 6.29 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.8 t -90.76 121.13 40.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.175 0.512 . . . . 0.0 109.868 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -82.95 105.16 13.72 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.437 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 56.8 t80 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 66.7 m-85 . . . . . 0 CA--C 1.545 0.768 0 CA-C-O 120.525 0.202 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.53 -33.75 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.932 0.893 . . . . 0.0 110.88 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.6 -168.58 30.88 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.474 -0.33 . . . . 0.0 112.76 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 6.5 pt-20 -147.83 179.46 7.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.396 1.078 . . . . 0.0 108.918 174.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -164.19 -172.24 2.69 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.679 0.791 . . . . 0.0 110.659 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -123.94 119.03 28.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.507 1.123 . . . . 0.0 109.576 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 43' ' ' PHE . 53.7 mt -71.81 131.78 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.217 1.007 . . . . 0.0 110.733 177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -138.13 -162.4 1.3 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.212 1.805 . . . . 0.0 107.773 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -38.96 116.0 0.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.821 1.249 . . . . 0.0 113.466 -160.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.9 m -96.18 106.36 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 121.735 0.778 . . . . 0.0 109.113 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 86.2 t -89.96 108.02 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.8 mt -89.37 120.32 30.6 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.504 0.722 . . . . 0.0 109.398 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.7 t -151.58 135.73 16.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.557 0.743 . . . . 0.0 110.091 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -70.97 -10.22 59.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.922 0.889 . . . . 0.0 111.837 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -110.12 122.56 38.46 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.58 -22.35 58.41 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.218 1.945 . . . . 0.0 112.282 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 47.5 mtm -70.33 -25.63 63.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.484 0.713 . . . . 0.0 111.415 -169.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -53.56 -35.57 60.93 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.215 1.006 . . . . 0.0 112.03 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.418 ' HE2' ' HB3' ' A' ' 109' ' ' TRP . 5.7 m-85 -77.39 -33.82 55.04 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.525 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CE2' HD22 ' A' ' 87' ' ' LEU . 88.1 m-85 -81.5 -16.64 51.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.517 0.727 . . . . 0.0 111.65 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -94.14 -33.57 13.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.462 0.305 . . . . 0.0 111.208 172.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.2 m -78.08 -52.07 9.31 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.989 0.423 . . . . 0.0 110.737 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.797 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 66.9 m-85 -100.16 -53.96 3.0 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.538 0.735 . . . . 0.0 109.951 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.71 -86.44 0.12 Allowed Glycine 0 C--N 1.357 1.731 0 O-C-N 123.938 0.774 . . . . 0.0 113.129 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.92 -43.49 91.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.41 0.684 . . . . 0.0 110.692 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.797 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 25.0 mmt180 -68.74 -18.6 64.25 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-O 118.328 -0.844 . . . . 0.0 112.292 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 76' ' ' PHE . 47.9 t -80.25 131.9 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.628 1.104 . . . . 0.0 108.592 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -51.9 -37.58 52.98 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 124.092 0.87 . . . . 0.0 113.336 -170.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.0 pt? -111.75 160.0 17.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.539 HG22 ' HG2' ' A' ' 86' ' ' GLU . 8.9 t -97.24 173.69 7.09 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -61.26 -27.29 68.35 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.462 0.705 . . . . 0.0 111.438 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.95 -53.14 51.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.569 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 9.2 mm-40 -61.64 -29.74 70.26 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.566 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.514 HD22 ' CE2' ' A' ' 73' ' ' PHE . 25.2 tp -63.5 -58.56 6.63 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.121 0.968 . . . . 0.0 111.096 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -59.92 -41.19 91.18 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.571 0.544 . . . . 0.0 111.607 -172.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.94 -23.74 44.41 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.028 0.531 . . . . 0.0 111.477 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.79 -45.99 73.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.21 0.604 . . . . 0.0 109.788 171.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.3 mtm -67.27 -39.78 86.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.138 0.575 . . . . 0.0 110.381 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.2 mmpt? -64.0 -38.4 90.95 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.606 0.566 . . . . 0.0 110.293 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.3 t . . . . . 0 N--CA 1.474 0.767 0 C-N-CA 123.432 0.693 . . . . 0.0 110.749 177.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.239 0.543 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 30' ' ' PRO . 31.6 tptt -134.97 145.27 47.97 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.306 1.042 . . . . 0.0 108.73 173.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -80.15 121.62 25.8 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.418 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 41.6 m95 -107.77 158.55 17.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.055 0.942 . . . . 0.0 109.347 174.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.2 ptm -144.47 130.92 19.84 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.283 0.633 . . . . 0.0 110.271 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -103.78 102.38 12.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.637 0.775 . . . . 0.0 109.49 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.81 117.54 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.96 113.0 19.57 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.484 HD11 ' CB ' ' A' ' 43' ' ' PHE . 4.3 mm? -92.53 135.36 34.13 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.063 0.545 . . . . 0.0 110.726 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.81 167.95 20.88 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.645 0.778 . . . . 0.0 109.365 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.2 t70 53.6 47.45 23.86 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.312 1.053 . . . . 0.0 110.586 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 50.5 t -69.84 107.56 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.531 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -93.62 107.12 19.03 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.942 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -68.42 123.36 20.58 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -71.98 96.88 1.77 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 170.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -63.84 -33.37 75.53 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.465 0.706 . . . . 0.0 109.954 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.9 137.85 33.24 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.312 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.16 105.53 1.98 Allowed 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.161 1.907 . . . . 0.0 110.844 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 21.1 mt -91.03 108.14 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.525 0.678 . . . . 0.0 110.566 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -74.64 139.88 74.6 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.968 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -86.7 170.31 7.62 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 122.728 2.285 . . . . 0.0 112.367 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -87.68 -28.14 22.0 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.711 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -144.31 165.91 26.56 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.483 0.713 . . . . 0.0 110.479 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.0 134.2 44.57 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.509 HG12 ' HD3' ' A' ' 10' ' ' PRO . 62.2 t -101.6 100.0 13.04 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.37 176.5 5.58 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.225 2.616 . . . . 0.0 112.308 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.37 -30.81 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.622 0.769 . . . . 0.0 113.063 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.29 -21.23 75.75 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.537 0.523 . . . . 0.0 113.393 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.88 159.06 31.67 Favored Glycine 0 C--N 1.345 1.042 0 C-N-CA 123.453 0.549 . . . . 0.0 112.506 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -115.07 154.49 28.78 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.971 0.908 . . . . 0.0 109.759 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -88.49 124.15 33.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.97 116.11 27.78 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 172.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.66 139.46 52.7 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.537 ' HB2' HG13 ' A' ' 5' ' ' VAL . 4.4 tm-20 . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 5' ' ' VAL . 30.5 mm 67.38 -176.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 C-N-CA 124.168 0.987 . . . . 0.0 109.254 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.451 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.4 m -157.93 -41.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 125.498 1.519 . . . . 0.0 108.041 158.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.94 -161.32 18.97 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.178 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.52 155.9 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.879 0.872 . . . . 0.0 109.267 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -126.56 140.19 52.63 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.723 0.809 . . . . 0.0 109.706 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -141.94 142.84 26.21 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.65 0.78 . . . . 0.0 111.116 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HD3' HG12 ' A' ' 130' ' ' VAL . 74.9 Cg_endo -74.99 -12.81 21.54 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.943 2.429 . . . . 0.0 112.565 167.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.1 mm 69.2 123.46 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.815 1.646 . . . . 0.0 109.837 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.43 -7.07 18.05 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 122.894 2.396 . . . . 0.0 113.944 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HE3' ' HB3' ' A' ' 86' ' ' GLU . 67.9 mttm -134.62 170.88 15.13 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.448 1.099 . . . . 0.0 109.941 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -75.29 -5.05 42.65 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.597 0.759 . . . . 0.0 110.312 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -76.19 26.81 0.12 Allowed 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.007 0.923 . . . . 0.0 113.319 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -60.26 -32.96 71.65 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.827 0.851 . . . . 0.0 110.057 163.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.18 -21.32 66.75 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.837 0.855 . . . . 0.0 112.913 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 81' ' ' PHE . 37.4 mmt180 -57.43 -45.75 84.3 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.496 0.718 . . . . 0.0 110.796 176.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.526 ' HB3' HG11 ' A' ' 117' ' ' VAL . 65.8 m-85 -63.04 -31.11 72.18 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.664 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -91.48 -18.52 24.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.981 0.913 . . . . 0.0 111.111 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -72.96 -46.96 49.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.671 1.188 . . . . 0.0 109.84 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.8 ptpt -106.85 -15.87 14.61 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.226 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.76 -5.67 56.84 Favored Glycine 0 N--CA 1.48 1.588 0 N-CA-C 114.27 0.468 . . . . 0.0 114.27 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -161.68 107.83 1.34 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.31 1.044 . . . . 0.0 108.961 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.7 t70 -124.4 179.66 4.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.468 1.107 . . . . 0.0 109.675 -169.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 79' ' ' ARG . 55.3 t -128.87 109.67 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.44 0.696 . . . . 0.0 109.494 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.462 ' HD2' HD12 ' A' ' 112' ' ' ILE . 88.9 t80 -84.32 111.84 19.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m -89.93 139.45 17.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-O 121.526 0.679 . . . . 0.0 110.208 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.646 ' HG2' HG22 ' A' ' 33' ' ' VAL . 1.5 tpmt? -135.37 127.71 17.94 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.813 1.245 . . . . 0.0 108.507 -174.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 63.1 Cg_endo -73.14 60.37 3.86 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.643 2.229 . . . . 0.0 112.725 172.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.93 21.83 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.215 1.406 . . . . 0.0 114.509 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -64.69 -43.03 94.82 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.641 0.776 . . . . 0.0 111.045 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.646 HG22 ' HG2' ' A' ' 29' ' ' LYS . 20.1 m -72.84 150.33 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.752 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -82.56 -174.17 5.04 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.593 0.757 . . . . 0.0 111.839 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -66.98 -9.27 36.95 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.905 1.282 . . . . 0.0 111.387 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -60.63 -24.82 65.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.883 0.873 . . . . 0.0 110.848 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.88 91.83 2.02 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.519 0.728 . . . . 0.0 110.344 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 154.42 47.9 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 123.099 0.559 . . . . 0.0 109.951 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.67 99.25 0.93 Allowed 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.822 2.348 . . . . 0.0 111.476 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.18 -15.77 0.67 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.518 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.46 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 25.0 mtm -76.65 -178.98 5.03 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 121.554 0.692 . . . . 0.0 112.223 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -106.3 160.08 15.63 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.091 0.956 . . . . 0.0 110.352 171.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -135.49 97.04 3.58 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 93.4 t -86.82 120.92 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.254 0.549 . . . . 0.0 110.003 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -82.44 102.6 11.41 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.49 0.716 . . . . 0.0 110.115 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.8 t80 . . . . . 0 CA--C 1.546 0.803 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.528 170.4 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.01 -33.34 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.395 0.678 . . . . 0.0 111.272 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.6 -160.48 23.84 Favored Glycine 0 C--N 1.345 1.078 0 C-N-CA 121.546 -0.359 . . . . 0.0 113.131 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 11.6 pt-20 -151.28 177.78 9.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.231 1.012 . . . . 0.0 109.263 175.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -162.49 -173.32 3.51 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.139 0.976 . . . . 0.0 109.573 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -128.01 125.99 40.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.373 0.669 . . . . 0.0 110.228 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.1 mt -74.16 130.31 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.926 1.29 . . . . 0.0 111.288 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 30.7 mmmt -129.8 -164.39 1.4 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.616 1.567 . . . . 0.0 108.017 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -40.95 114.03 0.44 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.818 1.247 . . . . 0.0 113.743 -163.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -85.42 107.75 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 53.3 t -88.96 109.33 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.0 mt -87.37 117.82 26.39 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.474 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.3 t -151.18 130.33 12.69 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.155 0.982 . . . . 0.0 108.671 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.81 -6.67 33.86 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -105.51 122.19 43.58 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 170.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.576 ' HG2' HD21 ' A' ' 87' ' ' LEU . 57.7 Cg_endo -70.85 -15.98 32.99 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.743 2.295 . . . . 0.0 112.647 172.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 36.1 mtm -79.31 -25.03 42.44 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.672 0.789 . . . . 0.0 110.167 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -57.63 -32.43 67.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.403 1.081 . . . . 0.0 110.752 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.69 -19.91 58.77 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.028 0.531 . . . . 0.0 111.722 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.551 ' HE2' HD22 ' A' ' 87' ' ' LEU . 26.1 m-85 -86.64 -34.2 19.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.837 0.455 . . . . 0.0 110.685 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.46 -28.34 56.5 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 120.39 0.138 . . . . 0.0 110.723 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.5 m -83.6 -43.55 15.53 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.223 0.609 . . . . 0.0 111.505 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.787 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 64.0 m-85 -115.19 -67.5 0.99 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.786 0.435 . . . . 0.0 110.123 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.25 -83.92 0.62 Allowed Glycine 0 C--N 1.353 1.521 0 O-C-N 123.601 0.563 . . . . 0.0 113.044 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.73 -22.57 64.32 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.685 0.794 . . . . 0.0 111.831 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.787 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 31.6 mmt180 -72.33 -40.55 67.36 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.845 0.458 . . . . 0.0 111.385 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.415 HG12 HD23 ' A' ' 82' ' ' LEU . 13.5 t -69.52 147.31 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.006 0.522 . . . . 0.0 110.856 -170.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.447 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 28.9 p90 -69.86 -17.85 63.4 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 1.8 pt? -137.09 167.61 21.21 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 85' ' ' ASP . 13.9 t -110.04 -179.53 3.82 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.15 -27.92 69.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.25 0.62 . . . . 0.0 111.35 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 83' ' ' THR . 10.5 m-20 -62.5 -47.09 85.49 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.573 0.749 . . . . 0.0 111.25 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.512 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 1.8 mp0 -68.48 -29.52 68.15 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.576 HD21 ' HG2' ' A' ' 69' ' ' PRO . 46.8 tp -68.91 -48.9 62.19 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.837 0.455 . . . . 0.0 110.837 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -68.63 -36.68 78.94 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.008 -172.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 8.7 pt-20 -66.6 -36.28 82.24 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.12 -47.33 74.51 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.869 0.868 . . . . 0.0 110.754 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 67.2 mtm -70.02 -36.9 75.42 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.158 0.583 . . . . 0.0 110.63 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -62.34 -43.0 99.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.04 0.536 . . . . 0.0 110.279 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.48 1.062 0 C-N-CA 123.913 0.885 . . . . 0.0 111.355 -177.267 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 152.2 51.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.086 0.555 . . . . 0.0 109.738 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -71.64 127.23 31.88 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -116.68 159.12 22.7 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.404 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 14.7 ptm -142.47 130.58 22.0 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.282 0.633 . . . . 0.0 109.873 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -104.24 101.61 11.33 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.737 0.815 . . . . 0.0 109.198 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.462 HD12 ' HD2' ' A' ' 27' ' ' PHE . 27.9 mt -82.2 120.07 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -81.87 98.37 8.48 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.4 mm? -81.56 131.41 35.27 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 122.005 -0.434 . . . . 0.0 109.938 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.477 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 1.0 OUTLIER -138.47 159.79 41.2 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.183 0.593 . . . . 0.0 109.415 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.8 t70 53.58 48.33 21.91 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.364 1.065 . . . . 0.0 110.757 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 19' ' ' PHE . 27.2 t -71.62 101.89 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.206 -174.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.24 154.02 21.03 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.441 -174.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -107.08 138.55 43.04 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.531 0.732 . . . . 0.0 110.01 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -86.34 85.83 7.33 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 169.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.44 -39.23 82.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.072 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -81.66 148.48 61.91 Favored Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.275 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.77 114.94 4.06 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.679 2.253 . . . . 0.0 112.114 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.5 mt -114.5 131.49 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 145.91 30.4 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.24 1.016 . . . . 0.0 109.114 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -80.4 132.89 9.33 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.574 2.183 . . . . 0.0 111.659 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -66.58 -25.35 66.59 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.565 0.746 . . . . 0.0 110.662 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -146.25 166.87 24.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.144 0.978 . . . . 0.0 110.436 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -79.31 135.53 36.76 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.452 HG12 ' HD3' ' A' ' 10' ' ' PRO . 39.1 t -114.09 105.0 54.7 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.86 -174.31 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.168 2.578 . . . . 0.0 112.668 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.4 -34.84 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.889 0.875 . . . . 0.0 110.617 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.54 -24.2 75.23 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.24 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.76 167.42 42.0 Favored Glycine 0 C--N 1.346 1.1 0 C-N-CA 123.201 0.429 . . . . 0.0 112.94 175.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -118.44 151.84 37.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.082 0.953 . . . . 0.0 109.377 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -89.56 128.1 35.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tt -89.09 118.47 28.83 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.79 115.18 18.25 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.25 1.109 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -170.442 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.556 HG22 ' H ' ' A' ' 5' ' ' VAL . 23.1 mm 62.14 -164.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -172.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.556 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.3 m -148.64 -40.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 154.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.89 -161.68 20.79 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.342 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.59 149.27 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 6.2 t -121.86 134.47 54.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.524 0.73 . . . . 0.0 109.043 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -128.32 144.73 52.98 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.929 0.892 . . . . 0.0 109.217 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 42.1 Cg_exo -56.94 -31.13 88.63 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.132 2.555 . . . . 0.0 111.928 170.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.9 mm 68.45 131.79 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 125.675 1.59 . . . . 0.0 111.033 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.79 135.89 50.31 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.914 2.409 . . . . 0.0 112.078 172.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -66.16 -25.51 66.99 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.781 0.832 . . . . 0.0 112.737 -169.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -66.01 -37.31 85.57 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.302 0.641 . . . . 0.0 110.442 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.417 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 25.2 m-85 -114.88 13.33 17.1 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.542 -162.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.7 ttp -60.77 -41.51 95.65 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.022 0.529 . . . . 0.0 110.733 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.47 -18.81 51.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.903 0.881 . . . . 0.0 112.738 -173.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 15' ' ' PHE . 1.3 mmp_? -52.48 -48.48 65.88 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.354 0.662 . . . . 0.0 112.142 -173.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -66.22 -30.09 70.48 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.54 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -94.23 -12.11 28.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.872 0.869 . . . . 0.0 111.379 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -78.66 -52.16 8.82 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.745 0.818 . . . . 0.0 108.858 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -101.72 -16.83 16.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.282 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.67 10.31 63.71 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 114.11 0.404 . . . . 0.0 114.11 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -163.27 92.91 0.76 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.159 0.984 . . . . 0.0 109.049 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -127.3 -177.72 4.17 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.43 -168.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -141.7 117.97 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.062 0.945 . . . . 0.0 109.068 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -100.39 114.16 27.47 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.325 0.65 . . . . 0.0 109.446 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -92.99 141.11 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.264 0.554 . . . . 0.0 111.175 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.88 125.33 20.21 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 125.25 1.42 . . . . 0.0 110.466 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.53 71.26 6.02 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.934 2.423 . . . . 0.0 112.411 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 54.34 23.93 4.74 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.064 1.346 . . . . 0.0 113.35 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -73.2 -49.12 29.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.376 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 m -74.14 149.21 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.592 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -73.39 179.25 4.08 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.367 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.11 -7.77 25.72 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.325 1.05 . . . . 0.0 112.85 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.76 -25.44 66.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.461 0.704 . . . . 0.0 111.007 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.22 93.17 0.13 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.644 0.777 . . . . 0.0 111.03 175.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.46 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -113.24 149.24 41.14 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.24 99.56 1.03 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.535 2.156 . . . . 0.0 111.184 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.9 -2.17 0.73 Allowed Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.955 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.46 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 29.5 mtm -83.2 -170.49 3.07 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.501 0.667 . . . . 0.0 111.607 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.3 ptpt -115.55 162.49 17.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.527 1.131 . . . . 0.0 110.338 171.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.526 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.14 101.05 4.73 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 58.9 t -83.83 119.5 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.532 0.682 . . . . 0.0 109.371 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -85.89 113.46 22.04 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 88.4 t80 . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 171.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 27.5 m-85 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 p -125.71 -31.66 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.026 0.93 . . . . 0.0 110.209 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.93 -167.51 35.53 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.154 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 13.6 pt-20 -146.62 177.64 8.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.875 0.87 . . . . 0.0 109.308 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.453 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.45 -172.4 3.54 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.362 1.065 . . . . 0.0 109.348 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 86.0 mmt-85 -123.58 118.81 28.17 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.679 0.792 . . . . 0.0 109.775 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' ' 43' ' ' PHE . 51.0 mt -69.99 129.27 34.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 O-C-N 124.449 1.093 . . . . 0.0 109.595 174.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 14.7 mmmm -134.41 -172.54 3.04 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 125.553 1.541 . . . . 0.0 108.671 -175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -32.29 110.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.884 1.674 . . . . 0.0 114.371 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.7 m -90.27 117.61 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 68.5 t -90.39 108.8 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.9 mt -86.44 118.97 26.21 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.0 t -152.65 134.27 14.57 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.865 0.866 . . . . 0.0 109.817 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.518 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 58.0 mt-10 -68.98 -11.86 61.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 122.868 0.467 . . . . 0.0 111.495 174.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.579 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 10.1 m-80 -103.23 117.33 60.53 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.488 ' HG2' HD21 ' A' ' 87' ' ' LEU . 59.3 Cg_endo -73.96 -10.24 22.83 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.262 1.975 . . . . 0.0 112.817 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -78.78 -25.12 44.35 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.328 0.651 . . . . 0.0 111.027 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.579 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 75.5 mt-30 -68.68 -21.9 64.4 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.678 176.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -75.44 -23.63 56.94 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.877 0.471 . . . . 0.0 110.801 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.556 ' HE2' HD22 ' A' ' 87' ' ' LEU . 31.2 m-85 -85.25 -32.4 22.6 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.489 0.316 . . . . 0.0 111.707 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.7 pt-20 -75.15 -30.85 60.88 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 120.523 0.202 . . . . 0.0 110.726 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -79.17 -58.36 3.26 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.212 0.605 . . . . 0.0 110.655 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.785 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 61.8 m-85 -101.61 -67.63 0.86 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.579 0.752 . . . . 0.0 110.156 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.7 -84.66 0.77 Allowed Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.83 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.64 -46.55 86.89 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.422 0.689 . . . . 0.0 110.38 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.785 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 29.8 mmt180 -62.43 -30.22 71.07 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 124.066 0.854 . . . . 0.0 111.76 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.489 HG12 HD23 ' A' ' 82' ' ' LEU . 30.8 t -68.15 136.0 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -56.98 -28.51 62.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.583 0.753 . . . . 0.0 112.748 -171.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.489 HD23 HG12 ' A' ' 80' ' ' VAL . 1.8 pt? -123.53 155.28 37.86 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.621 0.768 . . . . 0.0 109.197 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.557 HG22 ' HG2' ' A' ' 86' ' ' GLU . 15.1 t -91.49 176.92 6.38 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.4 -34.41 77.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.673 0.389 . . . . 0.0 111.514 -177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -61.44 -44.72 96.62 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.405 0.682 . . . . 0.0 110.767 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HG2' HG22 ' A' ' 83' ' ' THR . 63.8 mm-40 -66.1 -35.44 80.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.357 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.556 HD22 ' HE2' ' A' ' 73' ' ' PHE . 29.1 tp -68.2 -47.95 66.51 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -35.45 78.73 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.21 -31.74 67.97 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 123.162 0.289 . . . . 0.0 110.917 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -66.36 -44.85 82.07 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.77 0.828 . . . . 0.0 110.934 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.3 mtm -76.82 -34.34 57.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.116 0.567 . . . . 0.0 110.454 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -64.38 -35.34 80.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.18 0.592 . . . . 0.0 110.42 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.475 0.783 0 O-C-N 123.688 0.618 . . . . 0.0 110.549 176.746 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.2 tpmt? -134.77 144.71 47.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.7 0.4 . . . . 0.0 109.966 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.66 113.26 15.33 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -96.9 153.55 17.83 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.5 ptm -132.61 130.05 39.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.277 0.631 . . . . 0.0 109.62 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -98.13 102.45 14.2 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.631 0.772 . . . . 0.0 109.123 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.444 ' HA ' HG12 ' A' ' 63' ' ' VAL . 51.4 mt -78.95 121.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -78.9 133.15 36.96 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.216 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.5 mm? -122.01 119.23 30.84 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.351 0.66 . . . . 0.0 109.757 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -125.29 175.89 7.14 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.571 0.748 . . . . 0.0 109.427 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 t70 54.52 36.0 24.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.002 0.921 . . . . 0.0 111.03 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.3 t -65.54 111.07 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.523 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.86 112.92 24.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.111 0.965 . . . . 0.0 110.988 -172.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -67.18 139.34 57.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.813 0.845 . . . . 0.0 111.498 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -82.68 113.72 20.55 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.686 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.9 -28.85 61.75 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.433 0.693 . . . . 0.0 110.018 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -105.69 146.37 32.7 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.522 1.129 . . . . 0.0 110.156 -175.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.42 99.56 1.31 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.727 2.285 . . . . 0.0 111.428 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.4 mt -85.09 123.71 39.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.512 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -75.73 126.85 86.72 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.958 0.903 . . . . 0.0 109.973 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.79 130.13 22.55 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.097 1.865 . . . . 0.0 111.454 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 11.7 mptt -75.44 -23.5 56.93 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.593 0.757 . . . . 0.0 110.429 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 135' ' ' GLN . 20.3 ptt-85 -149.9 158.73 44.45 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.859 0.864 . . . . 0.0 108.812 171.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.77 142.23 58.26 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.534 0.733 . . . . 0.0 110.935 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.7 96.82 45.29 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 123.268 0.627 . . . . 0.0 109.728 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.49 173.18 9.2 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.049 2.5 . . . . 0.0 112.523 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.37 -19.99 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.634 0.773 . . . . 0.0 112.705 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.46 -18.84 79.53 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.447 0.467 . . . . 0.0 113.328 173.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.06 150.47 9.47 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.48 0.562 . . . . 0.0 112.696 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.413 ' HB3' ' NH2' ' A' ' 128' ' ' ARG . 31.2 mm-40 -109.39 132.65 53.93 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.723 0.809 . . . . 0.0 110.753 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -74.55 101.89 4.34 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.704 0.402 . . . . 0.0 110.326 172.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.76 118.25 13.31 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.402 ' H ' ' HD2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -122.6 127.33 49.27 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.563 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 5' ' ' VAL . 25.1 mm 63.04 -172.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 C-N-CA 124.296 1.039 . . . . 0.0 109.226 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.475 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.6 m -148.54 -45.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 156.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.14 -161.49 18.06 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.938 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.421 HG12 HD11 ' A' ' 60' ' ' ILE . 8.7 p -122.93 144.99 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 171.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -117.72 132.13 56.51 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.17 0.588 . . . . 0.0 109.681 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.443 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . 13.0 m-85 -131.92 142.24 44.45 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 124.09 0.956 . . . . 0.0 109.462 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.526 ' HD3' HG12 ' A' ' 130' ' ' VAL . 61.2 Cg_endo -70.52 -18.86 33.14 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.662 2.241 . . . . 0.0 112.621 175.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 mm 47.82 69.86 2.44 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.605 1.162 . . . . 0.0 109.231 -168.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD3' ' HG2' ' A' ' 10' ' ' PRO . 47.3 Cg_endo -83.54 52.97 4.01 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.334 2.689 . . . . 0.0 110.833 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -148.19 166.45 27.88 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.853 -171.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -59.45 -26.11 64.94 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.238 1.015 . . . . 0.0 111.792 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -84.53 14.62 4.38 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.458 1.103 . . . . 0.0 113.041 -168.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -57.79 -35.37 70.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.321 1.049 . . . . 0.0 111.664 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.97 -23.93 61.51 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -53.78 -51.7 62.59 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.026 0.93 . . . . 0.0 113.18 -172.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -61.58 -30.04 70.42 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.866 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -96.96 -14.17 21.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.035 0.934 . . . . 0.0 110.936 -175.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -78.41 -58.78 3.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.252 1.021 . . . . 0.0 109.453 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 24' ' ' LYS . 13.7 ptpt -93.49 -18.0 22.79 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.496 -171.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.04 -12.77 16.75 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 114.103 0.401 . . . . 0.0 114.103 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' H ' ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -147.6 90.95 1.9 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.826 0.85 . . . . 0.0 110.413 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.56 176.41 5.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.639 -174.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.9 t -132.65 110.02 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.954 0.902 . . . . 0.0 108.578 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.86 111.47 22.51 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.711 0.804 . . . . 0.0 110.066 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.7 m -96.05 141.78 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.216 0.606 . . . . 0.0 111.579 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -134.69 144.73 51.96 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.698 1.199 . . . . 0.0 110.533 171.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.75 51.51 3.62 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 123.441 2.761 . . . . 0.0 111.833 169.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 54.26 78.22 0.17 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.74 1.216 . . . . 0.0 111.681 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.2 m -101.77 -47.92 4.46 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.375 0.67 . . . . 0.0 109.869 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 m -81.42 150.17 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.474 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 76.8 m95 -79.7 -163.16 0.49 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.294 1.038 . . . . 0.0 112.385 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -69.6 -14.79 63.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.342 1.057 . . . . 0.0 112.738 -171.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.46 -24.67 67.23 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.403 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -66.01 111.54 3.4 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.09 152.7 70.47 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.743 0.817 . . . . 0.0 109.573 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.2 99.25 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.789 2.326 . . . . 0.0 111.424 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.3 -15.76 0.58 Allowed Glycine 0 N--CA 1.467 0.747 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.577 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.545 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 73.5 mtp -74.62 176.86 6.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.004 0.922 . . . . 0.0 111.804 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -102.67 164.34 11.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.549 0.74 . . . . 0.0 110.285 169.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.443 ' HE1' ' HB2' ' A' ' 9' ' ' TYR . 0.4 OUTLIER -136.7 100.16 4.25 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 175.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.3 t -88.79 120.97 38.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -89.59 107.62 19.19 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.918 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.8 t80 . . . . . 0 CA--C 1.554 1.125 0 C-N-CA 124.398 1.079 . . . . 0.0 109.831 173.043 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.09 -35.41 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.104 0.561 . . . . 0.0 109.972 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.97 -161.71 25.65 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.875 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -153.56 177.96 10.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.772 0.829 . . . . 0.0 109.08 170.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.496 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -158.81 -173.48 4.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.651 0.78 . . . . 0.0 109.727 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -125.14 120.81 32.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.421 0.688 . . . . 0.0 110.37 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.432 HG13 ' HB2' ' A' ' 43' ' ' PHE . 56.5 mt -69.07 135.65 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.843 1.257 . . . . 0.0 111.587 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -135.31 -176.47 4.28 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 126.293 1.837 . . . . 0.0 108.527 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -44.9 123.15 3.62 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.803 1.241 . . . . 0.0 113.74 -164.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 112' ' ' ILE . 33.9 m -92.67 118.64 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.244 -176.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 73.1 t -89.28 109.56 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.97 117.66 30.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.394 0.678 . . . . 0.0 109.343 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -152.11 134.74 15.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.784 0.834 . . . . 0.0 109.597 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 66.9 mt-10 -69.57 -16.29 63.38 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.312 0.645 . . . . 0.0 111.626 176.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 53.9 m-20 -95.34 119.27 65.74 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 36.5 Cg_endo -66.94 -20.99 50.66 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.145 1.897 . . . . 0.0 112.483 173.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.476 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.2 mpp? -73.83 -22.61 59.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.824 0.45 . . . . 0.0 110.875 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.409 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 78.6 mm-40 -57.16 -33.84 67.83 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.953 0.783 . . . . 0.0 111.62 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -78.26 -27.54 47.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 122.857 0.463 . . . . 0.0 111.164 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.443 ' HE2' HD22 ' A' ' 87' ' ' LEU . 71.4 m-85 -86.24 -23.14 26.52 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.987 0.515 . . . . 0.0 111.33 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.16 -27.27 19.7 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.438 0.295 . . . . 0.0 110.935 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.7 m -82.55 -58.03 3.09 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.212 0.53 . . . . 0.0 110.055 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.773 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 69.3 m-85 -96.49 -68.96 0.77 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.521 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.28 -80.72 0.73 Allowed Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.631 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.11 -23.5 64.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.096 0.958 . . . . 0.0 111.351 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.773 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 21.2 mmt85 -81.51 -32.46 32.37 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 122.958 0.503 . . . . 0.0 111.217 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 HD23 ' A' ' 82' ' ' LEU . 20.4 t -68.56 146.33 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -63.64 -27.22 69.08 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.466 ' H ' HD23 ' A' ' 82' ' ' LEU . 2.5 pt? -122.79 176.58 5.89 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.658 0.383 . . . . 0.0 110.267 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.54 HG22 ' HG2' ' A' ' 86' ' ' GLU . 12.6 t -108.33 172.48 6.82 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -68.13 -25.94 65.54 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.02 0.528 . . . . 0.0 111.222 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -68.77 -41.25 79.06 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.335 0.654 . . . . 0.0 109.893 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.54 ' HG2' HG22 ' A' ' 83' ' ' THR . 22.6 mm-40 -66.78 -35.22 79.58 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.162 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.443 HD22 ' HE2' ' A' ' 73' ' ' PHE . 32.1 tp -60.79 -54.26 47.33 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.882 0.873 . . . . 0.0 111.527 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -60.61 -43.36 97.54 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 123.494 0.496 . . . . 0.0 111.193 -172.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.37 -29.51 53.35 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.214 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -62.19 -43.78 98.06 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.453 0.701 . . . . 0.0 110.806 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.3 mtm -68.15 -36.93 80.44 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.356 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.7 mmpt? -69.08 -28.54 66.6 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.119 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 123.305 0.642 . . . . 0.0 110.589 176.869 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 121.348 0.594 . . . . 0.0 111.762 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.624 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -138.3 147.95 44.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.074 172.001 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.43 104.9 4.58 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -85.05 156.07 21.25 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.8 ptm -140.94 131.44 25.35 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.534 0.733 . . . . 0.0 109.494 -174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -111.25 102.32 10.74 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.447 0.699 . . . . 0.0 109.919 -176.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.463 ' HA ' HG12 ' A' ' 63' ' ' VAL . 27.8 mt -82.07 122.82 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.18 131.1 35.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -118.11 113.54 21.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.103 0.961 . . . . 0.0 109.446 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -114.83 176.09 5.21 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.2 t70 53.95 46.39 25.71 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.135 0.897 . . . . 0.0 111.016 170.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.7 t -74.38 106.59 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.959 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.457 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 1.7 tpmt? -83.66 155.52 23.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.671 1.188 . . . . 0.0 110.735 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -116.68 123.65 47.77 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.904 0.881 . . . . 0.0 109.103 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -74.11 98.42 3.12 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.54 -35.04 78.18 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.916 0.886 . . . . 0.0 109.812 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.4 ' HG3' HG13 ' A' ' 124' ' ' ILE . 15.9 ptpt -91.03 138.07 26.2 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.289 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -83.63 77.0 3.55 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.271 2.648 . . . . 0.0 112.466 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.4 HG13 ' HG3' ' A' ' 122' ' ' LYS . 72.6 mt -84.7 131.65 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -100.28 157.58 33.56 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.02 177.41 7.8 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.209 1.939 . . . . 0.0 111.761 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -94.98 2.6 55.38 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.457 0.703 . . . . 0.0 110.278 178.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -163.43 179.95 6.95 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.941 1.296 . . . . 0.0 109.274 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.79 130.39 35.04 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.526 HG12 ' HD3' ' A' ' 10' ' ' PRO . 39.8 t -104.79 96.39 10.53 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.5 -176.67 2.35 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.02 2.48 . . . . 0.0 112.887 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.46 -35.08 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.25 1.02 . . . . 0.0 111.292 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.77 -24.24 72.71 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.59 -0.732 . . . . 0.0 113.097 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.61 165.07 37.72 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 123.344 0.497 . . . . 0.0 113.002 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -118.37 143.75 46.41 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.694 0.797 . . . . 0.0 109.613 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.474 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 0.7 OUTLIER -79.67 112.89 17.38 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 167.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.7 121.43 26.38 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 145.09 51.88 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.998 0.519 . . . . 0.0 109.988 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.244 0.807 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.512 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 139' ' ' GLU . 22.2 ptmt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 113.331 0.864 . . . . 0.0 113.331 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 5' ' ' VAL . 30.7 mm 67.85 -179.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 C-N-CA 124.157 0.983 . . . . 0.0 109.61 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 139' ' ' GLU . 1.2 m -149.18 -34.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.758 1.223 . . . . 0.0 109.186 161.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.466 ' HA2' ' HE3' ' A' ' 41' ' ' MET . . . -171.35 -164.0 26.29 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-O 121.433 0.463 . . . . 0.0 112.787 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.91 161.17 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 t -134.5 133.2 40.09 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 122.979 0.512 . . . . 0.0 109.704 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.43 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . 7.2 m-85 -134.76 140.52 35.55 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.06 0.944 . . . . 0.0 110.132 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HD3' HG12 ' A' ' 130' ' ' VAL . 93.7 Cg_endo -76.5 -14.9 17.82 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.911 2.408 . . . . 0.0 112.431 172.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 mm 64.59 115.3 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 125.609 1.564 . . . . 0.0 109.559 -172.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -66.77 -14.9 45.63 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.095 2.53 . . . . 0.0 114.085 -168.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -132.61 -175.24 3.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.812 0.845 . . . . 0.0 110.267 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -69.33 2.99 2.5 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 124.184 0.993 . . . . 0.0 112.541 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.51 7.39 2.39 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -66.94 -34.04 76.9 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 119.024 0.829 . . . . 0.0 109.383 170.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.53 -30.04 70.38 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.595 1.158 . . . . 0.0 111.811 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 37.3 mmt180 -51.71 -47.35 64.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.423 1.089 . . . . 0.0 111.682 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.412 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 65.0 m-85 -66.43 -30.62 71.02 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.692 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.68 -20.17 25.22 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.573 0.749 . . . . 0.0 110.63 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -76.02 -56.92 4.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.392 1.077 . . . . 0.0 110.201 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.9 ptpt -96.06 -18.19 20.37 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.741 -171.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.79 -28.64 2.13 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -125.11 96.02 4.7 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 124.436 1.094 . . . . 0.0 108.259 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.412 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 13.9 t70 -110.36 176.31 5.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.195 0.598 . . . . 0.0 110.076 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.5 t -136.24 111.71 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.998 0.919 . . . . 0.0 109.114 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.483 ' HD2' HD12 ' A' ' 112' ' ' ILE . 88.3 t80 -84.7 109.07 17.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.479 0.711 . . . . 0.0 110.311 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.88 138.08 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.607 0.718 . . . . 0.0 110.531 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HE2' ' HD2' ' A' ' 30' ' ' PRO . 1.6 tpmt? -136.38 134.64 20.0 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.798 1.239 . . . . 0.0 108.461 -176.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 56.9 Cg_endo -72.86 57.0 3.07 Favored 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 122.745 2.297 . . . . 0.0 113.127 170.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.58 28.44 3.45 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 125.491 1.516 . . . . 0.0 114.005 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.45 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 5.3 m -69.66 -30.26 67.9 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.37 0.668 . . . . 0.0 110.518 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.631 HG11 HD23 ' A' ' 37' ' ' LEU . 21.9 t -85.82 149.02 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -78.14 -173.53 3.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.13 0.972 . . . . 0.0 111.811 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.506 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 7.6 tmtt? -71.59 -14.53 62.1 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 123.861 0.865 . . . . 0.0 110.188 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -51.43 -32.32 26.23 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.609 0.764 . . . . 0.0 111.245 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.631 HD23 HG11 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -69.48 102.26 1.76 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 123.568 0.747 . . . . 0.0 110.547 178.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -125.47 151.93 70.88 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.244 0.618 . . . . 0.0 109.987 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.5 99.21 0.7 Allowed 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.857 2.371 . . . . 0.0 111.611 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.77 2.69 0.88 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.497 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.489 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 29.1 mtm -92.77 -172.72 3.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.06 0.544 . . . . 0.0 111.157 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -109.99 160.01 16.79 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.906 0.882 . . . . 0.0 110.531 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.465 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.04 99.83 4.39 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.2 t -87.7 125.36 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.398 0.618 . . . . 0.0 109.931 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -91.01 114.24 26.72 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.753 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.417 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 37.6 t80 . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 171.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 110.848 -0.056 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.14 -32.26 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 168.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . -172.86 -167.22 32.5 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.143 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 16.0 pt-20 -158.47 178.28 10.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.612 0.765 . . . . 0.0 109.246 172.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.483 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -161.19 -173.8 4.03 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.069 0.548 . . . . 0.0 110.646 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -120.85 120.03 34.36 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.305 1.042 . . . . 0.0 109.996 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 43' ' ' PHE . 53.8 mt -70.62 138.43 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.569 1.148 . . . . 0.0 111.271 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -140.79 -166.73 2.21 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.907 2.083 . . . . 0.0 107.797 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -35.07 122.11 0.56 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.174 1.39 . . . . 0.0 114.524 -164.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.9 m -105.05 105.78 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 121.854 0.835 . . . . 0.0 109.52 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -91.75 114.56 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.593 0.757 . . . . 0.0 110.056 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.547 ' HB3' HD11 ' A' ' 108' ' ' LEU . 36.9 mt -96.41 117.95 31.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.651 0.78 . . . . 0.0 109.544 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.1 t -151.07 139.56 20.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.495 0.718 . . . . 0.0 110.354 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 24.1 mt-10 -66.76 -24.06 66.16 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.388 1.075 . . . . 0.0 111.803 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.557 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 81.5 m-20 -97.59 120.62 60.22 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HG2' HD21 ' A' ' 87' ' ' LEU . 38.3 Cg_endo -66.03 -19.2 57.72 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.361 2.041 . . . . 0.0 112.055 171.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 56.9 mtm -71.81 -24.59 61.75 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.08 0.952 . . . . 0.0 111.012 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.557 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 16.3 mm100 -60.96 -26.33 67.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.596 0.758 . . . . 0.0 111.507 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -81.82 -25.29 35.3 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.117 0.567 . . . . 0.0 110.844 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 87' ' ' LEU . 97.2 m-85 -89.66 -14.49 34.74 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.39 0.676 . . . . 0.0 111.641 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.47 -30.4 17.34 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.294 0.238 . . . . 0.0 110.619 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.8 m -78.07 -59.84 2.62 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.89 0.376 . . . . 0.0 110.771 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.784 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 58.8 m-85 -99.65 -59.1 1.78 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.529 0.732 . . . . 0.0 110.021 -173.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.98 -88.17 0.14 Allowed Glycine 0 C--N 1.356 1.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.494 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -69.49 -21.04 63.72 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.617 0.767 . . . . 0.0 111.699 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.784 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 37.4 mmt180 -72.87 -36.79 67.45 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.349 0.405 . . . . 0.0 110.433 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.47 HG12 HD23 ' A' ' 82' ' ' LEU . 21.4 t -64.07 151.4 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 122.593 0.357 . . . . 0.0 110.345 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.465 ' HD2' ' HA ' ' A' ' 27' ' ' PHE . 41.3 p90 -66.36 -7.88 21.88 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -147.69 172.04 14.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.343 0.657 . . . . 0.0 109.632 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 86' ' ' GLU . 7.4 t -96.38 170.66 9.08 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -66.43 -26.63 67.31 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.36 0.264 . . . . 0.0 110.671 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 4.0 m-20 -60.24 -53.86 52.63 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' H ' HG23 ' A' ' 83' ' ' THR . 49.5 mm-40 -58.81 -33.0 69.86 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.561 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.501 HD21 ' HG2' ' A' ' 69' ' ' PRO . 28.5 tp -62.92 -58.22 8.1 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.726 0.641 . . . . 0.0 111.037 174.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -62.64 -38.77 91.55 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.593 0.558 . . . . 0.0 111.917 -171.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 12.1 pt-20 -82.96 -21.92 33.9 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.301 0.64 . . . . 0.0 111.459 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -66.54 -47.05 74.08 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 69.1 mtm -67.69 -31.53 71.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.427 0.691 . . . . 0.0 110.595 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.4 mmpt? -60.71 -52.23 66.02 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 CA--C 1.551 1.019 0 C-N-CA 123.618 0.767 . . . . 0.0 111.638 -178.5 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 121.013 0.435 . . . . 0.0 109.996 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.612 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -134.13 152.65 51.93 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 169.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.7 tm? -76.19 121.35 22.76 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -106.81 159.72 16.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.232 1.013 . . . . 0.0 109.805 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.446 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 15.8 ptm -136.56 130.72 32.81 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.045 0.938 . . . . 0.0 110.045 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.07 102.06 11.07 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.685 0.794 . . . . 0.0 109.434 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.483 HD12 ' HD2' ' A' ' 27' ' ' PHE . 42.2 mt -85.0 121.08 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.75 133.38 35.34 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -117.76 133.3 56.08 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.207 1.003 . . . . 0.0 109.502 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.78 165.36 25.79 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.66 0.784 . . . . 0.0 110.062 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.2 t70 57.23 36.83 27.88 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.365 1.041 . . . . 0.0 110.846 168.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.2 t -63.24 109.56 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.718 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 165.31 23.42 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.031 1.333 . . . . 0.0 110.663 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -130.61 124.9 32.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.552 0.741 . . . . 0.0 110.238 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.415 ' H ' ' HA2' ' A' ' 56' ' ' GLY . 35.0 m-85 -88.29 82.48 7.05 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 168.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.56 -32.36 73.08 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.514 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -80.36 148.62 67.15 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.232 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.13 103.64 1.78 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.84 2.36 . . . . 0.0 112.672 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.7 mt -125.01 130.98 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.515 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -97.9 144.26 27.7 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.904 0.882 . . . . 0.0 108.912 178.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.79 176.75 8.71 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.815 2.344 . . . . 0.0 112.932 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -64.15 -32.22 73.71 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.817 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -157.5 163.51 38.36 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 123.62 0.768 . . . . 0.0 109.88 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.27 135.11 54.98 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.997 0.919 . . . . 0.0 108.976 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.557 HG12 ' HD3' ' A' ' 10' ' ' PRO . 47.9 t -108.17 94.6 13.43 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 123.464 0.705 . . . . 0.0 109.616 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.97 -175.35 1.65 Allowed 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.069 2.513 . . . . 0.0 112.868 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.3 m -56.85 -31.19 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.46 1.104 . . . . 0.0 113.711 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.17 -14.86 81.8 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.386 0.429 . . . . 0.0 113.496 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.45 150.83 6.94 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 123.193 0.425 . . . . 0.0 112.923 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.488 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -108.81 165.36 11.62 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.575 0.75 . . . . 0.0 110.178 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.0 130.04 46.12 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.99 0.516 . . . . 0.0 109.691 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.75 124.09 38.59 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.57 148.14 46.63 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 5' ' ' VAL . 3.4 tm-20 . . . . . 0 C--O 1.252 1.207 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 173.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.41 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 5' ' ' VAL . 29.1 mm 63.39 -172.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -174.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.6 m -151.09 -45.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 156.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.39 -160.87 18.61 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.168 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.98 139.79 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -107.82 132.31 53.55 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.518 0.727 . . . . 0.0 109.481 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -127.64 141.99 42.74 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.602 0.761 . . . . 0.0 110.485 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' HG12 ' A' ' 130' ' ' VAL . 95.9 Cg_endo -73.33 -19.81 21.83 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.167 2.578 . . . . 0.0 113.129 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mm 53.77 92.76 0.06 OUTLIER Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 125.258 1.423 . . . . 0.0 110.413 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.99 17.01 0.75 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.857 2.371 . . . . 0.0 113.291 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -124.72 153.33 42.53 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 110.24 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -11.84 61.15 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.596 1.158 . . . . 0.0 111.395 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -81.32 22.31 0.69 Allowed 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.486 1.114 . . . . 0.0 112.482 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.461 ' HG2' ' HE2' ' A' ' 20' ' ' PHE . 46.2 ttm -64.77 -41.14 96.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.971 0.908 . . . . 0.0 110.003 168.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.7 -19.23 65.64 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.979 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -47.64 -51.66 20.73 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.801 1.24 . . . . 0.0 112.682 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 49.7 m-85 -69.4 -30.76 68.8 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.451 -174.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.461 ' HE2' ' HG2' ' A' ' 16' ' ' MET . 54.7 m-85 -84.48 -24.68 29.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.714 0.806 . . . . 0.0 110.314 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -68.28 -49.09 62.9 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.92 1.288 . . . . 0.0 109.903 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -107.33 -16.55 14.36 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.545 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.46 -6.15 70.13 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 114.253 0.461 . . . . 0.0 114.253 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -157.81 111.69 2.55 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.881 0.873 . . . . 0.0 109.643 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.3 t70 -136.64 -171.54 2.94 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.42 124.73 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.261 1.391 . . . . 0.0 109.644 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -96.62 116.58 29.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.646 0.778 . . . . 0.0 109.322 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 m -89.35 146.86 5.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.494 0.664 . . . . 0.0 110.222 171.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.635 ' HG2' HG22 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -134.62 114.26 12.15 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.7 1.2 . . . . 0.0 109.047 -172.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.53 66.6 2.93 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.438 2.759 . . . . 0.0 113.478 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . 47.35 78.42 0.07 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.006 1.322 . . . . 0.0 113.454 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.438 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 37.8 m -125.49 -58.04 1.44 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.635 HG22 ' HG2' ' A' ' 29' ' ' LYS . 15.4 m -66.96 133.87 30.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.898 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -88.4 -157.58 0.43 Allowed 'General case' 0 CA--C 1.564 1.506 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.905 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -70.83 -1.77 12.73 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -166.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -67.48 -28.9 68.25 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.701 0.8 . . . . 0.0 110.419 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.571 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 1.1 mm? -66.55 119.59 11.96 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.538 0.735 . . . . 0.0 110.645 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 157.48 56.35 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.415 1.086 . . . . 0.0 109.255 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.92 88.84 0.9 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.381 2.054 . . . . 0.0 111.597 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.08 41.72 0.04 OUTLIER Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.042 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.571 ' SD ' ' HA ' ' A' ' 37' ' ' LEU . 87.1 mtp -118.94 -168.8 1.62 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.068 0.947 . . . . 0.0 109.391 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 15.2 ptpt -121.13 162.23 20.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.68 0.792 . . . . 0.0 110.276 168.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.456 ' HB2' HG13 ' A' ' 60' ' ' ILE . 17.5 t80 -134.77 97.1 3.68 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 94.1 t -83.12 119.65 32.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.39 0.614 . . . . 0.0 110.046 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -80.33 99.67 8.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.599 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.0 t80 . . . . . 0 CA--C 1.541 0.605 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.697 169.878 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 121.628 0.727 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.451 HG22 ' NZ ' ' A' ' 119' ' ' LYS . 10.0 p -87.62 -15.53 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.297 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.85 -171.15 41.76 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.297 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 7.9 pt-20 -147.56 178.86 8.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.833 0.853 . . . . 0.0 110.156 174.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.409 ' CB ' HD12 ' A' ' 114' ' ' LEU . . . -158.4 -171.11 3.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.718 1.207 . . . . 0.0 109.204 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 12.7 mmt85 -129.58 118.92 22.77 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.545 0.738 . . . . 0.0 110.709 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 41' ' ' MET . 54.4 mt -72.13 133.15 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.568 1.147 . . . . 0.0 111.421 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.0 mmmt -133.18 -177.11 4.37 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 126.166 1.786 . . . . 0.0 108.533 -176.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -28.42 113.87 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 126.275 1.83 . . . . 0.0 114.904 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 112' ' ' ILE . 35.2 m -95.44 117.45 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.659 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.6 t -90.18 108.65 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.534 ' HB3' HD11 ' A' ' 108' ' ' LEU . 69.3 mt -87.14 116.7 25.39 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.4 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 46.3 m -148.71 137.05 21.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.616 0.766 . . . . 0.0 109.986 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 18.8 mt-10 -66.5 -34.82 78.79 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.11 0.964 . . . . 0.0 112.068 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.646 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 73.9 m-20 -89.1 123.8 66.44 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.89 -21.23 64.39 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 122.354 2.036 . . . . 0.0 111.732 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 37.7 mtm -74.35 -19.02 60.6 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.09 0.956 . . . . 0.0 110.91 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.646 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 17.0 mm100 -60.42 -32.41 71.33 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.278 0.631 . . . . 0.0 110.695 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 66' ' ' SER . 5.4 m-85 -77.38 -27.29 52.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.681 -177.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.464 ' CE2' HD22 ' A' ' 87' ' ' LEU . 73.6 m-85 -91.11 -20.52 21.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.075 0.55 . . . . 0.0 111.94 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.17 -34.27 22.12 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.8 m -81.25 -59.68 2.55 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.999 0.52 . . . . 0.0 110.925 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.796 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 98.1 m-85 -93.19 -64.31 1.11 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.648 0.779 . . . . 0.0 110.207 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.25 -90.66 0.28 Allowed Glycine 0 C--N 1.352 1.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.375 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.29 -9.58 58.85 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.949 0.9 . . . . 0.0 111.808 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.796 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 28.0 mmt85 -78.21 -36.5 47.15 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.87 0.468 . . . . 0.0 110.262 170.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 82' ' ' LEU . 35.1 t -75.49 140.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.287 0.635 . . . . 0.0 110.741 -176.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -57.1 -20.63 26.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 1.8 pt? -134.0 170.15 16.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.9 t -108.11 -176.7 3.13 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 122.051 -0.405 . . . . 0.0 109.981 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.73 -25.37 67.27 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.244 0.618 . . . . 0.0 111.915 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.515 ' H ' HG23 ' A' ' 83' ' ' THR . 23.9 t70 -73.6 -36.42 65.52 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.32 0.648 . . . . 0.0 111.278 174.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 1.5 mp0 -74.51 -24.7 59.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.794 -0.566 . . . . 0.0 110.746 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.464 HD22 ' CE2' ' A' ' 73' ' ' PHE . 28.2 tp -67.57 -50.15 59.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.037 0.535 . . . . 0.0 109.691 175.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -40.45 96.11 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.465 0.478 . . . . 0.0 110.979 -175.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.476 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 8.6 pt-20 -64.86 -39.76 94.06 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -64.2 -49.46 71.91 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.987 0.915 . . . . 0.0 111.567 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 56.3 mtm -67.98 -44.89 75.61 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.402 0.681 . . . . 0.0 110.233 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -71.92 -26.25 62.22 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.883 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.488 1.467 0 CA-C-N 118.182 0.446 . . . . 0.0 110.802 174.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.26 147.21 49.73 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -176.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 65' ' ' LEU . 0.4 OUTLIER -82.92 100.44 10.39 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -87.49 159.92 18.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.918 0.887 . . . . 0.0 109.646 171.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.584 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 20.8 ptm -140.18 137.51 34.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.741 0.416 . . . . 0.0 111.436 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.46 102.7 11.29 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.852 0.861 . . . . 0.0 109.949 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.456 ' HA ' HG12 ' A' ' 63' ' ' VAL . 42.6 mt -83.29 121.1 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.753 0.821 . . . . 0.0 109.021 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 39.8 tt0 -80.16 138.04 36.82 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.409 HD12 ' CB ' ' A' ' 58' ' ' ALA . 4.0 mm? -119.13 129.71 55.17 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.88 0.872 . . . . 0.0 109.837 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -128.99 173.14 10.69 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 51.43 54.58 10.83 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.1 0.952 . . . . 0.0 111.762 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.96 115.98 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.692 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER -102.27 152.58 20.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.202 1.001 . . . . 0.0 110.627 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.451 ' NZ ' HG22 ' A' ' 55' ' ' VAL . 26.0 mmmt -104.58 139.73 39.03 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.414 1.086 . . . . 0.0 109.309 170.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -91.1 72.41 6.33 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.46 -24.93 62.96 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.07 173.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.409 ' HG3' HG13 ' A' ' 124' ' ' ILE . 0.2 OUTLIER -79.78 146.05 63.61 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.744 170.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.59 90.25 0.5 Allowed 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.395 2.063 . . . . 0.0 112.811 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 122' ' ' LYS . 24.7 mt -107.7 119.75 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.35 142.53 24.69 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.549 0.74 . . . . 0.0 109.556 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.74 133.98 41.74 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.33 2.02 . . . . 0.0 111.4 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -71.87 -24.6 61.71 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.829 0.851 . . . . 0.0 110.466 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.433 HH21 ' HB3' ' A' ' 135' ' ' GLN . 13.0 ptt180 -156.02 174.73 14.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.477 1.111 . . . . 0.0 109.459 174.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.87 143.49 55.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.225 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.49 HG12 ' HD3' ' A' ' 10' ' ' PRO . 60.3 t -122.83 102.14 38.57 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.89 -175.94 2.59 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.944 2.429 . . . . 0.0 111.854 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.6 p -57.68 -30.75 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 124.293 1.037 . . . . 0.0 112.751 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.34 -15.55 81.12 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.831 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.79 159.85 19.03 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.137 0.398 . . . . 0.0 113.02 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.433 ' HB3' HH21 ' A' ' 128' ' ' ARG . 31.6 mm-40 -116.98 146.92 42.71 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.783 0.833 . . . . 0.0 109.716 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -80.69 118.19 22.03 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.34 122.36 30.2 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.428 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -134.84 133.41 39.73 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.244 0.779 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.378 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 5' ' ' VAL . 21.4 mm 61.62 -163.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -171.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.582 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.8 m -149.47 -42.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 155.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.15 -162.12 21.88 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.101 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.56 149.44 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -117.21 132.52 56.62 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.354 0.662 . . . . 0.0 109.716 176.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -131.83 142.21 44.39 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.142 0.977 . . . . 0.0 109.598 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HD3' HG12 ' A' ' 130' ' ' VAL . 40.6 Cg_endo -66.7 -46.82 3.24 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.402 2.068 . . . . 0.0 111.73 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.3 mt 50.83 71.91 1.4 Allowed Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.218 1.007 . . . . 0.0 108.909 -167.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.29 39.32 0.83 Allowed 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.086 2.524 . . . . 0.0 112.415 -173.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -127.66 162.7 25.92 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.242 1.417 . . . . 0.0 109.116 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -67.62 -16.16 64.02 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.712 0.805 . . . . 0.0 112.392 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -73.76 0.02 14.3 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.107 0.963 . . . . 0.0 112.913 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -67.14 -18.87 65.48 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 117.908 0.322 . . . . 0.0 111.727 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.71 -31.12 72.2 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.243 1.017 . . . . 0.0 111.841 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 12.9 mmt85 -58.15 -38.55 76.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.567 1.147 . . . . 0.0 112.942 -167.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -70.98 -31.17 67.64 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.01 0.524 . . . . 0.0 110.195 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -93.24 -8.64 41.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.902 0.881 . . . . 0.0 110.237 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -85.6 -59.36 2.34 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 124.388 1.075 . . . . 0.0 110.032 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.4 ptpt -99.47 -15.52 18.67 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.196 -170.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.23 -39.54 2.78 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 113.579 0.192 . . . . 0.0 113.579 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -119.54 91.34 3.53 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.911 0.885 . . . . 0.0 109.291 173.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -99.43 175.05 5.99 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.943 0.897 . . . . 0.0 110.059 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.18 110.02 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.104 0.962 . . . . 0.0 108.981 175.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -88.77 118.23 28.31 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.444 0.698 . . . . 0.0 109.684 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.94 132.96 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 121.587 0.708 . . . . 0.0 111.117 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 5.1 mmpt? -120.0 138.7 27.27 Favored Pre-proline 0 C--O 1.215 -0.759 0 C-N-CA 125.376 1.471 . . . . 0.0 109.227 176.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.427 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 73.7 Cg_endo -77.24 46.78 2.06 Favored 'Trans proline' 0 CA--C 1.56 1.803 0 C-N-CA 122.481 2.121 . . . . 0.0 111.708 162.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.43 38.1 17.3 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.319 1.448 . . . . 0.0 112.61 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 m -64.28 -38.02 89.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.564 0.746 . . . . 0.0 110.225 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.8 149.88 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.908 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.566 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 90.6 m95 -72.2 -178.55 2.5 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.771 0.828 . . . . 0.0 111.667 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -79.2 10.71 3.35 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.34 0.656 . . . . 0.0 112.27 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -75.12 -20.88 59.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.892 0.877 . . . . 0.0 110.625 174.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.27 100.79 0.84 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.642 0.777 . . . . 0.0 110.32 -176.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 3.2 ptpp? -119.18 152.45 52.25 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.198 0.599 . . . . 0.0 109.755 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.57 97.69 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.65 2.233 . . . . 0.0 110.936 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.6 -4.73 0.33 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.203 -174.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.431 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 31.5 mtm -89.88 -171.27 3.1 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.436 0.694 . . . . 0.0 111.689 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 12.9 ptpt -112.6 162.15 16.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.227 1.011 . . . . 0.0 110.573 172.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.499 ' HB2' HG13 ' A' ' 60' ' ' ILE . 3.2 t80 -136.22 102.53 5.02 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 42.1 t -88.86 121.46 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.169 0.509 . . . . 0.0 110.287 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -86.11 126.51 34.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.258 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 52.5 t80 . . . . . 0 CA--C 1.539 0.524 0 C-N-CA 124.411 1.084 . . . . 0.0 109.452 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 25.7 m-85 . . . . . 0 CA--C 1.547 0.843 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.45 -36.11 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 122.829 0.452 . . . . 0.0 111.055 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.45 -160.52 21.18 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.575 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 14.9 pt-20 -154.88 177.16 11.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.606 1.162 . . . . 0.0 108.409 176.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.536 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -161.49 -173.54 3.83 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.698 0.799 . . . . 0.0 109.531 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -122.31 118.98 29.79 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.777 0.831 . . . . 0.0 109.927 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.499 HG13 ' HB2' ' A' ' 43' ' ' PHE . 51.7 mt -68.99 127.96 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.99 174.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -138.2 -164.59 1.65 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.461 1.504 . . . . 0.0 108.311 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -34.5 114.15 0.2 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 125.123 1.369 . . . . 0.0 113.956 -162.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.5 110.89 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-O 121.38 0.61 . . . . 0.0 109.799 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 97.4 t -91.02 108.43 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.8 mt -85.96 115.68 23.72 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 53.5 m -151.94 127.37 9.99 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 40.4 mt-10 -60.99 -47.6 85.72 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.577 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 43.3 m-20 -71.69 119.48 74.39 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.65 -21.39 70.11 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.486 2.124 . . . . 0.0 111.746 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 44.6 mtm -72.4 -20.17 61.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.002 0.921 . . . . 0.0 111.071 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.577 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 17.9 mm100 -60.97 -29.02 69.42 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.244 0.618 . . . . 0.0 111.005 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.488 ' HE2' ' HB3' ' A' ' 109' ' ' TRP . 6.3 m-85 -81.93 -27.99 33.04 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.634 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.498 ' CE2' HD22 ' A' ' 87' ' ' LEU . 87.0 m-85 -87.91 -18.19 29.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.163 0.585 . . . . 0.0 111.832 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.31 -33.32 20.65 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.5 m -82.4 -60.39 2.22 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.078 0.551 . . . . 0.0 111.491 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.755 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 59.5 m-85 -93.81 -55.26 3.31 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.178 0.591 . . . . 0.0 110.136 -177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 65.83 -89.37 0.12 Allowed Glycine 0 C--N 1.355 1.628 0 O-C-N 124.135 0.897 . . . . 0.0 113.55 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.2 -28.51 68.15 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.079 0.952 . . . . 0.0 110.829 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.755 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 16.0 mmt85 -72.2 -27.88 62.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.034 0.534 . . . . 0.0 111.892 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.435 HG12 HD23 ' A' ' 82' ' ' LEU . 25.2 t -68.72 151.76 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.41 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 41.0 p90 -63.24 -11.08 18.67 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -145.1 173.17 12.14 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.279 1.032 . . . . 0.0 109.138 174.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.612 HG22 ' HG2' ' A' ' 86' ' ' GLU . 15.1 t -104.26 173.85 6.13 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -63.6 -30.35 71.47 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.897 0.479 . . . . 0.0 111.548 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.83 -32.52 67.64 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.612 ' HG2' HG22 ' A' ' 83' ' ' THR . 26.3 mm-40 -70.01 -35.53 74.42 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 172.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.498 HD22 ' CE2' ' A' ' 73' ' ' PHE . 18.3 tp -62.66 -52.28 63.96 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.073 0.949 . . . . 0.0 111.544 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -42.17 98.41 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.928 -173.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.26 -29.77 65.48 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 122.959 0.162 . . . . 0.0 110.785 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -66.19 -46.86 75.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.557 0.743 . . . . 0.0 110.922 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.7 mtm -69.08 -33.8 74.13 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.969 0.507 . . . . 0.0 110.809 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -76.49 -27.5 56.09 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.948 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 121.235 0.541 . . . . 0.0 109.915 176.32 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.085 0.469 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -110.5 154.29 23.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.082 0.953 . . . . 0.0 109.268 -175.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.6 tm? -73.98 116.97 15.22 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.488 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 24.0 m95 -107.85 161.77 14.61 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.867 0.867 . . . . 0.0 108.96 172.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.419 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 12.5 ptm -145.89 130.83 18.2 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.48 0.712 . . . . 0.0 110.399 -176.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -101.93 103.66 14.33 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.206 1.002 . . . . 0.0 109.694 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.4 mt -90.3 120.8 39.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -78.11 109.81 12.52 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.56 0.618 . . . . 0.0 109.459 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -95.45 108.69 20.92 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 123.411 0.684 . . . . 0.0 110.536 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.31 172.64 8.49 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.5 t70 58.95 40.73 22.14 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.298 1.039 . . . . 0.0 110.63 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.9 t -70.48 107.93 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.204 -172.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -93.37 114.42 26.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.23 1.012 . . . . 0.0 111.126 -176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -74.33 136.7 42.55 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 170.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -80.5 110.68 16.19 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.88 -23.18 66.14 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.76 1.224 . . . . 0.0 111.3 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -125.25 149.21 63.31 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.568 1.147 . . . . 0.0 110.315 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.49 96.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 123.522 2.815 . . . . 0.0 113.654 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 17.3 mt -100.03 107.16 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.019 0.528 . . . . 0.0 109.67 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.52 150.25 89.01 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.872 -176.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.423 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 98.0 Cg_endo -72.94 164.88 34.33 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.079 1.852 . . . . 0.0 112.141 174.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -70.2 -41.06 74.17 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 173.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -153.46 177.01 11.38 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.522 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.69 132.93 53.42 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.136 0.974 . . . . 0.0 111.402 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.585 HG12 ' HD3' ' A' ' 10' ' ' PRO . 38.2 t -119.37 97.88 50.3 Favored Pre-proline 0 CA--C 1.553 1.079 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.65 -176.76 3.15 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.053 2.502 . . . . 0.0 112.579 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.18 -26.81 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.354 1.061 . . . . 0.0 112.079 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.04 -20.4 79.96 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.837 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.3 148.85 3.95 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.321 0.486 . . . . 0.0 113.103 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -106.96 151.45 25.27 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.355 0.662 . . . . 0.0 109.363 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.566 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 1.3 m-85 -89.82 122.9 33.32 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 174.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.03 116.84 27.61 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.89 127.32 39.93 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -171.985 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.587 HG13 ' HB3' ' A' ' 36' ' ' GLU . 25.3 mm 63.8 -169.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 C-N-CA 124.094 0.957 . . . . 0.0 108.764 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.516 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.5 m -149.48 -41.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.988 1.315 . . . . 0.0 107.524 156.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.06 -162.57 22.59 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.81 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 p -124.18 156.46 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.425 0.69 . . . . 0.0 109.275 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -126.41 133.03 51.38 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.329 0.652 . . . . 0.0 109.285 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.24 135.85 28.09 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 123.283 0.633 . . . . 0.0 110.745 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.457 ' HB3' ' HD2' ' A' ' 46' ' ' TYR . 43.1 Cg_endo -93.83 78.07 0.23 Allowed 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 124.078 3.186 . . . . 0.0 110.214 168.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.78 109.3 1.76 Allowed Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.822 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -83.93 30.86 0.52 Allowed 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.213 2.609 . . . . 0.0 112.428 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 15' ' ' PHE . 38.6 mmtm -133.41 148.68 51.81 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.428 1.491 . . . . 0.0 108.674 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -63.06 -15.96 58.3 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.011 0.924 . . . . 0.0 111.693 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.409 ' HD2' ' HB3' ' A' ' 13' ' ' LYS . 59.1 m-85 -72.89 7.05 2.2 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.375 1.07 . . . . 0.0 112.824 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.3 ttp -68.76 -24.18 64.41 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.14 0.576 . . . . 0.0 109.981 165.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.35 -29.02 70.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.998 0.919 . . . . 0.0 110.98 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 27.2 mmt180 -57.63 -41.0 80.49 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 124.382 1.051 . . . . 0.0 111.771 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.43 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 58.0 m-85 -65.1 -32.35 74.0 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 123.902 0.751 . . . . 0.0 110.042 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -89.47 -13.59 37.2 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.697 0.799 . . . . 0.0 111.125 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -82.83 -54.45 5.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.954 0.901 . . . . 0.0 110.393 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.2 ptpt -100.8 -8.89 22.22 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.712 -165.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.47 -42.17 3.13 Favored Glycine 0 N--CA 1.475 1.245 0 O-C-N 123.067 0.229 . . . . 0.0 113.109 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -129.64 106.1 8.5 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.395 0.678 . . . . 0.0 109.981 172.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.43 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.2 t70 -107.53 -177.37 3.33 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.494 1.117 . . . . 0.0 109.174 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.2 t -136.81 114.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.36 1.064 . . . . 0.0 109.229 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -85.09 111.65 19.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.599 0.759 . . . . 0.0 110.266 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.57 132.1 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-O 121.2 0.524 . . . . 0.0 110.461 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HD2' ' HD2' ' A' ' 30' ' ' PRO . 58.5 tptt -134.71 130.57 19.8 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.504 1.122 . . . . 0.0 108.335 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 109' ' ' TRP . 24.9 Cg_endo -61.68 94.95 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 121.872 1.715 . . . . 0.0 109.58 166.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -30.08 79.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.807 2.043 . . . . 0.0 115.674 -163.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 50.7 m -96.11 -30.51 13.49 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.068 172.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.82 142.7 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.315 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -67.41 168.76 10.15 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.263 0.625 . . . . 0.0 112.368 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -58.94 -11.52 3.46 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.21 1.404 . . . . 0.0 113.562 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.587 ' HB3' HG13 ' A' ' 4' ' ' ILE . 7.7 mm-40 -64.64 -17.3 63.91 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.968 0.907 . . . . 0.0 111.939 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.16 100.48 3.08 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.365 0.666 . . . . 0.0 110.04 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.3 152.33 42.57 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.77 82.93 2.03 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.66 2.24 . . . . 0.0 111.918 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.63 43.0 0.02 OUTLIER Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.122 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 34.0 mtm -122.39 -158.83 0.8 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.867 0.867 . . . . 0.0 110.026 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -121.05 158.88 26.85 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.09 0.956 . . . . 0.0 110.309 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.41 ' CB ' HD11 ' A' ' 114' ' ' LEU . 2.5 t80 -136.41 99.68 4.16 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 41.3 t -83.7 124.59 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.089 0.471 . . . . 0.0 110.068 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -89.51 115.32 26.84 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.498 0.719 . . . . 0.0 109.508 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.457 ' HD2' ' HB3' ' A' ' 10' ' ' PRO . 85.0 t80 . . . . . 0 CA--C 1.54 0.572 0 C-N-CA 124.459 1.103 . . . . 0.0 109.481 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.506 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 17.6 m-30 . . . . . 0 CA--C 1.552 1.026 0 CA-C-O 121.216 0.532 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -77.2 -33.42 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.004 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . -173.53 -166.4 31.77 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.843 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 2.2 pt-20 -149.61 179.36 8.05 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.576 1.15 . . . . 0.0 108.627 176.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.546 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -158.56 -173.65 4.39 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.819 0.848 . . . . 0.0 109.509 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -127.29 116.53 20.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.411 0.684 . . . . 0.0 109.64 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -66.63 137.69 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.915 1.286 . . . . 0.0 111.425 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -141.0 -170.6 3.08 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.351 1.86 . . . . 0.0 108.564 -175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -30.62 113.98 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.586 1.554 . . . . 0.0 114.798 -168.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -97.52 108.88 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-O 121.799 0.809 . . . . 0.0 109.694 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 95.7 t -92.65 109.26 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.93 0.892 . . . . 0.0 109.795 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.56 117.66 27.67 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.4 t -152.99 135.72 15.31 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.768 0.827 . . . . 0.0 109.814 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.469 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 38.1 mt-10 -63.72 -22.16 66.77 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.062 0.545 . . . . 0.0 111.53 172.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -87.76 119.88 70.73 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.188 0.595 . . . . 0.0 109.723 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.31 -8.39 22.62 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 122.418 2.078 . . . . 0.0 112.064 167.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 51.7 mtm -89.58 -26.0 21.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.407 1.083 . . . . 0.0 111.21 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.49 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 71.4 mt-30 -68.17 -20.91 64.91 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -74.52 -21.99 59.27 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.508 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.487 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 22.6 m-85 -89.99 -27.81 19.53 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.177 0.591 . . . . 0.0 111.482 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 13.0 pt-20 -76.33 -28.43 56.89 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.3 m -85.98 -60.75 1.92 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.897 0.479 . . . . 0.0 110.788 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.792 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 67.0 m-85 -101.32 -61.84 1.32 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.389 0.675 . . . . 0.0 110.205 -173.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 77.33 -87.54 1.01 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.703 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.33 -12.94 44.96 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.792 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 6.4 mmp_? -69.33 -34.05 74.05 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.291 169.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.433 HG12 HD23 ' A' ' 82' ' ' LEU . 34.7 t -67.62 147.16 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.8 0.44 . . . . 0.0 110.453 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -63.56 -22.27 66.8 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.433 HD23 HG12 ' A' ' 80' ' ' VAL . 2.1 pt? -131.38 162.06 30.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.177 0.591 . . . . 0.0 109.608 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.443 HG23 ' H ' ' A' ' 85' ' ' ASP . 5.6 t -106.05 -176.93 3.22 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -56.39 -43.15 78.99 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.37 0.668 . . . . 0.0 111.142 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.443 ' H ' HG23 ' A' ' 83' ' ' THR . 14.4 m-20 -60.38 -45.8 92.27 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.041 0.936 . . . . 0.0 111.772 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.52 -46.72 88.76 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 123.224 0.327 . . . . 0.0 110.45 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.422 HD22 ' HE2' ' A' ' 73' ' ' PHE . 43.8 tp -57.27 -50.04 74.16 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.115 0.884 . . . . 0.0 111.46 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.494 ' HD3' ' N ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -64.28 -45.85 86.22 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.477 0.486 . . . . 0.0 110.775 -175.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.494 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 13.0 pt-20 -74.04 -24.79 59.58 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.451 0.3 . . . . 0.0 110.984 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -71.82 -49.37 39.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.718 0.807 . . . . 0.0 109.997 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.3 mtm -66.73 -40.76 88.51 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.89 0.744 . . . . 0.0 110.105 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 31.2 mmmt -63.99 -35.59 81.2 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.714 0.634 . . . . 0.0 111.077 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 CA--C 1.55 0.956 0 C-N-CA 122.861 0.464 . . . . 0.0 110.949 176.842 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.469 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.554 1.123 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 16.9 tptm -132.65 165.05 25.35 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.445 0.698 . . . . 0.0 109.583 175.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.61 114.32 10.61 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.649 0.779 . . . . 0.0 109.496 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 19.5 m95 -100.35 161.99 13.24 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.319 1.048 . . . . 0.0 109.398 172.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.514 ' HE3' HD11 ' A' ' 112' ' ' ILE . 9.0 ptt? -143.25 138.93 29.96 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.933 0.397 . . . . 0.0 110.766 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -109.51 103.33 12.2 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.089 0.956 . . . . 0.0 109.74 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.514 HD11 ' HE3' ' A' ' 110' ' ' MET . 22.8 mt -87.03 122.06 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.36 129.77 34.76 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.6 mm? -117.18 107.58 14.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.795 0.838 . . . . 0.0 110.865 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -106.4 170.83 7.69 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.157 0.583 . . . . 0.0 110.327 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.6 t70 55.21 38.54 30.57 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 124.449 1.093 . . . . 0.0 111.09 168.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.3 t -66.92 101.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.523 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.32 110.66 23.17 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.921 -167.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -65.08 122.27 16.66 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.886 0.875 . . . . 0.0 110.947 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.506 ' HD2' ' HB3' ' A' ' 54' ' ' PHE . 12.8 m-30 -75.9 87.35 2.87 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.36 -30.56 70.97 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.278 172.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -81.91 131.94 55.61 Favored Pre-proline 0 CA--C 1.553 1.089 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.384 168.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.66 84.15 2.03 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.761 2.307 . . . . 0.0 111.557 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.4 mt -73.21 127.04 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.008 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -74.53 130.6 81.54 Favored Pre-proline 0 CA--C 1.553 1.066 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.865 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.454 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 65.7 Cg_endo -71.51 145.13 46.7 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.63 2.22 . . . . 0.0 110.707 169.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -83.55 -6.22 59.39 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.588 0.755 . . . . 0.0 111.228 -179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -167.83 177.98 5.46 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.621 1.168 . . . . 0.0 109.402 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.87 138.04 46.03 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 166.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.446 HG12 ' HD3' ' A' ' 10' ' ' PRO . 43.7 t -107.0 100.33 31.47 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 170.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.23 169.25 17.2 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.873 2.382 . . . . 0.0 112.138 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.442 ' HA ' ' HG2' ' A' ' 10' ' ' PRO . 18.7 m -59.25 -20.49 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -173.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.5 -21.93 76.33 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.144 0.277 . . . . 0.0 113.079 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.79 147.47 14.89 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.621 0.629 . . . . 0.0 112.096 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -108.88 148.59 30.39 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.509 0.724 . . . . 0.0 109.33 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -92.27 120.37 32.76 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.459 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.24 122.93 30.13 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 130.04 34.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.322 0.649 . . . . 0.0 109.254 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.588 -171.794 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mm 67.4 -178.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.933 1.293 . . . . 0.0 109.04 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 m -150.15 -47.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 156.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.527 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.05 -161.34 19.17 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.516 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.499 HG12 HD11 ' A' ' 60' ' ' ILE . 9.7 p -117.5 161.76 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -133.5 135.96 44.78 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.63 0.772 . . . . 0.0 109.25 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -136.03 146.03 54.92 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.924 0.89 . . . . 0.0 110.371 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD3' HG12 ' A' ' 130' ' ' VAL . 69.3 Cg_endo -70.7 -32.89 13.9 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.872 2.381 . . . . 0.0 112.624 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 mm 53.24 77.9 0.42 Allowed Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 124.105 0.962 . . . . 0.0 108.756 -168.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.17 41.65 1.14 Allowed 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.403 2.736 . . . . 0.0 112.868 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -138.49 158.95 43.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.353 1.461 . . . . 0.0 109.176 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -72.16 -10.95 60.47 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.128 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -79.51 11.61 2.96 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.43 1.092 . . . . 0.0 111.823 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 58.2 ttp -63.01 -35.37 80.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.715 0.806 . . . . 0.0 109.699 166.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.78 -26.17 68.58 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.893 0.877 . . . . 0.0 112.449 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -50.66 -48.02 58.5 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.844 0.858 . . . . 0.0 111.44 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.422 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 75.0 m-85 -67.53 -27.55 67.06 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.807 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -102.12 6.63 40.97 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.342 0.657 . . . . 0.0 110.922 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -93.52 -57.06 2.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.168 0.987 . . . . 0.0 109.41 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -110.98 -19.72 12.68 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.06 32.5 75.98 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 114.917 0.727 . . . . 0.0 114.917 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -161.86 41.77 0.14 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.278 1.031 . . . . 0.0 109.459 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' OD1' ' HA ' ' A' ' 19' ' ' PHE . 3.0 m-20 -81.93 -172.01 3.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.333 -172.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -142.36 110.69 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.412 ' H ' HD23 ' A' ' 114' ' ' LEU . 91.9 t80 -86.94 111.76 21.13 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 m -83.99 140.23 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.73 0.776 . . . . 0.0 110.561 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HD2' ' HB ' ' A' ' 32' ' ' THR . 15.2 tppt? -134.58 120.98 14.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.966 1.306 . . . . 0.0 109.699 -171.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 95.6 Cg_endo -77.54 53.86 4.5 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.13 2.554 . . . . 0.0 112.829 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 58.12 21.33 7.84 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.521 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 4.5 m -63.63 -36.42 83.77 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.349 0.522 . . . . 0.0 110.294 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -119.93 149.68 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.165 0.986 . . . . 0.0 109.092 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -167.57 -48.96 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.574 0.749 . . . . 0.0 110.348 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -41.59 -51.98 3.86 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.847 1.659 . . . . 0.0 113.641 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 22.8 mt-10 -109.68 -12.51 14.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.595 0.758 . . . . 0.0 110.306 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.425 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -69.23 115.44 8.52 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 123.294 0.637 . . . . 0.0 110.221 -177.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -143.85 152.15 54.8 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.992 0.917 . . . . 0.0 108.951 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.83 103.16 1.3 Allowed 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.597 2.198 . . . . 0.0 111.616 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.74 -7.07 0.91 Allowed Glycine 0 N--CA 1.476 1.348 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.789 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.527 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 79.0 mtp -83.01 -169.39 2.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.432 1.093 . . . . 0.0 111.068 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 12.3 ptpt -116.0 165.52 13.03 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.713 0.805 . . . . 0.0 110.608 168.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.535 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.1 t80 -135.37 99.06 4.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 87.3 t -84.96 120.07 34.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.23 0.538 . . . . 0.0 109.804 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -84.07 100.16 10.92 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.1 t80 . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 165.656 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.641 ' HB2' ' HB ' ' A' ' 124' ' ' ILE . 1.6 m-85 . . . . . 0 CA--C 1.544 0.734 0 CA-C-O 120.939 0.4 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.17 -38.87 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.93 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.13 -166.66 25.53 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.234 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -145.89 178.68 8.0 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.906 0.882 . . . . 0.0 108.755 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -164.16 -171.71 2.51 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.693 0.797 . . . . 0.0 110.016 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 11.3 mmt180 -128.73 122.32 30.41 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.249 1.019 . . . . 0.0 109.401 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' A' ' 43' ' ' PHE . 57.8 mt -74.34 131.37 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.201 1.0 . . . . 0.0 110.322 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -139.31 -164.71 1.72 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.925 1.69 . . . . 0.0 108.357 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -24.78 109.93 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 126.378 1.871 . . . . 0.0 114.769 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 112' ' ' ILE . 35.0 m -98.76 109.04 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 94.7 t -89.62 110.23 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -87.96 118.26 27.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.516 0.727 . . . . 0.0 109.669 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.3 t -153.62 134.86 14.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.781 0.832 . . . . 0.0 109.581 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 49.3 mt-10 -70.03 -17.53 63.26 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.102 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.494 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 36.5 m-80 -91.66 118.76 68.51 Favored Pre-proline 0 C--N 1.357 0.892 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.456 ' HG2' HD21 ' A' ' 87' ' ' LEU . 50.0 Cg_endo -69.21 -10.83 30.05 Favored 'Trans proline' 0 CA--C 1.556 1.615 0 C-N-CA 122.473 2.115 . . . . 0.0 112.259 171.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 46.4 mtm -81.25 -27.56 35.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.168 0.987 . . . . 0.0 111.499 -176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 47.5 mt-30 -66.21 -24.01 66.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.387 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -74.08 -25.2 59.69 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.872 0.469 . . . . 0.0 110.866 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.543 ' HE2' HD22 ' A' ' 87' ' ' LEU . 33.3 m-85 -80.87 -37.34 30.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.0 0.52 . . . . 0.0 110.892 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.55 -29.03 61.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 121.294 -0.162 . . . . 0.0 111.35 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.4 m -80.74 -47.22 14.26 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.981 0.512 . . . . 0.0 110.682 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 62.7 m-85 -116.33 -67.23 1.01 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.265 0.626 . . . . 0.0 109.935 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.76 -81.13 1.15 Allowed Glycine 0 C--N 1.35 1.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.835 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.5 -43.97 93.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.902 0.881 . . . . 0.0 110.83 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 25.8 mmt180 -66.44 -30.68 71.09 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.553 -176.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.424 HG12 HD23 ' A' ' 82' ' ' LEU . 40.3 t -66.03 131.21 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -62.51 -22.16 66.07 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -168.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.424 HD23 HG12 ' A' ' 80' ' ' VAL . 2.3 pt? -128.07 160.89 30.58 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 85' ' ' ASP . 8.2 t -97.01 179.33 4.97 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.913 0.324 . . . . 0.0 110.383 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -62.95 -32.59 73.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.104 0.562 . . . . 0.0 111.452 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.414 ' H ' HG23 ' A' ' 83' ' ' THR . 5.6 m-20 -66.5 -45.8 78.38 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.33 0.652 . . . . 0.0 110.627 176.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.93 -35.46 76.77 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.44 173.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.543 HD22 ' HE2' ' A' ' 73' ' ' PHE . 40.5 tp -64.14 -52.73 57.7 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.546 0.529 . . . . 0.0 110.874 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -67.14 -40.44 86.74 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.256 0.348 . . . . 0.0 111.365 -173.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.71 -33.32 73.74 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -63.64 -48.26 77.97 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.973 0.909 . . . . 0.0 110.292 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.5 mtm -65.58 -33.0 74.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.052 0.541 . . . . 0.0 110.388 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.2 mmpt? -71.4 -34.89 70.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.621 0.368 . . . . 0.0 110.957 175.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 122.932 0.493 . . . . 0.0 110.543 179.072 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 121.132 0.491 . . . . 0.0 112.096 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.4 tpmt? -101.46 151.53 21.83 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.435 -174.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 2.9 tm? -73.45 110.31 7.65 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 173.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -89.8 158.47 17.48 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.449 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 12.3 ptm -139.51 129.05 24.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.16 0.584 . . . . 0.0 109.796 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.402 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -100.87 100.95 11.67 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.454 ' HA ' HG12 ' A' ' 63' ' ' VAL . 23.3 mt -80.95 117.98 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -80.66 110.08 15.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.52 0.676 . . . . 0.0 109.67 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 27' ' ' PHE . 4.0 mm? -88.67 131.62 34.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.405 1.082 . . . . 0.0 109.824 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -139.07 173.29 11.71 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.18 0.592 . . . . 0.0 109.463 171.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.9 t70 56.17 34.56 24.13 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.856 0.862 . . . . 0.0 110.946 170.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.9 t -65.89 106.82 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.698 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.265 -175.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.95 162.84 19.26 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.6 1.16 . . . . 0.0 109.969 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.87 124.12 42.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.697 0.799 . . . . 0.0 109.336 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -79.68 103.4 9.56 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.266 0.555 . . . . 0.0 109.674 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.83 -28.23 68.83 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.671 1.188 . . . . 0.0 110.589 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -88.34 139.85 30.24 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.973 0.909 . . . . 0.0 109.831 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.4 92.22 0.94 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.709 2.273 . . . . 0.0 111.86 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.641 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 41.5 mt -80.34 138.38 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.88 140.24 23.5 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.67 123.39 12.91 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.53 2.153 . . . . 0.0 112.095 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -57.73 -34.05 69.1 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.553 0.741 . . . . 0.0 109.432 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -150.61 164.69 35.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.388 1.075 . . . . 0.0 109.056 172.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.55 126.52 29.91 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.36 0.664 . . . . 0.0 109.522 -175.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.482 HG12 ' HD3' ' A' ' 10' ' ' PRO . 19.1 t -109.51 99.73 38.62 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.65 -172.85 1.52 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.91 2.407 . . . . 0.0 112.137 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.23 -34.81 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.965 0.906 . . . . 0.0 110.966 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.77 -21.1 77.92 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.203 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.74 163.26 26.71 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 122.92 0.295 . . . . 0.0 113.12 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -115.54 149.89 37.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.999 0.919 . . . . 0.0 109.961 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 9.2 m-85 -85.24 120.1 26.35 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 169.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.7 125.54 33.95 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 128.86 42.28 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 C--O 1.247 0.965 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -171.75 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 5' ' ' VAL . 27.1 mm 64.35 -168.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.665 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -170.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.534 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.3 m -147.31 -39.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.024 0.929 . . . . 0.0 108.729 158.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.02 -161.83 21.21 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.284 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 13.4 p -127.88 155.12 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 t -126.94 136.63 52.54 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -137.15 139.95 29.74 Favored Pre-proline 0 N--CA 1.469 0.522 0 C-N-CA 124.419 1.088 . . . . 0.0 109.369 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 15.4 Cg_exo -65.76 -47.0 4.27 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 123.079 2.519 . . . . 0.0 110.825 169.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.6 mt 67.95 136.12 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 125.366 1.466 . . . . 0.0 110.2 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.482 ' HB2' ' HD2' ' A' ' 15' ' ' PHE . 81.6 Cg_exo -48.06 124.98 10.98 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.236 1.957 . . . . 0.0 111.356 171.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -59.31 -16.8 24.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.518 1.127 . . . . 0.0 113.052 -174.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -66.98 -45.64 77.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.571 0.748 . . . . 0.0 110.797 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.482 ' HD2' ' HB2' ' A' ' 12' ' ' PRO . 76.3 m-85 -101.2 1.56 39.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.414 1.086 . . . . 0.0 112.071 -174.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -73.15 -40.8 64.56 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.211 0.604 . . . . 0.0 110.354 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -63.86 -25.34 68.12 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.504 0.721 . . . . 0.0 112.132 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -50.67 -44.25 57.64 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 124.96 1.304 . . . . 0.0 112.581 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.54 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 47.9 m-85 -70.37 -27.13 64.08 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.494 0.718 . . . . 0.0 111.526 -174.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -95.97 -17.78 20.75 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.186 0.994 . . . . 0.0 110.15 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -74.6 -58.73 3.1 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.637 1.175 . . . . 0.0 110.506 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -92.57 -14.0 28.89 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.924 -172.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.13 -58.89 4.22 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.813 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -109.88 104.72 13.69 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.317 0.558 . . . . 0.0 110.186 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 11.4 t70 -101.63 179.23 4.41 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.176 0.99 . . . . 0.0 109.757 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.0 t -138.06 110.84 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.393 1.077 . . . . 0.0 109.023 171.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -88.48 111.45 21.83 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.707 0.803 . . . . 0.0 109.937 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.8 m -90.44 126.88 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.619 0.723 . . . . 0.0 111.149 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 7.4 mmpt? -110.18 134.97 20.6 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.124 1.369 . . . . 0.0 109.726 173.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.77 56.6 6.02 Favored 'Trans proline' 0 CA--C 1.557 1.668 0 C-N-CA 122.501 2.134 . . . . 0.0 110.909 166.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 50.79 37.51 17.16 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.035 1.334 . . . . 0.0 112.919 -176.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 10.7 m -64.65 -43.39 93.79 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.954 0.902 . . . . 0.0 110.246 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.41 151.32 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.081 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.466 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 62.6 m95 -73.5 -177.38 2.63 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.392 1.077 . . . . 0.0 112.016 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -68.2 -3.72 11.58 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.036 0.934 . . . . 0.0 113.018 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HB3' HG13 ' A' ' 4' ' ' ILE . 9.5 mm-40 -66.57 -24.81 66.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.214 0.606 . . . . 0.0 110.773 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 94.65 0.63 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.935 0.494 . . . . 0.0 109.891 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.472 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -115.12 149.99 43.54 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.207 0.603 . . . . 0.0 109.438 177.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.473 ' HA ' HG22 ' A' ' 60' ' ' ILE . 59.9 Cg_endo -70.95 103.17 1.32 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.948 2.432 . . . . 0.0 110.699 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.64 -16.05 1.09 Allowed Glycine 0 C--O 1.241 0.54 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.512 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.477 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 25.8 mtm -73.48 -174.49 1.69 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.362 0.665 . . . . 0.0 112.185 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -109.45 159.44 17.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.845 0.858 . . . . 0.0 110.456 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.9 t80 -137.0 98.14 3.68 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 46.7 t -84.55 129.4 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 109.955 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -93.0 119.28 32.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.564 0.746 . . . . 0.0 110.042 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 52.1 t80 . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 124.875 1.27 . . . . 0.0 109.111 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 p -85.3 -31.32 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.997 0.919 . . . . 0.0 110.782 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.33 -162.9 26.09 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.869 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 15.2 pt-20 -153.72 178.0 10.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.804 1.242 . . . . 0.0 108.215 175.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -164.24 -176.17 4.31 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.592 0.757 . . . . 0.0 110.091 177.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -122.92 130.6 53.03 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.641 0.776 . . . . 0.0 109.889 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 39' ' ' PRO . 45.4 mt -74.39 138.1 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.039 1.336 . . . . 0.0 110.751 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -133.4 -168.62 2.13 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.722 2.009 . . . . 0.0 108.438 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -31.28 113.03 0.1 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 126.113 1.765 . . . . 0.0 113.967 -166.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.3 m -92.79 103.23 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 86.7 t -90.71 109.0 20.35 Favored 'Isoleucine or valine' 0 C--N 1.348 0.512 0 C-N-CA 123.682 0.793 . . . . 0.0 109.067 -172.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.5 mt -84.85 118.54 24.55 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.405 ' HB3' ' CE1' ' A' ' 72' ' ' PHE . 47.5 t -149.31 130.35 14.41 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.785 0.834 . . . . 0.0 109.202 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.423 ' HG3' HD23 ' A' ' 108' ' ' LEU . 25.9 mt-10 -67.33 -15.9 63.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.745 0.818 . . . . 0.0 111.513 173.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -103.49 119.32 55.26 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 123.534 0.734 . . . . 0.0 109.099 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.42 -13.37 39.01 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.368 2.046 . . . . 0.0 112.663 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.0 mtm -82.6 -27.94 31.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.643 0.777 . . . . 0.0 111.479 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.51 -22.4 66.72 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.771 0.319 . . . . 0.0 111.545 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 66' ' ' SER . 15.0 m-85 -71.99 -25.63 61.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.039 0.535 . . . . 0.0 110.833 174.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.599 ' HE2' HD22 ' A' ' 87' ' ' LEU . 21.2 m-85 -87.72 -27.41 22.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.822 0.449 . . . . 0.0 111.572 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.94 -29.04 55.45 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.591 0.234 . . . . 0.0 110.717 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.6 m -86.32 -46.91 9.86 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.136 0.575 . . . . 0.0 111.443 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.771 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 69.3 m-85 -116.01 -62.89 1.53 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.469 0.708 . . . . 0.0 110.082 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 72.35 -92.06 0.57 Allowed Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.019 -0.537 . . . . 0.0 113.382 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.32 -19.2 61.7 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.647 0.779 . . . . 0.0 111.064 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.771 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 23.0 mmt180 -70.67 -37.84 73.72 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.573 173.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.9 t -63.65 149.62 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.711 0.405 . . . . 0.0 110.199 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -64.03 -16.04 60.79 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.0 pt? -142.12 158.59 43.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.476 1.111 . . . . 0.0 108.686 174.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.48 HG22 ' HG3' ' A' ' 86' ' ' GLU . 13.8 t -100.44 -177.53 3.53 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.68 -35.85 79.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.535 0.734 . . . . 0.0 111.751 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.68 -44.99 94.84 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.577 0.751 . . . . 0.0 110.813 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 30.0 mt-10 -72.13 -26.38 62.09 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.68 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.599 HD22 ' HE2' ' A' ' 73' ' ' PHE . 24.9 tp -71.36 -50.96 26.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.418 0.687 . . . . 0.0 110.785 176.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -66.61 -36.66 83.13 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.542 0.337 . . . . 0.0 111.205 -173.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.67 -32.88 68.34 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 175.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -65.0 -46.46 81.3 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.716 0.807 . . . . 0.0 110.986 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.3 mtm -70.43 -39.0 74.66 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.962 0.505 . . . . 0.0 110.696 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.7 mmmt -67.16 -32.34 73.37 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.35 0.26 . . . . 0.0 110.675 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 123.149 0.58 . . . . 0.0 110.66 174.942 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.702 0.287 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 31' ' ' ALA . 4.3 tmtp? -85.31 145.9 27.29 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.983 0.913 . . . . 0.0 109.292 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.482 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 3.1 tm? -76.33 107.62 8.71 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 170.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -91.75 162.31 14.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.825 0.85 . . . . 0.0 109.333 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.6 ptm -141.49 131.26 24.25 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.955 0.902 . . . . 0.0 109.321 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -102.45 101.56 11.78 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.3 mt -80.26 115.09 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -77.96 139.83 39.2 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -119.68 131.35 55.4 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.904 0.882 . . . . 0.0 109.292 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -136.39 168.85 18.67 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.744 1.218 . . . . 0.0 109.459 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.6 t70 53.42 36.7 23.74 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.412 1.085 . . . . 0.0 111.21 168.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.69 103.71 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.739 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -90.19 108.51 19.79 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.386 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -73.5 130.46 40.15 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -78.99 120.25 23.31 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -60.91 -35.3 76.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.022 0.929 . . . . 0.0 110.349 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -116.39 147.62 39.97 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.776 1.231 . . . . 0.0 109.798 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -64.8 97.13 0.27 Allowed 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 123.308 2.672 . . . . 0.0 111.591 172.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.5 mt -83.25 115.53 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.9 147.64 91.55 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.72 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.403 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 91.6 Cg_endo -87.16 154.81 8.24 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.473 2.115 . . . . 0.0 112.179 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -74.01 -23.11 59.38 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.44 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 126' ' ' PRO . 13.4 ptm180 -150.35 160.35 43.79 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.989 0.915 . . . . 0.0 109.342 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 129' ' ' LEU . 2.6 pt? -75.8 120.62 21.42 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.7 t -94.49 109.49 43.41 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.54 179.77 6.2 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.95 2.433 . . . . 0.0 111.838 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.4 t -59.15 -32.83 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 124.2 1.0 . . . . 0.0 111.794 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.64 -16.62 72.14 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.558 -0.747 . . . . 0.0 113.641 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.04 160.62 15.17 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.119 0.39 . . . . 0.0 113.149 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -118.1 139.07 51.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.599 0.759 . . . . 0.0 109.458 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.466 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 0.2 OUTLIER -79.42 106.91 11.79 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.49 114.12 18.17 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.4 ' HD3' ' H ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -110.07 148.96 30.72 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.524 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.253 1.239 0 CA-C-N 118.217 0.462 . . . . 0.0 110.127 172.189 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 5' ' ' VAL . 23.1 mm 68.78 178.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 C-N-CA 124.612 1.165 . . . . 0.0 109.759 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.419 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.7 m -145.41 -43.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.619 1.168 . . . . 0.0 108.181 160.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.97 -159.17 15.16 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.724 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 HD11 ' A' ' 60' ' ' ILE . 10.0 p -122.9 151.33 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -123.29 135.56 54.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.843 0.857 . . . . 0.0 109.528 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -137.47 138.88 25.81 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.556 0.742 . . . . 0.0 111.064 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 91.0 Cg_endo -74.35 -9.57 21.77 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.76 2.307 . . . . 0.0 111.86 169.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 mm 64.83 116.64 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.638 1.575 . . . . 0.0 109.284 -175.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.56 -11.49 20.36 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.815 2.343 . . . . 0.0 113.841 -172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HE2' ' HD1' ' A' ' 90' ' ' TYR . 63.8 mttm -133.66 176.91 8.12 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.543 1.137 . . . . 0.0 110.693 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -71.99 -5.91 38.3 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.021 0.929 . . . . 0.0 112.002 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -73.43 15.13 0.27 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.2 ptp -56.7 -32.29 65.32 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 157.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.28 -45.87 35.21 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.549 1.54 . . . . 0.0 111.79 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 84.2 mmt-85 -58.08 -36.58 73.03 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.134 0.896 . . . . 0.0 112.501 -173.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HB3' HG11 ' A' ' 117' ' ' VAL . 74.5 m-85 -66.35 -29.35 69.52 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.419 0.45 . . . . 0.0 110.565 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -98.23 -15.31 19.9 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.768 0.827 . . . . 0.0 110.928 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 18' ' ' ARG . 5.8 tmtm? -78.31 -48.06 16.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.78 1.232 . . . . 0.0 110.275 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.7 ptpt -102.55 -12.36 17.83 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.568 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.94 -14.03 59.74 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.988 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -164.0 114.72 1.3 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.834 0.854 . . . . 0.0 109.4 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 18.9 t70 -133.83 -175.37 3.81 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.1 0.96 . . . . 0.0 110.296 -162.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 113' ' ' GLU . 76.9 t -135.87 119.28 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 121.278 -0.889 . . . . 0.0 109.417 176.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -93.69 115.77 28.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.323 0.649 . . . . 0.0 109.929 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.8 m -93.68 143.56 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.838 0.827 . . . . 0.0 111.163 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.6 mmpt? -130.15 136.18 28.62 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 126.225 1.81 . . . . 0.0 108.951 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.72 55.21 5.12 Favored 'Trans proline' 0 CA--C 1.552 1.388 0 C-N-CA 122.421 2.081 . . . . 0.0 111.149 166.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.56 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.063 1.345 . . . . 0.0 112.394 -170.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.563 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 24.8 m -126.45 -50.84 1.51 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.35 107.52 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.858 0.863 . . . . 0.0 109.253 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -146.06 1.18 0.86 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.228 0.611 . . . . 0.0 111.533 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -64.47 -53.62 45.43 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.453 0.644 . . . . 0.0 110.275 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -109.4 -7.98 15.12 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.424 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.33 107.11 1.53 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.571 0.748 . . . . 0.0 110.872 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.471 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -135.9 152.26 75.44 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.279 0.632 . . . . 0.0 109.909 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.06 102.5 1.08 Allowed 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.971 2.447 . . . . 0.0 111.32 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.25 -19.83 1.2 Allowed Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.666 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.471 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 30.1 mtm -74.64 -177.88 3.38 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.078 0.466 . . . . 0.0 111.234 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -104.04 163.07 12.63 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.341 0.656 . . . . 0.0 110.869 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.489 ' CB ' HD11 ' A' ' 114' ' ' LEU . 2.5 t80 -134.55 102.03 5.16 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 48.7 t -90.17 123.87 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.339 0.59 . . . . 0.0 110.137 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.36 111.43 19.42 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.743 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 76.5 t80 . . . . . 0 CA--C 1.544 0.713 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.399 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.55 -19.69 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.709 0.804 . . . . 0.0 111.279 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.42 -171.45 40.94 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.093 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 21.2 pt-20 -153.82 178.95 9.33 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.788 0.835 . . . . 0.0 109.861 171.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -165.26 -171.33 2.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.705 0.802 . . . . 0.0 110.354 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -123.03 122.44 38.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.65 0.78 . . . . 0.0 111.362 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.457 HD11 HG12 ' A' ' 7' ' ' VAL . 74.6 mt -69.02 136.99 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.445 1.098 . . . . 0.0 111.224 175.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 30.9 mmmt -136.58 -167.73 2.12 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 126.877 2.071 . . . . 0.0 107.697 -177.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -39.88 112.89 0.3 Allowed 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 125.187 1.395 . . . . 0.0 113.706 -166.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.02 106.93 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 95.6 t -90.11 109.53 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.395 0.678 . . . . 0.0 109.26 -174.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 108' ' ' LEU . 39.1 mt -91.26 115.98 28.46 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 t -151.66 129.66 11.79 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.781 0.832 . . . . 0.0 109.137 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.515 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 45.0 mt-10 -61.75 -21.26 64.38 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.374 0.67 . . . . 0.0 112.248 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -100.58 118.97 59.9 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.509 ' HG2' HD21 ' A' ' 87' ' ' LEU . 56.3 Cg_endo -69.16 -8.69 24.29 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.956 2.437 . . . . 0.0 113.085 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 50.6 mtm -79.9 -24.72 40.94 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.383 0.673 . . . . 0.0 111.205 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.552 HE21 ' N ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -60.33 -26.49 66.61 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.607 0.763 . . . . 0.0 111.527 175.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -76.71 -20.49 56.51 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.06 0.544 . . . . 0.0 111.116 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.478 ' HE2' HD22 ' A' ' 87' ' ' LEU . 30.2 m-85 -85.81 -38.36 18.25 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.822 0.449 . . . . 0.0 110.537 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.0 pt-20 -72.42 -23.48 61.09 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 120.34 0.114 . . . . 0.0 111.0 175.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.3 m -88.5 -44.33 10.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.236 0.614 . . . . 0.0 111.063 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.763 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 64.7 m-85 -118.11 -66.96 1.03 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.071 0.548 . . . . 0.0 110.332 -176.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.09 -81.21 0.68 Allowed Glycine 0 C--N 1.355 1.62 0 O-C-N 123.472 0.483 . . . . 0.0 113.304 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.89 -27.66 69.51 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.363 1.065 . . . . 0.0 111.499 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.763 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 38.6 mmt180 -81.38 -33.12 32.54 Favored 'General case' 0 C--O 1.209 -1.072 0 O-C-N 123.992 0.807 . . . . 0.0 111.975 -176.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.463 HG12 HD23 ' A' ' 82' ' ' LEU . 21.7 t -66.57 145.47 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 118.451 0.569 . . . . 0.0 110.459 -174.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.447 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 34.7 p90 -64.05 -17.25 63.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.463 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -140.31 158.18 44.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.3 t -95.27 179.56 5.14 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -65.51 -27.13 68.25 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.518 0.727 . . . . 0.0 111.518 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.91 -49.64 67.31 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.905 0.882 . . . . 0.0 110.506 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -62.65 -31.45 72.32 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.186 176.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.509 HD21 ' HG2' ' A' ' 69' ' ' PRO . 46.1 tp -67.78 -52.15 40.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.433 0.693 . . . . 0.0 111.093 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -63.18 -38.58 91.73 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.234 0.334 . . . . 0.0 111.366 -174.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.412 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 13.0 pt-20 -78.88 -23.68 44.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.728 0.411 . . . . 0.0 111.343 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.416 ' HD1' ' HE2' ' A' ' 13' ' ' LYS . 56.9 t80 -66.08 -38.96 89.6 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.378 0.671 . . . . 0.0 109.97 170.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.6 mtm -77.57 -30.82 52.77 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.454 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.8 mmpt? -71.14 -28.83 64.56 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.397 0.279 . . . . 0.0 110.516 171.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.478 0.937 0 C-N-CA 123.388 0.675 . . . . 0.0 110.83 179.083 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 4.2 tmtp? -86.24 140.11 30.43 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 65' ' ' LEU . 2.8 tm? -74.28 107.83 6.69 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -89.04 161.85 16.33 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.552 0.741 . . . . 0.0 109.533 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.485 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 15.1 ptm -145.56 131.04 18.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.822 0.849 . . . . 0.0 109.781 -175.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -106.58 101.97 11.38 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.222 0.609 . . . . 0.0 109.56 -178.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.2 mt -78.4 115.46 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -80.95 133.75 35.58 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -177.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' ' 43' ' ' PHE . 3.3 mm? -122.92 122.3 38.25 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.455 0.702 . . . . 0.0 111.279 -174.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -124.41 165.23 18.1 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.572 0.749 . . . . 0.0 110.313 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.0 t70 50.23 53.25 13.2 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.124 1.37 . . . . 0.0 111.29 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.541 HG11 ' HB3' ' A' ' 19' ' ' PHE . 41.9 t -74.7 101.45 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.671 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -81.74 146.27 30.06 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.526 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -101.3 134.86 43.72 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.626 0.771 . . . . 0.0 109.337 171.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -86.43 88.14 7.57 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 170.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.24 -26.04 63.66 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.649 0.738 . . . . 0.0 109.066 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -81.24 135.98 50.19 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.645 173.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.06 91.94 1.15 Allowed 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.793 2.329 . . . . 0.0 112.573 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.5 mt -105.36 125.11 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.443 0.639 . . . . 0.0 110.651 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.63 148.35 34.46 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.703 1.201 . . . . 0.0 109.338 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.421 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 64.2 Cg_endo -77.9 178.43 7.61 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.194 2.596 . . . . 0.0 113.562 -170.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -84.74 -38.65 19.42 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.131 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -142.22 166.24 25.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.067 0.547 . . . . 0.0 110.832 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 129' ' ' LEU . 2.6 pt? -66.79 134.93 53.14 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 124.236 0.96 . . . . 0.0 109.779 174.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.466 HG12 ' HD3' ' A' ' 10' ' ' PRO . 41.0 t -118.29 102.23 50.62 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.93 178.9 2.55 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.326 2.684 . . . . 0.0 112.249 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.4 t -60.19 -31.74 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.77 0.828 . . . . 0.0 111.07 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.49 -12.53 77.28 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 115.572 -0.74 . . . . 0.0 114.287 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.65 157.83 16.96 Favored Glycine 0 C--N 1.35 1.357 0 C-N-CA 123.035 0.35 . . . . 0.0 113.662 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -117.83 147.23 43.25 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.709 0.803 . . . . 0.0 110.394 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -77.85 112.63 14.92 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 167.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.66 128.94 34.01 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.05 134.98 35.42 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.77 0.428 . . . . 0.0 110.521 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 . . . . . 0 C--O 1.25 1.089 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.779 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 5' ' ' VAL . 24.9 mm 64.5 -173.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.599 0 C-N-CA 124.045 0.938 . . . . 0.0 108.55 -174.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.473 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.1 m -152.43 -42.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 158.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.63 -159.69 16.03 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.611 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 11.6 p -126.63 152.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 171.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 t -123.72 134.57 53.67 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -127.37 151.08 74.25 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.519 0.728 . . . . 0.0 110.01 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HG3' ' HA ' ' A' ' 132' ' ' VAL . 56.8 Cg_endo -65.87 -34.46 39.31 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.854 2.369 . . . . 0.0 111.868 175.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.4 mm 67.62 132.98 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.935 1.294 . . . . 0.0 111.198 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.23 110.66 0.68 Allowed 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 121.832 1.688 . . . . 0.0 109.74 165.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.788 ' HA ' ' HB2' ' A' ' 16' ' ' MET . 19.3 pttp -68.77 -3.89 13.98 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -174.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -66.83 -40.52 88.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.602 1.161 . . . . 0.0 109.063 170.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -116.54 16.52 15.54 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.316 1.046 . . . . 0.0 112.0 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.788 ' HB2' ' HA ' ' A' ' 13' ' ' LYS . 56.6 ttp -62.27 -47.04 86.12 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.087 0.555 . . . . 0.0 110.426 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.66 -2.48 20.27 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.906 -175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 1.9 mmm180 -63.19 -49.77 72.94 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.052 0.541 . . . . 0.0 110.3 173.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 51.1 m-85 -61.93 -29.08 69.99 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 124.007 0.817 . . . . 0.0 110.395 -178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -96.97 -12.86 22.82 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.205 1.002 . . . . 0.0 111.527 -174.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.69 -50.18 14.3 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.842 0.857 . . . . 0.0 109.479 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.4 ptpt -101.07 -16.64 17.02 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.06 -169.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.87 -11.32 48.16 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-O 119.839 -0.423 . . . . 0.0 114.118 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -159.73 117.54 2.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.028 0.931 . . . . 0.0 109.428 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.465 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 17.9 t70 -124.88 -176.21 3.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.248 1.019 . . . . 0.0 109.307 -172.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -132.27 110.33 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.148 0.979 . . . . 0.0 108.791 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -90.54 109.25 20.4 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 110.0 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.4 m -85.8 129.03 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.545 0.688 . . . . 0.0 111.121 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -112.65 142.42 27.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.896 1.278 . . . . 0.0 109.518 170.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.41 46.23 2.07 Favored 'Trans proline' 0 C--N 1.367 1.5 0 C-N-CA 122.692 2.262 . . . . 0.0 112.16 168.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.21 86.42 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.201 1.401 . . . . 0.0 112.495 -172.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -122.31 7.43 9.63 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.595 0.758 . . . . 0.0 109.842 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.425 ' HB ' ' OH ' ' A' ' 136' ' ' TYR . 14.1 m -127.92 150.16 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.385 1.074 . . . . 0.0 109.776 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -80.9 -172.81 3.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.307 0.643 . . . . 0.0 110.99 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -73.1 9.53 1.19 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -71.61 -29.43 64.67 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.875 0.47 . . . . 0.0 109.845 172.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.89 104.85 1.17 Allowed 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.055 0.542 . . . . 0.0 110.053 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -135.5 153.65 77.86 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 123.279 0.632 . . . . 0.0 109.784 -177.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.81 97.12 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.761 2.307 . . . . 0.0 111.094 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.45 43.48 0.1 OUTLIER Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.495 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.419 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 32.5 mtm -126.94 -171.59 2.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.79 0.836 . . . . 0.0 109.525 174.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.6 ptpt -112.7 158.54 19.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.276 0.63 . . . . 0.0 110.251 169.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.54 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.2 t80 -135.67 101.25 4.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 40.7 t -86.18 130.18 36.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -95.56 112.69 24.36 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.258 0.623 . . . . 0.0 109.455 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.573 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 90.1 t80 . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.46 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 62.9 m-85 . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.457 HG11 ' SD ' ' A' ' 16' ' ' MET . 3.3 p -87.31 -30.12 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.661 0.784 . . . . 0.0 110.471 174.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.4 -157.76 20.37 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 120.062 -0.299 . . . . 0.0 112.768 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 16.2 pt-20 -154.17 178.61 9.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.179 0.992 . . . . 0.0 109.293 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -166.76 -172.66 2.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.01 0.924 . . . . 0.0 110.177 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 61.4 mmt-85 -128.22 125.5 39.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.858 0.863 . . . . 0.0 109.69 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.54 HG13 ' HB2' ' A' ' 43' ' ' PHE . 41.3 mt -73.63 137.08 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.199 1.0 . . . . 0.0 111.767 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -134.94 -176.88 4.39 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 126.879 2.072 . . . . 0.0 108.081 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -30.96 112.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.932 1.693 . . . . 0.0 114.328 -170.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 112' ' ' ILE . 27.5 m -91.61 106.26 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -88.22 110.78 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.4 mt -92.59 119.86 32.46 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.366 0.666 . . . . 0.0 109.436 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.2 t -151.51 134.24 15.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 44.4 mt-10 -74.67 -0.98 19.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.797 0.839 . . . . 0.0 112.299 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.682 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 12.9 m-80 -112.66 120.16 41.62 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.2 -20.84 55.89 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.342 2.028 . . . . 0.0 112.345 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 65.4 mtm -71.79 -24.63 61.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.184 0.994 . . . . 0.0 111.091 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.682 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 36.4 mm-40 -62.58 -28.89 70.19 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.875 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -76.31 -20.06 57.65 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.728 0.411 . . . . 0.0 111.185 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CE2' HD22 ' A' ' 87' ' ' LEU . 87.7 m-85 -93.45 -19.56 21.14 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.9 0.48 . . . . 0.0 111.09 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 9.1 pt-20 -84.8 -30.4 24.62 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.808 0.276 . . . . 0.0 110.573 168.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.3 m -80.39 -58.9 2.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.953 0.501 . . . . 0.0 110.644 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.64 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 85.8 m-85 -100.85 -69.68 0.77 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.73 -78.03 0.5 Allowed Glycine 0 C--N 1.353 1.516 0 O-C-N 123.5 0.5 . . . . 0.0 112.622 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.85 -44.68 91.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.756 1.222 . . . . 0.0 111.463 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.64 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 61.1 mmt-85 -64.97 -30.17 71.14 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.677 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.73 149.79 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.563 0.745 . . . . 0.0 111.142 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -65.5 -41.4 93.23 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.088 0.555 . . . . 0.0 112.355 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -109.55 169.03 8.97 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.466 HG22 ' HG2' ' A' ' 86' ' ' GLU . 8.8 t -98.26 168.36 10.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 172.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -68.17 -25.69 65.38 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.201 0.524 . . . . 0.0 111.375 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.7 -52.57 65.11 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.519 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.466 ' HG2' HG22 ' A' ' 83' ' ' THR . 48.6 mm-40 -57.78 -35.11 70.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.736 0.414 . . . . 0.0 110.78 176.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.419 HD22 ' CE2' ' A' ' 73' ' ' PHE . 26.5 tp -62.12 -57.27 12.19 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.945 0.898 . . . . 0.0 111.56 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -38.72 85.53 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -172.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -79.16 -27.48 42.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.688 0.395 . . . . 0.0 111.512 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -65.92 -41.67 91.08 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.269 0.628 . . . . 0.0 110.267 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 62.5 mtm -72.1 -30.03 64.68 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.763 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -73.86 -33.94 64.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.97 0.508 . . . . 0.0 110.678 171.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 123.359 0.663 . . . . 0.0 111.441 177.748 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.55 0.951 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -124.28 144.4 50.0 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.047 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.604 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 2.9 tm? -68.41 108.31 3.21 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -97.1 161.14 13.96 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.0 ptm -143.94 131.22 20.81 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.668 0.787 . . . . 0.0 109.568 -174.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.34 101.97 11.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.566 0.746 . . . . 0.0 109.107 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.419 ' HA ' HG12 ' A' ' 63' ' ' VAL . 36.9 mt -80.2 120.36 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -83.93 139.24 32.71 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -120.69 121.28 37.93 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.616 1.167 . . . . 0.0 109.026 -177.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -113.94 171.34 7.65 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.011 0.924 . . . . 0.0 108.894 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.4 t70 52.07 46.79 26.01 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.365 1.066 . . . . 0.0 112.167 166.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.9 t -74.88 108.25 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.534 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.76 153.68 20.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.004 0.922 . . . . 0.0 110.302 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -108.26 136.69 47.49 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.739 0.816 . . . . 0.0 110.379 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.46 ' HD2' ' HB2' ' A' ' 54' ' ' PHE . 10.1 m-30 -95.93 78.8 3.23 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.613 0.765 . . . . 0.0 109.128 172.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.95 -24.96 63.43 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.903 169.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.537 ' HG3' HG13 ' A' ' 124' ' ' ILE . 18.5 ptpt -81.7 145.57 54.61 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.385 1.074 . . . . 0.0 109.344 171.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.81 77.26 3.97 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.936 2.424 . . . . 0.0 113.076 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.537 HG13 ' HG3' ' A' ' 122' ' ' LYS . 54.2 mt -86.37 128.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -109.3 146.48 34.02 Favored Pre-proline 0 C--O 1.242 0.668 0 C-N-CA 123.943 0.897 . . . . 0.0 109.351 -177.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.26 147.04 41.45 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 122.879 2.386 . . . . 0.0 112.397 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -70.12 -26.49 63.98 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.647 0.779 . . . . 0.0 109.273 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -144.62 159.23 43.16 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.202 1.001 . . . . 0.0 109.439 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.5 133.21 38.62 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.0 t -105.85 95.31 10.42 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.45 -175.48 2.7 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.056 2.504 . . . . 0.0 111.957 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.585 ' HA ' ' HG3' ' A' ' 10' ' ' PRO . 27.1 m -57.74 -26.63 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.331 1.052 . . . . 0.0 113.816 -174.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.14 -22.22 74.24 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.259 0.349 . . . . 0.0 113.607 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.08 149.0 8.19 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 112.362 -0.295 . . . . 0.0 112.362 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -108.8 135.94 49.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.508 0.723 . . . . 0.0 109.829 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.425 ' OH ' ' HB ' ' A' ' 33' ' ' VAL . 1.6 m-85 -76.26 109.74 10.2 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.72 114.14 18.41 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -125.99 138.82 53.77 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.475 178.655 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 5' ' ' VAL . 27.1 mm 65.73 -171.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -143.49 -39.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 157.464 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.472 ' HA3' ' HG3' ' A' ' 42' ' ' LYS . . . -167.52 -164.35 23.04 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.438 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.448 HG12 HD11 ' A' ' 60' ' ' ILE . 10.9 p -132.08 144.43 37.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 t -113.87 137.64 51.39 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -132.66 145.12 55.8 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.884 0.874 . . . . 0.0 109.21 178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HD3' HG12 ' A' ' 130' ' ' VAL . 30.2 Cg_endo -61.96 -25.04 77.54 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.962 2.442 . . . . 0.0 112.016 173.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.9 mm 68.75 134.03 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.057 1.343 . . . . 0.0 111.913 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -54.62 114.43 1.84 Allowed 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.546 2.164 . . . . 0.0 110.25 169.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -63.47 -28.03 69.68 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.287 1.035 . . . . 0.0 113.436 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -61.43 -36.24 79.8 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.146 0.498 . . . . 0.0 110.46 172.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -107.91 19.15 20.42 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.143 -172.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.401 ' SD ' HG21 ' A' ' 55' ' ' VAL . 16.0 tmm? -66.94 -32.78 74.26 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.626 0.77 . . . . 0.0 110.153 175.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.32 -33.87 77.0 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.238 1.015 . . . . 0.0 112.195 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 81' ' ' PHE . 11.0 mmt180 -54.09 -52.92 59.47 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.655 1.182 . . . . 0.0 113.277 -164.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 47.9 m-85 -60.24 -29.36 68.71 Favored 'General case' 0 CA--C 1.554 1.104 0 O-C-N 124.121 0.888 . . . . 0.0 110.743 -174.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -94.7 -24.76 17.0 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.415 1.086 . . . . 0.0 110.674 -176.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.22 -42.73 79.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.92 1.288 . . . . 0.0 111.028 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.7 ptpt -109.33 -16.43 14.04 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.238 -171.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.93 -14.85 9.35 Favored Glycine 0 N--CA 1.479 1.503 0 N-CA-C 114.191 0.436 . . . . 0.0 114.191 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -150.06 105.64 3.4 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.668 1.187 . . . . 0.0 108.94 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.5 t70 -107.32 174.73 5.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 110.585 -175.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -133.88 109.07 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.435 ' HD2' HD12 ' A' ' 112' ' ' ILE . 76.9 t80 -91.12 108.92 20.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.337 0.655 . . . . 0.0 109.577 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 m -94.45 132.93 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.516 0.674 . . . . 0.0 110.673 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.645 ' HD3' ' HD2' ' A' ' 30' ' ' PRO . 14.9 tppt? -134.84 133.24 20.94 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.349 1.06 . . . . 0.0 108.793 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.645 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 59.5 Cg_endo -71.73 66.97 3.07 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.669 2.246 . . . . 0.0 113.2 172.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 55.07 17.02 1.74 Allowed 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.158 1.383 . . . . 0.0 114.672 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 m -70.32 -28.37 65.11 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.225 0.61 . . . . 0.0 110.875 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.45 HG23 ' HG2' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -87.6 148.62 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -87.72 -168.11 2.11 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.173 0.589 . . . . 0.0 110.917 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -74.58 -1.25 20.68 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -170.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.11 -30.59 70.45 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.967 0.507 . . . . 0.0 110.815 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.84 98.38 0.73 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.29 1.036 . . . . 0.0 111.55 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HG3' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -122.28 156.27 60.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.835 1.254 . . . . 0.0 108.883 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.82 107.0 2.11 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.256 1.971 . . . . 0.0 111.472 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.45 31.65 0.46 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.225 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.641 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 88.8 mtp -112.55 -173.99 2.36 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.911 0.884 . . . . 0.0 110.669 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.472 ' HG3' ' HA3' ' A' ' 6' ' ' GLY . 15.2 ptpt -116.85 156.44 27.3 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.387 1.075 . . . . 0.0 109.599 172.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.502 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -136.05 100.15 4.34 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 177.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.1 t -86.3 124.42 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.245 0.545 . . . . 0.0 110.131 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.422 ' HE2' HG13 ' A' ' 117' ' ' VAL . 25.7 m-85 -89.4 106.7 18.62 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.633 0.773 . . . . 0.0 109.876 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.406 ' HA ' ' CD1' ' A' ' 54' ' ' PHE . 78.3 t80 . . . . . 0 N--CA 1.472 0.654 0 O-C-N 124.94 1.4 . . . . 0.0 111.401 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 46' ' ' TYR . 98.4 m-85 . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.401 HG21 ' SD ' ' A' ' 16' ' ' MET . 7.7 p -118.31 -34.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.784 0.834 . . . . 0.0 110.449 173.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.13 -160.04 23.37 Favored Glycine 0 C--N 1.35 1.355 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.972 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.521 ' HG3' ' HB3' ' A' ' 118' ' ' LYS . 7.3 pt-20 -152.19 177.55 10.41 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.69 1.196 . . . . 0.0 109.526 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.494 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.59 -172.3 3.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.938 0.895 . . . . 0.0 110.035 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.8 mmt-85 -123.91 122.3 37.61 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.802 0.841 . . . . 0.0 109.952 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.641 ' HB ' ' HB2' ' A' ' 41' ' ' MET . 36.3 mt -74.56 128.49 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.856 0.862 . . . . 0.0 109.86 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.589 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 31.6 mmmt -132.49 -167.96 1.98 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 125.433 1.493 . . . . 0.0 107.609 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -41.7 113.22 0.4 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.702 1.201 . . . . 0.0 113.69 -163.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.18 111.91 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.738 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.7 109.68 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.19 117.84 26.2 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -148.62 127.39 12.56 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.316 1.047 . . . . 0.0 109.052 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 34.7 mt-10 -65.68 -20.94 66.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.607 0.763 . . . . 0.0 111.921 176.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -99.81 118.0 62.57 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.44 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 40.6 Cg_endo -67.47 -18.6 49.3 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.196 1.931 . . . . 0.0 112.855 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.44 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.2 mpp? -73.63 -25.63 60.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.754 0.421 . . . . 0.0 111.008 -173.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -64.4 -22.78 67.07 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.691 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -78.3 -30.83 48.55 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.022 0.529 . . . . 0.0 110.93 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.512 ' CE2' HD22 ' A' ' 87' ' ' LEU . 92.7 m-85 -82.74 -16.11 49.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.664 0.386 . . . . 0.0 111.915 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.83 -32.03 16.23 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.668 0.213 . . . . 0.0 110.794 171.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 92.8 m -76.75 -41.42 44.93 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 120.848 0.356 . . . . 0.0 111.109 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.712 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 44.0 m-85 -117.83 -67.29 1.0 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.426 0.69 . . . . 0.0 109.219 -175.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.06 -97.84 2.1 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.105 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.71 -22.15 61.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.8 0.44 . . . . 0.0 110.855 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.712 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 31.8 mmt180 -59.91 -37.78 80.42 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.007 0.523 . . . . 0.0 111.294 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.482 HG12 HD23 ' A' ' 82' ' ' LEU . 39.0 t -62.74 145.08 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 O-C-N 123.729 0.643 . . . . 0.0 109.767 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 41.2 p90 -60.06 -20.1 56.32 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.482 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -133.56 164.87 26.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.6 t -98.36 176.33 5.74 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.645 0.657 . . . . 0.0 109.435 173.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -61.63 -29.44 70.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.195 0.598 . . . . 0.0 111.196 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.46 ' H ' HG23 ' A' ' 83' ' ' THR . 3.2 m-20 -65.96 -45.83 80.34 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.954 0.902 . . . . 0.0 111.409 174.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.4 -36.34 83.4 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.183 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.512 HD22 ' CE2' ' A' ' 73' ' ' PHE . 27.1 tp -60.56 -54.81 40.93 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.469 0.708 . . . . 0.0 110.985 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -64.03 -42.51 97.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.158 -172.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -70.28 -31.11 68.33 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.35 0.26 . . . . 0.0 110.729 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -65.09 -43.62 91.52 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.652 0.781 . . . . 0.0 110.482 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 61.4 mtm -74.82 -31.65 61.74 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.365 0.666 . . . . 0.0 110.824 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 31.9 mmmt -69.76 -28.09 65.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.126 0.571 . . . . 0.0 110.691 172.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 CA--C 1.543 0.675 0 C-N-CA 122.965 0.506 . . . . 0.0 110.045 173.13 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -93.38 150.28 20.58 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.0 0.52 . . . . 0.0 109.728 178.083 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 3.1 tm? -69.29 122.95 19.91 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -106.04 156.25 18.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.489 0.715 . . . . 0.0 109.348 171.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.7 ptm -131.57 129.17 40.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.093 0.957 . . . . 0.0 108.828 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.69 102.24 11.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 60' ' ' ILE . 33.8 mt -82.61 121.31 35.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.14 101.43 8.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.494 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.1 mm? -87.11 120.56 28.51 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 122.902 0.481 . . . . 0.0 109.779 175.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.589 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 2.1 pp20? -138.34 168.8 18.98 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.1 t70 60.76 30.05 19.42 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.781 0.833 . . . . 0.0 110.654 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.422 HG13 ' HE2' ' A' ' 45' ' ' PHE . 61.0 t -61.19 118.11 3.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.219 -171.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . 1.6 tpmt? -102.01 152.39 21.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.069 0.947 . . . . 0.0 110.654 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -106.07 138.54 42.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.985 0.914 . . . . 0.0 109.396 174.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -87.18 90.68 8.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.05 -34.63 77.98 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.695 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -85.76 139.37 35.28 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.196 172.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.35 89.15 1.37 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.794 2.329 . . . . 0.0 111.742 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 21.2 mt -72.42 130.24 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.096 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 142.92 57.64 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.014 0.526 . . . . 0.0 109.623 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.02 155.74 19.93 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.404 2.069 . . . . 0.0 113.307 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -74.21 -25.83 59.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.825 173.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -170.49 173.6 5.49 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.194 0.998 . . . . 0.0 109.697 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -67.14 128.18 35.4 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 166.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.467 HG12 ' HD3' ' A' ' 10' ' ' PRO . 78.9 t -101.03 103.63 26.71 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.87 -177.81 1.74 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.229 2.619 . . . . 0.0 113.33 -174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.0 m -61.46 -27.19 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.981 0.913 . . . . 0.0 112.639 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.7 -15.32 75.94 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.183 0.302 . . . . 0.0 113.12 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.28 169.21 39.47 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.351 0.501 . . . . 0.0 112.928 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -120.65 146.51 46.33 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.008 0.923 . . . . 0.0 109.783 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -87.51 118.18 26.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.015 0.526 . . . . 0.0 110.141 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tt -84.7 128.0 34.38 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 172.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.439 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -133.1 136.96 46.15 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.794 0.438 . . . . 0.0 110.516 -175.009 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 CA--C 1.554 1.133 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.414 177.92 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.446 HG22 ' H ' ' A' ' 5' ' ' VAL . 26.2 mm 66.25 -174.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 124.408 1.083 . . . . 0.0 109.596 -175.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 139' ' ' GLU . 2.7 m -154.73 -40.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 125.269 1.427 . . . . 0.0 108.511 158.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.15 -159.15 14.15 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.204 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 12.6 p -126.68 160.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 t -135.41 139.59 44.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.276 0.63 . . . . 0.0 109.864 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -136.65 142.2 38.19 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.011 0.924 . . . . 0.0 109.789 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HD3' HG12 ' A' ' 130' ' ' VAL . 47.9 Cg_endo -69.03 -35.56 14.53 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.694 2.263 . . . . 0.0 111.226 168.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.7 mt 61.23 100.95 0.04 OUTLIER Pre-proline 0 C--N 1.361 1.098 0 C-N-CA 125.523 1.529 . . . . 0.0 110.928 -175.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.73 -179.4 2.87 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.456 2.104 . . . . 0.0 111.451 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.536 ' HG3' ' H ' ' A' ' 14' ' ' ARG . 31.8 tptt 67.86 -176.38 0.2 Allowed 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.744 0.818 . . . . 0.0 109.703 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.536 ' H ' ' HG3' ' A' ' 13' ' ' LYS . 79.8 mtp180 -76.79 -15.09 59.84 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.316 0.646 . . . . 0.0 112.245 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.527 ' CZ ' ' HG2' ' A' ' 86' ' ' GLU . 11.5 m-30 -74.28 7.52 2.76 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -165.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.623 ' SD ' HG11 ' A' ' 55' ' ' VAL . 18.2 tmm? -67.7 -44.54 77.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.217 0.607 . . . . 0.0 109.584 168.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.07 -15.71 63.51 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.859 0.864 . . . . 0.0 113.088 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG2' ' HA ' ' A' ' 15' ' ' PHE . 20.4 mmt180 -51.82 -50.9 59.92 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.138 0.975 . . . . 0.0 111.685 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.604 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 22.5 m-85 -62.33 -29.03 70.16 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.294 -170.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -93.06 -29.09 15.98 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.322 1.049 . . . . 0.0 110.411 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -63.06 -46.39 87.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.019 0.928 . . . . 0.0 110.638 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.6 ptpt -101.88 -15.35 16.9 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.356 -172.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.11 -7.71 27.99 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -159.31 107.14 1.78 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.6 1.16 . . . . 0.0 108.279 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.604 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.4 t70 -115.68 177.61 4.61 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.984 0.913 . . . . 0.0 109.773 -176.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -132.65 108.98 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -87.93 107.38 18.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 0.0 109.917 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 m -90.07 125.76 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 121.566 0.698 . . . . 0.0 110.906 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 7.4 mmpt? -108.96 131.58 21.71 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.924 1.29 . . . . 0.0 109.606 174.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.13 54.55 4.97 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.066 2.511 . . . . 0.0 112.267 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 57.6 87.17 0.07 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.609 1.164 . . . . 0.0 111.001 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 29.1 m -130.65 -68.72 0.68 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.49 0.716 . . . . 0.0 109.344 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -109.0 106.74 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -137.2 -10.67 1.7 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.234 1.014 . . . . 0.0 110.391 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -64.78 -55.7 18.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.211 1.004 . . . . 0.0 110.651 -170.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -102.41 -9.01 20.65 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.085 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 110.7 3.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.137 0.575 . . . . 0.0 110.979 -173.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -139.12 150.81 66.12 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.125 0.57 . . . . 0.0 109.476 177.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 105.85 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.838 2.359 . . . . 0.0 111.329 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.1 -17.93 1.74 Allowed Glycine 0 N--CA 1.467 0.716 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.417 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.486 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 29.2 mtm -75.28 -179.82 4.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.547 0.689 . . . . 0.0 111.418 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -106.63 161.69 14.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.931 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -137.24 104.73 5.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.97 134.77 27.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -97.67 102.49 14.26 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.459 ' HD2' ' HB3' ' A' ' 10' ' ' PRO . 88.1 t80 . . . . . 0 C--O 1.24 0.599 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.083 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.623 HG11 ' SD ' ' A' ' 16' ' ' MET . 7.3 p -90.11 -34.19 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.697 0.399 . . . . 0.0 111.289 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.06 -160.22 26.36 Favored Glycine 0 C--N 1.345 1.055 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.425 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -149.93 176.95 10.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.288 1.035 . . . . 0.0 109.215 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -167.01 -179.02 4.44 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.977 0.911 . . . . 0.0 110.44 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -120.34 125.33 47.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.621 0.768 . . . . 0.0 110.49 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.17 130.72 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.54 1.136 . . . . 0.0 110.822 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -126.74 -178.86 4.54 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 125.381 1.472 . . . . 0.0 108.94 176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -29.76 113.62 0.09 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.358 1.863 . . . . 0.0 114.562 -172.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.76 109.09 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.643 0.735 . . . . 0.0 109.06 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 96.6 t -87.86 109.41 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.2 mt -89.48 121.65 31.91 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.536 0.734 . . . . 0.0 109.399 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 t -149.79 140.31 22.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.502 0.721 . . . . 0.0 110.07 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.537 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 25.6 mt-10 -80.15 -9.4 59.71 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.519 177.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 73.7 m-20 -112.12 119.76 43.32 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 169.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HG2' HD21 ' A' ' 87' ' ' LEU . 38.3 Cg_endo -67.38 -15.22 45.06 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.903 2.402 . . . . 0.0 113.056 174.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.43 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.5 mpp? -74.41 -22.87 58.95 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.22 0.608 . . . . 0.0 111.013 -176.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.528 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 56.8 mt-30 -69.28 -26.51 64.79 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.628 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -71.58 -20.46 62.0 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.77 0.428 . . . . 0.0 111.312 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.551 ' HE2' HD22 ' A' ' 87' ' ' LEU . 24.9 m-85 -88.01 -39.99 14.23 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.828 0.451 . . . . 0.0 110.766 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 13.1 pt-20 -69.28 -27.59 65.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 120.542 0.21 . . . . 0.0 110.575 174.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.0 m -82.89 -61.29 1.91 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 123.042 0.537 . . . . 0.0 110.612 177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.72 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 56.0 m-85 -102.62 -67.78 0.86 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.215 0.606 . . . . 0.0 109.715 -177.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 75.3 -87.33 0.8 Allowed Glycine 0 C--N 1.352 1.436 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.656 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -56.25 -36.52 68.62 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.019 1.327 . . . . 0.0 111.732 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.72 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 34.4 mmt180 -69.35 -36.95 77.38 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.062 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.5 HG12 HD23 ' A' ' 82' ' ' LEU . 21.2 t -64.6 148.97 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -65.35 -8.64 19.34 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.2 pt? -149.79 168.71 22.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.936 0.895 . . . . 0.0 109.11 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.0 t -112.36 -176.5 2.93 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 172.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -59.69 -33.66 71.88 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.67 0.788 . . . . 0.0 111.922 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.454 ' H ' HG23 ' A' ' 83' ' ' THR . 15.7 m-20 -62.69 -43.33 99.08 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.052 0.541 . . . . 0.0 111.222 175.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 1.6 mp0 -73.0 -25.16 60.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.505 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.551 HD22 ' HE2' ' A' ' 73' ' ' PHE . 53.6 tp -70.69 -48.89 52.37 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.835 0.454 . . . . 0.0 110.491 176.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -65.76 -39.2 90.8 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.31 0.381 . . . . 0.0 110.964 -176.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 6.2 pt-20 -69.79 -33.29 72.17 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.025 0.203 . . . . 0.0 110.828 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -67.16 -43.8 81.37 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.197 0.599 . . . . 0.0 110.522 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 73.7 mtm -71.06 -40.15 71.82 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.421 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.0 mmpt? -67.26 -30.74 70.71 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 119.803 -0.142 . . . . 0.0 110.64 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.48 1.05 0 C-N-CA 123.753 0.821 . . . . 0.0 110.815 177.3 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.549 0.938 0 CA-C-O 121.169 0.509 . . . . 0.0 110.365 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 140.66 40.73 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.21 95.3 4.27 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -84.23 155.78 22.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 171.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.464 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 12.3 ptm -136.61 129.55 30.96 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -104.74 100.78 10.42 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -176.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.6 mt -82.18 114.31 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -80.63 102.31 9.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.2 mm? -86.4 109.27 18.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.19 0.596 . . . . 0.0 110.694 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -106.97 174.51 5.86 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.4 t70 60.2 35.28 21.01 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.03 0.932 . . . . 0.0 111.348 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.38 102.95 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.347 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.91 154.76 23.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.509 1.124 . . . . 0.0 110.362 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -110.6 136.17 50.11 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.031 0.933 . . . . 0.0 110.067 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -91.05 86.92 6.38 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.06 -27.72 64.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.509 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.04 137.68 49.64 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.358 1.063 . . . . 0.0 109.537 171.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -76.43 95.63 1.05 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.751 2.301 . . . . 0.0 111.84 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.4 mt -87.97 128.24 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.857 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -86.26 129.28 54.18 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.011 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.06 150.0 77.24 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.511 2.14 . . . . 0.0 113.961 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -67.85 -38.58 83.31 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.042 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.5 ptm85 -154.02 176.07 12.65 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.05 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.66 118.5 19.36 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.72 172.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.46 HG12 ' HD3' ' A' ' 10' ' ' PRO . 80.7 t -98.97 100.97 10.92 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.48 177.85 2.47 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.363 2.709 . . . . 0.0 112.528 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.58 -34.37 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 123.952 0.901 . . . . 0.0 111.849 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 -13.62 71.67 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.68 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.19 176.2 51.36 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 123.543 0.592 . . . . 0.0 112.939 175.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -126.27 137.28 53.5 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.54 106.82 4.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 166.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.09 124.71 27.49 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.5 119.98 19.15 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.457 ' HB3' HG11 ' A' ' 5' ' ' VAL . 12.5 tp10 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 5' ' ' VAL . 22.7 mm 63.46 -166.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 124.621 1.168 . . . . 0.0 108.526 -175.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.549 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.7 m -151.99 -42.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 156.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.22 -161.13 20.2 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.397 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.41 136.65 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.575 0.75 . . . . 0.0 109.504 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 t -103.16 134.13 47.1 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.515 0.726 . . . . 0.0 109.584 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.65 123.15 11.65 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 123.514 0.726 . . . . 0.0 110.205 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.611 ' HD3' HG12 ' A' ' 130' ' ' VAL . 74.0 Cg_endo -80.26 94.55 1.01 Allowed 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.419 2.079 . . . . 0.0 109.54 165.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.42 110.64 2.89 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.191 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -85.06 33.66 0.49 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.436 2.757 . . . . 0.0 111.683 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HG3' ' HD2' ' A' ' 15' ' ' PHE . 49.9 tptt -141.09 144.5 34.94 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -170.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -74.23 10.08 1.4 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.574 0.75 . . . . 0.0 112.611 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.427 ' HD2' ' HG3' ' A' ' 13' ' ' LYS . 97.6 m-85 -111.79 25.02 12.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.232 1.013 . . . . 0.0 111.758 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.553 ' SD ' HG11 ' A' ' 55' ' ' VAL . 45.2 ttm -62.08 -36.73 82.55 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.667 0.746 . . . . 0.0 109.549 166.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.32 -23.19 67.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.029 1.331 . . . . 0.0 112.417 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -59.58 -42.48 92.59 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.507 0.723 . . . . 0.0 112.09 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -65.28 -30.97 71.88 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.758 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -92.03 -16.07 26.97 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.723 0.809 . . . . 0.0 110.792 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -73.98 -49.94 22.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.389 1.076 . . . . 0.0 109.797 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -110.86 -15.61 13.75 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -172.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.92 8.3 63.92 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 113.992 0.357 . . . . 0.0 113.992 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -159.69 86.85 0.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.966 1.306 . . . . 0.0 107.744 -173.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -134.93 -178.03 4.9 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.795 0.838 . . . . 0.0 108.976 -171.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -139.7 121.51 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.265 0.939 . . . . 0.0 109.764 -171.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -98.0 114.47 26.61 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.646 0.778 . . . . 0.0 109.167 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.0 m -92.18 133.48 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.24 0.543 . . . . 0.0 111.091 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 6.0 mmpt? -119.56 130.51 24.8 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.352 1.461 . . . . 0.0 110.113 178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.25 55.52 5.1 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.07 2.513 . . . . 0.0 111.484 169.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 56.47 27.66 12.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.571 1.148 . . . . 0.0 112.923 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.479 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 4.5 m -64.33 -39.31 93.64 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.698 0.799 . . . . 0.0 110.389 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.5 m -82.71 151.14 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.285 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -80.47 -173.95 4.36 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.502 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -65.05 -18.11 65.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.498 1.119 . . . . 0.0 112.902 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -59.12 -22.56 61.05 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.37 0.668 . . . . 0.0 111.515 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 94.39 0.32 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.046 0.538 . . . . 0.0 110.328 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 3.7 ptpp? -109.66 157.78 36.57 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.55 55.46 5.32 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.212 2.608 . . . . 0.0 112.175 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.94 43.76 0.2 Allowed Glycine 0 C--O 1.239 0.467 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.786 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.521 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 30.9 mtm -130.11 -173.01 2.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.623 1.169 . . . . 0.0 111.074 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.75 165.23 12.76 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.55 1.14 . . . . 0.0 110.518 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.408 ' CB ' HD11 ' A' ' 114' ' ' LEU . 4.1 t80 -136.2 101.95 4.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 34.2 t -90.54 108.15 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.214 0.53 . . . . 0.0 110.193 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -75.61 120.36 20.91 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.754 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 33.1 t80 . . . . . 0 CA--C 1.551 0.994 0 C-N-CA 124.595 1.158 . . . . 0.0 110.134 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 19.7 m-85 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.553 HG11 ' SD ' ' A' ' 16' ' ' MET . 2.7 p -67.59 -34.74 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 122.996 0.518 . . . . 0.0 110.771 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.93 -165.71 33.76 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.58 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 17.2 pt-20 -141.17 176.75 8.58 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.05 0.94 . . . . 0.0 108.952 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.471 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.69 -173.84 4.15 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.077 0.951 . . . . 0.0 109.304 176.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -125.94 119.49 27.89 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.726 0.81 . . . . 0.0 109.494 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.8 mt -71.54 129.78 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 124.397 1.061 . . . . 0.0 110.669 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -132.29 177.26 7.72 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 126.187 1.795 . . . . 0.0 109.006 -174.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -30.35 111.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 125.463 1.727 . . . . 0.0 114.113 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.0 m -87.97 123.93 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.288 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 99.0 t -90.02 107.18 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.591 ' HB3' HD11 ' A' ' 108' ' ' LEU . 77.1 mt -88.43 116.76 26.88 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.6 t -153.07 135.76 15.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.644 0.778 . . . . 0.0 110.323 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.12 -34.62 78.47 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.84 0.856 . . . . 0.0 111.669 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.432 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 79.1 m-20 -94.41 120.17 65.51 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.004 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.557 ' HG2' HD21 ' A' ' 87' ' ' LEU . 61.1 Cg_endo -72.5 -7.11 20.31 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.082 2.521 . . . . 0.0 113.387 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 45.9 mtm -86.02 -21.93 27.53 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.013 0.525 . . . . 0.0 110.75 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.432 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 30.4 mt-30 -66.44 -22.24 66.21 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.247 174.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -71.59 -26.21 62.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.691 0.396 . . . . 0.0 110.659 175.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.41 ' HE2' HD22 ' A' ' 87' ' ' LEU . 33.1 m-85 -82.8 -31.26 28.27 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.797 0.439 . . . . 0.0 111.179 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.9 -28.86 60.8 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.932 0.333 . . . . 0.0 110.681 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.8 m -81.83 -58.95 2.76 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.132 0.573 . . . . 0.0 110.386 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.805 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 71.9 m-85 -100.86 -62.83 1.19 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.847 0.859 . . . . 0.0 110.329 -174.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.49 -83.23 0.56 Allowed Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.643 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -59.65 -44.09 93.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.622 0.769 . . . . 0.0 110.663 175.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.805 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 29.2 mmt180 -70.32 -19.48 63.07 Favored 'General case' 0 C--O 1.205 -1.278 0 O-C-N 124.013 0.821 . . . . 0.0 111.938 -173.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 76' ' ' PHE . 40.8 t -76.52 131.07 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -54.51 -45.73 73.35 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.903 0.752 . . . . 0.0 112.554 -171.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.417 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -100.95 156.93 17.11 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.578 HG22 ' HG2' ' A' ' 86' ' ' GLU . 11.3 t -92.85 173.45 7.75 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -50.78 -41.35 56.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.422 1.089 . . . . 0.0 110.962 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.06 -46.78 87.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.23 1.012 . . . . 0.0 111.353 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.578 ' HG2' HG22 ' A' ' 83' ' ' THR . 42.3 mm-40 -62.96 -37.36 86.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.205 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.557 HD21 ' HG2' ' A' ' 69' ' ' PRO . 45.2 tp -63.99 -54.11 39.57 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.882 0.739 . . . . 0.0 111.091 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -63.27 -43.59 97.51 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.27 0.356 . . . . 0.0 111.036 -173.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 12.9 pt-20 -73.89 -23.69 59.61 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.426 0.291 . . . . 0.0 111.181 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.17 -44.89 87.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.527 0.731 . . . . 0.0 110.122 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.8 mtm -76.53 -30.5 57.16 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.069 0.548 . . . . 0.0 110.908 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.1 mmmt -74.03 -20.11 60.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.201 0.601 . . . . 0.0 110.61 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.543 0.676 0 C-N-CA 122.944 0.498 . . . . 0.0 109.98 174.528 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 121.45 0.643 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -131.84 149.88 52.32 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 174.282 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.3 tm? -76.75 92.39 3.57 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 171.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -75.48 159.25 31.53 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.381 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.7 ptm -140.0 129.68 24.44 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.308 0.643 . . . . 0.0 109.702 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -97.12 101.36 12.91 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.54 ' HA ' HG12 ' A' ' 63' ' ' VAL . 35.5 mt -80.46 113.85 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.6 110.63 17.14 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -94.33 132.42 38.95 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.409 0.623 . . . . 0.0 110.701 177.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -138.37 170.73 15.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.283 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 t70 59.8 35.84 22.06 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.859 0.838 . . . . 0.0 110.117 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.47 102.59 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.181 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.3 145.6 28.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.624 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -101.32 122.44 43.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -80.58 84.6 6.13 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 165.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.32 -33.5 72.49 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.568 170.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -79.99 137.25 53.64 Favored Pre-proline 0 CA--C 1.553 1.095 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.44 173.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.08 95.7 1.04 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.782 2.322 . . . . 0.0 111.538 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.5 mt -94.63 123.76 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.14 143.57 26.36 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.476 0.71 . . . . 0.0 109.764 -175.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.27 158.69 41.0 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.862 2.375 . . . . 0.0 112.054 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -81.34 -10.44 59.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.463 0.705 . . . . 0.0 110.993 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.5 ptm85 -153.48 172.96 16.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.991 0.916 . . . . 0.0 110.246 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.13 119.31 18.16 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.611 HG12 ' HD3' ' A' ' 10' ' ' PRO . 23.1 t -102.9 99.42 13.76 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.26 -176.28 3.19 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.882 2.388 . . . . 0.0 112.61 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.0 -27.06 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.453 1.101 . . . . 0.0 112.164 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.05 -25.95 75.04 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.205 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.39 148.15 6.98 Favored Glycine 0 C--N 1.348 1.237 0 C-N-CA 123.003 0.335 . . . . 0.0 112.448 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -108.86 142.29 39.67 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.426 0.691 . . . . 0.0 109.581 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -78.62 107.49 11.33 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.79 116.8 14.82 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.09 134.07 52.63 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.867 -1.063 . . . . 0.0 108.365 -177.44 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 5' ' ' VAL . 35.6 mm 67.19 -175.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.456 0 C-N-CA 124.129 0.972 . . . . 0.0 108.71 -174.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' N ' HG22 ' A' ' 4' ' ' ILE . 2.0 m -148.35 -38.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.228 1.011 . . . . 0.0 108.683 158.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.77 -161.22 19.81 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.482 0.489 . . . . 0.0 113.689 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.425 HG12 HD11 ' A' ' 60' ' ' ILE . 13.5 p -132.02 147.89 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.866 0.866 . . . . 0.0 108.686 175.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -122.76 140.93 52.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.553 0.741 . . . . 0.0 109.958 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -137.63 141.36 33.01 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.13 0.972 . . . . 0.0 110.12 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 20.7 Cg_exo -63.21 -46.73 9.39 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.347 2.698 . . . . 0.0 111.909 175.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.3 mt 51.57 72.13 1.3 Allowed Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.263 1.025 . . . . 0.0 109.603 -171.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.74 38.59 0.75 Allowed 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.261 2.64 . . . . 0.0 112.617 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -124.8 172.7 9.12 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.657 1.183 . . . . 0.0 109.908 -174.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -65.35 -15.23 62.34 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.086 0.954 . . . . 0.0 112.001 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -82.26 0.92 39.16 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.863 0.865 . . . . 0.0 112.778 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -57.43 -36.76 71.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.182 0.993 . . . . 0.0 111.696 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.07 -14.06 58.17 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -53.47 -46.99 70.17 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.411 1.085 . . . . 0.0 112.571 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 57.7 m-85 -68.54 -28.96 67.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.684 -174.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -93.85 -15.83 24.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.777 0.831 . . . . 0.0 110.452 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -70.69 -49.06 51.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.38 1.072 . . . . 0.0 109.748 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -109.63 -15.14 14.23 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.35 7.07 77.44 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.834 0.293 . . . . 0.0 113.834 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -168.6 90.4 0.26 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.457 1.103 . . . . 0.0 109.944 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.446 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.2 t70 -119.34 -178.04 3.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.267 1.027 . . . . 0.0 108.905 -174.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 113' ' ' GLU . 40.0 t -132.52 119.41 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.053 -1.029 . . . . 0.0 109.396 -177.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 81' ' ' PHE . 56.8 t80 -95.43 110.9 22.88 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.3 m -87.27 139.42 17.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-O 121.377 0.608 . . . . 0.0 110.507 177.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.55 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 5.9 mmpt? -125.46 132.43 24.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.198 1.399 . . . . 0.0 109.71 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.39 49.16 3.08 Favored 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 123.124 2.549 . . . . 0.0 111.952 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . 58.27 81.34 0.16 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.171 1.388 . . . . 0.0 111.861 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 23.5 m -116.43 -72.99 0.66 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -97.76 126.9 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 50.2 t90 -160.25 -35.93 0.05 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.435 0.294 . . . . 0.0 111.246 -175.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -56.34 -45.96 80.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.539 0.736 . . . . 0.0 112.574 -174.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -93.1 -17.53 23.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.467 0.307 . . . . 0.0 110.528 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 34' ' ' TRP . 3.0 mm? -61.86 108.2 0.98 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.731 0.812 . . . . 0.0 111.19 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -131.53 150.58 76.75 Favored Pre-proline 0 C--O 1.244 0.765 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.964 172.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.25 103.98 1.48 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.432 2.088 . . . . 0.0 110.486 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.75 -8.89 1.35 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.366 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.406 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 24.1 mtm -80.08 -177.9 6.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.228 0.611 . . . . 0.0 111.649 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -107.22 161.66 14.58 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.835 0.854 . . . . 0.0 110.765 171.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.478 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -136.17 101.92 4.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 174.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.5 t -87.6 122.74 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 109.824 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -92.4 120.85 33.31 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.523 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 85.2 t80 . . . . . 0 CA--C 1.557 1.224 0 C-N-CA 124.758 1.223 . . . . 0.0 109.141 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 44.0 m-85 . . . . . 0 CA--C 1.544 0.742 0 CA-C-O 120.687 0.28 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 p -73.9 -37.05 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.886 0.874 . . . . 0.0 110.939 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.66 -163.23 29.11 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.539 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 6.5 pt-20 -143.3 178.88 7.43 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.882 0.873 . . . . 0.0 109.129 173.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.511 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -156.88 -172.38 4.02 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.276 1.03 . . . . 0.0 108.879 175.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -125.78 118.09 24.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.965 0.506 . . . . 0.0 110.092 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 43' ' ' PHE . 43.2 mt -63.93 125.34 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.925 175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.448 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 30.7 mmmt -133.9 -168.28 2.09 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 125.374 1.47 . . . . 0.0 107.721 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -19.65 110.16 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 126.092 1.757 . . . . 0.0 115.058 -171.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 112' ' ' ILE . 29.2 m -103.74 109.97 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.7 t -91.93 118.14 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.404 0.682 . . . . 0.0 109.745 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HB3' HD11 ' A' ' 108' ' ' LEU . 61.7 mt -94.71 123.26 38.05 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.664 0.786 . . . . 0.0 109.494 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 71' ' ' GLN . 33.4 t -153.16 136.97 16.14 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.503 0.721 . . . . 0.0 110.126 172.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.686 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 45.6 mt-10 -66.32 -17.81 64.98 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 176.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 14.1 m-20 -97.85 120.73 59.6 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.0 -26.11 58.7 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.436 2.091 . . . . 0.0 112.071 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.417 ' HA ' ' HD2' ' A' ' 73' ' ' PHE . 37.3 mtm -73.19 -22.21 60.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.597 0.759 . . . . 0.0 110.918 -171.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.47 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 21.4 mm-40 -57.3 -33.39 67.63 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.155 0.982 . . . . 0.0 111.587 175.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.52 -31.46 37.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.745 0.418 . . . . 0.0 110.819 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CE2' HD22 ' A' ' 87' ' ' LEU . 85.1 m-85 -79.06 -17.75 54.67 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.125 0.57 . . . . 0.0 111.572 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -94.61 -36.85 11.61 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.436 0.294 . . . . 0.0 111.208 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.6 m -74.8 -57.0 4.19 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.947 0.499 . . . . 0.0 110.809 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.843 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 92.2 m-85 -92.49 -61.73 1.54 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.339 0.656 . . . . 0.0 109.494 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.68 -85.26 0.45 Allowed Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.866 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.04 -37.2 84.04 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.913 0.885 . . . . 0.0 110.639 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.843 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 14.4 mmt85 -65.52 -35.02 79.63 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.223 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.494 HG12 HD23 ' A' ' 82' ' ' LEU . 21.9 t -67.76 143.95 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 118.211 0.46 . . . . 0.0 110.375 -176.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.42 ' HD2' ' HA ' ' A' ' 27' ' ' PHE . 45.2 p90 -62.9 -14.51 47.45 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -173.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.494 HD23 HG12 ' A' ' 80' ' ' VAL . 2.3 pt? -139.68 170.29 16.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.782 0.833 . . . . 0.0 109.272 176.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.9 t -100.09 170.58 8.38 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 172.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -62.48 -27.74 69.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.24 0.616 . . . . 0.0 111.196 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.54 -49.41 71.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.405 0.682 . . . . 0.0 109.956 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.498 ' HG2' HG22 ' A' ' 83' ' ' THR . 17.3 mm-40 -56.75 -40.77 76.38 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.306 176.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.476 HD22 ' CE2' ' A' ' 73' ' ' PHE . 31.0 tp -58.4 -56.19 25.33 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.911 0.884 . . . . 0.0 112.031 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -61.72 -39.97 93.41 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -171.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.64 -18.88 36.62 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.126 0.571 . . . . 0.0 111.747 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -69.77 -39.74 76.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.37 0.668 . . . . 0.0 109.655 170.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.0 mtm -73.49 -30.8 63.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.302 0.641 . . . . 0.0 110.418 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.5 mmpt? -67.11 -38.07 84.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.626 0.371 . . . . 0.0 110.006 170.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.473 0.708 0 O-C-N 123.831 0.707 . . . . 0.0 110.539 177.895 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.686 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.144 0.497 . . . . 0.0 110.657 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 18.2 tptm -101.56 156.67 17.34 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -174.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 65' ' ' LEU . 2.6 tm? -72.44 104.97 3.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -85.96 161.62 18.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.334 0.654 . . . . 0.0 109.251 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.537 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 14.9 ptm -141.67 154.36 45.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.865 0.866 . . . . 0.0 109.868 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.72 104.44 7.18 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.716 0.806 . . . . 0.0 109.825 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.506 ' HA ' HG12 ' A' ' 63' ' ' VAL . 43.0 mt -84.3 119.12 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 123.402 0.681 . . . . 0.0 109.454 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.555 ' HA ' HG22 ' A' ' 26' ' ' VAL . 37.6 tt0 -81.93 98.86 8.76 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -80.98 131.89 35.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.948 0.499 . . . . 0.0 110.25 174.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 1.3 pp20? -139.72 166.29 25.0 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.687 0.795 . . . . 0.0 109.128 175.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.3 t70 56.84 41.7 27.61 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.833 0.853 . . . . 0.0 111.178 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.32 108.92 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 121.351 0.596 . . . . 0.0 111.134 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.66 157.34 21.16 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.521 1.128 . . . . 0.0 110.216 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -122.91 117.73 26.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.896 0.878 . . . . 0.0 110.072 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -78.18 98.25 5.78 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -65.04 -31.44 72.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.838 0.855 . . . . 0.0 110.578 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -87.36 138.35 32.18 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.248 0.619 . . . . 0.0 110.157 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.33 89.14 1.21 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.658 2.239 . . . . 0.0 111.68 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.1 mt -78.73 131.26 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.398 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.424 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -100.69 144.17 27.98 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 122.986 0.514 . . . . 0.0 109.701 -178.204 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.34 161.09 28.95 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.315 2.01 . . . . 0.0 112.658 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 127' ' ' LYS . 11.1 mmpt? -68.91 -51.58 38.5 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.366 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -119.02 178.06 4.63 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.613 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.59 140.49 51.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.688 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.94 102.19 30.02 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.04 176.39 7.05 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.604 2.203 . . . . 0.0 112.212 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.2 t -58.89 -32.94 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.276 1.03 . . . . 0.0 111.132 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.68 -15.0 73.1 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.846 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.37 159.54 16.71 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.339 0.495 . . . . 0.0 113.237 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -113.54 145.77 40.7 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.585 0.754 . . . . 0.0 110.46 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -81.63 113.7 19.82 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.4 121.79 26.68 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.432 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -117.99 140.92 49.04 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 117.81 -1.09 . . . . 0.0 110.007 177.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.643 ' HB3' ' HG2' ' A' ' 3' ' ' LYS . 34.6 ttm . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t -64.93 -14.33 59.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.222 1.009 . . . . 0.0 112.575 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.643 ' HG2' ' HB3' ' A' ' 1' ' ' MET . 21.2 ptmt -62.24 -25.93 68.09 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.942 0.497 . . . . 0.0 111.723 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 5' ' ' VAL . 24.1 mm 62.12 -168.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -173.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.3 m -145.88 -42.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 154.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.09 -161.24 20.23 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.31 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.77 156.15 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.825 0.85 . . . . 0.0 108.711 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 4.9 t -125.48 135.85 52.75 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.484 0.713 . . . . 0.0 109.657 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -132.4 139.29 34.35 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 123.787 0.835 . . . . 0.0 110.305 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HD3' HG12 ' A' ' 130' ' ' VAL . 69.2 Cg_endo -71.75 -26.74 18.94 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.192 2.594 . . . . 0.0 111.901 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt 66.94 117.26 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 125.321 1.449 . . . . 0.0 109.802 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -62.11 -16.65 51.74 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.267 2.645 . . . . 0.0 114.213 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -130.69 -176.38 3.96 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.733 0.813 . . . . 0.0 110.77 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -74.92 6.76 3.73 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.817 0.847 . . . . 0.0 112.87 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -77.97 14.97 0.97 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -62.22 -33.08 73.88 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.863 0.363 . . . . 0.0 110.293 165.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -68.73 -25.8 64.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.505 1.122 . . . . 0.0 111.762 -173.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 6.1 mmp_? -53.49 -49.32 67.76 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.331 1.019 . . . . 0.0 111.574 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 58.9 m-85 -64.54 -31.17 72.26 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.741 -176.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -85.75 -26.61 25.74 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.385 0.674 . . . . 0.0 110.593 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -68.38 -52.63 30.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.607 1.163 . . . . 0.0 109.953 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.5 ptpt -99.79 -16.88 17.93 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.348 -172.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.95 -8.55 50.21 Favored Glycine 0 N--CA 1.475 1.284 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -158.57 107.17 1.94 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.882 0.873 . . . . 0.0 109.546 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 17.1 t70 -126.2 -179.58 4.79 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.333 1.053 . . . . 0.0 109.259 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.5 t -130.67 113.93 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.244 1.018 . . . . 0.0 109.271 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -94.04 115.03 27.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.159 0.584 . . . . 0.0 109.662 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.36 147.14 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.343 0.592 . . . . 0.0 111.452 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.561 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 5.0 mmpt? -134.76 128.83 19.05 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.369 1.468 . . . . 0.0 110.113 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 97.9 Cg_endo -78.44 54.15 4.87 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.827 2.351 . . . . 0.0 112.345 170.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 57.38 97.9 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.558 1.143 . . . . 0.0 111.525 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.46 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 44.8 m -136.8 -54.2 0.72 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.426 0.69 . . . . 0.0 109.817 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 m -79.27 148.59 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.881 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -93.31 -162.28 0.92 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.536 1.134 . . . . 0.0 110.651 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -73.43 3.38 6.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -67.45 -31.41 71.57 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.59 90.99 0.41 Allowed 'General case' 0 C--N 1.352 0.714 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.103 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.43 153.81 47.64 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.264 0.625 . . . . 0.0 109.459 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.25 102.79 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.228 1.952 . . . . 0.0 111.11 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.13 29.79 0.38 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.66 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.2 mtm -111.39 -166.53 1.08 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.643 0.777 . . . . 0.0 110.453 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.9 ptpt -117.14 161.09 20.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.893 0.877 . . . . 0.0 110.539 169.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.543 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 t80 -135.73 101.07 4.65 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 45.1 t -84.29 120.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.294 0.569 . . . . 0.0 109.875 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -84.54 108.69 17.44 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 68.0 t80 -76.76 145.66 38.43 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.257 175.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -104.95 -68.16 0.87 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.254 0.549 . . . . 0.0 110.331 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.1 t -158.75 177.15 11.49 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.303 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -82.01 -162.86 0.59 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.253 0.621 . . . . 0.0 110.584 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 66.78 -150.87 0.2 Allowed 'General case' 0 C--N 1.362 1.131 0 C-N-CA 123.85 0.86 . . . . 0.0 109.836 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 8.8 m-20 -77.25 -16.37 59.04 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.007 0.523 . . . . 0.0 112.174 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.4 p -102.76 81.12 1.97 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.668 0.746 . . . . 0.0 111.026 -173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.3 170.6 17.22 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.279 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.425 ' HE2' ' HA ' ' A' ' 126' ' ' PRO . 61.9 m-85 56.42 91.58 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.144 0.978 . . . . 0.0 112.217 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -77.98 -25.6 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 123.509 0.724 . . . . 0.0 111.268 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.28 -165.93 33.31 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 120.173 -0.237 . . . . 0.0 112.758 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 7.3 pt-20 -145.42 178.03 8.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.631 0.772 . . . . 0.0 109.491 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.551 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -157.46 -171.1 3.45 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.497 1.119 . . . . 0.0 108.81 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 24.2 mmt85 -125.79 117.84 24.25 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.438 0.695 . . . . 0.0 110.168 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 43' ' ' PHE . 49.1 mt -69.27 131.45 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.316 1.046 . . . . 0.0 110.472 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -141.5 -166.61 2.23 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 125.513 1.525 . . . . 0.0 108.967 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -42.68 114.53 0.6 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.744 1.217 . . . . 0.0 113.352 -162.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.5 m -89.3 123.68 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.286 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 90.4 t -90.17 108.2 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.574 ' HB3' HD11 ' A' ' 108' ' ' LEU . 77.8 mt -95.58 113.87 25.57 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.1 t -153.46 144.18 22.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.576 0.75 . . . . 0.0 109.716 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -74.26 -27.75 60.9 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.566 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 42.7 m-20 -94.88 123.56 57.25 Favored Pre-proline 0 N--CA 1.476 0.859 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 28.6 Cg_endo -63.84 -25.01 67.87 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.18 1.92 . . . . 0.0 112.447 173.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.524 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 3.5 mpp? -74.53 -18.15 60.64 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.799 0.44 . . . . 0.0 110.887 -174.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.566 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 25.9 mm-40 -58.2 -40.76 82.4 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.656 0.782 . . . . 0.0 110.21 170.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -73.7 -29.15 62.11 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.677 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' A' ' 87' ' ' LEU . 66.0 m-85 -86.94 -15.63 38.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.17 -31.87 14.61 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 117.941 0.337 . . . . 0.0 110.174 173.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -76.62 -58.08 3.49 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.096 0.558 . . . . 0.0 109.758 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.742 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 63.3 m-85 -98.42 -67.32 0.85 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.732 0.813 . . . . 0.0 110.091 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.98 -81.38 0.09 OUTLIER Glycine 0 C--N 1.358 1.792 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.482 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.09 -36.9 78.44 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.661 1.184 . . . . 0.0 111.921 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.742 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 26.2 mmt180 -76.19 -20.09 57.82 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.979 0.512 . . . . 0.0 111.322 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 76' ' ' PHE . 30.8 t -79.18 142.4 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -57.12 -41.34 78.82 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.43 HD23 HG12 ' A' ' 80' ' ' VAL . 2.1 pt? -106.43 163.18 13.06 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.0 t -98.76 175.71 5.87 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 173.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.31 -28.31 69.22 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.213 0.605 . . . . 0.0 110.89 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.75 -43.48 98.68 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.969 0.908 . . . . 0.0 110.243 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.497 ' HG2' HG22 ' A' ' 83' ' ' THR . 69.7 mm-40 -66.95 -33.9 76.58 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.957 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' A' ' 73' ' ' PHE . 32.6 tp -64.53 -52.56 57.13 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.382 0.673 . . . . 0.0 111.029 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -38.3 89.22 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.506 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.05 -33.42 70.25 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.012 0.195 . . . . 0.0 110.671 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.438 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 76.3 t80 -66.81 -48.05 70.14 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.136 0.975 . . . . 0.0 110.918 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.5 mtm -66.44 -41.0 89.78 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.684 0.615 . . . . 0.0 110.172 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -62.2 -40.76 97.17 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.545 0.528 . . . . 0.0 110.705 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.0 t -62.64 -37.75 87.54 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.205 0.602 . . . . 0.0 111.09 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 81.9 mm-40 -71.3 -34.94 71.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HA ' ' H ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -89.56 -22.13 22.53 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -101.23 -29.49 12.06 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.552 0.614 . . . . 0.0 111.762 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -104.62 -32.29 8.99 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.404 0.282 . . . . 0.0 111.038 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -86.72 56.21 4.67 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.901 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 62.44 -83.42 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.156 1.382 . . . . 0.0 110.138 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 33.6 ttm180 -166.13 73.5 0.17 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 174.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.459 ' H ' ' HA ' ' A' ' 95' ' ' GLU . 2.3 tmt_? -74.38 82.96 1.92 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -109.13 179.67 4.1 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.469 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.6 t -167.54 144.65 4.41 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -72.39 -25.84 61.65 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 124.096 0.872 . . . . 0.0 110.784 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -129.08 166.53 19.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.138 0.975 . . . . 0.0 109.453 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.554 ' H ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -94.58 160.11 14.78 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -109.9 168.53 9.35 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.181 0.592 . . . . 0.0 109.641 -175.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.3 tm? -78.2 107.27 10.66 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -89.33 158.4 17.82 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.7 0.8 . . . . 0.0 109.282 172.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.5 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 15.4 ptm -136.27 131.59 34.64 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.051 0.54 . . . . 0.0 110.754 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.51 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -113.0 102.91 10.86 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.763 0.825 . . . . 0.0 109.767 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.1 mt -83.11 128.13 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.448 0.699 . . . . 0.0 109.414 -175.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.91 111.86 18.5 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.551 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -99.17 112.52 24.65 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.47 0.708 . . . . 0.0 110.395 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -120.72 167.15 12.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.446 0.698 . . . . 0.0 109.65 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.5 t70 53.86 54.88 9.15 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.294 1.038 . . . . 0.0 110.35 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.11 107.62 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.415 -175.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -83.35 163.91 20.33 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.242 1.017 . . . . 0.0 109.815 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -126.48 132.51 51.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.666 0.786 . . . . 0.0 109.965 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -94.4 97.16 9.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -77.3 -18.26 57.65 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.829 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -83.67 139.19 40.73 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.872 0.869 . . . . 0.0 109.378 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.41 100.02 1.33 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.714 2.276 . . . . 0.0 111.115 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.2 mt -81.19 125.75 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.437 ' HG3' ' HA ' ' A' ' 51' ' ' ASP . 0.1 OUTLIER -78.78 116.46 59.91 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.425 ' HA ' ' HE2' ' A' ' 54' ' ' PHE . 9.8 Cg_endo -55.42 129.06 33.13 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.747 2.298 . . . . 0.0 113.182 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -70.3 -20.51 63.02 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.183 0.993 . . . . 0.0 110.416 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -159.27 165.72 32.86 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.92 1.288 . . . . 0.0 108.813 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -71.06 136.19 48.15 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.661 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.516 HG12 ' HD3' ' A' ' 10' ' ' PRO . 41.1 t -111.25 97.72 36.6 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.24 -177.99 2.66 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.546 2.831 . . . . 0.0 112.207 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.67 -33.47 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.521 0.728 . . . . 0.0 110.701 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.34 -25.31 72.45 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.946 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.54 163.16 30.79 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.009 0.338 . . . . 0.0 113.229 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -119.67 146.29 45.71 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.055 0.942 . . . . 0.0 110.66 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -84.16 110.25 18.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.305 0.642 . . . . 0.0 110.236 173.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 119.14 20.63 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 172.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.404 ' HD3' ' H ' ' A' ' 138' ' ' ARG . 0.4 OUTLIER -129.66 137.9 50.9 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.134 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.925 0.393 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m -67.25 -8.34 31.09 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.26 1.024 . . . . 0.0 113.318 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -62.95 -25.26 68.27 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.386 0.674 . . . . 0.0 111.909 174.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.45 HG22 ' H ' ' A' ' 5' ' ' VAL . 22.7 mm 65.78 -176.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 C-N-CA 124.469 1.107 . . . . 0.0 109.283 -176.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -145.92 -42.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.582 1.153 . . . . 0.0 108.045 158.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.23 -161.49 20.85 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.88 0.738 . . . . 0.0 113.595 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.436 HG12 HD11 ' A' ' 60' ' ' ILE . 9.7 p -121.38 162.0 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -137.42 138.77 40.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.116 0.567 . . . . 0.0 110.129 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -135.46 150.08 71.3 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.936 0.894 . . . . 0.0 110.446 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' HG12 ' A' ' 130' ' ' VAL . 91.2 Cg_endo -80.57 -10.83 13.12 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.787 2.325 . . . . 0.0 112.359 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.3 mm 59.79 97.96 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 125.675 1.59 . . . . 0.0 110.879 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -82.63 33.33 0.53 Allowed 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.232 2.621 . . . . 0.0 113.137 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -137.44 162.07 34.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.278 1.031 . . . . 0.0 110.507 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.527 ' H ' ' HD2' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -78.2 -15.72 58.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.76 0.824 . . . . 0.0 110.428 -174.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 82' ' ' LEU . 41.7 m-85 -90.51 31.74 1.01 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.22 1.008 . . . . 0.0 112.354 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -58.74 -22.98 59.06 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.853 0.861 . . . . 0.0 112.017 166.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.463 ' HA ' ' CD2' ' A' ' 49' ' ' HIS . 26.1 t70 -77.52 -27.45 51.71 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.409 1.084 . . . . 0.0 112.514 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -50.2 -48.69 54.17 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.471 1.108 . . . . 0.0 113.702 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -63.82 -29.41 70.61 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.765 0.666 . . . . 0.0 110.605 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -96.82 -12.58 23.41 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.623 0.769 . . . . 0.0 111.621 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -76.05 -50.17 15.5 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.834 0.853 . . . . 0.0 109.007 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HG3' ' H ' ' A' ' 24' ' ' LYS . 14.7 ptpt -109.2 -16.13 14.14 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.502 -172.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.82 9.04 74.48 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 114.216 0.446 . . . . 0.0 114.216 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.452 ' H ' ' HG3' ' A' ' 22' ' ' LYS . 55.3 pttt -163.25 92.36 0.74 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.33 1.052 . . . . 0.0 109.811 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -133.35 -176.87 4.29 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -136.43 121.19 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 120.188 1.358 . . . . 0.0 109.813 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -94.61 116.52 28.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.709 0.804 . . . . 0.0 109.922 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 m -98.2 143.29 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.346 0.593 . . . . 0.0 111.374 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.779 ' HG2' HG23 ' A' ' 33' ' ' VAL . 16.5 tppt? -136.64 140.52 32.39 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.5 1.12 . . . . 0.0 109.88 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.647 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 59.0 Cg_endo -72.7 59.52 3.41 Favored 'Trans proline' 0 CA--C 1.56 1.817 0 C-N-CA 122.996 2.464 . . . . 0.0 113.748 166.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.41 33.95 6.08 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.256 1.423 . . . . 0.0 113.856 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.408 ' H ' ' HG3' ' A' ' 29' ' ' LYS . 3.3 m -87.48 -17.64 31.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.408 0.683 . . . . 0.0 111.05 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.779 HG23 ' HG2' ' A' ' 29' ' ' LYS . 3.3 t -87.71 150.3 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.252 0.621 . . . . 0.0 109.493 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -70.02 174.96 4.8 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.53 0.681 . . . . 0.0 112.257 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -76.96 -1.36 28.25 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.636 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.67 -23.55 66.81 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.65 0.78 . . . . 0.0 111.034 173.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.536 HD23 HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -65.52 103.32 0.82 Allowed 'General case' 0 C--N 1.353 0.743 0 C-N-CA 123.0 0.52 . . . . 0.0 110.084 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.44 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -129.95 150.82 77.0 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.198 0.599 . . . . 0.0 109.65 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.81 107.84 1.96 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.836 2.358 . . . . 0.0 111.042 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.82 -14.57 1.76 Allowed Glycine 0 N--CA 1.467 0.749 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.92 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.567 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 27.9 mtm -78.65 -173.21 3.31 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.367 0.603 . . . . 0.0 111.881 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -112.21 162.74 15.15 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.976 0.91 . . . . 0.0 110.32 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.43 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -135.57 102.71 5.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.99 126.28 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.352 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -97.69 111.69 23.88 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -100.86 157.4 16.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.359 1.064 . . . . 0.0 108.934 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 72.48 165.38 0.29 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.648 1.179 . . . . 0.0 111.819 170.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.7 p 60.4 -167.01 0.19 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.505 1.522 . . . . 0.0 112.473 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.463 ' CD2' ' HA ' ' A' ' 17' ' ' ASP . 55.4 t-80 66.99 16.25 10.32 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.303 1.041 . . . . 0.0 112.06 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 65.15 25.07 12.42 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.265 1.026 . . . . 0.0 110.675 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -119.96 -48.78 2.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.779 0.832 . . . . 0.0 110.771 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.7 m 69.29 -75.1 0.07 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.497 1.119 . . . . 0.0 111.924 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.67 83.9 0.89 Allowed Glycine 0 C--N 1.351 1.371 0 N-CA-C 112.157 -0.377 . . . . 0.0 112.157 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 58.61 95.95 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.619 1.167 . . . . 0.0 111.903 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.45 -38.54 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 168.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.75 -157.16 28.03 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.526 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.22 179.26 9.13 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.081 0.952 . . . . 0.0 110.031 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.469 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -155.17 -172.24 4.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.652 0.781 . . . . 0.0 110.844 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -122.78 119.82 31.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.864 0.866 . . . . 0.0 110.043 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.436 HD11 HG12 ' A' ' 7' ' ' VAL . 45.9 mt -68.61 135.79 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.664 1.186 . . . . 0.0 111.3 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.7 mmmt -134.51 -178.36 5.02 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 126.344 1.858 . . . . 0.0 108.588 -174.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -40.77 116.45 0.71 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.2 1.4 . . . . 0.0 114.046 -165.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.3 m -89.11 116.99 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.857 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.98 115.68 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.736 0.814 . . . . 0.0 109.554 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.9 mt -88.79 119.49 29.33 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.959 0.504 . . . . 0.0 109.688 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -148.28 131.3 16.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.034 0.933 . . . . 0.0 108.796 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -63.0 -31.24 72.33 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.967 0.907 . . . . 0.0 111.576 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.591 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 25.8 m-80 -91.35 119.11 68.76 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.428 ' HG2' HD21 ' A' ' 87' ' ' LEU . 53.1 Cg_endo -68.75 -12.94 35.9 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.595 2.197 . . . . 0.0 112.238 172.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.6 mtm -81.5 -24.27 36.8 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.284 1.033 . . . . 0.0 110.704 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.591 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 79.0 mt-30 -70.32 -25.39 63.28 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -69.2 -28.34 66.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.421 0.288 . . . . 0.0 110.747 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.493 ' HE2' HD22 ' A' ' 87' ' ' LEU . 27.5 m-85 -81.65 -20.41 39.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.883 0.473 . . . . 0.0 112.256 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.6 pt-20 -90.84 -25.54 19.83 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 117.979 0.354 . . . . 0.0 111.194 172.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.6 m -85.91 -50.8 6.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.443 0.697 . . . . 0.0 110.957 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.765 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 82.1 m-85 -107.17 -57.68 2.04 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.993 0.917 . . . . 0.0 109.927 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.44 -90.63 0.24 Allowed Glycine 0 C--N 1.355 1.626 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.827 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.37 -35.21 76.84 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.846 0.858 . . . . 0.0 110.621 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.765 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 44.7 mmt-85 -71.37 -28.2 63.88 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-O 119.162 -0.447 . . . . 0.0 110.914 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 76' ' ' PHE . 57.2 t -71.04 132.3 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -56.78 -50.69 71.54 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.113 0.883 . . . . 0.0 112.213 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.515 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 1.8 pt? -94.6 157.47 15.96 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.451 HG22 ' HG2' ' A' ' 86' ' ' GLU . 14.4 t -88.53 168.31 12.69 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.87 -29.07 70.29 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.197 0.199 . . . . 0.0 110.72 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -61.03 -43.07 99.44 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.535 0.734 . . . . 0.0 111.314 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.451 ' HG2' HG22 ' A' ' 83' ' ' THR . 51.0 mm-40 -64.39 -40.09 95.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.284 0.634 . . . . 0.0 111.345 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.493 HD22 ' HE2' ' A' ' 73' ' ' PHE . 24.4 tp -62.98 -52.27 63.66 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.92 0.763 . . . . 0.0 110.841 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -68.05 -43.23 79.13 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.536 -173.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.23 -33.3 74.33 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.095 0.407 . . . . 0.0 110.106 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 49.5 t80 -65.26 -45.96 82.42 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.87 0.868 . . . . 0.0 110.638 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.9 mtm -74.16 -27.92 61.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.376 0.671 . . . . 0.0 111.296 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.8 mmmt -75.88 -37.37 58.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.5 m -60.48 -27.71 67.77 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.126 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 78.6 mm-40 -68.47 -54.08 19.26 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.041 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 100' ' ' ARG . 10.9 pt-20 -72.34 -25.44 61.54 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 6.8 ptm180 -97.79 -20.61 17.43 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -120.75 -64.84 1.2 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 118.172 0.442 . . . . 0.0 110.797 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.44 -94.52 0.33 Allowed Glycine 0 C--N 1.347 1.174 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.304 -172.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -161.33 137.31 8.06 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.103 0.961 . . . . 0.0 109.479 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.456 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 17.5 tpt180 -154.21 75.65 1.01 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.277 0.561 . . . . 0.0 109.834 169.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -78.53 -51.78 9.46 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 65.37 130.54 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 O-C-N 124.954 1.408 . . . . 0.0 113.422 165.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.8 p -69.14 163.63 24.41 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.159 0.584 . . . . 0.0 110.761 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -56.77 -29.12 62.32 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.881 0.872 . . . . 0.0 112.319 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -100.39 141.59 33.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.201 0.6 . . . . 0.0 109.692 172.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.462 ' HD2' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -64.87 169.04 5.55 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.536 0.734 . . . . 0.0 110.956 176.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -76.52 150.48 36.59 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.445 174.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.96 131.65 41.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -114.99 159.6 20.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.594 0.758 . . . . 0.0 109.681 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.8 ptm -138.01 130.65 29.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.173 0.989 . . . . 0.0 109.203 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.13 101.65 10.86 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.501 ' HA ' HG12 ' A' ' 63' ' ' VAL . 36.8 mt -82.04 118.36 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 44.4 tt0 -81.46 139.89 34.94 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -123.57 132.31 53.85 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.967 1.307 . . . . 0.0 109.126 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -140.24 165.5 27.22 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.642 0.777 . . . . 0.0 109.388 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.8 t70 59.0 39.59 23.33 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.275 1.03 . . . . 0.0 110.331 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.8 t -68.26 101.18 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.125 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -74.16 131.51 41.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.604 1.161 . . . . 0.0 109.862 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -92.56 125.97 37.43 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.239 0.543 . . . . 0.0 109.555 172.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.1 98.69 11.92 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.926 0.89 . . . . 0.0 109.338 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.85 -30.75 68.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.652 172.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -84.92 132.8 44.79 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.378 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.58 102.11 1.52 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.118 2.546 . . . . 0.0 111.606 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.8 mt -111.04 129.37 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.284 0.564 . . . . 0.0 110.463 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.79 141.52 64.25 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.938 0.895 . . . . 0.0 109.59 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.92 157.15 58.9 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.186 1.924 . . . . 0.0 112.13 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -63.21 -27.81 69.62 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.881 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -154.35 163.86 39.5 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.984 1.314 . . . . 0.0 107.755 166.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -61.21 136.03 57.93 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.49 HG12 ' HD3' ' A' ' 10' ' ' PRO . 28.7 t -106.01 103.62 45.53 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 -178.37 2.56 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.151 2.568 . . . . 0.0 112.278 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.97 -36.05 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.908 0.883 . . . . 0.0 111.622 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.62 -16.43 77.74 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-N 116.117 -0.492 . . . . 0.0 113.166 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.5 162.97 25.51 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 123.052 0.358 . . . . 0.0 112.962 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -114.79 152.51 31.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.547 0.739 . . . . 0.0 110.188 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.72 117.21 29.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 170.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.1 114.38 21.72 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.31 141.73 51.23 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.494 ' HB2' HG13 ' A' ' 5' ' ' VAL . 10.0 tp10 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 11.4 tpt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.753 -0.092 . . . . 0.0 110.753 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -59.91 -14.24 14.68 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.651 1.18 . . . . 0.0 114.041 -172.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -64.32 -20.21 65.94 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 5' ' ' VAL . 30.3 mm 66.05 -174.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.684 0 C-N-CA 124.163 0.985 . . . . 0.0 108.791 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' H ' HG22 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -150.64 -42.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.858 1.263 . . . . 0.0 107.776 160.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -167.44 -162.54 19.46 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.355 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.429 HG12 HD11 ' A' ' 60' ' ' ILE . 8.6 p -119.44 151.1 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 172.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -122.87 132.35 54.15 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.731 0.813 . . . . 0.0 108.845 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -131.42 144.14 52.16 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.066 0.946 . . . . 0.0 109.673 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.513 ' HD3' HG12 ' A' ' 130' ' ' VAL . 97.3 Cg_endo -74.48 -17.01 21.31 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.576 2.184 . . . . 0.0 112.028 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 16' ' ' MET . 14.2 mm 49.15 80.88 0.28 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.154 1.382 . . . . 0.0 109.678 -167.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HG3' HG23 ' A' ' 132' ' ' VAL . 96.5 Cg_endo -78.57 15.47 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.001 2.467 . . . . 0.0 112.94 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -104.8 152.74 22.21 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.46 1.104 . . . . 0.0 109.823 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -66.08 -8.38 23.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.652 1.181 . . . . 0.0 112.797 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -97.0 28.05 3.73 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.657 1.183 . . . . 0.0 112.323 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.507 ' HA ' HG21 ' A' ' 11' ' ' ILE . 27.0 ptt? -63.94 -30.16 71.26 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.287 0.565 . . . . 0.0 110.712 174.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -72.05 -21.85 61.47 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.523 1.129 . . . . 0.0 112.595 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 84.4 mmt-85 -58.36 -38.25 76.86 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.959 0.903 . . . . 0.0 112.615 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 64.5 m-85 -67.18 -30.35 70.28 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 121.087 0.47 . . . . 0.0 110.473 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -96.77 -8.58 30.86 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.158 0.983 . . . . 0.0 110.78 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -84.88 -54.64 4.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.813 1.245 . . . . 0.0 110.03 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.9 ptpt -98.3 -13.8 20.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.814 -171.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.46 -23.81 9.43 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 113.857 0.303 . . . . 0.0 113.857 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -148.72 116.86 6.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.026 0.93 . . . . 0.0 109.487 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 14.4 t70 -123.44 175.43 6.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.275 0.63 . . . . 0.0 110.001 -170.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.88 109.53 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.431 ' HD2' HD12 ' A' ' 112' ' ' ILE . 85.7 t80 -87.82 108.82 19.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.45 0.7 . . . . 0.0 109.561 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 m -92.59 138.44 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.181 0.515 . . . . 0.0 110.977 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HD2' ' HD2' ' A' ' 30' ' ' PRO . 13.9 mmtp -129.45 147.31 64.63 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.674 1.19 . . . . 0.0 110.068 170.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HD2' ' A' ' 29' ' ' LYS . 82.0 Cg_endo -77.15 53.17 4.12 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.985 2.457 . . . . 0.0 111.754 165.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 38.23 64.93 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.564 1.546 . . . . 0.0 112.928 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -94.02 -27.13 16.48 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.198 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.56 152.76 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.319 1.048 . . . . 0.0 111.141 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -65.87 169.38 6.68 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.505 0.722 . . . . 0.0 109.878 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -68.83 -2.16 8.89 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.66 -30.68 65.62 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.684 0.794 . . . . 0.0 111.502 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.401 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -62.24 116.3 4.89 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.557 0.743 . . . . 0.0 110.588 -179.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.83 152.99 53.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.968 0.907 . . . . 0.0 109.697 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.95 105.99 1.25 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.886 2.391 . . . . 0.0 111.305 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.92 -8.62 1.75 Allowed Glycine 0 N--CA 1.471 0.995 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.237 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.549 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 83.2 mtp -84.51 179.46 7.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.29 1.036 . . . . 0.0 111.305 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.408 ' HG3' ' HA3' ' A' ' 6' ' ' GLY . 14.4 ptpt -110.23 164.47 12.62 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.91 0.884 . . . . 0.0 110.162 172.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.44 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 t80 -135.44 94.87 3.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -83.09 120.48 34.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.226 0.536 . . . . 0.0 110.143 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -83.72 97.64 9.23 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.57 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -71.37 168.75 16.75 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 163.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -161.1 155.3 22.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 m 66.96 -175.64 0.19 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.971 0.909 . . . . 0.0 111.924 172.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -122.9 15.6 10.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.889 0.876 . . . . 0.0 109.072 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -86.75 166.27 15.4 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.268 1.027 . . . . 0.0 111.293 -172.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -37.6 -51.97 1.2 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.257 1.823 . . . . 0.0 113.406 173.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -111.34 145.02 39.6 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.54 45.78 0.26 Allowed Glycine 0 C--N 1.347 1.155 0 C-N-CA 121.406 -0.426 . . . . 0.0 113.706 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -105.81 104.01 13.63 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.61 -28.93 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 122.995 0.518 . . . . 0.0 110.408 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.44 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . 175.61 -164.05 34.12 Favored Glycine 0 C--N 1.344 1.019 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.838 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -151.14 178.9 8.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.812 0.845 . . . . 0.0 109.21 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -161.5 -172.27 3.29 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.18 0.992 . . . . 0.0 109.685 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -128.7 120.87 27.3 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.807 0.843 . . . . 0.0 110.087 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 43' ' ' PHE . 54.1 mt -70.66 134.32 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.483 1.113 . . . . 0.0 111.273 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.2 mmmt -131.76 178.42 6.77 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 126.091 1.756 . . . . 0.0 109.82 -175.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -29.13 110.45 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.774 2.03 . . . . 0.0 114.507 -175.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 112' ' ' ILE . 33.4 m -93.11 118.38 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.801 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.0 119.26 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.733 0.813 . . . . 0.0 109.077 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HB3' HD11 ' A' ' 108' ' ' LEU . 70.9 mt -101.99 120.77 40.95 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.78 0.832 . . . . 0.0 109.47 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.6 t -152.67 135.12 15.16 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.057 0.943 . . . . 0.0 110.113 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 14.8 mt-10 -63.84 -23.56 67.4 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.149 0.98 . . . . 0.0 112.19 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -102.84 120.16 53.41 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.453 ' HG2' HD21 ' A' ' 87' ' ' LEU . 36.7 Cg_endo -64.74 -19.75 64.66 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.689 2.259 . . . . 0.0 112.189 174.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 44.2 mtm -73.27 -23.86 60.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.847 0.859 . . . . 0.0 110.477 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 23.7 mt-30 -71.05 -23.52 62.16 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.529 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.31 -24.04 54.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.736 0.414 . . . . 0.0 111.017 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.504 ' HE2' HD22 ' A' ' 87' ' ' LEU . 55.4 m-85 -88.35 -27.5 21.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.088 0.555 . . . . 0.0 111.623 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.9 pt-20 -82.46 -27.46 31.85 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 120.388 0.137 . . . . 0.0 110.656 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.5 m -84.89 -50.65 7.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.686 0.394 . . . . 0.0 110.61 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.746 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 89.2 m-85 -107.41 -69.37 0.85 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.153 0.581 . . . . 0.0 110.628 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.2 -80.99 0.07 OUTLIER Glycine 0 C--N 1.358 1.75 0 O-C-N 123.546 0.528 . . . . 0.0 113.515 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.14 -31.86 67.61 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.811 1.244 . . . . 0.0 111.778 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.746 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 30.3 mmt180 -74.02 -36.12 64.41 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.35 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.32 148.84 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.973 0.509 . . . . 0.0 110.677 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.48 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 45.7 p90 -62.56 -34.14 76.36 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 82' ' ' LEU . 2.3 pt? -117.16 170.63 8.52 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.529 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.4 t -106.21 175.81 5.37 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -60.93 -31.78 71.3 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.134 0.974 . . . . 0.0 111.577 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.77 -43.01 90.13 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.292 0.637 . . . . 0.0 110.73 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HG2' HG22 ' A' ' 83' ' ' THR . 60.1 mm-40 -65.99 -33.86 76.79 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.143 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.504 HD22 ' HE2' ' A' ' 73' ' ' PHE . 26.7 tp -63.87 -54.54 33.23 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.415 0.686 . . . . 0.0 111.002 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -67.11 -36.88 82.88 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.751 -171.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 90' ' ' TYR . 6.7 pt-20 -66.25 -40.21 90.03 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 173.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.429 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 79.7 t80 -61.87 -40.21 94.61 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.223 1.009 . . . . 0.0 111.055 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.6 mtm -73.15 -35.07 66.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.068 0.547 . . . . 0.0 110.965 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.0 mmmt -69.85 -25.89 63.95 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.6 0.36 . . . . 0.0 110.608 173.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.46 ' HA ' ' HG2' ' A' ' 96' ' ' ARG . 68.0 m -72.05 -25.03 61.63 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.224 0.609 . . . . 0.0 111.463 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 75.9 mm-40 -78.28 -28.9 47.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.746 0.419 . . . . 0.0 111.75 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.45 -31.63 21.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.844 0.458 . . . . 0.0 111.114 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 93' ' ' SER . 11.9 ptm85 -85.54 -20.65 29.3 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -124.22 28.89 6.56 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.224 0.535 . . . . 0.0 111.326 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -167.41 -172.72 34.87 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.005 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.78 25.5 3.57 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.441 1.097 . . . . 0.0 111.109 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 71.11 -15.13 0.42 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 126.048 1.739 . . . . 0.0 113.211 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 67.98 -55.94 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 125.738 1.615 . . . . 0.0 111.636 -165.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 63.24 78.94 0.27 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.745 1.218 . . . . 0.0 110.742 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -87.48 115.72 25.1 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -64.58 -35.77 82.08 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.13 0.572 . . . . 0.0 111.327 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HG3' ' HD2' ' A' ' 106' ' ' LYS . 1.6 tpmt? -104.8 160.38 15.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HD2' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -68.44 158.72 33.11 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 3.9 tmtp? -102.73 138.8 39.15 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 65' ' ' LEU . 3.0 tm? -77.2 104.65 7.83 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.422 ' CE3' ' HB3' ' A' ' 69' ' ' PRO . 24.8 m95 -82.93 161.08 21.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.205 0.602 . . . . 0.0 109.524 174.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.6 ptm -136.72 141.96 43.07 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.129 0.971 . . . . 0.0 109.754 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.17 103.97 9.7 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.125 0.97 . . . . 0.0 109.006 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.501 ' HA ' HG12 ' A' ' 63' ' ' VAL . 30.9 mt -81.45 122.45 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -82.96 136.65 34.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -123.3 132.73 54.11 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.223 0.609 . . . . 0.0 110.356 -175.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -131.87 172.57 12.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.888 0.875 . . . . 0.0 110.294 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.1 t70 49.05 50.01 18.59 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.809 1.243 . . . . 0.0 111.874 170.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.34 101.61 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.153 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -77.87 148.41 34.65 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.512 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -111.28 111.86 23.21 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.164 0.585 . . . . 0.0 110.32 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.44 ' H ' ' HA2' ' A' ' 56' ' ' GLY . 4.8 m-85 -83.9 87.06 7.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.961 0.904 . . . . 0.0 109.244 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.45 -15.08 56.16 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.701 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -80.47 137.61 51.78 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.296 1.039 . . . . 0.0 110.294 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.21 79.6 3.33 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 123.079 2.519 . . . . 0.0 113.178 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.8 mt -98.49 137.4 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.153 0.581 . . . . 0.0 110.598 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -71.22 151.32 94.52 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.258 1.023 . . . . 0.0 111.032 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.42 153.84 65.6 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.195 1.93 . . . . 0.0 111.384 167.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -36.55 74.95 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -152.19 169.51 22.28 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.202 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.98 132.48 48.0 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.32 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.513 HG12 ' HD3' ' A' ' 10' ' ' PRO . 17.6 t -118.89 99.6 51.07 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.093 0.557 . . . . 0.0 109.704 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.19 -174.87 2.12 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.478 2.785 . . . . 0.0 112.591 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.575 HG23 ' HG3' ' A' ' 12' ' ' PRO . 5.5 p -54.91 -40.3 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.661 1.184 . . . . 0.0 112.62 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.63 -12.91 82.41 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 113.581 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.95 159.49 15.09 Favored Glycine 0 C--N 1.348 1.208 0 C-N-CA 122.9 0.286 . . . . 0.0 112.838 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -113.58 150.02 33.65 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.534 0.734 . . . . 0.0 109.082 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -84.05 115.55 22.42 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.42 125.76 29.65 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -133.99 122.27 22.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.427 ' HB3' HG11 ' A' ' 5' ' ' VAL . 9.9 tp10 . . . . . 0 C--O 1.243 0.763 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.05 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.503 ' HB3' ' HG3' ' A' ' 138' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.565 0.221 . . . . 0.0 111.251 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -69.2 -11.09 60.5 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.36 0.664 . . . . 0.0 112.705 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -76.96 -17.29 58.99 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.721 0.808 . . . . 0.0 112.381 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 5' ' ' VAL . 16.9 mm 64.45 -171.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.879 0 C-N-CA 124.005 0.922 . . . . 0.0 108.912 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.523 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.3 m -156.22 -32.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 125.497 1.519 . . . . 0.0 109.131 156.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -166.97 -164.05 21.91 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.324 0.39 . . . . 0.0 112.839 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.466 HG12 HD11 ' A' ' 60' ' ' ILE . 10.4 p -139.0 144.81 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.508 0.723 . . . . 0.0 109.158 173.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 t -116.97 132.59 56.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.946 0.898 . . . . 0.0 110.0 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -133.18 140.64 37.99 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.561 1.144 . . . . 0.0 108.8 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 25.1 Cg_exo -63.8 -41.32 24.58 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.085 2.524 . . . . 0.0 111.828 169.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.4 mt 54.11 77.38 0.44 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 124.67 1.188 . . . . 0.0 110.001 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.63 0.24 6.6 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.103 2.535 . . . . 0.0 113.501 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -69.21 144.86 53.61 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 121.501 0.667 . . . . 0.0 110.499 172.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -59.22 -10.77 3.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.18 1.392 . . . . 0.0 112.852 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -99.43 22.1 11.18 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.445 1.098 . . . . 0.0 112.491 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.9 -29.27 70.2 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.937 0.495 . . . . 0.0 109.877 168.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -67.81 -27.25 66.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.825 1.25 . . . . 0.0 111.898 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 24.3 mmt180 -55.69 -37.03 67.81 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.935 0.894 . . . . 0.0 113.134 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.415 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 62.2 m-85 -66.19 -29.67 69.98 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.107 0.479 . . . . 0.0 110.865 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.13 -23.24 18.67 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.585 1.154 . . . . 0.0 110.282 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -74.01 -55.51 6.05 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.815 1.246 . . . . 0.0 110.673 -174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.2 ptpt -93.99 -12.61 28.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.444 0.698 . . . . 0.0 111.24 -175.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.49 -30.63 5.92 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 122.924 0.297 . . . . 0.0 113.192 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.82 118.39 7.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.873 0.869 . . . . 0.0 108.857 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 16.5 t70 -123.25 -179.43 4.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.765 0.826 . . . . 0.0 109.918 -168.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -134.34 110.55 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.324 1.05 . . . . 0.0 108.847 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -92.94 120.96 33.8 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.86 137.78 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.458 0.646 . . . . 0.0 111.113 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.6 mmpt? -127.58 133.63 25.3 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.476 1.51 . . . . 0.0 109.947 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.5 55.95 4.92 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.803 2.335 . . . . 0.0 111.113 166.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.2 36.11 4.25 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.201 1.4 . . . . 0.0 113.215 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 9.1 m -64.12 -28.26 69.65 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.667 0.746 . . . . 0.0 110.266 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.1 m -90.48 150.45 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.756 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -79.88 178.0 8.52 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.91 0.884 . . . . 0.0 109.788 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -69.91 4.24 2.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.217 1.007 . . . . 0.0 113.697 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.7 -26.23 68.56 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.245 0.618 . . . . 0.0 110.198 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.48 110.77 2.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.796 0.838 . . . . 0.0 110.718 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -134.31 152.07 77.46 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.23 102.6 0.96 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.38 2.053 . . . . 0.0 110.845 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.75 35.95 0.21 Allowed Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.365 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.499 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 24.5 mtm -119.0 -168.02 1.49 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.448 0.699 . . . . 0.0 110.726 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -110.1 157.06 19.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.19 0.996 . . . . 0.0 108.864 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.562 ' HB2' HG13 ' A' ' 60' ' ' ILE . 2.7 t80 -134.64 104.43 6.05 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 40.5 t -94.6 121.5 45.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.485 0.66 . . . . 0.0 109.823 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -86.21 103.51 14.9 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.249 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 16.2 t80 -72.99 133.59 44.35 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 170.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -69.86 -54.34 13.96 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.143 0.429 . . . . 0.0 111.528 -170.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.5 p -164.63 156.46 15.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.603 0.761 . . . . 0.0 109.155 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -92.34 33.26 1.11 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.377 0.608 . . . . 0.0 111.025 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.77 36.85 1.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.53 1.132 . . . . 0.0 109.157 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 56.16 74.96 0.36 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.749 1.22 . . . . 0.0 109.429 -169.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 m -133.38 175.07 9.73 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.857 -169.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 125' ' ' LYS . . . -101.64 -160.84 26.89 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 170.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -83.83 146.07 28.31 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.332 0.653 . . . . 0.0 110.669 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.26 -23.32 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.041 0.536 . . . . 0.0 109.714 169.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.432 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . 176.07 -165.1 35.46 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.017 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 11.1 pt-20 -153.65 178.1 10.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.073 0.949 . . . . 0.0 109.581 172.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -162.31 -172.42 3.18 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.013 0.925 . . . . 0.0 110.181 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -124.2 122.74 38.6 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.786 0.834 . . . . 0.0 109.773 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 43' ' ' PHE . 41.4 mt -72.16 133.52 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.067 0.947 . . . . 0.0 110.6 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -140.16 -166.18 2.05 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.166 1.787 . . . . 0.0 108.065 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -37.71 118.81 0.69 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.273 1.429 . . . . 0.0 114.565 -165.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -98.27 116.21 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 123.087 0.555 . . . . 0.0 109.8 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -91.12 113.05 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.367 0.667 . . . . 0.0 109.36 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.517 ' HB3' HD11 ' A' ' 108' ' ' LEU . 57.5 mt -90.24 124.68 35.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.512 0.725 . . . . 0.0 109.743 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -152.55 138.23 17.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.004 0.921 . . . . 0.0 110.222 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -75.33 -12.05 60.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.582 0.753 . . . . 0.0 111.556 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.554 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 74.7 m-20 -112.01 119.88 43.22 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.329 0.652 . . . . 0.0 109.274 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HG2' HD21 ' A' ' 87' ' ' LEU . 53.6 Cg_endo -67.94 -12.83 36.56 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.8 2.333 . . . . 0.0 113.33 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.3 mtm -81.99 -22.61 36.47 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.485 0.714 . . . . 0.0 110.945 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.554 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 62.3 mt-30 -70.73 -20.27 62.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.984 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -74.59 -25.53 59.32 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.052 0.541 . . . . 0.0 110.927 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.598 ' HE2' HD22 ' A' ' 87' ' ' LEU . 37.0 m-85 -85.19 -27.72 25.93 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.969 0.508 . . . . 0.0 111.728 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.36 -33.7 48.84 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 120.508 0.194 . . . . 0.0 110.675 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -79.77 -56.42 4.29 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.974 0.51 . . . . 0.0 111.132 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.702 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 37.3 m-85 -103.28 -68.0 0.86 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.249 0.619 . . . . 0.0 109.702 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.76 -81.51 0.12 Allowed Glycine 0 C--N 1.355 1.614 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.118 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.84 -36.18 69.7 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.592 1.157 . . . . 0.0 111.327 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.702 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 26.5 mmt180 -78.54 -30.27 46.85 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.801 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 76' ' ' PHE . 42.7 t -65.12 140.62 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -57.5 -45.99 84.28 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 122.606 0.362 . . . . 0.0 111.697 -174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -105.46 164.04 12.18 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.479 HG22 ' HG2' ' A' ' 86' ' ' GLU . 13.0 t -99.24 -179.69 4.32 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -68.76 -29.85 68.33 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.908 0.483 . . . . 0.0 111.338 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 2.9 m-20 -68.96 -30.23 68.62 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.324 0.583 . . . . 0.0 111.269 174.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.479 ' HG2' HG22 ' A' ' 83' ' ' THR . 58.8 mm-40 -75.32 -28.52 59.69 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.827 174.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.598 HD22 ' HE2' ' A' ' 73' ' ' PHE . 56.5 tp -69.23 -47.15 65.55 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.712 0.405 . . . . 0.0 110.582 174.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -65.13 -40.16 94.06 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.854 -175.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.32 -33.95 73.93 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.707 0.23 . . . . 0.0 110.664 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.433 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 68.4 t80 -62.99 -44.52 95.79 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.708 0.803 . . . . 0.0 111.221 176.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.8 mtm -77.05 -35.6 56.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.295 0.638 . . . . 0.0 111.186 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -70.05 -23.69 63.14 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.423 0.289 . . . . 0.0 110.41 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.8 t -69.62 -31.37 69.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.818 0.447 . . . . 0.0 111.008 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 26.2 mm-40 -77.74 -13.61 59.85 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -174.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -102.48 -29.71 11.43 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -105.68 -19.92 13.62 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -118.08 -30.14 5.41 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.176 0.59 . . . . 0.0 110.16 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.29 28.63 9.42 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.472 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 73.4 149.44 0.1 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.67 1.588 . . . . 0.0 112.771 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -76.67 -176.39 3.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.35 1.06 . . . . 0.0 111.755 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 71.71 93.15 0.08 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.45 1.5 . . . . 0.0 109.517 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -175.76 5.92 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.094 0.958 . . . . 0.0 109.578 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.7 p -142.9 150.16 39.43 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.585 0.754 . . . . 0.0 110.809 -173.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -70.24 -22.07 62.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.893 0.877 . . . . 0.0 111.112 173.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -67.74 153.49 43.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.481 0.712 . . . . 0.0 110.531 -178.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.25 -171.41 1.87 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.451 0.7 . . . . 0.0 109.161 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HD3' ' H ' ' A' ' 108' ' ' LEU . 4.8 tmtp? -135.37 144.42 46.61 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.5 tm? -77.77 100.25 6.2 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -82.92 159.69 22.25 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.367 0.667 . . . . 0.0 109.381 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.0 ptm -143.37 131.06 21.32 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.611 0.764 . . . . 0.0 110.279 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.17 102.59 11.99 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.813 0.845 . . . . 0.0 109.487 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.424 HG21 HG12 ' A' ' 60' ' ' ILE . 36.0 mt -81.26 127.89 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.748 0.819 . . . . 0.0 109.394 -177.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -81.61 123.47 28.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.3 mm? -105.27 129.1 53.71 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.159 0.983 . . . . 0.0 109.528 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.64 175.25 9.72 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.208 1.003 . . . . 0.0 108.492 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 t70 57.63 36.41 26.69 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.876 0.845 . . . . 0.0 110.737 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.16 105.17 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.742 -171.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.65 160.21 21.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.184 0.993 . . . . 0.0 110.472 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -117.5 123.19 45.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.178 0.991 . . . . 0.0 110.54 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.432 ' H ' ' HA2' ' A' ' 56' ' ' GLY . 10.3 m-85 -97.12 82.33 3.17 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.49 -24.77 65.62 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.513 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -81.87 139.42 46.58 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.796 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -83.29 65.9 7.7 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 123.235 2.624 . . . . 0.0 112.924 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.3 mt -77.02 114.34 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 12.9 mptt -71.35 145.38 90.55 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.198 -178.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.99 155.19 70.61 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.612 2.208 . . . . 0.0 111.86 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -68.22 -31.07 70.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.617 0.767 . . . . 0.0 109.479 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -128.88 162.21 28.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.144 0.978 . . . . 0.0 109.824 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -77.3 121.88 24.33 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.477 ' HA ' ' HG2' ' A' ' 135' ' ' GLN . 17.8 t -107.69 100.07 32.88 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 122.829 0.451 . . . . 0.0 110.195 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.82 -176.94 3.41 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.01 2.473 . . . . 0.0 111.699 172.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -57.77 -31.22 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.322 1.049 . . . . 0.0 112.756 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.25 -19.27 72.13 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.708 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.76 142.21 3.12 Favored Glycine 0 C--N 1.351 1.361 0 C-N-CA 122.984 0.326 . . . . 0.0 113.031 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.477 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -109.73 157.67 18.89 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.437 0.695 . . . . 0.0 109.836 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -87.35 129.1 35.15 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 170.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.1 tt -90.58 125.13 35.53 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.503 ' HG3' ' HB3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -134.26 144.29 48.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttm . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m -63.05 -7.03 4.63 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.347 1.059 . . . . 0.0 113.689 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -59.96 -27.43 66.81 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.243 0.617 . . . . 0.0 112.031 171.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 5' ' ' VAL . 26.3 mm 64.85 -177.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 C-N-CA 124.402 1.081 . . . . 0.0 109.577 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 139' ' ' GLU . 1.3 m -150.24 -39.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.807 1.243 . . . . 0.0 108.712 158.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.39 -163.38 22.27 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.178 -176.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.432 HG11 HD21 ' A' ' 37' ' ' LEU . 9.0 p -137.1 141.39 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.663 0.785 . . . . 0.0 109.068 175.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 t -113.93 139.26 49.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.445 0.698 . . . . 0.0 110.163 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -131.55 143.74 50.46 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 123.695 0.798 . . . . 0.0 109.805 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' HG12 ' A' ' 130' ' ' VAL . 85.8 Cg_endo -73.98 -14.59 23.74 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.994 2.463 . . . . 0.0 112.354 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.1 mm 53.6 89.77 0.1 OUTLIER Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.922 1.289 . . . . 0.0 109.86 -174.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.03 24.35 0.54 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.905 2.403 . . . . 0.0 112.702 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 159.52 39.23 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.532 1.533 . . . . 0.0 108.499 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -74.93 -13.07 60.49 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.446 0.698 . . . . 0.0 111.239 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -72.52 6.85 2.13 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.234 1.013 . . . . 0.0 113.597 -172.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -56.76 -34.21 67.36 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.002 0.43 . . . . 0.0 110.058 164.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.47 ' N ' ' SD ' ' A' ' 16' ' ' MET . 19.6 t70 -49.42 -41.49 39.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.647 1.579 . . . . 0.0 112.428 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -54.56 -48.2 72.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.262 1.025 . . . . 0.0 112.465 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 64.5 m-85 -66.75 -28.9 68.78 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.988 0.805 . . . . 0.0 110.406 -177.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -91.1 -19.32 23.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.01 0.524 . . . . 0.0 111.376 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -76.74 -59.67 2.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.321 0.648 . . . . 0.0 109.497 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -92.73 -10.23 37.83 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.222 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.3 3.02 69.08 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.416 0.447 . . . . 0.0 114.006 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -168.16 100.43 0.44 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.009 0.924 . . . . 0.0 109.736 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 20.1 t70 -129.05 -170.74 2.33 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.0 t -133.18 117.51 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.94 1.245 . . . . 0.0 109.248 -174.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -90.49 107.33 19.09 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.278 0.631 . . . . 0.0 109.517 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.3 m -87.67 142.85 12.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.423 0.63 . . . . 0.0 109.903 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HE2' ' HD2' ' A' ' 30' ' ' PRO . 2.1 tpmt? -135.05 128.07 18.43 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.383 1.073 . . . . 0.0 108.53 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 79.7 Cg_endo -76.26 59.29 5.97 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.716 2.277 . . . . 0.0 111.736 171.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 39.49 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.882 1.673 . . . . 0.0 113.487 -174.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.499 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 27.9 m -127.91 -31.48 2.4 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.384 0.674 . . . . 0.0 109.754 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.79 148.47 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.41 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -87.98 -164.14 1.06 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.129 0.972 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -70.13 -2.21 12.34 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -63.38 -31.32 72.44 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.234 0.47 . . . . 0.0 110.765 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.432 HD21 HG11 ' A' ' 7' ' ' VAL . 1.1 mm? -64.93 117.44 7.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.132 0.573 . . . . 0.0 111.614 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.07 149.81 46.85 Favored Pre-proline 0 C--O 1.244 0.787 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.791 173.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.31 101.88 0.65 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.541 2.16 . . . . 0.0 111.047 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.83 0.62 0.78 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.483 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.427 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 26.2 mtm -89.7 -169.75 2.57 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 117.319 0.56 . . . . 0.0 110.984 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -107.86 160.06 16.04 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.507 0.723 . . . . 0.0 109.474 173.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CB ' HD11 ' A' ' 114' ' ' LEU . 12.3 t80 -134.98 105.25 6.29 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.8 t -90.76 121.13 40.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.175 0.512 . . . . 0.0 109.868 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -82.95 105.16 13.72 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.437 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 56.8 t80 -79.73 126.28 30.75 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.507 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 24.4 tp60 -76.34 115.8 16.43 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -56.01 83.37 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.809 1.244 . . . . 0.0 113.8 -173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.8 p80 174.19 173.43 0.18 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.01 1.724 . . . . 0.0 109.271 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.31 -178.78 4.13 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.907 0.883 . . . . 0.0 111.718 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.49 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 32.7 t70 61.37 -86.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.174 1.39 . . . . 0.0 112.363 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.49 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 27.2 m -54.07 -35.23 61.82 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.174 0.99 . . . . 0.0 111.977 -172.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.548 ' HA3' ' HD3' ' A' ' 126' ' ' PRO . . . 68.89 -90.87 0.26 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-N 114.799 -1.091 . . . . 0.0 113.517 170.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 66.7 m-85 -102.14 124.34 47.56 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.617 0.767 . . . . 0.0 111.195 -172.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 47' ' ' GLN . 2.6 p -84.53 -33.75 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.932 0.893 . . . . 0.0 110.88 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.6 -168.58 30.88 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.474 -0.33 . . . . 0.0 112.76 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 6.5 pt-20 -147.83 179.46 7.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.396 1.078 . . . . 0.0 108.918 174.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -164.19 -172.24 2.69 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.679 0.791 . . . . 0.0 110.659 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -123.94 119.03 28.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.507 1.123 . . . . 0.0 109.576 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 43' ' ' PHE . 53.7 mt -71.81 131.78 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.217 1.007 . . . . 0.0 110.733 177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -138.13 -162.4 1.3 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.212 1.805 . . . . 0.0 107.773 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -38.96 116.0 0.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.821 1.249 . . . . 0.0 113.466 -160.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.9 m -96.18 106.36 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 121.735 0.778 . . . . 0.0 109.113 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 86.2 t -89.96 108.02 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.8 mt -89.37 120.32 30.6 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.504 0.722 . . . . 0.0 109.398 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.7 t -151.58 135.73 16.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.557 0.743 . . . . 0.0 110.091 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -70.97 -10.22 59.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.922 0.889 . . . . 0.0 111.837 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -110.12 122.56 38.46 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.58 -22.35 58.41 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.218 1.945 . . . . 0.0 112.282 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 47.5 mtm -70.33 -25.63 63.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.484 0.713 . . . . 0.0 111.415 -169.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -53.56 -35.57 60.93 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.215 1.006 . . . . 0.0 112.03 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.418 ' HE2' ' HB3' ' A' ' 109' ' ' TRP . 5.7 m-85 -77.39 -33.82 55.04 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.525 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CE2' HD22 ' A' ' 87' ' ' LEU . 88.1 m-85 -81.5 -16.64 51.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.517 0.727 . . . . 0.0 111.65 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -94.14 -33.57 13.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.462 0.305 . . . . 0.0 111.208 172.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.2 m -78.08 -52.07 9.31 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.989 0.423 . . . . 0.0 110.737 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.797 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 66.9 m-85 -100.16 -53.96 3.0 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.538 0.735 . . . . 0.0 109.951 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.71 -86.44 0.12 Allowed Glycine 0 C--N 1.357 1.731 0 O-C-N 123.938 0.774 . . . . 0.0 113.129 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.92 -43.49 91.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.41 0.684 . . . . 0.0 110.692 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.797 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 25.0 mmt180 -68.74 -18.6 64.25 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-O 118.328 -0.844 . . . . 0.0 112.292 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 76' ' ' PHE . 47.9 t -80.25 131.9 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.628 1.104 . . . . 0.0 108.592 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -51.9 -37.58 52.98 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 124.092 0.87 . . . . 0.0 113.336 -170.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.0 pt? -111.75 160.0 17.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.539 HG22 ' HG2' ' A' ' 86' ' ' GLU . 8.9 t -97.24 173.69 7.09 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -61.26 -27.29 68.35 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.462 0.705 . . . . 0.0 111.438 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.95 -53.14 51.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.569 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 9.2 mm-40 -61.64 -29.74 70.26 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.566 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.514 HD22 ' CE2' ' A' ' 73' ' ' PHE . 25.2 tp -63.5 -58.56 6.63 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.121 0.968 . . . . 0.0 111.096 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -59.92 -41.19 91.18 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.571 0.544 . . . . 0.0 111.607 -172.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.94 -23.74 44.41 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.028 0.531 . . . . 0.0 111.477 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.45 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 62.4 t80 -67.79 -45.99 73.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.21 0.604 . . . . 0.0 109.788 171.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.3 mtm -67.27 -39.78 86.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.138 0.575 . . . . 0.0 110.381 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.2 mmpt? -64.0 -38.4 90.95 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.606 0.566 . . . . 0.0 110.293 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.3 t -62.03 -43.79 98.09 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.432 0.693 . . . . 0.0 110.749 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 28.5 mm-40 -64.25 -43.05 96.08 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.917 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.642 ' HB3' HH11 ' A' ' 99' ' ' ARG . 12.7 pt-20 -88.02 -2.81 58.83 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -99.16 -33.66 10.68 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.796 0.725 . . . . 0.0 110.344 173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -91.36 -20.41 21.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.702 0.401 . . . . 0.0 111.624 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.35 97.36 0.19 Allowed Glycine 0 C--N 1.349 1.252 0 N-CA-C 112.246 -0.341 . . . . 0.0 112.246 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.642 HH11 ' HB3' ' A' ' 95' ' ' GLU . 10.0 tpt180 -72.9 -38.0 67.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.35 0.66 . . . . 0.0 110.695 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 66.49 -80.97 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.369 1.468 . . . . 0.0 111.919 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -84.93 105.62 15.83 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -71.9 90.04 1.11 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.638 0.775 . . . . 0.0 110.045 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.4 m -74.16 84.93 1.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -68.95 156.32 38.77 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.443 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 66.34 -89.38 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.789 1.236 . . . . 0.0 111.135 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.48 -171.54 3.16 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.239 0.543 . . . . 0.0 111.191 172.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 30' ' ' PRO . 31.6 tptt -134.97 145.27 47.97 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.306 1.042 . . . . 0.0 108.73 173.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -80.15 121.62 25.8 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.418 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 41.6 m95 -107.77 158.55 17.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.055 0.942 . . . . 0.0 109.347 174.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.2 ptm -144.47 130.92 19.84 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.283 0.633 . . . . 0.0 110.271 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -103.78 102.38 12.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.637 0.775 . . . . 0.0 109.49 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.81 117.54 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.96 113.0 19.57 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.484 HD11 ' CB ' ' A' ' 43' ' ' PHE . 4.3 mm? -92.53 135.36 34.13 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.063 0.545 . . . . 0.0 110.726 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.81 167.95 20.88 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.645 0.778 . . . . 0.0 109.365 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.2 t70 53.6 47.45 23.86 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.312 1.053 . . . . 0.0 110.586 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 50.5 t -69.84 107.56 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.531 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -93.62 107.12 19.03 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.942 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -68.42 123.36 20.58 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -71.98 96.88 1.77 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 170.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -63.84 -33.37 75.53 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.465 0.706 . . . . 0.0 109.954 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.9 137.85 33.24 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.312 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.16 105.53 1.98 Allowed 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.161 1.907 . . . . 0.0 110.844 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 21.1 mt -91.03 108.14 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.525 0.678 . . . . 0.0 110.566 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -74.64 139.88 74.6 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.968 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.548 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 63.6 Cg_endo -86.7 170.31 7.62 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 122.728 2.285 . . . . 0.0 112.367 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -87.68 -28.14 22.0 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.711 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -144.31 165.91 26.56 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.483 0.713 . . . . 0.0 110.479 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.0 134.2 44.57 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.509 HG12 ' HD3' ' A' ' 10' ' ' PRO . 62.2 t -101.6 100.0 13.04 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.37 176.5 5.58 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.225 2.616 . . . . 0.0 112.308 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.37 -30.81 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.622 0.769 . . . . 0.0 113.063 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.29 -21.23 75.75 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.537 0.523 . . . . 0.0 113.393 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.88 159.06 31.67 Favored Glycine 0 C--N 1.345 1.042 0 C-N-CA 123.453 0.549 . . . . 0.0 112.506 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -115.07 154.49 28.78 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.971 0.908 . . . . 0.0 109.759 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -88.49 124.15 33.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.97 116.11 27.78 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 172.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.66 139.46 52.7 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.537 ' HB2' HG13 ' A' ' 5' ' ' VAL . 4.4 tm-20 . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.456 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 12.0 tpt . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 119.475 -0.298 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.4 m -40.42 -29.83 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 126.656 1.982 . . . . 0.0 115.861 -171.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -62.79 -13.06 28.73 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 5' ' ' VAL . 30.5 mm 67.38 -176.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 C-N-CA 124.168 0.987 . . . . 0.0 109.254 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.4 m -157.93 -41.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 125.498 1.519 . . . . 0.0 108.041 158.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.94 -161.32 18.97 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.178 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.52 155.9 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.879 0.872 . . . . 0.0 109.267 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -126.56 140.19 52.63 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.723 0.809 . . . . 0.0 109.706 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -141.94 142.84 26.21 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.65 0.78 . . . . 0.0 111.116 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HD3' HG12 ' A' ' 130' ' ' VAL . 74.9 Cg_endo -74.99 -12.81 21.54 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.943 2.429 . . . . 0.0 112.565 167.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.1 mm 69.2 123.46 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.815 1.646 . . . . 0.0 109.837 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.43 -7.07 18.05 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 122.894 2.396 . . . . 0.0 113.944 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HE3' ' HB3' ' A' ' 86' ' ' GLU . 67.9 mttm -134.62 170.88 15.13 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.448 1.099 . . . . 0.0 109.941 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -75.29 -5.05 42.65 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.597 0.759 . . . . 0.0 110.312 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -76.19 26.81 0.12 Allowed 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.007 0.923 . . . . 0.0 113.319 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -60.26 -32.96 71.65 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.827 0.851 . . . . 0.0 110.057 163.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.18 -21.32 66.75 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.837 0.855 . . . . 0.0 112.913 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 81' ' ' PHE . 37.4 mmt180 -57.43 -45.75 84.3 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.496 0.718 . . . . 0.0 110.796 176.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.526 ' HB3' HG11 ' A' ' 117' ' ' VAL . 65.8 m-85 -63.04 -31.11 72.18 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.664 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -91.48 -18.52 24.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.981 0.913 . . . . 0.0 111.111 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -72.96 -46.96 49.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.671 1.188 . . . . 0.0 109.84 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.8 ptpt -106.85 -15.87 14.61 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.226 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.76 -5.67 56.84 Favored Glycine 0 N--CA 1.48 1.588 0 N-CA-C 114.27 0.468 . . . . 0.0 114.27 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -161.68 107.83 1.34 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.31 1.044 . . . . 0.0 108.961 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.7 t70 -124.4 179.66 4.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.468 1.107 . . . . 0.0 109.675 -169.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 79' ' ' ARG . 55.3 t -128.87 109.67 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.44 0.696 . . . . 0.0 109.494 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.462 ' HD2' HD12 ' A' ' 112' ' ' ILE . 88.9 t80 -84.32 111.84 19.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m -89.93 139.45 17.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-O 121.526 0.679 . . . . 0.0 110.208 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.646 ' HG2' HG22 ' A' ' 33' ' ' VAL . 1.5 tpmt? -135.37 127.71 17.94 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.813 1.245 . . . . 0.0 108.507 -174.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 63.1 Cg_endo -73.14 60.37 3.86 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.643 2.229 . . . . 0.0 112.725 172.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.93 21.83 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.215 1.406 . . . . 0.0 114.509 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -64.69 -43.03 94.82 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.641 0.776 . . . . 0.0 111.045 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.646 HG22 ' HG2' ' A' ' 29' ' ' LYS . 20.1 m -72.84 150.33 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.752 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -82.56 -174.17 5.04 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.593 0.757 . . . . 0.0 111.839 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -66.98 -9.27 36.95 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.905 1.282 . . . . 0.0 111.387 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -60.63 -24.82 65.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.883 0.873 . . . . 0.0 110.848 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.88 91.83 2.02 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.519 0.728 . . . . 0.0 110.344 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 154.42 47.9 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 123.099 0.559 . . . . 0.0 109.951 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.67 99.25 0.93 Allowed 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.822 2.348 . . . . 0.0 111.476 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.18 -15.77 0.67 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.518 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.46 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 25.0 mtm -76.65 -178.98 5.03 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 121.554 0.692 . . . . 0.0 112.223 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -106.3 160.08 15.63 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.091 0.956 . . . . 0.0 110.352 171.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -135.49 97.04 3.58 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 93.4 t -86.82 120.92 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.254 0.549 . . . . 0.0 110.003 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -82.44 102.6 11.41 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.49 0.716 . . . . 0.0 110.115 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -74.95 160.98 29.91 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.528 170.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 70.79 97.07 0.07 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.129 1.372 . . . . 0.0 111.185 174.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.466 ' HB3' ' H ' ' A' ' 52' ' ' THR . 22.7 t -93.68 36.07 1.11 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.488 0.715 . . . . 0.0 109.59 172.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 57.46 -83.86 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.908 1.283 . . . . 0.0 110.412 -170.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -143.39 77.21 1.55 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.986 0.914 . . . . 0.0 109.157 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -150.99 -66.88 0.19 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.798 0.839 . . . . 0.0 108.906 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.466 ' H ' ' HB3' ' A' ' 48' ' ' SER . 8.9 t -142.84 173.15 11.8 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.074 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.12 -37.57 87.27 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.623 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -127.89 124.72 38.12 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.39 0.676 . . . . 0.0 110.122 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.01 -33.34 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.395 0.678 . . . . 0.0 111.272 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.6 -160.48 23.84 Favored Glycine 0 C--N 1.345 1.078 0 C-N-CA 121.546 -0.359 . . . . 0.0 113.131 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 11.6 pt-20 -151.28 177.78 9.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.231 1.012 . . . . 0.0 109.263 175.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -162.49 -173.32 3.51 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.139 0.976 . . . . 0.0 109.573 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -128.01 125.99 40.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.373 0.669 . . . . 0.0 110.228 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.1 mt -74.16 130.31 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.926 1.29 . . . . 0.0 111.288 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 30.7 mmmt -129.8 -164.39 1.4 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.616 1.567 . . . . 0.0 108.017 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -40.95 114.03 0.44 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.818 1.247 . . . . 0.0 113.743 -163.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.9 m -85.42 107.75 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 53.3 t -88.96 109.33 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.0 mt -87.37 117.82 26.39 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.474 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.3 t -151.18 130.33 12.69 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.155 0.982 . . . . 0.0 108.671 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.81 -6.67 33.86 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -105.51 122.19 43.58 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 170.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.576 ' HG2' HD21 ' A' ' 87' ' ' LEU . 57.7 Cg_endo -70.85 -15.98 32.99 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.743 2.295 . . . . 0.0 112.647 172.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 36.1 mtm -79.31 -25.03 42.44 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.672 0.789 . . . . 0.0 110.167 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -57.63 -32.43 67.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.403 1.081 . . . . 0.0 110.752 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.69 -19.91 58.77 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.028 0.531 . . . . 0.0 111.722 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.551 ' HE2' HD22 ' A' ' 87' ' ' LEU . 26.1 m-85 -86.64 -34.2 19.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.837 0.455 . . . . 0.0 110.685 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.46 -28.34 56.5 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 120.39 0.138 . . . . 0.0 110.723 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.5 m -83.6 -43.55 15.53 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.223 0.609 . . . . 0.0 111.505 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.787 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 64.0 m-85 -115.19 -67.5 0.99 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.786 0.435 . . . . 0.0 110.123 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.25 -83.92 0.62 Allowed Glycine 0 C--N 1.353 1.521 0 O-C-N 123.601 0.563 . . . . 0.0 113.044 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.73 -22.57 64.32 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.685 0.794 . . . . 0.0 111.831 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.787 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 31.6 mmt180 -72.33 -40.55 67.36 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.845 0.458 . . . . 0.0 111.385 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.415 HG12 HD23 ' A' ' 82' ' ' LEU . 13.5 t -69.52 147.31 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.006 0.522 . . . . 0.0 110.856 -170.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.447 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 28.9 p90 -69.86 -17.85 63.4 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 1.8 pt? -137.09 167.61 21.21 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 85' ' ' ASP . 13.9 t -110.04 -179.53 3.82 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.15 -27.92 69.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.25 0.62 . . . . 0.0 111.35 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 83' ' ' THR . 10.5 m-20 -62.5 -47.09 85.49 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.573 0.749 . . . . 0.0 111.25 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.512 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 1.8 mp0 -68.48 -29.52 68.15 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.576 HD21 ' HG2' ' A' ' 69' ' ' PRO . 46.8 tp -68.91 -48.9 62.19 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.837 0.455 . . . . 0.0 110.837 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -68.63 -36.68 78.94 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.008 -172.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 8.7 pt-20 -66.6 -36.28 82.24 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.12 -47.33 74.51 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.869 0.868 . . . . 0.0 110.754 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 67.2 mtm -70.02 -36.9 75.42 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.158 0.583 . . . . 0.0 110.63 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -62.34 -43.0 99.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.04 0.536 . . . . 0.0 110.279 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 t -58.65 -29.75 66.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.913 0.885 . . . . 0.0 111.355 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -73.09 -54.17 9.19 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -80.94 -5.97 58.12 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -169.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -106.09 -26.74 11.49 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.294 0.497 . . . . 0.0 111.539 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -101.32 -80.65 0.49 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.424 0.29 . . . . 0.0 110.814 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -101.56 -77.32 1.25 Allowed Glycine 0 C--N 1.348 1.194 0 N-CA-C 113.773 0.269 . . . . 0.0 113.773 -169.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -81.68 80.59 7.98 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 122.108 0.956 . . . . 0.0 110.654 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.631 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 41.7 mtm180 -92.91 165.26 12.98 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.919 -175.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 68.51 91.65 0.09 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.856 1.262 . . . . 0.0 111.813 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -168.23 106.36 0.49 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.4 m -148.81 -32.98 0.22 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -172.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -66.25 -55.98 13.49 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.427 0.691 . . . . 0.0 110.055 -175.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -102.74 157.25 17.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.934 -176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.482 ' HD2' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -111.44 -178.8 3.54 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.186 0.594 . . . . 0.0 110.233 -178.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 152.2 51.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.086 0.555 . . . . 0.0 109.738 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -71.64 127.23 31.88 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -116.68 159.12 22.7 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.404 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 14.7 ptm -142.47 130.58 22.0 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.282 0.633 . . . . 0.0 109.873 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -104.24 101.61 11.33 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.737 0.815 . . . . 0.0 109.198 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.462 HD12 ' HD2' ' A' ' 27' ' ' PHE . 27.9 mt -82.2 120.07 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -81.87 98.37 8.48 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.4 mm? -81.56 131.41 35.27 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 122.005 -0.434 . . . . 0.0 109.938 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.477 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 1.0 OUTLIER -138.47 159.79 41.2 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.183 0.593 . . . . 0.0 109.415 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.8 t70 53.58 48.33 21.91 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.364 1.065 . . . . 0.0 110.757 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 19' ' ' PHE . 27.2 t -71.62 101.89 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.206 -174.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.24 154.02 21.03 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.441 -174.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -107.08 138.55 43.04 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.531 0.732 . . . . 0.0 110.01 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -86.34 85.83 7.33 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 169.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.44 -39.23 82.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.072 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -81.66 148.48 61.91 Favored Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.275 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.77 114.94 4.06 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.679 2.253 . . . . 0.0 112.114 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.5 mt -114.5 131.49 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 145.91 30.4 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.24 1.016 . . . . 0.0 109.114 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -80.4 132.89 9.33 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.574 2.183 . . . . 0.0 111.659 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -66.58 -25.35 66.59 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.565 0.746 . . . . 0.0 110.662 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -146.25 166.87 24.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.144 0.978 . . . . 0.0 110.436 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -79.31 135.53 36.76 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.452 HG12 ' HD3' ' A' ' 10' ' ' PRO . 39.1 t -114.09 105.0 54.7 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.86 -174.31 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.168 2.578 . . . . 0.0 112.668 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.4 -34.84 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.889 0.875 . . . . 0.0 110.617 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.54 -24.2 75.23 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.24 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.76 167.42 42.0 Favored Glycine 0 C--N 1.346 1.1 0 C-N-CA 123.201 0.429 . . . . 0.0 112.94 175.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -118.44 151.84 37.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.082 0.953 . . . . 0.0 109.377 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -89.56 128.1 35.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tt -89.09 118.47 28.83 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -127.79 115.18 18.25 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.25 1.109 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -170.442 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.867 0.365 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -77.6 -12.88 60.01 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.047 0.939 . . . . 0.0 110.998 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -62.23 -24.12 67.06 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.668 0.787 . . . . 0.0 112.416 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.556 HG22 ' H ' ' A' ' 5' ' ' VAL . 23.1 mm 62.14 -164.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -172.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.556 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.3 m -148.64 -40.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 154.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.89 -161.68 20.79 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.342 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.59 149.27 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 6.2 t -121.86 134.47 54.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.524 0.73 . . . . 0.0 109.043 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -128.32 144.73 52.98 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.929 0.892 . . . . 0.0 109.217 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 42.1 Cg_exo -56.94 -31.13 88.63 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.132 2.555 . . . . 0.0 111.928 170.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.9 mm 68.45 131.79 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 125.675 1.59 . . . . 0.0 111.033 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.79 135.89 50.31 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.914 2.409 . . . . 0.0 112.078 172.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -66.16 -25.51 66.99 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.781 0.832 . . . . 0.0 112.737 -169.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -66.01 -37.31 85.57 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.302 0.641 . . . . 0.0 110.442 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.417 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 25.2 m-85 -114.88 13.33 17.1 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.542 -162.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.7 ttp -60.77 -41.51 95.65 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.022 0.529 . . . . 0.0 110.733 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.47 -18.81 51.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.903 0.881 . . . . 0.0 112.738 -173.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 15' ' ' PHE . 1.3 mmp_? -52.48 -48.48 65.88 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.354 0.662 . . . . 0.0 112.142 -173.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -66.22 -30.09 70.48 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.54 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -94.23 -12.11 28.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.872 0.869 . . . . 0.0 111.379 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -78.66 -52.16 8.82 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.745 0.818 . . . . 0.0 108.858 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -101.72 -16.83 16.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.282 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.67 10.31 63.71 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 114.11 0.404 . . . . 0.0 114.11 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -163.27 92.91 0.76 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.159 0.984 . . . . 0.0 109.049 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -127.3 -177.72 4.17 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.43 -168.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -141.7 117.97 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.062 0.945 . . . . 0.0 109.068 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -100.39 114.16 27.47 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.325 0.65 . . . . 0.0 109.446 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -92.99 141.11 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.264 0.554 . . . . 0.0 111.175 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.88 125.33 20.21 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 125.25 1.42 . . . . 0.0 110.466 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.53 71.26 6.02 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.934 2.423 . . . . 0.0 112.411 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 54.34 23.93 4.74 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.064 1.346 . . . . 0.0 113.35 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -73.2 -49.12 29.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.376 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 m -74.14 149.21 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.592 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -73.39 179.25 4.08 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.367 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.11 -7.77 25.72 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.325 1.05 . . . . 0.0 112.85 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.76 -25.44 66.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.461 0.704 . . . . 0.0 111.007 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.22 93.17 0.13 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.644 0.777 . . . . 0.0 111.03 175.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.46 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -113.24 149.24 41.14 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.24 99.56 1.03 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.535 2.156 . . . . 0.0 111.184 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.9 -2.17 0.73 Allowed Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.955 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.46 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 29.5 mtm -83.2 -170.49 3.07 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.501 0.667 . . . . 0.0 111.607 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.3 ptpt -115.55 162.49 17.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.527 1.131 . . . . 0.0 110.338 171.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.526 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.14 101.05 4.73 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 58.9 t -83.83 119.5 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.532 0.682 . . . . 0.0 109.371 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -85.89 113.46 22.04 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 88.4 t80 -72.16 145.99 47.7 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 171.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' A' ' 49' ' ' HIS . 59.8 tt0 -66.51 107.2 1.99 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.517 0.727 . . . . 0.0 110.317 -175.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.9 t -74.16 75.16 1.78 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.85 0.833 . . . . 0.0 109.778 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.427 ' HB2' ' HG2' ' A' ' 47' ' ' GLN . 9.1 m80 -175.04 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.687 1.995 . . . . 0.0 108.066 -170.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 61.07 29.57 19.01 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 124.256 1.022 . . . . 0.0 110.99 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -69.79 -51.6 32.42 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.231 1.012 . . . . 0.0 110.118 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.4 t -139.95 -37.77 0.47 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.561 0.744 . . . . 0.0 110.786 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.91 134.12 4.23 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-O 119.699 -0.5 . . . . 0.0 112.077 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 27.5 m-85 64.53 139.35 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.567 1.547 . . . . 0.0 113.556 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 p -125.71 -31.66 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.026 0.93 . . . . 0.0 110.209 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.93 -167.51 35.53 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.154 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 13.6 pt-20 -146.62 177.64 8.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.875 0.87 . . . . 0.0 109.308 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.453 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.45 -172.4 3.54 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.362 1.065 . . . . 0.0 109.348 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 86.0 mmt-85 -123.58 118.81 28.17 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.679 0.792 . . . . 0.0 109.775 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' ' 43' ' ' PHE . 51.0 mt -69.99 129.27 34.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 O-C-N 124.449 1.093 . . . . 0.0 109.595 174.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 14.7 mmmm -134.41 -172.54 3.04 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 125.553 1.541 . . . . 0.0 108.671 -175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -32.29 110.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.884 1.674 . . . . 0.0 114.371 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.7 m -90.27 117.61 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 68.5 t -90.39 108.8 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.9 mt -86.44 118.97 26.21 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.0 t -152.65 134.27 14.57 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.865 0.866 . . . . 0.0 109.817 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.518 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 58.0 mt-10 -68.98 -11.86 61.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 122.868 0.467 . . . . 0.0 111.495 174.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.579 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 10.1 m-80 -103.23 117.33 60.53 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.488 ' HG2' HD21 ' A' ' 87' ' ' LEU . 59.3 Cg_endo -73.96 -10.24 22.83 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.262 1.975 . . . . 0.0 112.817 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -78.78 -25.12 44.35 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.328 0.651 . . . . 0.0 111.027 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.579 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 75.5 mt-30 -68.68 -21.9 64.4 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.678 176.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -75.44 -23.63 56.94 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.877 0.471 . . . . 0.0 110.801 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.556 ' HE2' HD22 ' A' ' 87' ' ' LEU . 31.2 m-85 -85.25 -32.4 22.6 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.489 0.316 . . . . 0.0 111.707 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.7 pt-20 -75.15 -30.85 60.88 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 120.523 0.202 . . . . 0.0 110.726 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -79.17 -58.36 3.26 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.212 0.605 . . . . 0.0 110.655 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.785 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 61.8 m-85 -101.61 -67.63 0.86 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.579 0.752 . . . . 0.0 110.156 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.7 -84.66 0.77 Allowed Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.83 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.64 -46.55 86.89 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.422 0.689 . . . . 0.0 110.38 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.785 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 29.8 mmt180 -62.43 -30.22 71.07 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 124.066 0.854 . . . . 0.0 111.76 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.489 HG12 HD23 ' A' ' 82' ' ' LEU . 30.8 t -68.15 136.0 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -56.98 -28.51 62.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.583 0.753 . . . . 0.0 112.748 -171.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.489 HD23 HG12 ' A' ' 80' ' ' VAL . 1.8 pt? -123.53 155.28 37.86 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.621 0.768 . . . . 0.0 109.197 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.557 HG22 ' HG2' ' A' ' 86' ' ' GLU . 15.1 t -91.49 176.92 6.38 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.4 -34.41 77.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.673 0.389 . . . . 0.0 111.514 -177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -61.44 -44.72 96.62 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.405 0.682 . . . . 0.0 110.767 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HG2' HG22 ' A' ' 83' ' ' THR . 63.8 mm-40 -66.1 -35.44 80.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.357 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.556 HD22 ' HE2' ' A' ' 73' ' ' PHE . 29.1 tp -68.2 -47.95 66.51 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -35.45 78.73 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.21 -31.74 67.97 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 123.162 0.289 . . . . 0.0 110.917 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -66.36 -44.85 82.07 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.77 0.828 . . . . 0.0 110.934 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.3 mtm -76.82 -34.34 57.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.116 0.567 . . . . 0.0 110.454 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -64.38 -35.34 80.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.18 0.592 . . . . 0.0 110.42 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.0 t -56.65 -44.87 81.73 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.688 0.618 . . . . 0.0 110.549 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -66.17 -27.98 68.43 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.779 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.5 -22.32 14.55 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -84.56 -32.72 23.67 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 120.698 0.285 . . . . 0.0 110.587 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.82 -7.1 59.33 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.63 0.372 . . . . 0.0 111.393 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.2 -95.23 0.12 Allowed Glycine 0 C--N 1.345 1.041 0 O-C-N 123.138 0.274 . . . . 0.0 112.58 168.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 56.78 79.81 0.17 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.084 1.354 . . . . 0.0 111.685 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -73.03 -28.72 62.51 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.312 0.645 . . . . 0.0 111.499 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -78.31 132.44 37.45 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -65.38 -29.05 69.73 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.605 0.762 . . . . 0.0 111.797 -168.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m 61.65 49.8 4.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.562 1.145 . . . . 0.0 110.536 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -63.21 -33.37 75.34 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.529 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -96.06 157.72 15.77 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -87.81 -165.69 1.38 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.226 1.01 . . . . 0.0 109.834 -177.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.2 tpmt? -134.77 144.71 47.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.7 0.4 . . . . 0.0 109.966 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.66 113.26 15.33 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -96.9 153.55 17.83 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.5 ptm -132.61 130.05 39.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.277 0.631 . . . . 0.0 109.62 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -98.13 102.45 14.2 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.631 0.772 . . . . 0.0 109.123 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.444 ' HA ' HG12 ' A' ' 63' ' ' VAL . 51.4 mt -78.95 121.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -78.9 133.15 36.96 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.216 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.5 mm? -122.01 119.23 30.84 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.351 0.66 . . . . 0.0 109.757 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -125.29 175.89 7.14 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.571 0.748 . . . . 0.0 109.427 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 t70 54.52 36.0 24.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.002 0.921 . . . . 0.0 111.03 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.3 t -65.54 111.07 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.523 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.86 112.92 24.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.111 0.965 . . . . 0.0 110.988 -172.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -67.18 139.34 57.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.813 0.845 . . . . 0.0 111.498 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -82.68 113.72 20.55 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.686 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.9 -28.85 61.75 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.433 0.693 . . . . 0.0 110.018 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -105.69 146.37 32.7 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.522 1.129 . . . . 0.0 110.156 -175.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.42 99.56 1.31 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.727 2.285 . . . . 0.0 111.428 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.4 mt -85.09 123.71 39.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.512 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -75.73 126.85 86.72 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.958 0.903 . . . . 0.0 109.973 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.79 130.13 22.55 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.097 1.865 . . . . 0.0 111.454 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 11.7 mptt -75.44 -23.5 56.93 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.593 0.757 . . . . 0.0 110.429 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 135' ' ' GLN . 20.3 ptt-85 -149.9 158.73 44.45 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.859 0.864 . . . . 0.0 108.812 171.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.77 142.23 58.26 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.534 0.733 . . . . 0.0 110.935 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.7 96.82 45.29 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 123.268 0.627 . . . . 0.0 109.728 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.49 173.18 9.2 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.049 2.5 . . . . 0.0 112.523 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.37 -19.99 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.634 0.773 . . . . 0.0 112.705 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.46 -18.84 79.53 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.447 0.467 . . . . 0.0 113.328 173.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.06 150.47 9.47 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.48 0.562 . . . . 0.0 112.696 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.413 ' HB3' ' NH2' ' A' ' 128' ' ' ARG . 31.2 mm-40 -109.39 132.65 53.93 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.723 0.809 . . . . 0.0 110.753 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -74.55 101.89 4.34 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.704 0.402 . . . . 0.0 110.326 172.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.76 118.25 13.31 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.402 ' H ' ' HD2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -122.6 127.33 49.27 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.563 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m -71.68 -8.53 54.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.738 0.815 . . . . 0.0 112.897 -174.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -64.21 -26.09 68.36 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.515 0.326 . . . . 0.0 111.638 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 5' ' ' VAL . 25.1 mm 63.04 -172.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 C-N-CA 124.296 1.039 . . . . 0.0 109.226 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.475 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.6 m -148.54 -45.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 156.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -168.14 -161.49 18.06 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.938 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.421 HG12 HD11 ' A' ' 60' ' ' ILE . 8.7 p -122.93 144.99 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 171.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -117.72 132.13 56.51 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.17 0.588 . . . . 0.0 109.681 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.443 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . 13.0 m-85 -131.92 142.24 44.45 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 124.09 0.956 . . . . 0.0 109.462 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.526 ' HD3' HG12 ' A' ' 130' ' ' VAL . 61.2 Cg_endo -70.52 -18.86 33.14 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.662 2.241 . . . . 0.0 112.621 175.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 mm 47.82 69.86 2.44 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.605 1.162 . . . . 0.0 109.231 -168.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD3' ' HG2' ' A' ' 10' ' ' PRO . 47.3 Cg_endo -83.54 52.97 4.01 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.334 2.689 . . . . 0.0 110.833 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -148.19 166.45 27.88 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.853 -171.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -59.45 -26.11 64.94 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.238 1.015 . . . . 0.0 111.792 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -84.53 14.62 4.38 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.458 1.103 . . . . 0.0 113.041 -168.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -57.79 -35.37 70.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.321 1.049 . . . . 0.0 111.664 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.97 -23.93 61.51 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -53.78 -51.7 62.59 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.026 0.93 . . . . 0.0 113.18 -172.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -61.58 -30.04 70.42 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.866 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -96.96 -14.17 21.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.035 0.934 . . . . 0.0 110.936 -175.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -78.41 -58.78 3.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.252 1.021 . . . . 0.0 109.453 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 24' ' ' LYS . 13.7 ptpt -93.49 -18.0 22.79 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.496 -171.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.04 -12.77 16.75 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 114.103 0.401 . . . . 0.0 114.103 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' H ' ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -147.6 90.95 1.9 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.826 0.85 . . . . 0.0 110.413 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.56 176.41 5.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.639 -174.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.9 t -132.65 110.02 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.954 0.902 . . . . 0.0 108.578 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.86 111.47 22.51 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.711 0.804 . . . . 0.0 110.066 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.7 m -96.05 141.78 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.216 0.606 . . . . 0.0 111.579 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -134.69 144.73 51.96 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.698 1.199 . . . . 0.0 110.533 171.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.75 51.51 3.62 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 123.441 2.761 . . . . 0.0 111.833 169.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 54.26 78.22 0.17 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.74 1.216 . . . . 0.0 111.681 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.2 m -101.77 -47.92 4.46 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.375 0.67 . . . . 0.0 109.869 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 m -81.42 150.17 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.474 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 76.8 m95 -79.7 -163.16 0.49 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.294 1.038 . . . . 0.0 112.385 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -69.6 -14.79 63.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.342 1.057 . . . . 0.0 112.738 -171.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.46 -24.67 67.23 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.403 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -66.01 111.54 3.4 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.09 152.7 70.47 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.743 0.817 . . . . 0.0 109.573 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.2 99.25 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.789 2.326 . . . . 0.0 111.424 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.3 -15.76 0.58 Allowed Glycine 0 N--CA 1.467 0.747 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.577 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.545 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 73.5 mtp -74.62 176.86 6.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.004 0.922 . . . . 0.0 111.804 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -102.67 164.34 11.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.549 0.74 . . . . 0.0 110.285 169.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.443 ' HE1' ' HB2' ' A' ' 9' ' ' TYR . 0.4 OUTLIER -136.7 100.16 4.25 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 175.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.3 t -88.79 120.97 38.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -89.59 107.62 19.19 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.918 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -78.28 169.79 17.69 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.398 1.079 . . . . 0.0 109.831 173.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 70.98 95.53 0.07 Allowed 'General case' 0 C--N 1.356 0.863 0 C-N-CA 125.443 1.497 . . . . 0.0 108.881 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.0 p -52.51 -34.44 49.66 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.823 1.249 . . . . 0.0 111.867 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 169.94 -37.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.904 2.082 . . . . 0.0 107.15 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -136.14 -53.12 0.74 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.011 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -94.14 165.65 12.51 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.161 0.584 . . . . 0.0 111.63 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -64.25 118.99 9.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.721 1.208 . . . . 0.0 111.312 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.95 161.31 10.69 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -83.1 129.64 35.04 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.226 1.013 . . . . 0.0 109.782 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.09 -35.41 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.104 0.561 . . . . 0.0 109.972 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.97 -161.71 25.65 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.875 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -153.56 177.96 10.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.772 0.829 . . . . 0.0 109.08 170.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.496 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -158.81 -173.48 4.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.651 0.78 . . . . 0.0 109.727 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -125.14 120.81 32.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.421 0.688 . . . . 0.0 110.37 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.432 HG13 ' HB2' ' A' ' 43' ' ' PHE . 56.5 mt -69.07 135.65 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.843 1.257 . . . . 0.0 111.587 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -135.31 -176.47 4.28 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 126.293 1.837 . . . . 0.0 108.527 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -44.9 123.15 3.62 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.803 1.241 . . . . 0.0 113.74 -164.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 112' ' ' ILE . 33.9 m -92.67 118.64 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.244 -176.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 73.1 t -89.28 109.56 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.97 117.66 30.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.394 0.678 . . . . 0.0 109.343 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -152.11 134.74 15.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.784 0.834 . . . . 0.0 109.597 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 66.9 mt-10 -69.57 -16.29 63.38 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.312 0.645 . . . . 0.0 111.626 176.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 53.9 m-20 -95.34 119.27 65.74 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 36.5 Cg_endo -66.94 -20.99 50.66 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.145 1.897 . . . . 0.0 112.483 173.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.476 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.2 mpp? -73.83 -22.61 59.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.824 0.45 . . . . 0.0 110.875 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.409 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 78.6 mm-40 -57.16 -33.84 67.83 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.953 0.783 . . . . 0.0 111.62 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -78.26 -27.54 47.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 122.857 0.463 . . . . 0.0 111.164 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.443 ' HE2' HD22 ' A' ' 87' ' ' LEU . 71.4 m-85 -86.24 -23.14 26.52 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.987 0.515 . . . . 0.0 111.33 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.16 -27.27 19.7 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.438 0.295 . . . . 0.0 110.935 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.7 m -82.55 -58.03 3.09 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.212 0.53 . . . . 0.0 110.055 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.773 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 69.3 m-85 -96.49 -68.96 0.77 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.521 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.28 -80.72 0.73 Allowed Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.631 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.11 -23.5 64.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.096 0.958 . . . . 0.0 111.351 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.773 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 21.2 mmt85 -81.51 -32.46 32.37 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 122.958 0.503 . . . . 0.0 111.217 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 HD23 ' A' ' 82' ' ' LEU . 20.4 t -68.56 146.33 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -63.64 -27.22 69.08 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.466 ' H ' HD23 ' A' ' 82' ' ' LEU . 2.5 pt? -122.79 176.58 5.89 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.658 0.383 . . . . 0.0 110.267 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.54 HG22 ' HG2' ' A' ' 86' ' ' GLU . 12.6 t -108.33 172.48 6.82 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -68.13 -25.94 65.54 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.02 0.528 . . . . 0.0 111.222 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -68.77 -41.25 79.06 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.335 0.654 . . . . 0.0 109.893 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.54 ' HG2' HG22 ' A' ' 83' ' ' THR . 22.6 mm-40 -66.78 -35.22 79.58 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.162 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.443 HD22 ' HE2' ' A' ' 73' ' ' PHE . 32.1 tp -60.79 -54.26 47.33 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.882 0.873 . . . . 0.0 111.527 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -60.61 -43.36 97.54 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 123.494 0.496 . . . . 0.0 111.193 -172.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.37 -29.51 53.35 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.214 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -62.19 -43.78 98.06 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.453 0.701 . . . . 0.0 110.806 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.3 mtm -68.15 -36.93 80.44 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.356 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.7 mmpt? -69.08 -28.54 66.6 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.119 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.482 ' HA ' ' HG2' ' A' ' 96' ' ' ARG . 73.7 m -72.13 -36.86 69.51 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.305 0.642 . . . . 0.0 110.589 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -64.88 -38.45 91.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.923 0.489 . . . . 0.0 111.614 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -86.16 -17.19 35.59 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.482 ' HG2' ' HA ' ' A' ' 93' ' ' SER . 5.3 ptp180 -96.03 -22.74 17.18 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.395 0.543 . . . . 0.0 111.741 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -110.85 -33.96 6.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.608 0.363 . . . . 0.0 111.963 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -124.9 -97.98 1.18 Allowed Glycine 0 N--CA 1.471 1.0 0 C-N-CA 121.763 -0.256 . . . . 0.0 113.349 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -78.44 76.84 4.94 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.555 1.142 . . . . 0.0 111.404 -170.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -72.56 134.98 45.48 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.429 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.475 ' HG2' ' H ' ' A' ' 102' ' ' GLU . 53.1 ttt180 68.37 -179.65 0.23 Allowed 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 124.202 1.001 . . . . 0.0 111.106 169.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.475 ' H ' ' HG2' ' A' ' 101' ' ' ARG . 3.7 mp0 57.63 29.73 17.71 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.371 1.069 . . . . 0.0 111.722 -174.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.9 m -106.63 77.65 1.21 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.807 0.843 . . . . 0.0 109.567 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -122.22 -65.36 1.12 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.058 0.543 . . . . 0.0 110.031 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -73.24 147.4 44.66 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.065 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -69.7 179.0 2.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.462 0.705 . . . . 0.0 111.762 -176.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.624 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -138.3 147.95 44.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.074 172.001 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.43 104.9 4.58 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -85.05 156.07 21.25 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.8 ptm -140.94 131.44 25.35 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.534 0.733 . . . . 0.0 109.494 -174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -111.25 102.32 10.74 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.447 0.699 . . . . 0.0 109.919 -176.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.463 ' HA ' HG12 ' A' ' 63' ' ' VAL . 27.8 mt -82.07 122.82 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.18 131.1 35.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -118.11 113.54 21.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.103 0.961 . . . . 0.0 109.446 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -114.83 176.09 5.21 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.2 t70 53.95 46.39 25.71 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.135 0.897 . . . . 0.0 111.016 170.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.7 t -74.38 106.59 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.959 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.457 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 1.7 tpmt? -83.66 155.52 23.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.671 1.188 . . . . 0.0 110.735 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -116.68 123.65 47.77 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.904 0.881 . . . . 0.0 109.103 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -74.11 98.42 3.12 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.54 -35.04 78.18 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.916 0.886 . . . . 0.0 109.812 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.4 ' HG3' HG13 ' A' ' 124' ' ' ILE . 15.9 ptpt -91.03 138.07 26.2 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.289 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -83.63 77.0 3.55 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.271 2.648 . . . . 0.0 112.466 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.4 HG13 ' HG3' ' A' ' 122' ' ' LYS . 72.6 mt -84.7 131.65 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -100.28 157.58 33.56 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.02 177.41 7.8 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.209 1.939 . . . . 0.0 111.761 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -94.98 2.6 55.38 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.457 0.703 . . . . 0.0 110.278 178.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -163.43 179.95 6.95 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.941 1.296 . . . . 0.0 109.274 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.79 130.39 35.04 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.526 HG12 ' HD3' ' A' ' 10' ' ' PRO . 39.8 t -104.79 96.39 10.53 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.5 -176.67 2.35 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.02 2.48 . . . . 0.0 112.887 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.46 -35.08 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.25 1.02 . . . . 0.0 111.292 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.77 -24.24 72.71 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.59 -0.732 . . . . 0.0 113.097 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.61 165.07 37.72 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 123.344 0.497 . . . . 0.0 113.002 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -118.37 143.75 46.41 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.694 0.797 . . . . 0.0 109.613 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.474 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 0.7 OUTLIER -79.67 112.89 17.38 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 167.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.7 121.43 26.38 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 145.09 51.88 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.998 0.519 . . . . 0.0 109.988 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.244 0.807 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.512 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -64.74 -7.43 10.89 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.375 1.07 . . . . 0.0 113.272 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 139' ' ' GLU . 22.2 ptmt -58.89 -23.03 60.59 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.03 0.932 . . . . 0.0 113.331 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 5' ' ' VAL . 30.7 mm 67.85 -179.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 C-N-CA 124.157 0.983 . . . . 0.0 109.61 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 139' ' ' GLU . 1.2 m -149.18 -34.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.758 1.223 . . . . 0.0 109.186 161.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.466 ' HA2' ' HE3' ' A' ' 41' ' ' MET . . . -171.35 -164.0 26.29 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-O 121.433 0.463 . . . . 0.0 112.787 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.91 161.17 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 t -134.5 133.2 40.09 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 122.979 0.512 . . . . 0.0 109.704 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.43 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . 7.2 m-85 -134.76 140.52 35.55 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.06 0.944 . . . . 0.0 110.132 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HD3' HG12 ' A' ' 130' ' ' VAL . 93.7 Cg_endo -76.5 -14.9 17.82 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.911 2.408 . . . . 0.0 112.431 172.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 mm 64.59 115.3 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 125.609 1.564 . . . . 0.0 109.559 -172.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -66.77 -14.9 45.63 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.095 2.53 . . . . 0.0 114.085 -168.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -132.61 -175.24 3.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.812 0.845 . . . . 0.0 110.267 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -69.33 2.99 2.5 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 124.184 0.993 . . . . 0.0 112.541 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.51 7.39 2.39 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -66.94 -34.04 76.9 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 119.024 0.829 . . . . 0.0 109.383 170.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.53 -30.04 70.38 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.595 1.158 . . . . 0.0 111.811 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 37.3 mmt180 -51.71 -47.35 64.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.423 1.089 . . . . 0.0 111.682 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.412 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 65.0 m-85 -66.43 -30.62 71.02 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.692 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.68 -20.17 25.22 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.573 0.749 . . . . 0.0 110.63 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -76.02 -56.92 4.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.392 1.077 . . . . 0.0 110.201 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.9 ptpt -96.06 -18.19 20.37 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.741 -171.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.79 -28.64 2.13 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -125.11 96.02 4.7 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 124.436 1.094 . . . . 0.0 108.259 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 13.9 t70 -110.36 176.31 5.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.195 0.598 . . . . 0.0 110.076 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.5 t -136.24 111.71 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.998 0.919 . . . . 0.0 109.114 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.483 ' HD2' HD12 ' A' ' 112' ' ' ILE . 88.3 t80 -84.7 109.07 17.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.479 0.711 . . . . 0.0 110.311 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.88 138.08 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.607 0.718 . . . . 0.0 110.531 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HE2' ' HD2' ' A' ' 30' ' ' PRO . 1.6 tpmt? -136.38 134.64 20.0 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.798 1.239 . . . . 0.0 108.461 -176.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 56.9 Cg_endo -72.86 57.0 3.07 Favored 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 122.745 2.297 . . . . 0.0 113.127 170.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.58 28.44 3.45 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 125.491 1.516 . . . . 0.0 114.005 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.45 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 5.3 m -69.66 -30.26 67.9 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.37 0.668 . . . . 0.0 110.518 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.631 HG11 HD23 ' A' ' 37' ' ' LEU . 21.9 t -85.82 149.02 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -78.14 -173.53 3.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.13 0.972 . . . . 0.0 111.811 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 7.6 tmtt? -71.59 -14.53 62.1 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 123.861 0.865 . . . . 0.0 110.188 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -51.43 -32.32 26.23 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.609 0.764 . . . . 0.0 111.245 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.631 HD23 HG11 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -69.48 102.26 1.76 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 123.568 0.747 . . . . 0.0 110.547 178.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -125.47 151.93 70.88 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.244 0.618 . . . . 0.0 109.987 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.5 99.21 0.7 Allowed 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.857 2.371 . . . . 0.0 111.611 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.77 2.69 0.88 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.497 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.489 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 29.1 mtm -92.77 -172.72 3.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.06 0.544 . . . . 0.0 111.157 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -109.99 160.01 16.79 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.906 0.882 . . . . 0.0 110.531 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.465 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.04 99.83 4.39 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.2 t -87.7 125.36 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.398 0.618 . . . . 0.0 109.931 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -91.01 114.24 26.72 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.753 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.417 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 37.6 t80 -74.24 145.74 43.83 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 171.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -84.89 70.4 10.87 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.867 0.467 . . . . 0.0 110.363 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 81.0 p 42.09 -81.7 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.361 1.864 . . . . 0.0 113.959 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -154.17 88.73 1.25 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.519 1.128 . . . . 0.0 109.819 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -164.02 170.85 16.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.224 0.61 . . . . 0.0 110.421 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.92 -48.26 82.63 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.413 1.085 . . . . 0.0 111.687 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 p -70.02 102.32 2.0 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.054 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.767 ' HA3' ' HD3' ' A' ' 126' ' ' PRO . . . -62.35 -47.96 85.78 Favored Glycine 0 C--O 1.216 -1.022 0 CA-C-N 114.764 -1.107 . . . . 0.0 114.024 -170.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -97.89 129.47 44.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 117.171 0.486 . . . . 0.0 110.848 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.14 -32.26 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 168.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . -172.86 -167.22 32.5 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.143 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 16.0 pt-20 -158.47 178.28 10.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.612 0.765 . . . . 0.0 109.246 172.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.483 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -161.19 -173.8 4.03 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.069 0.548 . . . . 0.0 110.646 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -120.85 120.03 34.36 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.305 1.042 . . . . 0.0 109.996 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 43' ' ' PHE . 53.8 mt -70.62 138.43 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.569 1.148 . . . . 0.0 111.271 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -140.79 -166.73 2.21 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.907 2.083 . . . . 0.0 107.797 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -35.07 122.11 0.56 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.174 1.39 . . . . 0.0 114.524 -164.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.9 m -105.05 105.78 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 121.854 0.835 . . . . 0.0 109.52 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -91.75 114.56 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.593 0.757 . . . . 0.0 110.056 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.547 ' HB3' HD11 ' A' ' 108' ' ' LEU . 36.9 mt -96.41 117.95 31.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.651 0.78 . . . . 0.0 109.544 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.1 t -151.07 139.56 20.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.495 0.718 . . . . 0.0 110.354 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 24.1 mt-10 -66.76 -24.06 66.16 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.388 1.075 . . . . 0.0 111.803 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.557 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 81.5 m-20 -97.59 120.62 60.22 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HG2' HD21 ' A' ' 87' ' ' LEU . 38.3 Cg_endo -66.03 -19.2 57.72 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.361 2.041 . . . . 0.0 112.055 171.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 56.9 mtm -71.81 -24.59 61.75 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.08 0.952 . . . . 0.0 111.012 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.557 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 16.3 mm100 -60.96 -26.33 67.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.596 0.758 . . . . 0.0 111.507 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -81.82 -25.29 35.3 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.117 0.567 . . . . 0.0 110.844 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 87' ' ' LEU . 97.2 m-85 -89.66 -14.49 34.74 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.39 0.676 . . . . 0.0 111.641 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.47 -30.4 17.34 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.294 0.238 . . . . 0.0 110.619 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.8 m -78.07 -59.84 2.62 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.89 0.376 . . . . 0.0 110.771 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.784 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 58.8 m-85 -99.65 -59.1 1.78 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.529 0.732 . . . . 0.0 110.021 -173.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.98 -88.17 0.14 Allowed Glycine 0 C--N 1.356 1.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.494 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -69.49 -21.04 63.72 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.617 0.767 . . . . 0.0 111.699 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.784 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 37.4 mmt180 -72.87 -36.79 67.45 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.349 0.405 . . . . 0.0 110.433 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.47 HG12 HD23 ' A' ' 82' ' ' LEU . 21.4 t -64.07 151.4 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 122.593 0.357 . . . . 0.0 110.345 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.465 ' HD2' ' HA ' ' A' ' 27' ' ' PHE . 41.3 p90 -66.36 -7.88 21.88 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -147.69 172.04 14.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.343 0.657 . . . . 0.0 109.632 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 86' ' ' GLU . 7.4 t -96.38 170.66 9.08 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -66.43 -26.63 67.31 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.36 0.264 . . . . 0.0 110.671 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 4.0 m-20 -60.24 -53.86 52.63 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' H ' HG23 ' A' ' 83' ' ' THR . 49.5 mm-40 -58.81 -33.0 69.86 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.561 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.501 HD21 ' HG2' ' A' ' 69' ' ' PRO . 28.5 tp -62.92 -58.22 8.1 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.726 0.641 . . . . 0.0 111.037 174.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -62.64 -38.77 91.55 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.593 0.558 . . . . 0.0 111.917 -171.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 12.1 pt-20 -82.96 -21.92 33.9 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.301 0.64 . . . . 0.0 111.459 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 56.5 t80 -66.54 -47.05 74.08 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 168.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 69.1 mtm -67.69 -31.53 71.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.427 0.691 . . . . 0.0 110.595 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.4 mmpt? -60.71 -52.23 66.02 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.9 t -58.35 -33.01 69.09 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.618 0.767 . . . . 0.0 111.638 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 29.6 mm-40 -71.38 -44.53 64.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.042 0.537 . . . . 0.0 111.145 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.73 -23.68 31.51 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -96.51 -41.32 8.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.216 0.207 . . . . 0.0 111.008 -172.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -91.08 -48.74 6.79 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.66 0.384 . . . . 0.0 110.045 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -73.94 -78.95 0.55 Allowed Glycine 0 C--N 1.345 1.079 0 O-C-N 123.96 0.787 . . . . 0.0 111.762 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 55.91 89.63 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.011 1.324 . . . . 0.0 110.498 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -71.92 -28.9 63.78 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.278 0.631 . . . . 0.0 110.837 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.515 ' HG3' ' H ' ' A' ' 102' ' ' GLU . 14.3 ptt180 -165.99 -65.01 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.204 1.002 . . . . 0.0 110.033 172.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.515 ' H ' ' HG3' ' A' ' 101' ' ' ARG . 1.2 tm-20 179.0 147.86 0.2 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.9 p -144.38 98.77 3.26 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.866 0.467 . . . . 0.0 111.679 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -103.49 -42.43 5.69 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.441 0.696 . . . . 0.0 109.481 165.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -70.65 155.75 40.35 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.617 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -80.45 179.99 7.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.446 0.698 . . . . 0.0 109.996 175.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.612 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -134.13 152.65 51.93 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 169.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.7 tm? -76.19 121.35 22.76 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -106.81 159.72 16.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.232 1.013 . . . . 0.0 109.805 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.446 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 15.8 ptm -136.56 130.72 32.81 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.045 0.938 . . . . 0.0 110.045 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.07 102.06 11.07 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.685 0.794 . . . . 0.0 109.434 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.483 HD12 ' HD2' ' A' ' 27' ' ' PHE . 42.2 mt -85.0 121.08 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.75 133.38 35.34 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -117.76 133.3 56.08 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.207 1.003 . . . . 0.0 109.502 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.78 165.36 25.79 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.66 0.784 . . . . 0.0 110.062 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.2 t70 57.23 36.83 27.88 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.365 1.041 . . . . 0.0 110.846 168.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.2 t -63.24 109.56 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.718 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 165.31 23.42 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.031 1.333 . . . . 0.0 110.663 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -130.61 124.9 32.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.552 0.741 . . . . 0.0 110.238 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.415 ' H ' ' HA2' ' A' ' 56' ' ' GLY . 35.0 m-85 -88.29 82.48 7.05 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 168.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.56 -32.36 73.08 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.514 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -80.36 148.62 67.15 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.232 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.13 103.64 1.78 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.84 2.36 . . . . 0.0 112.672 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.7 mt -125.01 130.98 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.515 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -97.9 144.26 27.7 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.904 0.882 . . . . 0.0 108.912 178.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.767 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 86.8 Cg_endo -80.79 176.75 8.71 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.815 2.344 . . . . 0.0 112.932 -177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -64.15 -32.22 73.71 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.817 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -157.5 163.51 38.36 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 123.62 0.768 . . . . 0.0 109.88 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.27 135.11 54.98 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.997 0.919 . . . . 0.0 108.976 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.557 HG12 ' HD3' ' A' ' 10' ' ' PRO . 47.9 t -108.17 94.6 13.43 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 123.464 0.705 . . . . 0.0 109.616 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.97 -175.35 1.65 Allowed 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.069 2.513 . . . . 0.0 112.868 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.3 m -56.85 -31.19 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.46 1.104 . . . . 0.0 113.711 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.17 -14.86 81.8 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.386 0.429 . . . . 0.0 113.496 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.45 150.83 6.94 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 123.193 0.425 . . . . 0.0 112.923 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.488 ' HG2' ' HA ' ' A' ' 130' ' ' VAL . 31.3 mm-40 -108.81 165.36 11.62 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.575 0.75 . . . . 0.0 110.178 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.0 130.04 46.12 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.99 0.516 . . . . 0.0 109.691 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.75 124.09 38.59 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.57 148.14 46.63 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 5' ' ' VAL . 3.4 tm-20 . . . . . 0 C--O 1.252 1.207 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 173.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 2' ' ' SER . 8.2 tmm? . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.488 ' N ' ' SD ' ' A' ' 1' ' ' MET . 18.4 m -53.09 -22.17 5.75 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.917 1.687 . . . . 0.0 114.832 -171.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -62.48 -18.89 62.87 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 5' ' ' VAL . 29.1 mm 63.39 -172.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -174.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.6 m -151.09 -45.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 156.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.39 -160.87 18.61 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.168 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.98 139.79 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -107.82 132.31 53.55 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.518 0.727 . . . . 0.0 109.481 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -127.64 141.99 42.74 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.602 0.761 . . . . 0.0 110.485 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' HG12 ' A' ' 130' ' ' VAL . 95.9 Cg_endo -73.33 -19.81 21.83 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.167 2.578 . . . . 0.0 113.129 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mm 53.77 92.76 0.06 OUTLIER Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 125.258 1.423 . . . . 0.0 110.413 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.99 17.01 0.75 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.857 2.371 . . . . 0.0 113.291 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -124.72 153.33 42.53 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 110.24 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -11.84 61.15 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.596 1.158 . . . . 0.0 111.395 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -81.32 22.31 0.69 Allowed 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.486 1.114 . . . . 0.0 112.482 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.461 ' HG2' ' HE2' ' A' ' 20' ' ' PHE . 46.2 ttm -64.77 -41.14 96.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.971 0.908 . . . . 0.0 110.003 168.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.7 -19.23 65.64 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.979 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -47.64 -51.66 20.73 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.801 1.24 . . . . 0.0 112.682 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 49.7 m-85 -69.4 -30.76 68.8 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.451 -174.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.461 ' HE2' ' HG2' ' A' ' 16' ' ' MET . 54.7 m-85 -84.48 -24.68 29.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.714 0.806 . . . . 0.0 110.314 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -68.28 -49.09 62.9 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.92 1.288 . . . . 0.0 109.903 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -107.33 -16.55 14.36 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.545 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.46 -6.15 70.13 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 114.253 0.461 . . . . 0.0 114.253 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -157.81 111.69 2.55 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.881 0.873 . . . . 0.0 109.643 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.3 t70 -136.64 -171.54 2.94 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.42 124.73 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.261 1.391 . . . . 0.0 109.644 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -96.62 116.58 29.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.646 0.778 . . . . 0.0 109.322 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 m -89.35 146.86 5.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.494 0.664 . . . . 0.0 110.222 171.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.635 ' HG2' HG22 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -134.62 114.26 12.15 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.7 1.2 . . . . 0.0 109.047 -172.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.53 66.6 2.93 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.438 2.759 . . . . 0.0 113.478 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . 47.35 78.42 0.07 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.006 1.322 . . . . 0.0 113.454 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.438 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 37.8 m -125.49 -58.04 1.44 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.635 HG22 ' HG2' ' A' ' 29' ' ' LYS . 15.4 m -66.96 133.87 30.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.898 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -88.4 -157.58 0.43 Allowed 'General case' 0 CA--C 1.564 1.506 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.905 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -70.83 -1.77 12.73 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -166.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -67.48 -28.9 68.25 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.701 0.8 . . . . 0.0 110.419 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.571 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 1.1 mm? -66.55 119.59 11.96 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.538 0.735 . . . . 0.0 110.645 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 157.48 56.35 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.415 1.086 . . . . 0.0 109.255 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.92 88.84 0.9 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.381 2.054 . . . . 0.0 111.597 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.08 41.72 0.04 OUTLIER Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.042 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.571 ' SD ' ' HA ' ' A' ' 37' ' ' LEU . 87.1 mtp -118.94 -168.8 1.62 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.068 0.947 . . . . 0.0 109.391 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 15.2 ptpt -121.13 162.23 20.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.68 0.792 . . . . 0.0 110.276 168.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.456 ' HB2' HG13 ' A' ' 60' ' ' ILE . 17.5 t80 -134.77 97.1 3.68 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 94.1 t -83.12 119.65 32.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.39 0.614 . . . . 0.0 110.046 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -80.33 99.67 8.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.599 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.612 ' HA ' ' H ' ' A' ' 54' ' ' PHE . 67.0 t80 -75.83 163.15 27.53 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.697 169.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -136.11 102.96 5.17 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.4 p -92.03 54.35 2.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.763 0.825 . . . . 0.0 111.23 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -161.69 107.35 1.31 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 69.79 -68.8 0.18 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.269 1.428 . . . . 0.0 111.985 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.95 144.31 57.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.877 0.871 . . . . 0.0 109.766 172.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 p -56.91 -45.09 82.9 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.346 0.658 . . . . 0.0 111.989 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.46 -173.47 24.4 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.539 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.612 ' H ' ' HA ' ' A' ' 46' ' ' TYR . 3.2 m-30 56.62 66.88 1.08 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.174 0.99 . . . . 0.0 110.828 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.451 HG22 ' NZ ' ' A' ' 119' ' ' LYS . 10.0 p -87.62 -15.53 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.297 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.85 -171.15 41.76 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.297 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 7.9 pt-20 -147.56 178.86 8.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.833 0.853 . . . . 0.0 110.156 174.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.409 ' CB ' HD12 ' A' ' 114' ' ' LEU . . . -158.4 -171.11 3.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.718 1.207 . . . . 0.0 109.204 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 12.7 mmt85 -129.58 118.92 22.77 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.545 0.738 . . . . 0.0 110.709 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 41' ' ' MET . 54.4 mt -72.13 133.15 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.568 1.147 . . . . 0.0 111.421 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 31.0 mmmt -133.18 -177.11 4.37 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 126.166 1.786 . . . . 0.0 108.533 -176.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -28.42 113.87 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 126.275 1.83 . . . . 0.0 114.904 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 112' ' ' ILE . 35.2 m -95.44 117.45 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.659 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.6 t -90.18 108.65 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.534 ' HB3' HD11 ' A' ' 108' ' ' LEU . 69.3 mt -87.14 116.7 25.39 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.4 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 46.3 m -148.71 137.05 21.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.616 0.766 . . . . 0.0 109.986 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 18.8 mt-10 -66.5 -34.82 78.79 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.11 0.964 . . . . 0.0 112.068 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.646 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 73.9 m-20 -89.1 123.8 66.44 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.89 -21.23 64.39 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 122.354 2.036 . . . . 0.0 111.732 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 37.7 mtm -74.35 -19.02 60.6 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.09 0.956 . . . . 0.0 110.91 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.646 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 17.0 mm100 -60.42 -32.41 71.33 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.278 0.631 . . . . 0.0 110.695 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 66' ' ' SER . 5.4 m-85 -77.38 -27.29 52.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.681 -177.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.464 ' CE2' HD22 ' A' ' 87' ' ' LEU . 73.6 m-85 -91.11 -20.52 21.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.075 0.55 . . . . 0.0 111.94 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.17 -34.27 22.12 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.8 m -81.25 -59.68 2.55 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.999 0.52 . . . . 0.0 110.925 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.796 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 98.1 m-85 -93.19 -64.31 1.11 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.648 0.779 . . . . 0.0 110.207 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.25 -90.66 0.28 Allowed Glycine 0 C--N 1.352 1.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.375 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.29 -9.58 58.85 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.949 0.9 . . . . 0.0 111.808 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.796 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 28.0 mmt85 -78.21 -36.5 47.15 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.87 0.468 . . . . 0.0 110.262 170.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 82' ' ' LEU . 35.1 t -75.49 140.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.287 0.635 . . . . 0.0 110.741 -176.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -57.1 -20.63 26.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 1.8 pt? -134.0 170.15 16.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.9 t -108.11 -176.7 3.13 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 122.051 -0.405 . . . . 0.0 109.981 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.73 -25.37 67.27 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.244 0.618 . . . . 0.0 111.915 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.515 ' H ' HG23 ' A' ' 83' ' ' THR . 23.9 t70 -73.6 -36.42 65.52 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.32 0.648 . . . . 0.0 111.278 174.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 1.5 mp0 -74.51 -24.7 59.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.794 -0.566 . . . . 0.0 110.746 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD22 ' CE2' ' A' ' 73' ' ' PHE . 28.2 tp -67.57 -50.15 59.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.037 0.535 . . . . 0.0 109.691 175.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -40.45 96.11 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.465 0.478 . . . . 0.0 110.979 -175.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.476 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 8.6 pt-20 -64.86 -39.76 94.06 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -64.2 -49.46 71.91 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.987 0.915 . . . . 0.0 111.567 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 56.3 mtm -67.98 -44.89 75.61 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.402 0.681 . . . . 0.0 110.233 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -71.92 -26.25 62.22 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.883 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.471 ' HA ' ' HG2' ' A' ' 96' ' ' ARG . 43.4 m -62.73 -33.79 75.86 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.182 0.446 . . . . 0.0 110.802 174.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -68.23 -25.18 65.07 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.653 0.596 . . . . 0.0 111.413 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -113.27 -18.25 12.12 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -173.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' A' ' 93' ' ' SER . 13.1 ptm180 -91.85 -27.94 17.63 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 118.233 0.47 . . . . 0.0 110.283 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -102.24 2.23 36.84 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.372 0.669 . . . . 0.0 109.385 169.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -133.97 -134.49 3.45 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.58 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.4 mmt85 -107.99 115.85 30.88 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.013 0.525 . . . . 0.0 110.084 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.584 ' HA ' ' HB2' ' A' ' 95' ' ' GLU . 41.4 ttm180 -78.99 72.84 5.53 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.31 0.644 . . . . 0.0 110.608 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -177.53 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.624 1.57 . . . . 0.0 108.795 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -61.7 92.91 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.949 0.9 . . . . 0.0 109.362 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 t 63.58 -173.26 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.204 1.002 . . . . 0.0 110.783 -172.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -130.53 -49.7 1.07 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -78.68 162.82 25.93 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.657 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -58.51 161.82 4.25 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.765 0.826 . . . . 0.0 112.303 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.26 147.21 49.73 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -176.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 65' ' ' LEU . 0.4 OUTLIER -82.92 100.44 10.39 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -87.49 159.92 18.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.918 0.887 . . . . 0.0 109.646 171.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.584 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 20.8 ptm -140.18 137.51 34.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.741 0.416 . . . . 0.0 111.436 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.46 102.7 11.29 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.852 0.861 . . . . 0.0 109.949 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.456 ' HA ' HG12 ' A' ' 63' ' ' VAL . 42.6 mt -83.29 121.1 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.753 0.821 . . . . 0.0 109.021 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 39.8 tt0 -80.16 138.04 36.82 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.409 HD12 ' CB ' ' A' ' 58' ' ' ALA . 4.0 mm? -119.13 129.71 55.17 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.88 0.872 . . . . 0.0 109.837 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -128.99 173.14 10.69 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 51.43 54.58 10.83 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.1 0.952 . . . . 0.0 111.762 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.96 115.98 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.692 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER -102.27 152.58 20.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.202 1.001 . . . . 0.0 110.627 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.451 ' NZ ' HG22 ' A' ' 55' ' ' VAL . 26.0 mmmt -104.58 139.73 39.03 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.414 1.086 . . . . 0.0 109.309 170.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -91.1 72.41 6.33 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.46 -24.93 62.96 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.07 173.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.409 ' HG3' HG13 ' A' ' 124' ' ' ILE . 0.2 OUTLIER -79.78 146.05 63.61 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.744 170.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.59 90.25 0.5 Allowed 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.395 2.063 . . . . 0.0 112.811 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 122' ' ' LYS . 24.7 mt -107.7 119.75 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.35 142.53 24.69 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.549 0.74 . . . . 0.0 109.556 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.74 133.98 41.74 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.33 2.02 . . . . 0.0 111.4 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -71.87 -24.6 61.71 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.829 0.851 . . . . 0.0 110.466 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.433 HH21 ' HB3' ' A' ' 135' ' ' GLN . 13.0 ptt180 -156.02 174.73 14.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.477 1.111 . . . . 0.0 109.459 174.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.87 143.49 55.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.225 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.49 HG12 ' HD3' ' A' ' 10' ' ' PRO . 60.3 t -122.83 102.14 38.57 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.89 -175.94 2.59 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.944 2.429 . . . . 0.0 111.854 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.6 p -57.68 -30.75 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 124.293 1.037 . . . . 0.0 112.751 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.34 -15.55 81.12 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.831 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.79 159.85 19.03 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.137 0.398 . . . . 0.0 113.02 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.433 ' HB3' HH21 ' A' ' 128' ' ' ARG . 31.6 mm-40 -116.98 146.92 42.71 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.783 0.833 . . . . 0.0 109.716 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -80.69 118.19 22.03 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.34 122.36 30.2 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.428 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -134.84 133.41 39.73 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.244 0.779 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.378 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.4 ttm . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -68.62 -15.32 63.49 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.119 0.968 . . . . 0.0 112.803 -172.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -63.09 -23.33 67.39 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.027 0.531 . . . . 0.0 111.866 173.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 5' ' ' VAL . 21.4 mm 61.62 -163.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -171.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.582 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.8 m -149.47 -42.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 155.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.15 -162.12 21.88 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.101 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.56 149.44 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -117.21 132.52 56.62 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.354 0.662 . . . . 0.0 109.716 176.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -131.83 142.21 44.39 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.142 0.977 . . . . 0.0 109.598 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HD3' HG12 ' A' ' 130' ' ' VAL . 40.6 Cg_endo -66.7 -46.82 3.24 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.402 2.068 . . . . 0.0 111.73 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.3 mt 50.83 71.91 1.4 Allowed Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.218 1.007 . . . . 0.0 108.909 -167.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.29 39.32 0.83 Allowed 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.086 2.524 . . . . 0.0 112.415 -173.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -127.66 162.7 25.92 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.242 1.417 . . . . 0.0 109.116 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -67.62 -16.16 64.02 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.712 0.805 . . . . 0.0 112.392 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -73.76 0.02 14.3 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.107 0.963 . . . . 0.0 112.913 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -67.14 -18.87 65.48 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 117.908 0.322 . . . . 0.0 111.727 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.71 -31.12 72.2 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.243 1.017 . . . . 0.0 111.841 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 12.9 mmt85 -58.15 -38.55 76.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.567 1.147 . . . . 0.0 112.942 -167.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -70.98 -31.17 67.64 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.01 0.524 . . . . 0.0 110.195 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -93.24 -8.64 41.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.902 0.881 . . . . 0.0 110.237 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -85.6 -59.36 2.34 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 124.388 1.075 . . . . 0.0 110.032 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.4 ptpt -99.47 -15.52 18.67 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.196 -170.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.23 -39.54 2.78 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 113.579 0.192 . . . . 0.0 113.579 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -119.54 91.34 3.53 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.911 0.885 . . . . 0.0 109.291 173.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -99.43 175.05 5.99 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.943 0.897 . . . . 0.0 110.059 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.18 110.02 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.104 0.962 . . . . 0.0 108.981 175.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -88.77 118.23 28.31 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.444 0.698 . . . . 0.0 109.684 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.94 132.96 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 121.587 0.708 . . . . 0.0 111.117 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 5.1 mmpt? -120.0 138.7 27.27 Favored Pre-proline 0 C--O 1.215 -0.759 0 C-N-CA 125.376 1.471 . . . . 0.0 109.227 176.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.427 ' HD2' ' HE2' ' A' ' 29' ' ' LYS . 73.7 Cg_endo -77.24 46.78 2.06 Favored 'Trans proline' 0 CA--C 1.56 1.803 0 C-N-CA 122.481 2.121 . . . . 0.0 111.708 162.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.43 38.1 17.3 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.319 1.448 . . . . 0.0 112.61 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 m -64.28 -38.02 89.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.564 0.746 . . . . 0.0 110.225 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.8 149.88 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.908 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.566 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 90.6 m95 -72.2 -178.55 2.5 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.771 0.828 . . . . 0.0 111.667 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -79.2 10.71 3.35 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.34 0.656 . . . . 0.0 112.27 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -75.12 -20.88 59.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.892 0.877 . . . . 0.0 110.625 174.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.27 100.79 0.84 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.642 0.777 . . . . 0.0 110.32 -176.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 3.2 ptpp? -119.18 152.45 52.25 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.198 0.599 . . . . 0.0 109.755 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.57 97.69 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.65 2.233 . . . . 0.0 110.936 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.6 -4.73 0.33 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.203 -174.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.431 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 31.5 mtm -89.88 -171.27 3.1 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.436 0.694 . . . . 0.0 111.689 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 12.9 ptpt -112.6 162.15 16.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.227 1.011 . . . . 0.0 110.573 172.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.499 ' HB2' HG13 ' A' ' 60' ' ' ILE . 3.2 t80 -136.22 102.53 5.02 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 42.1 t -88.86 121.46 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.169 0.509 . . . . 0.0 110.287 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -86.11 126.51 34.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.258 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 52.5 t80 -103.04 122.79 45.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.411 1.084 . . . . 0.0 109.452 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -79.28 -65.47 0.99 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.056 0.455 . . . . 0.0 110.344 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.3 t -169.27 -178.0 3.03 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.454 -170.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -83.12 3.7 29.57 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.07 0.548 . . . . 0.0 111.43 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 32.6 tt0 -147.65 178.12 8.72 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.939 0.896 . . . . 0.0 109.345 -177.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.469 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 21.3 t70 77.95 -78.08 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.806 1.642 . . . . 0.0 110.549 174.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.2 t -126.05 -5.53 6.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.392 0.277 . . . . 0.0 111.489 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.22 -82.75 0.25 Allowed Glycine 0 C--N 1.353 1.511 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -176.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 25.7 m-85 -93.86 129.93 40.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.275 1.03 . . . . 0.0 108.899 168.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.45 -36.11 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 122.829 0.452 . . . . 0.0 111.055 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.45 -160.52 21.18 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.575 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 14.9 pt-20 -154.88 177.16 11.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.606 1.162 . . . . 0.0 108.409 176.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.536 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -161.49 -173.54 3.83 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.698 0.799 . . . . 0.0 109.531 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -122.31 118.98 29.79 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.777 0.831 . . . . 0.0 109.927 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.499 HG13 ' HB2' ' A' ' 43' ' ' PHE . 51.7 mt -68.99 127.96 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.99 174.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -138.2 -164.59 1.65 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.461 1.504 . . . . 0.0 108.311 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -34.5 114.15 0.2 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 125.123 1.369 . . . . 0.0 113.956 -162.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.5 110.89 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-O 121.38 0.61 . . . . 0.0 109.799 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 97.4 t -91.02 108.43 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.8 mt -85.96 115.68 23.72 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 53.5 m -151.94 127.37 9.99 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 40.4 mt-10 -60.99 -47.6 85.72 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.577 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 43.3 m-20 -71.69 119.48 74.39 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.65 -21.39 70.11 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.486 2.124 . . . . 0.0 111.746 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 44.6 mtm -72.4 -20.17 61.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.002 0.921 . . . . 0.0 111.071 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.577 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 17.9 mm100 -60.97 -29.02 69.42 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.244 0.618 . . . . 0.0 111.005 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.488 ' HE2' ' HB3' ' A' ' 109' ' ' TRP . 6.3 m-85 -81.93 -27.99 33.04 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.634 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.498 ' CE2' HD22 ' A' ' 87' ' ' LEU . 87.0 m-85 -87.91 -18.19 29.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.163 0.585 . . . . 0.0 111.832 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.31 -33.32 20.65 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.5 m -82.4 -60.39 2.22 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.078 0.551 . . . . 0.0 111.491 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.755 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 59.5 m-85 -93.81 -55.26 3.31 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.178 0.591 . . . . 0.0 110.136 -177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 65.83 -89.37 0.12 Allowed Glycine 0 C--N 1.355 1.628 0 O-C-N 124.135 0.897 . . . . 0.0 113.55 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.2 -28.51 68.15 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.079 0.952 . . . . 0.0 110.829 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.755 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 16.0 mmt85 -72.2 -27.88 62.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.034 0.534 . . . . 0.0 111.892 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.435 HG12 HD23 ' A' ' 82' ' ' LEU . 25.2 t -68.72 151.76 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.41 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 41.0 p90 -63.24 -11.08 18.67 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -145.1 173.17 12.14 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.279 1.032 . . . . 0.0 109.138 174.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.612 HG22 ' HG2' ' A' ' 86' ' ' GLU . 15.1 t -104.26 173.85 6.13 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -63.6 -30.35 71.47 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.897 0.479 . . . . 0.0 111.548 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.83 -32.52 67.64 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.612 ' HG2' HG22 ' A' ' 83' ' ' THR . 26.3 mm-40 -70.01 -35.53 74.42 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 172.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.498 HD22 ' CE2' ' A' ' 73' ' ' PHE . 18.3 tp -62.66 -52.28 63.96 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.073 0.949 . . . . 0.0 111.544 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -42.17 98.41 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.928 -173.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.26 -29.77 65.48 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 122.959 0.162 . . . . 0.0 110.785 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.412 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 63.3 t80 -66.19 -46.86 75.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.557 0.743 . . . . 0.0 110.922 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.7 mtm -69.08 -33.8 74.13 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.969 0.507 . . . . 0.0 110.809 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -76.49 -27.5 56.09 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.948 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.424 ' HA ' ' HG2' ' A' ' 96' ' ' ARG . 26.7 t -63.88 -33.29 75.37 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.235 0.541 . . . . 0.0 109.915 176.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 87.5 mm-40 -73.09 -3.46 26.49 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.874 0.87 . . . . 0.0 112.892 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -126.07 -30.53 2.94 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.424 ' HG2' ' HA ' ' A' ' 93' ' ' SER . 15.4 ptm180 -73.16 -27.86 61.89 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.691 0.397 . . . . 0.0 111.82 -175.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -92.55 -21.72 19.94 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.877 0.471 . . . . 0.0 111.039 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.23 171.02 35.27 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.46 -0.634 . . . . 0.0 112.421 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 69.98 123.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.928 1.291 . . . . 0.0 111.557 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -69.74 112.72 6.39 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.515 0.726 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.612 ' H ' ' HD3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -56.29 96.07 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.454 1.101 . . . . 0.0 111.847 177.318 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -131.38 110.31 10.96 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.0 p -138.66 -43.48 0.49 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.456 1.103 . . . . 0.0 108.938 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.9 tptt 71.76 -72.69 0.11 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.401 1.48 . . . . 0.0 110.398 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -95.57 156.02 16.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.288 1.035 . . . . 0.0 109.085 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HD2' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -66.36 158.13 30.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.958 0.503 . . . . 0.0 110.769 178.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -110.5 154.29 23.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.082 0.953 . . . . 0.0 109.268 -175.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.6 tm? -73.98 116.97 15.22 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.488 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 24.0 m95 -107.85 161.77 14.61 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.867 0.867 . . . . 0.0 108.96 172.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.419 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 12.5 ptm -145.89 130.83 18.2 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.48 0.712 . . . . 0.0 110.399 -176.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -101.93 103.66 14.33 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.206 1.002 . . . . 0.0 109.694 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.4 mt -90.3 120.8 39.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -78.11 109.81 12.52 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.56 0.618 . . . . 0.0 109.459 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -95.45 108.69 20.92 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 123.411 0.684 . . . . 0.0 110.536 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.31 172.64 8.49 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.5 t70 58.95 40.73 22.14 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.298 1.039 . . . . 0.0 110.63 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.9 t -70.48 107.93 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.204 -172.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -93.37 114.42 26.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.23 1.012 . . . . 0.0 111.126 -176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -74.33 136.7 42.55 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 170.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -80.5 110.68 16.19 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.88 -23.18 66.14 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.76 1.224 . . . . 0.0 111.3 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -125.25 149.21 63.31 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.568 1.147 . . . . 0.0 110.315 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.49 96.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 123.522 2.815 . . . . 0.0 113.654 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 17.3 mt -100.03 107.16 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.019 0.528 . . . . 0.0 109.67 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.52 150.25 89.01 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.872 -176.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.423 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 98.0 Cg_endo -72.94 164.88 34.33 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.079 1.852 . . . . 0.0 112.141 174.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -70.2 -41.06 74.17 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 173.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -153.46 177.01 11.38 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.522 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.69 132.93 53.42 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.136 0.974 . . . . 0.0 111.402 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.585 HG12 ' HD3' ' A' ' 10' ' ' PRO . 38.2 t -119.37 97.88 50.3 Favored Pre-proline 0 CA--C 1.553 1.079 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.65 -176.76 3.15 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.053 2.502 . . . . 0.0 112.579 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.18 -26.81 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.354 1.061 . . . . 0.0 112.079 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.04 -20.4 79.96 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.837 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.3 148.85 3.95 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.321 0.486 . . . . 0.0 113.103 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -106.96 151.45 25.27 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.355 0.662 . . . . 0.0 109.363 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.566 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 1.3 m-85 -89.82 122.9 33.32 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 174.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.03 116.84 27.61 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.89 127.32 39.93 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -171.985 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -66.6 -16.49 64.22 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.912 0.885 . . . . 0.0 111.958 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.45 -27.44 69.12 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.881 0.872 . . . . 0.0 111.806 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.587 HG13 ' HB3' ' A' ' 36' ' ' GLU . 25.3 mm 63.8 -169.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 C-N-CA 124.094 0.957 . . . . 0.0 108.764 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.516 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.5 m -149.48 -41.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.988 1.315 . . . . 0.0 107.524 156.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.06 -162.57 22.59 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.81 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 p -124.18 156.46 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.425 0.69 . . . . 0.0 109.275 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -126.41 133.03 51.38 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.329 0.652 . . . . 0.0 109.285 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.24 135.85 28.09 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 123.283 0.633 . . . . 0.0 110.745 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.457 ' HB3' ' HD2' ' A' ' 46' ' ' TYR . 43.1 Cg_endo -93.83 78.07 0.23 Allowed 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 124.078 3.186 . . . . 0.0 110.214 168.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.78 109.3 1.76 Allowed Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.822 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -83.93 30.86 0.52 Allowed 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.213 2.609 . . . . 0.0 112.428 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 15' ' ' PHE . 38.6 mmtm -133.41 148.68 51.81 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.428 1.491 . . . . 0.0 108.674 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -63.06 -15.96 58.3 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.011 0.924 . . . . 0.0 111.693 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.409 ' HD2' ' HB3' ' A' ' 13' ' ' LYS . 59.1 m-85 -72.89 7.05 2.2 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.375 1.07 . . . . 0.0 112.824 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.3 ttp -68.76 -24.18 64.41 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.14 0.576 . . . . 0.0 109.981 165.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.35 -29.02 70.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.998 0.919 . . . . 0.0 110.98 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 27.2 mmt180 -57.63 -41.0 80.49 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 124.382 1.051 . . . . 0.0 111.771 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.43 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 58.0 m-85 -65.1 -32.35 74.0 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 123.902 0.751 . . . . 0.0 110.042 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -89.47 -13.59 37.2 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.697 0.799 . . . . 0.0 111.125 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -82.83 -54.45 5.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.954 0.901 . . . . 0.0 110.393 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.2 ptpt -100.8 -8.89 22.22 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.712 -165.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.47 -42.17 3.13 Favored Glycine 0 N--CA 1.475 1.245 0 O-C-N 123.067 0.229 . . . . 0.0 113.109 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -129.64 106.1 8.5 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.395 0.678 . . . . 0.0 109.981 172.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.43 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.2 t70 -107.53 -177.37 3.33 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.494 1.117 . . . . 0.0 109.174 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.2 t -136.81 114.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.36 1.064 . . . . 0.0 109.229 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -85.09 111.65 19.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.599 0.759 . . . . 0.0 110.266 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.57 132.1 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-O 121.2 0.524 . . . . 0.0 110.461 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HD2' ' HD2' ' A' ' 30' ' ' PRO . 58.5 tptt -134.71 130.57 19.8 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.504 1.122 . . . . 0.0 108.335 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 109' ' ' TRP . 24.9 Cg_endo -61.68 94.95 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 121.872 1.715 . . . . 0.0 109.58 166.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -30.08 79.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.807 2.043 . . . . 0.0 115.674 -163.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 50.7 m -96.11 -30.51 13.49 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.068 172.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.82 142.7 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.315 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -67.41 168.76 10.15 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.263 0.625 . . . . 0.0 112.368 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -58.94 -11.52 3.46 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.21 1.404 . . . . 0.0 113.562 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.587 ' HB3' HG13 ' A' ' 4' ' ' ILE . 7.7 mm-40 -64.64 -17.3 63.91 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.968 0.907 . . . . 0.0 111.939 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.16 100.48 3.08 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.365 0.666 . . . . 0.0 110.04 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.3 152.33 42.57 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.77 82.93 2.03 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.66 2.24 . . . . 0.0 111.918 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.63 43.0 0.02 OUTLIER Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.122 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 34.0 mtm -122.39 -158.83 0.8 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.867 0.867 . . . . 0.0 110.026 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -121.05 158.88 26.85 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.09 0.956 . . . . 0.0 110.309 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.41 ' CB ' HD11 ' A' ' 114' ' ' LEU . 2.5 t80 -136.41 99.68 4.16 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 41.3 t -83.7 124.59 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.089 0.471 . . . . 0.0 110.068 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -89.51 115.32 26.84 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.498 0.719 . . . . 0.0 109.508 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.457 ' HD2' ' HB3' ' A' ' 10' ' ' PRO . 85.0 t80 -101.45 92.6 4.99 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.459 1.103 . . . . 0.0 109.481 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -74.9 96.37 3.12 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 t -85.12 52.2 2.38 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.73 0.776 . . . . 0.0 109.281 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -161.53 21.75 0.12 Allowed 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.61 1.164 . . . . 0.0 109.691 -170.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -131.35 -80.86 0.52 Allowed 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.41 -0.806 . . . . 0.0 110.826 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -166.01 -79.74 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -172.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -77.71 -40.86 39.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.884 0.473 . . . . 0.0 110.557 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.72 -70.77 0.5 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.506 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 17.6 m-30 -60.93 96.39 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.436 0.695 . . . . 0.0 111.363 -177.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -77.2 -33.42 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.004 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA2' ' H ' ' A' ' 120' ' ' TYR . . . -173.53 -166.4 31.77 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.843 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 2.2 pt-20 -149.61 179.36 8.05 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.576 1.15 . . . . 0.0 108.627 176.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.546 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -158.56 -173.65 4.39 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.819 0.848 . . . . 0.0 109.509 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -127.29 116.53 20.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.411 0.684 . . . . 0.0 109.64 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -66.63 137.69 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.915 1.286 . . . . 0.0 111.425 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -141.0 -170.6 3.08 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.351 1.86 . . . . 0.0 108.564 -175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -30.62 113.98 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.586 1.554 . . . . 0.0 114.798 -168.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -97.52 108.88 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-O 121.799 0.809 . . . . 0.0 109.694 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 95.7 t -92.65 109.26 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.93 0.892 . . . . 0.0 109.795 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.56 117.66 27.67 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.4 t -152.99 135.72 15.31 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.768 0.827 . . . . 0.0 109.814 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.469 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 38.1 mt-10 -63.72 -22.16 66.77 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.062 0.545 . . . . 0.0 111.53 172.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -87.76 119.88 70.73 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.188 0.595 . . . . 0.0 109.723 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.31 -8.39 22.62 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 122.418 2.078 . . . . 0.0 112.064 167.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 51.7 mtm -89.58 -26.0 21.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.407 1.083 . . . . 0.0 111.21 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.49 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 71.4 mt-30 -68.17 -20.91 64.91 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -74.52 -21.99 59.27 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.508 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.487 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 22.6 m-85 -89.99 -27.81 19.53 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.177 0.591 . . . . 0.0 111.482 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 13.0 pt-20 -76.33 -28.43 56.89 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.3 m -85.98 -60.75 1.92 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.897 0.479 . . . . 0.0 110.788 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.792 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 67.0 m-85 -101.32 -61.84 1.32 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.389 0.675 . . . . 0.0 110.205 -173.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 77.33 -87.54 1.01 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.703 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.33 -12.94 44.96 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.792 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 6.4 mmp_? -69.33 -34.05 74.05 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.291 169.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.433 HG12 HD23 ' A' ' 82' ' ' LEU . 34.7 t -67.62 147.16 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.8 0.44 . . . . 0.0 110.453 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -63.56 -22.27 66.8 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.433 HD23 HG12 ' A' ' 80' ' ' VAL . 2.1 pt? -131.38 162.06 30.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.177 0.591 . . . . 0.0 109.608 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.443 HG23 ' H ' ' A' ' 85' ' ' ASP . 5.6 t -106.05 -176.93 3.22 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -56.39 -43.15 78.99 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.37 0.668 . . . . 0.0 111.142 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.443 ' H ' HG23 ' A' ' 83' ' ' THR . 14.4 m-20 -60.38 -45.8 92.27 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.041 0.936 . . . . 0.0 111.772 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.52 -46.72 88.76 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 123.224 0.327 . . . . 0.0 110.45 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.422 HD22 ' HE2' ' A' ' 73' ' ' PHE . 43.8 tp -57.27 -50.04 74.16 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.115 0.884 . . . . 0.0 111.46 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.494 ' HD3' ' N ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -64.28 -45.85 86.22 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.477 0.486 . . . . 0.0 110.775 -175.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.494 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 13.0 pt-20 -74.04 -24.79 59.58 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.451 0.3 . . . . 0.0 110.984 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 69.4 t80 -71.82 -49.37 39.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.718 0.807 . . . . 0.0 109.997 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 64.3 mtm -66.73 -40.76 88.51 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.89 0.744 . . . . 0.0 110.105 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HE3' HH21 ' A' ' 96' ' ' ARG . 31.2 mmmt -63.99 -35.59 81.2 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.714 0.634 . . . . 0.0 111.077 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.2 t -63.14 -37.42 87.15 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.861 0.464 . . . . 0.0 110.949 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 67.9 mm-40 -71.28 -41.41 70.03 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.871 0.469 . . . . 0.0 111.218 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -3.5 51.7 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.426 HH21 ' HE3' ' A' ' 92' ' ' LYS . 15.9 ptp180 -115.18 -40.16 3.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.005 0.522 . . . . 0.0 111.808 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -83.4 -42.93 16.45 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.88 -93.63 0.38 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 169.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -177.12 151.06 0.78 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.541 1.136 . . . . 0.0 108.1 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -82.16 170.39 15.51 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -102.41 22.2 13.84 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.707 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 50.12 -89.13 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.777 1.631 . . . . 0.0 110.932 -171.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.7 t -172.95 132.73 0.53 Allowed 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.024 0.93 . . . . 0.0 108.681 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -149.91 -68.08 0.2 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -157.29 -92.87 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.469 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -176.36 -160.85 0.07 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.468 1.507 . . . . 0.0 108.046 178.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 16.9 tptm -132.65 165.05 25.35 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.445 0.698 . . . . 0.0 109.583 175.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.61 114.32 10.61 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.649 0.779 . . . . 0.0 109.496 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 19.5 m95 -100.35 161.99 13.24 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.319 1.048 . . . . 0.0 109.398 172.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.514 ' HE3' HD11 ' A' ' 112' ' ' ILE . 9.0 ptt? -143.25 138.93 29.96 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.933 0.397 . . . . 0.0 110.766 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -109.51 103.33 12.2 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.089 0.956 . . . . 0.0 109.74 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.514 HD11 ' HE3' ' A' ' 110' ' ' MET . 22.8 mt -87.03 122.06 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.36 129.77 34.76 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.6 mm? -117.18 107.58 14.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.795 0.838 . . . . 0.0 110.865 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -106.4 170.83 7.69 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.157 0.583 . . . . 0.0 110.327 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.6 t70 55.21 38.54 30.57 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 124.449 1.093 . . . . 0.0 111.09 168.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.3 t -66.92 101.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.523 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.32 110.66 23.17 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.921 -167.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -65.08 122.27 16.66 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.886 0.875 . . . . 0.0 110.947 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.506 ' HD2' ' HB3' ' A' ' 54' ' ' PHE . 12.8 m-30 -75.9 87.35 2.87 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.36 -30.56 70.97 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.278 172.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -81.91 131.94 55.61 Favored Pre-proline 0 CA--C 1.553 1.089 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.384 168.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.66 84.15 2.03 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.761 2.307 . . . . 0.0 111.557 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.4 mt -73.21 127.04 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.008 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -74.53 130.6 81.54 Favored Pre-proline 0 CA--C 1.553 1.066 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.865 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.454 ' HG3' ' HE1' ' A' ' 46' ' ' TYR . 65.7 Cg_endo -71.51 145.13 46.7 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.63 2.22 . . . . 0.0 110.707 169.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -83.55 -6.22 59.39 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.588 0.755 . . . . 0.0 111.228 -179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -167.83 177.98 5.46 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.621 1.168 . . . . 0.0 109.402 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.87 138.04 46.03 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 166.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.446 HG12 ' HD3' ' A' ' 10' ' ' PRO . 43.7 t -107.0 100.33 31.47 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 170.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.23 169.25 17.2 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.873 2.382 . . . . 0.0 112.138 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.442 ' HA ' ' HG2' ' A' ' 10' ' ' PRO . 18.7 m -59.25 -20.49 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -173.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.5 -21.93 76.33 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.144 0.277 . . . . 0.0 113.079 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.79 147.47 14.89 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.621 0.629 . . . . 0.0 112.096 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -108.88 148.59 30.39 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.509 0.724 . . . . 0.0 109.33 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -92.27 120.37 32.76 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.459 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.24 122.93 30.13 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 130.04 34.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.322 0.649 . . . . 0.0 109.254 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.588 -171.794 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 92.0 mmm . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 111.326 0.121 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -60.46 -6.63 1.66 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.36 1.464 . . . . 0.0 114.172 -173.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -61.87 -12.51 18.13 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.739 0.816 . . . . 0.0 112.356 167.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mm 67.4 -178.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.933 1.293 . . . . 0.0 109.04 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 m -150.15 -47.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 156.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.527 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.05 -161.34 19.17 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.516 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.499 HG12 HD11 ' A' ' 60' ' ' ILE . 9.7 p -117.5 161.76 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -133.5 135.96 44.78 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.63 0.772 . . . . 0.0 109.25 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -136.03 146.03 54.92 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.924 0.89 . . . . 0.0 110.371 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD3' HG12 ' A' ' 130' ' ' VAL . 69.3 Cg_endo -70.7 -32.89 13.9 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.872 2.381 . . . . 0.0 112.624 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 mm 53.24 77.9 0.42 Allowed Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 124.105 0.962 . . . . 0.0 108.756 -168.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.17 41.65 1.14 Allowed 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.403 2.736 . . . . 0.0 112.868 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -138.49 158.95 43.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.353 1.461 . . . . 0.0 109.176 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -72.16 -10.95 60.47 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.128 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -79.51 11.61 2.96 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.43 1.092 . . . . 0.0 111.823 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 58.2 ttp -63.01 -35.37 80.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.715 0.806 . . . . 0.0 109.699 166.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.78 -26.17 68.58 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.893 0.877 . . . . 0.0 112.449 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -50.66 -48.02 58.5 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.844 0.858 . . . . 0.0 111.44 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.422 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 75.0 m-85 -67.53 -27.55 67.06 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.807 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -102.12 6.63 40.97 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.342 0.657 . . . . 0.0 110.922 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -93.52 -57.06 2.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.168 0.987 . . . . 0.0 109.41 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -110.98 -19.72 12.68 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.06 32.5 75.98 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 114.917 0.727 . . . . 0.0 114.917 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -161.86 41.77 0.14 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.278 1.031 . . . . 0.0 109.459 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' OD1' ' HA ' ' A' ' 19' ' ' PHE . 3.0 m-20 -81.93 -172.01 3.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.333 -172.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -142.36 110.69 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.412 ' H ' HD23 ' A' ' 114' ' ' LEU . 91.9 t80 -86.94 111.76 21.13 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 m -83.99 140.23 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.73 0.776 . . . . 0.0 110.561 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HD2' ' HB ' ' A' ' 32' ' ' THR . 15.2 tppt? -134.58 120.98 14.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.966 1.306 . . . . 0.0 109.699 -171.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 95.6 Cg_endo -77.54 53.86 4.5 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.13 2.554 . . . . 0.0 112.829 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 58.12 21.33 7.84 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.521 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 4.5 m -63.63 -36.42 83.77 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.349 0.522 . . . . 0.0 110.294 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -119.93 149.68 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.165 0.986 . . . . 0.0 109.092 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -167.57 -48.96 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.574 0.749 . . . . 0.0 110.348 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -41.59 -51.98 3.86 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.847 1.659 . . . . 0.0 113.641 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 22.8 mt-10 -109.68 -12.51 14.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.595 0.758 . . . . 0.0 110.306 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.425 ' HA ' ' SD ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -69.23 115.44 8.52 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 123.294 0.637 . . . . 0.0 110.221 -177.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -143.85 152.15 54.8 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.992 0.917 . . . . 0.0 108.951 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.83 103.16 1.3 Allowed 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.597 2.198 . . . . 0.0 111.616 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.74 -7.07 0.91 Allowed Glycine 0 N--CA 1.476 1.348 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.789 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.527 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 79.0 mtp -83.01 -169.39 2.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.432 1.093 . . . . 0.0 111.068 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 12.3 ptpt -116.0 165.52 13.03 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.713 0.805 . . . . 0.0 110.608 168.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.535 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.1 t80 -135.37 99.06 4.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 87.3 t -84.96 120.07 34.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.23 0.538 . . . . 0.0 109.804 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -84.07 100.16 10.92 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.41 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 61.1 t80 -64.05 130.22 43.12 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 165.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.464 ' HB3' ' HA2' ' A' ' 53' ' ' GLY . 51.1 tt0 -74.9 108.9 7.93 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.0 t -65.1 87.57 0.07 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -131.62 -90.31 0.43 Allowed 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.237 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -155.57 -79.3 0.09 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.851 0.86 . . . . 0.0 109.162 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.59 -60.01 1.61 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.1 m -66.61 132.8 48.96 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.428 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 47' ' ' GLN . . . -133.85 -162.5 10.04 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.828 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.641 ' HB2' ' HB ' ' A' ' 124' ' ' ILE . 1.6 m-85 50.64 69.14 0.67 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.279 1.032 . . . . 0.0 111.203 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.17 -38.87 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.93 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.13 -166.66 25.53 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.234 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -145.89 178.68 8.0 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.906 0.882 . . . . 0.0 108.755 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -164.16 -171.71 2.51 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.693 0.797 . . . . 0.0 110.016 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 11.3 mmt180 -128.73 122.32 30.41 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.249 1.019 . . . . 0.0 109.401 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' A' ' 43' ' ' PHE . 57.8 mt -74.34 131.37 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.201 1.0 . . . . 0.0 110.322 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -139.31 -164.71 1.72 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.925 1.69 . . . . 0.0 108.357 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -24.78 109.93 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 126.378 1.871 . . . . 0.0 114.769 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 112' ' ' ILE . 35.0 m -98.76 109.04 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 94.7 t -89.62 110.23 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -87.96 118.26 27.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.516 0.727 . . . . 0.0 109.669 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.3 t -153.62 134.86 14.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.781 0.832 . . . . 0.0 109.581 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 49.3 mt-10 -70.03 -17.53 63.26 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.102 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.494 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 36.5 m-80 -91.66 118.76 68.51 Favored Pre-proline 0 C--N 1.357 0.892 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.456 ' HG2' HD21 ' A' ' 87' ' ' LEU . 50.0 Cg_endo -69.21 -10.83 30.05 Favored 'Trans proline' 0 CA--C 1.556 1.615 0 C-N-CA 122.473 2.115 . . . . 0.0 112.259 171.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 46.4 mtm -81.25 -27.56 35.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.168 0.987 . . . . 0.0 111.499 -176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 47.5 mt-30 -66.21 -24.01 66.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.387 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -74.08 -25.2 59.69 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.872 0.469 . . . . 0.0 110.866 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.543 ' HE2' HD22 ' A' ' 87' ' ' LEU . 33.3 m-85 -80.87 -37.34 30.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.0 0.52 . . . . 0.0 110.892 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.55 -29.03 61.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 121.294 -0.162 . . . . 0.0 111.35 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.4 m -80.74 -47.22 14.26 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.981 0.512 . . . . 0.0 110.682 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 62.7 m-85 -116.33 -67.23 1.01 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.265 0.626 . . . . 0.0 109.935 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.76 -81.13 1.15 Allowed Glycine 0 C--N 1.35 1.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.835 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.5 -43.97 93.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.902 0.881 . . . . 0.0 110.83 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 25.8 mmt180 -66.44 -30.68 71.09 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.553 -176.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.424 HG12 HD23 ' A' ' 82' ' ' LEU . 40.3 t -66.03 131.21 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -62.51 -22.16 66.07 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -168.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.424 HD23 HG12 ' A' ' 80' ' ' VAL . 2.3 pt? -128.07 160.89 30.58 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 85' ' ' ASP . 8.2 t -97.01 179.33 4.97 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.913 0.324 . . . . 0.0 110.383 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -62.95 -32.59 73.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.104 0.562 . . . . 0.0 111.452 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.414 ' H ' HG23 ' A' ' 83' ' ' THR . 5.6 m-20 -66.5 -45.8 78.38 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.33 0.652 . . . . 0.0 110.627 176.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.93 -35.46 76.77 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.44 173.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.543 HD22 ' HE2' ' A' ' 73' ' ' PHE . 40.5 tp -64.14 -52.73 57.7 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.546 0.529 . . . . 0.0 110.874 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -67.14 -40.44 86.74 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.256 0.348 . . . . 0.0 111.365 -173.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.71 -33.32 73.74 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -63.64 -48.26 77.97 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.973 0.909 . . . . 0.0 110.292 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.5 mtm -65.58 -33.0 74.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.052 0.541 . . . . 0.0 110.388 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 9.2 mmpt? -71.4 -34.89 70.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.621 0.368 . . . . 0.0 110.957 175.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.2 m -70.42 -42.06 72.09 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.932 0.493 . . . . 0.0 110.543 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -72.34 -22.48 61.16 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.239 0.616 . . . . 0.0 111.747 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -89.33 -36.89 15.28 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 119.457 -0.306 . . . . 0.0 111.452 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -77.42 -40.98 41.59 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.454 0.57 . . . . 0.0 111.079 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -82.98 -24.23 33.02 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.785 0.434 . . . . 0.0 110.146 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.13 -77.23 0.66 Allowed Glycine 0 C--N 1.351 1.399 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -173.1 -57.58 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.972 1.309 . . . . 0.0 107.878 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -167.98 164.47 13.78 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -69.03 83.74 0.33 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -82.19 95.15 7.44 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.401 -1.272 . . . . 0.0 107.976 -169.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -165.54 -170.18 1.77 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.121 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -158.62 -55.29 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 172.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -93.89 124.55 37.97 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.762 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.541 ' H ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -61.72 157.49 17.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.936 0.894 . . . . 0.0 112.096 -178.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.4 tpmt? -101.46 151.53 21.83 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.435 -174.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 2.9 tm? -73.45 110.31 7.65 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 173.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -89.8 158.47 17.48 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.449 ' HG3' ' HB3' ' A' ' 29' ' ' LYS . 12.3 ptm -139.51 129.05 24.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.16 0.584 . . . . 0.0 109.796 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.402 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -100.87 100.95 11.67 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.454 ' HA ' HG12 ' A' ' 63' ' ' VAL . 23.3 mt -80.95 117.98 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -80.66 110.08 15.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.52 0.676 . . . . 0.0 109.67 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 27' ' ' PHE . 4.0 mm? -88.67 131.62 34.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.405 1.082 . . . . 0.0 109.824 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -139.07 173.29 11.71 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.18 0.592 . . . . 0.0 109.463 171.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.9 t70 56.17 34.56 24.13 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.856 0.862 . . . . 0.0 110.946 170.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.9 t -65.89 106.82 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.698 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.265 -175.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.95 162.84 19.26 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.6 1.16 . . . . 0.0 109.969 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.87 124.12 42.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.697 0.799 . . . . 0.0 109.336 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -79.68 103.4 9.56 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.266 0.555 . . . . 0.0 109.674 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.83 -28.23 68.83 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.671 1.188 . . . . 0.0 110.589 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -88.34 139.85 30.24 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.973 0.909 . . . . 0.0 109.831 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.4 92.22 0.94 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.709 2.273 . . . . 0.0 111.86 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.641 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 41.5 mt -80.34 138.38 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.88 140.24 23.5 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.67 123.39 12.91 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.53 2.153 . . . . 0.0 112.095 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -57.73 -34.05 69.1 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.553 0.741 . . . . 0.0 109.432 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -150.61 164.69 35.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.388 1.075 . . . . 0.0 109.056 172.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.55 126.52 29.91 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.36 0.664 . . . . 0.0 109.522 -175.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.482 HG12 ' HD3' ' A' ' 10' ' ' PRO . 19.1 t -109.51 99.73 38.62 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.65 -172.85 1.52 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.91 2.407 . . . . 0.0 112.137 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.23 -34.81 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.965 0.906 . . . . 0.0 110.966 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.77 -21.1 77.92 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.203 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.74 163.26 26.71 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 122.92 0.295 . . . . 0.0 113.12 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -115.54 149.89 37.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.999 0.919 . . . . 0.0 109.961 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 9.2 m-85 -85.24 120.1 26.35 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 169.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.7 125.54 33.95 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -130.36 128.86 42.28 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.266 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 C--O 1.247 0.965 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -171.75 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 tpp . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 m -62.47 -18.65 62.28 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.543 1.137 . . . . 0.0 113.639 -170.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -60.68 -22.74 64.22 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.838 0.855 . . . . 0.0 112.929 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 5' ' ' VAL . 27.1 mm 64.35 -168.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.665 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -170.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.534 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.3 m -147.31 -39.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.024 0.929 . . . . 0.0 108.729 158.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -170.02 -161.83 21.21 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.284 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 13.4 p -127.88 155.12 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 t -126.94 136.63 52.54 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -137.15 139.95 29.74 Favored Pre-proline 0 N--CA 1.469 0.522 0 C-N-CA 124.419 1.088 . . . . 0.0 109.369 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 15.4 Cg_exo -65.76 -47.0 4.27 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 123.079 2.519 . . . . 0.0 110.825 169.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.6 mt 67.95 136.12 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 125.366 1.466 . . . . 0.0 110.2 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.482 ' HB2' ' HD2' ' A' ' 15' ' ' PHE . 81.6 Cg_exo -48.06 124.98 10.98 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.236 1.957 . . . . 0.0 111.356 171.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -59.31 -16.8 24.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.518 1.127 . . . . 0.0 113.052 -174.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -66.98 -45.64 77.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.571 0.748 . . . . 0.0 110.797 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.482 ' HD2' ' HB2' ' A' ' 12' ' ' PRO . 76.3 m-85 -101.2 1.56 39.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.414 1.086 . . . . 0.0 112.071 -174.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -73.15 -40.8 64.56 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.211 0.604 . . . . 0.0 110.354 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -63.86 -25.34 68.12 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.504 0.721 . . . . 0.0 112.132 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -50.67 -44.25 57.64 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 124.96 1.304 . . . . 0.0 112.581 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.54 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 47.9 m-85 -70.37 -27.13 64.08 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.494 0.718 . . . . 0.0 111.526 -174.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -95.97 -17.78 20.75 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.186 0.994 . . . . 0.0 110.15 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -74.6 -58.73 3.1 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.637 1.175 . . . . 0.0 110.506 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -92.57 -14.0 28.89 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.924 -172.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.13 -58.89 4.22 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.813 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -109.88 104.72 13.69 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.317 0.558 . . . . 0.0 110.186 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 11.4 t70 -101.63 179.23 4.41 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.176 0.99 . . . . 0.0 109.757 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.0 t -138.06 110.84 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.393 1.077 . . . . 0.0 109.023 171.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -88.48 111.45 21.83 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.707 0.803 . . . . 0.0 109.937 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.8 m -90.44 126.88 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.619 0.723 . . . . 0.0 111.149 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 7.4 mmpt? -110.18 134.97 20.6 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.124 1.369 . . . . 0.0 109.726 173.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.77 56.6 6.02 Favored 'Trans proline' 0 CA--C 1.557 1.668 0 C-N-CA 122.501 2.134 . . . . 0.0 110.909 166.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 50.79 37.51 17.16 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.035 1.334 . . . . 0.0 112.919 -176.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 10.7 m -64.65 -43.39 93.79 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.954 0.902 . . . . 0.0 110.246 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.41 151.32 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.081 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.466 ' H ' ' HE2' ' A' ' 136' ' ' TYR . 62.6 m95 -73.5 -177.38 2.63 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.392 1.077 . . . . 0.0 112.016 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -68.2 -3.72 11.58 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.036 0.934 . . . . 0.0 113.018 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HB3' HG13 ' A' ' 4' ' ' ILE . 9.5 mm-40 -66.57 -24.81 66.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.214 0.606 . . . . 0.0 110.773 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 94.65 0.63 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.935 0.494 . . . . 0.0 109.891 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.472 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -115.12 149.99 43.54 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.207 0.603 . . . . 0.0 109.438 177.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.473 ' HA ' HG22 ' A' ' 60' ' ' ILE . 59.9 Cg_endo -70.95 103.17 1.32 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.948 2.432 . . . . 0.0 110.699 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.64 -16.05 1.09 Allowed Glycine 0 C--O 1.241 0.54 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.512 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.477 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 25.8 mtm -73.48 -174.49 1.69 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.362 0.665 . . . . 0.0 112.185 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -109.45 159.44 17.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.845 0.858 . . . . 0.0 110.456 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.9 t80 -137.0 98.14 3.68 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 46.7 t -84.55 129.4 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 109.955 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -93.0 119.28 32.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.564 0.746 . . . . 0.0 110.042 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 52.1 t80 -91.04 144.32 25.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.875 1.27 . . . . 0.0 109.111 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.636 HE21 HG21 ' A' ' 52' ' ' THR . 9.8 tt0 -139.55 125.92 20.24 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.133 0.573 . . . . 0.0 109.74 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 51' ' ' ASP . 25.3 m 65.21 131.32 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.548 1.539 . . . . 0.0 112.725 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -63.12 -43.01 99.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.491 0.717 . . . . 0.0 112.536 -174.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.11 10.59 10.08 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.435 0.694 . . . . 0.0 111.866 -169.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 48' ' ' SER . 33.3 t70 -147.71 154.16 40.21 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.611 0.764 . . . . 0.0 109.193 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.636 HG21 HE21 ' A' ' 47' ' ' GLN . 55.0 m 64.15 -72.74 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.977 1.311 . . . . 0.0 111.827 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 126' ' ' PRO . . . 104.46 -69.82 0.26 Allowed Glycine 0 C--O 1.22 -0.761 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -178.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -129.45 127.84 41.71 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.312 0.645 . . . . 0.0 110.293 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 47' ' ' GLN . 3.2 p -85.3 -31.32 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.997 0.919 . . . . 0.0 110.782 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.33 -162.9 26.09 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.869 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 15.2 pt-20 -153.72 178.0 10.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.804 1.242 . . . . 0.0 108.215 175.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -164.24 -176.17 4.31 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.592 0.757 . . . . 0.0 110.091 177.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -122.92 130.6 53.03 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.641 0.776 . . . . 0.0 109.889 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 39' ' ' PRO . 45.4 mt -74.39 138.1 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.039 1.336 . . . . 0.0 110.751 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -133.4 -168.62 2.13 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.722 2.009 . . . . 0.0 108.438 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -31.28 113.03 0.1 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 126.113 1.765 . . . . 0.0 113.967 -166.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.3 m -92.79 103.23 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 86.7 t -90.71 109.0 20.35 Favored 'Isoleucine or valine' 0 C--N 1.348 0.512 0 C-N-CA 123.682 0.793 . . . . 0.0 109.067 -172.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.5 mt -84.85 118.54 24.55 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.405 ' HB3' ' CE1' ' A' ' 72' ' ' PHE . 47.5 t -149.31 130.35 14.41 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.785 0.834 . . . . 0.0 109.202 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' HG3' HD23 ' A' ' 108' ' ' LEU . 25.9 mt-10 -67.33 -15.9 63.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.745 0.818 . . . . 0.0 111.513 173.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -103.49 119.32 55.26 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 123.534 0.734 . . . . 0.0 109.099 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.42 -13.37 39.01 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.368 2.046 . . . . 0.0 112.663 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.0 mtm -82.6 -27.94 31.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.643 0.777 . . . . 0.0 111.479 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.51 -22.4 66.72 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.771 0.319 . . . . 0.0 111.545 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 66' ' ' SER . 15.0 m-85 -71.99 -25.63 61.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.039 0.535 . . . . 0.0 110.833 174.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.599 ' HE2' HD22 ' A' ' 87' ' ' LEU . 21.2 m-85 -87.72 -27.41 22.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.822 0.449 . . . . 0.0 111.572 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.94 -29.04 55.45 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.591 0.234 . . . . 0.0 110.717 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.6 m -86.32 -46.91 9.86 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.136 0.575 . . . . 0.0 111.443 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.771 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 69.3 m-85 -116.01 -62.89 1.53 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.469 0.708 . . . . 0.0 110.082 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 72.35 -92.06 0.57 Allowed Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.019 -0.537 . . . . 0.0 113.382 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.32 -19.2 61.7 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.647 0.779 . . . . 0.0 111.064 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.771 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 23.0 mmt180 -70.67 -37.84 73.72 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.573 173.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.9 t -63.65 149.62 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.711 0.405 . . . . 0.0 110.199 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -64.03 -16.04 60.79 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.0 pt? -142.12 158.59 43.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.476 1.111 . . . . 0.0 108.686 174.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.48 HG22 ' HG3' ' A' ' 86' ' ' GLU . 13.8 t -100.44 -177.53 3.53 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.68 -35.85 79.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.535 0.734 . . . . 0.0 111.751 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.68 -44.99 94.84 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.577 0.751 . . . . 0.0 110.813 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 30.0 mt-10 -72.13 -26.38 62.09 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.68 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.599 HD22 ' HE2' ' A' ' 73' ' ' PHE . 24.9 tp -71.36 -50.96 26.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.418 0.687 . . . . 0.0 110.785 176.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -66.61 -36.66 83.13 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.542 0.337 . . . . 0.0 111.205 -173.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.67 -32.88 68.34 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 175.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.418 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 70.9 t80 -65.0 -46.46 81.3 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.716 0.807 . . . . 0.0 110.986 175.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.3 mtm -70.43 -39.0 74.66 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.962 0.505 . . . . 0.0 110.696 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.7 mmmt -67.16 -32.34 73.37 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.35 0.26 . . . . 0.0 110.675 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t -65.25 -37.36 86.99 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.149 0.58 . . . . 0.0 110.66 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 89.3 mm-40 -75.7 -7.43 54.34 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' HB3' ' HD3' ' A' ' 100' ' ' ARG . 10.5 pt-20 -112.6 -18.42 12.38 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 118.33 0.514 . . . . 0.0 111.57 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -100.31 -20.87 15.66 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.457 0.303 . . . . 0.0 111.463 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -117.36 -55.07 2.34 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.16 -140.44 2.84 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.304 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -155.77 102.93 2.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.292 0.637 . . . . 0.0 109.648 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.436 ' HD3' ' HB3' ' A' ' 95' ' ' GLU . 80.8 mtp180 -83.14 -72.77 0.44 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? 59.48 88.46 0.07 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.235 1.014 . . . . 0.0 109.832 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -174.79 140.31 0.56 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.053 0.941 . . . . 0.0 109.614 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.6 p -159.92 -4.61 0.06 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.571 0.748 . . . . 0.0 111.007 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -93.6 -57.63 2.52 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.713 0.805 . . . . 0.0 110.928 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -137.27 121.76 18.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.977 0.511 . . . . 0.0 111.118 -172.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HD2' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -62.62 157.87 19.63 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.045 0.938 . . . . 0.0 111.46 176.202 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 31' ' ' ALA . 4.3 tmtp? -85.31 145.9 27.29 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.983 0.913 . . . . 0.0 109.292 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.482 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 3.1 tm? -76.33 107.62 8.71 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 170.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -91.75 162.31 14.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.825 0.85 . . . . 0.0 109.333 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.6 ptm -141.49 131.26 24.25 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.955 0.902 . . . . 0.0 109.321 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -102.45 101.56 11.78 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.3 mt -80.26 115.09 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -77.96 139.83 39.2 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -119.68 131.35 55.4 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.904 0.882 . . . . 0.0 109.292 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -136.39 168.85 18.67 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.744 1.218 . . . . 0.0 109.459 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.6 t70 53.42 36.7 23.74 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.412 1.085 . . . . 0.0 111.21 168.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.69 103.71 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.739 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -90.19 108.51 19.79 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.386 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -73.5 130.46 40.15 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -78.99 120.25 23.31 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -60.91 -35.3 76.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.022 0.929 . . . . 0.0 110.349 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -116.39 147.62 39.97 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.776 1.231 . . . . 0.0 109.798 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.627 ' HB3' ' HA ' ' A' ' 52' ' ' THR . 20.3 Cg_exo -64.8 97.13 0.27 Allowed 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 123.308 2.672 . . . . 0.0 111.591 172.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.5 mt -83.25 115.53 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.9 147.64 91.55 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.72 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.454 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 91.6 Cg_endo -87.16 154.81 8.24 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.473 2.115 . . . . 0.0 112.179 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -74.01 -23.11 59.38 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.44 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 126' ' ' PRO . 13.4 ptm180 -150.35 160.35 43.79 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.989 0.915 . . . . 0.0 109.342 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 129' ' ' LEU . 2.6 pt? -75.8 120.62 21.42 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.7 t -94.49 109.49 43.41 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.54 179.77 6.2 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.95 2.433 . . . . 0.0 111.838 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.4 t -59.15 -32.83 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 124.2 1.0 . . . . 0.0 111.794 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.64 -16.62 72.14 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.558 -0.747 . . . . 0.0 113.641 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.04 160.62 15.17 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.119 0.39 . . . . 0.0 113.149 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -118.1 139.07 51.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.599 0.759 . . . . 0.0 109.458 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.466 ' HE2' ' H ' ' A' ' 34' ' ' TRP . 0.2 OUTLIER -79.42 106.91 11.79 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.49 114.12 18.17 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.4 ' HD3' ' H ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -110.07 148.96 30.72 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.524 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.253 1.239 0 CA-C-N 118.217 0.462 . . . . 0.0 110.127 172.189 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 47.0 ttp . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.5 t -56.56 -15.33 4.16 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -165.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -65.24 -20.5 66.46 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 5' ' ' VAL . 23.1 mm 68.78 178.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 C-N-CA 124.612 1.165 . . . . 0.0 109.759 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.419 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.7 m -145.41 -43.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.619 1.168 . . . . 0.0 108.181 160.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.97 -159.17 15.16 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.724 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 HD11 ' A' ' 60' ' ' ILE . 10.0 p -122.9 151.33 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -123.29 135.56 54.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.843 0.857 . . . . 0.0 109.528 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -137.47 138.88 25.81 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.556 0.742 . . . . 0.0 111.064 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 91.0 Cg_endo -74.35 -9.57 21.77 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.76 2.307 . . . . 0.0 111.86 169.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 mm 64.83 116.64 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.638 1.575 . . . . 0.0 109.284 -175.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.56 -11.49 20.36 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.815 2.343 . . . . 0.0 113.841 -172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HE2' ' HD1' ' A' ' 90' ' ' TYR . 63.8 mttm -133.66 176.91 8.12 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.543 1.137 . . . . 0.0 110.693 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -71.99 -5.91 38.3 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.021 0.929 . . . . 0.0 112.002 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -73.43 15.13 0.27 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.2 ptp -56.7 -32.29 65.32 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 157.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.28 -45.87 35.21 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.549 1.54 . . . . 0.0 111.79 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 84.2 mmt-85 -58.08 -36.58 73.03 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.134 0.896 . . . . 0.0 112.501 -173.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HB3' HG11 ' A' ' 117' ' ' VAL . 74.5 m-85 -66.35 -29.35 69.52 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.419 0.45 . . . . 0.0 110.565 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -98.23 -15.31 19.9 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.768 0.827 . . . . 0.0 110.928 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 18' ' ' ARG . 5.8 tmtm? -78.31 -48.06 16.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.78 1.232 . . . . 0.0 110.275 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.7 ptpt -102.55 -12.36 17.83 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.568 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.94 -14.03 59.74 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.988 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -164.0 114.72 1.3 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.834 0.854 . . . . 0.0 109.4 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 18.9 t70 -133.83 -175.37 3.81 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.1 0.96 . . . . 0.0 110.296 -162.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 113' ' ' GLU . 76.9 t -135.87 119.28 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 121.278 -0.889 . . . . 0.0 109.417 176.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -93.69 115.77 28.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.323 0.649 . . . . 0.0 109.929 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.8 m -93.68 143.56 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.838 0.827 . . . . 0.0 111.163 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 6.6 mmpt? -130.15 136.18 28.62 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 126.225 1.81 . . . . 0.0 108.951 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.72 55.21 5.12 Favored 'Trans proline' 0 CA--C 1.552 1.388 0 C-N-CA 122.421 2.081 . . . . 0.0 111.149 166.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 50.56 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.063 1.345 . . . . 0.0 112.394 -170.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.563 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 24.8 m -126.45 -50.84 1.51 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.35 107.52 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.858 0.863 . . . . 0.0 109.253 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -146.06 1.18 0.86 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.228 0.611 . . . . 0.0 111.533 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -64.47 -53.62 45.43 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.453 0.644 . . . . 0.0 110.275 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -109.4 -7.98 15.12 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.424 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.33 107.11 1.53 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.571 0.748 . . . . 0.0 110.872 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.471 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -135.9 152.26 75.44 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.279 0.632 . . . . 0.0 109.909 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.06 102.5 1.08 Allowed 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.971 2.447 . . . . 0.0 111.32 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.25 -19.83 1.2 Allowed Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.666 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.471 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 30.1 mtm -74.64 -177.88 3.38 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.078 0.466 . . . . 0.0 111.234 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -104.04 163.07 12.63 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.341 0.656 . . . . 0.0 110.869 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.489 ' CB ' HD11 ' A' ' 114' ' ' LEU . 2.5 t80 -134.55 102.03 5.16 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 48.7 t -90.17 123.87 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.339 0.59 . . . . 0.0 110.137 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.36 111.43 19.42 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.743 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 76.5 t80 -83.17 136.49 34.42 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.399 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.709 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 48.4 tt0 -95.28 165.67 12.27 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.8 t -60.68 178.02 0.26 Allowed 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.736 0.814 . . . . 0.0 111.523 172.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -69.75 12.95 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.968 1.307 . . . . 0.0 113.834 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -67.01 -65.74 0.64 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.72 1.208 . . . . 0.0 110.82 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -175.02 148.99 1.05 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.311 1.045 . . . . 0.0 109.155 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.3 m 62.04 100.11 0.03 OUTLIER 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.671 1.232 . . . . 0.0 111.095 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.713 ' HA3' ' HD3' ' A' ' 126' ' ' PRO . . . -57.46 -35.81 74.14 Favored Glycine 0 C--O 1.209 -1.447 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.613 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -107.43 102.61 11.87 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.716 0.758 . . . . 0.0 110.453 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 47' ' ' GLN . 13.8 p -79.55 -19.69 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.709 0.804 . . . . 0.0 111.279 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.42 -171.45 40.94 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.093 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 21.2 pt-20 -153.82 178.95 9.33 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.788 0.835 . . . . 0.0 109.861 171.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -165.26 -171.33 2.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.705 0.802 . . . . 0.0 110.354 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -123.03 122.44 38.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.65 0.78 . . . . 0.0 111.362 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.457 HD11 HG12 ' A' ' 7' ' ' VAL . 74.6 mt -69.02 136.99 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.445 1.098 . . . . 0.0 111.224 175.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 30.9 mmmt -136.58 -167.73 2.12 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 126.877 2.071 . . . . 0.0 107.697 -177.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -39.88 112.89 0.3 Allowed 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 125.187 1.395 . . . . 0.0 113.706 -166.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.02 106.93 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 95.6 t -90.11 109.53 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.395 0.678 . . . . 0.0 109.26 -174.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 108' ' ' LEU . 39.1 mt -91.26 115.98 28.46 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 t -151.66 129.66 11.79 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.781 0.832 . . . . 0.0 109.137 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.515 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 45.0 mt-10 -61.75 -21.26 64.38 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.374 0.67 . . . . 0.0 112.248 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -100.58 118.97 59.9 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.509 ' HG2' HD21 ' A' ' 87' ' ' LEU . 56.3 Cg_endo -69.16 -8.69 24.29 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.956 2.437 . . . . 0.0 113.085 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 50.6 mtm -79.9 -24.72 40.94 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.383 0.673 . . . . 0.0 111.205 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.552 HE21 ' N ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -60.33 -26.49 66.61 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.607 0.763 . . . . 0.0 111.527 175.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -76.71 -20.49 56.51 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.06 0.544 . . . . 0.0 111.116 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.478 ' HE2' HD22 ' A' ' 87' ' ' LEU . 30.2 m-85 -85.81 -38.36 18.25 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.822 0.449 . . . . 0.0 110.537 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 12.0 pt-20 -72.42 -23.48 61.09 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 120.34 0.114 . . . . 0.0 111.0 175.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.3 m -88.5 -44.33 10.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.236 0.614 . . . . 0.0 111.063 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.763 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 64.7 m-85 -118.11 -66.96 1.03 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.071 0.548 . . . . 0.0 110.332 -176.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.09 -81.21 0.68 Allowed Glycine 0 C--N 1.355 1.62 0 O-C-N 123.472 0.483 . . . . 0.0 113.304 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.89 -27.66 69.51 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.363 1.065 . . . . 0.0 111.499 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.763 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 38.6 mmt180 -81.38 -33.12 32.54 Favored 'General case' 0 C--O 1.209 -1.072 0 O-C-N 123.992 0.807 . . . . 0.0 111.975 -176.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.463 HG12 HD23 ' A' ' 82' ' ' LEU . 21.7 t -66.57 145.47 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 118.451 0.569 . . . . 0.0 110.459 -174.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.447 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 34.7 p90 -64.05 -17.25 63.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.463 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -140.31 158.18 44.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.3 t -95.27 179.56 5.14 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -65.51 -27.13 68.25 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.518 0.727 . . . . 0.0 111.518 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.91 -49.64 67.31 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.905 0.882 . . . . 0.0 110.506 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -62.65 -31.45 72.32 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.186 176.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.509 HD21 ' HG2' ' A' ' 69' ' ' PRO . 46.1 tp -67.78 -52.15 40.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.433 0.693 . . . . 0.0 111.093 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -63.18 -38.58 91.73 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.234 0.334 . . . . 0.0 111.366 -174.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.412 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 13.0 pt-20 -78.88 -23.68 44.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.728 0.411 . . . . 0.0 111.343 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.416 ' HD1' ' HE2' ' A' ' 13' ' ' LYS . 56.9 t80 -66.08 -38.96 89.6 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.378 0.671 . . . . 0.0 109.97 170.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.6 mtm -77.57 -30.82 52.77 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.454 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.8 mmpt? -71.14 -28.83 64.56 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.397 0.279 . . . . 0.0 110.516 171.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.2 t -62.91 -31.39 72.45 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.388 0.675 . . . . 0.0 110.83 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -73.99 -22.09 59.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.546 0.738 . . . . 0.0 112.22 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -103.12 -36.04 8.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.928 0.491 . . . . 0.0 111.638 -177.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -82.38 -34.71 28.26 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.342 0.257 . . . . 0.0 111.49 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -97.68 -42.03 7.83 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.73 -159.19 26.11 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.704 172.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -156.1 155.38 32.47 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 70.94 118.45 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.933 1.293 . . . . 0.0 111.168 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 102' ' ' GLU . 44.6 ttt85 -153.48 173.45 15.67 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.021 0.928 . . . . 0.0 108.754 -176.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.471 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 44.3 mt-10 77.2 108.75 0.08 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 125.286 1.434 . . . . 0.0 110.753 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.7 m -145.51 142.03 28.83 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.467 1.107 . . . . 0.0 108.822 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -64.43 140.52 58.88 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.465 ' HE2' ' HD3' ' A' ' 106' ' ' LYS . 1.8 tpmt? 72.75 148.17 0.09 Allowed 'General case' 0 N--CA 1.482 1.14 0 O-C-N 125.056 1.472 . . . . 0.0 110.301 -166.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -101.6 166.25 10.8 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.087 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 4.2 tmtp? -86.24 140.11 30.43 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 65' ' ' LEU . 2.8 tm? -74.28 107.83 6.69 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -89.04 161.85 16.33 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.552 0.741 . . . . 0.0 109.533 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.485 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 15.1 ptm -145.56 131.04 18.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.822 0.849 . . . . 0.0 109.781 -175.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -106.58 101.97 11.38 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.222 0.609 . . . . 0.0 109.56 -178.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.2 mt -78.4 115.46 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -80.95 133.75 35.58 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -177.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' ' 43' ' ' PHE . 3.3 mm? -122.92 122.3 38.25 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.455 0.702 . . . . 0.0 111.279 -174.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -124.41 165.23 18.1 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.572 0.749 . . . . 0.0 110.313 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.0 t70 50.23 53.25 13.2 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.124 1.37 . . . . 0.0 111.29 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.541 HG11 ' HB3' ' A' ' 19' ' ' PHE . 41.9 t -74.7 101.45 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.671 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -81.74 146.27 30.06 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.526 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -101.3 134.86 43.72 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.626 0.771 . . . . 0.0 109.337 171.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -86.43 88.14 7.57 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 170.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.24 -26.04 63.66 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.649 0.738 . . . . 0.0 109.066 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -81.24 135.98 50.19 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.645 173.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.06 91.94 1.15 Allowed 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.793 2.329 . . . . 0.0 112.573 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.5 mt -105.36 125.11 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.443 0.639 . . . . 0.0 110.651 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.63 148.35 34.46 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.703 1.201 . . . . 0.0 109.338 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.713 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 64.2 Cg_endo -77.9 178.43 7.61 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.194 2.596 . . . . 0.0 113.562 -170.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -84.74 -38.65 19.42 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.131 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -142.22 166.24 25.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.067 0.547 . . . . 0.0 110.832 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 129' ' ' LEU . 2.6 pt? -66.79 134.93 53.14 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 124.236 0.96 . . . . 0.0 109.779 174.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.466 HG12 ' HD3' ' A' ' 10' ' ' PRO . 41.0 t -118.29 102.23 50.62 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.93 178.9 2.55 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.326 2.684 . . . . 0.0 112.249 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.4 t -60.19 -31.74 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.77 0.828 . . . . 0.0 111.07 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.49 -12.53 77.28 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 115.572 -0.74 . . . . 0.0 114.287 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.65 157.83 16.96 Favored Glycine 0 C--N 1.35 1.357 0 C-N-CA 123.035 0.35 . . . . 0.0 113.662 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -117.83 147.23 43.25 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.709 0.803 . . . . 0.0 110.394 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -77.85 112.63 14.92 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 167.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.66 128.94 34.01 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -138.05 134.98 35.42 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.77 0.428 . . . . 0.0 110.521 -176.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 . . . . . 0 C--O 1.25 1.089 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.779 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 t -63.77 -11.09 23.6 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.544 1.137 . . . . 0.0 113.196 -172.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -59.47 -21.54 60.22 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 5' ' ' VAL . 24.9 mm 64.5 -173.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.599 0 C-N-CA 124.045 0.938 . . . . 0.0 108.55 -174.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.473 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.1 m -152.43 -42.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 158.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.63 -159.69 16.03 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.611 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 11.6 p -126.63 152.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 171.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 t -123.72 134.57 53.67 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -127.37 151.08 74.25 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.519 0.728 . . . . 0.0 110.01 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HG3' ' HA ' ' A' ' 132' ' ' VAL . 56.8 Cg_endo -65.87 -34.46 39.31 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.854 2.369 . . . . 0.0 111.868 175.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.4 mm 67.62 132.98 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.935 1.294 . . . . 0.0 111.198 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.23 110.66 0.68 Allowed 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 121.832 1.688 . . . . 0.0 109.74 165.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.788 ' HA ' ' HB2' ' A' ' 16' ' ' MET . 19.3 pttp -68.77 -3.89 13.98 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -174.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -66.83 -40.52 88.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.602 1.161 . . . . 0.0 109.063 170.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -116.54 16.52 15.54 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.316 1.046 . . . . 0.0 112.0 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.788 ' HB2' ' HA ' ' A' ' 13' ' ' LYS . 56.6 ttp -62.27 -47.04 86.12 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.087 0.555 . . . . 0.0 110.426 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.66 -2.48 20.27 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.906 -175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 1.9 mmm180 -63.19 -49.77 72.94 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.052 0.541 . . . . 0.0 110.3 173.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 51.1 m-85 -61.93 -29.08 69.99 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 124.007 0.817 . . . . 0.0 110.395 -178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -96.97 -12.86 22.82 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.205 1.002 . . . . 0.0 111.527 -174.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.69 -50.18 14.3 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.842 0.857 . . . . 0.0 109.479 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.4 ptpt -101.07 -16.64 17.02 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.06 -169.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.87 -11.32 48.16 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-O 119.839 -0.423 . . . . 0.0 114.118 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -159.73 117.54 2.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.028 0.931 . . . . 0.0 109.428 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.465 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 17.9 t70 -124.88 -176.21 3.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.248 1.019 . . . . 0.0 109.307 -172.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -132.27 110.33 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.148 0.979 . . . . 0.0 108.791 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -90.54 109.25 20.4 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 110.0 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.4 m -85.8 129.03 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.545 0.688 . . . . 0.0 111.121 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -112.65 142.42 27.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.896 1.278 . . . . 0.0 109.518 170.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.41 46.23 2.07 Favored 'Trans proline' 0 C--N 1.367 1.5 0 C-N-CA 122.692 2.262 . . . . 0.0 112.16 168.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.21 86.42 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.201 1.401 . . . . 0.0 112.495 -172.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -122.31 7.43 9.63 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.595 0.758 . . . . 0.0 109.842 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.425 ' HB ' ' OH ' ' A' ' 136' ' ' TYR . 14.1 m -127.92 150.16 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.385 1.074 . . . . 0.0 109.776 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -80.9 -172.81 3.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.307 0.643 . . . . 0.0 110.99 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -73.1 9.53 1.19 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -71.61 -29.43 64.67 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.875 0.47 . . . . 0.0 109.845 172.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.89 104.85 1.17 Allowed 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.055 0.542 . . . . 0.0 110.053 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -135.5 153.65 77.86 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 123.279 0.632 . . . . 0.0 109.784 -177.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.81 97.12 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.761 2.307 . . . . 0.0 111.094 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.45 43.48 0.1 OUTLIER Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.495 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.419 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 32.5 mtm -126.94 -171.59 2.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.79 0.836 . . . . 0.0 109.525 174.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 13.6 ptpt -112.7 158.54 19.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.276 0.63 . . . . 0.0 110.251 169.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.54 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.2 t80 -135.67 101.25 4.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 40.7 t -86.18 130.18 36.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -95.56 112.69 24.36 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.258 0.623 . . . . 0.0 109.455 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.573 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 90.1 t80 -75.11 150.32 38.83 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -82.64 72.28 9.72 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -177.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.645 ' HB3' ' HB3' ' A' ' 13' ' ' LYS . 92.1 p 51.37 -76.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 127.174 2.19 . . . . 0.0 114.627 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -170.82 176.0 4.31 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 124.542 1.137 . . . . 0.0 108.738 -172.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 71.63 -69.89 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.383 1.473 . . . . 0.0 111.038 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -69.37 118.13 11.86 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.476 0.711 . . . . 0.0 109.342 172.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.488 HG22 ' HD2' ' A' ' 126' ' ' PRO . 12.7 m -82.28 78.09 8.99 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.62 0.724 . . . . 0.0 109.414 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.536 ' HA2' ' HD3' ' A' ' 126' ' ' PRO . . . -165.14 162.35 35.63 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.186 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.46 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 62.9 m-85 -95.18 147.35 23.54 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.719 0.408 . . . . 0.0 110.059 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.457 HG11 ' SD ' ' A' ' 16' ' ' MET . 3.3 p -87.31 -30.12 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.661 0.784 . . . . 0.0 110.471 174.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.4 -157.76 20.37 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 120.062 -0.299 . . . . 0.0 112.768 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 16.2 pt-20 -154.17 178.61 9.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.179 0.992 . . . . 0.0 109.293 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -166.76 -172.66 2.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.01 0.924 . . . . 0.0 110.177 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 61.4 mmt-85 -128.22 125.5 39.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.858 0.863 . . . . 0.0 109.69 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.54 HG13 ' HB2' ' A' ' 43' ' ' PHE . 41.3 mt -73.63 137.08 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.199 1.0 . . . . 0.0 111.767 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -134.94 -176.88 4.39 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 126.879 2.072 . . . . 0.0 108.081 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -30.96 112.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.932 1.693 . . . . 0.0 114.328 -170.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 112' ' ' ILE . 27.5 m -91.61 106.26 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -88.22 110.78 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.4 mt -92.59 119.86 32.46 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.366 0.666 . . . . 0.0 109.436 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.2 t -151.51 134.24 15.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 44.4 mt-10 -74.67 -0.98 19.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.797 0.839 . . . . 0.0 112.299 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.682 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 12.9 m-80 -112.66 120.16 41.62 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.2 -20.84 55.89 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.342 2.028 . . . . 0.0 112.345 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 65.4 mtm -71.79 -24.63 61.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.184 0.994 . . . . 0.0 111.091 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.682 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 36.4 mm-40 -62.58 -28.89 70.19 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.875 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -76.31 -20.06 57.65 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.728 0.411 . . . . 0.0 111.185 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CE2' HD22 ' A' ' 87' ' ' LEU . 87.7 m-85 -93.45 -19.56 21.14 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.9 0.48 . . . . 0.0 111.09 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 9.1 pt-20 -84.8 -30.4 24.62 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.808 0.276 . . . . 0.0 110.573 168.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.3 m -80.39 -58.9 2.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.953 0.501 . . . . 0.0 110.644 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.64 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 85.8 m-85 -100.85 -69.68 0.77 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.73 -78.03 0.5 Allowed Glycine 0 C--N 1.353 1.516 0 O-C-N 123.5 0.5 . . . . 0.0 112.622 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.85 -44.68 91.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.756 1.222 . . . . 0.0 111.463 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.64 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 61.1 mmt-85 -64.97 -30.17 71.14 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.677 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.73 149.79 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.563 0.745 . . . . 0.0 111.142 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -65.5 -41.4 93.23 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.088 0.555 . . . . 0.0 112.355 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -109.55 169.03 8.97 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.466 HG22 ' HG2' ' A' ' 86' ' ' GLU . 8.8 t -98.26 168.36 10.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 172.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -68.17 -25.69 65.38 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.201 0.524 . . . . 0.0 111.375 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.7 -52.57 65.11 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.519 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.466 ' HG2' HG22 ' A' ' 83' ' ' THR . 48.6 mm-40 -57.78 -35.11 70.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.736 0.414 . . . . 0.0 110.78 176.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.419 HD22 ' CE2' ' A' ' 73' ' ' PHE . 26.5 tp -62.12 -57.27 12.19 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.945 0.898 . . . . 0.0 111.56 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -38.72 85.53 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -172.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -79.16 -27.48 42.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.688 0.395 . . . . 0.0 111.512 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -65.92 -41.67 91.08 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.269 0.628 . . . . 0.0 110.267 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 62.5 mtm -72.1 -30.03 64.68 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.763 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -73.86 -33.94 64.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.97 0.508 . . . . 0.0 110.678 171.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 m -65.09 -26.6 68.29 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.359 0.663 . . . . 0.0 111.441 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -64.47 -47.15 80.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.616 0.366 . . . . 0.0 110.454 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.43 -30.33 23.64 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -172.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -82.35 -42.65 18.44 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.461 0.573 . . . . 0.0 111.864 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -84.2 -20.82 31.71 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.504 0.322 . . . . 0.0 110.855 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.9 -97.12 0.26 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -149.79 -64.61 0.22 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.602 1.161 . . . . 0.0 108.46 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -169.23 158.19 8.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.979 1.312 . . . . 0.0 109.308 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -159.79 116.6 2.56 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.76 162.85 22.76 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.412 1.085 . . . . 0.0 110.031 -175.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.4 m -54.25 -57.37 11.47 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.72 0.637 . . . . 0.0 110.323 176.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.493 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 6.8 mmpt? 50.35 -84.18 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.289 1.435 . . . . 0.0 112.778 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.635 ' HG3' ' HD2' ' A' ' 106' ' ' LYS . 1.0 OUTLIER -156.18 159.03 38.61 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.994 0.918 . . . . 0.0 109.33 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.635 ' HD2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -72.52 170.31 14.63 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.787 175.086 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -124.28 144.4 50.0 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.047 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.604 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 2.9 tm? -68.41 108.31 3.21 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -97.1 161.14 13.96 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.0 ptm -143.94 131.22 20.81 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.668 0.787 . . . . 0.0 109.568 -174.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.34 101.97 11.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.566 0.746 . . . . 0.0 109.107 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.419 ' HA ' HG12 ' A' ' 63' ' ' VAL . 36.9 mt -80.2 120.36 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -83.93 139.24 32.71 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.8 mm? -120.69 121.28 37.93 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.616 1.167 . . . . 0.0 109.026 -177.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -113.94 171.34 7.65 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.011 0.924 . . . . 0.0 108.894 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.4 t70 52.07 46.79 26.01 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.365 1.066 . . . . 0.0 112.167 166.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.9 t -74.88 108.25 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.534 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.76 153.68 20.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.004 0.922 . . . . 0.0 110.302 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -108.26 136.69 47.49 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.739 0.816 . . . . 0.0 110.379 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.46 ' HD2' ' HB2' ' A' ' 54' ' ' PHE . 10.1 m-30 -95.93 78.8 3.23 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.613 0.765 . . . . 0.0 109.128 172.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.95 -24.96 63.43 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.903 169.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.537 ' HG3' HG13 ' A' ' 124' ' ' ILE . 18.5 ptpt -81.7 145.57 54.61 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.385 1.074 . . . . 0.0 109.344 171.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.81 77.26 3.97 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.936 2.424 . . . . 0.0 113.076 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.537 HG13 ' HG3' ' A' ' 122' ' ' LYS . 54.2 mt -86.37 128.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -109.3 146.48 34.02 Favored Pre-proline 0 C--O 1.242 0.668 0 C-N-CA 123.943 0.897 . . . . 0.0 109.351 -177.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.536 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 10.3 Cg_exo -73.26 147.04 41.45 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 122.879 2.386 . . . . 0.0 112.397 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -70.12 -26.49 63.98 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.647 0.779 . . . . 0.0 109.273 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -144.62 159.23 43.16 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.202 1.001 . . . . 0.0 109.439 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.5 133.21 38.62 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.0 t -105.85 95.31 10.42 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.45 -175.48 2.7 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.056 2.504 . . . . 0.0 111.957 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.585 ' HA ' ' HG3' ' A' ' 10' ' ' PRO . 27.1 m -57.74 -26.63 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.331 1.052 . . . . 0.0 113.816 -174.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.14 -22.22 74.24 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.259 0.349 . . . . 0.0 113.607 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.08 149.0 8.19 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 112.362 -0.295 . . . . 0.0 112.362 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -108.8 135.94 49.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.508 0.723 . . . . 0.0 109.829 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.425 ' OH ' ' HB ' ' A' ' 33' ' ' VAL . 1.6 m-85 -76.26 109.74 10.2 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.72 114.14 18.41 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -125.99 138.82 53.77 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.475 178.655 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 121.539 0.685 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -73.93 -17.46 61.02 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.915 -166.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -67.23 -16.32 64.22 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 5' ' ' VAL . 27.1 mm 65.73 -171.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -143.49 -39.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 157.464 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.472 ' HA3' ' HG3' ' A' ' 42' ' ' LYS . . . -167.52 -164.35 23.04 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.438 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.448 HG12 HD11 ' A' ' 60' ' ' ILE . 10.9 p -132.08 144.43 37.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 t -113.87 137.64 51.39 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -132.66 145.12 55.8 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.884 0.874 . . . . 0.0 109.21 178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HD3' HG12 ' A' ' 130' ' ' VAL . 30.2 Cg_endo -61.96 -25.04 77.54 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.962 2.442 . . . . 0.0 112.016 173.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.9 mm 68.75 134.03 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.057 1.343 . . . . 0.0 111.913 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -54.62 114.43 1.84 Allowed 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.546 2.164 . . . . 0.0 110.25 169.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -63.47 -28.03 69.68 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.287 1.035 . . . . 0.0 113.436 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -61.43 -36.24 79.8 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.146 0.498 . . . . 0.0 110.46 172.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -107.91 19.15 20.42 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.143 -172.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.401 ' SD ' HG21 ' A' ' 55' ' ' VAL . 16.0 tmm? -66.94 -32.78 74.26 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.626 0.77 . . . . 0.0 110.153 175.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.32 -33.87 77.0 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.238 1.015 . . . . 0.0 112.195 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 81' ' ' PHE . 11.0 mmt180 -54.09 -52.92 59.47 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.655 1.182 . . . . 0.0 113.277 -164.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 47.9 m-85 -60.24 -29.36 68.71 Favored 'General case' 0 CA--C 1.554 1.104 0 O-C-N 124.121 0.888 . . . . 0.0 110.743 -174.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -94.7 -24.76 17.0 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.415 1.086 . . . . 0.0 110.674 -176.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.22 -42.73 79.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.92 1.288 . . . . 0.0 111.028 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 13.7 ptpt -109.33 -16.43 14.04 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.238 -171.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.93 -14.85 9.35 Favored Glycine 0 N--CA 1.479 1.503 0 N-CA-C 114.191 0.436 . . . . 0.0 114.191 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -150.06 105.64 3.4 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.668 1.187 . . . . 0.0 108.94 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.5 t70 -107.32 174.73 5.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 110.585 -175.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -133.88 109.07 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.435 ' HD2' HD12 ' A' ' 112' ' ' ILE . 76.9 t80 -91.12 108.92 20.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.337 0.655 . . . . 0.0 109.577 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 m -94.45 132.93 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.516 0.674 . . . . 0.0 110.673 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.645 ' HD3' ' HD2' ' A' ' 30' ' ' PRO . 14.9 tppt? -134.84 133.24 20.94 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.349 1.06 . . . . 0.0 108.793 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.645 ' HD2' ' HD3' ' A' ' 29' ' ' LYS . 59.5 Cg_endo -71.73 66.97 3.07 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.669 2.246 . . . . 0.0 113.2 172.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 55.07 17.02 1.74 Allowed 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.158 1.383 . . . . 0.0 114.672 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 m -70.32 -28.37 65.11 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.225 0.61 . . . . 0.0 110.875 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.45 HG23 ' HG2' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -87.6 148.62 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -87.72 -168.11 2.11 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.173 0.589 . . . . 0.0 110.917 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -74.58 -1.25 20.68 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -170.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.11 -30.59 70.45 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.967 0.507 . . . . 0.0 110.815 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.84 98.38 0.73 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.29 1.036 . . . . 0.0 111.55 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HG3' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -122.28 156.27 60.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.835 1.254 . . . . 0.0 108.883 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.82 107.0 2.11 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.256 1.971 . . . . 0.0 111.472 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.45 31.65 0.46 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.225 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.641 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 88.8 mtp -112.55 -173.99 2.36 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.911 0.884 . . . . 0.0 110.669 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.472 ' HG3' ' HA3' ' A' ' 6' ' ' GLY . 15.2 ptpt -116.85 156.44 27.3 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.387 1.075 . . . . 0.0 109.599 172.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.502 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -136.05 100.15 4.34 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 177.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.1 t -86.3 124.42 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.245 0.545 . . . . 0.0 110.131 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.422 ' HE2' HG13 ' A' ' 117' ' ' VAL . 25.7 m-85 -89.4 106.7 18.62 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.633 0.773 . . . . 0.0 109.876 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.406 ' HA ' ' CD1' ' A' ' 54' ' ' PHE . 78.3 t80 -77.94 155.92 30.55 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.94 1.4 . . . . 0.0 111.401 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 56.04 -172.19 0.07 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.282 1.833 . . . . 0.0 111.588 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.4 t -165.91 -164.06 0.68 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.246 0.618 . . . . 0.0 109.65 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -56.88 -37.97 72.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.668 0.787 . . . . 0.0 110.359 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -127.26 175.58 8.06 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.945 0.898 . . . . 0.0 110.436 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -77.23 82.94 3.71 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.786 0.834 . . . . 0.0 109.553 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.7 p -121.76 7.92 9.97 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.141 0.976 . . . . 0.0 111.505 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.42 -67.59 3.04 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.238 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 46' ' ' TYR . 98.4 m-85 -132.44 174.01 10.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.249 1.019 . . . . 0.0 109.947 175.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.401 HG21 ' SD ' ' A' ' 16' ' ' MET . 7.7 p -118.31 -34.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.784 0.834 . . . . 0.0 110.449 173.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.13 -160.04 23.37 Favored Glycine 0 C--N 1.35 1.355 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.972 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.521 ' HG3' ' HB3' ' A' ' 118' ' ' LYS . 7.3 pt-20 -152.19 177.55 10.41 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.69 1.196 . . . . 0.0 109.526 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.494 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.59 -172.3 3.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.938 0.895 . . . . 0.0 110.035 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.8 mmt-85 -123.91 122.3 37.61 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.802 0.841 . . . . 0.0 109.952 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.641 ' HB ' ' HB2' ' A' ' 41' ' ' MET . 36.3 mt -74.56 128.49 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.856 0.862 . . . . 0.0 109.86 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.589 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 31.6 mmmt -132.49 -167.96 1.98 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 125.433 1.493 . . . . 0.0 107.609 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -41.7 113.22 0.4 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.702 1.201 . . . . 0.0 113.69 -163.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.18 111.91 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.738 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.7 109.68 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.19 117.84 26.2 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -148.62 127.39 12.56 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.316 1.047 . . . . 0.0 109.052 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 34.7 mt-10 -65.68 -20.94 66.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.607 0.763 . . . . 0.0 111.921 176.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -99.81 118.0 62.57 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.44 ' HG2' ' SD ' ' A' ' 70' ' ' MET . 40.6 Cg_endo -67.47 -18.6 49.3 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.196 1.931 . . . . 0.0 112.855 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.44 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.2 mpp? -73.63 -25.63 60.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.754 0.421 . . . . 0.0 111.008 -173.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -64.4 -22.78 67.07 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.691 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -78.3 -30.83 48.55 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.022 0.529 . . . . 0.0 110.93 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.512 ' CE2' HD22 ' A' ' 87' ' ' LEU . 92.7 m-85 -82.74 -16.11 49.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.664 0.386 . . . . 0.0 111.915 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.83 -32.03 16.23 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.668 0.213 . . . . 0.0 110.794 171.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 92.8 m -76.75 -41.42 44.93 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 120.848 0.356 . . . . 0.0 111.109 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.712 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 44.0 m-85 -117.83 -67.29 1.0 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.426 0.69 . . . . 0.0 109.219 -175.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.06 -97.84 2.1 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.105 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.71 -22.15 61.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.8 0.44 . . . . 0.0 110.855 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.712 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 31.8 mmt180 -59.91 -37.78 80.42 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.007 0.523 . . . . 0.0 111.294 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.482 HG12 HD23 ' A' ' 82' ' ' LEU . 39.0 t -62.74 145.08 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 O-C-N 123.729 0.643 . . . . 0.0 109.767 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 41.2 p90 -60.06 -20.1 56.32 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.482 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -133.56 164.87 26.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.6 t -98.36 176.33 5.74 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.645 0.657 . . . . 0.0 109.435 173.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -61.63 -29.44 70.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.195 0.598 . . . . 0.0 111.196 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.46 ' H ' HG23 ' A' ' 83' ' ' THR . 3.2 m-20 -65.96 -45.83 80.34 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.954 0.902 . . . . 0.0 111.409 174.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.4 -36.34 83.4 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.183 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.512 HD22 ' CE2' ' A' ' 73' ' ' PHE . 27.1 tp -60.56 -54.81 40.93 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.469 0.708 . . . . 0.0 110.985 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -64.03 -42.51 97.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.158 -172.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -70.28 -31.11 68.33 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.35 0.26 . . . . 0.0 110.729 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 76.0 t80 -65.09 -43.62 91.52 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.652 0.781 . . . . 0.0 110.482 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 61.4 mtm -74.82 -31.65 61.74 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.365 0.666 . . . . 0.0 110.824 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 31.9 mmmt -69.76 -28.09 65.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.126 0.571 . . . . 0.0 110.691 172.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.7 m -74.32 -41.33 61.28 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.965 0.506 . . . . 0.0 110.045 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 90.1 mm-40 -60.74 -46.28 91.04 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.658 0.383 . . . . 0.0 111.565 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.82 -24.86 65.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.862 0.465 . . . . 0.0 112.143 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -97.22 -30.71 12.83 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.69 0.396 . . . . 0.0 111.402 -174.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -89.19 -26.05 21.46 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.692 0.397 . . . . 0.0 111.092 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -155.12 -148.45 5.01 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? 66.58 101.25 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.679 1.192 . . . . 0.0 111.653 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -73.95 -68.57 0.5 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.376 0.67 . . . . 0.0 110.465 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -155.22 103.55 2.37 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -79.31 -168.38 1.49 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.585 0.754 . . . . 0.0 112.15 -170.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -61.25 -11.62 10.2 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.477 1.111 . . . . 0.0 113.876 -171.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.9 tptt 62.63 26.85 15.9 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 123.037 1.399 . . . . 0.0 109.316 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.528 ' HG3' ' HD2' ' A' ' 106' ' ' LYS . 1.1 tpmt? -163.61 162.76 24.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.64 -174.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.528 ' HD2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -71.62 147.21 47.79 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -93.38 150.28 20.58 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.0 0.52 . . . . 0.0 109.728 178.083 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 3.1 tm? -69.29 122.95 19.91 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -106.04 156.25 18.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.489 0.715 . . . . 0.0 109.348 171.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.7 ptm -131.57 129.17 40.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.093 0.957 . . . . 0.0 108.828 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.69 102.24 11.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 60' ' ' ILE . 33.8 mt -82.61 121.31 35.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.14 101.43 8.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.494 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.1 mm? -87.11 120.56 28.51 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 122.902 0.481 . . . . 0.0 109.779 175.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.589 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 2.1 pp20? -138.34 168.8 18.98 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.1 t70 60.76 30.05 19.42 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.781 0.833 . . . . 0.0 110.654 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.422 HG13 ' HE2' ' A' ' 45' ' ' PHE . 61.0 t -61.19 118.11 3.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.219 -171.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . 1.6 tpmt? -102.01 152.39 21.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.069 0.947 . . . . 0.0 110.654 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -106.07 138.54 42.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.985 0.914 . . . . 0.0 109.396 174.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -87.18 90.68 8.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.05 -34.63 77.98 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.695 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -85.76 139.37 35.28 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.196 172.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.35 89.15 1.37 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.794 2.329 . . . . 0.0 111.742 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 21.2 mt -72.42 130.24 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.096 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 142.92 57.64 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.014 0.526 . . . . 0.0 109.623 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.02 155.74 19.93 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.404 2.069 . . . . 0.0 113.307 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -74.21 -25.83 59.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.825 173.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -170.49 173.6 5.49 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.194 0.998 . . . . 0.0 109.697 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -67.14 128.18 35.4 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 166.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.467 HG12 ' HD3' ' A' ' 10' ' ' PRO . 78.9 t -101.03 103.63 26.71 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.87 -177.81 1.74 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.229 2.619 . . . . 0.0 113.33 -174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.0 m -61.46 -27.19 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.981 0.913 . . . . 0.0 112.639 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.7 -15.32 75.94 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.183 0.302 . . . . 0.0 113.12 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.28 169.21 39.47 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.351 0.501 . . . . 0.0 112.928 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -120.65 146.51 46.33 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.008 0.923 . . . . 0.0 109.783 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -87.51 118.18 26.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.015 0.526 . . . . 0.0 110.141 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tt -84.7 128.0 34.38 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 172.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.439 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -133.1 136.96 46.15 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.794 0.438 . . . . 0.0 110.516 -175.009 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 CA--C 1.554 1.133 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.414 177.92 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 14.7 tpt . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.4 t -54.18 -18.36 3.73 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.721 1.208 . . . . 0.0 114.1 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -61.03 -21.52 63.69 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.439 1.096 . . . . 0.0 113.545 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.446 HG22 ' H ' ' A' ' 5' ' ' VAL . 26.2 mm 66.25 -174.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 124.408 1.083 . . . . 0.0 109.596 -175.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 139' ' ' GLU . 2.7 m -154.73 -40.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 125.269 1.427 . . . . 0.0 108.511 158.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 41' ' ' MET . . . -169.15 -159.15 14.15 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.204 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 12.6 p -126.68 160.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 t -135.41 139.59 44.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.276 0.63 . . . . 0.0 109.864 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -136.65 142.2 38.19 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.011 0.924 . . . . 0.0 109.789 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HD3' HG12 ' A' ' 130' ' ' VAL . 47.9 Cg_endo -69.03 -35.56 14.53 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.694 2.263 . . . . 0.0 111.226 168.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.7 mt 61.23 100.95 0.04 OUTLIER Pre-proline 0 C--N 1.361 1.098 0 C-N-CA 125.523 1.529 . . . . 0.0 110.928 -175.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.73 -179.4 2.87 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.456 2.104 . . . . 0.0 111.451 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.536 ' HG3' ' H ' ' A' ' 14' ' ' ARG . 31.8 tptt 67.86 -176.38 0.2 Allowed 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.744 0.818 . . . . 0.0 109.703 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.536 ' H ' ' HG3' ' A' ' 13' ' ' LYS . 79.8 mtp180 -76.79 -15.09 59.84 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.316 0.646 . . . . 0.0 112.245 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.527 ' CZ ' ' HG2' ' A' ' 86' ' ' GLU . 11.5 m-30 -74.28 7.52 2.76 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -165.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.623 ' SD ' HG11 ' A' ' 55' ' ' VAL . 18.2 tmm? -67.7 -44.54 77.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.217 0.607 . . . . 0.0 109.584 168.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.07 -15.71 63.51 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.859 0.864 . . . . 0.0 113.088 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG2' ' HA ' ' A' ' 15' ' ' PHE . 20.4 mmt180 -51.82 -50.9 59.92 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.138 0.975 . . . . 0.0 111.685 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.604 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 22.5 m-85 -62.33 -29.03 70.16 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.294 -170.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -93.06 -29.09 15.98 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.322 1.049 . . . . 0.0 110.411 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -63.06 -46.39 87.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.019 0.928 . . . . 0.0 110.638 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 14.6 ptpt -101.88 -15.35 16.9 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.356 -172.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.11 -7.71 27.99 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -159.31 107.14 1.78 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.6 1.16 . . . . 0.0 108.279 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.604 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 14.4 t70 -115.68 177.61 4.61 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.984 0.913 . . . . 0.0 109.773 -176.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -132.65 108.98 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -87.93 107.38 18.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 0.0 109.917 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 m -90.07 125.76 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 121.566 0.698 . . . . 0.0 110.906 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 7.4 mmpt? -108.96 131.58 21.71 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.924 1.29 . . . . 0.0 109.606 174.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.13 54.55 4.97 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.066 2.511 . . . . 0.0 112.267 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 57.6 87.17 0.07 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.609 1.164 . . . . 0.0 111.001 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 29.1 m -130.65 -68.72 0.68 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.49 0.716 . . . . 0.0 109.344 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -109.0 106.74 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -137.2 -10.67 1.7 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.234 1.014 . . . . 0.0 110.391 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -64.78 -55.7 18.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.211 1.004 . . . . 0.0 110.651 -170.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -102.41 -9.01 20.65 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.085 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 110.7 3.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.137 0.575 . . . . 0.0 110.979 -173.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -139.12 150.81 66.12 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.125 0.57 . . . . 0.0 109.476 177.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 105.85 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.838 2.359 . . . . 0.0 111.329 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.1 -17.93 1.74 Allowed Glycine 0 N--CA 1.467 0.716 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.417 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.486 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 29.2 mtm -75.28 -179.82 4.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.547 0.689 . . . . 0.0 111.418 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -106.63 161.69 14.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.931 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -137.24 104.73 5.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.97 134.77 27.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -97.67 102.49 14.26 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.459 ' HD2' ' HB3' ' A' ' 10' ' ' PRO . 88.1 t80 -70.4 153.42 43.0 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.083 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 69.12 143.47 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.523 1.129 . . . . 0.0 111.222 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.638 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 48.1 m -105.03 178.66 4.5 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.064 0.546 . . . . 0.0 110.77 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -64.07 92.44 0.08 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.527 0.731 . . . . 0.0 109.355 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 75.46 -51.26 0.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.271 1.828 . . . . 0.0 111.95 -167.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.04 162.17 14.63 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.13 0.972 . . . . 0.0 112.977 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.3 m -98.23 142.28 30.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.537 1.135 . . . . 0.0 111.02 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.506 ' HA2' ' HD3' ' A' ' 126' ' ' PRO . . . 137.81 -114.02 1.05 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 176.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -144.56 140.63 28.92 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.248 1.019 . . . . 0.0 108.27 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.638 ' HB ' ' HA ' ' A' ' 48' ' ' SER . 7.3 p -90.11 -34.19 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.697 0.399 . . . . 0.0 111.289 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.06 -160.22 26.36 Favored Glycine 0 C--N 1.345 1.055 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.425 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -149.93 176.95 10.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.288 1.035 . . . . 0.0 109.215 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -167.01 -179.02 4.44 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.977 0.911 . . . . 0.0 110.44 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -120.34 125.33 47.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.621 0.768 . . . . 0.0 110.49 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.17 130.72 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.54 1.136 . . . . 0.0 110.822 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -126.74 -178.86 4.54 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 125.381 1.472 . . . . 0.0 108.94 176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -29.76 113.62 0.09 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.358 1.863 . . . . 0.0 114.562 -172.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.76 109.09 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.643 0.735 . . . . 0.0 109.06 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 96.6 t -87.86 109.41 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.2 mt -89.48 121.65 31.91 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.536 0.734 . . . . 0.0 109.399 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 t -149.79 140.31 22.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.502 0.721 . . . . 0.0 110.07 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.537 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 25.6 mt-10 -80.15 -9.4 59.71 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.519 177.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 73.7 m-20 -112.12 119.76 43.32 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 169.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HG2' HD21 ' A' ' 87' ' ' LEU . 38.3 Cg_endo -67.38 -15.22 45.06 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.903 2.402 . . . . 0.0 113.056 174.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.43 ' SD ' ' HG2' ' A' ' 69' ' ' PRO . 4.5 mpp? -74.41 -22.87 58.95 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.22 0.608 . . . . 0.0 111.013 -176.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.528 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 56.8 mt-30 -69.28 -26.51 64.79 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.628 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -71.58 -20.46 62.0 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.77 0.428 . . . . 0.0 111.312 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.551 ' HE2' HD22 ' A' ' 87' ' ' LEU . 24.9 m-85 -88.01 -39.99 14.23 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.828 0.451 . . . . 0.0 110.766 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 13.1 pt-20 -69.28 -27.59 65.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 120.542 0.21 . . . . 0.0 110.575 174.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.0 m -82.89 -61.29 1.91 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 123.042 0.537 . . . . 0.0 110.612 177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.72 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 56.0 m-85 -102.62 -67.78 0.86 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.215 0.606 . . . . 0.0 109.715 -177.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 73' ' ' PHE . . . 75.3 -87.33 0.8 Allowed Glycine 0 C--N 1.352 1.436 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.656 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -56.25 -36.52 68.62 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.019 1.327 . . . . 0.0 111.732 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.72 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 34.4 mmt180 -69.35 -36.95 77.38 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.062 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.5 HG12 HD23 ' A' ' 82' ' ' LEU . 21.2 t -64.6 148.97 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -65.35 -8.64 19.34 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 2.2 pt? -149.79 168.71 22.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.936 0.895 . . . . 0.0 109.11 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.0 t -112.36 -176.5 2.93 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 172.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -59.69 -33.66 71.88 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.67 0.788 . . . . 0.0 111.922 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.454 ' H ' HG23 ' A' ' 83' ' ' THR . 15.7 m-20 -62.69 -43.33 99.08 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.052 0.541 . . . . 0.0 111.222 175.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 1.6 mp0 -73.0 -25.16 60.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.505 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.551 HD22 ' HE2' ' A' ' 73' ' ' PHE . 53.6 tp -70.69 -48.89 52.37 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.835 0.454 . . . . 0.0 110.491 176.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -65.76 -39.2 90.8 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.31 0.381 . . . . 0.0 110.964 -176.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 6.2 pt-20 -69.79 -33.29 72.17 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.025 0.203 . . . . 0.0 110.828 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.472 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 55.7 t80 -67.16 -43.8 81.37 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.197 0.599 . . . . 0.0 110.522 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 73.7 mtm -71.06 -40.15 71.82 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.421 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.0 mmpt? -67.26 -30.74 70.71 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 119.803 -0.142 . . . . 0.0 110.64 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.2 t -60.99 -44.65 97.09 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.753 0.821 . . . . 0.0 110.815 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 82.5 mm-40 -75.11 -1.81 24.74 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.688 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.505 ' HB3' ' HG2' ' A' ' 100' ' ' ARG . 11.7 pt-20 -121.85 -22.37 5.78 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 175.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 15.1 ptp180 -88.25 -49.54 6.92 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 118.44 0.564 . . . . 0.0 109.621 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -81.15 -38.52 27.03 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -90.77 -138.91 7.8 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.255 175.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -165.33 133.86 3.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.055 0.542 . . . . 0.0 110.294 -174.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.505 ' HG2' ' HB3' ' A' ' 95' ' ' GLU . 8.5 ptp85 -166.84 148.83 6.23 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.846 0.858 . . . . 0.0 109.834 171.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 178.05 78.0 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.702 1.201 . . . . 0.0 109.355 172.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -171.59 127.21 0.64 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.381 0.673 . . . . 0.0 110.001 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 t 58.22 96.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.179 1.392 . . . . 0.0 111.744 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.64 93.65 2.57 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 173.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -134.09 156.44 48.27 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.774 1.229 . . . . 0.0 108.868 -171.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HG3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -74.4 179.81 4.39 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.22 0.608 . . . . 0.0 110.365 173.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 140.66 40.73 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.21 95.3 4.27 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -84.23 155.78 22.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 171.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.464 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 12.3 ptm -136.61 129.55 30.96 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -104.74 100.78 10.42 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -176.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.6 mt -82.18 114.31 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -80.63 102.31 9.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 58' ' ' ALA . 4.2 mm? -86.4 109.27 18.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.19 0.596 . . . . 0.0 110.694 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -106.97 174.51 5.86 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.4 t70 60.2 35.28 21.01 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.03 0.932 . . . . 0.0 111.348 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.38 102.95 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.347 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.91 154.76 23.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.509 1.124 . . . . 0.0 110.362 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -110.6 136.17 50.11 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.031 0.933 . . . . 0.0 110.067 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -91.05 86.92 6.38 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.06 -27.72 64.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.509 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.04 137.68 49.64 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.358 1.063 . . . . 0.0 109.537 171.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -76.43 95.63 1.05 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.751 2.301 . . . . 0.0 111.84 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.4 mt -87.97 128.24 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.857 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -86.26 129.28 54.18 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.011 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.506 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 35.1 Cg_endo -68.06 150.0 77.24 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.511 2.14 . . . . 0.0 113.961 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -67.85 -38.58 83.31 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.042 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.5 ptm85 -154.02 176.07 12.65 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.05 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.66 118.5 19.36 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.72 172.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.46 HG12 ' HD3' ' A' ' 10' ' ' PRO . 80.7 t -98.97 100.97 10.92 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.48 177.85 2.47 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.363 2.709 . . . . 0.0 112.528 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.58 -34.37 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 123.952 0.901 . . . . 0.0 111.849 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 -13.62 71.67 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.68 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.19 176.2 51.36 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 123.543 0.592 . . . . 0.0 112.939 175.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -126.27 137.28 53.5 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.54 106.82 4.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 166.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.09 124.71 27.49 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -134.5 119.98 19.15 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.457 ' HB3' HG11 ' A' ' 5' ' ' VAL . 12.5 tp10 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 m -64.95 -8.47 15.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -173.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -66.69 -21.83 66.08 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.977 0.511 . . . . 0.0 111.616 172.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 5' ' ' VAL . 22.7 mm 63.46 -166.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 124.621 1.168 . . . . 0.0 108.526 -175.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.549 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.7 m -151.99 -42.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 156.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.22 -161.13 20.2 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.397 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.41 136.65 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.575 0.75 . . . . 0.0 109.504 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 t -103.16 134.13 47.1 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.515 0.726 . . . . 0.0 109.584 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.65 123.15 11.65 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 123.514 0.726 . . . . 0.0 110.205 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.611 ' HD3' HG12 ' A' ' 130' ' ' VAL . 74.0 Cg_endo -80.26 94.55 1.01 Allowed 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.419 2.079 . . . . 0.0 109.54 165.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.42 110.64 2.89 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.191 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -85.06 33.66 0.49 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.436 2.757 . . . . 0.0 111.683 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HG3' ' HD2' ' A' ' 15' ' ' PHE . 49.9 tptt -141.09 144.5 34.94 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -170.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -74.23 10.08 1.4 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.574 0.75 . . . . 0.0 112.611 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.427 ' HD2' ' HG3' ' A' ' 13' ' ' LYS . 97.6 m-85 -111.79 25.02 12.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.232 1.013 . . . . 0.0 111.758 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.553 ' SD ' HG11 ' A' ' 55' ' ' VAL . 45.2 ttm -62.08 -36.73 82.55 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.667 0.746 . . . . 0.0 109.549 166.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.32 -23.19 67.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.029 1.331 . . . . 0.0 112.417 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -59.58 -42.48 92.59 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.507 0.723 . . . . 0.0 112.09 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -65.28 -30.97 71.88 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.758 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -92.03 -16.07 26.97 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.723 0.809 . . . . 0.0 110.792 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -73.98 -49.94 22.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.389 1.076 . . . . 0.0 109.797 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -110.86 -15.61 13.75 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -172.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.92 8.3 63.92 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 113.992 0.357 . . . . 0.0 113.992 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -159.69 86.85 0.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.966 1.306 . . . . 0.0 107.744 -173.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -134.93 -178.03 4.9 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.795 0.838 . . . . 0.0 108.976 -171.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -139.7 121.51 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.265 0.939 . . . . 0.0 109.764 -171.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -98.0 114.47 26.61 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.646 0.778 . . . . 0.0 109.167 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.0 m -92.18 133.48 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.24 0.543 . . . . 0.0 111.091 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 6.0 mmpt? -119.56 130.51 24.8 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.352 1.461 . . . . 0.0 110.113 178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.25 55.52 5.1 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.07 2.513 . . . . 0.0 111.484 169.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 56.47 27.66 12.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.571 1.148 . . . . 0.0 112.923 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.479 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 4.5 m -64.33 -39.31 93.64 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.698 0.799 . . . . 0.0 110.389 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.5 m -82.71 151.14 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.285 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -80.47 -173.95 4.36 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.502 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -65.05 -18.11 65.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.498 1.119 . . . . 0.0 112.902 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -59.12 -22.56 61.05 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.37 0.668 . . . . 0.0 111.515 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 94.39 0.32 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.046 0.538 . . . . 0.0 110.328 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 3.7 ptpp? -109.66 157.78 36.57 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.55 55.46 5.32 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.212 2.608 . . . . 0.0 112.175 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.94 43.76 0.2 Allowed Glycine 0 C--O 1.239 0.467 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.786 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.521 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 30.9 mtm -130.11 -173.01 2.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.623 1.169 . . . . 0.0 111.074 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.75 165.23 12.76 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.55 1.14 . . . . 0.0 110.518 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.408 ' CB ' HD11 ' A' ' 114' ' ' LEU . 4.1 t80 -136.2 101.95 4.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 34.2 t -90.54 108.15 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.214 0.53 . . . . 0.0 110.193 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -75.61 120.36 20.91 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.754 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' PHE . 33.1 t80 -105.59 161.56 14.26 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.595 1.158 . . . . 0.0 110.134 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 66.25 76.57 0.31 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.297 1.439 . . . . 0.0 109.655 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.4 t -60.22 153.85 21.26 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.998 -172.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -57.13 -31.8 65.71 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.231 173.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -106.91 -66.01 1.05 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.842 0.857 . . . . 0.0 110.985 -175.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -97.21 -177.2 3.76 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.767 0.827 . . . . 0.0 111.458 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.1 m -111.82 94.3 4.88 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.432 0.693 . . . . 0.0 109.546 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.26 -173.33 44.23 Favored Glycine 0 C--O 1.243 0.675 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 19.7 m-85 -61.42 108.8 1.0 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 172.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG11 ' SD ' ' A' ' 16' ' ' MET . 2.7 p -67.59 -34.74 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 122.996 0.518 . . . . 0.0 110.771 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.93 -165.71 33.76 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.58 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 17.2 pt-20 -141.17 176.75 8.58 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.05 0.94 . . . . 0.0 108.952 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.471 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -160.69 -173.84 4.15 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.077 0.951 . . . . 0.0 109.304 176.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -125.94 119.49 27.89 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.726 0.81 . . . . 0.0 109.494 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.8 mt -71.54 129.78 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 124.397 1.061 . . . . 0.0 110.669 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -132.29 177.26 7.72 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 126.187 1.795 . . . . 0.0 109.006 -174.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -30.35 111.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 125.463 1.727 . . . . 0.0 114.113 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 112' ' ' ILE . 34.0 m -87.97 123.93 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.288 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 99.0 t -90.02 107.18 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.591 ' HB3' HD11 ' A' ' 108' ' ' LEU . 77.1 mt -88.43 116.76 26.88 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.6 t -153.07 135.76 15.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.644 0.778 . . . . 0.0 110.323 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.12 -34.62 78.47 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.84 0.856 . . . . 0.0 111.669 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.432 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 79.1 m-20 -94.41 120.17 65.51 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.004 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.557 ' HG2' HD21 ' A' ' 87' ' ' LEU . 61.1 Cg_endo -72.5 -7.11 20.31 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.082 2.521 . . . . 0.0 113.387 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 45.9 mtm -86.02 -21.93 27.53 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.013 0.525 . . . . 0.0 110.75 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.432 ' HG3' ' HB2' ' A' ' 68' ' ' ASN . 30.4 mt-30 -66.44 -22.24 66.21 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.247 174.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -71.59 -26.21 62.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.691 0.396 . . . . 0.0 110.659 175.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.41 ' HE2' HD22 ' A' ' 87' ' ' LEU . 33.1 m-85 -82.8 -31.26 28.27 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.797 0.439 . . . . 0.0 111.179 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.9 -28.86 60.8 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.932 0.333 . . . . 0.0 110.681 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.8 m -81.83 -58.95 2.76 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.132 0.573 . . . . 0.0 110.386 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.805 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 71.9 m-85 -100.86 -62.83 1.19 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.847 0.859 . . . . 0.0 110.329 -174.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.49 -83.23 0.56 Allowed Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.643 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -59.65 -44.09 93.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.622 0.769 . . . . 0.0 110.663 175.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.805 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 29.2 mmt180 -70.32 -19.48 63.07 Favored 'General case' 0 C--O 1.205 -1.278 0 O-C-N 124.013 0.821 . . . . 0.0 111.938 -173.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 76' ' ' PHE . 40.8 t -76.52 131.07 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -54.51 -45.73 73.35 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.903 0.752 . . . . 0.0 112.554 -171.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.417 HD23 HG12 ' A' ' 80' ' ' VAL . 1.9 pt? -100.95 156.93 17.11 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.578 HG22 ' HG2' ' A' ' 86' ' ' GLU . 11.3 t -92.85 173.45 7.75 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -50.78 -41.35 56.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.422 1.089 . . . . 0.0 110.962 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.06 -46.78 87.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.23 1.012 . . . . 0.0 111.353 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.578 ' HG2' HG22 ' A' ' 83' ' ' THR . 42.3 mm-40 -62.96 -37.36 86.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.205 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.557 HD21 ' HG2' ' A' ' 69' ' ' PRO . 45.2 tp -63.99 -54.11 39.57 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.882 0.739 . . . . 0.0 111.091 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -63.27 -43.59 97.51 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.27 0.356 . . . . 0.0 111.036 -173.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 12.9 pt-20 -73.89 -23.69 59.61 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.426 0.291 . . . . 0.0 111.181 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.445 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 61.6 t80 -65.17 -44.89 87.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.527 0.731 . . . . 0.0 110.122 172.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 72.8 mtm -76.53 -30.5 57.16 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.069 0.548 . . . . 0.0 110.908 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 32.1 mmmt -74.03 -20.11 60.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.201 0.601 . . . . 0.0 110.61 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -75.37 -34.1 61.1 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.944 0.498 . . . . 0.0 109.98 174.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 62.8 mm-40 -72.65 -18.84 61.53 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -93.22 -10.37 35.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.625 0.37 . . . . 0.0 111.908 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -101.59 -25.63 13.82 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.191 0.451 . . . . 0.0 110.72 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -95.25 -22.84 17.54 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.777 0.431 . . . . 0.0 110.64 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.03 -176.22 14.24 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -99.09 108.07 20.61 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.319 0.648 . . . . 0.0 109.513 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -131.3 38.71 3.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.734 0.813 . . . . 0.0 109.313 171.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -93.34 -21.5 19.53 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.857 0.463 . . . . 0.0 110.357 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.36 -54.28 35.37 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.325 1.05 . . . . 0.0 109.737 -173.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.5 t -162.07 175.67 11.52 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.28 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -77.59 -58.24 3.38 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.349 0.66 . . . . 0.0 109.849 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp 48.9 110.37 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.03 1.332 . . . . 0.0 112.352 -168.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 168.21 20.47 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.45 0.643 . . . . 0.0 110.084 -177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -131.84 149.88 52.32 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 174.282 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 65' ' ' LEU . 1.3 tm? -76.75 92.39 3.57 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 171.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -75.48 159.25 31.53 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.381 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.7 ptm -140.0 129.68 24.44 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.308 0.643 . . . . 0.0 109.702 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . . . -97.12 101.36 12.91 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.54 ' HA ' HG12 ' A' ' 63' ' ' VAL . 35.5 mt -80.46 113.85 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.6 110.63 17.14 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -94.33 132.42 38.95 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.409 0.623 . . . . 0.0 110.701 177.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -138.37 170.73 15.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.283 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 t70 59.8 35.84 22.06 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.859 0.838 . . . . 0.0 110.117 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.47 102.59 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.181 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.3 145.6 28.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.624 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -101.32 122.44 43.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -80.58 84.6 6.13 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 165.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.32 -33.5 72.49 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.568 170.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -79.99 137.25 53.64 Favored Pre-proline 0 CA--C 1.553 1.095 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.44 173.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.08 95.7 1.04 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.782 2.322 . . . . 0.0 111.538 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.5 mt -94.63 123.76 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.14 143.57 26.36 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.476 0.71 . . . . 0.0 109.764 -175.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.27 158.69 41.0 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.862 2.375 . . . . 0.0 112.054 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -81.34 -10.44 59.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.463 0.705 . . . . 0.0 110.993 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.5 ptm85 -153.48 172.96 16.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.991 0.916 . . . . 0.0 110.246 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.13 119.31 18.16 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.611 HG12 ' HD3' ' A' ' 10' ' ' PRO . 23.1 t -102.9 99.42 13.76 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.26 -176.28 3.19 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.882 2.388 . . . . 0.0 112.61 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.0 -27.06 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.453 1.101 . . . . 0.0 112.164 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.05 -25.95 75.04 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.205 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.39 148.15 6.98 Favored Glycine 0 C--N 1.348 1.237 0 C-N-CA 123.003 0.335 . . . . 0.0 112.448 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -108.86 142.29 39.67 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.426 0.691 . . . . 0.0 109.581 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -78.62 107.49 11.33 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.79 116.8 14.82 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.09 134.07 52.63 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.867 -1.063 . . . . 0.0 108.365 -177.44 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 2' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.415 ' N ' ' SD ' ' A' ' 1' ' ' MET . 51.0 m -60.3 -8.64 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.682 1.193 . . . . 0.0 114.181 -174.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 1' ' ' MET . 17.4 ptmt -61.84 -18.11 58.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.915 0.886 . . . . 0.0 112.421 173.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 5' ' ' VAL . 35.6 mm 67.19 -175.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.456 0 C-N-CA 124.129 0.972 . . . . 0.0 108.71 -174.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' N ' HG22 ' A' ' 4' ' ' ILE . 2.0 m -148.35 -38.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.228 1.011 . . . . 0.0 108.683 158.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.77 -161.22 19.81 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.482 0.489 . . . . 0.0 113.689 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.425 HG12 HD11 ' A' ' 60' ' ' ILE . 13.5 p -132.02 147.89 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.866 0.866 . . . . 0.0 108.686 175.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -122.76 140.93 52.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.553 0.741 . . . . 0.0 109.958 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -137.63 141.36 33.01 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.13 0.972 . . . . 0.0 110.12 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . 20.7 Cg_exo -63.21 -46.73 9.39 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.347 2.698 . . . . 0.0 111.909 175.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.3 mt 51.57 72.13 1.3 Allowed Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.263 1.025 . . . . 0.0 109.603 -171.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.74 38.59 0.75 Allowed 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.261 2.64 . . . . 0.0 112.617 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -124.8 172.7 9.12 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.657 1.183 . . . . 0.0 109.908 -174.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -65.35 -15.23 62.34 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.086 0.954 . . . . 0.0 112.001 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -82.26 0.92 39.16 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.863 0.865 . . . . 0.0 112.778 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -57.43 -36.76 71.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.182 0.993 . . . . 0.0 111.696 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.07 -14.06 58.17 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -53.47 -46.99 70.17 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.411 1.085 . . . . 0.0 112.571 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 57.7 m-85 -68.54 -28.96 67.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.684 -174.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -93.85 -15.83 24.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.777 0.831 . . . . 0.0 110.452 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -70.69 -49.06 51.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.38 1.072 . . . . 0.0 109.748 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -109.63 -15.14 14.23 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.35 7.07 77.44 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.834 0.293 . . . . 0.0 113.834 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -168.6 90.4 0.26 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.457 1.103 . . . . 0.0 109.944 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 19.2 t70 -119.34 -178.04 3.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.267 1.027 . . . . 0.0 108.905 -174.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 113' ' ' GLU . 40.0 t -132.52 119.41 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.053 -1.029 . . . . 0.0 109.396 -177.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 81' ' ' PHE . 56.8 t80 -95.43 110.9 22.88 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.3 m -87.27 139.42 17.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-O 121.377 0.608 . . . . 0.0 110.507 177.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.55 ' HD3' ' HB ' ' A' ' 32' ' ' THR . 5.9 mmpt? -125.46 132.43 24.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.198 1.399 . . . . 0.0 109.71 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.39 49.16 3.08 Favored 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 123.124 2.549 . . . . 0.0 111.952 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . 58.27 81.34 0.16 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.171 1.388 . . . . 0.0 111.861 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 23.5 m -116.43 -72.99 0.66 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -97.76 126.9 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 50.2 t90 -160.25 -35.93 0.05 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.435 0.294 . . . . 0.0 111.246 -175.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -56.34 -45.96 80.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.539 0.736 . . . . 0.0 112.574 -174.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -93.1 -17.53 23.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.467 0.307 . . . . 0.0 110.528 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 34' ' ' TRP . 3.0 mm? -61.86 108.2 0.98 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.731 0.812 . . . . 0.0 111.19 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 41' ' ' MET . 0.0 OUTLIER -131.53 150.58 76.75 Favored Pre-proline 0 C--O 1.244 0.765 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.964 172.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.25 103.98 1.48 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.432 2.088 . . . . 0.0 110.486 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.75 -8.89 1.35 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.366 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.406 ' HG3' ' HG3' ' A' ' 38' ' ' LYS . 24.1 mtm -80.08 -177.9 6.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.228 0.611 . . . . 0.0 111.649 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -107.22 161.66 14.58 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.835 0.854 . . . . 0.0 110.765 171.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.478 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -136.17 101.92 4.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 174.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 59.5 t -87.6 122.74 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 109.824 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -92.4 120.85 33.31 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.523 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 85.2 t80 -87.26 174.05 8.82 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.758 1.223 . . . . 0.0 109.141 174.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 68.09 95.55 0.06 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.651 1.58 . . . . 0.0 109.114 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.825 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 53.9 p -76.35 67.54 2.59 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.141 0.976 . . . . 0.0 111.633 -173.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 82.7 t60 46.9 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.547 1.539 . . . . 0.0 112.017 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 77.62 -47.53 0.48 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 125.355 1.462 . . . . 0.0 111.139 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.22 167.96 20.58 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.449 1.1 . . . . 0.0 110.933 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.1 p -96.01 143.51 27.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.287 0.635 . . . . 0.0 110.486 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 132.71 163.53 10.63 Favored Glycine 0 C--O 1.215 -1.07 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' TYR . 44.0 m-85 -71.47 113.3 8.36 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 118.203 1.001 . . . . 0.0 110.8 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.825 ' HB ' ' HA ' ' A' ' 48' ' ' SER . 2.7 p -73.9 -37.05 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.886 0.874 . . . . 0.0 110.939 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.66 -163.23 29.11 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.539 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 6.5 pt-20 -143.3 178.88 7.43 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.882 0.873 . . . . 0.0 109.129 173.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.511 ' HB3' HD12 ' A' ' 114' ' ' LEU . . . -156.88 -172.38 4.02 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.276 1.03 . . . . 0.0 108.879 175.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -125.78 118.09 24.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.965 0.506 . . . . 0.0 110.092 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 43' ' ' PHE . 43.2 mt -63.93 125.34 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.925 175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.448 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 30.7 mmmt -133.9 -168.28 2.09 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 125.374 1.47 . . . . 0.0 107.721 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -19.65 110.16 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 126.092 1.757 . . . . 0.0 115.058 -171.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 112' ' ' ILE . 29.2 m -103.74 109.97 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.7 t -91.93 118.14 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.404 0.682 . . . . 0.0 109.745 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HB3' HD11 ' A' ' 108' ' ' LEU . 61.7 mt -94.71 123.26 38.05 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.664 0.786 . . . . 0.0 109.494 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 71' ' ' GLN . 33.4 t -153.16 136.97 16.14 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.503 0.721 . . . . 0.0 110.126 172.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.686 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 45.6 mt-10 -66.32 -17.81 64.98 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 176.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 14.1 m-20 -97.85 120.73 59.6 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.0 -26.11 58.7 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.436 2.091 . . . . 0.0 112.071 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.417 ' HA ' ' HD2' ' A' ' 73' ' ' PHE . 37.3 mtm -73.19 -22.21 60.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.597 0.759 . . . . 0.0 110.918 -171.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 21.4 mm-40 -57.3 -33.39 67.63 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.155 0.982 . . . . 0.0 111.587 175.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.52 -31.46 37.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.745 0.418 . . . . 0.0 110.819 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CE2' HD22 ' A' ' 87' ' ' LEU . 85.1 m-85 -79.06 -17.75 54.67 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.125 0.57 . . . . 0.0 111.572 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -94.61 -36.85 11.61 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.436 0.294 . . . . 0.0 111.208 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.6 m -74.8 -57.0 4.19 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.947 0.499 . . . . 0.0 110.809 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.843 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 92.2 m-85 -92.49 -61.73 1.54 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.339 0.656 . . . . 0.0 109.494 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.68 -85.26 0.45 Allowed Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.866 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.04 -37.2 84.04 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.913 0.885 . . . . 0.0 110.639 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.843 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 14.4 mmt85 -65.52 -35.02 79.63 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.223 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.494 HG12 HD23 ' A' ' 82' ' ' LEU . 21.9 t -67.76 143.95 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 118.211 0.46 . . . . 0.0 110.375 -176.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.42 ' HD2' ' HA ' ' A' ' 27' ' ' PHE . 45.2 p90 -62.9 -14.51 47.45 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -173.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.494 HD23 HG12 ' A' ' 80' ' ' VAL . 2.3 pt? -139.68 170.29 16.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.782 0.833 . . . . 0.0 109.272 176.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 86' ' ' GLU . 9.9 t -100.09 170.58 8.38 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 172.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -62.48 -27.74 69.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.24 0.616 . . . . 0.0 111.196 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.54 -49.41 71.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.405 0.682 . . . . 0.0 109.956 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.498 ' HG2' HG22 ' A' ' 83' ' ' THR . 17.3 mm-40 -56.75 -40.77 76.38 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.306 176.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.476 HD22 ' CE2' ' A' ' 73' ' ' PHE . 31.0 tp -58.4 -56.19 25.33 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.911 0.884 . . . . 0.0 112.031 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -61.72 -39.97 93.41 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -171.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.64 -18.88 36.62 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.126 0.571 . . . . 0.0 111.747 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.459 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 81.9 t80 -69.77 -39.74 76.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.37 0.668 . . . . 0.0 109.655 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 71.0 mtm -73.49 -30.8 63.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.302 0.641 . . . . 0.0 110.418 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 88' ' ' LYS . 10.5 mmpt? -67.11 -38.07 84.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.626 0.371 . . . . 0.0 110.006 170.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.1 t -65.73 -32.06 73.39 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.831 0.707 . . . . 0.0 110.539 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 87.1 mm-40 -68.11 -56.26 9.47 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.603 ' HB3' ' HD3' ' A' ' 100' ' ' ARG . 10.6 pt-20 -64.5 -26.1 68.28 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -173.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -91.57 -31.03 16.07 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -110.22 -68.71 0.91 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.016 0.371 . . . . 0.0 111.223 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.2 1.27 50.02 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 114.026 0.37 . . . . 0.0 114.026 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 68.19 151.95 0.08 Allowed 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.009 1.723 . . . . 0.0 112.405 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.603 ' HD3' ' HB3' ' A' ' 95' ' ' GLU . 36.9 mtp180 -143.88 126.01 15.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -69.84 -49.64 50.53 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -170.38 172.15 6.26 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.649 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -81.03 -42.67 20.74 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 160.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 tptp 68.15 -71.32 0.11 Allowed 'General case' 0 C--N 1.364 1.219 0 C-N-CA 125.588 1.555 . . . . 0.0 109.481 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -146.01 143.28 29.35 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.15 1.38 . . . . 0.0 107.596 167.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.686 ' HG2' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -57.95 146.63 31.68 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.144 0.497 . . . . 0.0 110.657 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 18.2 tptm -101.56 156.67 17.34 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -174.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 65' ' ' LEU . 2.6 tm? -72.44 104.97 3.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -85.96 161.62 18.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.334 0.654 . . . . 0.0 109.251 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.537 ' HG3' ' HB2' ' A' ' 29' ' ' LYS . 14.9 ptm -141.67 154.36 45.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.865 0.866 . . . . 0.0 109.868 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.72 104.44 7.18 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.716 0.806 . . . . 0.0 109.825 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.506 ' HA ' HG12 ' A' ' 63' ' ' VAL . 43.0 mt -84.3 119.12 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 123.402 0.681 . . . . 0.0 109.454 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.555 ' HA ' HG22 ' A' ' 26' ' ' VAL . 37.6 tt0 -81.93 98.86 8.76 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 58' ' ' ALA . 3.9 mm? -80.98 131.89 35.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.948 0.499 . . . . 0.0 110.25 174.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 61' ' ' LYS . 1.3 pp20? -139.72 166.29 25.0 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.687 0.795 . . . . 0.0 109.128 175.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.3 t70 56.84 41.7 27.61 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.833 0.853 . . . . 0.0 111.178 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.32 108.92 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 121.351 0.596 . . . . 0.0 111.134 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.66 157.34 21.16 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.521 1.128 . . . . 0.0 110.216 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -122.91 117.73 26.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.896 0.878 . . . . 0.0 110.072 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -78.18 98.25 5.78 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -65.04 -31.44 72.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.838 0.855 . . . . 0.0 110.578 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -87.36 138.35 32.18 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.248 0.619 . . . . 0.0 110.157 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.33 89.14 1.21 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.658 2.239 . . . . 0.0 111.68 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.1 mt -78.73 131.26 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.398 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.424 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -100.69 144.17 27.98 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 122.986 0.514 . . . . 0.0 109.701 -178.204 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.34 161.09 28.95 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.315 2.01 . . . . 0.0 112.658 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 127' ' ' LYS . 11.1 mmpt? -68.91 -51.58 38.5 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.366 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -119.02 178.06 4.63 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.613 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.59 140.49 51.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.688 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.94 102.19 30.02 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.04 176.39 7.05 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.604 2.203 . . . . 0.0 112.212 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.2 t -58.89 -32.94 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.276 1.03 . . . . 0.0 111.132 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.68 -15.0 73.1 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.846 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.37 159.54 16.71 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.339 0.495 . . . . 0.0 113.237 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -113.54 145.77 40.7 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.585 0.754 . . . . 0.0 110.46 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -81.63 113.7 19.82 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.4 121.79 26.68 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.432 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -117.99 140.92 49.04 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 117.81 -1.09 . . . . 0.0 110.007 177.996 . . . . . . . . 0 0 . 1 stop_ save_